data_2ksf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ksf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.239 0.542 0 CA-C-O 120.896 0.379 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 445' ' ' ARG . 13.2 tt -73.56 101.1 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.95 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.433 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 4.7 mm-40 66.66 80.11 0.22 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.325 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -133.04 -134.52 3.51 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.071 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 13.4 m -47.09 -38.91 12.16 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 35.5 t -59.79 -47.35 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.452 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 12.7 t -60.51 -48.32 88.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.406 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.68 69.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.738 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.68 -50.45 73.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.064 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -57.85 -55.95 28.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.14 -40.57 85.91 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.652 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 37.8 t -57.12 -57.59 11.9 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.301 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -53.18 -42.32 66.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.705 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.441 HG22 ' CG2' ' A' ' 438' ' ' VAL . 25.0 t -61.61 -59.06 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.27 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.0 tp -55.5 -43.48 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 121.358 -0.137 . . . . 0.0 110.948 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 52.9 m -59.58 -51.52 69.49 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 8.5 tp -57.94 -46.44 85.04 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.368 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.449 HG12 HD13 ' A' ' 431' ' ' LEU . 75.0 mt -57.71 -52.44 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.601 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.29 -48.42 80.53 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.058 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 22.3 mtt -59.66 -52.81 63.92 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.024 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -60.57 -47.31 86.74 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.353 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . 0.513 ' HA ' ' O ' ' A' ' 424' ' ' ASP . 0.0 OUTLIER -59.56 -44.07 93.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.945 0.402 . . . . 0.0 110.185 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 4.9 tt -64.12 -42.57 96.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 6.1 tpt -67.84 126.9 30.9 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.871 0.367 . . . . 0.0 111.727 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 70.82 -98.98 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.918 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.23 41.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.661 0.267 . . . . 0.0 111.519 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 419' ' ' TRP . 4.5 p30 . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.805 0.336 . . . . 0.0 111.198 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 71.4 t -143.61 -69.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.915 -0.13 . . . . 0.0 111.311 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -52.49 34.19 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.671 0.272 . . . . 0.0 111.111 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.449 HD13 HG12 ' A' ' 415' ' ' ILE . 17.5 tp -62.97 -40.52 97.97 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.04 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 462' ' ' PHE . 54.0 t80 -67.18 -48.57 67.53 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.928 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.28 -59.38 5.03 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.7 0.286 . . . . 0.0 110.568 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -45.19 92.93 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.293 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -53.85 -55.06 27.51 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.859 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 39.3 t -55.17 -47.74 77.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 59.6 t -54.03 -50.2 55.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.441 ' CG2' HG22 ' A' ' 411' ' ' VAL . 41.2 t -61.27 -43.04 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.158 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.9 -45.83 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -58.32 -47.09 84.83 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.1 tp -56.14 -44.71 79.49 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.171 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -64.38 -45.2 88.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.552 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -52.87 -43.39 66.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.355 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -74.72 48.39 1.94 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.874 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.437 ' O ' HG13 ' A' ' 399' ' ' ILE . 0.6 OUTLIER -136.68 29.45 2.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.41 0.284 . . . . 0.0 110.8 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . 0.401 ' CB ' ' O ' ' A' ' 445' ' ' ARG . 0.0 OUTLIER 83.74 125.88 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.561 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.21 97.16 1.12 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.669 2.246 . . . . 0.0 112.728 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.0 m -121.3 38.95 3.95 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.861 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 97.7 t 67.76 -55.13 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.0 m -41.83 -46.76 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -59.63 -47.5 85.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.851 0.358 . . . . 0.0 110.205 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 20.8 m -56.46 -49.16 75.41 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.929 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.3 -52.97 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.343 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 19.8 mt -53.3 -50.81 45.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.752 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -59.82 -51.91 67.72 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.666 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.9 t -54.05 -52.21 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 54.6 t -52.01 -54.55 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.509 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -44.2 92.03 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.827 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -57.41 -57.51 12.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.834 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -41.95 91.52 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.847 0.356 . . . . 0.0 110.695 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.55 ' HG ' ' CB ' ' A' ' 482' ' ' ALA . 1.3 mm? -68.59 -21.01 64.54 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.461 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 432' ' ' TYR . 60.5 t80 -61.68 76.25 0.02 OUTLIER 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.568 0.699 . . . . 0.0 111.135 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 461' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.331 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 477' ' ' TYR . 10.4 t0 . . . . . 0 C--O 1.235 0.334 0 CA-C-O 121.103 0.478 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 95.9 t -56.49 -48.3 80.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.205 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -47.61 76.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.874 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . 0.433 ' HB2' ' HB3' ' A' ' 474' ' ' ASP . 1.3 m-85 -66.38 -52.83 42.78 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.026 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.15 -51.55 57.29 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.617 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 17.1 tp -61.18 -46.98 88.25 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.046 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 82.8 m -52.32 -49.4 64.32 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.626 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.33 -52.87 63.8 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.39 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . 0.55 ' CB ' ' HG ' ' A' ' 461' ' ' LEU . . . -54.74 -42.27 71.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.842 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.48 -49.08 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.003 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 9.2 ttm -56.99 -52.36 65.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.585 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 28.7 tp -56.02 -50.35 71.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.933 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 35.8 m -56.02 -47.13 78.39 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.285 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 42.1 t -57.57 -48.39 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.909 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -54.08 -43.92 73.28 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.509 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 4.7 mt -64.19 -49.52 71.7 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.78 0.324 . . . . 0.0 110.25 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.66 -55.27 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.352 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 20.9 tt -57.21 -42.29 79.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.857 -0.156 . . . . 0.0 110.795 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -60.67 -50.3 69.07 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.504 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -61.03 -54.7 41.57 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.574 0.226 . . . . 0.0 110.526 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.11 -43.53 66.94 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.662 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 58.3 m -61.85 -50.61 71.55 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.206 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.11 82.86 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.174 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -57.63 -51.33 58.58 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.455 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 92.5 t -71.19 -47.73 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 120.988 0.423 . . . . 0.0 110.72 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 499' ' ' ARG . 1.1 tmm_? -105.35 87.33 2.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.114 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 29.3 t80 . . . . . 0 CA--C 1.532 0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.614 -179.361 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.583 0 CA-C-O 120.9 0.381 . . . . 0.0 111.636 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 2.7 pt -73.71 149.02 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.714 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 61.48 -167.46 0.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.883 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 84.29 -110.66 3.37 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.542 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 33.7 m -52.99 -48.14 67.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.578 0.227 . . . . 0.0 111.472 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.557 ' CG1' ' HA ' ' A' ' 442' ' ' PHE . 10.5 t -55.13 -52.97 39.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.931 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 494' ' ' LEU . 22.8 t -60.41 -46.44 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.24 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.26 76.97 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.566 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.56 -55.06 35.01 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.652 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -56.37 -48.49 76.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.434 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.453 HD12 HG13 ' A' ' 487' ' ' VAL . 2.1 tp -57.95 -49.48 76.64 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.388 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 41.0 t -53.64 -48.13 69.66 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.63 82.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.262 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 41.7 t -63.23 -42.54 96.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.151 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 23.8 mt -61.84 -53.31 49.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.585 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 42.7 p -58.54 -44.92 89.78 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 18.2 tp -57.46 -49.42 76.33 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.137 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 14.9 mm -59.75 -54.14 38.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.924 0.393 . . . . 0.0 110.19 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -52.1 -49.84 62.81 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.894 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 10.5 mtt -63.7 -43.15 97.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.838 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -45.67 84.86 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.183 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -35.21 36.39 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -51.83 -57.39 9.47 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 4.6 mtp -145.71 59.86 1.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.957 0.408 . . . . 0.0 111.603 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -171.83 -177.06 1.87 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.394 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -91.89 150.69 20.91 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.74 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.409 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.473 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 N--CA 1.467 0.415 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.3 t -54.67 -61.95 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 8.2 mmt -55.77 -47.89 76.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.855 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.58 -50.05 74.4 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.903 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.06 -49.95 70.31 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.039 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.18 -55.84 28.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.859 0.361 . . . . 0.0 110.57 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.421 ' O ' HG21 ' A' ' 438' ' ' VAL . 5.2 mp -57.58 -47.32 82.41 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.981 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -52.98 -57.87 13.38 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.687 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 27.5 m -54.99 -39.96 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 117.044 0.422 . . . . 0.0 110.93 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 53.1 t -60.63 -57.75 10.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.074 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 434' ' ' LEU . 15.8 m -60.93 -39.29 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.661 0.267 . . . . 0.0 110.666 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 55.8 t -59.1 -50.65 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.047 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.28 -47.78 77.94 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.974 0.416 . . . . 0.0 110.141 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.41 -47.87 80.6 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.58 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . 0.557 ' HA ' ' CG1' ' A' ' 403' ' ' VAL . 39.8 t80 -62.09 -46.13 90.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.763 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -60.44 -44.49 95.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.451 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -67.59 53.93 0.33 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.549 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.23 45.61 0.74 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 79.96 126.39 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.614 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.78 124.23 7.99 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.58 2.187 . . . . 0.0 112.407 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.7 t -143.18 152.0 41.28 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.28 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 11.9 p -50.79 -45.85 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.629 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.8 t -57.48 -53.0 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.606 0.241 . . . . 0.0 110.668 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -56.08 -50.79 70.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.292 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 28.7 m -55.81 -45.59 78.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 96.3 t -58.75 -51.66 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.491 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 8.3 mt -57.86 -52.06 62.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 120.863 0.363 . . . . 0.0 110.589 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.62 -51.66 66.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.597 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 55.9 t -57.67 -55.69 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.742 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.0 t -45.75 -52.11 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.685 0.278 . . . . 0.0 110.615 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -43.85 98.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.817 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.47 -58.27 9.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.987 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.41 -41.94 69.89 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.976 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.79 -27.92 63.27 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.994 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -63.56 102.65 0.45 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.892 0.377 . . . . 0.0 111.584 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 25.5 t80 . . . . . 0 N--CA 1.464 0.259 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.257 179.795 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.236 0.392 0 CA-C-O 120.947 0.403 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 10.7 p -55.55 -38.81 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.095 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -45.59 74.3 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.951 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.88 -49.99 46.84 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.675 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -52.63 61.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.53 -50.73 72.38 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.545 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 95.2 m -53.89 -46.44 71.38 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.443 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.86 -47.68 84.76 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.286 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -57.9 -44.42 86.77 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.126 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.74 -45.6 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.039 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 65.9 mtp -58.19 -52.76 64.2 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.14 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.73 -43.22 76.38 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 46.5 m -58.94 -48.3 81.98 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.623 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.453 HG13 HD12 ' A' ' 408' ' ' LEU . 24.2 t -56.32 -50.5 71.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.684 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -54.69 -46.63 74.39 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.06 -49.56 76.49 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 79.6 t -55.93 -47.89 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.375 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . 0.442 ' O ' ' HG ' ' A' ' 494' ' ' LEU . 52.6 mt -54.89 -42.35 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.531 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -69.28 -45.9 59.31 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.55 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -56.21 -52.08 65.71 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.586 0.232 . . . . 0.0 110.916 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 491' ' ' ILE . 4.0 pp -62.6 -44.83 95.33 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.422 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 90.7 m -57.23 -43.87 83.28 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 500' ' ' TYR . . . -66.53 -54.32 25.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.584 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -53.7 -52.98 38.59 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.704 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 4.8 t -47.89 -33.58 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 120.609 0.243 . . . . 0.0 111.355 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.05 22.6 15.71 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.419 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 496' ' ' ALA . 1.6 t80 . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 120.791 0.329 . . . . 0.0 111.011 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . 0.404 ' O ' ' HB ' ' A' ' 399' ' ' ILE . 32.8 tt0 . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.356 0.122 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 446' ' ' TRP . 19.5 mm 70.83 131.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 123.39 0.431 . . . . 0.0 111.165 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 54.86 51.67 13.28 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.593 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.628 ' HA2' ' OG1' ' A' ' 495' ' ' THR . . . -147.09 -123.79 1.47 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.293 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 55.0 m -56.95 -49.69 74.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.65 0.262 . . . . 0.0 111.537 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 443' ' ' TYR . 30.1 m -55.76 -48.3 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.614 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.424 ' HB ' HG21 ' A' ' 491' ' ' ILE . 40.8 t -69.13 -40.91 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.75 97.54 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -62.27 -51.44 67.68 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.794 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -55.01 -49.24 72.03 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.677 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.04 -42.88 86.31 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.761 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -50.48 62.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.056 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.16 -48.5 78.56 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.929 0.395 . . . . 0.0 109.996 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.3 t -55.55 -57.92 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.017 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.42 HD11 ' CD1' ' A' ' 485' ' ' LEU . 19.2 tt -56.75 -41.14 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.489 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 1.3 m -56.97 -50.07 73.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.75 -47.31 86.88 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.934 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 93.7 mt -52.37 -49.98 40.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.994 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.63 77.87 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.08 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 2.0 mtt -56.5 -44.92 81.18 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.258 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.658 ' HA ' ' CB ' ' A' ' 422' ' ' ALA . 2.9 tm0? -60.18 -50.16 74.76 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.116 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -57.67 -35.82 71.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.205 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -50.93 42.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.826 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 1.1 ttp 179.46 65.43 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . 0.658 ' CB ' ' HA ' ' A' ' 418' ' ' GLN . . . -151.25 -174.9 4.96 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 122.379 -0.201 . . . . 0.0 111.463 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . 0.435 ' O ' HG13 ' A' ' 429' ' ' VAL . 0.2 OUTLIER -119.05 178.03 4.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.933 0.397 . . . . 0.0 111.988 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.418 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.677 0.275 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 423' ' ' PHE . 7.3 p -55.41 -33.56 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.805 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' MET . . . . . 0.429 ' N ' HG11 ' A' ' 429' ' ' VAL . 0.0 OUTLIER -57.0 -52.25 66.02 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.254 178.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.15 -44.3 95.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.072 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -56.97 -56.72 18.1 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.733 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.28 -44.29 79.66 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.068 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 6.2 tp -54.56 -51.16 66.12 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.94 -45.95 93.08 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.08 -44.28 82.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 98.4 t -55.87 -47.04 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.874 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.71 -47.07 86.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.419 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.62 -51.78 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.594 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -57.65 -50.08 74.36 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.543 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -47.91 79.3 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.406 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.09 -40.89 95.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.377 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . 0.515 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 6.7 m-30 -65.88 -44.99 83.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.006 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.82 58.62 1.74 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.488 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 445' ' ' ARG . 21.2 tpt180 -89.86 60.13 4.86 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.184 0.516 . . . . 0.0 110.922 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . 0.451 ' NE1' ' OG ' ' A' ' 448' ' ' SER . 15.4 t-105 -178.56 125.7 0.26 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.466 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -95.01 128.23 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.289 2.659 . . . . 0.0 112.939 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.451 ' OG ' ' NE1' ' A' ' 446' ' ' TRP . 14.6 m -164.69 65.82 0.14 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.791 0.329 . . . . 0.0 111.725 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 60.5 t 64.92 -69.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.969 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.9 t -53.26 -46.2 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.564 0.221 . . . . 0.0 110.812 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.57 90.97 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 1.4 m -61.14 -52.29 65.5 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.28 -47.73 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.771 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.36 -50.04 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.757 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.31 -48.76 70.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.949 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 63.1 t -56.02 -56.14 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.215 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.72 -46.1 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.819 0.342 . . . . 0.0 110.097 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 18.0 t -54.63 -47.42 73.5 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.92 -50.66 72.88 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.414 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.37 -41.82 76.81 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.794 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.7 tt -70.97 -38.18 72.78 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.811 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.48 150.1 2.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.513 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.663 -179.242 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . 0.44 ' HB3' ' CB ' ' A' ' 477' ' ' TYR . 7.9 t70 . . . . . 0 C--O 1.235 0.338 0 CA-C-O 120.925 0.393 . . . . 0.0 111.762 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.85 -40.86 74.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.996 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -66.01 -42.49 89.63 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . 0.44 ' CB ' ' HB3' ' A' ' 474' ' ' ASP . 0.8 OUTLIER -59.7 -54.96 40.3 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.381 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.7 tt -55.67 -48.75 74.52 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.207 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.19 -45.23 79.88 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.955 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 24.8 m -57.56 -44.66 85.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.819 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -61.48 -48.95 78.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.76 80.38 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.482 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.68 -48.39 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.85 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 21.6 mtt -54.47 -55.07 32.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.546 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.42 ' CD1' HD11 ' A' ' 412' ' ' ILE . 2.0 tp -52.8 -48.37 66.96 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.999 0.428 . . . . 0.0 109.969 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 24.2 m -56.41 -48.93 75.94 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.935 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.422 HG12 ' CD1' ' A' ' 491' ' ' ILE . 91.7 t -56.98 -42.4 78.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.092 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.395 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . 0.513 ' HA2' HD13 ' A' ' 491' ' ' ILE . . . -56.65 -45.84 89.86 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.47 -49.85 71.42 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.47 -44.25 88.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.867 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . 0.513 HD13 ' HA2' ' A' ' 488' ' ' GLY . 15.7 mt -55.89 -42.29 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.967 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.17 -49.31 76.02 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.479 -0.867 . . . . 0.0 110.995 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -54.06 -48.93 70.06 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.747 0.308 . . . . 0.0 110.348 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 11.1 tp -67.79 -35.93 79.54 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.665 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.628 ' OG1' ' HA2' ' A' ' 401' ' ' GLY . 98.0 m -51.51 -49.86 61.09 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -64.71 -47.05 79.74 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.509 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -54.46 -43.29 77.1 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.876 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 68.0 t -76.12 -43.13 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.752 0.311 . . . . 0.0 110.524 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -62.11 -47.14 85.92 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.294 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 120.992 0.425 . . . . 0.0 110.984 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 120.58 0.229 . . . . 0.0 111.338 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 19.5 tt -144.34 114.62 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.704 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.4 ' HB2' HD12 ' A' ' 494' ' ' LEU . 0.0 OUTLIER 66.46 -175.04 0.19 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.475 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.522 ' HA2' ' OG1' ' A' ' 495' ' ' THR . . . 115.71 -131.43 9.65 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.975 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -37.22 72.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.43 0.157 . . . . 0.0 111.373 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 443' ' ' TYR . 15.2 m -55.8 -57.8 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.525 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.401 ' CG2' HG12 ' A' ' 491' ' ' ILE . 24.6 m -63.55 -38.02 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.85 76.7 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.119 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 409' ' ' SER . . . -61.68 -46.09 91.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.631 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -56.46 -56.59 19.27 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.362 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.18 -39.95 84.14 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.127 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 406' ' ' ALA . 33.6 t -51.08 -51.6 51.71 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.326 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.46 -47.43 81.85 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.308 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.439 HG22 HG21 ' A' ' 436' ' ' VAL . 69.7 t -53.57 -58.19 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.66 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 4.2 tp -58.5 -39.91 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.602 0.239 . . . . 0.0 110.74 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 85.9 m -61.33 -44.36 97.33 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 109.809 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -50.06 72.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.857 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 8.7 mm -56.49 -46.11 82.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.044 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -54.38 -49.42 69.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.779 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 1.7 ttm -57.82 -42.77 84.98 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.074 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.639 ' HA ' ' CB ' ' A' ' 422' ' ' ALA . 0.8 OUTLIER -55.43 -50.86 68.7 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.083 178.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -58.25 -41.99 85.42 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.63 -54.44 42.75 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.725 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -179.19 78.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . 0.639 ' CB ' ' HA ' ' A' ' 418' ' ' GLN . . . -155.21 168.99 25.22 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 111.933 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -67.65 178.58 1.62 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.644 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.534 0.364 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.768 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 120.505 0.193 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.407 HG21 ' HG2' ' A' ' 418' ' ' GLN . 40.3 t -51.42 -51.28 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.483 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 3.2 ttm -55.68 -43.78 76.72 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 110.195 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.51 -48.75 78.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.799 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -57.45 -48.01 80.3 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.678 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 3.2 tp -57.52 -47.1 82.89 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.009 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -48.78 71.98 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.834 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -56.53 -57.72 18.01 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.508 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 411' ' ' VAL . 10.1 m -56.08 -44.34 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.723 0.262 . . . . 0.0 110.653 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 56.3 t -57.77 -46.54 86.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 37.9 t -58.14 -45.58 88.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 51.8 t -55.88 -47.41 79.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.65 -47.26 86.32 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.167 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -41.41 81.84 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.316 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -66.79 -44.88 80.13 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.627 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . 0.436 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 9.9 m-85 -70.77 -47.68 58.36 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.344 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -61.89 134.68 46.55 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.807 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -138.58 -56.12 0.63 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.568 0.223 . . . . 0.0 111.386 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.84 121.08 75.91 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 120.772 0.32 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -88.87 161.28 6.1 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.159 2.573 . . . . 0.0 114.237 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.2 p 176.9 -174.14 0.11 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.453 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.7 t -45.91 -48.17 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.573 0.225 . . . . 0.0 111.434 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 47.3 t -58.35 -50.39 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.633 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -57.22 -45.63 83.66 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.255 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 93.0 m -54.99 -52.15 64.02 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.59 -46.52 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.227 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 53.8 mt -55.59 -50.25 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.598 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -53.4 56.66 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.817 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 64.5 t -53.52 -55.73 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 111.159 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 57.9 t -54.65 -47.6 72.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 4.4 t -59.56 -44.31 93.32 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.288 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -53.1 -49.59 66.16 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.467 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.75 -46.97 73.72 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.358 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.22 -36.89 53.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.016 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.89 59.14 0.16 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.18 0.514 . . . . 0.0 111.022 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 10.1 t80 . . . . . 0 CA--C 1.533 0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.775 -179.683 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 8.6 t70 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.433 0.158 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 59.7 t -42.24 -42.78 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.016 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -54.48 -55.23 31.14 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.819 0.342 . . . . 0.0 111.107 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -69.82 -49.98 47.37 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.147 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.49 -54.93 25.99 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.968 0.413 . . . . 0.0 110.803 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.38 -48.8 80.25 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.617 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 73.8 m -57.59 -39.19 76.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.928 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -49.46 74.75 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.04 -44.08 91.74 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.036 0.446 . . . . 0.0 110.353 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 85.8 t -62.06 -52.27 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.269 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -49.5 74.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.488 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 4.5 tt -56.21 -47.15 78.96 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 35.0 m -58.44 -50.98 71.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.224 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.5 -47.42 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.413 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -57.3 -48.67 78.55 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 5.7 tt -55.42 -50.23 70.34 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 55.2 t -56.53 -48.39 80.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.859 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . 0.401 HG12 ' CG2' ' A' ' 404' ' ' VAL . 90.4 mt -58.55 -41.24 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.454 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.56 -58.31 12.82 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.666 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -55.58 -47.4 76.5 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.065 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 400' ' ' GLN . 2.7 tm? -58.74 -44.99 90.64 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.455 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.522 ' OG1' ' HA2' ' A' ' 401' ' ' GLY . 72.0 m -59.7 -42.93 94.11 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.94 -57.93 9.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.959 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.78 -48.17 85.69 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.615 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.9 p -60.92 -29.64 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 3.7 ttm105 -91.66 -43.04 9.84 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.672 0.272 . . . . 0.0 110.91 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.031 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 37.2 mm -56.99 -38.97 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.022 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.97 140.05 47.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.823 0.344 . . . . 0.0 111.356 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.474 ' O ' HG21 ' A' ' 404' ' ' VAL . . . 165.08 -110.27 0.41 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.252 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.6 t -53.92 -44.76 70.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 110.168 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.71 -54.28 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.788 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 401' ' ' GLY . 21.3 m -61.06 -42.48 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.536 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.81 53.7 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.8 87.73 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.934 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -55.86 -51.83 66.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.836 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.4 HD11 ' CD1' ' A' ' 412' ' ' ILE . 2.4 tm? -55.19 -43.93 74.84 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.2 t -57.81 -44.56 86.44 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.129 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.35 96.57 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.239 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 79.2 t -60.06 -51.39 73.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.107 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.493 HD13 HG22 ' A' ' 412' ' ' ILE . 51.6 mt -56.16 -46.28 81.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' THR . . . . . 0.445 HG23 ' SD ' ' A' ' 417' ' ' MET . 36.5 m -57.69 -48.01 80.74 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.142 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.465 ' CD1' ' HB3' ' A' ' 432' ' ' TYR . 9.3 tp -59.11 -57.42 13.15 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.358 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 5.2 tt -58.23 -43.97 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.583 0.23 . . . . 0.0 111.053 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.37 -54.69 43.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.465 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' MET . . . . . 0.445 ' SD ' HG23 ' A' ' 413' ' ' THR . 7.1 mtp -55.86 -49.99 71.83 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.86 -53.51 39.68 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.735 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -57.79 -43.04 85.35 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.526 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.0 -50.44 62.22 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.518 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.17 126.04 14.41 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.617 0.246 . . . . 0.0 111.518 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 68.92 88.14 0.11 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.684 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 424' ' ' ASP . 4.2 t80 -76.21 149.31 37.25 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.354 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 423' ' ' PHE . 54.8 m-20 . . . . . 0 N--CA 1.468 0.43 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.923 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 120.641 0.258 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 85.4 t -51.19 -37.71 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.61 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.5 -44.95 12.92 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.572 0.225 . . . . 0.0 110.978 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.91 -51.17 69.24 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 109.961 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . 0.465 ' HB3' ' CD1' ' A' ' 414' ' ' LEU . 56.2 m-85 -57.83 -46.63 84.46 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.137 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -57.51 -51.99 67.2 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.69 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 1.8 mp -56.0 -46.71 78.66 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.015 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -51.45 -50.98 39.42 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 87.5 t -56.94 -45.81 83.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.867 0.365 . . . . 0.0 110.047 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 85.4 t -57.89 -43.82 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.345 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 88.4 t -57.33 -53.22 46.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.517 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.02 -48.69 87.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.744 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.436 ' HA ' ' CE2' ' A' ' 443' ' ' TYR . . . -55.5 -49.67 71.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.138 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.63 -48.98 70.36 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.91 -44.02 73.79 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . 0.436 ' CE2' ' HA ' ' A' ' 440' ' ' ALA . 0.1 OUTLIER -86.02 -34.26 20.82 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -67.44 71.55 0.23 Allowed Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.136 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 446' ' ' TRP . 4.9 mtm180 -122.53 151.78 41.02 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.444 0.164 . . . . 0.0 110.928 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . 0.435 ' CB ' ' O ' ' A' ' 445' ' ' ARG . 1.6 t-105 83.07 131.66 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.031 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.401 ' HD2' ' CD1' ' A' ' 446' ' ' TRP . 19.5 Cg_endo -57.13 111.01 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.652 2.234 . . . . 0.0 112.13 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.3 t -145.03 136.19 24.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.493 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 39.1 t -45.66 -59.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.698 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 14.1 m -54.38 -46.34 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.408 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -64.18 -47.72 78.71 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.826 0.346 . . . . 0.0 110.65 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 28.5 m -57.45 -56.73 18.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.253 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 34.4 m -59.73 -44.44 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.124 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 36.7 mt -59.27 -50.08 81.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.13 -49.47 66.49 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.321 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 52.0 t -54.88 -53.64 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.956 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.4 t -51.57 -52.56 20.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 462' ' ' PHE . 2.0 p -57.71 -38.76 75.81 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.012 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -60.89 -48.87 79.84 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -60.43 -46.65 89.26 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.8 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.95 -19.62 62.55 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.821 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 458' ' ' SER . 0.1 OUTLIER -66.72 -167.77 0.05 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 111.217 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 6.9 t80 . . . . . 0 N--CA 1.465 0.289 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.207 -179.65 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.369 0.128 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 7.3 p -39.29 -48.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.65 -40.49 87.86 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.507 0.194 . . . . 0.0 111.245 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -72.66 -49.13 33.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.622 0.249 . . . . 0.0 110.413 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.13 -51.44 67.92 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.234 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.24 -50.02 75.05 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.691 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 97.8 m -54.19 -42.04 69.26 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.999 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -58.5 -48.92 79.21 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.459 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.85 96.72 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.731 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.69 -49.18 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.235 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -49.04 79.37 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.103 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 6.1 tt -56.61 -46.49 80.87 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 45.8 m -56.67 -48.47 77.54 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.435 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.0 -47.72 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.002 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.64 -46.58 88.66 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 16.8 tp -58.11 -48.7 79.38 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.413 HG12 HD23 ' A' ' 494' ' ' LEU . 89.6 t -60.31 -48.55 87.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.64 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . 0.435 ' O ' ' HG ' ' A' ' 494' ' ' LEU . 83.7 mt -57.06 -46.17 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.152 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.44 -44.14 97.18 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.13 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -57.54 -56.51 20.89 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.325 0.25 . . . . 0.0 111.125 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 491' ' ' ILE . 3.0 pp -58.71 -43.32 90.06 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 15.3 m -61.13 -49.24 78.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.687 0.28 . . . . 0.0 110.589 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.84 97.89 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.036 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.65 67.64 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.446 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 499' ' ' ARG . 8.1 p -66.06 -44.25 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . 0.404 ' N ' HG13 ' A' ' 498' ' ' VAL . 0.0 OUTLIER -80.46 63.71 5.01 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.043 0.449 . . . . 0.0 110.812 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.292 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.667 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 . . . . . 0 C--O 1.235 0.315 0 CA-C-O 120.705 0.288 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.93 -164.96 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.627 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 11.8 mt-30 -68.79 69.05 0.16 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.771 0.319 . . . . 0.0 111.839 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 494' ' ' LEU . . . -124.89 -124.8 2.87 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.653 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.61 -55.66 12.82 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 51.0 t -52.17 -48.15 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 110.828 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.627 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 2.9 t -59.78 -48.11 88.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.48 80.85 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.772 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.7 -55.92 28.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.927 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -54.82 -49.45 70.99 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.795 0.331 . . . . 0.0 110.564 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.4 ' O ' HG12 ' A' ' 412' ' ' ILE . 0.7 OUTLIER -56.06 -49.68 73.09 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.205 178.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 30.0 t -49.66 -53.01 26.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.292 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -55.48 -47.29 76.38 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.498 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 37.7 t -57.07 -46.49 84.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.337 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 408' ' ' LEU . 38.1 mm -55.69 -46.81 79.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.154 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -39.71 95.36 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.197 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 432' ' ' TYR . 0.7 OUTLIER -62.63 -52.13 64.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.724 179.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 3.0 tp -59.07 -42.03 85.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.59 -49.17 78.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 4.0 ttt -58.95 -42.88 90.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.128 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.568 ' HG2' ' HG ' ' A' ' 428' ' ' LEU . 0.0 OUTLIER -56.5 -54.6 43.85 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.031 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -54.88 -41.72 71.22 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 3.7 tp -75.08 50.06 0.46 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.14 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 2.0 mtt 177.26 -59.08 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -153.29 129.04 10.13 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.462 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -92.26 33.16 1.1 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.882 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 121.081 0.467 . . . . 0.0 111.353 179.757 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . 0.568 ' HG ' ' HG2' ' A' ' 418' ' ' GLN . 4.6 mm? . . . . . 0 C--O 1.238 0.462 0 CA-C-O 120.662 0.268 . . . . 0.0 111.652 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 1.5 p -46.05 -42.24 4.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.033 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 85.1 mmm -51.23 -54.44 25.65 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 110.929 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 2.7 mp -64.31 -47.89 77.72 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.491 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . 0.482 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . 28.4 t80 -59.95 -50.49 73.53 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.517 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 462' ' ' PHE . 19.8 mt -54.97 -43.86 73.89 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.407 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 4.1 tt -57.6 -54.09 50.8 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -58.46 -50.42 66.97 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.239 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 76.9 t -58.39 -44.52 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.12 -48.22 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 97.8 t -55.87 -46.0 79.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 23.9 t -60.07 -50.21 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.492 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -57.24 -48.85 77.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.8 tt -53.74 -45.4 70.52 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -65.33 -38.76 91.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.005 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 400' ' ' GLN . 0.2 OUTLIER -65.42 -45.41 84.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.445 179.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.434 ' O ' ' HD3' ' A' ' 445' ' ' ARG . . . -64.17 76.79 0.05 OUTLIER Glycine 0 C--N 1.337 0.584 0 N-CA-C 114.61 0.604 . . . . 0.0 114.61 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 444' ' ' GLY . 0.0 OUTLIER -148.61 -65.78 0.24 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.775 0.322 . . . . 0.0 110.422 178.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -128.84 66.28 75.13 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 121.186 0.517 . . . . 0.0 109.823 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.496 ' CB ' ' HB2' ' A' ' 451' ' ' ALA . 83.3 Cg_endo -80.13 155.69 22.74 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.018 2.479 . . . . 0.0 113.819 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.8 73.87 1.44 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.488 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 79.2 t 72.12 -65.74 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.499 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . 0.41 HG22 ' OE1' ' A' ' 400' ' ' GLN . 2.9 m -50.98 -53.21 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 120.553 0.216 . . . . 0.0 110.96 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . 0.496 ' HB2' ' CB ' ' A' ' 447' ' ' PRO . . . -58.46 -39.8 80.89 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.923 0.392 . . . . 0.0 110.384 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.89 -50.46 73.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.326 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 45.0 t -55.85 -52.39 49.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.853 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . 0.468 HG23 ' HA ' ' A' ' 451' ' ' ALA . 17.3 tt -60.93 -39.38 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.446 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -56.22 -46.85 79.36 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 78.3 t -58.83 -54.99 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.907 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 42.1 t -52.72 -41.81 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.286 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 1.4 t -56.96 -44.09 82.23 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.0 -50.02 74.84 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.911 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -58.99 -42.06 89.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.926 0.393 . . . . 0.0 110.51 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -43.43 84.2 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.65 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . 0.428 ' HA ' ' CD1' ' A' ' 433' ' ' LEU . 6.3 t80 -68.9 58.56 0.09 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.215 0.531 . . . . 0.0 111.122 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 CA--C 1.532 0.273 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.173 -179.684 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.614 0 CA-C-O 120.843 0.354 . . . . 0.0 111.743 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 11.2 p -51.13 -44.52 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.92 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -61.52 -58.13 9.37 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.588 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -55.15 -44.59 75.26 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.048 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.8 tt -56.94 -52.25 65.96 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.776 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.58 -46.23 90.78 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 55.3 m -54.49 -47.47 72.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.198 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -61.8 -53.94 49.03 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.667 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -53.91 -44.77 70.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.948 0.404 . . . . 0.0 110.738 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.0 -50.18 76.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.332 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 34.2 mtt -53.93 -53.58 50.73 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.722 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 21.3 tp -55.78 -50.79 69.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.397 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 25.7 m -55.72 -47.25 77.22 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.543 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 78.9 t -60.34 -49.24 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.46 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -58.11 -45.5 93.85 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.752 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 20.5 mt -62.45 -48.09 81.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.84 0.352 . . . . 0.0 110.09 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 5.0 t -58.76 -59.33 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.043 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 2.6 pp -55.84 -35.39 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.087 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -60.36 -56.41 24.64 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.368 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -41.74 99.54 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.608 ' HA ' ' HA2' ' A' ' 401' ' ' GLY . 0.2 OUTLIER -57.86 -50.23 74.0 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.166 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 1.1 m -64.23 -44.36 92.12 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.6 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.82 80.29 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.988 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -67.2 -46.32 72.87 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.455 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 90.4 t -74.37 -42.66 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.737 0.303 . . . . 0.0 111.342 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -96.83 101.14 12.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.851 0.358 . . . . 0.0 110.922 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.466 0.372 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.776 -179.753 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 1.5 tp -165.57 -61.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.437 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.533 ' HG3' ' CE1' ' A' ' 443' ' ' TYR . 21.9 tt0 -150.24 114.83 5.23 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.615 0.245 . . . . 0.0 111.08 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.451 ' HA2' ' CG2' ' A' ' 495' ' ' THR . . . -175.7 -113.01 0.32 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.697 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.98 -52.19 2.47 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.773 0.656 . . . . 0.0 112.773 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.504 HG13 HG13 ' A' ' 439' ' ' VAL . 29.5 t -50.53 -56.2 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.746 0.308 . . . . 0.0 111.414 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.475 HG12 HG21 ' A' ' 491' ' ' ILE . 12.1 t -64.98 -40.79 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.873 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.7 82.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.81 83.96 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.661 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.453 ' HB1' HG21 ' A' ' 439' ' ' VAL . . . -53.54 -56.7 14.86 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.15 178.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 2.9 mp -55.89 -43.05 76.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.315 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.1 m -55.91 -53.25 59.1 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.78 -48.96 78.18 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.137 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 55.8 t -55.05 -41.9 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.335 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.418 ' O ' HG22 ' A' ' 415' ' ' ILE . 11.9 mm -58.46 -50.87 77.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.2 -38.8 77.45 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.257 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 9.3 mt -65.65 -58.11 6.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 412' ' ' ILE . 2.3 tp -55.3 -39.7 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.601 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.98 83.87 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 32.5 ttm -54.79 -50.92 67.32 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.836 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -60.73 -40.19 91.43 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.202 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . 0.46 ' CE2' ' HB3' ' A' ' 477' ' ' TYR . 1.0 OUTLIER -56.44 -39.72 73.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.049 179.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.66 -36.8 16.03 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.842 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' MET . . . . . 0.406 ' HB3' ' CE2' ' A' ' 423' ' ' PHE . 0.0 OUTLIER -88.98 -164.82 1.2 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.926 0.393 . . . . 0.0 111.405 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -159.46 124.74 4.15 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.213 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 421' ' ' MET . 3.6 p90 -177.07 172.07 2.01 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.853 0.358 . . . . 0.0 111.246 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 CA--C 1.534 0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.182 0 N-CA-C 111.292 0.108 . . . . 0.0 111.292 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' ' 433' ' ' LEU . 7.4 p -50.2 -39.91 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 121.175 -0.21 . . . . 0.0 110.763 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -51.58 35.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.395 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.46 -48.61 78.71 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -57.96 -51.83 68.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.724 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.494 ' CD1' ' HA ' ' A' ' 462' ' ' PHE . 0.0 OUTLIER -55.13 -42.63 73.26 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.121 178.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 3.6 tp -55.16 -51.89 65.04 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -59.28 -48.32 86.51 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.786 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 57.9 t -57.44 -41.33 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.682 0.277 . . . . 0.0 110.375 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.75 -43.02 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.928 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 71.8 t -59.15 -50.31 80.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.504 HG13 HG13 ' A' ' 403' ' ' VAL . 69.7 t -60.8 -43.45 95.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.844 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 444' ' ' GLY . . . -57.71 -50.51 72.95 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.415 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.58 -40.16 78.37 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.847 0.356 . . . . 0.0 110.197 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . 0.474 ' HB3' HG12 ' A' ' 403' ' ' VAL . 1.3 t80 -69.11 -35.97 77.01 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.275 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . 0.533 ' CE1' ' HG3' ' A' ' 400' ' ' GLN . 8.0 t80 -88.26 -19.26 27.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 440' ' ' ALA . . . -60.35 64.1 0.01 OUTLIER Glycine 0 C--N 1.337 0.612 0 N-CA-C 114.753 0.661 . . . . 0.0 114.753 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.0 OUTLIER -97.49 -34.78 10.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 109.99 178.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . 0.441 ' CZ3' ' HD3' ' A' ' 445' ' ' ARG . 6.1 m-90 -152.15 130.5 6.23 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.1 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.22 -62.8 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.564 2.176 . . . . 0.0 112.413 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 45.2 t 47.64 33.47 3.05 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 49.0 t 66.29 -60.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 9.9 m -48.26 -52.2 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.3 82.62 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.663 0.268 . . . . 0.0 111.078 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.57 -52.51 64.87 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.033 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 67.6 t -54.08 -48.14 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.544 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 17.2 mm -53.89 -57.63 5.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 110.473 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -49.62 66.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.595 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 92.8 t -55.37 -54.06 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.527 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 45.7 t -48.29 -50.45 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -40.02 87.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.634 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.27 -56.87 15.62 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.207 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.99 -41.55 97.48 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.342 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 1.0 OUTLIER -65.07 -31.18 72.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . 0.494 ' HA ' ' CD1' ' A' ' 433' ' ' LEU . 70.2 t80 -38.56 135.43 0.8 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.901 0.381 . . . . 0.0 111.8 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.469 0.48 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.297 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 13.8 m -50.23 -43.9 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.664 -0.243 . . . . 0.0 111.616 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.98 -40.75 94.6 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.886 0.374 . . . . 0.0 110.654 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . 0.46 ' HB3' ' CE2' ' A' ' 419' ' ' TRP . 16.7 m-85 -68.79 -51.89 36.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.7 -49.33 73.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.64 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 2.1 tt -57.62 -53.29 59.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.289 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 48.0 m -53.83 -45.95 71.02 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.33 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -47.7 85.21 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.101 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -55.98 -45.41 78.97 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.329 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.64 -50.47 79.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.131 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 26.3 ttm -54.64 -48.23 72.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.723 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.73 -46.11 86.87 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.195 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 52.0 m -55.49 -57.89 10.03 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.729 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 27.2 m -57.53 -42.04 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.501 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -58.42 -47.15 91.42 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.97 -44.34 82.54 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.7 -53.52 47.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.006 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . 0.475 HG21 HG12 ' A' ' 404' ' ' VAL . 48.9 mt -56.62 -40.0 66.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.465 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.53 -50.42 59.3 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -49.05 76.38 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 4.8 tt -58.12 -48.91 78.77 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.451 ' CG2' ' HA2' ' A' ' 401' ' ' GLY . 88.7 m -52.17 -49.22 64.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.734 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.16 89.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.868 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -66.95 -28.64 73.88 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.685 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 39.9 t -92.98 -44.36 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.576 0.227 . . . . 0.0 111.526 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.68 63.83 0.62 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 N--CA 1.468 0.45 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.714 -179.955 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 120.982 0.42 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.15 168.28 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.979 0.419 . . . . 0.0 111.907 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.576 ' HG3' ' HA ' ' A' ' 494' ' ' LEU . 9.6 pt20 -59.72 101.95 0.13 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.201 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -162.8 -77.46 0.03 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.439 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.4 t -60.54 -56.01 26.45 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.706 0.289 . . . . 0.0 111.244 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' A' ' 443' ' ' TYR . 1.6 t -61.24 -46.76 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.922 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.424 HG22 ' CA ' ' A' ' 400' ' ' GLN . 60.8 t -58.9 -47.91 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.326 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.89 83.61 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.091 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -57.03 -51.78 67.9 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.41 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -56.08 -51.27 68.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.185 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 4.1 tt -55.62 -44.02 76.67 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.312 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.57 -54.03 46.71 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.474 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.7 78.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.752 0.31 . . . . 0.0 110.454 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 88.7 t -60.4 -55.2 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.292 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.48 ' HA ' HG22 ' A' ' 415' ' ' ILE . 0.6 OUTLIER -59.59 -41.99 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.195 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 2.9 m -61.53 -54.8 38.4 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.677 0.275 . . . . 0.0 110.467 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.71 -50.05 75.02 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.062 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 412' ' ' ILE . 4.4 tt -59.81 -41.46 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.761 -0.199 . . . . 0.0 111.029 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.95 78.26 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 34.4 mtt -59.6 -47.26 86.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.852 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -56.08 -55.1 37.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.758 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -56.23 -46.47 79.54 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.121 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.04 -48.74 80.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.401 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' MET . . . . . 0.513 ' SD ' ' HB2' ' A' ' 423' ' ' PHE . 1.4 ttm -65.97 -34.93 79.23 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.021 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 76.8 62.36 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.126 0.489 . . . . 0.0 111.329 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . 0.513 ' HB2' ' SD ' ' A' ' 421' ' ' MET . 4.9 t80 -136.55 148.17 47.42 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.666 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.46 ' HA ' ' NE2' ' A' ' 476' ' ' GLN . 0.3 OUTLIER . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.254 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.775 0.321 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 8.5 p -48.91 -39.85 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.397 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -62.68 -54.05 45.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.659 0.266 . . . . 0.0 110.358 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 16.5 tp -59.63 -43.14 93.95 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -58.48 -51.93 67.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.409 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -49.53 72.21 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.839 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.58 -55.05 18.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.484 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.52 -51.27 58.82 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.726 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 52.4 t -53.46 -42.67 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 120.675 0.274 . . . . 0.0 110.68 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.49 -46.23 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.45 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.19 -55.57 19.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 120.912 0.387 . . . . 0.0 110.135 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.61 -46.23 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.172 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -55.57 -47.79 75.85 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.44 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.09 -45.41 75.41 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.574 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -74.72 -27.74 60.5 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.909 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . 0.423 ' HB2' ' CG1' ' A' ' 403' ' ' VAL . 9.8 t80 -86.48 -41.06 14.7 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -67.31 57.81 0.27 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 114.151 0.42 . . . . 0.0 114.151 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -46.41 6.75 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.51 66.92 75.33 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.835 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.527 ' HA ' ' HB1' ' A' ' 451' ' ' ALA . 56.0 Cg_endo -69.37 86.09 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.617 2.211 . . . . 0.0 112.869 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.56 62.78 0.39 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.681 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 54.8 t 68.8 -59.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.071 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 89.3 t -52.06 -62.92 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.595 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 447' ' ' PRO . . . -52.01 -40.2 60.64 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.689 0.281 . . . . 0.0 111.382 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.66 -54.63 36.58 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.194 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 66.7 t -55.07 -45.62 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.417 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . 0.472 ' CD1' HG22 ' A' ' 490' ' ' VAL . 27.3 mt -56.77 -50.54 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.525 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -61.22 -48.14 82.84 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.085 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.06 -58.5 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.244 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 4.0 t -50.36 -49.33 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.285 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -48.08 79.85 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.073 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -58.2 -54.35 48.02 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.651 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -58.01 -51.5 69.42 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.298 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.429 ' HG ' ' HG ' ' A' ' 479' ' ' LEU . 6.9 mp -61.14 -58.12 9.67 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.838 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -80.82 68.16 6.97 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.613 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.5 t80 . . . . . 0 N--CA 1.465 0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.283 -179.774 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.96 0.41 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.81 -59.81 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.223 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 424' ' ' ASP . 4.0 tt0 -56.1 -40.73 74.11 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.656 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -49.85 74.69 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -47.77 83.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.103 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . 0.429 ' HG ' ' HG ' ' A' ' 461' ' ' LEU . 6.2 mp -58.79 -52.99 63.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.138 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 18.1 m -54.48 -47.48 72.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.252 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -59.72 -48.93 79.71 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.726 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.92 83.64 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.481 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.66 -41.84 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 50.8 mtp -58.81 -52.52 65.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -45.87 81.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 490' ' ' VAL . 85.4 m -55.27 -48.99 73.22 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.443 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 99.5 t -57.63 -47.6 85.11 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.617 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -53.02 -45.7 61.92 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 1.3 tt -58.68 -46.88 86.24 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.472 HG22 ' CD1' ' A' ' 454' ' ' ILE . 41.4 t -58.02 -41.65 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.889 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 55.0 mt -58.14 -53.28 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.97 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -56.79 -49.4 70.86 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.888 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -45.32 92.27 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.687 0.279 . . . . 0.0 110.761 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.576 ' HA ' ' HG3' ' A' ' 400' ' ' GLN . 0.2 OUTLIER -62.74 -46.47 87.93 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.077 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.478 ' N ' ' HG ' ' A' ' 494' ' ' LEU . 3.5 m -53.84 -46.44 71.2 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.49 -45.75 91.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.681 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.14 -47.85 88.95 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.24 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . 0.458 HG12 HD11 ' A' ' 494' ' ' LEU . 7.4 p -73.68 59.86 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.588 0.709 . . . . 0.0 110.672 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 82.7 mmt-85 -152.32 -62.48 0.16 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.442 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--N 1.332 -0.181 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.767 179.548 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.511 HG23 ' HD3' ' A' ' 445' ' ' ARG . 34.0 pt 44.66 -152.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.042 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.48 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 52.6 tp60 45.83 47.82 12.05 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.191 0.52 . . . . 0.0 111.616 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -141.7 -137.49 3.39 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.192 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.8 -41.92 57.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.735 0.268 . . . . 0.0 111.272 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 8.6 m -59.36 -47.56 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.894 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 39.0 t -64.53 -41.54 92.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.83 88.57 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.076 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.99 -50.06 74.93 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.119 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -54.44 -51.71 64.11 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.285 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 2.7 mp -58.68 -45.68 88.89 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.171 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.3 t -54.58 -50.72 67.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.04 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.46 -52.3 58.71 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.033 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 46.6 t -52.92 -53.08 23.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.333 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.42 ' O ' HG22 ' A' ' 415' ' ' ILE . 35.9 mt -61.92 -49.91 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.207 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 39.5 m -55.28 -45.63 76.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.675 0.274 . . . . 0.0 110.502 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 3.1 mp -65.47 -54.59 26.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.265 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.466 ' HB ' ' CE1' ' A' ' 432' ' ' TYR . 0.1 OUTLIER -56.81 -44.18 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.452 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -61.23 -51.42 69.05 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.648 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 33.8 mtp -59.2 -49.4 78.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.579 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.517 ' HG2' ' HB3' ' A' ' 428' ' ' LEU . 2.8 mt-30 -60.09 -61.14 2.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.308 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 35.7 t90 -47.54 -44.9 26.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.699 0.285 . . . . 0.0 110.573 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 4.7 tt -63.45 -46.5 85.96 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.551 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 1.8 ttt -68.14 -39.97 82.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.959 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -139.09 96.95 3.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -71.2 59.24 0.26 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 C--O 1.236 0.354 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.872 -179.375 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . 0.517 ' HB3' ' HG2' ' A' ' 418' ' ' GLN . 1.5 mm? . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.16 -26.02 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.15 -51.11 63.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.587 0.232 . . . . 0.0 111.05 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.2 -40.9 97.61 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.154 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . 0.466 ' CE1' ' HB ' ' A' ' 415' ' ' ILE . 54.9 t80 -62.11 -50.98 69.73 Favored 'General case' 0 CA--C 1.526 0.034 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.612 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 6.1 tt -52.7 -52.38 56.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.37 -50.64 67.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.266 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.31 -49.09 75.4 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.679 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 64.8 t -55.77 -47.79 78.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 47.4 t -56.09 -47.13 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.063 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.0 -52.99 54.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.398 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 66.5 t -54.49 -51.96 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.573 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 444' ' ' GLY . . . -59.92 -42.33 93.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.321 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 6.8 tt -64.15 -50.53 67.83 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.67 0.271 . . . . 0.0 111.651 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . 0.483 ' O ' ' HD2' ' A' ' 445' ' ' ARG . 0.6 OUTLIER -70.92 -35.62 72.33 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . 0.562 ' OH ' ' HB ' ' A' ' 450' ' ' VAL . 37.0 t80 -87.78 -26.64 22.77 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 440' ' ' ALA . . . -61.98 -6.23 9.24 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 115.076 0.79 . . . . 0.0 115.076 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.511 ' HD3' HG23 ' A' ' 399' ' ' ILE . 2.7 ptm180 -63.08 -23.79 67.61 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.112 0.956 . . . . 0.0 111.475 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . 0.482 ' CB ' HD12 ' A' ' 399' ' ' ILE . 0.0 OUTLIER -131.6 93.0 29.63 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 120.71 0.29 . . . . 0.0 110.751 179.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.663 ' HA ' ' HB2' ' A' ' 451' ' ' ALA . 11.7 Cg_endo -56.03 -67.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.772 2.315 . . . . 0.0 112.843 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 10.8 t 58.03 -89.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.355 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 21.7 t -148.97 -59.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.664 0.269 . . . . 0.0 110.857 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . 0.562 ' HB ' ' OH ' ' A' ' 443' ' ' TYR . 40.7 t -52.74 -47.35 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . 0.663 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . . . -59.71 -40.97 89.73 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 93.3 m -59.41 -47.41 85.57 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.15 -48.59 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.485 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 16.4 mm -54.06 -43.56 59.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.998 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -58.11 -50.27 74.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.845 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 42.4 t -57.77 -52.41 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.663 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 77.5 t -54.08 -50.34 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.239 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 13.1 t -58.3 -44.57 88.62 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.954 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -55.37 -59.21 5.12 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.888 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.49 -50.08 75.32 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.678 0.275 . . . . 0.0 110.452 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 9.1 tt -50.74 -43.51 58.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.716 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -55.51 -26.37 42.53 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.375 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 72.4 t80 . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 120.648 0.261 . . . . 0.0 110.963 179.11 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 42.8 t -40.75 -44.34 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 122.421 0.289 . . . . 0.0 111.545 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -62.54 -40.41 96.7 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.599 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -51.91 55.85 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.7 tt -55.33 -54.28 45.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.802 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.99 -48.43 73.31 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.975 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 69.0 m -55.0 -44.0 74.12 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.802 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.22 -50.46 71.19 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.337 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.46 88.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.635 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 91.9 t -63.14 -50.05 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.953 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 21.8 mtt -56.45 -52.67 63.8 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.141 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 2.5 tp -54.87 -46.29 74.7 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 42.9 m -57.36 -48.74 78.22 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.914 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 73.1 t -56.55 -46.33 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.47 -44.54 90.3 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 42.0 tp -56.52 -46.69 80.43 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.941 0.401 . . . . 0.0 109.983 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 34.3 t -63.22 -46.28 96.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.855 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . 0.5 HG21 HD11 ' A' ' 491' ' ' ILE . 15.9 mt -55.67 -44.68 77.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.218 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.54 -45.75 92.18 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.694 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -54.43 -53.32 55.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.595 0.236 . . . . 0.0 110.971 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 450' ' ' VAL . 2.2 pp -68.57 -41.03 80.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.552 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 79.6 m -60.16 -45.0 94.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.802 0.335 . . . . 0.0 110.415 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.15 79.37 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.449 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.35 -47.12 92.6 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.242 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.84 -30.96 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.644 0.259 . . . . 0.0 111.235 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.59 66.71 0.73 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.897 0.379 . . . . 0.0 110.769 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.469 0.48 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.92 -179.735 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 120.766 0.317 . . . . 0.0 111.676 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 tt -173.62 -49.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.922 0.391 . . . . 0.0 111.324 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.564 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 0.0 OUTLIER -149.37 163.57 37.36 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.928 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.492 ' HA2' ' CG2' ' A' ' 495' ' ' THR . . . 131.08 -137.03 9.17 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.825 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.2 t -54.32 -49.69 69.11 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.54 -52.57 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.053 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.564 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 21.2 t -59.94 -48.68 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.587 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.81 69.87 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.654 0.264 . . . . 0.0 110.372 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -55.84 -49.96 71.87 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.167 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.05 80.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.004 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 1.6 mp -56.76 -47.34 80.32 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 38.5 t -51.85 -52.48 49.18 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.042 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -55.06 -55.06 35.29 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.326 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 42.2 t -52.72 -43.94 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.751 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.19 -55.07 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.476 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 44.3 p -55.93 -42.31 75.91 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.69 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -56.37 17.46 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.57 -43.82 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.733 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -60.44 -52.14 66.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.572 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 8.2 mtt -50.67 -49.73 56.53 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.72 -42.67 85.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.929 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -56.45 -44.24 80.29 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.352 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.43 45.7 1.3 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.114 0.483 . . . . 0.0 110.548 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 11.3 ttm -163.97 144.82 8.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.466 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -75.74 75.62 2.71 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.895 0.378 . . . . 0.0 111.604 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' A' ' 428' ' ' LEU . 0.8 OUTLIER -138.13 128.27 25.83 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.052 0.453 . . . . 0.0 111.635 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 C--O 1.236 0.365 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.646 -179.935 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . 0.552 ' HB2' ' CE1' ' A' ' 423' ' ' PHE . 1.1 tt . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.683 0.278 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 4.4 p -52.15 -28.07 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.78 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 30.2 mtt -51.37 -44.56 62.14 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.722 0.296 . . . . 0.0 110.455 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -47.69 84.62 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.175 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -62.2 -47.29 85.12 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 7.8 tt -53.48 -51.54 62.42 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.78 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 5.0 mp -60.33 -46.4 90.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.86 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -53.18 -55.42 24.33 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.314 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 20.0 m -61.2 -39.61 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.659 0.229 . . . . 0.0 110.462 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 34.3 t -57.89 -48.49 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 65.1 t -61.14 -48.02 90.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 443' ' ' TYR . 94.4 t -51.84 -51.37 28.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.063 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.696 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -62.49 -42.21 99.33 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.787 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 3.1 tp -49.11 -46.21 44.57 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -79.76 -36.89 36.55 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.38 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 439' ' ' VAL . 1.2 t80 -60.29 -23.67 64.35 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.131 0.573 . . . . 0.0 112.485 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 446' ' ' TRP . . . -69.0 -123.13 0.03 OUTLIER Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.653 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.71 -67.96 0.13 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.629 0.252 . . . . 0.0 110.871 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . 0.414 ' N ' ' O ' ' A' ' 444' ' ' GLY . 7.9 m-90 -126.99 71.02 75.21 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-O 121.111 0.481 . . . . 0.0 109.764 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.71 70.43 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.69 2.26 . . . . 0.0 113.249 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -57.41 12.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.824 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 27.2 t -153.53 -61.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.031 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 454' ' ' ILE . 0.2 OUTLIER -44.88 -43.54 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.159 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -54.04 -52.21 61.58 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.933 0.397 . . . . 0.0 110.718 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.04 -43.53 95.28 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.894 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 88.4 t -56.46 -52.22 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.561 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 450' ' ' VAL . 38.3 mm -61.07 -45.03 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.709 0.29 . . . . 0.0 110.305 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -55.93 -46.11 78.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.825 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 90.5 t -65.97 -47.48 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.506 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 57.7 t -54.66 -47.41 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.709 0.29 . . . . 0.0 110.657 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 70.0 m -60.88 -54.02 50.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -52.58 -47.73 66.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.474 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -60.05 4.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.755 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.9 tp -44.12 -41.45 5.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.656 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -39.97 -36.63 0.49 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.9 t80 . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 477' ' ' TYR . 7.5 t0 . . . . . 0 C--O 1.237 0.429 0 CA-C-O 121.151 0.5 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.25 -43.67 77.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.93 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -51.17 70.4 Favored 'General case' 0 C--O 1.228 -0.056 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 474' ' ' ASP . 34.6 t80 -53.14 -47.91 68.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.352 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.5 tt -53.24 -46.97 69.4 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -44.72 94.34 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.512 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 19.6 m -53.29 -47.87 68.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.294 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -61.49 -47.29 86.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.257 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -57.52 -45.75 84.63 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.584 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 67.7 t -64.76 -52.9 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.324 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.3 ttt -52.85 -52.35 57.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.802 0.334 . . . . 0.0 110.487 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.8 -49.75 74.42 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.086 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 41.8 m -54.78 -45.94 74.35 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.012 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 65.3 t -54.95 -51.91 48.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.905 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.52 80.05 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.418 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.41 -46.77 76.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.857 0.36 . . . . 0.0 110.134 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.91 -49.67 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.221 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.52 -38.33 56.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.99 -52.19 39.27 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -55.31 -48.5 74.03 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.944 0.402 . . . . 0.0 109.992 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -45.78 90.62 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.216 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' THR . . . . . 0.492 ' CG2' ' HA2' ' A' ' 401' ' ' GLY . 55.9 m -52.98 -43.72 66.63 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.339 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.45 85.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.307 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -69.11 -52.25 24.17 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.08 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.76 -25.23 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 14.9 tpp85 -51.4 -25.88 6.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 179.379 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . 0.439 ' O ' ' HD3' ' A' ' 445' ' ' ARG . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.53 0.205 . . . . 0.0 111.217 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.7 tp -42.1 -42.26 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.502 ' HB3' HG21 ' A' ' 404' ' ' VAL . 0.8 OUTLIER -166.71 67.58 0.1 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.85 0.357 . . . . 0.0 110.8 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -99.55 -113.1 3.42 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.771 -0.728 . . . . 0.0 114.345 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 14.3 m -34.5 -55.28 0.54 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 442' ' ' PHE . 23.7 m -53.37 -44.11 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.502 HG21 ' HB3' ' A' ' 400' ' ' GLN . 75.3 t -71.21 -44.08 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.905 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.21 76.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.25 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.66 -48.81 70.87 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.607 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -55.94 -60.09 3.97 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.998 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.04 -53.99 41.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.022 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 23.9 t -53.95 -52.18 61.46 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.427 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -53.48 -48.51 68.86 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.013 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 31.8 t -57.17 -49.41 79.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.258 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 53.4 mt -57.32 -50.92 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.49 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 25.6 m -57.37 -48.07 80.0 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.824 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -59.93 -52.27 66.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.645 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 94.7 mt -56.95 -49.23 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.894 0.378 . . . . 0.0 110.559 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.92 -55.2 37.6 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.292 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 24.1 ttm -54.2 -46.22 72.4 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.27 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.576 ' HA ' ' CB ' ' A' ' 422' ' ' ALA . 39.1 mt-30 -50.57 -50.45 53.67 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.819 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -70.87 -37.77 73.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.161 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.11 -56.99 12.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.414 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.55 77.0 0.33 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.974 0.416 . . . . 0.0 111.524 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . 0.576 ' CB ' ' HA ' ' A' ' 418' ' ' GLN . . . -163.31 -170.58 2.31 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.19 168.87 9.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 111.633 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.396 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.239 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.532 0.28 0 CA-C-O 121.179 0.514 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.37 -67.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.807 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -53.54 56.03 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -38.16 84.36 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.836 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -63.88 -54.77 29.61 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -54.58 45.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.727 0.299 . . . . 0.0 110.717 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.63 -53.62 55.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.946 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.11 -50.97 60.29 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.732 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 43.0 t -57.42 -44.56 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.857 0.328 . . . . 0.0 110.725 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 20.3 t -57.04 -60.7 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.24 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 35.5 m -60.77 -43.62 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.543 0.211 . . . . 0.0 111.273 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.2 t -56.39 -51.0 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -61.85 -48.42 80.62 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.271 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.85 -44.67 70.54 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.829 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . 0.554 ' HA ' ' CG2' ' A' ' 403' ' ' VAL . 0.0 OUTLIER -71.62 -52.46 17.88 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.165 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . 0.419 ' O ' ' N ' ' A' ' 445' ' ' ARG . 4.1 t80 -55.01 -29.21 56.86 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.996 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -65.7 58.77 0.13 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.74 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 446' ' ' TRP . 0.1 OUTLIER -164.9 42.18 0.08 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.968 0.507 . . . . 0.0 110.601 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . 0.469 ' HB2' ' O ' ' A' ' 445' ' ' ARG . 27.4 m0 76.4 142.34 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.065 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.54 -39.87 20.08 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.469 2.112 . . . . 0.0 112.08 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 51.14 20.11 0.82 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 39.5 t 65.62 -63.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 1.8 m -52.18 -48.14 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -61.19 -47.68 85.02 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.739 0.304 . . . . 0.0 110.719 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 30.5 m -59.25 -55.09 39.35 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.401 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.65 -43.04 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.266 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . 0.442 HG21 HG23 ' A' ' 486' ' ' THR . 10.1 mt -63.63 -59.29 4.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.6 0.238 . . . . 0.0 111.069 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -54.3 -48.58 71.13 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 38.7 t -60.95 -65.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.261 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 54.9 t -47.26 -47.26 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.601 0.238 . . . . 0.0 111.072 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 11.3 t -55.83 -58.13 9.13 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.02 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.19 -51.64 68.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.164 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.25 -43.29 78.54 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.536 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 1.4 mp -68.66 -46.08 70.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.284 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -55.88 107.5 0.35 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.926 0.394 . . . . 0.0 110.893 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 CA--C 1.53 0.188 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.448 -179.815 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.466 0.345 0 CA-C-O 120.807 0.337 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 76.4 t -59.47 -52.19 63.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.01 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -63.55 -37.0 85.64 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.854 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -64.5 -55.77 18.46 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.6 -47.16 82.9 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.88 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 5.7 mt -56.48 -52.88 63.04 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 37.8 m -54.72 -45.86 74.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.13 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -59.96 -46.93 87.84 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.032 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.77 72.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.412 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 28.5 m -64.34 -45.54 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 121.142 -0.223 . . . . 0.0 110.7 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 16.1 mtt -56.82 -55.03 39.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.23 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.27 -46.18 79.79 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.004 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' THR . . . . . 0.442 HG23 HG21 ' A' ' 454' ' ' ILE . 88.9 m -54.13 -51.91 62.75 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.959 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 94.5 t -55.94 -51.82 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.652 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.6 -48.11 79.37 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.407 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.89 -46.81 88.14 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.736 0.303 . . . . 0.0 110.78 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 454' ' ' ILE . 63.6 t -65.38 -60.11 3.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.367 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . 0.408 ' HA ' ' CD2' ' A' ' 494' ' ' LEU . 0.6 OUTLIER -52.8 -43.56 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.36 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.56 -53.31 42.52 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.065 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -58.3 -51.72 68.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.559 0.219 . . . . 0.0 111.499 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.423 ' CD2' HG12 ' A' ' 404' ' ' VAL . 1.2 pp -61.97 -47.21 85.87 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 56.8 m -57.43 -48.14 79.92 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.652 0.263 . . . . 0.0 110.909 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.51 56.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.732 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -54.73 -49.44 61.61 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.159 -0.544 . . . . 0.0 112.994 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . 0.411 HG23 ' CB ' ' A' ' 398' ' ' GLN . 8.6 p -65.83 -41.5 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 16.8 mtm105 -68.51 -44.19 75.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.842 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 121.254 0.55 . . . . 0.0 111.719 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.523 ' O ' ' HG2' ' A' ' 400' ' ' GLN . 1.1 tp -56.07 113.87 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.805 0.336 . . . . 0.0 110.451 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.634 ' HG3' ' HA ' ' A' ' 494' ' ' LEU . 0.0 OUTLIER 59.58 69.46 0.71 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.824 0.821 . . . . 0.0 111.086 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.518 ' HA2' ' CG2' ' A' ' 498' ' ' VAL . . . -128.58 -150.27 7.17 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.817 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.86 -51.33 61.42 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.291 0.236 . . . . 0.0 111.525 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 20.1 m -55.22 -40.19 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.477 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.472 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 2.7 t -62.42 -49.57 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.217 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 494' ' ' LEU . . . -59.17 -48.58 81.1 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.877 0.37 . . . . 0.0 110.192 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.9 81.24 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.223 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -59.04 -47.93 83.45 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.113 178.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.82 -51.15 68.47 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.925 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -45.23 86.62 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.341 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.11 82.13 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.196 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 53.5 t -55.7 -56.96 9.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.579 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 51.0 mt -53.17 -42.52 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.892 0.377 . . . . 0.0 110.114 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 29.2 m -60.68 -46.38 90.59 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.817 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.77 -44.32 93.93 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.874 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 61.4 mt -54.87 -48.46 74.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.29 83.6 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.562 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 10.5 mtt -59.87 -52.1 66.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.817 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.422 ' NE2' ' HA ' ' A' ' 428' ' ' LEU . 14.4 mm100 -56.76 -50.77 71.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.479 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -42.12 88.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.621 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -30.08 71.07 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.322 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 7.3 ttt -91.66 -43.51 9.56 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.558 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . 0.413 ' HB1' ' CD2' ' A' ' 428' ' ' LEU . . . -135.33 156.32 49.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.819 0.343 . . . . 0.0 111.431 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -116.41 25.4 10.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.622 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 111.617 -179.977 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . 0.422 ' HA ' ' NE2' ' A' ' 418' ' ' GLN . 45.0 mt . . . . . 0 C--O 1.236 0.394 0 CA-C-O 120.611 0.243 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 3.4 t -60.92 -45.04 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.921 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 20.7 mtt -48.64 -57.06 6.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 110.237 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.79 -47.76 83.67 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.103 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -52.97 -52.39 58.35 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.148 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.539 ' HG ' ' CD1' ' A' ' 462' ' ' PHE . 0.2 OUTLIER -60.49 -42.88 97.21 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.514 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.39 -48.52 65.6 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -61.11 -44.23 98.42 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 69.6 t -56.9 -40.82 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 65.7 t -61.19 -47.91 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.37 -48.33 85.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 76.9 t -57.42 -50.17 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.969 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.11 82.9 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.451 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.17 -50.48 64.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.897 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -70.76 -21.43 62.52 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.177 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . 0.401 ' CZ ' HG11 ' A' ' 404' ' ' VAL . 0.2 OUTLIER -77.24 -2.47 34.84 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -71.1 -161.38 4.2 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.807 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 446' ' ' TRP . 0.0 OUTLIER 78.33 106.08 0.07 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.932 0.493 . . . . 0.0 111.159 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . 0.415 ' HB2' ' O ' ' A' ' 445' ' ' ARG . 46.2 m0 67.51 89.29 0.1 OUTLIER Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.67 128.77 25.52 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 112.821 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 91.7 p -113.07 -87.18 0.56 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.302 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 7.2 p -178.17 -46.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.548 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.39 -48.58 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.103 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . 0.49 ' O ' HG13 ' A' ' 454' ' ' ILE . . . -54.86 -42.35 71.92 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.172 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -49.08 74.11 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.973 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.69 -56.18 17.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.799 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 451' ' ' ALA . 1.9 pp -59.17 -41.73 84.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.717 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 451' ' ' ALA . 1.2 m120 -55.82 -52.21 64.79 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 93.0 t -55.18 -47.86 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.871 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 40.3 t -48.79 -54.08 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.282 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -43.23 93.81 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.463 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -54.98 -58.46 7.52 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.368 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -62.13 -37.38 84.94 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.269 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 463' ' ' PHE . 1.6 tp -64.78 -22.96 67.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.531 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . 0.539 ' CD1' ' HG ' ' A' ' 433' ' ' LEU . 15.5 t80 -58.9 70.17 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.347 0.594 . . . . 0.0 111.463 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 461' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.088 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.775 0.322 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 83.0 t -53.19 -45.74 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.331 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -35.05 71.9 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.387 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -71.01 -50.95 28.54 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 42.6 mt -58.9 -49.17 78.8 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.596 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -57.51 -52.14 66.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.261 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' THR . . . . . 0.467 ' HA ' HG21 ' A' ' 483' ' ' VAL . 39.0 m -57.19 -42.7 81.73 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.976 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -58.03 -49.04 78.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.309 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.02 -49.44 76.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.368 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 480' ' ' THR . 17.4 m -65.64 -37.36 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.751 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 8.7 mtt -62.66 -53.76 49.59 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 4.7 tp -56.02 -43.34 77.66 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.428 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 32.9 m -59.15 -48.18 82.56 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.784 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 15.6 t -58.03 -47.68 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.096 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . 0.514 ' O ' HG13 ' A' ' 491' ' ' ILE . . . -53.41 -44.72 66.53 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -45.77 83.2 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.796 0.331 . . . . 0.0 110.169 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 69.8 t -58.88 -54.37 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.553 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 488' ' ' GLY . 2.3 pp -57.29 -42.45 80.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.71 -45.04 95.43 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.294 -0.955 . . . . 0.0 110.982 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.59 -55.7 28.96 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.304 0.241 . . . . 0.0 110.797 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.634 ' HA ' ' HG3' ' A' ' 400' ' ' GLN . 3.2 pp -61.76 -39.56 92.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.804 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 96.4 m -52.87 -48.77 66.86 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -72.72 -48.8 35.67 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.706 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -51.43 -36.26 37.73 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 116.33 -0.395 . . . . 0.0 113.611 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . 0.518 ' CG2' ' HA2' ' A' ' 401' ' ' GLY . 76.0 t -74.36 -10.11 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.945 0.373 . . . . 0.0 111.883 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -122.27 179.04 4.69 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.014 0.435 . . . . 0.0 111.299 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.996 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 120.769 0.318 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 2.9 mt -74.32 -53.34 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.408 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.05 44.64 1.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.48 ' O ' HG11 ' A' ' 404' ' ' VAL . . . -111.12 -101.48 2.62 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.278 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 9.1 t -47.23 -40.84 17.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.844 0.322 . . . . 0.0 111.142 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 22.4 m -63.04 -48.74 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.755 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.48 HG11 ' O ' ' A' ' 401' ' ' GLY . 2.5 p -69.01 -42.19 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 121.159 -0.217 . . . . 0.0 111.309 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.04 -57.35 13.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 111.048 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.53 -49.4 77.94 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.72 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -54.43 -58.68 6.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.43 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.532 HD22 ' CG1' ' A' ' 487' ' ' VAL . 0.1 OUTLIER -61.47 -49.93 74.8 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.283 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.7 t -51.43 -52.65 44.41 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.68 68.63 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.109 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 15.1 t -52.06 -41.81 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 18.7 mm -62.58 -52.3 61.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.923 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 24.3 p -60.1 -48.13 82.99 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.763 -0.199 . . . . 0.0 110.644 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.33 -51.06 71.54 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.745 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 40.2 mt -59.61 -48.29 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.6 -56.36 22.95 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.755 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 9.2 mtt -53.03 -46.74 68.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.656 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.477 ' HG3' ' CE1' ' A' ' 432' ' ' TYR . 18.1 tm0? -60.77 -58.29 9.1 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.63 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -51.93 -42.8 63.1 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.007 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.32 -25.55 67.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.448 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.55 137.08 34.11 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.953 0.406 . . . . 0.0 110.905 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -72.76 75.16 1.13 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 111.439 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.07 173.81 13.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.125 0.488 . . . . 0.0 111.698 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 C--O 1.237 0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.541 -179.915 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' A' ' 431' ' ' LEU . 2.3 mm? . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 11.0 p -48.0 -43.53 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' MET . . . . . 0.466 ' O ' ' HB2' ' A' ' 434' ' ' LEU . 21.4 ttm -57.6 -57.58 12.08 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.026 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.502 ' CD1' HD11 ' A' ' 428' ' ' LEU . 1.1 mt -57.84 -42.58 84.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.028 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . 0.477 ' CE1' ' HG3' ' A' ' 418' ' ' GLN . 5.7 m-85 -62.42 -60.03 4.13 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.055 0.455 . . . . 0.0 110.597 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.74 -57.06 14.08 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.483 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 430' ' ' MET . 8.1 mp -52.11 -46.84 65.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.984 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.18 -65.14 3.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.897 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 34.4 m -59.11 -38.23 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 441' ' ' LEU . 19.5 t -63.48 -52.35 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.923 -0.126 . . . . 0.0 110.796 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 14.9 t -55.76 -52.73 45.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 110.377 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 96.5 t -58.41 -54.62 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.256 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.95 -52.09 66.58 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 437' ' ' VAL . 1.3 tp -56.73 -47.92 78.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.609 0.242 . . . . 0.0 110.963 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -67.24 -28.98 68.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.964 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -67.84 176.62 2.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.245 0.545 . . . . 0.0 111.629 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 122.15 42.72 0.42 Allowed Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 113.104 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -134.97 116.38 14.62 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.317 0.247 . . . . 0.0 110.391 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 25.6 m95 64.77 97.85 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.598 0 CA-C-O 120.872 0.368 . . . . 0.0 111.899 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.61 76.91 1.84 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.504 2.136 . . . . 0.0 112.279 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 449' ' ' VAL . 97.6 p -104.37 -85.07 0.47 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.683 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.42 ' N ' ' OG ' ' A' ' 448' ' ' SER . 2.7 p -137.68 -51.26 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 4.5 m -46.24 -46.14 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . 0.478 ' O ' HG13 ' A' ' 454' ' ' ILE . . . -58.78 -49.07 79.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.886 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 8.2 m -57.51 -41.65 81.2 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.731 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.08 -59.0 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 451' ' ' ALA . 1.8 pp -60.5 -42.24 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.478 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 451' ' ' ALA . 1.4 t30 -58.88 -54.68 44.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.545 0.212 . . . . 0.0 110.705 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.93 -55.48 23.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.522 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 3.1 t -48.45 -45.34 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.212 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 2.6 t -59.8 -57.13 14.23 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.156 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -46.35 -51.21 15.26 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.726 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -64.84 -44.64 89.11 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.595 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.0 tt -48.83 -38.81 23.29 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.52 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -51.12 -26.39 6.53 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.263 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 CA--C 1.539 0.551 0 CA-C-O 120.818 0.342 . . . . 0.0 111.178 179.327 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.237 0.419 0 CA-C-O 120.626 0.251 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 17.8 m -50.22 -41.45 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.301 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -53.23 -58.32 7.48 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.706 0.289 . . . . 0.0 111.024 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -56.94 -50.09 73.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -56.18 23.39 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.003 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.89 -50.71 71.69 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.815 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' THR . . . . . 0.474 HG23 ' SD ' ' A' ' 484' ' ' MET . 18.1 m -55.27 -51.5 66.46 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.687 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -59.32 -55.77 30.5 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.02 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -54.14 -47.63 71.7 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.653 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.92 -53.84 36.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.163 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' MET . . . . . 0.474 ' SD ' HG23 ' A' ' 480' ' ' THR . 52.2 mtp -53.9 -52.52 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.282 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -56.12 25.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.997 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 9.7 m -56.01 -57.68 11.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.988 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.532 ' CG1' HD22 ' A' ' 408' ' ' LEU . 39.2 t -53.2 -53.03 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.239 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -55.48 -52.92 44.63 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.2 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.1 -45.95 79.26 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.655 0.264 . . . . 0.0 110.377 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 68.4 t -60.34 -50.01 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.034 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 97.2 mt -51.64 -48.22 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 120.788 0.328 . . . . 0.0 110.368 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -67.65 -45.04 79.46 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.954 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -49.41 73.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.288 0.235 . . . . 0.0 111.477 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.22 -43.96 73.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.373 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 26.6 m -63.73 -41.31 98.08 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.561 0.22 . . . . 0.0 111.304 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -68.47 -50.03 55.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.313 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -67.97 -56.98 9.29 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.151 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 32.2 t -75.52 64.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.319 0.581 . . . . 0.0 110.987 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . 0.404 ' NH1' ' HB3' ' A' ' 499' ' ' ARG . 7.6 ttp-105 -148.73 41.73 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.946 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.386 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.475 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.448 0.166 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.08 -76.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.211 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.521 ' HG2' ' CG1' ' A' ' 404' ' ' VAL . 5.6 mt-30 -117.07 124.82 50.18 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.874 -0.148 . . . . 0.0 110.94 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.595 ' HA2' ' CD2' ' A' ' 494' ' ' LEU . . . -158.22 -132.66 1.44 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.364 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -41.09 61.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.93 0.365 . . . . 0.0 110.988 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 18.0 m -55.86 -52.49 48.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.599 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.521 ' CG1' ' HG2' ' A' ' 400' ' ' GLN . 16.3 m -72.79 -31.79 37.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 121.194 -0.203 . . . . 0.0 110.94 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.07 -45.05 90.47 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.889 0.375 . . . . 0.0 110.101 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.48 -50.91 61.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.874 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.43 ' HB2' ' HB1' ' A' ' 440' ' ' ALA . . . -56.01 -48.11 76.52 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.099 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.428 HD11 ' HA ' ' A' ' 487' ' ' VAL . 2.9 tp -58.99 -45.01 91.69 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.812 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 58.1 m -53.28 -44.32 68.16 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.24 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.16 80.14 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.266 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 75.3 t -57.7 -54.66 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.355 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 93.4 mt -52.68 -48.23 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.885 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 35.7 m -57.38 -45.23 84.68 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.661 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -56.7 -55.95 27.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.208 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.407 HD12 HG11 ' A' ' 483' ' ' VAL . 9.7 mt -54.86 -47.12 75.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.442 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.14 79.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.08 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -44.84 82.49 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.549 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.697 ' HA ' ' CB ' ' A' ' 422' ' ' ALA . 14.4 tt0 -57.7 -58.13 9.7 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.607 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -57.3 -35.77 70.24 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.62 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.62 -53.49 15.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.476 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 1.7 mtt -171.83 71.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . 0.697 ' CB ' ' HA ' ' A' ' 418' ' ' GLN . . . -156.71 115.04 3.29 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.918 0.389 . . . . 0.0 111.061 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -72.98 94.22 1.84 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.036 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 CA--C 1.536 0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.865 179.138 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 120.485 0.183 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 89.2 t -53.28 -46.37 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.888 0.375 . . . . 0.0 110.302 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -49.47 76.02 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.125 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 4.0 mp -58.42 -48.44 80.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.362 -0.381 . . . . 0.0 109.979 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -54.97 37.32 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.172 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.62 -43.11 79.88 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.183 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -52.21 65.53 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -55.22 -47.7 72.95 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 92.3 t -56.43 -47.3 81.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 68.1 t -58.43 -44.61 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.848 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 64.2 t -58.44 -45.55 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.432 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 72.6 t -56.81 -53.11 46.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.977 0.418 . . . . 0.0 110.328 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 407' ' ' ALA . . . -59.71 -47.09 87.02 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.405 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -40.97 80.22 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.595 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.66 -37.4 86.41 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.699 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.23 -43.64 15.87 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.578 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.48 172.94 37.75 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.469 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 451' ' ' ALA . 3.7 mtt180 -130.63 -170.82 2.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 111.961 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . 0.444 ' H ' ' HD2' ' A' ' 447' ' ' PRO . 22.8 m-90 -110.93 -59.64 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.444 ' HD2' ' H ' ' A' ' 446' ' ' TRP . 53.7 Cg_endo -69.03 61.38 1.33 Allowed 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.205 1.937 . . . . 0.0 113.311 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.12 29.21 1.09 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.332 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 92.9 t 56.63 -83.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.68 0.392 . . . . 0.0 111.814 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 15.6 m -54.6 -44.83 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.563 0.221 . . . . 0.0 110.893 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 445' ' ' ARG . . . -57.76 -43.43 85.43 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.756 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -50.5 73.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.066 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 49.1 t -59.38 -48.59 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.57 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.12 -47.48 86.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.154 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.2 -49.97 75.81 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.12 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 31.8 t -54.69 -53.79 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.443 ' CG1' HD12 ' A' ' 461' ' ' LEU . 24.3 t -48.94 -53.49 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.147 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -39.81 72.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.59 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -56.21 -55.81 28.64 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.414 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.93 -42.26 99.74 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.858 0.361 . . . . 0.0 110.656 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.443 HD12 ' CG1' ' A' ' 457' ' ' VAL . 0.1 OUTLIER -63.78 -23.8 67.5 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.511 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -67.72 73.48 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.197 0.523 . . . . 0.0 110.918 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.252 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.994 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.681 0.277 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 99.1 t -59.47 -58.32 7.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.321 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -33.61 67.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.136 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -70.55 -53.45 16.05 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.17 -48.32 73.94 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.033 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.24 -48.52 78.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.652 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 61.3 m -57.87 -42.75 85.19 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.437 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -56.18 -50.9 69.89 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.887 0.375 . . . . 0.0 110.14 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.75 88.23 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.142 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . 0.407 HG11 HD12 ' A' ' 415' ' ' ILE . 54.4 t -61.62 -45.34 98.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.803 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 95.4 mtp -55.11 -54.64 40.6 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.756 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.47 -44.06 84.56 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 62.6 m -53.92 -49.77 67.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.071 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.428 ' HA ' HD11 ' A' ' 408' ' ' LEU . 88.5 t -62.44 -50.51 79.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.113 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -52.55 -42.76 58.28 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.9 -46.51 87.46 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.99 -53.34 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.232 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 7.2 tp -59.64 -39.85 80.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 120.571 0.224 . . . . 0.0 110.967 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -66.49 -47.58 68.8 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -56.14 -40.68 74.19 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.628 -0.286 . . . . 0.0 110.241 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.595 ' CD2' ' HA2' ' A' ' 401' ' ' GLY . 0.0 OUTLIER -69.59 -47.15 64.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 91.3 m -49.97 -48.45 52.19 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.638 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -83.13 -45.28 14.14 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.681 0.277 . . . . 0.0 111.474 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -47.84 -61.73 4.6 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.812 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.34 60.08 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.551 0.691 . . . . 0.0 110.122 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -169.81 -52.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.654 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 120.88 0.372 . . . . 0.0 111.884 179.567 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.447 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.51 HD12 HG21 ' A' ' 399' ' ' ILE . 0.2 OUTLIER -61.59 129.59 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.863 0.363 . . . . 0.0 110.924 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 57.78 64.23 1.6 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.195 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -128.64 -169.24 12.57 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.75 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 24.9 t -41.0 -56.42 2.28 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.626 0.25 . . . . 0.0 111.608 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 98.2 t -53.04 -43.17 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.84 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.5 -46.72 94.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.233 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . 0.422 ' HB3' HD11 ' A' ' 494' ' ' LEU . . . -55.67 -49.42 72.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.84 0.352 . . . . 0.0 110.068 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.66 -53.27 59.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.679 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -52.19 -49.28 64.16 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.783 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.462 ' HA ' HG23 ' A' ' 411' ' ' VAL . 1.1 tp -60.27 -44.17 95.56 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -45.7 89.89 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.881 0.372 . . . . 0.0 110.262 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.27 -53.88 42.0 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.216 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 415' ' ' ILE . 35.4 m -58.86 -48.23 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.136 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.406 HD12 HG23 ' A' ' 412' ' ' ILE . 56.9 mt -55.04 -46.84 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 82.5 m -57.12 -45.47 83.44 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.762 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.3 mp -59.9 -50.76 72.49 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.215 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 411' ' ' VAL . 12.2 mm -55.76 -47.9 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.023 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.06 92.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.053 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 1.5 tpt -57.25 -46.98 82.52 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.055 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -65.53 -37.67 87.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.181 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . 0.468 ' CE3' HG22 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -60.61 -37.35 81.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.614 179.055 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.17 57.2 0.1 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.202 0.525 . . . . 0.0 110.886 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' MET . . . . . 0.451 ' O ' ' CB ' ' A' ' 422' ' ' ALA . 4.3 mtp -136.49 -37.26 0.69 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.829 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 421' ' ' MET . . . 90.54 84.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.136 0.574 . . . . 0.0 111.161 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.3 -174.01 0.38 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.737 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 14.5 p30 . . . . . 0 CA--C 1.536 0.439 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.927 179.573 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 14.7 p -45.28 -34.17 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 29.1 mtt -56.74 -58.97 5.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.834 0.35 . . . . 0.0 110.275 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 6.1 mp -67.85 -40.3 83.71 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -54.49 -56.45 18.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.913 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.53 -45.67 84.78 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.22 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.93 -51.26 61.97 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -63.42 -44.05 97.34 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.846 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.503 HG11 ' CZ ' ' A' ' 459' ' ' PHE . 39.9 t -56.34 -53.73 36.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.48 0.181 . . . . 0.0 111.025 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.73 -43.38 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.602 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 44.0 t -58.71 -52.45 59.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 70.2 t -56.11 -53.64 36.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.405 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -53.75 -47.13 70.96 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.463 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 4.0 tt -52.02 -47.26 65.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.776 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -68.4 -33.3 74.0 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.717 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 445' ' ' ARG . 3.8 m-85 -70.38 -21.86 62.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.607 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -63.53 67.55 0.04 OUTLIER Glycine 0 C--N 1.341 0.826 0 C-N-CA 121.571 -0.347 . . . . 0.0 113.271 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.0 OUTLIER -140.71 -61.83 0.49 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.121 0.486 . . . . 0.0 110.076 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -154.05 88.38 3.51 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.999 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.24 176.17 2.18 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.941 2.427 . . . . 0.0 113.663 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.8 m -171.21 153.19 3.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.409 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.0 t -39.9 -60.92 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.567 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 46.7 t -51.06 -56.29 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . 0.437 ' CB ' HD13 ' A' ' 399' ' ' ILE . . . -53.55 -48.41 69.13 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.782 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 88.7 m -57.97 -46.12 85.66 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.248 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 88.9 t -60.97 -44.12 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.121 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 30.6 mt -56.57 -50.96 71.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 120.889 0.376 . . . . 0.0 110.218 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.62 -50.29 73.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.71 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 90.3 t -56.43 -52.34 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.145 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.2 t -53.68 -49.79 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.722 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -44.75 96.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.375 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . 0.503 ' CZ ' HG11 ' A' ' 436' ' ' VAL . 2.3 m-85 -58.58 -48.65 80.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.774 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.93 -44.91 96.56 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.943 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 30.0 tp -58.9 -48.23 82.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.989 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -87.14 92.94 9.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.019 0.438 . . . . 0.0 111.475 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 28.8 t80 . . . . . 0 CA--C 1.539 0.553 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.044 -179.747 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 479' ' ' LEU . 6.7 p -53.52 -42.86 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.25 -47.67 85.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.579 0.228 . . . . 0.0 111.269 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.29 -51.0 61.74 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.609 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.7 -53.44 56.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.861 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 475' ' ' VAL . 0.1 OUTLIER -57.9 -48.08 80.9 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.173 179.139 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 99.4 m -53.9 -52.54 60.2 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.397 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -59.3 -48.61 80.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.709 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.85 75.17 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.995 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . 0.406 ' O ' HG22 ' A' ' 487' ' ' VAL . 93.6 t -65.52 -52.84 46.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.497 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 3.3 ttt -52.23 -51.73 56.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.866 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -49.43 77.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.333 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 88.6 m -54.57 -58.27 8.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.159 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 483' ' ' VAL . 36.0 m -59.81 -43.92 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.814 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -55.24 -51.45 54.13 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 5.6 mt -55.36 -46.57 76.46 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.451 HG12 HD22 ' A' ' 408' ' ' LEU . 59.0 t -57.07 -45.17 84.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.577 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 50.3 mt -58.46 -46.31 89.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.792 0.33 . . . . 0.0 110.615 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.76 -53.57 33.84 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.93 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -56.76 -46.52 81.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.642 0.258 . . . . 0.0 110.78 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.422 HD11 ' HB3' ' A' ' 405' ' ' ALA . 0.6 OUTLIER -60.38 -46.3 90.47 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.165 178.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 89.9 m -54.86 -51.13 66.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.948 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.7 84.57 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.009 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -57.86 -44.0 94.52 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.439 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.56 -48.49 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 120.581 0.229 . . . . 0.0 110.498 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -79.4 54.1 1.65 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.136 0.493 . . . . 0.0 110.325 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 C--O 1.233 0.206 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.701 -179.343 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.556 0.217 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.526 ' HB ' HD21 ' A' ' 494' ' ' LEU . 1.2 mp -90.51 -58.1 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.733 0.302 . . . . 0.0 110.455 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.523 ' HB2' HD22 ' A' ' 494' ' ' LEU . 0.7 OUTLIER -159.62 91.43 0.99 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.625 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -141.82 -98.13 0.31 Allowed Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.172 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 5.5 t -55.25 -55.03 36.04 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.667 0.27 . . . . 0.0 111.254 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 443' ' ' TYR . 17.6 m -50.46 -45.0 25.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.055 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.434 HG11 HG12 ' A' ' 491' ' ' ILE . 3.2 t -70.44 -37.42 70.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.379 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.31 96.67 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.31 -49.99 67.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.784 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -55.61 -50.79 69.21 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.327 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -45.88 89.43 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.229 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 53.4 m -52.94 -42.22 65.25 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.145 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.41 -48.52 75.09 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.393 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 17.4 t -57.89 -46.93 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.393 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 23.0 mm -59.71 -45.33 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 49.0 m -58.78 -48.19 82.11 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.028 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.507 HD23 HG21 ' A' ' 436' ' ' VAL . 1.6 mp -56.18 -48.47 76.29 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.149 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 32.5 mm -61.53 -45.78 97.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.389 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -52.44 -51.58 58.47 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.033 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -47.36 85.94 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.624 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -50.63 -42.49 56.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.54 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -67.78 -45.02 76.03 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.503 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.51 -40.47 93.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.424 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 29.2 mtt -146.17 134.19 21.47 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.137 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 72.04 74.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.205 0.526 . . . . 0.0 111.398 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -55.02 159.47 2.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.877 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 . . . . . 0 CA--C 1.536 0.414 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.452 -179.888 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.442 HG12 HD21 ' A' ' 414' ' ' LEU . 54.8 t -41.52 -37.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -41.17 -54.3 2.93 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 7.1 tp -57.64 -52.55 64.97 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.005 0.431 . . . . 0.0 110.494 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -58.36 -48.94 78.95 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.085 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.47 -47.76 69.46 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.915 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . 0.412 ' O ' HG22 ' A' ' 437' ' ' VAL . 2.8 tp -53.66 -49.68 67.42 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.888 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -61.49 -44.47 97.96 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.79 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . 0.507 HG21 HD23 ' A' ' 414' ' ' LEU . 63.8 t -58.16 -52.56 57.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 122.058 0.143 . . . . 0.0 111.011 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . 0.415 HG21 ' N ' ' A' ' 438' ' ' VAL . 33.3 m -56.57 -40.92 71.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.415 ' N ' HG21 ' A' ' 437' ' ' VAL . 24.6 t -59.7 -46.78 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 99.1 t -55.33 -49.62 71.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.12 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.01 75.42 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.542 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -37.9 73.2 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.734 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -70.63 -45.19 65.65 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.508 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . 0.458 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 2.9 m-85 -68.63 -49.1 61.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.508 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.466 ' O ' ' HD2' ' A' ' 445' ' ' ARG . . . -67.43 161.33 48.45 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.787 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 444' ' ' GLY . 0.0 OUTLIER -155.86 -61.01 0.11 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 122.631 -0.335 . . . . 0.0 111.501 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -81.02 108.23 9.71 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.689 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.476 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 29.7 Cg_endo -64.02 -50.21 3.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.352 2.034 . . . . 0.0 112.528 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 58.2 m 43.31 43.67 4.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.859 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 26.9 t 68.42 -57.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.1 t -47.5 -55.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 447' ' ' PRO . . . -57.57 -48.24 79.9 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.635 0.255 . . . . 0.0 110.976 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 12.6 m -56.21 -53.59 55.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.665 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 42.8 t -56.24 -54.51 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.664 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 52.3 mt -52.63 -52.2 28.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.578 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -55.72 -53.41 56.98 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.396 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 44.8 t -51.88 -52.34 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.516 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 86.2 t -49.73 -52.75 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.672 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 1.2 p -60.75 -41.25 95.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.762 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -61.12 -41.23 96.32 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.807 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -73.03 -42.16 63.46 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.478 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.6 tt -59.18 -46.56 88.09 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.769 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -101.17 -167.23 1.4 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.114 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.348 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 35.7 t70 . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 33.3 t -56.0 -59.77 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -40.79 95.9 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.16 -51.35 54.85 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.531 0.205 . . . . 0.0 110.849 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -51.86 67.28 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.829 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.18 -53.67 54.32 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.642 0.258 . . . . 0.0 110.378 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 42.8 m -54.29 -48.65 71.03 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.776 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -61.3 -47.38 86.21 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 110.979 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.57 73.55 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.267 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 31.3 m -64.13 -42.25 94.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 22.3 mtt -57.74 -52.82 63.89 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.336 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.33 -47.02 85.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.21 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 28.0 m -56.09 -50.21 71.67 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.197 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 491' ' ' ILE . 84.7 t -59.64 -52.77 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.005 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . 0.432 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -52.91 -44.47 61.6 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.692 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 7.1 tt -55.43 -56.49 19.55 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 30.0 m -61.07 -37.39 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.561 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . 0.434 HG12 HG11 ' A' ' 404' ' ' VAL . 62.8 mt -59.61 -44.96 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.25 -51.4 50.01 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.34 -46.34 72.9 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 110.1 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.526 HD21 ' HB ' ' A' ' 399' ' ' ILE . 16.2 tp -64.81 -44.9 88.39 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.901 178.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 98.0 m -52.1 -51.29 58.69 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -58.68 -48.2 81.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.236 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -60.5 -50.84 63.23 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.056 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 7.0 p -73.1 -40.43 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 49.63 1.77 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.083 0.468 . . . . 0.0 111.205 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.62 179.63 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 120.971 0.415 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.423 HG23 ' CZ3' ' A' ' 446' ' ' TRP . 3.4 tp -167.09 144.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.202 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.508 ' HG2' ' CE1' ' A' ' 443' ' ' TYR . 3.5 mm-40 52.2 50.67 17.93 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.942 0.401 . . . . 0.0 111.331 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -159.28 -98.96 0.15 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.031 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.8 m -45.72 -54.17 8.28 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.02 -44.62 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.992 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 71.8 t -59.4 -51.8 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.478 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.21 -55.84 29.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.896 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -55.14 -47.67 74.75 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.896 0.379 . . . . 0.0 110.534 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.538 ' HB1' HG23 ' A' ' 439' ' ' VAL . . . -56.41 -60.24 3.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.377 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -51.65 67.04 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.292 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 3.2 m -55.59 -53.4 56.89 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.567 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.97 -49.13 77.32 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.598 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.401 ' O ' ' HB ' ' A' ' 415' ' ' ILE . 35.2 t -60.6 -57.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.605 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.2 tp -55.0 -42.55 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 46.4 m -61.47 -56.59 18.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.047 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.41 -50.04 75.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.812 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.455 HG22 ' CD2' ' A' ' 419' ' ' TRP . 1.1 mp -55.69 -53.04 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 420' ' ' LEU . . . -57.66 -53.99 51.95 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.109 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 26.5 mtp -56.88 -54.95 40.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -51.92 61.13 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . 0.455 ' CD2' HG22 ' A' ' 415' ' ' ILE . 43.7 m0 -57.65 -33.0 67.84 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.148 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 3.7 tp -57.26 -29.51 63.88 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 110.904 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 2.8 ttp -97.39 -45.66 6.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.054 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 419' ' ' TRP . . . -131.18 116.74 18.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.643 0.259 . . . . 0.0 111.267 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -86.24 44.87 1.17 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.286 179.752 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.623 0.249 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 5.3 p -131.32 -52.9 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.578 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 1.4 mmt -51.2 -47.19 62.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.611 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 1.5 mt -58.5 -58.75 7.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.339 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -51.72 -51.51 55.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.796 0.331 . . . . 0.0 110.456 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.05 -58.17 9.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.624 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 1.7 mp -49.11 -51.39 32.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.371 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -63.43 -59.7 8.48 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.894 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 38.3 t -52.35 -50.71 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.25 -56.87 14.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 24.2 t -53.58 -50.91 47.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.566 0.222 . . . . 0.0 110.903 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.538 HG23 ' HB1' ' A' ' 407' ' ' ALA . 75.0 t -56.38 -55.01 21.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.883 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -53.93 -50.1 67.19 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.086 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -54.26 48.66 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.221 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -32.1 67.51 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.776 0.322 . . . . 0.0 111.06 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . 0.508 ' CE1' ' HG2' ' A' ' 400' ' ' GLN . 14.1 t80 -84.43 -1.38 55.53 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.447 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.18 -169.17 7.53 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.322 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 63.81 44.68 4.79 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.836 0.351 . . . . 0.0 111.35 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . 0.423 ' CZ3' HG23 ' A' ' 399' ' ' ILE . 22.0 t-105 -164.7 133.9 2.82 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.629 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -87.04 122.41 1.85 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.844 2.363 . . . . 0.0 112.62 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 28.5 t -176.2 171.4 2.5 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.137 0.494 . . . . 0.0 111.873 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 26.3 t -89.14 -21.28 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.563 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.94 -58.02 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.838 -0.165 . . . . 0.0 111.376 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . 0.416 ' HB3' ' CE2' ' A' ' 443' ' ' TYR . . . -53.05 -44.04 67.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.629 0.252 . . . . 0.0 111.192 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -61.23 2.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.744 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 41.9 t -53.73 -45.54 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.71 0.29 . . . . 0.0 110.788 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 16.2 mm -58.91 -55.2 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.23 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -56.35 -49.29 74.83 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 77.1 t -58.95 -57.29 11.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 120.609 0.242 . . . . 0.0 110.843 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 17.5 t -55.4 -49.77 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.02 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 59.5 p -58.33 -47.9 82.25 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.589 0.233 . . . . 0.0 110.949 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -60.8 -58.82 6.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.41 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.17 -45.01 92.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.619 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -63.57 -33.64 76.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.279 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -70.46 59.96 0.2 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.032 0.444 . . . . 0.0 111.098 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.503 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.87 -50.98 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.0 -37.36 78.66 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.834 -0.166 . . . . 0.0 111.357 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.47 -47.85 84.34 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.96 -47.33 71.95 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.116 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.8 -47.15 74.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.622 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 12.1 m -64.18 -51.75 62.26 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -56.74 -44.16 81.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.582 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.76 -53.22 60.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.369 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 35.0 m -63.19 -43.0 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.061 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 6.8 mtt -60.7 -56.1 25.26 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.676 0.274 . . . . 0.0 110.766 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 9.7 tp -55.43 -44.67 76.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.397 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 35.7 m -60.01 -52.81 63.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.4 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 69.8 t -56.27 -48.76 79.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.716 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 491' ' ' ILE . . . -60.7 -51.67 57.21 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.381 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.95 80.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.742 0.306 . . . . 0.0 110.859 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.4 -54.75 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.573 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . 0.52 ' HA ' ' CD2' ' A' ' 494' ' ' LEU . 4.7 tp -55.68 -41.38 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 120.474 0.178 . . . . 0.0 111.208 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.69 -54.78 29.0 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.476 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -63.2 -43.42 98.23 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.52 ' CD2' ' HA ' ' A' ' 491' ' ' ILE . 0.5 OUTLIER -61.81 -46.03 91.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 121.413 -0.115 . . . . 0.0 111.298 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 1.2 m -65.58 -40.79 93.15 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.521 0.201 . . . . 0.0 110.719 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -70.22 -37.33 74.99 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.697 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -79.43 -42.86 11.06 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.589 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.25 -31.84 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 117.033 0.417 . . . . 0.0 111.829 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -104.16 123.97 48.26 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.874 0.368 . . . . 0.0 110.559 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.492 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.872 0.368 . . . . 0.0 111.553 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.49 ' CG1' ' HB2' ' A' ' 446' ' ' TRP . 2.9 mp -53.88 100.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.878 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.6 ' HB3' ' HA ' ' A' ' 494' ' ' LEU . 2.8 mm100 70.53 87.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.404 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -151.94 -150.16 5.28 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.824 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 29.0 t -53.01 -49.63 65.83 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.482 0.182 . . . . 0.0 111.304 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 39.7 t -54.74 -49.45 68.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 110.19 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.485 HG21 ' HA ' ' A' ' 400' ' ' GLN . 54.2 t -58.85 -46.73 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.281 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.65 77.7 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.884 0.374 . . . . 0.0 110.173 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.96 67.8 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.505 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -55.75 -48.73 74.75 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.254 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.41 HD12 HG22 ' A' ' 490' ' ' VAL . 0.1 OUTLIER -56.22 -47.84 77.63 Favored 'General case' 0 C--O 1.23 0.056 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.722 178.556 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.6 t -52.78 -43.0 65.54 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.155 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.4 71.8 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.836 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . 0.407 HG21 HG21 ' A' ' 439' ' ' VAL . 97.3 t -58.75 -50.59 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.914 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 27.2 mt -57.03 -45.61 83.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.231 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 41.3 m -60.38 -49.11 78.87 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.127 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.8 mt -58.14 -53.09 62.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.295 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -61.16 -45.97 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.893 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -54.73 -54.07 46.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.665 0.269 . . . . 0.0 110.387 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 2.2 ttm -61.89 -42.91 99.64 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.514 ' CG ' ' HB3' ' A' ' 428' ' ' LEU . 0.5 OUTLIER -60.1 -28.47 67.86 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.544 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -40.41 12.25 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.566 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 421' ' ' MET . 1.6 tt -73.78 87.09 1.72 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.96 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' MET . . . . . 0.416 ' CB ' ' O ' ' A' ' 420' ' ' LEU . 1.5 ttt 83.11 158.97 0.12 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.701 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 54.04 59.86 3.98 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 110.587 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.31 173.23 1.6 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.501 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 49.9 t0 . . . . . 0 N--CA 1.467 0.383 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.523 -179.88 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . 0.514 ' HB3' ' CG ' ' A' ' 418' ' ' GLN . 4.5 mm? . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 9.1 p -47.33 -35.67 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.64 -52.32 40.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.137 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.78 -45.82 77.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.834 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.2 -50.17 70.05 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.193 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -49.71 76.34 Favored 'General case' 0 N--CA 1.46 0.032 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.008 178.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 1.7 tt -51.99 -46.23 64.8 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.77 68.71 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.728 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.67 -39.81 65.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.776 0.322 . . . . 0.0 110.5 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.05 -57.02 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.675 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 30.2 m -59.23 -39.4 78.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 120.748 0.309 . . . . 0.0 110.397 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . 0.407 HG21 HG21 ' A' ' 411' ' ' VAL . 4.0 t -59.43 -58.75 5.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.138 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.37 -42.78 78.39 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.612 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.7 tp -51.35 -52.68 43.48 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.556 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -71.61 -36.74 70.9 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.964 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -63.09 -38.13 89.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.445 ' O ' ' HD2' ' A' ' 445' ' ' ARG . . . -47.92 104.77 0.09 OUTLIER Glycine 0 C--N 1.339 0.728 0 CA-C-N 116.366 -0.379 . . . . 0.0 113.477 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 444' ' ' GLY . 0.1 OUTLIER -144.72 -66.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.621 0.248 . . . . 0.0 110.908 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . 0.49 ' HB2' ' CG1' ' A' ' 399' ' ' ILE . 0.6 OUTLIER -127.26 125.12 23.95 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.633 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.27 87.78 1.03 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.488 2.125 . . . . 0.0 112.554 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 449' ' ' VAL . 91.0 p -108.24 -93.47 0.41 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.356 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.408 ' N ' ' OG ' ' A' ' 448' ' ' SER . 3.4 p -146.16 -49.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 1.5 m -46.18 -54.16 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.599 0.238 . . . . 0.0 111.337 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -57.28 -41.44 79.73 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.887 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.06 -52.97 61.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.393 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 69.8 t -54.29 -50.1 58.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.68 -47.23 86.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.082 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -55.87 -49.7 72.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.433 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.97 -56.73 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.332 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.31 -41.7 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.891 0.377 . . . . 0.0 110.763 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 19.3 m -65.58 -48.91 70.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.651 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.66 -48.67 80.28 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.132 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.41 -54.97 39.22 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.015 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.8 -45.58 70.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.542 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -38.84 -40.54 0.64 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.44 0.296 . . . . 0.0 111.307 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 65.0 t80 . . . . . 0 CA--C 1.533 0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.2 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 17.9 t70 . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.4 0.143 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 15.3 m -47.99 -45.16 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -32.87 73.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.537 0.208 . . . . 0.0 110.716 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -47.51 55.78 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 4.6 tt -59.15 -48.97 79.64 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.977 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 479' ' ' LEU . 0.6 OUTLIER -59.03 -49.39 78.06 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.844 178.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 87.7 m -55.98 -44.0 78.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.914 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -56.42 -49.12 75.45 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.75 -43.56 94.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.475 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.48 -50.1 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.376 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 34.9 mtp -59.3 -52.37 65.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.359 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -47.42 73.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.936 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 34.7 m -58.83 -50.8 72.62 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.049 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . 0.423 ' O ' HG21 ' A' ' 490' ' ' VAL . 24.4 t -55.06 -52.65 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.784 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.83 87.56 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.054 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.26 -51.24 70.8 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.375 0.131 . . . . 0.0 110.92 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 487' ' ' VAL . 25.8 m -63.21 -39.37 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.011 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . 0.487 ' O ' ' HG ' ' A' ' 494' ' ' LEU . 26.1 mt -56.5 -50.77 71.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 120.966 0.412 . . . . 0.0 110.194 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -66.98 -45.45 82.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.363 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.3 -52.31 61.89 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.155 0.182 . . . . 0.0 111.082 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.6 ' HA ' ' HB3' ' A' ' 400' ' ' GLN . 4.5 pp -64.15 -39.79 94.77 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 91.6 m -57.81 -43.99 86.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.164 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -73.74 -56.66 4.72 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.037 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -50.48 -42.65 43.73 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.338 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 4.9 p -69.38 -10.49 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.38 104.18 14.65 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.563 0.221 . . . . 0.0 110.777 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 N--CA 1.47 0.57 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.45 -179.783 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.723 0.296 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.5 tp -150.73 139.57 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.16 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.511 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 43.5 tt0 -59.82 136.45 58.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.066 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 132.44 -101.88 0.47 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.878 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 12.7 t -58.74 -72.19 0.1 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . 0.5 ' HB ' ' CD2' ' A' ' 441' ' ' LEU . 34.1 m -48.03 -43.75 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 120.554 0.216 . . . . 0.0 111.525 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.511 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 76.9 t -60.76 -54.57 33.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.812 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.14 83.68 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.21 65.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.509 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . 0.426 ' HB2' ' CG2' ' A' ' 438' ' ' VAL . . . -55.76 -55.69 29.36 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.604 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.62 -44.23 85.38 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.458 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' SER . . . . . 0.423 ' O ' HG21 ' A' ' 412' ' ' ILE . 35.8 t -52.61 -44.61 66.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.641 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.33 -46.77 82.05 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.276 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 75.5 t -59.13 -52.25 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.481 ' HA ' HG22 ' A' ' 415' ' ' ILE . 0.4 OUTLIER -59.25 -41.73 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.384 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 59.8 m -63.28 -45.48 91.25 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.5 -57.04 14.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.235 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 412' ' ' ILE . 18.4 tt -56.99 -39.82 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.263 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.31 75.08 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 32.3 mtt -60.09 -45.28 93.46 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.763 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 415' ' ' ILE . 98.9 mt-30 -54.74 -57.18 12.54 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . 0.446 ' HB2' ' CD2' ' A' ' 423' ' ' PHE . 0.1 OUTLIER -48.29 -45.45 34.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.226 178.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.28 -32.19 47.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' MET . . . . . 0.523 ' O ' ' CB ' ' A' ' 422' ' ' ALA . 0.8 OUTLIER -120.7 42.72 2.94 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.929 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 421' ' ' MET . . . 99.64 110.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.657 0.783 . . . . 0.0 111.706 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . 0.446 ' CD2' ' HB2' ' A' ' 419' ' ' TRP . 5.5 t80 -70.64 98.41 1.49 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.417 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 21.1 t0 . . . . . 0 CA--C 1.534 0.334 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.208 179.72 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.463 0.21 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.36 -51.35 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.694 0.283 . . . . 0.0 110.35 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 7.1 ttt -65.4 -49.14 70.35 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.41 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -46.68 85.7 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -60.66 -51.13 70.68 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 9.2 tt -54.74 -51.13 66.62 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.307 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 2.1 tp -58.36 -47.5 83.59 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.637 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -61.5 -58.65 12.23 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.859 -0.61 . . . . 0.0 113.072 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.92 -42.93 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.811 0.305 . . . . 0.0 111.684 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 28.9 t -61.44 -57.54 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.536 0.207 . . . . 0.0 110.676 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . 0.426 ' CG2' ' HB2' ' A' ' 407' ' ' ALA . 99.4 t -56.62 -49.64 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.999 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 73.1 t -57.25 -48.34 82.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.107 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -55.08 -48.21 73.85 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.5 ' CD2' ' HB ' ' A' ' 403' ' ' VAL . 0.2 OUTLIER -58.04 -42.83 86.2 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.176 177.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . 0.432 ' O ' ' HG2' ' A' ' 445' ' ' ARG . 0.2 OUTLIER -63.84 -41.5 97.81 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.211 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 445' ' ' ARG . 22.4 t80 -77.35 -37.9 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.191 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -63.92 67.87 0.05 OUTLIER Glycine 0 C--N 1.338 0.666 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.34 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.491 ' NH2' ' OG ' ' A' ' 448' ' ' SER . 0.0 OUTLIER -140.43 -55.22 0.52 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.594 0.235 . . . . 0.0 110.962 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . 0.507 ' CD2' ' HD2' ' A' ' 447' ' ' PRO . 0.0 OUTLIER 175.34 139.14 0.19 Allowed Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.156 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 446' ' ' TRP . 36.5 Cg_endo -64.12 67.88 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.592 2.195 . . . . 0.0 112.343 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.491 ' OG ' ' NH2' ' A' ' 445' ' ' ARG . 0.8 OUTLIER -104.39 42.28 1.22 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.518 -179.311 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 50.6 t 67.27 -64.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.928 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.7 m -50.81 -47.9 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -54.22 -53.3 55.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 110.393 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.03 -48.74 75.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.611 178.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 84.6 t -53.71 -46.42 62.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.464 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 34.5 mt -55.75 -45.27 79.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -61.72 -45.66 93.01 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 58.0 t -53.36 -50.93 45.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.02 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 74.6 t -53.08 -50.31 46.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 1.4 t -55.06 -43.11 73.54 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.737 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.49 -45.91 92.23 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.23 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.67 -37.72 68.68 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.285 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -22.45 33.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.366 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -66.58 70.71 0.07 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 111.838 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 CA--C 1.534 0.362 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.955 179.694 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 11.6 p -51.89 -44.05 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.087 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.5 -44.35 82.84 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -56.17 -58.14 9.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.086 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 1.5 mp -59.66 -51.45 69.74 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.047 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 7.4 tt -55.47 -58.22 8.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.732 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 3.1 m -54.45 -41.83 69.89 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.574 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -56.45 -47.87 78.23 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.86 94.24 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.275 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.14 -47.04 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.021 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -59.81 -51.54 69.31 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 tt -54.77 -45.06 74.17 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 490' ' ' VAL . 70.6 m -58.99 -49.25 78.6 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.993 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 18.2 t -52.21 -51.5 30.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.119 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . 0.48 ' O ' HG13 ' A' ' 491' ' ' ILE . . . -55.75 -45.59 85.12 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.858 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.03 -46.07 92.2 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 110.353 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 486' ' ' THR . 94.9 t -61.55 -56.52 17.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.007 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 488' ' ' GLY . 2.5 pp -58.83 -37.02 64.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.692 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.43 -59.22 8.03 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -53.8 -46.41 71.06 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 494' ' ' LEU . 1.3 tm? -55.33 -46.66 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.703 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 99.2 m -54.33 -50.01 68.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.228 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.42 77.65 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.358 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -54.52 -50.6 56.43 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.218 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.89 -35.34 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.76 0.314 . . . . 0.0 110.664 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . 0.456 ' HD2' ' HB2' ' A' ' 500' ' ' TYR . 7.0 tmm_? -62.06 -51.39 68.18 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.132 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . 0.456 ' HB2' ' HD2' ' A' ' 499' ' ' ARG . 11.3 t80 . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 120.721 0.296 . . . . 0.0 111.678 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 120.625 0.25 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.405 ' CG2' HG21 ' A' ' 498' ' ' VAL . 1.0 OUTLIER -76.61 -167.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . 0.7 ' HA ' HG22 ' A' ' 404' ' ' VAL . 3.6 tt0 -60.29 93.89 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.958 -0.464 . . . . 0.0 111.228 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.527 ' HA3' HG22 ' A' ' 498' ' ' VAL . . . -156.82 -120.84 0.66 Allowed Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.269 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 67.0 m -50.74 -46.2 59.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.764 0.282 . . . . 0.0 111.256 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 15.9 m -55.88 -41.42 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.945 0.402 . . . . 0.0 110.963 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' A' ' 400' ' ' GLN . 58.9 t -73.44 -43.62 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.796 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.14 -47.53 80.92 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.78 -48.33 81.12 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.163 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -54.83 -50.71 67.93 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.465 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -49.84 76.07 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.23 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' SER . . . . . 0.445 ' O ' HG22 ' A' ' 412' ' ' ILE . 0.3 OUTLIER -56.73 -40.09 75.09 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.147 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -66.71 -54.77 19.47 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.612 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 55.9 t -55.69 -48.38 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.057 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' ILE . . . . . 0.451 ' HA ' HG23 ' A' ' 415' ' ' ILE . 0.3 OUTLIER -60.46 -42.32 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.422 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 91.2 m -61.48 -45.52 93.9 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 431' ' ' LEU . 20.6 mt -60.21 -57.2 13.81 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.546 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.451 HG23 ' HA ' ' A' ' 412' ' ' ILE . 16.2 tt -57.76 -39.93 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.953 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -62.81 -51.56 66.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.812 0.339 . . . . 0.0 110.305 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 20.9 mtp -58.46 -47.34 84.34 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.545 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -46.1 89.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.834 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' TRP . . . . . 0.471 ' HA ' ' O ' ' A' ' 422' ' ' ALA . 1.2 m0 -57.35 -38.89 74.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.52 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.42 -28.1 58.44 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.983 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -44.63 6.44 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.776 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 419' ' ' TRP . . . -125.97 138.14 53.73 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.845 0.355 . . . . 0.0 111.601 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.81 162.24 24.12 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--O 1.236 0.388 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.473 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.492 0.187 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 4.0 p -44.91 -51.12 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.697 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 4.7 mtm -66.73 -47.22 72.97 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.779 0.323 . . . . 0.0 110.365 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' LEU . . . . . 0.419 ' CD1' ' HB3' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -55.65 -51.45 67.18 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.388 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' TYR . . . . . 0.472 ' OH ' ' HB2' ' A' ' 458' ' ' SER . 44.0 t80 -59.15 -44.59 92.11 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.163 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.83 -54.21 47.3 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 6.1 mt -57.48 -42.38 82.53 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.187 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -61.15 -58.43 13.57 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.479 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 32.8 m -53.99 -34.67 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.784 0.292 . . . . 0.0 110.607 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 54.3 t -63.26 -51.25 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.14 -46.4 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.373 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.1 t -60.46 -46.11 95.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.135 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.76 76.39 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.127 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.34 -46.57 69.54 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -63.67 -38.52 91.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.45 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 445' ' ' ARG . 5.6 m-85 -74.13 -17.82 60.88 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.79 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -56.76 80.32 0.01 OUTLIER Glycine 0 C--N 1.342 0.876 0 C-N-CA 121.711 -0.281 . . . . 0.0 112.96 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 443' ' ' TYR . 12.3 ttt85 -174.11 -55.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.32 0.248 . . . . 0.0 110.841 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -163.88 81.15 1.44 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.456 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -89.91 158.98 4.99 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.959 2.439 . . . . 0.0 113.075 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.0 t -129.63 178.73 6.27 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.982 0.42 . . . . 0.0 111.678 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 91.5 t -55.34 -39.29 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.964 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 9.2 m -48.14 -46.36 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.645 0.259 . . . . 0.0 111.443 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -64.28 -45.21 89.01 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -48.54 81.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.526 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.28 -54.75 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.326 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . 0.48 HG23 ' CG2' ' A' ' 490' ' ' VAL . 33.2 pt -57.11 -40.54 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.378 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -68.01 -50.34 56.08 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.36 -52.74 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 37.6 t -55.88 -41.41 66.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.285 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' SER . . . . . 0.472 ' HB2' ' OH ' ' A' ' 432' ' ' TYR . 64.9 m -62.95 -50.45 70.77 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.19 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -55.26 -52.36 63.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.559 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.4 -53.42 58.39 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.806 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.9 mp -56.2 -38.71 71.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.887 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -75.09 -28.65 60.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.978 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.9 t80 . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.977 0.418 . . . . 0.0 111.524 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 C--O 1.237 0.403 0 CA-C-O 120.771 0.319 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.34 -37.01 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.771 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -57.99 -39.91 79.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.488 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -46.7 64.15 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.01 -53.38 57.66 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.873 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.83 -43.97 90.78 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.013 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 54.7 m -54.15 -47.47 71.89 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -64.63 -46.6 81.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.449 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.47 78.26 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.528 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.69 -43.53 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.901 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 26.7 mtt -57.45 -51.09 70.85 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.183 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.0 tp -59.57 -45.53 91.59 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.827 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 88.1 m -56.11 -48.97 75.15 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.269 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.02 -51.24 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.494 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 491' ' ' ILE . . . -54.69 -47.03 72.97 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.983 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -47.34 84.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.668 0.27 . . . . 0.0 110.491 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.48 ' CG2' HG23 ' A' ' 454' ' ' ILE . 39.2 t -60.18 -52.95 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.58 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . 0.541 ' HA ' HD22 ' A' ' 494' ' ' LEU . 9.2 tp -57.47 -42.32 80.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.84 -0.164 . . . . 0.0 110.662 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.8 -42.73 94.97 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -57.37 -56.25 24.25 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.642 0.377 . . . . 0.0 110.79 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . 0.541 HD22 ' HA ' ' A' ' 491' ' ' ILE . 3.9 pp -61.88 -40.46 95.46 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.344 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 45.5 m -62.88 -33.76 75.97 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.374 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -83.08 -42.2 17.7 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.192 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -63.54 -57.73 13.76 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.408 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . 0.527 HG22 ' HA3' ' A' ' 401' ' ' GLY . 2.7 t -62.83 94.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.868 0.366 . . . . 0.0 111.229 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' A' ' 498' ' ' VAL . 3.8 ptm180 154.67 -37.22 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.942 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 120.894 0.378 . . . . 0.0 111.269 -179.575 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 3.0 mmm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.481 0.181 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.34 123.5 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.74 0.305 . . . . 0.0 111.541 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.07 154.59 24.03 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.401 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 445' ' ' ARG . 13.2 tt -73.56 101.1 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.95 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.433 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 4.7 mm-40 66.66 80.11 0.22 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.325 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -133.04 -134.52 3.51 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.071 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 13.4 m -47.09 -38.91 12.16 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 35.5 t -59.79 -47.35 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.452 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 12.7 t -60.51 -48.32 88.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.406 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.68 69.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.738 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.68 -50.45 73.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.064 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -57.85 -55.95 28.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.14 -40.57 85.91 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.652 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 37.8 t -57.12 -57.59 11.9 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.301 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -53.18 -42.32 66.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.705 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.441 HG22 ' CG2' ' A' ' 438' ' ' VAL . 25.0 t -61.61 -59.06 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.27 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.0 tp -55.5 -43.48 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 121.358 -0.137 . . . . 0.0 110.948 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 52.9 m -59.58 -51.52 69.49 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 8.5 tp -57.94 -46.44 85.04 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.368 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.449 HG12 HD13 ' A' ' 431' ' ' LEU . 75.0 mt -57.71 -52.44 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.601 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.29 -48.42 80.53 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.058 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 22.3 mtt -59.66 -52.81 63.92 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.024 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -60.57 -47.31 86.74 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.353 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . 0.513 ' HA ' ' O ' ' A' ' 424' ' ' ASP . 0.0 OUTLIER -59.56 -44.07 93.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.945 0.402 . . . . 0.0 110.185 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 4.9 tt -64.12 -42.57 96.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 6.1 tpt -67.84 126.9 30.9 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.871 0.367 . . . . 0.0 111.727 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 70.82 -98.98 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.918 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.23 41.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.661 0.267 . . . . 0.0 111.519 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 419' ' ' TRP . 4.5 p30 -148.44 157.25 43.35 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.805 0.336 . . . . 0.0 111.198 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.15 -30.74 67.97 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.211 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . 167.06 163.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.523 0.515 . . . . 0.0 110.758 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -90.05 38.07 0.91 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.754 0.311 . . . . 0.0 111.247 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 7.9 mt 47.46 30.63 1.67 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 71.4 t -143.61 -69.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.915 -0.13 . . . . 0.0 111.311 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -52.49 34.19 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.671 0.272 . . . . 0.0 111.111 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.449 HD13 HG12 ' A' ' 415' ' ' ILE . 17.5 tp -62.97 -40.52 97.97 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.04 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 462' ' ' PHE . 54.0 t80 -67.18 -48.57 67.53 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.928 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.28 -59.38 5.03 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.7 0.286 . . . . 0.0 110.568 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -45.19 92.93 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.293 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -53.85 -55.06 27.51 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.859 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 39.3 t -55.17 -47.74 77.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 59.6 t -54.03 -50.2 55.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.441 ' CG2' HG22 ' A' ' 411' ' ' VAL . 41.2 t -61.27 -43.04 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.158 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.9 -45.83 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -58.32 -47.09 84.83 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.1 tp -56.14 -44.71 79.49 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.171 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -64.38 -45.2 88.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.552 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -52.87 -43.39 66.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.355 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -74.72 48.39 1.94 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.874 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.437 ' O ' HG13 ' A' ' 399' ' ' ILE . 0.6 OUTLIER -136.68 29.45 2.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.41 0.284 . . . . 0.0 110.8 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . 0.401 ' CB ' ' O ' ' A' ' 445' ' ' ARG . 0.0 OUTLIER 83.74 125.88 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.561 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.21 97.16 1.12 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.669 2.246 . . . . 0.0 112.728 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.0 m -121.3 38.95 3.95 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.861 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 97.7 t 67.76 -55.13 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.0 m -41.83 -46.76 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -59.63 -47.5 85.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.851 0.358 . . . . 0.0 110.205 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 20.8 m -56.46 -49.16 75.41 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.929 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.3 -52.97 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.343 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 19.8 mt -53.3 -50.81 45.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.752 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -59.82 -51.91 67.72 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.666 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.9 t -54.05 -52.21 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 54.6 t -52.01 -54.55 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.509 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -44.2 92.03 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.827 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -57.41 -57.51 12.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.834 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -41.95 91.52 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.847 0.356 . . . . 0.0 110.695 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.55 ' HG ' ' CB ' ' A' ' 482' ' ' ALA . 1.3 mm? -68.59 -21.01 64.54 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.461 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 432' ' ' TYR . 60.5 t80 -61.68 76.25 0.02 OUTLIER 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.568 0.699 . . . . 0.0 111.135 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 461' ' ' LEU . 0.9 OUTLIER 179.37 -55.36 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.331 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.51 ' HA ' ' CG2' ' A' ' 469' ' ' THR . 17.8 tt -91.45 50.44 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.254 0.55 . . . . 0.0 111.24 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . 0.481 ' CB ' ' HD3' ' A' ' 466' ' ' PRO . . . -98.78 -59.47 0.13 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.625 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . 0.481 ' HD3' ' CB ' ' A' ' 465' ' ' ALA . 37.9 Cg_exo -57.91 149.81 67.68 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.533 2.155 . . . . 0.0 112.762 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.15 61.03 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.088 0.47 . . . . 0.0 111.593 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 466' ' ' PRO . . . 160.32 -72.21 0.22 Allowed Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.433 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' THR . . . . . 0.51 ' CG2' ' HA ' ' A' ' 464' ' ' ILE . 15.3 t 31.02 46.01 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 43.52 35.29 0.93 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -91.42 167.02 12.57 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.991 0.424 . . . . 0.0 111.825 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.12 -40.25 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.65 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 22.7 t -84.67 -176.78 6.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.879 0.371 . . . . 0.0 111.378 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 477' ' ' TYR . 10.4 t0 -74.54 98.52 3.38 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.103 0.478 . . . . 0.0 110.948 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.449 HG22 HG13 ' A' ' 464' ' ' ILE . 95.9 t -56.49 -48.3 80.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.205 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -47.61 76.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.874 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . 0.433 ' HB2' ' HB3' ' A' ' 474' ' ' ASP . 1.3 m-85 -66.38 -52.83 42.78 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.026 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.15 -51.55 57.29 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.617 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 17.1 tp -61.18 -46.98 88.25 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.046 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 82.8 m -52.32 -49.4 64.32 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.626 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.33 -52.87 63.8 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.39 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . 0.55 ' CB ' ' HG ' ' A' ' 461' ' ' LEU . . . -54.74 -42.27 71.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.842 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.48 -49.08 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.003 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 9.2 ttm -56.99 -52.36 65.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.585 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 28.7 tp -56.02 -50.35 71.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.933 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 35.8 m -56.02 -47.13 78.39 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.285 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 42.1 t -57.57 -48.39 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.909 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -54.08 -43.92 73.28 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.509 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 4.7 mt -64.19 -49.52 71.7 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.78 0.324 . . . . 0.0 110.25 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.66 -55.27 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.352 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 20.9 tt -57.21 -42.29 79.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.857 -0.156 . . . . 0.0 110.795 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -60.67 -50.3 69.07 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.504 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -61.03 -54.7 41.57 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.574 0.226 . . . . 0.0 110.526 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.11 -43.53 66.94 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.662 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 58.3 m -61.85 -50.61 71.55 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.206 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.11 82.86 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.174 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -57.63 -51.33 58.58 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.455 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 92.5 t -71.19 -47.73 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 120.988 0.423 . . . . 0.0 110.72 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . 0.505 ' O ' ' HD2' ' A' ' 499' ' ' ARG . 1.1 tmm_? -105.35 87.33 2.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.114 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -57.85 -52.31 65.99 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.614 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.51 160.43 38.07 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 111.422 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.413 ' CB ' ' HD3' ' A' ' 499' ' ' ARG . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.059 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 120.883 0.373 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 8.1 p -166.9 131.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.249 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 502' ' ' ALA . 0.0 OUTLIER 63.62 -171.73 0.17 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.636 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 2.7 pt -73.71 149.02 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.714 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 61.48 -167.46 0.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.883 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 84.29 -110.66 3.37 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.542 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 33.7 m -52.99 -48.14 67.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.578 0.227 . . . . 0.0 111.472 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.557 ' CG1' ' HA ' ' A' ' 442' ' ' PHE . 10.5 t -55.13 -52.97 39.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.931 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' A' ' 494' ' ' LEU . 22.8 t -60.41 -46.44 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.24 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.26 76.97 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.566 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.56 -55.06 35.01 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.652 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -56.37 -48.49 76.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.434 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.453 HD12 HG13 ' A' ' 487' ' ' VAL . 2.1 tp -57.95 -49.48 76.64 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.388 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 41.0 t -53.64 -48.13 69.66 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.63 82.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.262 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 41.7 t -63.23 -42.54 96.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.151 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 23.8 mt -61.84 -53.31 49.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.585 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 42.7 p -58.54 -44.92 89.78 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 18.2 tp -57.46 -49.42 76.33 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.137 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 14.9 mm -59.75 -54.14 38.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.924 0.393 . . . . 0.0 110.19 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -52.1 -49.84 62.81 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.894 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 10.5 mtt -63.7 -43.15 97.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.838 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.56 -45.67 84.86 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.183 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -35.21 36.39 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -51.83 -57.39 9.47 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 4.6 mtp -145.71 59.86 1.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.957 0.408 . . . . 0.0 111.603 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -171.83 -177.06 1.87 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.394 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . 0.499 ' HB2' ' HB2' ' A' ' 426' ' ' ALA . 53.6 m-85 -91.89 150.69 20.91 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.74 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.552 ' HB3' ' N ' ' A' ' 469' ' ' THR . 0.8 OUTLIER -48.56 116.58 1.65 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.473 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 59.0 24.05 12.23 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 423' ' ' PHE . . . -66.17 163.25 18.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.727 0.299 . . . . 0.0 111.245 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . 0.433 ' CG ' ' HB2' ' A' ' 430' ' ' MET . 7.3 t-20 77.72 63.48 0.03 OUTLIER 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.997 0.427 . . . . 0.0 111.11 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -48.54 -50.35 32.45 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.65 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.3 t -54.67 -61.95 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' MET . . . . . 0.433 ' HB2' ' CG ' ' A' ' 427' ' ' ASN . 8.2 mmt -55.77 -47.89 76.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.855 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.58 -50.05 74.4 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.903 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.06 -49.95 70.31 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.039 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.18 -55.84 28.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.859 0.361 . . . . 0.0 110.57 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.421 ' O ' HG21 ' A' ' 438' ' ' VAL . 5.2 mp -57.58 -47.32 82.41 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.981 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -52.98 -57.87 13.38 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.687 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 27.5 m -54.99 -39.96 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 117.044 0.422 . . . . 0.0 110.93 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 53.1 t -60.63 -57.75 10.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.074 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 434' ' ' LEU . 15.8 m -60.93 -39.29 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.661 0.267 . . . . 0.0 110.666 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 55.8 t -59.1 -50.65 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.047 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.28 -47.78 77.94 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.974 0.416 . . . . 0.0 110.141 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.41 -47.87 80.6 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.58 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . 0.557 ' HA ' ' CG1' ' A' ' 403' ' ' VAL . 39.8 t80 -62.09 -46.13 90.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.763 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -60.44 -44.49 95.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.451 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -67.59 53.93 0.33 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.549 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.23 45.61 0.74 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 79.96 126.39 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.614 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.78 124.23 7.99 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.58 2.187 . . . . 0.0 112.407 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.7 t -143.18 152.0 41.28 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.28 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 11.9 p -50.79 -45.85 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.629 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.8 t -57.48 -53.0 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.606 0.241 . . . . 0.0 110.668 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -56.08 -50.79 70.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.292 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 28.7 m -55.81 -45.59 78.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 96.3 t -58.75 -51.66 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.491 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 8.3 mt -57.86 -52.06 62.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 120.863 0.363 . . . . 0.0 110.589 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.62 -51.66 66.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.597 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 55.9 t -57.67 -55.69 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.742 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.0 t -45.75 -52.11 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.685 0.278 . . . . 0.0 110.615 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -43.85 98.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.817 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.47 -58.27 9.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.987 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.41 -41.94 69.89 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.976 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.79 -27.92 63.27 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.994 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . 0.562 ' CD2' ' HG3' ' A' ' 466' ' ' PRO . 6.1 t80 -63.56 102.65 0.45 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.892 0.377 . . . . 0.0 111.584 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -144.49 81.97 1.68 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.257 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 20.2 mt 58.12 87.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.455 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . 74.98 72.12 0.22 Allowed Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.715 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . 0.562 ' HG3' ' CD2' ' A' ' 462' ' ' PHE . 54.8 Cg_endo -68.1 156.0 67.44 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.679 2.253 . . . . 0.0 113.129 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . 0.552 ' HB2' ' O ' ' A' ' 466' ' ' PRO . 0.0 OUTLIER 84.67 -70.6 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.865 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.522 ' C ' ' HB3' ' A' ' 424' ' ' ASP . . . -123.01 165.14 15.69 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.985 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' THR . . . . . 0.552 ' N ' ' HB3' ' A' ' 424' ' ' ASP . 2.7 t -175.13 160.38 2.71 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.724 0.297 . . . . 0.0 111.279 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.38 66.35 3.94 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.075 0.464 . . . . 0.0 110.815 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -124.17 -63.79 1.18 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.133 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . 0.481 HG23 HG11 ' A' ' 475' ' ' VAL . 0.3 OUTLIER -142.54 151.87 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.976 0.417 . . . . 0.0 112.115 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.5 t -92.76 30.07 1.64 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.203 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.24 -69.39 0.81 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.947 0.403 . . . . 0.0 110.623 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.481 HG11 HG23 ' A' ' 472' ' ' VAL . 10.7 p -55.55 -38.81 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.095 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -45.59 74.3 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.951 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.88 -49.99 46.84 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.675 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -52.63 61.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.53 -50.73 72.38 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.545 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 95.2 m -53.89 -46.44 71.38 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.443 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.86 -47.68 84.76 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.286 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -57.9 -44.42 86.77 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.126 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.74 -45.6 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.039 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 65.9 mtp -58.19 -52.76 64.2 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.14 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.73 -43.22 76.38 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 46.5 m -58.94 -48.3 81.98 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.623 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.453 HG13 HD12 ' A' ' 408' ' ' LEU . 24.2 t -56.32 -50.5 71.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.684 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -54.69 -46.63 74.39 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.06 -49.56 76.49 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 79.6 t -55.93 -47.89 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.375 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . 0.442 ' O ' ' HG ' ' A' ' 494' ' ' LEU . 52.6 mt -54.89 -42.35 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.531 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -69.28 -45.9 59.31 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.55 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -56.21 -52.08 65.71 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.586 0.232 . . . . 0.0 110.916 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 491' ' ' ILE . 4.0 pp -62.6 -44.83 95.33 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.422 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 90.7 m -57.23 -43.87 83.28 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 500' ' ' TYR . . . -66.53 -54.32 25.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.584 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -53.7 -52.98 38.59 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.704 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 4.8 t -47.89 -33.58 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 120.609 0.243 . . . . 0.0 111.355 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.05 22.6 15.71 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.419 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 496' ' ' ALA . 1.6 t80 -137.03 61.46 1.62 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.791 0.329 . . . . 0.0 111.011 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 79.82 130.88 0.05 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.193 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 398' ' ' GLN . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.65 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 120.43 0.157 . . . . 0.0 111.414 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 6.8 m -93.15 129.59 43.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.832 0.349 . . . . 0.0 111.09 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . 0.404 ' O ' ' HB ' ' A' ' 399' ' ' ILE . 32.8 tt0 -54.79 -56.11 22.93 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.274 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 446' ' ' TRP . 19.5 mm 70.83 131.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 123.39 0.431 . . . . 0.0 111.165 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 54.86 51.67 13.28 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.593 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.628 ' HA2' ' OG1' ' A' ' 495' ' ' THR . . . -147.09 -123.79 1.47 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.293 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 55.0 m -56.95 -49.69 74.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.65 0.262 . . . . 0.0 111.537 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 443' ' ' TYR . 30.1 m -55.76 -48.3 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.614 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.424 ' HB ' HG21 ' A' ' 491' ' ' ILE . 40.8 t -69.13 -40.91 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.75 97.54 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -62.27 -51.44 67.68 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.794 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -55.01 -49.24 72.03 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.677 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.04 -42.88 86.31 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.761 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -50.48 62.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.056 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.16 -48.5 78.56 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.929 0.395 . . . . 0.0 109.996 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.3 t -55.55 -57.92 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.017 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.42 HD11 ' CD1' ' A' ' 485' ' ' LEU . 19.2 tt -56.75 -41.14 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.489 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 1.3 m -56.97 -50.07 73.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.75 -47.31 86.88 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.934 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 93.7 mt -52.37 -49.98 40.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.994 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.63 77.87 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.08 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 2.0 mtt -56.5 -44.92 81.18 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.258 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.658 ' HA ' ' CB ' ' A' ' 422' ' ' ALA . 2.9 tm0? -60.18 -50.16 74.76 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.116 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -57.67 -35.82 71.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.205 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -50.93 42.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.826 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 1.1 ttp 179.46 65.43 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . 0.658 ' CB ' ' HA ' ' A' ' 418' ' ' GLN . . . -151.25 -174.9 4.96 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 122.379 -0.201 . . . . 0.0 111.463 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . 0.435 ' O ' HG13 ' A' ' 429' ' ' VAL . 0.2 OUTLIER -119.05 178.03 4.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.933 0.397 . . . . 0.0 111.988 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.41 98.19 10.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.418 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 430' ' ' MET . . . 45.86 43.39 10.04 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -81.43 -73.16 0.39 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.201 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -125.81 -84.71 0.63 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.069 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.29 -56.97 15.34 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.677 0.275 . . . . 0.0 110.907 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 423' ' ' PHE . 7.3 p -55.41 -33.56 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.805 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 425' ' ' ALA . 0.0 OUTLIER -57.0 -52.25 66.02 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.254 178.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.15 -44.3 95.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.072 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -56.97 -56.72 18.1 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.733 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.28 -44.29 79.66 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.068 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 6.2 tp -54.56 -51.16 66.12 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.94 -45.95 93.08 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.08 -44.28 82.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 98.4 t -55.87 -47.04 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.874 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.71 -47.07 86.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.419 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.62 -51.78 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.594 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -57.65 -50.08 74.36 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.543 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -47.91 79.3 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.406 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.09 -40.89 95.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.377 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . 0.515 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 6.7 m-30 -65.88 -44.99 83.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.006 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.82 58.62 1.74 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.488 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 445' ' ' ARG . 21.2 tpt180 -89.86 60.13 4.86 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.184 0.516 . . . . 0.0 110.922 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . 0.451 ' NE1' ' OG ' ' A' ' 448' ' ' SER . 15.4 t-105 -178.56 125.7 0.26 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.466 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -95.01 128.23 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.289 2.659 . . . . 0.0 112.939 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.451 ' OG ' ' NE1' ' A' ' 446' ' ' TRP . 14.6 m -164.69 65.82 0.14 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.791 0.329 . . . . 0.0 111.725 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 60.5 t 64.92 -69.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.969 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.9 t -53.26 -46.2 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.564 0.221 . . . . 0.0 110.812 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.57 90.97 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 1.4 m -61.14 -52.29 65.5 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.28 -47.73 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.771 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.36 -50.04 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.757 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.31 -48.76 70.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.949 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 63.1 t -56.02 -56.14 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.215 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.72 -46.1 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.819 0.342 . . . . 0.0 110.097 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 18.0 t -54.63 -47.42 73.5 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.92 -50.66 72.88 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.414 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.37 -41.82 76.81 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.794 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.7 tt -70.97 -38.18 72.78 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.811 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.48 150.1 2.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.513 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 6.4 t80 69.65 -61.08 0.45 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.663 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.452 HD13 HG23 ' A' ' 464' ' ' ILE . 64.2 mt -55.35 -56.29 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.13 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -44.81 -61.52 2.16 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.7 -18.71 19.3 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.66 2.24 . . . . 0.0 113.521 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.67 63.91 1.56 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.179 0.514 . . . . 0.0 111.253 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 146.74 57.15 0.02 OUTLIER Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.104 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 3.2 m -147.83 144.12 27.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.699 0.285 . . . . 0.0 110.824 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . 0.426 HD21 ' HB ' ' A' ' 472' ' ' VAL . 0.7 OUTLIER -102.71 97.6 7.75 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.012 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.85 56.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . 0.426 ' HB ' HD21 ' A' ' 470' ' ' LEU . 69.2 t -151.96 -54.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 29.6 t -154.37 42.33 0.5 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . 0.44 ' HB3' ' CB ' ' A' ' 477' ' ' TYR . 7.9 t70 -66.48 112.61 4.17 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.925 0.393 . . . . 0.0 111.762 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.85 -40.86 74.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.996 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -66.01 -42.49 89.63 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . 0.44 ' CB ' ' HB3' ' A' ' 474' ' ' ASP . 0.8 OUTLIER -59.7 -54.96 40.3 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.381 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.7 tt -55.67 -48.75 74.52 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.207 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.19 -45.23 79.88 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.955 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 24.8 m -57.56 -44.66 85.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.819 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -61.48 -48.95 78.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.76 80.38 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.482 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 78.0 t -63.68 -48.39 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.85 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 21.6 mtt -54.47 -55.07 32.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.546 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.42 ' CD1' HD11 ' A' ' 412' ' ' ILE . 2.0 tp -52.8 -48.37 66.96 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.999 0.428 . . . . 0.0 109.969 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 24.2 m -56.41 -48.93 75.94 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.935 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.422 HG12 ' CD1' ' A' ' 491' ' ' ILE . 91.7 t -56.98 -42.4 78.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.092 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.395 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . 0.513 ' HA2' HD13 ' A' ' 491' ' ' ILE . . . -56.65 -45.84 89.86 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.47 -49.85 71.42 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.47 -44.25 88.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.867 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . 0.513 HD13 ' HA2' ' A' ' 488' ' ' GLY . 15.7 mt -55.89 -42.29 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.967 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.17 -49.31 76.02 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.479 -0.867 . . . . 0.0 110.995 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -54.06 -48.93 70.06 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.747 0.308 . . . . 0.0 110.348 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 11.1 tp -67.79 -35.93 79.54 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.665 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.628 ' OG1' ' HA2' ' A' ' 401' ' ' GLY . 98.0 m -51.51 -49.86 61.09 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -64.71 -47.05 79.74 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.509 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -54.46 -43.29 77.1 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.876 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 68.0 t -76.12 -43.13 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.752 0.311 . . . . 0.0 110.524 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -62.11 -47.14 85.92 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.294 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -97.38 60.83 1.65 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.992 0.425 . . . . 0.0 110.984 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -129.85 147.71 51.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.238 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.098 179.879 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.153 0.025 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 36.6 t 77.07 136.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 123.473 0.483 . . . . 0.0 111.192 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.84 -61.08 1.13 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.338 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 19.5 tt -144.34 114.62 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.704 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.4 ' HB2' HD12 ' A' ' 494' ' ' LEU . 0.0 OUTLIER 66.46 -175.04 0.19 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.475 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.522 ' HA2' ' OG1' ' A' ' 495' ' ' THR . . . 115.71 -131.43 9.65 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.975 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -37.22 72.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.43 0.157 . . . . 0.0 111.373 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 443' ' ' TYR . 15.2 m -55.8 -57.8 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.525 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.401 ' CG2' HG12 ' A' ' 491' ' ' ILE . 24.6 m -63.55 -38.02 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.85 76.7 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.119 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 409' ' ' SER . . . -61.68 -46.09 91.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.631 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -56.46 -56.59 19.27 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.362 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.18 -39.95 84.14 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.127 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 406' ' ' ALA . 33.6 t -51.08 -51.6 51.71 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.326 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.46 -47.43 81.85 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.308 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.439 HG22 HG21 ' A' ' 436' ' ' VAL . 69.7 t -53.57 -58.19 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.66 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 4.2 tp -58.5 -39.91 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.602 0.239 . . . . 0.0 110.74 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 85.9 m -61.33 -44.36 97.33 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 109.809 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -50.06 72.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.857 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 8.7 mm -56.49 -46.11 82.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.044 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -54.38 -49.42 69.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.779 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 1.7 ttm -57.82 -42.77 84.98 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.074 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.639 ' HA ' ' CB ' ' A' ' 422' ' ' ALA . 0.8 OUTLIER -55.43 -50.86 68.7 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.083 178.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -58.25 -41.99 85.42 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.63 -54.44 42.75 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.725 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -179.19 78.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . 0.639 ' CB ' ' HA ' ' A' ' 418' ' ' GLN . . . -155.21 168.99 25.22 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 111.933 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -67.65 178.58 1.62 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.644 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.476 ' HB2' HG22 ' A' ' 469' ' ' THR . 0.6 OUTLIER -87.17 -177.76 6.07 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.768 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -66.81 57.64 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.118 0.485 . . . . 0.0 111.664 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -152.5 -61.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.554 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -89.65 117.46 28.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.24 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 72.52 -58.57 0.59 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.264 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.407 HG21 ' HG2' ' A' ' 418' ' ' GLN . 40.3 t -51.42 -51.28 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.483 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 3.2 ttm -55.68 -43.78 76.72 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 110.195 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.51 -48.75 78.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.799 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -57.45 -48.01 80.3 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.678 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 3.2 tp -57.52 -47.1 82.89 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.009 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -48.78 71.98 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.834 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -56.53 -57.72 18.01 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.508 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 411' ' ' VAL . 10.1 m -56.08 -44.34 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.723 0.262 . . . . 0.0 110.653 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 56.3 t -57.77 -46.54 86.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 37.9 t -58.14 -45.58 88.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 51.8 t -55.88 -47.41 79.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.65 -47.26 86.32 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.167 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -41.41 81.84 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.316 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -66.79 -44.88 80.13 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.627 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . 0.436 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 9.9 m-85 -70.77 -47.68 58.36 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.344 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -61.89 134.68 46.55 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.807 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -138.58 -56.12 0.63 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.568 0.223 . . . . 0.0 111.386 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.84 121.08 75.91 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 120.772 0.32 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -88.87 161.28 6.1 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.159 2.573 . . . . 0.0 114.237 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.2 p 176.9 -174.14 0.11 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.453 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.7 t -45.91 -48.17 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.573 0.225 . . . . 0.0 111.434 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 47.3 t -58.35 -50.39 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.633 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -57.22 -45.63 83.66 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.255 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 93.0 m -54.99 -52.15 64.02 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.59 -46.52 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.227 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 53.8 mt -55.59 -50.25 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.598 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -53.4 56.66 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.817 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 64.5 t -53.52 -55.73 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 111.159 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 57.9 t -54.65 -47.6 72.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 4.4 t -59.56 -44.31 93.32 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.288 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -53.1 -49.59 66.16 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.467 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.75 -46.97 73.72 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.358 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 466' ' ' PRO . 0.4 OUTLIER -52.22 -36.89 53.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.016 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.89 59.14 0.16 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.18 0.514 . . . . 0.0 111.022 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -158.18 61.72 0.45 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.775 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 4.3 mt 63.1 31.85 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.231 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . 0.555 ' HB2' ' HB ' ' A' ' 469' ' ' THR . . . 51.71 73.08 1.03 Allowed Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.981 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 461' ' ' LEU . 77.7 Cg_exo -50.31 95.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.178 2.585 . . . . 0.0 112.501 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . 0.439 ' NH1' ' OG1' ' A' ' 480' ' ' THR . 1.5 ttm180 173.52 -50.06 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.42 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 149.53 53.59 0.02 OUTLIER Glycine 0 C--N 1.33 0.25 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.598 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' THR . . . . . 0.555 ' HB ' ' HB2' ' A' ' 465' ' ' ALA . 6.0 t -65.46 -34.62 78.72 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -75.19 -54.0 7.86 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.613 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -119.31 76.66 1.14 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.134 0.492 . . . . 0.0 111.409 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 14.5 p -78.25 130.3 36.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.612 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 46.9 m -121.98 -77.16 0.59 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -135.12 -65.48 0.61 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.433 0.158 . . . . 0.0 111.27 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 59.7 t -42.24 -42.78 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.016 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -54.48 -55.23 31.14 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.819 0.342 . . . . 0.0 111.107 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -69.82 -49.98 47.37 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.147 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.49 -54.93 25.99 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.968 0.413 . . . . 0.0 110.803 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.38 -48.8 80.25 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.617 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' THR . . . . . 0.439 ' OG1' ' NH1' ' A' ' 467' ' ' ARG . 73.8 m -57.59 -39.19 76.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.928 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -49.46 74.75 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.04 -44.08 91.74 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.036 0.446 . . . . 0.0 110.353 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 85.8 t -62.06 -52.27 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.269 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -49.5 74.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.488 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 4.5 tt -56.21 -47.15 78.96 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 35.0 m -58.44 -50.98 71.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.224 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 60.6 t -57.5 -47.42 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.413 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -57.3 -48.67 78.55 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 5.7 tt -55.42 -50.23 70.34 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 55.2 t -56.53 -48.39 80.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.859 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . 0.401 HG12 ' CG2' ' A' ' 404' ' ' VAL . 90.4 mt -58.55 -41.24 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.454 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.56 -58.31 12.82 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.666 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -55.58 -47.4 76.5 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.065 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 400' ' ' GLN . 2.7 tm? -58.74 -44.99 90.64 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.455 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.522 ' OG1' ' HA2' ' A' ' 401' ' ' GLY . 72.0 m -59.7 -42.93 94.11 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.94 -57.93 9.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.959 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.78 -48.17 85.69 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.615 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.9 p -60.92 -29.64 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 3.7 ttm105 -91.66 -43.04 9.84 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.672 0.272 . . . . 0.0 110.91 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.64 95.95 5.39 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.031 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.44 -36.04 34.14 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.365 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.071 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 1.2 mmm . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 6.2 m -63.65 125.61 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.937 0.399 . . . . 0.0 111.602 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -91.74 74.21 5.79 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 110.721 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 37.2 mm -56.99 -38.97 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.022 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.97 140.05 47.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.823 0.344 . . . . 0.0 111.356 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.474 ' O ' HG21 ' A' ' 404' ' ' VAL . . . 165.08 -110.27 0.41 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.252 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.6 t -53.92 -44.76 70.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 110.168 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.71 -54.28 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.788 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 401' ' ' GLY . 21.3 m -61.06 -42.48 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.536 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.81 53.7 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.8 87.73 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.934 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -55.86 -51.83 66.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.836 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.4 HD11 ' CD1' ' A' ' 412' ' ' ILE . 2.4 tm? -55.19 -43.93 74.84 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.2 t -57.81 -44.56 86.44 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.129 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.35 96.57 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.239 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 79.2 t -60.06 -51.39 73.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.107 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.493 HD13 HG22 ' A' ' 412' ' ' ILE . 51.6 mt -56.16 -46.28 81.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' THR . . . . . 0.445 HG23 ' SD ' ' A' ' 417' ' ' MET . 36.5 m -57.69 -48.01 80.74 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.142 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.465 ' CD1' ' HB3' ' A' ' 432' ' ' TYR . 9.3 tp -59.11 -57.42 13.15 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.358 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 5.2 tt -58.23 -43.97 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.583 0.23 . . . . 0.0 111.053 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.37 -54.69 43.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.465 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' MET . . . . . 0.445 ' SD ' HG23 ' A' ' 413' ' ' THR . 7.1 mtp -55.86 -49.99 71.83 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.86 -53.51 39.68 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.735 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -57.79 -43.04 85.35 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.526 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.0 -50.44 62.22 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.518 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.17 126.04 14.41 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.617 0.246 . . . . 0.0 111.518 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 68.92 88.14 0.11 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.684 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 424' ' ' ASP . 4.2 t80 -76.21 149.31 37.25 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.354 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.515 ' CG ' ' HB ' ' A' ' 469' ' ' THR . 54.8 m-20 69.75 174.18 0.3 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.923 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . 0.443 ' HA ' ' CG1' ' A' ' 429' ' ' VAL . . . -96.06 98.2 10.17 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.83 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -140.83 -100.62 0.15 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.08 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -82.31 136.24 35.06 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.1 mp 69.08 -56.01 0.55 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.351 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 425' ' ' ALA . 85.4 t -51.19 -37.71 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.61 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.5 -44.95 12.92 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.572 0.225 . . . . 0.0 110.978 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.91 -51.17 69.24 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 109.961 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . 0.465 ' HB3' ' CD1' ' A' ' 414' ' ' LEU . 56.2 m-85 -57.83 -46.63 84.46 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.137 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -57.51 -51.99 67.2 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.69 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 1.8 mp -56.0 -46.71 78.66 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.015 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -51.45 -50.98 39.42 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 87.5 t -56.94 -45.81 83.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.867 0.365 . . . . 0.0 110.047 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 85.4 t -57.89 -43.82 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.345 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 88.4 t -57.33 -53.22 46.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.517 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.02 -48.69 87.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.744 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.436 ' HA ' ' CE2' ' A' ' 443' ' ' TYR . . . -55.5 -49.67 71.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.138 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.63 -48.98 70.36 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.91 -44.02 73.79 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . 0.436 ' CE2' ' HA ' ' A' ' 440' ' ' ALA . 0.1 OUTLIER -86.02 -34.26 20.82 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -67.44 71.55 0.23 Allowed Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.136 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 446' ' ' TRP . 4.9 mtm180 -122.53 151.78 41.02 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.444 0.164 . . . . 0.0 110.928 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . 0.435 ' CB ' ' O ' ' A' ' 445' ' ' ARG . 1.6 t-105 83.07 131.66 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.031 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.401 ' HD2' ' CD1' ' A' ' 446' ' ' TRP . 19.5 Cg_endo -57.13 111.01 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.652 2.234 . . . . 0.0 112.13 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.3 t -145.03 136.19 24.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.493 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 39.1 t -45.66 -59.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.698 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 14.1 m -54.38 -46.34 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.408 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -64.18 -47.72 78.71 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.826 0.346 . . . . 0.0 110.65 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 28.5 m -57.45 -56.73 18.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.253 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 34.4 m -59.73 -44.44 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.124 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 36.7 mt -59.27 -50.08 81.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.13 -49.47 66.49 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.321 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 52.0 t -54.88 -53.64 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.956 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.4 t -51.57 -52.56 20.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 462' ' ' PHE . 2.0 p -57.71 -38.76 75.81 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.012 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -60.89 -48.87 79.84 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -60.43 -46.65 89.26 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.8 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.95 -19.62 62.55 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.821 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . 0.406 ' CE2' ' HG3' ' A' ' 466' ' ' PRO . 0.1 OUTLIER -66.72 -167.77 0.05 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 111.217 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' A' ' 467' ' ' ARG . 6.9 t80 69.59 -59.17 0.5 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.207 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 17.5 tt -73.61 -42.25 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.618 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -66.56 -61.55 5.01 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.794 -0.185 . . . . 0.0 111.076 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . 0.406 ' HG3' ' CE2' ' A' ' 462' ' ' PHE . 71.7 Cg_endo -73.45 56.87 3.41 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.374 2.049 . . . . 0.0 111.964 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 463' ' ' PHE . 0.0 OUTLIER -157.28 -50.25 0.07 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.625 -179.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 136.75 89.36 0.25 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.443 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' THR . . . . . 0.515 ' HB ' ' CG ' ' A' ' 424' ' ' ASP . 0.2 OUTLIER -90.19 139.28 30.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 111.417 -179.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.47 38.27 0.77 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.368 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -157.57 82.02 0.89 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.086 0.47 . . . . 0.0 111.049 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . 0.529 ' HA ' ' HB2' ' A' ' 476' ' ' GLN . 38.7 t -109.13 -60.08 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.553 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.58 -66.15 0.19 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.614 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -158.96 -66.19 0.08 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.173 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 7.3 p -39.29 -48.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.529 ' HB2' ' HA ' ' A' ' 472' ' ' VAL . 0.3 OUTLIER -59.65 -40.49 87.86 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.507 0.194 . . . . 0.0 111.245 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -72.66 -49.13 33.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.622 0.249 . . . . 0.0 110.413 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.13 -51.44 67.92 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.234 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.24 -50.02 75.05 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.691 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 97.8 m -54.19 -42.04 69.26 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.999 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -58.5 -48.92 79.21 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.459 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.85 96.72 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.731 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.69 -49.18 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.235 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -49.04 79.37 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.103 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 6.1 tt -56.61 -46.49 80.87 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 45.8 m -56.67 -48.47 77.54 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.435 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.0 -47.72 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.002 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.64 -46.58 88.66 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 16.8 tp -58.11 -48.7 79.38 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.413 HG12 HD23 ' A' ' 494' ' ' LEU . 89.6 t -60.31 -48.55 87.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.64 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . 0.435 ' O ' ' HG ' ' A' ' 494' ' ' LEU . 83.7 mt -57.06 -46.17 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.152 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.44 -44.14 97.18 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.13 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -57.54 -56.51 20.89 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.325 0.25 . . . . 0.0 111.125 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 491' ' ' ILE . 3.0 pp -58.71 -43.32 90.06 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 15.3 m -61.13 -49.24 78.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.687 0.28 . . . . 0.0 110.589 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.84 97.89 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.036 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.65 67.64 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.446 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 499' ' ' ARG . 8.1 p -66.06 -44.25 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . 0.404 ' N ' HG13 ' A' ' 498' ' ' VAL . 0.0 OUTLIER -80.46 63.71 5.01 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.043 0.449 . . . . 0.0 110.812 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.86 119.15 3.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.667 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -123.71 39.3 3.99 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.992 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.27 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.135 -179.937 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.368 0.128 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 6.4 m -134.9 48.13 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.972 0.415 . . . . 0.0 111.562 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -62.13 115.92 4.52 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.769 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.93 -164.96 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.627 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 11.8 mt-30 -68.79 69.05 0.16 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.771 0.319 . . . . 0.0 111.839 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 494' ' ' LEU . . . -124.89 -124.8 2.87 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.653 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.61 -55.66 12.82 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 51.0 t -52.17 -48.15 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 110.828 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.627 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 2.9 t -59.78 -48.11 88.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.48 80.85 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.772 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.7 -55.92 28.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.927 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -54.82 -49.45 70.99 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.795 0.331 . . . . 0.0 110.564 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.4 ' O ' HG12 ' A' ' 412' ' ' ILE . 0.7 OUTLIER -56.06 -49.68 73.09 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.205 178.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 30.0 t -49.66 -53.01 26.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.292 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -55.48 -47.29 76.38 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.498 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 37.7 t -57.07 -46.49 84.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.337 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 408' ' ' LEU . 38.1 mm -55.69 -46.81 79.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.154 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -39.71 95.36 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.197 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 432' ' ' TYR . 0.7 OUTLIER -62.63 -52.13 64.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.724 179.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 3.0 tp -59.07 -42.03 85.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.59 -49.17 78.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 4.0 ttt -58.95 -42.88 90.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.128 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.568 ' HG2' ' HG ' ' A' ' 428' ' ' LEU . 0.0 OUTLIER -56.5 -54.6 43.85 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.031 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -54.88 -41.72 71.22 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 3.7 tp -75.08 50.06 0.46 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.14 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 2.0 mtt 177.26 -59.08 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -153.29 129.04 10.13 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.462 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -92.26 33.16 1.1 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.882 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -100.26 168.8 9.55 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.081 0.467 . . . . 0.0 111.353 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 464' ' ' ILE . . . -126.87 32.89 5.04 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.01 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -105.93 -55.15 2.37 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.432 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.92 -63.31 1.3 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.384 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.568 ' HG ' ' HG2' ' A' ' 418' ' ' GLN . 4.6 mm? -54.56 -38.35 66.54 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.652 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.423 ' HB ' ' C ' ' A' ' 425' ' ' ALA . 1.5 p -46.05 -42.24 4.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.033 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 85.1 mmm -51.23 -54.44 25.65 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 110.929 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 2.7 mp -64.31 -47.89 77.72 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.491 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . 0.482 ' HA ' ' CD2' ' A' ' 414' ' ' LEU . 28.4 t80 -59.95 -50.49 73.53 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.517 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 462' ' ' PHE . 19.8 mt -54.97 -43.86 73.89 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.407 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 4.1 tt -57.6 -54.09 50.8 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -58.46 -50.42 66.97 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.239 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 76.9 t -58.39 -44.52 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.12 -48.22 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 97.8 t -55.87 -46.0 79.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 23.9 t -60.07 -50.21 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.492 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -57.24 -48.85 77.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.8 tt -53.74 -45.4 70.52 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -65.33 -38.76 91.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.005 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 400' ' ' GLN . 0.2 OUTLIER -65.42 -45.41 84.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.445 179.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.434 ' O ' ' HD3' ' A' ' 445' ' ' ARG . . . -64.17 76.79 0.05 OUTLIER Glycine 0 C--N 1.337 0.584 0 N-CA-C 114.61 0.604 . . . . 0.0 114.61 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 444' ' ' GLY . 0.0 OUTLIER -148.61 -65.78 0.24 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.775 0.322 . . . . 0.0 110.422 178.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -128.84 66.28 75.13 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 121.186 0.517 . . . . 0.0 109.823 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.496 ' CB ' ' HB2' ' A' ' 451' ' ' ALA . 83.3 Cg_endo -80.13 155.69 22.74 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.018 2.479 . . . . 0.0 113.819 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.8 73.87 1.44 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.488 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 79.2 t 72.12 -65.74 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.499 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . 0.41 HG22 ' OE1' ' A' ' 400' ' ' GLN . 2.9 m -50.98 -53.21 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 120.553 0.216 . . . . 0.0 110.96 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.496 ' HB2' ' CB ' ' A' ' 447' ' ' PRO . . . -58.46 -39.8 80.89 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.923 0.392 . . . . 0.0 110.384 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.89 -50.46 73.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.326 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 45.0 t -55.85 -52.39 49.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.853 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . 0.468 HG23 ' HA ' ' A' ' 451' ' ' ALA . 17.3 tt -60.93 -39.38 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.446 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -56.22 -46.85 79.36 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 78.3 t -58.83 -54.99 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.907 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 42.1 t -52.72 -41.81 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.286 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 1.4 t -56.96 -44.09 82.23 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.0 -50.02 74.84 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.911 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -58.99 -42.06 89.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.926 0.393 . . . . 0.0 110.51 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -43.43 84.2 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.65 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . 0.428 ' HA ' ' CD1' ' A' ' 433' ' ' LEU . 6.3 t80 -68.9 58.56 0.09 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.215 0.531 . . . . 0.0 111.122 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -176.78 49.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.173 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 425' ' ' ALA . 10.1 mt 58.83 37.44 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.439 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . 71.79 136.66 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.168 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -38.24 -38.61 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.624 2.883 . . . . 0.0 113.484 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.05 25.14 5.26 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 464' ' ' ILE . . . 87.8 -63.66 3.79 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.691 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 8.6 t -160.12 155.01 24.43 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.723 0.296 . . . . 0.0 110.781 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . 0.475 ' HB3' HG23 ' A' ' 475' ' ' VAL . 12.9 tp -75.41 67.63 1.99 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.99 0.424 . . . . 0.0 111.636 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -109.39 67.55 0.65 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.126 0.488 . . . . 0.0 111.453 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 1.1 t -141.08 35.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.525 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 6.3 t 71.22 160.29 0.22 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.555 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.14 33.03 1.59 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.743 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.475 HG23 ' HB3' ' A' ' 470' ' ' LEU . 11.2 p -51.13 -44.52 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.92 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -61.52 -58.13 9.37 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.588 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -55.15 -44.59 75.26 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.048 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . 0.456 ' HB3' HD23 ' A' ' 470' ' ' LEU . 2.8 tt -56.94 -52.25 65.96 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.776 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.58 -46.23 90.78 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 55.3 m -54.49 -47.47 72.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.198 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -61.8 -53.94 49.03 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.667 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -53.91 -44.77 70.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.948 0.404 . . . . 0.0 110.738 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.0 -50.18 76.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.332 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 34.2 mtt -53.93 -53.58 50.73 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.722 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 21.3 tp -55.78 -50.79 69.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.397 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 25.7 m -55.72 -47.25 77.22 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.543 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 78.9 t -60.34 -49.24 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.46 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -58.11 -45.5 93.85 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.752 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 20.5 mt -62.45 -48.09 81.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.84 0.352 . . . . 0.0 110.09 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 5.0 t -58.76 -59.33 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.043 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 2.6 pp -55.84 -35.39 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.087 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -60.36 -56.41 24.64 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.368 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -41.74 99.54 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.608 ' HA ' ' HA2' ' A' ' 401' ' ' GLY . 0.2 OUTLIER -57.86 -50.23 74.0 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.166 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 1.1 m -64.23 -44.36 92.12 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.6 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.82 80.29 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.988 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -67.2 -46.32 72.87 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.455 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 90.4 t -74.37 -42.66 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.737 0.303 . . . . 0.0 111.342 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -96.83 101.14 12.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.851 0.358 . . . . 0.0 110.922 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -53.17 115.97 2.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.776 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.45 144.47 28.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.119 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.437 -0.792 . . . . 0.0 111.315 179.878 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 2.1 tmt? . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.481 0.182 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 8.0 p -160.69 140.51 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.01 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -54.51 -65.87 0.5 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.591 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 1.5 tp -165.57 -61.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.437 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.533 ' HG3' ' CE1' ' A' ' 443' ' ' TYR . 21.9 tt0 -150.24 114.83 5.23 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.615 0.245 . . . . 0.0 111.08 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.451 ' HA2' ' CG2' ' A' ' 495' ' ' THR . . . -175.7 -113.01 0.32 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.697 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.98 -52.19 2.47 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.773 0.656 . . . . 0.0 112.773 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.504 HG13 HG13 ' A' ' 439' ' ' VAL . 29.5 t -50.53 -56.2 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.746 0.308 . . . . 0.0 111.414 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.475 HG12 HG21 ' A' ' 491' ' ' ILE . 12.1 t -64.98 -40.79 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.873 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.7 82.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.81 83.96 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.661 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.453 ' HB1' HG21 ' A' ' 439' ' ' VAL . . . -53.54 -56.7 14.86 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.15 178.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 2.9 mp -55.89 -43.05 76.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.315 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.1 m -55.91 -53.25 59.1 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.78 -48.96 78.18 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.137 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 55.8 t -55.05 -41.9 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.335 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.418 ' O ' HG22 ' A' ' 415' ' ' ILE . 11.9 mm -58.46 -50.87 77.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.2 -38.8 77.45 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.257 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 9.3 mt -65.65 -58.11 6.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 412' ' ' ILE . 2.3 tp -55.3 -39.7 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.601 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.98 83.87 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 32.5 ttm -54.79 -50.92 67.32 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.836 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -60.73 -40.19 91.43 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.202 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . 0.46 ' CE2' ' HB3' ' A' ' 477' ' ' TYR . 1.0 OUTLIER -56.44 -39.72 73.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.049 179.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.66 -36.8 16.03 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.842 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' MET . . . . . 0.406 ' HB3' ' CE2' ' A' ' 423' ' ' PHE . 0.0 OUTLIER -88.98 -164.82 1.2 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.926 0.393 . . . . 0.0 111.405 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -159.46 124.74 4.15 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.213 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . 0.406 ' CE2' ' HB3' ' A' ' 421' ' ' MET . 3.6 p90 -177.07 172.07 2.01 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.853 0.358 . . . . 0.0 111.246 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.46 178.38 5.31 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . 0.401 ' HB2' ' HB1' ' A' ' 465' ' ' ALA . . . -87.19 -19.41 28.44 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -55.58 155.38 5.62 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 49.5 t30 68.52 -63.55 0.34 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.583 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.92 -49.25 78.44 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.292 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' ' 433' ' ' LEU . 7.4 p -50.2 -39.91 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 121.175 -0.21 . . . . 0.0 110.763 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -51.58 35.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.395 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.46 -48.61 78.71 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -57.96 -51.83 68.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.724 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.494 ' CD1' ' HA ' ' A' ' 462' ' ' PHE . 0.0 OUTLIER -55.13 -42.63 73.26 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.121 178.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 3.6 tp -55.16 -51.89 65.04 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -59.28 -48.32 86.51 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.786 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 57.9 t -57.44 -41.33 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.682 0.277 . . . . 0.0 110.375 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.75 -43.02 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.928 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 71.8 t -59.15 -50.31 80.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.504 HG13 HG13 ' A' ' 403' ' ' VAL . 69.7 t -60.8 -43.45 95.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.844 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 444' ' ' GLY . . . -57.71 -50.51 72.95 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.415 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.58 -40.16 78.37 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.847 0.356 . . . . 0.0 110.197 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . 0.474 ' HB3' HG12 ' A' ' 403' ' ' VAL . 1.3 t80 -69.11 -35.97 77.01 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.275 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . 0.533 ' CE1' ' HG3' ' A' ' 400' ' ' GLN . 8.0 t80 -88.26 -19.26 27.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 440' ' ' ALA . . . -60.35 64.1 0.01 OUTLIER Glycine 0 C--N 1.337 0.612 0 N-CA-C 114.753 0.661 . . . . 0.0 114.753 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.0 OUTLIER -97.49 -34.78 10.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 109.99 178.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . 0.441 ' CZ3' ' HD3' ' A' ' 445' ' ' ARG . 6.1 m-90 -152.15 130.5 6.23 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.1 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.22 -62.8 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.564 2.176 . . . . 0.0 112.413 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 45.2 t 47.64 33.47 3.05 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 49.0 t 66.29 -60.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 9.9 m -48.26 -52.2 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.3 82.62 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.663 0.268 . . . . 0.0 111.078 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.57 -52.51 64.87 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.033 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 67.6 t -54.08 -48.14 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.544 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 17.2 mm -53.89 -57.63 5.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 110.473 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -49.62 66.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.595 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 92.8 t -55.37 -54.06 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.527 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 45.7 t -48.29 -50.45 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -40.02 87.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.634 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.27 -56.87 15.62 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.207 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.99 -41.55 97.48 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.342 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 1.0 OUTLIER -65.07 -31.18 72.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . 0.494 ' HA ' ' CD1' ' A' ' 433' ' ' LEU . 70.2 t80 -38.56 135.43 0.8 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.901 0.381 . . . . 0.0 111.8 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 77.01 -50.29 0.55 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.297 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 6.0 mt -74.89 -47.77 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . 0.587 ' CB ' ' HD2' ' A' ' 466' ' ' PRO . . . 72.1 178.9 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 120.63 0.253 . . . . 0.0 111.382 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 465' ' ' ALA . 36.7 Cg_endo -65.58 161.46 38.45 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.366 2.044 . . . . 0.0 112.483 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 17.9 mtt85 -65.25 165.02 12.26 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.024 0.44 . . . . 0.0 111.707 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 86.85 29.16 24.22 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.537 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 3.1 m -101.63 -58.24 1.92 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.957 0.378 . . . . 0.0 111.507 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.42 -46.36 11.77 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.674 0.273 . . . . 0.0 111.587 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -95.78 133.61 39.71 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.244 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.15 130.75 35.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.978 0.418 . . . . 0.0 111.142 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.3 m -173.63 99.77 0.11 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.2 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -53.29 -42.62 66.78 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.57 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 13.8 m -50.23 -43.9 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.664 -0.243 . . . . 0.0 111.616 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.98 -40.75 94.6 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.886 0.374 . . . . 0.0 110.654 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . 0.46 ' HB3' ' CE2' ' A' ' 419' ' ' TRP . 16.7 m-85 -68.79 -51.89 36.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.7 -49.33 73.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.64 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 2.1 tt -57.62 -53.29 59.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.289 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 48.0 m -53.83 -45.95 71.02 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.33 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -47.7 85.21 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.101 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -55.98 -45.41 78.97 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.329 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.64 -50.47 79.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.131 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 26.3 ttm -54.64 -48.23 72.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.723 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.73 -46.11 86.87 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.195 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 52.0 m -55.49 -57.89 10.03 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.729 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 27.2 m -57.53 -42.04 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.501 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -58.42 -47.15 91.42 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.97 -44.34 82.54 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.7 -53.52 47.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.006 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . 0.475 HG21 HG12 ' A' ' 404' ' ' VAL . 48.9 mt -56.62 -40.0 66.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.465 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.53 -50.42 59.3 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -49.05 76.38 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 4.8 tt -58.12 -48.91 78.77 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.451 ' CG2' ' HA2' ' A' ' 401' ' ' GLY . 88.7 m -52.17 -49.22 64.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.734 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.16 89.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.868 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -66.95 -28.64 73.88 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.685 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 39.9 t -92.98 -44.36 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.576 0.227 . . . . 0.0 111.526 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.68 63.83 0.62 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -90.09 -76.42 0.43 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.714 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.92 -50.86 6.39 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.911 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.262 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.372 179.361 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' MET . . . . . 0.411 ' HB2' HG22 ' A' ' 498' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.395 0.141 . . . . 0.0 111.109 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 12.1 m -148.36 125.53 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.399 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 46.2 46.41 13.2 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.982 0.42 . . . . 0.0 111.51 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.15 168.28 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.979 0.419 . . . . 0.0 111.907 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.576 ' HG3' ' HA ' ' A' ' 494' ' ' LEU . 9.6 pt20 -59.72 101.95 0.13 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.201 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -162.8 -77.46 0.03 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.439 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.4 t -60.54 -56.01 26.45 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.706 0.289 . . . . 0.0 111.244 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' A' ' 443' ' ' TYR . 1.6 t -61.24 -46.76 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.922 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.424 HG22 ' CA ' ' A' ' 400' ' ' GLN . 60.8 t -58.9 -47.91 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.326 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.89 83.61 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.091 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -57.03 -51.78 67.9 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.41 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -56.08 -51.27 68.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.185 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 4.1 tt -55.62 -44.02 76.67 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.312 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.57 -54.03 46.71 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.474 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.7 78.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.752 0.31 . . . . 0.0 110.454 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 88.7 t -60.4 -55.2 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.292 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.48 ' HA ' HG22 ' A' ' 415' ' ' ILE . 0.6 OUTLIER -59.59 -41.99 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.195 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 2.9 m -61.53 -54.8 38.4 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.677 0.275 . . . . 0.0 110.467 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.71 -50.05 75.02 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.062 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 412' ' ' ILE . 4.4 tt -59.81 -41.46 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.761 -0.199 . . . . 0.0 111.029 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.95 78.26 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 34.4 mtt -59.6 -47.26 86.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.852 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -56.08 -55.1 37.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.758 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -56.23 -46.47 79.54 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.121 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.04 -48.74 80.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.401 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' MET . . . . . 0.513 ' SD ' ' HB2' ' A' ' 423' ' ' PHE . 1.4 ttm -65.97 -34.93 79.23 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.021 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 76.8 62.36 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.126 0.489 . . . . 0.0 111.329 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . 0.513 ' HB2' ' SD ' ' A' ' 421' ' ' MET . 4.9 t80 -136.55 148.17 47.42 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.666 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.46 ' HA ' ' NE2' ' A' ' 476' ' ' GLN . 0.3 OUTLIER -79.69 -164.72 0.69 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.254 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -81.7 90.15 6.31 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.813 0.339 . . . . 0.0 111.515 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -153.29 134.32 14.01 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 466' ' ' PRO . 1.6 m-80 63.9 -77.55 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.097 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.45 -41.89 30.79 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.775 0.321 . . . . 0.0 110.885 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 8.5 p -48.91 -39.85 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.397 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -62.68 -54.05 45.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.659 0.266 . . . . 0.0 110.358 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 16.5 tp -59.63 -43.14 93.95 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -58.48 -51.93 67.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.409 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.475 HD23 ' HB ' ' A' ' 464' ' ' ILE . 0.1 OUTLIER -55.44 -49.53 72.21 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.839 178.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.58 -55.05 18.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.484 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.52 -51.27 58.82 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.726 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 52.4 t -53.46 -42.67 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 120.675 0.274 . . . . 0.0 110.68 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.49 -46.23 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.45 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.19 -55.57 19.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 120.912 0.387 . . . . 0.0 110.135 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.61 -46.23 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.172 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -55.57 -47.79 75.85 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.44 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.09 -45.41 75.41 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.574 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -74.72 -27.74 60.5 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.909 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . 0.423 ' HB2' ' CG1' ' A' ' 403' ' ' VAL . 9.8 t80 -86.48 -41.06 14.7 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -67.31 57.81 0.27 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 114.151 0.42 . . . . 0.0 114.151 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -46.41 6.75 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.51 66.92 75.33 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.835 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.527 ' HA ' ' HB1' ' A' ' 451' ' ' ALA . 56.0 Cg_endo -69.37 86.09 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.617 2.211 . . . . 0.0 112.869 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.56 62.78 0.39 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.681 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 54.8 t 68.8 -59.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.071 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 89.3 t -52.06 -62.92 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.595 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 447' ' ' PRO . . . -52.01 -40.2 60.64 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.689 0.281 . . . . 0.0 111.382 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.66 -54.63 36.58 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.194 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 66.7 t -55.07 -45.62 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.417 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . 0.472 ' CD1' HG22 ' A' ' 490' ' ' VAL . 27.3 mt -56.77 -50.54 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.525 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -61.22 -48.14 82.84 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.085 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.06 -58.5 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.244 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 4.0 t -50.36 -49.33 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.285 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -48.08 79.85 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.073 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -58.2 -54.35 48.02 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.651 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -58.01 -51.5 69.42 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.298 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.429 ' HG ' ' HG ' ' A' ' 479' ' ' LEU . 6.9 mp -61.14 -58.12 9.67 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.838 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -80.82 68.16 6.97 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.613 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -56.52 135.19 54.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.283 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.475 ' HB ' HD23 ' A' ' 433' ' ' LEU . 4.8 tt -65.96 77.0 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.366 0.603 . . . . 0.0 111.498 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -100.45 96.33 5.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.151 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . 0.41 ' O ' ' HA ' ' A' ' 427' ' ' ASN . 6.8 Cg_endo -48.55 -52.28 8.78 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.755 2.304 . . . . 0.0 112.283 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.4 -36.51 22.37 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.766 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 131.64 -160.53 23.52 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.166 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 23.6 m -158.73 156.57 30.1 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.682 -0.305 . . . . 0.0 110.778 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 4.6 mt -85.29 156.08 21.09 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.742 0.306 . . . . 0.0 111.12 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -126.77 137.0 53.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.732 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.68 -26.69 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.978 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.5 m -177.13 -53.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.139 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.73 49.82 1.29 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.96 0.41 . . . . 0.0 111.797 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.81 -59.81 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.223 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 424' ' ' ASP . 4.0 tt0 -56.1 -40.73 74.11 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.656 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -49.85 74.69 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -47.77 83.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.103 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . 0.429 ' HG ' ' HG ' ' A' ' 461' ' ' LEU . 6.2 mp -58.79 -52.99 63.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.138 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 18.1 m -54.48 -47.48 72.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.252 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -59.72 -48.93 79.71 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.726 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.92 83.64 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.481 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.66 -41.84 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 50.8 mtp -58.81 -52.52 65.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -45.87 81.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 490' ' ' VAL . 85.4 m -55.27 -48.99 73.22 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.443 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 99.5 t -57.63 -47.6 85.11 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.617 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -53.02 -45.7 61.92 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 1.3 tt -58.68 -46.88 86.24 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.472 HG22 ' CD1' ' A' ' 454' ' ' ILE . 41.4 t -58.02 -41.65 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.889 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 55.0 mt -58.14 -53.28 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.97 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -56.79 -49.4 70.86 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.888 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -45.32 92.27 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.687 0.279 . . . . 0.0 110.761 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.576 ' HA ' ' HG3' ' A' ' 400' ' ' GLN . 0.2 OUTLIER -62.74 -46.47 87.93 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.077 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.478 ' N ' ' HG ' ' A' ' 494' ' ' LEU . 3.5 m -53.84 -46.44 71.2 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.49 -45.75 91.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.681 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.14 -47.85 88.95 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.24 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . 0.458 HG12 HD11 ' A' ' 494' ' ' LEU . 7.4 p -73.68 59.86 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.588 0.709 . . . . 0.0 110.672 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 82.7 mmt-85 -152.32 -62.48 0.16 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.442 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -153.62 128.02 9.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.767 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.77 135.35 33.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.898 0.38 . . . . 0.0 111.302 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.168 179.922 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 120.392 0.139 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.2 143.94 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.112 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -101.01 65.22 1.08 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.152 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.511 HG23 ' HD3' ' A' ' 445' ' ' ARG . 34.0 pt 44.66 -152.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.042 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.48 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 52.6 tp60 45.83 47.82 12.05 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.191 0.52 . . . . 0.0 111.616 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -141.7 -137.49 3.39 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.192 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.8 -41.92 57.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.735 0.268 . . . . 0.0 111.272 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 8.6 m -59.36 -47.56 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.894 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 39.0 t -64.53 -41.54 92.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.83 88.57 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.076 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.99 -50.06 74.93 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.119 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -54.44 -51.71 64.11 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.285 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 2.7 mp -58.68 -45.68 88.89 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.171 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.3 t -54.58 -50.72 67.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.04 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.46 -52.3 58.71 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.033 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 46.6 t -52.92 -53.08 23.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.333 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.42 ' O ' HG22 ' A' ' 415' ' ' ILE . 35.9 mt -61.92 -49.91 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.207 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 39.5 m -55.28 -45.63 76.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.675 0.274 . . . . 0.0 110.502 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 3.1 mp -65.47 -54.59 26.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.265 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.466 ' HB ' ' CE1' ' A' ' 432' ' ' TYR . 0.1 OUTLIER -56.81 -44.18 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.452 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -61.23 -51.42 69.05 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.648 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 33.8 mtp -59.2 -49.4 78.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.579 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.517 ' HG2' ' HB3' ' A' ' 428' ' ' LEU . 2.8 mt-30 -60.09 -61.14 2.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.308 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 35.7 t90 -47.54 -44.9 26.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.699 0.285 . . . . 0.0 110.573 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 4.7 tt -63.45 -46.5 85.96 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.551 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 1.8 ttt -68.14 -39.97 82.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.959 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -139.09 96.95 3.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -71.2 59.24 0.26 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -169.39 118.78 0.66 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.872 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.31 67.57 2.57 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.045 0.45 . . . . 0.0 111.254 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -109.26 -74.02 0.67 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.728 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -95.59 -59.27 1.91 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.517 ' HB3' ' HG2' ' A' ' 418' ' ' GLN . 1.5 mm? -48.26 -35.01 11.24 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.16 -26.02 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.15 -51.11 63.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.587 0.232 . . . . 0.0 111.05 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.2 -40.9 97.61 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.154 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . 0.466 ' CE1' ' HB ' ' A' ' 415' ' ' ILE . 54.9 t80 -62.11 -50.98 69.73 Favored 'General case' 0 CA--C 1.526 0.034 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.612 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 6.1 tt -52.7 -52.38 56.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.37 -50.64 67.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.266 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.31 -49.09 75.4 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.679 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 64.8 t -55.77 -47.79 78.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 47.4 t -56.09 -47.13 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.063 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.0 -52.99 54.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.398 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 66.5 t -54.49 -51.96 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.573 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 444' ' ' GLY . . . -59.92 -42.33 93.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.321 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 6.8 tt -64.15 -50.53 67.83 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.67 0.271 . . . . 0.0 111.651 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . 0.483 ' O ' ' HD2' ' A' ' 445' ' ' ARG . 0.6 OUTLIER -70.92 -35.62 72.33 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . 0.562 ' OH ' ' HB ' ' A' ' 450' ' ' VAL . 37.0 t80 -87.78 -26.64 22.77 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 440' ' ' ALA . . . -61.98 -6.23 9.24 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 115.076 0.79 . . . . 0.0 115.076 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.511 ' HD3' HG23 ' A' ' 399' ' ' ILE . 2.7 ptm180 -63.08 -23.79 67.61 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.112 0.956 . . . . 0.0 111.475 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . 0.482 ' CB ' HD12 ' A' ' 399' ' ' ILE . 0.0 OUTLIER -131.6 93.0 29.63 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 120.71 0.29 . . . . 0.0 110.751 179.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.663 ' HA ' ' HB2' ' A' ' 451' ' ' ALA . 11.7 Cg_endo -56.03 -67.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.772 2.315 . . . . 0.0 112.843 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 10.8 t 58.03 -89.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.355 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 21.7 t -148.97 -59.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.664 0.269 . . . . 0.0 110.857 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . 0.562 ' HB ' ' OH ' ' A' ' 443' ' ' TYR . 40.7 t -52.74 -47.35 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.663 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . . . -59.71 -40.97 89.73 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 93.3 m -59.41 -47.41 85.57 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.15 -48.59 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.485 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 16.4 mm -54.06 -43.56 59.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.998 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -58.11 -50.27 74.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.845 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 42.4 t -57.77 -52.41 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.663 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 77.5 t -54.08 -50.34 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.239 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 13.1 t -58.3 -44.57 88.62 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.954 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -55.37 -59.21 5.12 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.888 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.49 -50.08 75.32 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.678 0.275 . . . . 0.0 110.452 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 9.1 tt -50.74 -43.51 58.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.716 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . 0.508 ' O ' ' HB3' ' A' ' 466' ' ' PRO . 7.5 t80 -55.51 -26.37 42.53 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.375 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -86.06 -27.33 24.8 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.648 0.261 . . . . 0.0 110.963 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 10.1 mt -87.31 -48.74 15.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -133.67 58.2 31.15 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . 0.508 ' HB3' ' O ' ' A' ' 462' ' ' PHE . 56.7 Cg_endo -73.69 -45.9 0.37 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.151 1.901 . . . . 0.0 112.493 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 466' ' ' PRO . 2.1 ttt85 176.82 -47.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.233 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . -93.0 57.89 2.47 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.151 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 7.6 t -122.99 138.24 54.74 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.87 132.47 55.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.061 0.458 . . . . 0.0 111.681 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -80.4 161.96 24.71 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.79 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 8.4 p 176.71 -38.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.841 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 15.0 p -89.42 -45.3 9.55 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.568 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 33.5 t70 71.85 -45.28 0.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.809 0.444 . . . . 0.0 111.93 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 42.8 t -40.75 -44.34 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 122.421 0.289 . . . . 0.0 111.545 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -62.54 -40.41 96.7 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.599 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -51.91 55.85 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.7 tt -55.33 -54.28 45.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.802 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.99 -48.43 73.31 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.975 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 69.0 m -55.0 -44.0 74.12 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.802 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.22 -50.46 71.19 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.337 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.46 88.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.635 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 91.9 t -63.14 -50.05 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.953 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 21.8 mtt -56.45 -52.67 63.8 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.141 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 2.5 tp -54.87 -46.29 74.7 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 42.9 m -57.36 -48.74 78.22 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.914 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 73.1 t -56.55 -46.33 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.47 -44.54 90.3 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 42.0 tp -56.52 -46.69 80.43 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.941 0.401 . . . . 0.0 109.983 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 34.3 t -63.22 -46.28 96.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.855 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . 0.5 HG21 HD11 ' A' ' 491' ' ' ILE . 15.9 mt -55.67 -44.68 77.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.218 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.54 -45.75 92.18 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.694 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -54.43 -53.32 55.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.595 0.236 . . . . 0.0 110.971 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 450' ' ' VAL . 2.2 pp -68.57 -41.03 80.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.552 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 79.6 m -60.16 -45.0 94.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.802 0.335 . . . . 0.0 110.415 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.15 79.37 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.449 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.35 -47.12 92.6 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.242 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 8.0 p -64.84 -30.96 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.644 0.259 . . . . 0.0 111.235 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.59 66.71 0.73 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.897 0.379 . . . . 0.0 110.769 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 5.0 t80 76.91 80.85 0.09 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.92 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -84.33 145.41 28.26 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.672 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.03 179.588 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.061 -0.019 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 96.8 t 65.7 92.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.973 0.416 . . . . 0.0 111.524 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -128.9 35.95 4.27 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.676 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.8 tt -173.62 -49.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.922 0.391 . . . . 0.0 111.324 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.564 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 0.0 OUTLIER -149.37 163.57 37.36 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.928 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.492 ' HA2' ' CG2' ' A' ' 495' ' ' THR . . . 131.08 -137.03 9.17 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.825 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.2 t -54.32 -49.69 69.11 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.54 -52.57 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.053 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.564 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 21.2 t -59.94 -48.68 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.587 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.81 69.87 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.654 0.264 . . . . 0.0 110.372 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -55.84 -49.96 71.87 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.167 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.05 80.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.004 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 1.6 mp -56.76 -47.34 80.32 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 38.5 t -51.85 -52.48 49.18 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.042 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -55.06 -55.06 35.29 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.326 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 42.2 t -52.72 -43.94 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.751 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.19 -55.07 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.476 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 44.3 p -55.93 -42.31 75.91 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.69 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -56.37 17.46 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.57 -43.82 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.733 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -60.44 -52.14 66.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.572 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 8.2 mtt -50.67 -49.73 56.53 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.72 -42.67 85.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.929 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . 0.401 ' O ' ' HG ' ' A' ' 470' ' ' LEU . 4.7 t90 -56.45 -44.24 80.29 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.352 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.43 45.7 1.3 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.114 0.483 . . . . 0.0 110.548 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 11.3 ttm -163.97 144.82 8.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.466 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -75.74 75.62 2.71 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.895 0.378 . . . . 0.0 111.604 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' A' ' 428' ' ' LEU . 0.8 OUTLIER -138.13 128.27 25.83 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.052 0.453 . . . . 0.0 111.635 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.486 ' HA ' ' HA2' ' A' ' 468' ' ' GLY . 3.1 m-20 -80.26 159.98 25.7 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.646 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -71.56 59.5 0.31 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.185 0.517 . . . . 0.0 111.48 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -146.51 141.52 27.12 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 66.4 -66.6 0.17 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.1 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.552 ' HB2' ' CE1' ' A' ' 423' ' ' PHE . 1.1 tt -63.73 -39.12 93.51 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.683 0.278 . . . . 0.0 110.787 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 4.4 p -52.15 -28.07 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.78 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 30.2 mtt -51.37 -44.56 62.14 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.722 0.296 . . . . 0.0 110.455 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -47.69 84.62 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.175 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -62.2 -47.29 85.12 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 7.8 tt -53.48 -51.54 62.42 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.78 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 5.0 mp -60.33 -46.4 90.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.86 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -53.18 -55.42 24.33 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.314 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 20.0 m -61.2 -39.61 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.659 0.229 . . . . 0.0 110.462 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 34.3 t -57.89 -48.49 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 65.1 t -61.14 -48.02 90.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 443' ' ' TYR . 94.4 t -51.84 -51.37 28.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.063 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.696 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -62.49 -42.21 99.33 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.787 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 3.1 tp -49.11 -46.21 44.57 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -79.76 -36.89 36.55 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.38 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 439' ' ' VAL . 1.2 t80 -60.29 -23.67 64.35 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.131 0.573 . . . . 0.0 112.485 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 446' ' ' TRP . . . -69.0 -123.13 0.03 OUTLIER Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.653 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.71 -67.96 0.13 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.629 0.252 . . . . 0.0 110.871 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . 0.414 ' N ' ' O ' ' A' ' 444' ' ' GLY . 7.9 m-90 -126.99 71.02 75.21 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-O 121.111 0.481 . . . . 0.0 109.764 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.71 70.43 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.69 2.26 . . . . 0.0 113.249 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -57.41 12.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.824 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 27.2 t -153.53 -61.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.031 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 454' ' ' ILE . 0.2 OUTLIER -44.88 -43.54 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.159 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -54.04 -52.21 61.58 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.933 0.397 . . . . 0.0 110.718 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.04 -43.53 95.28 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.894 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 88.4 t -56.46 -52.22 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.561 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 450' ' ' VAL . 38.3 mm -61.07 -45.03 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.709 0.29 . . . . 0.0 110.305 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -55.93 -46.11 78.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.825 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 90.5 t -65.97 -47.48 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.506 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 57.7 t -54.66 -47.41 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.709 0.29 . . . . 0.0 110.657 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 70.0 m -60.88 -54.02 50.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -52.58 -47.73 66.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.474 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -60.05 4.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.755 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.9 tp -44.12 -41.45 5.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.656 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -39.97 -36.63 0.49 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -118.73 31.36 6.69 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 18.0 mt -107.86 -47.74 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.698 0.285 . . . . 0.0 111.444 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.0 113.39 4.56 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.774 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.67 59.28 1.13 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.885 2.39 . . . . 0.0 112.697 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.0 -70.89 0.12 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.888 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 424' ' ' ASP . . . -82.27 113.53 3.67 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.33 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.29 58.56 0.18 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 419' ' ' TRP . 4.0 tt -165.69 -60.15 0.03 OUTLIER 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.085 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . 59.27 -161.47 0.26 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.27 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.38 -49.57 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.607 0.242 . . . . 0.0 111.452 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 6.2 t -151.04 76.54 1.24 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.048 0.451 . . . . 0.0 110.81 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 477' ' ' TYR . 7.5 t0 -90.22 100.08 12.98 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.151 0.5 . . . . 0.0 111.482 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.25 -43.67 77.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.93 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -51.17 70.4 Favored 'General case' 0 C--O 1.228 -0.056 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 474' ' ' ASP . 34.6 t80 -53.14 -47.91 68.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.352 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.5 tt -53.24 -46.97 69.4 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -44.72 94.34 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.512 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 19.6 m -53.29 -47.87 68.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.294 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -61.49 -47.29 86.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.257 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -57.52 -45.75 84.63 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.584 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 67.7 t -64.76 -52.9 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.324 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.3 ttt -52.85 -52.35 57.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.802 0.334 . . . . 0.0 110.487 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.8 -49.75 74.42 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.086 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 41.8 m -54.78 -45.94 74.35 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.012 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 65.3 t -54.95 -51.91 48.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.905 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.52 80.05 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.418 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.41 -46.77 76.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.857 0.36 . . . . 0.0 110.134 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.91 -49.67 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.221 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.52 -38.33 56.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.99 -52.19 39.27 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -55.31 -48.5 74.03 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.944 0.402 . . . . 0.0 109.992 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -45.78 90.62 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.216 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' THR . . . . . 0.492 ' CG2' ' HA2' ' A' ' 401' ' ' GLY . 55.9 m -52.98 -43.72 66.63 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.339 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.45 85.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.307 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -69.11 -52.25 24.17 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.08 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.76 -25.23 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 14.9 tpp85 -51.4 -25.88 6.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -75.82 -1.21 24.09 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -125.03 132.46 53.21 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.611 0.243 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.138 -0.935 . . . . 0.0 111.396 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 6.4 mmm . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.414 0.15 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 40.5 t 70.64 96.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.121 0.486 . . . . 0.0 110.755 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . 0.439 ' O ' ' HD3' ' A' ' 445' ' ' ARG . 0.5 OUTLIER -158.63 170.31 22.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.217 -179.414 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.7 tp -42.1 -42.26 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.502 ' HB3' HG21 ' A' ' 404' ' ' VAL . 0.8 OUTLIER -166.71 67.58 0.1 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.85 0.357 . . . . 0.0 110.8 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -99.55 -113.1 3.42 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.771 -0.728 . . . . 0.0 114.345 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 14.3 m -34.5 -55.28 0.54 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 442' ' ' PHE . 23.7 m -53.37 -44.11 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.502 HG21 ' HB3' ' A' ' 400' ' ' GLN . 75.3 t -71.21 -44.08 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.905 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.21 76.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.25 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.66 -48.81 70.87 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.607 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -55.94 -60.09 3.97 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.998 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.04 -53.99 41.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.022 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 23.9 t -53.95 -52.18 61.46 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.427 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -53.48 -48.51 68.86 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.013 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 31.8 t -57.17 -49.41 79.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.258 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 53.4 mt -57.32 -50.92 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.49 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 25.6 m -57.37 -48.07 80.0 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.824 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -59.93 -52.27 66.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.645 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.544 HG12 ' CG ' ' A' ' 466' ' ' PRO . 94.7 mt -56.95 -49.23 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.894 0.378 . . . . 0.0 110.559 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.92 -55.2 37.6 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.292 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 24.1 ttm -54.2 -46.22 72.4 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.27 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.576 ' HA ' ' CB ' ' A' ' 422' ' ' ALA . 39.1 mt-30 -50.57 -50.45 53.67 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.819 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -70.87 -37.77 73.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.161 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.11 -56.99 12.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.414 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.55 77.0 0.33 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.974 0.416 . . . . 0.0 111.524 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . 0.576 ' CB ' ' HA ' ' A' ' 418' ' ' GLN . . . -163.31 -170.58 2.31 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.19 168.87 9.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 111.633 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -36.9 111.44 0.15 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.239 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . 54.67 23.59 4.87 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . 61.77 39.94 13.48 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.913 0.387 . . . . 0.0 111.803 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 71.78 161.07 0.23 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.868 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 2.6 mp -93.3 57.71 2.71 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.143 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.37 -67.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.807 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -53.54 56.03 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -38.16 84.36 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.836 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -63.88 -54.77 29.61 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -54.58 45.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.727 0.299 . . . . 0.0 110.717 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.63 -53.62 55.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.946 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.11 -50.97 60.29 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.732 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 43.0 t -57.42 -44.56 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.857 0.328 . . . . 0.0 110.725 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 20.3 t -57.04 -60.7 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.24 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 35.5 m -60.77 -43.62 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.543 0.211 . . . . 0.0 111.273 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.2 t -56.39 -51.0 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -61.85 -48.42 80.62 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.271 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.85 -44.67 70.54 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.829 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . 0.554 ' HA ' ' CG2' ' A' ' 403' ' ' VAL . 0.0 OUTLIER -71.62 -52.46 17.88 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.165 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . 0.419 ' O ' ' N ' ' A' ' 445' ' ' ARG . 4.1 t80 -55.01 -29.21 56.86 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.996 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -65.7 58.77 0.13 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.74 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 446' ' ' TRP . 0.1 OUTLIER -164.9 42.18 0.08 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.968 0.507 . . . . 0.0 110.601 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . 0.469 ' HB2' ' O ' ' A' ' 445' ' ' ARG . 27.4 m0 76.4 142.34 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.065 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.54 -39.87 20.08 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.469 2.112 . . . . 0.0 112.08 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 51.14 20.11 0.82 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 39.5 t 65.62 -63.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 1.8 m -52.18 -48.14 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -61.19 -47.68 85.02 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.739 0.304 . . . . 0.0 110.719 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 30.5 m -59.25 -55.09 39.35 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.401 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.65 -43.04 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.266 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . 0.442 HG21 HG23 ' A' ' 486' ' ' THR . 10.1 mt -63.63 -59.29 4.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.6 0.238 . . . . 0.0 111.069 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -54.3 -48.58 71.13 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 38.7 t -60.95 -65.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.261 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 54.9 t -47.26 -47.26 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.601 0.238 . . . . 0.0 111.072 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 11.3 t -55.83 -58.13 9.13 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.02 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.19 -51.64 68.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.164 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.25 -43.29 78.54 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.536 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 1.4 mp -68.66 -46.08 70.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.284 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -55.88 107.5 0.35 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.926 0.394 . . . . 0.0 110.893 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -98.42 -61.42 1.38 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.448 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -116.2 -54.32 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.541 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . 0.489 ' CB ' ' HB ' ' A' ' 469' ' ' THR . . . -137.15 144.49 46.21 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 111.575 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . 0.544 ' CG ' HG12 ' A' ' 415' ' ' ILE . 37.6 Cg_endo -65.29 -19.29 62.05 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.823 2.349 . . . . 0.0 113.173 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 466' ' ' PRO . 0.0 OUTLIER 177.54 64.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.051 0.453 . . . . 0.0 110.322 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 148.86 81.88 0.04 OUTLIER Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.586 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' THR . . . . . 0.489 ' HB ' ' CB ' ' A' ' 465' ' ' ALA . 0.1 OUTLIER -136.01 -70.8 0.47 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.501 0.191 . . . . 0.0 111.161 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.41 159.6 15.28 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.742 0.306 . . . . 0.0 110.785 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -70.96 62.31 0.29 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.144 0.497 . . . . 0.0 111.006 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 58.8 t -138.82 121.34 17.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.095 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' SER . . . . . 0.618 ' HA ' ' HG2' ' A' ' 476' ' ' GLN . 0.3 OUTLIER -70.84 -46.54 62.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.833 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.69 -49.37 10.48 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.599 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 76.4 t -59.47 -52.19 63.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.01 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.618 ' HG2' ' HA ' ' A' ' 473' ' ' SER . 20.7 pt20 -63.55 -37.0 85.64 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.854 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -64.5 -55.77 18.46 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.6 -47.16 82.9 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.88 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . 0.52 ' HB3' ' O ' ' A' ' 466' ' ' PRO . 5.7 mt -56.48 -52.88 63.04 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 37.8 m -54.72 -45.86 74.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.13 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -59.96 -46.93 87.84 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.032 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.77 72.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.412 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 28.5 m -64.34 -45.54 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 121.142 -0.223 . . . . 0.0 110.7 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 16.1 mtt -56.82 -55.03 39.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.23 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.27 -46.18 79.79 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.004 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' THR . . . . . 0.442 HG23 HG21 ' A' ' 454' ' ' ILE . 88.9 m -54.13 -51.91 62.75 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.959 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 94.5 t -55.94 -51.82 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.652 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.6 -48.11 79.37 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.407 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.89 -46.81 88.14 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.736 0.303 . . . . 0.0 110.78 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 454' ' ' ILE . 63.6 t -65.38 -60.11 3.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.367 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . 0.408 ' HA ' ' CD2' ' A' ' 494' ' ' LEU . 0.6 OUTLIER -52.8 -43.56 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.36 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.56 -53.31 42.52 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.065 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -58.3 -51.72 68.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.559 0.219 . . . . 0.0 111.499 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.423 ' CD2' HG12 ' A' ' 404' ' ' VAL . 1.2 pp -61.97 -47.21 85.87 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 56.8 m -57.43 -48.14 79.92 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.652 0.263 . . . . 0.0 110.909 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.51 56.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.732 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -54.73 -49.44 61.61 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.159 -0.544 . . . . 0.0 112.994 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . 0.411 HG23 ' CB ' ' A' ' 398' ' ' GLN . 8.6 p -65.83 -41.5 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 16.8 mtm105 -68.51 -44.19 75.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.842 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 76.82 136.33 0.06 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.254 0.55 . . . . 0.0 111.719 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -142.73 47.35 1.56 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.756 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.116 -179.911 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.701 0.286 . . . . 0.0 111.629 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 5.3 m -108.25 111.89 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.307 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -169.96 169.63 8.06 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.496 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.523 ' O ' ' HG2' ' A' ' 400' ' ' GLN . 1.1 tp -56.07 113.87 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.805 0.336 . . . . 0.0 110.451 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.634 ' HG3' ' HA ' ' A' ' 494' ' ' LEU . 0.0 OUTLIER 59.58 69.46 0.71 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.824 0.821 . . . . 0.0 111.086 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.518 ' HA2' ' CG2' ' A' ' 498' ' ' VAL . . . -128.58 -150.27 7.17 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.817 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.86 -51.33 61.42 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.291 0.236 . . . . 0.0 111.525 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 20.1 m -55.22 -40.19 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.477 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.472 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 2.7 t -62.42 -49.57 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.217 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 494' ' ' LEU . . . -59.17 -48.58 81.1 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.877 0.37 . . . . 0.0 110.192 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.9 81.24 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.223 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -59.04 -47.93 83.45 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.113 178.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.82 -51.15 68.47 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.925 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -45.23 86.62 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.341 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.11 82.13 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.196 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 53.5 t -55.7 -56.96 9.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.579 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 51.0 mt -53.17 -42.52 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.892 0.377 . . . . 0.0 110.114 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 29.2 m -60.68 -46.38 90.59 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.817 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.77 -44.32 93.93 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.874 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 61.4 mt -54.87 -48.46 74.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.29 83.6 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.562 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 10.5 mtt -59.87 -52.1 66.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.817 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.422 ' NE2' ' HA ' ' A' ' 428' ' ' LEU . 14.4 mm100 -56.76 -50.77 71.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.479 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . 0.519 ' HB2' ' HA2' ' A' ' 468' ' ' GLY . 0.0 OUTLIER -58.78 -42.12 88.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.621 179.229 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -30.08 71.07 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.322 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 7.3 ttt -91.66 -43.51 9.56 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.558 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . 0.413 ' HB1' ' CD2' ' A' ' 428' ' ' LEU . . . -135.33 156.32 49.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.819 0.343 . . . . 0.0 111.431 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -116.41 25.4 10.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.622 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -102.64 163.35 12.27 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 111.617 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -115.8 33.13 5.67 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -118.44 -71.34 0.74 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.061 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -65.15 -41.26 94.9 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.993 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.422 ' HA ' ' NE2' ' A' ' 418' ' ' GLN . 45.0 mt -69.81 -45.17 68.49 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.876 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.487 HG23 ' HB1' ' A' ' 465' ' ' ALA . 3.4 t -60.92 -45.04 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.921 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 20.7 mtt -48.64 -57.06 6.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 110.237 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.79 -47.76 83.67 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.103 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -52.97 -52.39 58.35 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.148 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.539 ' HG ' ' CD1' ' A' ' 462' ' ' PHE . 0.2 OUTLIER -60.49 -42.88 97.21 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.514 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.39 -48.52 65.6 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -61.11 -44.23 98.42 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 69.6 t -56.9 -40.82 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 65.7 t -61.19 -47.91 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.37 -48.33 85.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 76.9 t -57.42 -50.17 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.969 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.11 82.9 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.451 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.17 -50.48 64.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.897 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -70.76 -21.43 62.52 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.177 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . 0.401 ' CZ ' HG11 ' A' ' 404' ' ' VAL . 0.2 OUTLIER -77.24 -2.47 34.84 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -71.1 -161.38 4.2 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.807 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 446' ' ' TRP . 0.0 OUTLIER 78.33 106.08 0.07 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.932 0.493 . . . . 0.0 111.159 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . 0.415 ' HB2' ' O ' ' A' ' 445' ' ' ARG . 46.2 m0 67.51 89.29 0.1 OUTLIER Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.67 128.77 25.52 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 112.821 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 91.7 p -113.07 -87.18 0.56 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.302 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 7.2 p -178.17 -46.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.548 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.39 -48.58 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.103 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.49 ' O ' HG13 ' A' ' 454' ' ' ILE . . . -54.86 -42.35 71.92 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.172 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -49.08 74.11 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.973 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.69 -56.18 17.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.799 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 451' ' ' ALA . 1.9 pp -59.17 -41.73 84.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.717 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 451' ' ' ALA . 1.2 m120 -55.82 -52.21 64.79 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 93.0 t -55.18 -47.86 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.871 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 40.3 t -48.79 -54.08 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.282 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -43.23 93.81 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.463 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -54.98 -58.46 7.52 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.368 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -62.13 -37.38 84.94 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.269 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 463' ' ' PHE . 1.6 tp -64.78 -22.96 67.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.531 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . 0.539 ' CD1' ' HG ' ' A' ' 433' ' ' LEU . 15.5 t80 -58.9 70.17 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.347 0.594 . . . . 0.0 111.463 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 461' ' ' LEU . 0.4 OUTLIER 175.33 -45.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.088 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 36.4 mm -131.46 97.57 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.006 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . 0.487 ' HB1' HG23 ' A' ' 429' ' ' VAL . . . -94.91 148.16 34.28 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . 0.582 ' HG3' ' CG1' ' A' ' 483' ' ' VAL . 88.8 Cg_endo -76.43 170.84 19.17 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.01 2.473 . . . . 0.0 112.825 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.19 76.73 0.09 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.364 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' A' ' 419' ' ' TRP . . . 161.1 -66.68 0.26 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.317 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 476' ' ' GLN . 5.5 t -81.43 115.0 20.56 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.813 0.339 . . . . 0.0 111.86 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 473' ' ' SER . 3.7 mm? 55.17 66.29 1.27 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.301 0.572 . . . . 0.0 111.306 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -49.76 140.06 12.09 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.186 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 8.4 p 43.09 32.04 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.913 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' SER . . . . . 0.542 ' HB2' ' HB3' ' A' ' 470' ' ' LEU . 49.0 m -104.02 57.41 0.72 Allowed 'General case' 0 C--O 1.234 0.246 0 O-C-N 122.218 -0.301 . . . . 0.0 111.216 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 9.9 t70 63.78 -74.51 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.209 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 83.0 t -53.19 -45.74 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.331 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 469' ' ' THR . 0.0 OUTLIER -58.64 -35.05 71.9 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.387 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -71.01 -50.95 28.54 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 42.6 mt -58.9 -49.17 78.8 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.596 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' A' ' 466' ' ' PRO . 2.9 mm? -57.51 -52.14 66.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.261 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' THR . . . . . 0.467 ' HA ' HG21 ' A' ' 483' ' ' VAL . 39.0 m -57.19 -42.7 81.73 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.976 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -58.03 -49.04 78.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.309 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.02 -49.44 76.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.368 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . 0.582 ' CG1' ' HG3' ' A' ' 466' ' ' PRO . 17.4 m -65.64 -37.36 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.751 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 8.7 mtt -62.66 -53.76 49.59 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 4.7 tp -56.02 -43.34 77.66 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.428 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 32.9 m -59.15 -48.18 82.56 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.784 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 15.6 t -58.03 -47.68 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.096 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . 0.514 ' O ' HG13 ' A' ' 491' ' ' ILE . . . -53.41 -44.72 66.53 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -45.77 83.2 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.796 0.331 . . . . 0.0 110.169 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 69.8 t -58.88 -54.37 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.553 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 488' ' ' GLY . 2.3 pp -57.29 -42.45 80.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.71 -45.04 95.43 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.294 -0.955 . . . . 0.0 110.982 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.59 -55.7 28.96 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.304 0.241 . . . . 0.0 110.797 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.634 ' HA ' ' HG3' ' A' ' 400' ' ' GLN . 3.2 pp -61.76 -39.56 92.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.804 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 96.4 m -52.87 -48.77 66.86 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -72.72 -48.8 35.67 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.706 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -51.43 -36.26 37.73 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 116.33 -0.395 . . . . 0.0 113.611 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . 0.518 ' CG2' ' HA2' ' A' ' 401' ' ' GLY . 76.0 t -74.36 -10.11 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.945 0.373 . . . . 0.0 111.883 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -122.27 179.04 4.69 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.014 0.435 . . . . 0.0 111.299 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -116.78 125.37 51.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.996 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -147.0 145.21 29.65 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.132 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.24 179.425 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.605 0.24 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 4.0 m -120.52 136.15 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.01 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -165.45 162.8 19.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.569 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 2.9 mt -74.32 -53.34 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.408 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.05 44.64 1.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.48 ' O ' HG11 ' A' ' 404' ' ' VAL . . . -111.12 -101.48 2.62 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.278 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 9.1 t -47.23 -40.84 17.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.844 0.322 . . . . 0.0 111.142 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 22.4 m -63.04 -48.74 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.755 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.48 HG11 ' O ' ' A' ' 401' ' ' GLY . 2.5 p -69.01 -42.19 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 121.159 -0.217 . . . . 0.0 111.309 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.04 -57.35 13.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 111.048 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.53 -49.4 77.94 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.72 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -54.43 -58.68 6.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.43 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.532 HD22 ' CG1' ' A' ' 487' ' ' VAL . 0.1 OUTLIER -61.47 -49.93 74.8 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.283 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 13.7 t -51.43 -52.65 44.41 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.68 68.63 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.109 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 15.1 t -52.06 -41.81 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 18.7 mm -62.58 -52.3 61.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.923 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 24.3 p -60.1 -48.13 82.99 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.763 -0.199 . . . . 0.0 110.644 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.33 -51.06 71.54 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.745 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 40.2 mt -59.61 -48.29 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.6 -56.36 22.95 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.755 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 9.2 mtt -53.03 -46.74 68.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.656 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.477 ' HG3' ' CE1' ' A' ' 432' ' ' TYR . 18.1 tm0? -60.77 -58.29 9.1 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.63 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -51.93 -42.8 63.1 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.007 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.32 -25.55 67.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.448 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.55 137.08 34.11 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.953 0.406 . . . . 0.0 110.905 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -72.76 75.16 1.13 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 111.439 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . 0.485 ' CD1' ' HB2' ' A' ' 427' ' ' ASN . 0.2 OUTLIER -162.07 173.81 13.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.125 0.488 . . . . 0.0 111.698 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -99.37 -177.08 3.48 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.541 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . 0.584 ' CB ' ' HB2' ' A' ' 465' ' ' ALA . . . -68.38 -32.64 72.87 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.945 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -49.08 -45.25 42.91 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . 0.485 ' HB2' ' CD1' ' A' ' 423' ' ' PHE . 21.0 t-20 -60.86 -47.6 85.65 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.678 0.275 . . . . 0.0 111.367 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' A' ' 431' ' ' LEU . 2.3 mm? -91.52 28.45 1.72 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 11.0 p -48.0 -43.53 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' MET . . . . . 0.466 ' O ' ' HB2' ' A' ' 434' ' ' LEU . 21.4 ttm -57.6 -57.58 12.08 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.026 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.502 ' CD1' HD11 ' A' ' 428' ' ' LEU . 1.1 mt -57.84 -42.58 84.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.028 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . 0.477 ' CE1' ' HG3' ' A' ' 418' ' ' GLN . 5.7 m-85 -62.42 -60.03 4.13 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.055 0.455 . . . . 0.0 110.597 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.74 -57.06 14.08 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.483 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 430' ' ' MET . 8.1 mp -52.11 -46.84 65.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.984 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.18 -65.14 3.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.897 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 34.4 m -59.11 -38.23 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 441' ' ' LEU . 19.5 t -63.48 -52.35 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.923 -0.126 . . . . 0.0 110.796 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 14.9 t -55.76 -52.73 45.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 110.377 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 96.5 t -58.41 -54.62 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.256 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.95 -52.09 66.58 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 437' ' ' VAL . 1.3 tp -56.73 -47.92 78.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.609 0.242 . . . . 0.0 110.963 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -67.24 -28.98 68.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.964 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -67.84 176.62 2.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.245 0.545 . . . . 0.0 111.629 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 122.15 42.72 0.42 Allowed Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 113.104 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -134.97 116.38 14.62 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.317 0.247 . . . . 0.0 110.391 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 25.6 m95 64.77 97.85 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.598 0 CA-C-O 120.872 0.368 . . . . 0.0 111.899 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.61 76.91 1.84 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.504 2.136 . . . . 0.0 112.279 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 449' ' ' VAL . 97.6 p -104.37 -85.07 0.47 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.683 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.42 ' N ' ' OG ' ' A' ' 448' ' ' SER . 2.7 p -137.68 -51.26 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 4.5 m -46.24 -46.14 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.478 ' O ' HG13 ' A' ' 454' ' ' ILE . . . -58.78 -49.07 79.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.886 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 8.2 m -57.51 -41.65 81.2 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.731 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.08 -59.0 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 451' ' ' ALA . 1.8 pp -60.5 -42.24 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.478 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 451' ' ' ALA . 1.4 t30 -58.88 -54.68 44.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.545 0.212 . . . . 0.0 110.705 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.93 -55.48 23.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.522 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.41 HG11 ' HG3' ' A' ' 466' ' ' PRO . 3.1 t -48.45 -45.34 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.212 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 2.6 t -59.8 -57.13 14.23 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.156 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -46.35 -51.21 15.26 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.726 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . 0.51 ' CB ' ' HA ' ' A' ' 466' ' ' PRO . 11.8 m-20 -64.84 -44.64 89.11 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.595 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.594 ' HA ' ' C ' ' A' ' 465' ' ' ALA . 2.0 tt -48.83 -38.81 23.29 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.52 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -51.12 -26.39 6.53 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.263 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -100.99 48.68 0.89 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.818 0.342 . . . . 0.0 111.178 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 2.3 mt 70.95 66.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.176 0.512 . . . . 0.0 111.371 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . 0.594 ' C ' ' HA ' ' A' ' 461' ' ' LEU . . . 72.89 150.02 0.13 Allowed Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.646 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . 0.51 ' HA ' ' CB ' ' A' ' 460' ' ' ASP . 43.3 Cg_endo -66.22 55.75 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.592 2.195 . . . . 0.0 112.207 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 466' ' ' PRO . 3.2 mpp_? -164.97 -55.76 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.809 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 142.67 -59.46 0.54 Allowed Glycine 0 C--N 1.337 0.616 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.447 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 62.2 p -151.18 179.38 8.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.634 0.254 . . . . 0.0 110.763 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.02 -172.8 2.16 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 111.736 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . 57.79 -120.71 1.29 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.666 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 473' ' ' SER . 95.9 t 66.96 -59.01 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 472' ' ' VAL . 48.1 t 104.42 158.95 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.926 0.89 . . . . 0.0 111.171 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 64.49 -62.69 0.18 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.607 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 17.8 m -50.22 -41.45 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.301 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -53.23 -58.32 7.48 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.706 0.289 . . . . 0.0 111.024 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -56.94 -50.09 73.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -56.18 23.39 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.003 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.89 -50.71 71.69 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.815 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' THR . . . . . 0.474 HG23 ' SD ' ' A' ' 484' ' ' MET . 18.1 m -55.27 -51.5 66.46 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.687 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -59.32 -55.77 30.5 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.02 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -54.14 -47.63 71.7 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.653 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.92 -53.84 36.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.163 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' MET . . . . . 0.474 ' SD ' HG23 ' A' ' 480' ' ' THR . 52.2 mtp -53.9 -52.52 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.282 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -56.12 25.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.997 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 9.7 m -56.01 -57.68 11.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.988 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.532 ' CG1' HD22 ' A' ' 408' ' ' LEU . 39.2 t -53.2 -53.03 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.239 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -55.48 -52.92 44.63 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.2 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.1 -45.95 79.26 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.655 0.264 . . . . 0.0 110.377 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 68.4 t -60.34 -50.01 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.034 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 97.2 mt -51.64 -48.22 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 120.788 0.328 . . . . 0.0 110.368 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -67.65 -45.04 79.46 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.954 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -49.41 73.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.288 0.235 . . . . 0.0 111.477 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.22 -43.96 73.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.373 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 26.6 m -63.73 -41.31 98.08 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.561 0.22 . . . . 0.0 111.304 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -68.47 -50.03 55.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.313 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -67.97 -56.98 9.29 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.151 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 32.2 t -75.52 64.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.319 0.581 . . . . 0.0 110.987 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . 0.404 ' HB3' ' NH1' ' A' ' 499' ' ' ARG . 7.6 ttp-105 -148.73 41.73 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.946 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 59.87 46.24 11.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.475 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.47 -35.2 12.41 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.32 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.379 -0.82 . . . . 0.0 110.975 179.894 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 59.6 ttp . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.436 0.16 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 3.9 m -150.46 131.83 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.964 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -89.76 -38.39 13.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.08 -76.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.211 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.521 ' HG2' ' CG1' ' A' ' 404' ' ' VAL . 5.6 mt-30 -117.07 124.82 50.18 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.874 -0.148 . . . . 0.0 110.94 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.595 ' HA2' ' CD2' ' A' ' 494' ' ' LEU . . . -158.22 -132.66 1.44 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.364 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -41.09 61.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.93 0.365 . . . . 0.0 110.988 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 18.0 m -55.86 -52.49 48.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.599 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.521 ' CG1' ' HG2' ' A' ' 400' ' ' GLN . 16.3 m -72.79 -31.79 37.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 121.194 -0.203 . . . . 0.0 110.94 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.07 -45.05 90.47 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.889 0.375 . . . . 0.0 110.101 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.48 -50.91 61.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.874 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.43 ' HB2' ' HB1' ' A' ' 440' ' ' ALA . . . -56.01 -48.11 76.52 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.099 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.428 HD11 ' HA ' ' A' ' 487' ' ' VAL . 2.9 tp -58.99 -45.01 91.69 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.812 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 58.1 m -53.28 -44.32 68.16 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.24 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.16 80.14 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.266 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 75.3 t -57.7 -54.66 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.355 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 93.4 mt -52.68 -48.23 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.885 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 35.7 m -57.38 -45.23 84.68 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.661 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -56.7 -55.95 27.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.208 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.407 HD12 HG11 ' A' ' 483' ' ' VAL . 9.7 mt -54.86 -47.12 75.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.442 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.14 79.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.08 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -44.84 82.49 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.549 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.697 ' HA ' ' CB ' ' A' ' 422' ' ' ALA . 14.4 tt0 -57.7 -58.13 9.7 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.607 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -57.3 -35.77 70.24 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.62 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.62 -53.49 15.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.476 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 1.7 mtt -171.83 71.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . 0.697 ' CB ' ' HA ' ' A' ' 418' ' ' GLN . . . -156.71 115.04 3.29 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.918 0.389 . . . . 0.0 111.061 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -72.98 94.22 1.84 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.036 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 57.93 -177.22 0.07 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.865 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . 0.444 ' HA ' ' CG1' ' A' ' 429' ' ' VAL . . . -91.86 50.44 1.68 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 111.391 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -131.42 146.68 52.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.785 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 63.16 103.43 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.921 0.391 . . . . 0.0 111.02 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.9 -60.06 0.52 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.832 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.444 ' CG1' ' HA ' ' A' ' 425' ' ' ALA . 89.2 t -53.28 -46.37 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.888 0.375 . . . . 0.0 110.302 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -49.47 76.02 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.125 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 4.0 mp -58.42 -48.44 80.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.362 -0.381 . . . . 0.0 109.979 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -54.97 37.32 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.172 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.62 -43.11 79.88 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.183 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.46 -52.21 65.53 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -55.22 -47.7 72.95 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 92.3 t -56.43 -47.3 81.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 68.1 t -58.43 -44.61 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.848 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 64.2 t -58.44 -45.55 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.432 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 72.6 t -56.81 -53.11 46.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.977 0.418 . . . . 0.0 110.328 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 407' ' ' ALA . . . -59.71 -47.09 87.02 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.405 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -40.97 80.22 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.595 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.66 -37.4 86.41 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.699 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.23 -43.64 15.87 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.578 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.48 172.94 37.75 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.469 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 451' ' ' ALA . 3.7 mtt180 -130.63 -170.82 2.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 111.961 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . 0.444 ' H ' ' HD2' ' A' ' 447' ' ' PRO . 22.8 m-90 -110.93 -59.64 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.444 ' HD2' ' H ' ' A' ' 446' ' ' TRP . 53.7 Cg_endo -69.03 61.38 1.33 Allowed 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.205 1.937 . . . . 0.0 113.311 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.12 29.21 1.09 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.332 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 92.9 t 56.63 -83.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.68 0.392 . . . . 0.0 111.814 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 15.6 m -54.6 -44.83 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.563 0.221 . . . . 0.0 110.893 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 445' ' ' ARG . . . -57.76 -43.43 85.43 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.756 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -50.5 73.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.066 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 49.1 t -59.38 -48.59 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.57 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.12 -47.48 86.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.154 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.2 -49.97 75.81 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.12 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 31.8 t -54.69 -53.79 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.443 ' CG1' HD12 ' A' ' 461' ' ' LEU . 24.3 t -48.94 -53.49 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.147 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -39.81 72.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.59 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -56.21 -55.81 28.64 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.414 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.93 -42.26 99.74 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.858 0.361 . . . . 0.0 110.656 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.489 ' HG ' ' HG2' ' A' ' 466' ' ' PRO . 0.1 OUTLIER -63.78 -23.8 67.5 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.511 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -67.72 73.48 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.197 0.523 . . . . 0.0 110.918 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.54 -66.62 0.21 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.994 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.82 31.47 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.124 0.488 . . . . 0.0 111.423 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . 0.406 ' O ' ' HB1' ' A' ' 425' ' ' ALA . . . 48.79 65.31 7.26 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.814 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . 0.489 ' HG2' ' HG ' ' A' ' 461' ' ' LEU . 31.2 Cg_exo -60.63 76.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.93 2.42 . . . . 0.0 113.051 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.66 84.13 2.12 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 476' ' ' GLN . . . 57.2 40.29 91.41 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.786 -0.643 . . . . 0.0 113.32 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 8.8 t -85.81 81.34 8.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.273 0.559 . . . . 0.0 111.238 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 475' ' ' VAL . 0.1 OUTLIER 175.9 108.07 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.685 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -69.45 67.95 0.22 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.119 0.485 . . . . 0.0 112.107 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 8.6 p -159.85 141.63 4.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.883 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 42.3 t -72.48 58.13 0.4 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.866 0.365 . . . . 0.0 111.005 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.58 -74.91 0.16 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' A' ' 470' ' ' LEU . 99.1 t -59.47 -58.32 7.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.321 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.555 ' HA ' ' HA2' ' A' ' 468' ' ' GLY . 0.0 OUTLIER -57.01 -33.61 67.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.136 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -70.55 -53.45 16.05 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.17 -48.32 73.94 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.033 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.24 -48.52 78.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.652 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 61.3 m -57.87 -42.75 85.19 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.437 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -56.18 -50.9 69.89 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.887 0.375 . . . . 0.0 110.14 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.75 88.23 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.142 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . 0.407 HG11 HD12 ' A' ' 415' ' ' ILE . 54.4 t -61.62 -45.34 98.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.803 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 95.4 mtp -55.11 -54.64 40.6 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.756 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.47 -44.06 84.56 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 62.6 m -53.92 -49.77 67.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.071 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.428 ' HA ' HD11 ' A' ' 408' ' ' LEU . 88.5 t -62.44 -50.51 79.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.113 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -52.55 -42.76 58.28 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.9 -46.51 87.46 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.99 -53.34 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.232 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 7.2 tp -59.64 -39.85 80.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 120.571 0.224 . . . . 0.0 110.967 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -66.49 -47.58 68.8 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -56.14 -40.68 74.19 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.628 -0.286 . . . . 0.0 110.241 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.595 ' CD2' ' HA2' ' A' ' 401' ' ' GLY . 0.0 OUTLIER -69.59 -47.15 64.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 91.3 m -49.97 -48.45 52.19 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.638 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -83.13 -45.28 14.14 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.681 0.277 . . . . 0.0 111.474 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.583 ' HA2' ' HB3' ' A' ' 501' ' ' GLN . . . -47.84 -61.73 4.6 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.812 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.34 60.08 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.551 0.691 . . . . 0.0 110.122 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -169.81 -52.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.654 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -170.89 67.16 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.88 0.372 . . . . 0.0 111.884 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.583 ' HB3' ' HA2' ' A' ' 497' ' ' GLY . 0.7 OUTLIER -144.58 124.14 13.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.198 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.966 179.854 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 111.17 0.063 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 2.5 m 56.03 179.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 123.572 0.545 . . . . 0.0 112.237 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.8 -158.34 0.09 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.489 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.51 HD12 HG21 ' A' ' 399' ' ' ILE . 0.2 OUTLIER -61.59 129.59 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.863 0.363 . . . . 0.0 110.924 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 57.78 64.23 1.6 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.195 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -128.64 -169.24 12.57 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.75 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 24.9 t -41.0 -56.42 2.28 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.626 0.25 . . . . 0.0 111.608 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 98.2 t -53.04 -43.17 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.84 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.5 -46.72 94.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.233 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . 0.422 ' HB3' HD11 ' A' ' 494' ' ' LEU . . . -55.67 -49.42 72.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.84 0.352 . . . . 0.0 110.068 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.66 -53.27 59.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.679 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -52.19 -49.28 64.16 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.783 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.462 ' HA ' HG23 ' A' ' 411' ' ' VAL . 1.1 tp -60.27 -44.17 95.56 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -45.7 89.89 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.881 0.372 . . . . 0.0 110.262 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.27 -53.88 42.0 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.216 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 415' ' ' ILE . 35.4 m -58.86 -48.23 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.136 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.406 HD12 HG23 ' A' ' 412' ' ' ILE . 56.9 mt -55.04 -46.84 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 82.5 m -57.12 -45.47 83.44 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.762 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.3 mp -59.9 -50.76 72.49 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.215 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 411' ' ' VAL . 12.2 mm -55.76 -47.9 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.023 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.06 92.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.053 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 1.5 tpt -57.25 -46.98 82.52 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.055 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -65.53 -37.67 87.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.181 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . 0.468 ' CE3' HG22 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -60.61 -37.35 81.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.614 179.055 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.17 57.2 0.1 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.202 0.525 . . . . 0.0 110.886 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' MET . . . . . 0.451 ' O ' ' CB ' ' A' ' 422' ' ' ALA . 4.3 mtp -136.49 -37.26 0.69 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.829 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 421' ' ' MET . . . 90.54 84.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.136 0.574 . . . . 0.0 111.161 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.3 -174.01 0.38 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.737 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 14.5 p30 -75.77 -169.13 1.0 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.927 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . 0.422 ' HB2' ' HD2' ' A' ' 466' ' ' PRO . . . -85.95 5.52 32.78 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . 0.488 ' HA ' ' CB ' ' A' ' 465' ' ' ALA . . . -66.29 165.44 13.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.796 0.331 . . . . 0.0 111.203 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 70.31 -58.25 0.55 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.129 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -40.8 -36.36 0.62 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' A' ' 465' ' ' ALA . 14.7 p -45.28 -34.17 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 29.1 mtt -56.74 -58.97 5.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.834 0.35 . . . . 0.0 110.275 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 6.1 mp -67.85 -40.3 83.71 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -54.49 -56.45 18.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.913 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.53 -45.67 84.78 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.22 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.93 -51.26 61.97 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -63.42 -44.05 97.34 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.846 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.503 HG11 ' CZ ' ' A' ' 459' ' ' PHE . 39.9 t -56.34 -53.73 36.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.48 0.181 . . . . 0.0 111.025 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.73 -43.38 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.602 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 44.0 t -58.71 -52.45 59.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 70.2 t -56.11 -53.64 36.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.405 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -53.75 -47.13 70.96 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.463 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 4.0 tt -52.02 -47.26 65.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.776 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -68.4 -33.3 74.0 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.717 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 445' ' ' ARG . 3.8 m-85 -70.38 -21.86 62.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.607 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -63.53 67.55 0.04 OUTLIER Glycine 0 C--N 1.341 0.826 0 C-N-CA 121.571 -0.347 . . . . 0.0 113.271 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.0 OUTLIER -140.71 -61.83 0.49 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.121 0.486 . . . . 0.0 110.076 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -154.05 88.38 3.51 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.999 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.24 176.17 2.18 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.941 2.427 . . . . 0.0 113.663 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.8 m -171.21 153.19 3.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.409 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.0 t -39.9 -60.92 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.567 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 46.7 t -51.06 -56.29 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.437 ' CB ' HD13 ' A' ' 399' ' ' ILE . . . -53.55 -48.41 69.13 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.782 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 88.7 m -57.97 -46.12 85.66 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.248 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 88.9 t -60.97 -44.12 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.121 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 30.6 mt -56.57 -50.96 71.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 120.889 0.376 . . . . 0.0 110.218 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.62 -50.29 73.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.71 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 90.3 t -56.43 -52.34 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.145 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 55.2 t -53.68 -49.79 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.722 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -44.75 96.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.375 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . 0.503 ' CZ ' HG11 ' A' ' 436' ' ' VAL . 2.3 m-85 -58.58 -48.65 80.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.774 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.93 -44.91 96.56 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.943 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 30.0 tp -58.9 -48.23 82.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.989 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -87.14 92.94 9.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.019 0.438 . . . . 0.0 111.475 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . 0.42 ' HB3' ' HB3' ' A' ' 466' ' ' PRO . 28.8 t80 -68.12 61.8 0.08 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.044 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 11.1 mt 38.99 50.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.894 0.378 . . . . 0.0 111.999 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . 0.535 ' HB1' ' HB ' ' A' ' 429' ' ' VAL . . . 66.52 65.68 0.76 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.111 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 425' ' ' ALA . 38.5 Cg_endo -65.75 147.23 85.44 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.48 2.12 . . . . 0.0 112.156 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . 0.467 ' HD3' ' HA ' ' A' ' 467' ' ' ARG . 6.9 mmt180 -79.15 147.93 32.5 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.066 0.46 . . . . 0.0 111.175 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 78.17 -65.61 3.29 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.589 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.2 m 47.71 24.49 0.56 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.97 -53.69 2.66 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.553 0.216 . . . . 0.0 111.125 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -72.8 64.35 0.66 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.109 0.48 . . . . 0.0 111.177 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . 0.591 ' HB ' ' HB ' ' A' ' 475' ' ' VAL . 78.0 t -126.69 121.89 59.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.85 115.06 1.13 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.948 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.34 42.03 17.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.374 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.591 ' HB ' ' HB ' ' A' ' 472' ' ' VAL . 6.7 p -53.52 -42.86 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.25 -47.67 85.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.579 0.228 . . . . 0.0 111.269 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.29 -51.0 61.74 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.609 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.7 -53.44 56.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.861 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 475' ' ' VAL . 0.1 OUTLIER -57.9 -48.08 80.9 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.173 179.139 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 99.4 m -53.9 -52.54 60.2 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.397 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -59.3 -48.61 80.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.709 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.85 75.17 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.995 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . 0.406 ' O ' HG22 ' A' ' 487' ' ' VAL . 93.6 t -65.52 -52.84 46.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.497 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 3.3 ttt -52.23 -51.73 56.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.866 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -49.43 77.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.333 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 88.6 m -54.57 -58.27 8.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.159 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 483' ' ' VAL . 36.0 m -59.81 -43.92 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.814 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -55.24 -51.45 54.13 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 5.6 mt -55.36 -46.57 76.46 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.451 HG12 HD22 ' A' ' 408' ' ' LEU . 59.0 t -57.07 -45.17 84.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.577 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 50.3 mt -58.46 -46.31 89.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.792 0.33 . . . . 0.0 110.615 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.76 -53.57 33.84 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.93 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -56.76 -46.52 81.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.642 0.258 . . . . 0.0 110.78 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.422 HD11 ' HB3' ' A' ' 405' ' ' ALA . 0.6 OUTLIER -60.38 -46.3 90.47 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.165 178.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 89.9 m -54.86 -51.13 66.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.948 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.7 84.57 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.009 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -57.86 -44.0 94.52 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.439 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.56 -48.49 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 120.581 0.229 . . . . 0.0 110.498 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -79.4 54.1 1.65 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.136 0.493 . . . . 0.0 110.325 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -67.45 126.34 28.98 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.701 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -151.43 -64.74 0.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.057 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.379 179.898 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.394 0.14 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.32 138.78 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.089 0.471 . . . . 0.0 112.094 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -161.59 150.81 16.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.524 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.526 ' HB ' HD21 ' A' ' 494' ' ' LEU . 1.2 mp -90.51 -58.1 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.733 0.302 . . . . 0.0 110.455 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.523 ' HB2' HD22 ' A' ' 494' ' ' LEU . 0.7 OUTLIER -159.62 91.43 0.99 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.625 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -141.82 -98.13 0.31 Allowed Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.172 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 5.5 t -55.25 -55.03 36.04 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.667 0.27 . . . . 0.0 111.254 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 443' ' ' TYR . 17.6 m -50.46 -45.0 25.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.055 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.434 HG11 HG12 ' A' ' 491' ' ' ILE . 3.2 t -70.44 -37.42 70.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.379 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.31 96.67 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.31 -49.99 67.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.784 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -55.61 -50.79 69.21 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.327 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.96 -45.88 89.43 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.229 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 53.4 m -52.94 -42.22 65.25 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.145 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.41 -48.52 75.09 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.393 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 17.4 t -57.89 -46.93 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.393 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 23.0 mm -59.71 -45.33 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 49.0 m -58.78 -48.19 82.11 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.028 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.507 HD23 HG21 ' A' ' 436' ' ' VAL . 1.6 mp -56.18 -48.47 76.29 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.149 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 32.5 mm -61.53 -45.78 97.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.389 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -52.44 -51.58 58.47 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.033 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -47.36 85.94 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.624 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -50.63 -42.49 56.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.54 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -67.78 -45.02 76.03 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.503 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.51 -40.47 93.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.424 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 29.2 mtt -146.17 134.19 21.47 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.137 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 72.04 74.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.205 0.526 . . . . 0.0 111.398 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -55.02 159.47 2.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.877 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 65.16 173.45 0.21 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.452 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -101.2 39.2 1.44 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.74 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -141.7 84.64 1.91 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.917 0.389 . . . . 0.0 111.568 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -174.73 -67.23 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.265 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.87 -38.98 1.1 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.442 HG12 HD21 ' A' ' 414' ' ' LEU . 54.8 t -41.52 -37.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -41.17 -54.3 2.93 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 7.1 tp -57.64 -52.55 64.97 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.005 0.431 . . . . 0.0 110.494 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -58.36 -48.94 78.95 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.085 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.47 -47.76 69.46 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.915 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . 0.412 ' O ' HG22 ' A' ' 437' ' ' VAL . 2.8 tp -53.66 -49.68 67.42 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.888 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -61.49 -44.47 97.96 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.79 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . 0.507 HG21 HD23 ' A' ' 414' ' ' LEU . 63.8 t -58.16 -52.56 57.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 122.058 0.143 . . . . 0.0 111.011 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . 0.415 HG21 ' N ' ' A' ' 438' ' ' VAL . 33.3 m -56.57 -40.92 71.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.415 ' N ' HG21 ' A' ' 437' ' ' VAL . 24.6 t -59.7 -46.78 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 99.1 t -55.33 -49.62 71.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.12 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.01 75.42 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.542 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -37.9 73.2 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.734 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -70.63 -45.19 65.65 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.508 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . 0.458 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 2.9 m-85 -68.63 -49.1 61.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.508 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.466 ' O ' ' HD2' ' A' ' 445' ' ' ARG . . . -67.43 161.33 48.45 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.787 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 444' ' ' GLY . 0.0 OUTLIER -155.86 -61.01 0.11 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 122.631 -0.335 . . . . 0.0 111.501 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -81.02 108.23 9.71 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.689 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.476 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 29.7 Cg_endo -64.02 -50.21 3.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.352 2.034 . . . . 0.0 112.528 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 58.2 m 43.31 43.67 4.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.859 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 26.9 t 68.42 -57.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 13.1 t -47.5 -55.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 447' ' ' PRO . . . -57.57 -48.24 79.9 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.635 0.255 . . . . 0.0 110.976 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 12.6 m -56.21 -53.59 55.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.665 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 42.8 t -56.24 -54.51 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.664 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 52.3 mt -52.63 -52.2 28.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.578 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -55.72 -53.41 56.98 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.396 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 44.8 t -51.88 -52.34 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.516 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 86.2 t -49.73 -52.75 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.672 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 1.2 p -60.75 -41.25 95.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.762 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -61.12 -41.23 96.32 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.807 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -73.03 -42.16 63.46 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.478 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.6 tt -59.18 -46.56 88.09 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.769 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -101.17 -167.23 1.4 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.114 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -169.25 41.12 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 3.8 mt 48.75 70.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.571 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -44.1 100.87 0.24 Allowed Pre-proline 0 N--CA 1.47 0.528 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.7 -55.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.097 2.531 . . . . 0.0 112.687 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -132.76 -58.65 0.92 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.732 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . -132.41 124.26 3.83 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 18.3 m -98.81 -75.9 0.55 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.801 0.3 . . . . 0.0 111.362 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.48 159.65 0.43 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.647 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -70.86 121.61 18.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.174 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 14.9 t -53.21 -57.8 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 33.5 t 54.53 -150.39 0.4 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.057 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -83.38 -42.83 16.59 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 33.3 t -56.0 -59.77 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -40.79 95.9 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.16 -51.35 54.85 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.531 0.205 . . . . 0.0 110.849 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -51.86 67.28 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.829 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.18 -53.67 54.32 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.642 0.258 . . . . 0.0 110.378 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 42.8 m -54.29 -48.65 71.03 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.776 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -61.3 -47.38 86.21 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 110.979 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.57 73.55 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.267 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 31.3 m -64.13 -42.25 94.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 22.3 mtt -57.74 -52.82 63.89 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.336 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.33 -47.02 85.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.21 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 28.0 m -56.09 -50.21 71.67 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.197 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 491' ' ' ILE . 84.7 t -59.64 -52.77 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.005 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . 0.432 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -52.91 -44.47 61.6 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.692 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 7.1 tt -55.43 -56.49 19.55 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 30.0 m -61.07 -37.39 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.561 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . 0.434 HG12 HG11 ' A' ' 404' ' ' VAL . 62.8 mt -59.61 -44.96 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.25 -51.4 50.01 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.34 -46.34 72.9 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 110.1 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.526 HD21 ' HB ' ' A' ' 399' ' ' ILE . 16.2 tp -64.81 -44.9 88.39 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.901 178.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 98.0 m -52.1 -51.29 58.69 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -58.68 -48.2 81.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.236 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -60.5 -50.84 63.23 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.056 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 7.0 p -73.1 -40.43 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 49.63 1.77 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.083 0.468 . . . . 0.0 111.205 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -131.79 -49.78 0.96 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.62 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -105.42 -171.75 1.97 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.53 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.423 179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 120.398 0.142 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 90.2 t -150.44 109.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.732 0.301 . . . . 0.0 111.13 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -99.22 52.03 0.95 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.971 0.415 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.423 HG23 ' CZ3' ' A' ' 446' ' ' TRP . 3.4 tp -167.09 144.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.202 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.508 ' HG2' ' CE1' ' A' ' 443' ' ' TYR . 3.5 mm-40 52.2 50.67 17.93 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.942 0.401 . . . . 0.0 111.331 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -159.28 -98.96 0.15 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.031 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.8 m -45.72 -54.17 8.28 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.02 -44.62 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.992 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 71.8 t -59.4 -51.8 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.478 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.21 -55.84 29.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.896 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -55.14 -47.67 74.75 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.896 0.379 . . . . 0.0 110.534 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.538 ' HB1' HG23 ' A' ' 439' ' ' VAL . . . -56.41 -60.24 3.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.377 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -51.65 67.04 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.292 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 3.2 m -55.59 -53.4 56.89 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.567 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.97 -49.13 77.32 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.598 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.401 ' O ' ' HB ' ' A' ' 415' ' ' ILE . 35.2 t -60.6 -57.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.605 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.2 tp -55.0 -42.55 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 46.4 m -61.47 -56.59 18.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.047 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.41 -50.04 75.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.812 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.455 HG22 ' CD2' ' A' ' 419' ' ' TRP . 1.1 mp -55.69 -53.04 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 420' ' ' LEU . . . -57.66 -53.99 51.95 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.109 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 26.5 mtp -56.88 -54.95 40.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -51.92 61.13 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . 0.455 ' CD2' HG22 ' A' ' 415' ' ' ILE . 43.7 m0 -57.65 -33.0 67.84 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.148 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 3.7 tp -57.26 -29.51 63.88 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 110.904 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 2.8 ttp -97.39 -45.66 6.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.054 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 419' ' ' TRP . . . -131.18 116.74 18.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.643 0.259 . . . . 0.0 111.267 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -86.24 44.87 1.17 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -126.34 152.75 45.81 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.286 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -131.44 28.11 4.68 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.805 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -86.6 -52.32 5.62 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.797 0.332 . . . . 0.0 110.641 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -74.27 -35.34 63.75 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.665 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.11 101.93 3.43 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.533 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 5.3 p -131.32 -52.9 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.578 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 1.4 mmt -51.2 -47.19 62.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.611 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 1.5 mt -58.5 -58.75 7.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.339 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -51.72 -51.51 55.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.796 0.331 . . . . 0.0 110.456 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.05 -58.17 9.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.624 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 1.7 mp -49.11 -51.39 32.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.371 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -63.43 -59.7 8.48 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.894 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 38.3 t -52.35 -50.71 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.25 -56.87 14.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 24.2 t -53.58 -50.91 47.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.566 0.222 . . . . 0.0 110.903 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.538 HG23 ' HB1' ' A' ' 407' ' ' ALA . 75.0 t -56.38 -55.01 21.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.883 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -53.93 -50.1 67.19 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.086 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -54.26 48.66 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.221 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -32.1 67.51 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.776 0.322 . . . . 0.0 111.06 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . 0.508 ' CE1' ' HG2' ' A' ' 400' ' ' GLN . 14.1 t80 -84.43 -1.38 55.53 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.447 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.18 -169.17 7.53 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.322 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 63.81 44.68 4.79 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.836 0.351 . . . . 0.0 111.35 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . 0.423 ' CZ3' HG23 ' A' ' 399' ' ' ILE . 22.0 t-105 -164.7 133.9 2.82 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.629 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -87.04 122.41 1.85 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.844 2.363 . . . . 0.0 112.62 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 28.5 t -176.2 171.4 2.5 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.137 0.494 . . . . 0.0 111.873 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 26.3 t -89.14 -21.28 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.563 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.94 -58.02 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.838 -0.165 . . . . 0.0 111.376 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . 0.416 ' HB3' ' CE2' ' A' ' 443' ' ' TYR . . . -53.05 -44.04 67.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.629 0.252 . . . . 0.0 111.192 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -61.23 2.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.744 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 41.9 t -53.73 -45.54 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.71 0.29 . . . . 0.0 110.788 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 16.2 mm -58.91 -55.2 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.23 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -56.35 -49.29 74.83 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 77.1 t -58.95 -57.29 11.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 120.609 0.242 . . . . 0.0 110.843 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 17.5 t -55.4 -49.77 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.02 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 59.5 p -58.33 -47.9 82.25 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.589 0.233 . . . . 0.0 110.949 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -60.8 -58.82 6.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.41 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.17 -45.01 92.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.619 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -63.57 -33.64 76.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.279 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -70.46 59.96 0.2 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.032 0.444 . . . . 0.0 111.098 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.5 32.4 4.84 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.503 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 55.4 mt 69.28 104.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.987 0.422 . . . . 0.0 111.929 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -64.61 144.43 98.72 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.9 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.81 171.45 10.99 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.594 2.196 . . . . 0.0 113.128 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -64.71 78.47 0.04 OUTLIER 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.893 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 142.89 62.26 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.709 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 5.0 t -107.52 40.76 1.63 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.987 0.422 . . . . 0.0 111.438 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 16.9 tp -153.31 80.49 1.18 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.58 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . 51.01 44.8 28.44 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.054 0.454 . . . . 0.0 111.872 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 476' ' ' GLN . 8.0 p -78.07 -35.23 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.167 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 37.4 t -177.71 -163.22 0.07 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.5 0.191 . . . . 0.0 111.063 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -43.1 -57.2 3.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.875 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 7.3 p -47.87 -50.98 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.482 ' HB2' HG12 ' A' ' 472' ' ' VAL . 0.8 OUTLIER -69.0 -37.36 78.66 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.834 -0.166 . . . . 0.0 111.357 179.675 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.47 -47.85 84.34 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.96 -47.33 71.95 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.116 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.8 -47.15 74.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.622 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 12.1 m -64.18 -51.75 62.26 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -56.74 -44.16 81.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.582 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.76 -53.22 60.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.369 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 35.0 m -63.19 -43.0 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.061 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 6.8 mtt -60.7 -56.1 25.26 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.676 0.274 . . . . 0.0 110.766 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 9.7 tp -55.43 -44.67 76.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.397 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 35.7 m -60.01 -52.81 63.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.4 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 69.8 t -56.27 -48.76 79.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.716 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 491' ' ' ILE . . . -60.7 -51.67 57.21 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.381 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.95 80.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.742 0.306 . . . . 0.0 110.859 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.4 -54.75 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.573 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . 0.52 ' HA ' ' CD2' ' A' ' 494' ' ' LEU . 4.7 tp -55.68 -41.38 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 120.474 0.178 . . . . 0.0 111.208 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.69 -54.78 29.0 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.476 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -63.2 -43.42 98.23 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.52 ' CD2' ' HA ' ' A' ' 491' ' ' ILE . 0.5 OUTLIER -61.81 -46.03 91.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 121.413 -0.115 . . . . 0.0 111.298 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 1.2 m -65.58 -40.79 93.15 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.521 0.201 . . . . 0.0 110.719 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -70.22 -37.33 74.99 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.697 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -79.43 -42.86 11.06 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.589 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.25 -31.84 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 117.033 0.417 . . . . 0.0 111.829 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 502' ' ' ALA . 15.4 ttm105 -104.16 123.97 48.26 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.874 0.368 . . . . 0.0 110.559 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . 0.432 ' O ' ' HB2' ' A' ' 501' ' ' GLN . 0.2 OUTLIER -52.47 104.77 0.1 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.492 -179.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 500' ' ' TYR . 2.8 mp0 68.74 38.13 2.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.335 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.439 ' O ' ' HD2' ' A' ' 499' ' ' ARG . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 117.833 -1.079 . . . . 0.0 112.15 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 111.367 0.136 . . . . 0.0 111.367 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 6.1 m -79.22 65.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.198 0.523 . . . . 0.0 110.959 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.47 166.91 14.02 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.553 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.49 ' CG1' ' HB2' ' A' ' 446' ' ' TRP . 2.9 mp -53.88 100.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.878 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.6 ' HB3' ' HA ' ' A' ' 494' ' ' LEU . 2.8 mm100 70.53 87.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.404 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -151.94 -150.16 5.28 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.824 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 29.0 t -53.01 -49.63 65.83 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.482 0.182 . . . . 0.0 111.304 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 39.7 t -54.74 -49.45 68.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 110.19 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.485 HG21 ' HA ' ' A' ' 400' ' ' GLN . 54.2 t -58.85 -46.73 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.281 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.65 77.7 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.884 0.374 . . . . 0.0 110.173 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.96 67.8 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.505 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -55.75 -48.73 74.75 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.254 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.41 HD12 HG22 ' A' ' 490' ' ' VAL . 0.1 OUTLIER -56.22 -47.84 77.63 Favored 'General case' 0 C--O 1.23 0.056 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.722 178.556 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.6 t -52.78 -43.0 65.54 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.155 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.4 71.8 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.836 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.407 HG21 HG21 ' A' ' 439' ' ' VAL . 97.3 t -58.75 -50.59 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.914 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 27.2 mt -57.03 -45.61 83.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.231 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 41.3 m -60.38 -49.11 78.87 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.127 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.8 mt -58.14 -53.09 62.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.295 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -61.16 -45.97 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.893 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -54.73 -54.07 46.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.665 0.269 . . . . 0.0 110.387 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 2.2 ttm -61.89 -42.91 99.64 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.514 ' CG ' ' HB3' ' A' ' 428' ' ' LEU . 0.5 OUTLIER -60.1 -28.47 67.86 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.544 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -40.41 12.25 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.566 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 421' ' ' MET . 1.6 tt -73.78 87.09 1.72 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.96 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' MET . . . . . 0.416 ' CB ' ' O ' ' A' ' 420' ' ' LEU . 1.5 ttt 83.11 158.97 0.12 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.701 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 54.04 59.86 3.98 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 110.587 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.31 173.23 1.6 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.501 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.504 ' HA ' ' CG2' ' A' ' 469' ' ' THR . 49.9 t0 85.27 126.48 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.523 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -88.51 -14.55 37.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.584 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -38.58 -56.13 1.34 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.71 0.29 . . . . 0.0 111.647 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -92.75 -39.38 11.28 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.802 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.514 ' HB3' ' CG ' ' A' ' 418' ' ' GLN . 4.5 mm? -60.12 -36.36 77.29 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 9.1 p -47.33 -35.67 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.64 -52.32 40.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.137 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.78 -45.82 77.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.834 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.2 -50.17 70.05 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.193 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -49.71 76.34 Favored 'General case' 0 N--CA 1.46 0.032 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.008 178.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 1.7 tt -51.99 -46.23 64.8 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.77 68.71 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.728 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.67 -39.81 65.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.776 0.322 . . . . 0.0 110.5 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.05 -57.02 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.675 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 30.2 m -59.23 -39.4 78.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 120.748 0.309 . . . . 0.0 110.397 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.407 HG21 HG21 ' A' ' 411' ' ' VAL . 4.0 t -59.43 -58.75 5.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.138 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.37 -42.78 78.39 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.612 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.7 tp -51.35 -52.68 43.48 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.556 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -71.61 -36.74 70.9 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.964 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -63.09 -38.13 89.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.445 ' O ' ' HD2' ' A' ' 445' ' ' ARG . . . -47.92 104.77 0.09 OUTLIER Glycine 0 C--N 1.339 0.728 0 CA-C-N 116.366 -0.379 . . . . 0.0 113.477 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 444' ' ' GLY . 0.1 OUTLIER -144.72 -66.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.621 0.248 . . . . 0.0 110.908 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . 0.49 ' HB2' ' CG1' ' A' ' 399' ' ' ILE . 0.6 OUTLIER -127.26 125.12 23.95 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.633 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.27 87.78 1.03 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.488 2.125 . . . . 0.0 112.554 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 449' ' ' VAL . 91.0 p -108.24 -93.47 0.41 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.356 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.408 ' N ' ' OG ' ' A' ' 448' ' ' SER . 3.4 p -146.16 -49.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 1.5 m -46.18 -54.16 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.599 0.238 . . . . 0.0 111.337 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -57.28 -41.44 79.73 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.887 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.06 -52.97 61.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.393 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 69.8 t -54.29 -50.1 58.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.68 -47.23 86.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.082 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -55.87 -49.7 72.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.433 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.97 -56.73 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.332 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.31 -41.7 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.891 0.377 . . . . 0.0 110.763 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 19.3 m -65.58 -48.91 70.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.651 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.66 -48.67 80.28 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.132 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.41 -54.97 39.22 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.015 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.444 ' HG ' ' HB1' ' A' ' 465' ' ' ALA . 0.5 OUTLIER -53.8 -45.58 70.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.542 179.438 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -38.84 -40.54 0.64 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.44 0.296 . . . . 0.0 111.307 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -105.03 -44.17 4.86 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.25 -32.52 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . 0.444 ' HB1' ' HG ' ' A' ' 461' ' ' LEU . . . -67.98 -62.15 3.53 Favored Pre-proline 0 CA--C 1.535 0.372 0 O-C-N 122.272 -0.268 . . . . 0.0 111.195 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.88 -39.8 23.87 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.468 2.112 . . . . 0.0 112.307 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -85.95 62.61 7.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.104 0.478 . . . . 0.0 111.201 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 138.26 42.95 0.09 OUTLIER Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.336 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' THR . . . . . 0.504 ' CG2' ' HA ' ' A' ' 424' ' ' ASP . 2.0 t -79.94 -31.17 40.02 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.32 72.6 0.67 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 110.819 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.449 ' CB ' ' HB2' ' A' ' 476' ' ' GLN . . . -84.57 126.67 33.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.948 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 13.2 p -75.38 56.12 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.438 0.637 . . . . 0.0 111.731 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 30.9 m 53.16 35.75 20.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -138.05 -79.46 0.36 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.881 -0.145 . . . . 0.0 111.235 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 15.3 m -47.99 -45.16 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.449 ' HB2' ' CB ' ' A' ' 471' ' ' ALA . 0.0 OUTLIER -62.63 -32.87 73.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.537 0.208 . . . . 0.0 110.716 179.257 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -47.51 55.78 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 4.6 tt -59.15 -48.97 79.64 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.977 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 479' ' ' LEU . 0.6 OUTLIER -59.03 -49.39 78.06 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.844 178.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 87.7 m -55.98 -44.0 78.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.914 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -56.42 -49.12 75.45 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.75 -43.56 94.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.475 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 69.5 t -60.48 -50.1 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.376 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 34.9 mtp -59.3 -52.37 65.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.359 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -47.42 73.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.936 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 34.7 m -58.83 -50.8 72.62 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.049 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . 0.423 ' O ' HG21 ' A' ' 490' ' ' VAL . 24.4 t -55.06 -52.65 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.784 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.83 87.56 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.054 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.26 -51.24 70.8 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.375 0.131 . . . . 0.0 110.92 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 487' ' ' VAL . 25.8 m -63.21 -39.37 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.011 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . 0.487 ' O ' ' HG ' ' A' ' 494' ' ' LEU . 26.1 mt -56.5 -50.77 71.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 120.966 0.412 . . . . 0.0 110.194 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -66.98 -45.45 82.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.363 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.3 -52.31 61.89 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.155 0.182 . . . . 0.0 111.082 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.6 ' HA ' ' HB3' ' A' ' 400' ' ' GLN . 4.5 pp -64.15 -39.79 94.77 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 91.6 m -57.81 -43.99 86.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.164 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -73.74 -56.66 4.72 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.037 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -50.48 -42.65 43.73 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.338 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 4.9 p -69.38 -10.49 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.38 104.18 14.65 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.563 0.221 . . . . 0.0 110.777 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.1 t80 79.63 166.59 0.19 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.45 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.39 -52.11 4.29 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.008 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.14 -0.933 . . . . 0.0 111.08 179.992 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 2.4 tpt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.511 0.195 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.41 142.68 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -140.16 142.54 35.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.367 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.5 tp -150.73 139.57 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.16 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.511 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 43.5 tt0 -59.82 136.45 58.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.066 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 132.44 -101.88 0.47 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.878 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 12.7 t -58.74 -72.19 0.1 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . 0.5 ' HB ' ' CD2' ' A' ' 441' ' ' LEU . 34.1 m -48.03 -43.75 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 120.554 0.216 . . . . 0.0 111.525 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.511 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 76.9 t -60.76 -54.57 33.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.812 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.14 83.68 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.21 65.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.509 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . 0.426 ' HB2' ' CG2' ' A' ' 438' ' ' VAL . . . -55.76 -55.69 29.36 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.604 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.62 -44.23 85.38 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.458 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' SER . . . . . 0.423 ' O ' HG21 ' A' ' 412' ' ' ILE . 35.8 t -52.61 -44.61 66.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.641 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.33 -46.77 82.05 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.276 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 75.5 t -59.13 -52.25 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.481 ' HA ' HG22 ' A' ' 415' ' ' ILE . 0.4 OUTLIER -59.25 -41.73 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.384 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 59.8 m -63.28 -45.48 91.25 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.5 -57.04 14.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.235 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 412' ' ' ILE . 18.4 tt -56.99 -39.82 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.263 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.31 75.08 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 32.3 mtt -60.09 -45.28 93.46 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.763 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 415' ' ' ILE . 98.9 mt-30 -54.74 -57.18 12.54 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . 0.446 ' HB2' ' CD2' ' A' ' 423' ' ' PHE . 0.1 OUTLIER -48.29 -45.45 34.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.226 178.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.28 -32.19 47.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' MET . . . . . 0.523 ' O ' ' CB ' ' A' ' 422' ' ' ALA . 0.8 OUTLIER -120.7 42.72 2.94 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.929 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 421' ' ' MET . . . 99.64 110.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.657 0.783 . . . . 0.0 111.706 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . 0.446 ' CD2' ' HB2' ' A' ' 419' ' ' TRP . 5.5 t80 -70.64 98.41 1.49 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.417 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -159.96 158.08 30.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.208 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -72.86 65.29 0.72 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.081 0.467 . . . . 0.0 111.174 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -54.1 127.99 28.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.592 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 57.36 75.3 0.38 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.515 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 464' ' ' ILE . 0.9 OUTLIER -45.57 -49.12 14.26 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.438 -179.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.36 -51.35 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.694 0.283 . . . . 0.0 110.35 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 7.1 ttt -65.4 -49.14 70.35 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.41 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -46.68 85.7 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -60.66 -51.13 70.68 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 9.2 tt -54.74 -51.13 66.62 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.307 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 2.1 tp -58.36 -47.5 83.59 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.637 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -61.5 -58.65 12.23 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.859 -0.61 . . . . 0.0 113.072 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.92 -42.93 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.811 0.305 . . . . 0.0 111.684 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 28.9 t -61.44 -57.54 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.536 0.207 . . . . 0.0 110.676 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . 0.426 ' CG2' ' HB2' ' A' ' 407' ' ' ALA . 99.4 t -56.62 -49.64 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.999 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 73.1 t -57.25 -48.34 82.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.107 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -55.08 -48.21 73.85 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.5 ' CD2' ' HB ' ' A' ' 403' ' ' VAL . 0.2 OUTLIER -58.04 -42.83 86.2 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.176 177.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . 0.432 ' O ' ' HG2' ' A' ' 445' ' ' ARG . 0.2 OUTLIER -63.84 -41.5 97.81 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.211 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 445' ' ' ARG . 22.4 t80 -77.35 -37.9 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.191 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -63.92 67.87 0.05 OUTLIER Glycine 0 C--N 1.338 0.666 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.34 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.491 ' NH2' ' OG ' ' A' ' 448' ' ' SER . 0.0 OUTLIER -140.43 -55.22 0.52 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.594 0.235 . . . . 0.0 110.962 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . 0.507 ' CD2' ' HD2' ' A' ' 447' ' ' PRO . 0.0 OUTLIER 175.34 139.14 0.19 Allowed Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.156 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 446' ' ' TRP . 36.5 Cg_endo -64.12 67.88 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.592 2.195 . . . . 0.0 112.343 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.491 ' OG ' ' NH2' ' A' ' 445' ' ' ARG . 0.8 OUTLIER -104.39 42.28 1.22 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.518 -179.311 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 50.6 t 67.27 -64.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.928 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.7 m -50.81 -47.9 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -54.22 -53.3 55.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 110.393 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.03 -48.74 75.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.611 178.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 84.6 t -53.71 -46.42 62.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.464 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 34.5 mt -55.75 -45.27 79.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -61.72 -45.66 93.01 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 58.0 t -53.36 -50.93 45.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.02 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 74.6 t -53.08 -50.31 46.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 1.4 t -55.06 -43.11 73.54 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.737 177.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.49 -45.91 92.23 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.23 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.67 -37.72 68.68 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.285 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -22.45 33.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.366 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -66.58 70.71 0.07 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 111.838 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -162.5 42.98 0.13 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.955 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.578 ' HA ' HD12 ' A' ' 428' ' ' LEU . 34.0 mt 45.23 64.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.429 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . 54.41 63.67 7.09 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 120.995 0.426 . . . . 0.0 110.706 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.6 -52.84 7.63 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.893 2.395 . . . . 0.0 113.381 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . 0.493 ' O ' ' HD2' ' A' ' 467' ' ' ARG . 0.0 OUTLIER -167.79 72.13 0.11 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.94 0.4 . . . . 0.0 111.599 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . -178.38 44.34 0.09 OUTLIER Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.04 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.3 p -143.88 99.24 3.37 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 117.105 0.453 . . . . 0.0 110.948 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.05 147.17 17.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.079 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 423' ' ' PHE . . . -64.17 -46.51 83.72 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.449 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 3.0 m -115.49 94.7 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 111.15 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 46.5 t -149.93 99.19 2.81 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.691 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -55.05 -47.67 74.49 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.571 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 11.6 p -51.89 -44.05 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.087 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.5 -44.35 82.84 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -56.17 -58.14 9.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.086 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 1.5 mp -59.66 -51.45 69.74 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.047 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 7.4 tt -55.47 -58.22 8.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.732 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 3.1 m -54.45 -41.83 69.89 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.574 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -56.45 -47.87 78.23 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.86 94.24 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.275 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.14 -47.04 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.021 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -59.81 -51.54 69.31 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 tt -54.77 -45.06 74.17 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 490' ' ' VAL . 70.6 m -58.99 -49.25 78.6 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.993 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 18.2 t -52.21 -51.5 30.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.119 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . 0.48 ' O ' HG13 ' A' ' 491' ' ' ILE . . . -55.75 -45.59 85.12 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.858 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.03 -46.07 92.2 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 110.353 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 486' ' ' THR . 94.9 t -61.55 -56.52 17.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.007 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 488' ' ' GLY . 2.5 pp -58.83 -37.02 64.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.692 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.43 -59.22 8.03 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -53.8 -46.41 71.06 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 494' ' ' LEU . 1.3 tm? -55.33 -46.66 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.703 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 99.2 m -54.33 -50.01 68.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.228 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.42 77.65 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.358 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 501' ' ' GLN . . . -54.52 -50.6 56.43 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.218 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.89 -35.34 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.76 0.314 . . . . 0.0 110.664 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . 0.456 ' HD2' ' HB2' ' A' ' 500' ' ' TYR . 7.0 tmm_? -62.06 -51.39 68.18 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.132 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . 0.456 ' HB2' ' HD2' ' A' ' 499' ' ' ARG . 11.3 t80 -174.98 70.15 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.721 0.296 . . . . 0.0 111.678 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.444 ' O ' ' HA2' ' A' ' 497' ' ' GLY . 58.4 mt-30 68.54 -56.36 0.51 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.829 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.681 -0.675 . . . . 0.0 111.341 179.93 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.572 0.225 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.91 131.78 67.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.833 0.349 . . . . 0.0 111.374 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -171.89 1.92 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.405 ' CG2' HG21 ' A' ' 498' ' ' VAL . 1.0 OUTLIER -76.61 -167.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . 0.7 ' HA ' HG22 ' A' ' 404' ' ' VAL . 3.6 tt0 -60.29 93.89 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.958 -0.464 . . . . 0.0 111.228 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.527 ' HA3' HG22 ' A' ' 498' ' ' VAL . . . -156.82 -120.84 0.66 Allowed Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.269 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 67.0 m -50.74 -46.2 59.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.764 0.282 . . . . 0.0 111.256 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 15.9 m -55.88 -41.42 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.945 0.402 . . . . 0.0 110.963 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' A' ' 400' ' ' GLN . 58.9 t -73.44 -43.62 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.796 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.14 -47.53 80.92 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.78 -48.33 81.12 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.163 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -54.83 -50.71 67.93 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.465 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -49.84 76.07 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.23 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' SER . . . . . 0.445 ' O ' HG22 ' A' ' 412' ' ' ILE . 0.3 OUTLIER -56.73 -40.09 75.09 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.147 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -66.71 -54.77 19.47 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.612 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 55.9 t -55.69 -48.38 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.057 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' ILE . . . . . 0.451 ' HA ' HG23 ' A' ' 415' ' ' ILE . 0.3 OUTLIER -60.46 -42.32 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.422 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 91.2 m -61.48 -45.52 93.9 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 431' ' ' LEU . 20.6 mt -60.21 -57.2 13.81 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.546 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.451 HG23 ' HA ' ' A' ' 412' ' ' ILE . 16.2 tt -57.76 -39.93 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.953 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -62.81 -51.56 66.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.812 0.339 . . . . 0.0 110.305 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 20.9 mtp -58.46 -47.34 84.34 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.545 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -46.1 89.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.834 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' TRP . . . . . 0.471 ' HA ' ' O ' ' A' ' 422' ' ' ALA . 1.2 m0 -57.35 -38.89 74.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.52 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.42 -28.1 58.44 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.983 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -44.63 6.44 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.776 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 419' ' ' TRP . . . -125.97 138.14 53.73 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.845 0.355 . . . . 0.0 111.601 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.81 162.24 24.12 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 60.66 -91.48 0.03 OUTLIER 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.473 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -151.03 -74.64 0.15 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . 67.08 -68.12 0.15 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.636 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -115.39 13.98 16.65 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.45 -32.72 74.47 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.492 0.187 . . . . 0.0 111.281 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 4.0 p -44.91 -51.12 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.697 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 4.7 mtm -66.73 -47.22 72.97 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.779 0.323 . . . . 0.0 110.365 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.419 ' CD1' ' HB3' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -55.65 -51.45 67.18 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.388 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' TYR . . . . . 0.472 ' OH ' ' HB2' ' A' ' 458' ' ' SER . 44.0 t80 -59.15 -44.59 92.11 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.163 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.83 -54.21 47.3 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 6.1 mt -57.48 -42.38 82.53 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.187 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -61.15 -58.43 13.57 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.479 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 32.8 m -53.99 -34.67 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.784 0.292 . . . . 0.0 110.607 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 54.3 t -63.26 -51.25 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.14 -46.4 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.373 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.1 t -60.46 -46.11 95.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.135 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.76 76.39 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.127 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.34 -46.57 69.54 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -63.67 -38.52 91.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.45 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' A' ' 445' ' ' ARG . 5.6 m-85 -74.13 -17.82 60.88 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.79 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -56.76 80.32 0.01 OUTLIER Glycine 0 C--N 1.342 0.876 0 C-N-CA 121.711 -0.281 . . . . 0.0 112.96 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 443' ' ' TYR . 12.3 ttt85 -174.11 -55.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.32 0.248 . . . . 0.0 110.841 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -163.88 81.15 1.44 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.456 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -89.91 158.98 4.99 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.959 2.439 . . . . 0.0 113.075 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.0 t -129.63 178.73 6.27 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.982 0.42 . . . . 0.0 111.678 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 91.5 t -55.34 -39.29 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.964 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 9.2 m -48.14 -46.36 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.645 0.259 . . . . 0.0 111.443 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -64.28 -45.21 89.01 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -48.54 81.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.526 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.28 -54.75 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.326 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . 0.48 HG23 ' CG2' ' A' ' 490' ' ' VAL . 33.2 pt -57.11 -40.54 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.378 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -68.01 -50.34 56.08 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.36 -52.74 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 37.6 t -55.88 -41.41 66.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.285 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' SER . . . . . 0.472 ' HB2' ' OH ' ' A' ' 432' ' ' TYR . 64.9 m -62.95 -50.45 70.77 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.19 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -55.26 -52.36 63.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.559 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.4 -53.42 58.39 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.806 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.9 mp -56.2 -38.71 71.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.887 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -75.09 -28.65 60.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.978 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.9 t80 53.56 45.78 27.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.977 0.418 . . . . 0.0 111.524 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 6.1 mm 64.54 12.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.34 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . 36.6 73.7 0.66 Allowed Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.1 161.18 27.23 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.922 2.414 . . . . 0.0 113.046 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 8.7 mtm-85 -53.97 -35.11 61.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.552 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . -133.79 116.9 1.76 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.313 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 4.9 m -95.63 155.45 16.74 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.874 0.369 . . . . 0.0 110.938 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 1.2 mp -55.16 -34.26 63.66 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . 61.46 49.35 5.27 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.192 0.52 . . . . 0.0 111.218 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 37.4 t -107.11 150.86 9.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.487 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 6.5 t -75.6 -168.22 0.81 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.041 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 65.55 -66.63 0.15 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.744 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.34 -37.01 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.771 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -57.99 -39.91 79.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.488 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -46.7 64.15 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.01 -53.38 57.66 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.873 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.83 -43.97 90.78 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.013 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 54.7 m -54.15 -47.47 71.89 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -64.63 -46.6 81.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.449 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.47 78.26 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.528 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.69 -43.53 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.901 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 26.7 mtt -57.45 -51.09 70.85 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.183 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.0 tp -59.57 -45.53 91.59 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.827 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 88.1 m -56.11 -48.97 75.15 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.269 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.02 -51.24 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.494 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 491' ' ' ILE . . . -54.69 -47.03 72.97 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.983 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -47.34 84.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.668 0.27 . . . . 0.0 110.491 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.48 ' CG2' HG23 ' A' ' 454' ' ' ILE . 39.2 t -60.18 -52.95 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.58 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . 0.541 ' HA ' HD22 ' A' ' 494' ' ' LEU . 9.2 tp -57.47 -42.32 80.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.84 -0.164 . . . . 0.0 110.662 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.8 -42.73 94.97 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -57.37 -56.25 24.25 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.642 0.377 . . . . 0.0 110.79 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . 0.541 HD22 ' HA ' ' A' ' 491' ' ' ILE . 3.9 pp -61.88 -40.46 95.46 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.344 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 45.5 m -62.88 -33.76 75.97 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.374 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -83.08 -42.2 17.7 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.192 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -63.54 -57.73 13.76 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.408 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . 0.527 HG22 ' HA3' ' A' ' 401' ' ' GLY . 2.7 t -62.83 94.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.868 0.366 . . . . 0.0 111.229 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' A' ' 498' ' ' VAL . 3.8 ptm180 154.67 -37.22 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.942 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -70.38 63.79 0.26 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.894 0.378 . . . . 0.0 111.269 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 69.6 85.39 0.14 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.68 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.327 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.728 -179.477 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.239 0.542 0 CA-C-O 120.896 0.379 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 399' ' ' ILE . 13.2 tt -73.56 101.1 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.95 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.444 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 4.7 mm-40 66.66 80.11 0.22 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.325 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -133.04 -134.52 3.51 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.071 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 13.4 m -47.09 -38.91 12.16 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 35.5 t -59.79 -47.35 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.452 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.589 HG13 ' CE2' ' A' ' 442' ' ' PHE . 12.7 t -60.51 -48.32 88.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.406 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.68 69.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.738 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.68 -50.45 73.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.064 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 1.084 ' HB1' HG13 ' A' ' 438' ' ' VAL . . . -57.85 -55.95 28.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.67 ' HG ' HG11 ' A' ' 490' ' ' VAL . 0.4 OUTLIER -59.14 -40.57 85.91 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.652 179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 37.8 t -57.12 -57.59 11.9 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.301 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -53.18 -42.32 66.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.705 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.795 HG23 HG21 ' A' ' 438' ' ' VAL . 25.0 t -61.61 -59.06 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.27 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.0 tp -55.5 -43.48 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 121.358 -0.137 . . . . 0.0 110.948 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 52.9 m -59.58 -51.52 69.49 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 434' ' ' LEU . 8.5 tp -57.94 -46.44 85.04 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.368 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.799 HG12 HD11 ' A' ' 431' ' ' LEU . 75.0 mt -57.71 -52.44 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.601 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.29 -48.42 80.53 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.058 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 22.3 mtt -59.66 -52.81 63.92 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.024 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -60.57 -47.31 86.74 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.353 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' TRP . . . . . 0.519 ' HA ' ' O ' ' A' ' 424' ' ' ASP . 0.0 OUTLIER -59.56 -44.07 93.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.945 0.402 . . . . 0.0 110.185 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 4.9 tt -64.12 -42.57 96.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 6.1 tpt -67.84 126.9 30.9 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.871 0.367 . . . . 0.0 111.727 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 70.82 -98.98 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.918 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.23 41.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.661 0.267 . . . . 0.0 111.519 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 419' ' ' TRP . 4.5 p30 . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.805 0.336 . . . . 0.0 111.198 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 71.4 t -143.61 -69.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.915 -0.13 . . . . 0.0 111.311 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -52.49 34.19 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.671 0.272 . . . . 0.0 111.111 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.799 HD11 HG12 ' A' ' 415' ' ' ILE . 17.5 tp -62.97 -40.52 97.97 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.04 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 462' ' ' PHE . 54.0 t80 -67.18 -48.57 67.53 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.928 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.8 OUTLIER -56.28 -59.38 5.03 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.7 0.286 . . . . 0.0 110.568 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 414' ' ' LEU . 0.1 OUTLIER -59.72 -45.19 92.93 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.293 178.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.734 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -53.85 -55.06 27.51 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.859 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 39.3 t -55.17 -47.74 77.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 433' ' ' LEU . 59.6 t -54.03 -50.2 55.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 1.084 HG13 ' HB1' ' A' ' 407' ' ' ALA . 41.2 t -61.27 -43.04 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.158 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 435' ' ' GLY . 98.0 t -54.9 -45.83 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -58.32 -47.09 84.83 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.672 HD23 ' HB2' ' A' ' 407' ' ' ALA . 2.1 tp -56.14 -44.71 79.49 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.171 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' PHE . . . . . 0.589 ' CE2' HG13 ' A' ' 404' ' ' VAL . 3.2 t80 -64.38 -45.2 88.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.552 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -52.87 -43.39 66.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.355 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -74.72 48.39 1.94 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.874 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 399' ' ' ILE . 0.6 OUTLIER -136.68 29.45 2.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.41 0.284 . . . . 0.0 110.8 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 446' ' ' TRP . . . . . 0.401 ' CB ' ' O ' ' A' ' 445' ' ' ARG . 0.0 OUTLIER 83.74 125.88 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.561 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.21 97.16 1.12 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.669 2.246 . . . . 0.0 112.728 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.0 m -121.3 38.95 3.95 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.861 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 97.7 t 67.76 -55.13 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.794 HG21 ' OD1' ' A' ' 493' ' ' ASN . 7.0 m -41.83 -46.76 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -59.63 -47.5 85.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.851 0.358 . . . . 0.0 110.205 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 20.8 m -56.46 -49.16 75.41 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.929 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.3 -52.97 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.343 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.577 HG23 HG23 ' A' ' 486' ' ' THR . 19.8 mt -53.3 -50.81 45.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.752 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -59.82 -51.91 67.72 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.666 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.9 t -54.05 -52.21 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 54.6 t -52.01 -54.55 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.509 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -44.2 92.03 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.827 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -57.41 -57.51 12.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.834 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -41.95 91.52 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.847 0.356 . . . . 0.0 110.695 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.556 ' HG ' ' CB ' ' A' ' 482' ' ' ALA . 1.3 mm? -68.59 -21.01 64.54 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.461 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 432' ' ' TYR . 60.5 t80 -61.68 76.25 0.02 OUTLIER 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.568 0.699 . . . . 0.0 111.135 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 461' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.331 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 474' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 477' ' ' TYR . 10.4 t0 . . . . . 0 C--O 1.235 0.334 0 CA-C-O 121.103 0.478 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 95.9 t -56.49 -48.3 80.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.205 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -47.61 76.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.874 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 477' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 474' ' ' ASP . 1.3 m-85 -66.38 -52.83 42.78 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.026 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.15 -51.55 57.29 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.617 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 479' ' ' LEU . . . . . 0.667 ' O ' HG23 ' A' ' 483' ' ' VAL . 17.1 tp -61.18 -46.98 88.25 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.046 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 82.8 m -52.32 -49.4 64.32 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.626 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.33 -52.87 63.8 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.39 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 482' ' ' ALA . . . . . 0.556 ' CB ' ' HG ' ' A' ' 461' ' ' LEU . . . -54.74 -42.27 71.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.842 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 479' ' ' LEU . 88.1 t -64.48 -49.08 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.003 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 9.2 ttm -56.99 -52.36 65.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.585 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 28.7 tp -56.02 -50.35 71.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.933 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 486' ' ' THR . . . . . 0.691 ' HA ' HD12 ' A' ' 489' ' ' LEU . 35.8 m -56.02 -47.13 78.39 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.285 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 483' ' ' VAL . 42.1 t -57.57 -48.39 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.909 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -54.08 -43.92 73.28 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.509 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 489' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 486' ' ' THR . 4.7 mt -64.19 -49.52 71.7 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.78 0.324 . . . . 0.0 110.25 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.67 HG11 ' HG ' ' A' ' 408' ' ' LEU . 65.2 t -58.66 -55.27 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.352 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 20.9 tt -57.21 -42.29 79.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.857 -0.156 . . . . 0.0 110.795 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -60.67 -50.3 69.07 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.504 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 493' ' ' ASN . . . . . 0.794 ' OD1' HG21 ' A' ' 450' ' ' VAL . 15.9 m-80 -61.03 -54.7 41.57 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.574 0.226 . . . . 0.0 110.526 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.11 -43.53 66.94 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.662 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 58.3 m -61.85 -50.61 71.55 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.206 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.11 82.86 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.174 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -57.63 -51.33 58.58 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.455 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 92.5 t -71.19 -47.73 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 120.988 0.423 . . . . 0.0 110.72 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 499' ' ' ARG . . . . . 0.506 ' O ' ' HD2' ' A' ' 499' ' ' ARG . 1.1 tmm_? -105.35 87.33 2.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.114 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 29.3 t80 . . . . . 0 CA--C 1.532 0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.614 -179.361 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.583 0 CA-C-O 120.9 0.381 . . . . 0.0 111.636 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.413 HD12 ' OE1' ' A' ' 400' ' ' GLN . 2.7 pt -73.71 149.02 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.714 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.413 ' OE1' HD12 ' A' ' 399' ' ' ILE . 2.4 mp0 61.48 -167.46 0.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.883 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 84.29 -110.66 3.37 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.542 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 33.7 m -52.99 -48.14 67.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.578 0.227 . . . . 0.0 111.472 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.782 HG21 ' HG2' ' A' ' 445' ' ' ARG . 10.5 t -55.13 -52.97 39.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.931 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.496 HG11 HD23 ' A' ' 494' ' ' LEU . 22.8 t -60.41 -46.44 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.24 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.26 76.97 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.566 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.56 -55.06 35.01 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.652 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -56.37 -48.49 76.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.434 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.98 HD11 HG13 ' A' ' 487' ' ' VAL . 2.1 tp -57.95 -49.48 76.64 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.388 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' SER . . . . . 0.667 ' HA ' HD12 ' A' ' 412' ' ' ILE . 41.0 t -53.64 -48.13 69.66 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.63 82.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.262 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 407' ' ' ALA . 41.7 t -63.23 -42.54 96.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.151 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 409' ' ' SER . 23.8 mt -61.84 -53.31 49.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.585 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 409' ' ' SER . 42.7 p -58.54 -44.92 89.78 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.449 HD21 ' HG ' ' A' ' 431' ' ' LEU . 18.2 tp -57.46 -49.42 76.33 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.137 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 14.9 mm -59.75 -54.14 38.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.924 0.393 . . . . 0.0 110.19 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -52.1 -49.84 62.81 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.894 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 10.5 mtt -63.7 -43.15 97.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.838 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 0.3 OUTLIER -57.56 -45.67 84.86 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.183 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -35.21 36.39 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -51.83 -57.39 9.47 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 4.6 mtp -145.71 59.86 1.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.957 0.408 . . . . 0.0 111.603 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 418' ' ' GLN . . . -171.83 -177.06 1.87 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.394 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -91.89 150.69 20.91 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.74 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.409 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.473 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 N--CA 1.467 0.415 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.3 t -54.67 -61.95 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 8.2 mmt -55.77 -47.89 76.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.855 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.449 ' HG ' HD21 ' A' ' 414' ' ' LEU . 0.5 OUTLIER -57.58 -50.05 74.4 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.903 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.06 -49.95 70.31 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.039 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.8 OUTLIER -56.18 -55.84 28.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.859 0.361 . . . . 0.0 110.57 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.439 ' O ' HG22 ' A' ' 438' ' ' VAL . 5.2 mp -57.58 -47.32 82.41 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.981 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.605 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -52.98 -57.87 13.38 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.687 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 433' ' ' LEU . 27.5 m -54.99 -39.96 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 117.044 0.422 . . . . 0.0 110.93 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 433' ' ' LEU . 53.1 t -60.63 -57.75 10.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.074 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 434' ' ' LEU . 15.8 m -60.93 -39.29 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.661 0.267 . . . . 0.0 110.666 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 435' ' ' GLY . 55.8 t -59.1 -50.65 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.047 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.28 -47.78 77.94 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.974 0.416 . . . . 0.0 110.141 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.41 -47.87 80.6 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.58 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' PHE . . . . . 0.562 ' HA ' ' CG1' ' A' ' 403' ' ' VAL . 39.8 t80 -62.09 -46.13 90.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.763 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -60.44 -44.49 95.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.451 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.415 ' O ' ' HD3' ' A' ' 445' ' ' ARG . . . -67.59 53.93 0.33 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.549 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.782 ' HG2' HG21 ' A' ' 403' ' ' VAL . 0.7 OUTLIER -152.23 45.61 0.74 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 79.96 126.39 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.614 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.78 124.23 7.99 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.58 2.187 . . . . 0.0 112.407 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.7 t -143.18 152.0 41.28 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.28 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 453' ' ' VAL . 11.9 p -50.79 -45.85 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.629 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.571 HG12 HD11 ' A' ' 454' ' ' ILE . 13.8 t -57.48 -53.0 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.606 0.241 . . . . 0.0 110.668 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -56.08 -50.79 70.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.292 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 456' ' ' VAL . 28.7 m -55.81 -45.59 78.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 449' ' ' VAL . 96.3 t -58.75 -51.66 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.491 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.571 HD11 HG12 ' A' ' 450' ' ' VAL . 8.3 mt -57.86 -52.06 62.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 120.863 0.363 . . . . 0.0 110.589 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.62 -51.66 66.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.597 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 456' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 452' ' ' THR . 55.9 t -57.67 -55.69 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.742 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 453' ' ' VAL . 54.0 t -45.75 -52.11 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.685 0.278 . . . . 0.0 110.615 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -43.85 98.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.817 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.47 -58.27 9.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.987 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.41 -41.94 69.89 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.976 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.79 -27.92 63.27 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.994 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -63.56 102.65 0.45 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.892 0.377 . . . . 0.0 111.584 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 25.5 t80 . . . . . 0 N--CA 1.464 0.259 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.257 179.795 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.236 0.392 0 CA-C-O 120.947 0.403 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.455 HG22 HD13 ' A' ' 479' ' ' LEU . 10.7 p -55.55 -38.81 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.095 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -45.59 74.3 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.951 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.88 -49.99 46.84 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.675 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -52.63 61.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 479' ' ' LEU . . . . . 0.455 HD13 HG22 ' A' ' 475' ' ' VAL . 7.1 mp -60.53 -50.73 72.38 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.545 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 95.2 m -53.89 -46.44 71.38 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.443 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.86 -47.68 84.76 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.286 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -57.9 -44.42 86.77 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.126 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.74 -45.6 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.039 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 65.9 mtp -58.19 -52.76 64.2 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.14 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.73 -43.22 76.38 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 46.5 m -58.94 -48.3 81.98 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.623 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.98 HG13 HD11 ' A' ' 408' ' ' LEU . 24.2 t -56.32 -50.5 71.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.684 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 488' ' ' GLY . . . . . 0.464 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -54.69 -46.63 74.39 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.06 -49.56 76.49 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.476 HG12 HD23 ' A' ' 494' ' ' LEU . 79.6 t -55.93 -47.89 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.375 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.601 ' HA ' HD21 ' A' ' 494' ' ' LEU . 52.6 mt -54.89 -42.35 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.531 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -69.28 -45.9 59.31 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.55 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -56.21 -52.08 65.71 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.586 0.232 . . . . 0.0 110.916 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.601 HD21 ' HA ' ' A' ' 491' ' ' ILE . 4.0 pp -62.6 -44.83 95.33 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.422 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.57 ' N ' HD12 ' A' ' 494' ' ' LEU . 90.7 m -57.23 -43.87 83.28 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 496' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 500' ' ' TYR . . . -66.53 -54.32 25.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.584 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -53.7 -52.98 38.59 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.704 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 4.8 t -47.89 -33.58 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 120.609 0.243 . . . . 0.0 111.355 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.05 22.6 15.71 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.419 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 500' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 496' ' ' ALA . 1.6 t80 . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 120.791 0.329 . . . . 0.0 111.011 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' GLN . . . . . 0.445 HE22 HG23 ' A' ' 495' ' ' THR . 32.8 tt0 . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.356 0.122 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.454 ' CD1' ' HB3' ' A' ' 446' ' ' TRP . 19.5 mm 70.83 131.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 123.39 0.431 . . . . 0.0 111.165 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.59 ' HA ' HG21 ' A' ' 404' ' ' VAL . 42.1 mt-30 54.86 51.67 13.28 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.593 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.647 ' HA2' ' OG1' ' A' ' 495' ' ' THR . . . -147.09 -123.79 1.47 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.293 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 55.0 m -56.95 -49.69 74.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.65 0.262 . . . . 0.0 111.537 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 443' ' ' TYR . 30.1 m -55.76 -48.3 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.614 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.641 HG12 HD13 ' A' ' 491' ' ' ILE . 40.8 t -69.13 -40.91 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.75 97.54 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -62.27 -51.44 67.68 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.794 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' A' ' 440' ' ' ALA . . . -55.01 -49.24 72.03 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.677 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 484' ' ' MET . 0.5 OUTLIER -58.04 -42.88 86.31 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.761 178.229 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -50.48 62.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.056 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.16 -48.5 78.56 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.929 0.395 . . . . 0.0 109.996 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.3 t -55.55 -57.92 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.017 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.579 HD12 ' CD1' ' A' ' 485' ' ' LEU . 19.2 tt -56.75 -41.14 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.489 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 1.3 m -56.97 -50.07 73.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.694 HD12 HG23 ' A' ' 429' ' ' VAL . 3.1 mm? -60.75 -47.31 86.88 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.934 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 412' ' ' ILE . 93.7 mt -52.37 -49.98 40.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.994 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.63 77.87 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.08 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 2.0 mtt -56.5 -44.92 81.18 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.258 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 1.02 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 2.9 tm0? -60.18 -50.16 74.76 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.116 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -57.67 -35.82 71.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.205 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -50.93 42.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.826 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 1.1 ttp 179.46 65.43 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 1.02 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -151.25 -174.9 4.96 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 122.379 -0.201 . . . . 0.0 111.463 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' PHE . . . . . 0.582 ' O ' HG11 ' A' ' 429' ' ' VAL . 0.2 OUTLIER -119.05 178.03 4.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.933 0.397 . . . . 0.0 111.988 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.418 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.677 0.275 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.694 HG23 HD12 ' A' ' 414' ' ' LEU . 7.3 p -55.41 -33.56 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.805 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' MET . . . . . 0.59 ' CE ' HD13 ' A' ' 434' ' ' LEU . 0.0 OUTLIER -57.0 -52.25 66.02 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.254 178.76 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.15 -44.3 95.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.072 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.695 ' O ' HG23 ' A' ' 436' ' ' VAL . 8.1 m-85 -56.97 -56.72 18.1 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.733 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.679 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.4 OUTLIER -56.28 -44.29 79.66 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.068 178.554 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.59 HD13 ' CE ' ' A' ' 430' ' ' MET . 6.2 tp -54.56 -51.16 66.12 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.94 -45.95 93.08 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 432' ' ' TYR . 42.9 t -57.08 -44.28 82.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 433' ' ' LEU . 98.4 t -55.87 -47.04 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.874 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.71 -47.07 86.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.419 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.62 -51.78 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.594 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.423 ' HB2' ' HB1' ' A' ' 407' ' ' ALA . . . -57.65 -50.08 74.36 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.543 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -47.91 79.3 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.406 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.09 -40.89 95.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.377 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.516 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 6.7 m-30 -65.88 -44.99 83.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.006 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.82 58.62 1.74 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.488 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 445' ' ' ARG . 21.2 tpt180 -89.86 60.13 4.86 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.184 0.516 . . . . 0.0 110.922 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 446' ' ' TRP . . . . . 0.454 ' HB3' ' CD1' ' A' ' 399' ' ' ILE . 15.4 t-105 -178.56 125.7 0.26 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.466 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 446' ' ' TRP . 68.9 Cg_endo -95.01 128.23 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.289 2.659 . . . . 0.0 112.939 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.451 ' OG ' ' NE1' ' A' ' 446' ' ' TRP . 14.6 m -164.69 65.82 0.14 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.791 0.329 . . . . 0.0 111.725 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 453' ' ' VAL . 60.5 t 64.92 -69.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.969 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.9 t -53.26 -46.2 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.564 0.221 . . . . 0.0 110.812 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.57 90.97 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 1.4 m -61.14 -52.29 65.5 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 449' ' ' VAL . 47.4 t -55.28 -47.73 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.771 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.36 -50.04 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.757 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.31 -48.76 70.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.949 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 63.1 t -56.02 -56.14 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.215 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.72 -46.1 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.819 0.342 . . . . 0.0 110.097 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 18.0 t -54.63 -47.42 73.5 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.92 -50.66 72.88 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.414 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.37 -41.82 76.81 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.794 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.7 tt -70.97 -38.18 72.78 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.811 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.48 150.1 2.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.513 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.663 -179.242 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 474' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 477' ' ' TYR . 7.9 t70 . . . . . 0 C--O 1.235 0.338 0 CA-C-O 120.925 0.393 . . . . 0.0 111.762 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.85 -40.86 74.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.996 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -66.01 -42.49 89.63 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' TYR . . . . . 0.461 ' HB2' ' HB3' ' A' ' 474' ' ' ASP . 0.8 OUTLIER -59.7 -54.96 40.3 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.381 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.7 tt -55.67 -48.75 74.52 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.207 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.19 -45.23 79.88 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.955 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 480' ' ' THR . . . . . 0.417 HG22 ' SD ' ' A' ' 484' ' ' MET . 24.8 m -57.56 -44.66 85.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.819 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 481' ' ' PHE . . . . . 0.413 ' CE1' HD13 ' A' ' 485' ' ' LEU . 26.1 t80 -61.48 -48.95 78.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.76 80.38 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.482 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 487' ' ' VAL . 78.0 t -63.68 -48.39 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.85 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 484' ' ' MET . . . . . 0.494 ' O ' HD11 ' A' ' 408' ' ' LEU . 21.6 mtt -54.47 -55.07 32.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.546 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.579 ' CD1' HD12 ' A' ' 412' ' ' ILE . 2.0 tp -52.8 -48.37 66.96 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.999 0.428 . . . . 0.0 109.969 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 24.2 m -56.41 -48.93 75.94 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.935 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 483' ' ' VAL . 91.7 t -56.98 -42.4 78.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.092 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.395 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 488' ' ' GLY . . . . . 0.757 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -56.65 -45.84 89.86 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.47 -49.85 71.42 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.47 -44.25 88.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.867 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.757 HD12 ' HA2' ' A' ' 488' ' ' GLY . 15.7 mt -55.89 -42.29 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.967 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 492' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 495' ' ' THR . . . -62.17 -49.31 76.02 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.479 -0.867 . . . . 0.0 110.995 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -54.06 -48.93 70.06 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.747 0.308 . . . . 0.0 110.348 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.526 HD23 ' CB ' ' A' ' 400' ' ' GLN . 11.1 tp -67.79 -35.93 79.54 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.665 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.647 ' OG1' ' HA2' ' A' ' 401' ' ' GLY . 98.0 m -51.51 -49.86 61.09 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -64.71 -47.05 79.74 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.509 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -54.46 -43.29 77.1 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.876 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 68.0 t -76.12 -43.13 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.752 0.311 . . . . 0.0 110.524 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -62.11 -47.14 85.92 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.294 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 120.992 0.425 . . . . 0.0 110.984 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 120.58 0.229 . . . . 0.0 111.338 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 399' ' ' ILE . 19.5 tt -144.34 114.62 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.704 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.558 ' NE2' HG11 ' A' ' 450' ' ' VAL . 0.0 OUTLIER 66.46 -175.04 0.19 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.475 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.541 ' HA2' ' OG1' ' A' ' 495' ' ' THR . . . 115.71 -131.43 9.65 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.975 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -37.22 72.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.43 0.157 . . . . 0.0 111.373 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.52 HG23 ' H ' ' A' ' 404' ' ' VAL . 15.2 m -55.8 -57.8 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.525 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.52 ' H ' HG23 ' A' ' 403' ' ' VAL . 24.6 m -63.55 -38.02 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.457 ' HB2' HG21 ' A' ' 491' ' ' ILE . . . -56.67 -48.85 76.7 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.119 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 409' ' ' SER . . . -61.68 -46.09 91.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.631 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -56.46 -56.59 19.27 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.362 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.513 HD21 ' HG2' ' A' ' 484' ' ' MET . 0.6 OUTLIER -59.18 -39.95 84.14 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.127 178.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 409' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 406' ' ' ALA . 33.6 t -51.08 -51.6 51.71 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.326 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.46 -47.43 81.85 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.308 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.579 HG22 HG21 ' A' ' 436' ' ' VAL . 69.7 t -53.57 -58.19 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.66 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.598 HD13 ' HG3' ' A' ' 484' ' ' MET . 4.2 tp -58.5 -39.91 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.602 0.239 . . . . 0.0 110.74 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 85.9 m -61.33 -44.36 97.33 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 109.809 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -50.06 72.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.857 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.42 HD13 ' OE1' ' A' ' 418' ' ' GLN . 8.7 mm -56.49 -46.11 82.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.044 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -54.38 -49.42 69.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.779 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 1.7 ttm -57.82 -42.77 84.98 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.074 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 1.052 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 0.8 OUTLIER -55.43 -50.86 68.7 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.083 178.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -58.25 -41.99 85.42 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.63 -54.44 42.75 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.725 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -179.19 78.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 1.052 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -155.21 168.99 25.22 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 111.933 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -67.65 178.58 1.62 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.644 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.534 0.364 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.768 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 120.505 0.193 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.424 HG22 ' NE2' ' A' ' 418' ' ' GLN . 40.3 t -51.42 -51.28 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.483 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 3.2 ttm -55.68 -43.78 76.72 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 110.195 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.51 -48.75 78.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.799 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.413 ' O ' HG22 ' A' ' 436' ' ' VAL . 7.5 m-85 -57.45 -48.01 80.3 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.678 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 437' ' ' VAL . 3.2 tp -57.52 -47.1 82.89 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.009 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 438' ' ' VAL . 0.1 OUTLIER -54.68 -48.78 71.98 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.834 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -56.53 -57.72 18.01 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.508 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.579 HG21 HG22 ' A' ' 411' ' ' VAL . 10.1 m -56.08 -44.34 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.723 0.262 . . . . 0.0 110.653 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 433' ' ' LEU . 56.3 t -57.77 -46.54 86.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 434' ' ' LEU . 37.9 t -58.14 -45.58 88.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 51.8 t -55.88 -47.41 79.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.65 -47.26 86.32 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.167 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -41.41 81.84 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.316 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -66.79 -44.88 80.13 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.627 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.433 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 9.9 m-85 -70.77 -47.68 58.36 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.344 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -61.89 134.68 46.55 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.807 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -138.58 -56.12 0.63 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.568 0.223 . . . . 0.0 111.386 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.84 121.08 75.91 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 120.772 0.32 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -88.87 161.28 6.1 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.159 2.573 . . . . 0.0 114.237 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.551 ' H ' ' HB3' ' A' ' 451' ' ' ALA . 1.2 p 176.9 -174.14 0.11 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.453 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.7 t -45.91 -48.17 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.573 0.225 . . . . 0.0 111.434 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.558 HG11 ' NE2' ' A' ' 400' ' ' GLN . 47.3 t -58.35 -50.39 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.633 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 451' ' ' ALA . . . . . 0.551 ' HB3' ' H ' ' A' ' 448' ' ' SER . . . -57.22 -45.63 83.66 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.255 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 93.0 m -54.99 -52.15 64.02 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.59 -46.52 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.227 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 451' ' ' ALA . 53.8 mt -55.59 -50.25 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.598 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -53.4 56.66 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.817 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 64.5 t -53.52 -55.73 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 111.159 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 57.9 t -54.65 -47.6 72.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 4.4 t -59.56 -44.31 93.32 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.288 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -53.1 -49.59 66.16 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.467 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.75 -46.97 73.72 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.358 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.22 -36.89 53.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.016 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.89 59.14 0.16 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.18 0.514 . . . . 0.0 111.022 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 10.1 t80 . . . . . 0 CA--C 1.533 0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.775 -179.683 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 8.6 t70 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.433 0.158 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 59.7 t -42.24 -42.78 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.016 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -54.48 -55.23 31.14 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.819 0.342 . . . . 0.0 111.107 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -69.82 -49.98 47.37 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.147 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.49 -54.93 25.99 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.968 0.413 . . . . 0.0 110.803 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 479' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 483' ' ' VAL . 3.2 tt -59.38 -48.8 80.25 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.617 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 73.8 m -57.59 -39.19 76.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.928 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -49.46 74.75 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.04 -44.08 91.74 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.036 0.446 . . . . 0.0 110.353 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 479' ' ' LEU . 85.8 t -62.06 -52.27 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.269 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 484' ' ' MET . . . . . 0.598 ' HG3' HD13 ' A' ' 412' ' ' ILE . 0.0 OUTLIER -56.69 -49.5 74.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.488 179.106 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 4.5 tt -56.21 -47.15 78.96 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 35.0 m -58.44 -50.98 71.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.224 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.475 ' CG1' HD13 ' A' ' 408' ' ' LEU . 60.6 t -57.5 -47.42 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.413 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -57.3 -48.67 78.55 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 5.7 tt -55.42 -50.23 70.34 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 55.2 t -56.53 -48.39 80.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.859 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' A' ' 405' ' ' ALA . 90.4 mt -58.55 -41.24 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.454 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.56 -58.31 12.82 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.666 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -55.58 -47.4 76.5 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.065 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.462 HD12 ' HB3' ' A' ' 400' ' ' GLN . 2.7 tm? -58.74 -44.99 90.64 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.455 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.541 ' OG1' ' HA2' ' A' ' 401' ' ' GLY . 72.0 m -59.7 -42.93 94.11 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.94 -57.93 9.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.959 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.78 -48.17 85.69 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.615 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.9 p -60.92 -29.64 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 3.7 ttm105 -91.66 -43.04 9.84 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.672 0.272 . . . . 0.0 110.91 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.031 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 37.2 mm -56.99 -38.97 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.022 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.97 140.05 47.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.823 0.344 . . . . 0.0 111.356 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 165.08 -110.27 0.41 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.252 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.6 t -53.92 -44.76 70.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 110.168 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.711 HG11 ' CB ' ' A' ' 443' ' ' TYR . 19.9 t -59.71 -54.28 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.788 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 21.3 m -61.06 -42.48 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.536 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.81 53.7 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.8 87.73 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.934 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -55.86 -51.83 66.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.836 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.465 HD23 HD12 ' A' ' 491' ' ' ILE . 2.4 tm? -55.19 -43.93 74.84 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.2 t -57.81 -44.56 86.44 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.129 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.35 96.57 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.239 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 407' ' ' ALA . 79.2 t -60.06 -51.39 73.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.107 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.422 HD11 HD11 ' A' ' 408' ' ' LEU . 51.6 mt -56.16 -46.28 81.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' THR . . . . . 0.447 HG22 ' SD ' ' A' ' 417' ' ' MET . 36.5 m -57.69 -48.01 80.74 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.142 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 432' ' ' TYR . 9.3 tp -59.11 -57.42 13.15 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.358 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 5.2 tt -58.23 -43.97 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.583 0.23 . . . . 0.0 111.053 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.37 -54.69 43.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.465 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' MET . . . . . 0.447 ' SD ' HG22 ' A' ' 413' ' ' THR . 7.1 mtp -55.86 -49.99 71.83 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.86 -53.51 39.68 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.735 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -57.79 -43.04 85.35 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.526 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 421' ' ' MET . 6.1 tt -67.0 -50.44 62.22 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.518 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' MET . . . . . 0.683 ' HB2' HD23 ' A' ' 420' ' ' LEU . 0.0 OUTLIER -145.17 126.04 14.41 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.617 0.246 . . . . 0.0 111.518 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 68.92 88.14 0.11 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.684 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 424' ' ' ASP . 4.2 t80 -76.21 149.31 37.25 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.354 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 423' ' ' PHE . 54.8 m-20 . . . . . 0 N--CA 1.468 0.43 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.923 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 120.641 0.258 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 85.4 t -51.19 -37.71 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.61 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.5 -44.95 12.92 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.572 0.225 . . . . 0.0 110.978 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.91 -51.17 69.24 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 109.961 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.489 ' HB3' ' CD1' ' A' ' 414' ' ' LEU . 56.2 m-85 -57.83 -46.63 84.46 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.137 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 437' ' ' VAL . 2.5 tm? -57.51 -51.99 67.2 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.69 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 438' ' ' VAL . 1.8 mp -56.0 -46.71 78.66 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.015 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -51.45 -50.98 39.42 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 87.5 t -56.94 -45.81 83.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.867 0.365 . . . . 0.0 110.047 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 433' ' ' LEU . 85.4 t -57.89 -43.82 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.345 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 434' ' ' LEU . 88.4 t -57.33 -53.22 46.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.517 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.02 -48.69 87.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.744 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.452 ' HA ' ' CE2' ' A' ' 443' ' ' TYR . . . -55.5 -49.67 71.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.138 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.63 -48.98 70.36 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.91 -44.02 73.79 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.711 ' CB ' HG11 ' A' ' 403' ' ' VAL . 0.1 OUTLIER -86.02 -34.26 20.82 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -67.44 71.55 0.23 Allowed Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.136 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 446' ' ' TRP . 4.9 mtm180 -122.53 151.78 41.02 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.444 0.164 . . . . 0.0 110.928 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' TRP . . . . . 0.435 ' CB ' ' O ' ' A' ' 445' ' ' ARG . 1.6 t-105 83.07 131.66 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.031 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.13 111.01 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.652 2.234 . . . . 0.0 112.13 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.3 t -145.03 136.19 24.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.493 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.499 ' O ' HG22 ' A' ' 453' ' ' VAL . 39.1 t -45.66 -59.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.698 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.604 HG11 ' HB3' ' A' ' 494' ' ' LEU . 14.1 m -54.38 -46.34 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.408 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -64.18 -47.72 78.71 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.826 0.346 . . . . 0.0 110.65 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 28.5 m -57.45 -56.73 18.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.253 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 449' ' ' VAL . 34.4 m -59.73 -44.44 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.124 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.402 ' N ' HG23 ' A' ' 453' ' ' VAL . 36.7 mt -59.27 -50.08 81.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.13 -49.47 66.49 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.321 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 52.0 t -54.88 -53.64 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.956 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.4 t -51.57 -52.56 20.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 2.0 p -57.71 -38.76 75.81 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.012 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -60.89 -48.87 79.84 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -60.43 -46.65 89.26 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.8 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.95 -19.62 62.55 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.821 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -167.77 0.05 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 111.217 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 6.9 t80 . . . . . 0 N--CA 1.465 0.289 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.207 -179.65 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.369 0.128 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 476' ' ' GLN . 7.3 p -39.29 -48.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.412 ' N ' HG13 ' A' ' 475' ' ' VAL . 0.3 OUTLIER -59.65 -40.49 87.86 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.507 0.194 . . . . 0.0 111.245 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -72.66 -49.13 33.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.622 0.249 . . . . 0.0 110.413 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.13 -51.44 67.92 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.234 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.24 -50.02 75.05 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.691 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 97.8 m -54.19 -42.04 69.26 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.999 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -58.5 -48.92 79.21 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.459 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.85 96.72 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.731 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.69 -49.18 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.235 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -49.04 79.37 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.103 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 6.1 tt -56.61 -46.49 80.87 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 486' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 490' ' ' VAL . 45.8 m -56.67 -48.47 77.54 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.435 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.0 -47.72 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.002 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.64 -46.58 88.66 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 16.8 tp -58.11 -48.7 79.38 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 486' ' ' THR . 89.6 t -60.31 -48.55 87.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.64 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.544 ' HA ' HD21 ' A' ' 494' ' ' LEU . 83.7 mt -57.06 -46.17 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.152 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.44 -44.14 97.18 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.13 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -57.54 -56.51 20.89 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.325 0.25 . . . . 0.0 111.125 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.604 ' HB3' HG11 ' A' ' 450' ' ' VAL . 3.0 pp -58.71 -43.32 90.06 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.485 ' N ' HD12 ' A' ' 494' ' ' LEU . 15.3 m -61.13 -49.24 78.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.687 0.28 . . . . 0.0 110.589 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.84 97.89 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.036 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.65 67.64 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.446 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 499' ' ' ARG . 8.1 p -66.06 -44.25 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 499' ' ' ARG . . . . . 0.421 ' N ' HG13 ' A' ' 498' ' ' VAL . 0.0 OUTLIER -80.46 63.71 5.01 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.043 0.449 . . . . 0.0 110.812 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.292 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.667 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 . . . . . 0 C--O 1.235 0.315 0 CA-C-O 120.705 0.288 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.93 -164.96 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.728 ' HA ' HG21 ' A' ' 404' ' ' VAL . 11.8 mt-30 -68.79 69.05 0.16 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.771 0.319 . . . . 0.0 111.839 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 494' ' ' LEU . . . -124.89 -124.8 2.87 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.653 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.61 -55.66 12.82 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 51.0 t -52.17 -48.15 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 110.828 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' A' ' 400' ' ' GLN . 2.9 t -59.78 -48.11 88.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.442 ' HB2' HD22 ' A' ' 494' ' ' LEU . . . -58.61 -48.48 80.85 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.772 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.7 -55.92 28.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.927 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.644 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -54.82 -49.45 70.99 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.795 0.331 . . . . 0.0 110.564 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 1.048 HD13 HG21 ' A' ' 490' ' ' VAL . 0.7 OUTLIER -56.06 -49.68 73.09 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.205 178.705 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 30.0 t -49.66 -53.01 26.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.292 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -55.48 -47.29 76.38 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.498 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.441 ' CG2' HG21 ' A' ' 439' ' ' VAL . 37.7 t -57.07 -46.49 84.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.337 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 408' ' ' LEU . 38.1 mm -55.69 -46.81 79.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.154 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -39.71 95.36 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.197 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.585 HD23 ' HD1' ' A' ' 432' ' ' TYR . 0.7 OUTLIER -62.63 -52.13 64.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.724 179.337 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.41 ' HB ' ' CE1' ' A' ' 432' ' ' TYR . 3.0 tp -59.07 -42.03 85.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.59 -49.17 78.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 4.0 ttt -58.95 -42.88 90.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.128 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.604 ' HG2' ' HG ' ' A' ' 428' ' ' LEU . 0.0 OUTLIER -56.5 -54.6 43.85 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.031 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -54.88 -41.72 71.22 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 3.7 tp -75.08 50.06 0.46 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.14 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 2.0 mtt 177.26 -59.08 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -153.29 129.04 10.13 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.462 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -92.26 33.16 1.1 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.882 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 121.081 0.467 . . . . 0.0 111.353 179.757 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.604 ' HG ' ' HG2' ' A' ' 418' ' ' GLN . 4.6 mm? . . . . . 0 C--O 1.238 0.462 0 CA-C-O 120.662 0.268 . . . . 0.0 111.652 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.885 HG22 ' HG ' ' A' ' 433' ' ' LEU . 1.5 p -46.05 -42.24 4.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.033 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 85.1 mmm -51.23 -54.44 25.65 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 110.929 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 431' ' ' LEU . 2.7 mp -64.31 -47.89 77.72 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.491 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.585 ' HD1' HD23 ' A' ' 414' ' ' LEU . 28.4 t80 -59.95 -50.49 73.53 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.517 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.885 ' HG ' HG22 ' A' ' 429' ' ' VAL . 19.8 mt -54.97 -43.86 73.89 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.407 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 438' ' ' VAL . 4.1 tt -57.6 -54.09 50.8 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.579 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -58.46 -50.42 66.97 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.239 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 432' ' ' TYR . 76.9 t -58.39 -44.52 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.12 -48.22 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 434' ' ' LEU . 97.8 t -55.87 -46.0 79.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.644 HG22 ' HB1' ' A' ' 407' ' ' ALA . 23.9 t -60.07 -50.21 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.492 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -57.24 -48.85 77.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.8 tt -53.74 -45.4 70.52 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -65.33 -38.76 91.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.005 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.662 ' CE1' HG22 ' A' ' 404' ' ' VAL . 0.2 OUTLIER -65.42 -45.41 84.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.445 179.369 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 445' ' ' ARG . . . -64.17 76.79 0.05 OUTLIER Glycine 0 C--N 1.337 0.584 0 N-CA-C 114.61 0.604 . . . . 0.0 114.61 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' A' ' 444' ' ' GLY . 0.0 OUTLIER -148.61 -65.78 0.24 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.775 0.322 . . . . 0.0 110.422 178.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -128.84 66.28 75.13 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 121.186 0.517 . . . . 0.0 109.823 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.649 ' CB ' ' HB3' ' A' ' 451' ' ' ALA . 83.3 Cg_endo -80.13 155.69 22.74 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.018 2.479 . . . . 0.0 113.819 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.8 73.87 1.44 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.488 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 453' ' ' VAL . 79.2 t 72.12 -65.74 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.499 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.476 ' CG1' HD22 ' A' ' 489' ' ' LEU . 2.9 m -50.98 -53.21 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 120.553 0.216 . . . . 0.0 110.96 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 451' ' ' ALA . . . . . 0.649 ' HB3' ' CB ' ' A' ' 447' ' ' PRO . . . -58.46 -39.8 80.89 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.923 0.392 . . . . 0.0 110.384 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.89 -50.46 73.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.326 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 449' ' ' VAL . 45.0 t -55.85 -52.39 49.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.853 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' A' ' 451' ' ' ALA . 17.3 tt -60.93 -39.38 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.446 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -56.22 -46.85 79.36 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 78.3 t -58.83 -54.99 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.907 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 42.1 t -52.72 -41.81 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.286 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 1.4 t -56.96 -44.09 82.23 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.0 -50.02 74.84 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.911 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -58.99 -42.06 89.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.926 0.393 . . . . 0.0 110.51 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -43.43 84.2 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.65 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 462' ' ' PHE . . . . . 0.463 ' HA ' HD13 ' A' ' 433' ' ' LEU . 6.3 t80 -68.9 58.56 0.09 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.215 0.531 . . . . 0.0 111.122 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 CA--C 1.532 0.273 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.173 -179.684 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.614 0 CA-C-O 120.843 0.354 . . . . 0.0 111.743 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 476' ' ' GLN . 11.2 p -51.13 -44.52 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.92 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.407 ' N ' HG13 ' A' ' 475' ' ' VAL . 1.3 tt0 -61.52 -58.13 9.37 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.588 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -55.15 -44.59 75.26 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.048 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.8 tt -56.94 -52.25 65.96 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.776 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.58 -46.23 90.78 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 55.3 m -54.49 -47.47 72.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.198 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -61.8 -53.94 49.03 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.667 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -53.91 -44.77 70.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.948 0.404 . . . . 0.0 110.738 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 487' ' ' VAL . 40.2 t -65.0 -50.18 76.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.332 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 34.2 mtt -53.93 -53.58 50.73 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.722 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 21.3 tp -55.78 -50.79 69.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.397 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 486' ' ' THR . . . . . 0.59 HG22 HD11 ' A' ' 408' ' ' LEU . 25.7 m -55.72 -47.25 77.22 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.543 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 483' ' ' VAL . 78.9 t -60.34 -49.24 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.46 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -58.11 -45.5 93.85 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.752 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 489' ' ' LEU . . . . . 0.476 HD22 ' CG1' ' A' ' 450' ' ' VAL . 20.5 mt -62.45 -48.09 81.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.84 0.352 . . . . 0.0 110.09 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 1.048 HG21 HD13 ' A' ' 408' ' ' LEU . 5.0 t -58.76 -59.33 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.043 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.504 ' HA ' HD23 ' A' ' 494' ' ' LEU . 2.6 pp -55.84 -35.39 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.087 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -60.36 -56.41 24.64 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.368 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -41.74 99.54 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.642 ' HA ' ' HA2' ' A' ' 401' ' ' GLY . 0.2 OUTLIER -57.86 -50.23 74.0 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.166 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 1.1 m -64.23 -44.36 92.12 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.6 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.82 80.29 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.988 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -67.2 -46.32 72.87 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.455 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 90.4 t -74.37 -42.66 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.737 0.303 . . . . 0.0 111.342 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -96.83 101.14 12.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.851 0.358 . . . . 0.0 110.922 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.466 0.372 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.776 -179.753 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.523 HG23 ' H ' ' A' ' 400' ' ' GLN . 1.5 tp -165.57 -61.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.437 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.536 ' HG3' ' CE1' ' A' ' 443' ' ' TYR . 21.9 tt0 -150.24 114.83 5.23 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.615 0.245 . . . . 0.0 111.08 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.475 ' HA2' ' CG2' ' A' ' 495' ' ' THR . . . -175.7 -113.01 0.32 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.697 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.98 -52.19 2.47 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.773 0.656 . . . . 0.0 112.773 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.595 HG12 HG13 ' A' ' 439' ' ' VAL . 29.5 t -50.53 -56.2 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.746 0.308 . . . . 0.0 111.414 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 491' ' ' ILE . 12.1 t -64.98 -40.79 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.873 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.7 82.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.81 83.96 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.661 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.97 ' HB2' HG11 ' A' ' 439' ' ' VAL . . . -53.54 -56.7 14.86 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.15 178.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.408 ' CD2' ' HA2' ' A' ' 488' ' ' GLY . 2.9 mp -55.89 -43.05 76.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.315 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.1 m -55.91 -53.25 59.1 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.78 -48.96 78.18 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.137 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.789 HG22 ' HE1' ' A' ' 432' ' ' TYR . 55.8 t -55.05 -41.9 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.335 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 415' ' ' ILE . 11.9 mm -58.46 -50.87 77.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.2 -38.8 77.45 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.257 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 411' ' ' VAL . 9.3 mt -65.65 -58.11 6.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 412' ' ' ILE . 2.3 tp -55.3 -39.7 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.601 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.98 83.87 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 32.5 ttm -54.79 -50.92 67.32 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.836 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -60.73 -40.19 91.43 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.202 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' TRP . . . . . 0.468 ' CE2' ' HB3' ' A' ' 477' ' ' TYR . 1.0 OUTLIER -56.44 -39.72 73.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.049 179.416 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.66 -36.8 16.03 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.842 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' MET . . . . . 0.415 ' HB3' ' CE2' ' A' ' 423' ' ' PHE . 0.0 OUTLIER -88.98 -164.82 1.2 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.926 0.393 . . . . 0.0 111.405 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -159.46 124.74 4.15 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.213 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' PHE . . . . . 0.479 ' CE1' HD13 ' A' ' 428' ' ' LEU . 3.6 p90 -177.07 172.07 2.01 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.853 0.358 . . . . 0.0 111.246 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 CA--C 1.534 0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.479 HD13 ' CE1' ' A' ' 423' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.182 0 N-CA-C 111.292 0.108 . . . . 0.0 111.292 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 433' ' ' LEU . 7.4 p -50.2 -39.91 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 121.175 -0.21 . . . . 0.0 110.763 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -51.58 35.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.395 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.46 -48.61 78.71 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.789 ' HE1' HG22 ' A' ' 411' ' ' VAL . 22.2 t80 -57.96 -51.83 68.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.724 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.621 HD22 ' HD1' ' A' ' 462' ' ' PHE . 0.0 OUTLIER -55.13 -42.63 73.26 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.121 178.706 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.493 ' O ' HG23 ' A' ' 438' ' ' VAL . 3.6 tp -55.16 -51.89 65.04 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -59.28 -48.32 86.51 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.786 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 432' ' ' TYR . 57.9 t -57.44 -41.33 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.682 0.277 . . . . 0.0 110.375 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 433' ' ' LEU . 53.6 t -62.75 -43.02 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.928 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 434' ' ' LEU . 71.8 t -59.15 -50.31 80.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.97 HG11 ' HB2' ' A' ' 407' ' ' ALA . 69.7 t -60.8 -43.45 95.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.844 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 444' ' ' GLY . . . -57.71 -50.51 72.95 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.415 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.58 -40.16 78.37 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.847 0.356 . . . . 0.0 110.197 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' PHE . . . . . 0.446 ' HB3' ' CG1' ' A' ' 403' ' ' VAL . 1.3 t80 -69.11 -35.97 77.01 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.275 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.536 ' CE1' ' HG3' ' A' ' 400' ' ' GLN . 8.0 t80 -88.26 -19.26 27.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 440' ' ' ALA . . . -60.35 64.1 0.01 OUTLIER Glycine 0 C--N 1.337 0.612 0 N-CA-C 114.753 0.661 . . . . 0.0 114.753 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.0 OUTLIER -97.49 -34.78 10.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 109.99 178.54 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 446' ' ' TRP . . . . . 0.433 ' CZ3' ' HD3' ' A' ' 445' ' ' ARG . 6.1 m-90 -152.15 130.5 6.23 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.1 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.452 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 10.1 Cg_endo -51.22 -62.8 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.564 2.176 . . . . 0.0 112.413 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 45.2 t 47.64 33.47 3.05 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 453' ' ' VAL . 49.0 t 66.29 -60.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 451' ' ' ALA . 9.9 m -48.26 -52.2 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 451' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 447' ' ' PRO . . . -57.07 -46.3 82.62 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.663 0.268 . . . . 0.0 111.078 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.565 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.8 OUTLIER -60.57 -52.51 64.87 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.033 178.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 449' ' ' VAL . 67.6 t -54.08 -48.14 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.544 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 454' ' ' ILE . 17.2 mm -53.89 -57.63 5.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 110.473 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -49.62 66.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.595 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 456' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 452' ' ' THR . 92.8 t -55.37 -54.06 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.527 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 45.7 t -48.29 -50.45 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -40.02 87.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.634 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.27 -56.87 15.62 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.207 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.99 -41.55 97.48 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.342 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 1.0 OUTLIER -65.07 -31.18 72.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 462' ' ' PHE . . . . . 0.621 ' HD1' HD22 ' A' ' 433' ' ' LEU . 70.2 t80 -38.56 135.43 0.8 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.901 0.381 . . . . 0.0 111.8 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.469 0.48 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.297 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 13.8 m -50.23 -43.9 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.664 -0.243 . . . . 0.0 111.616 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.98 -40.75 94.6 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.886 0.374 . . . . 0.0 110.654 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' TYR . . . . . 0.468 ' HB3' ' CE2' ' A' ' 419' ' ' TRP . 16.7 m-85 -68.79 -51.89 36.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.7 -49.33 73.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.64 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 2.1 tt -57.62 -53.29 59.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.289 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 48.0 m -53.83 -45.95 71.02 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.33 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -47.7 85.21 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.101 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -55.98 -45.41 78.97 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.329 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 487' ' ' VAL . 78.8 t -62.64 -50.47 79.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.131 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 26.3 ttm -54.64 -48.23 72.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.723 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.73 -46.11 86.87 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.195 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 52.0 m -55.49 -57.89 10.03 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.729 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 483' ' ' VAL . 27.2 m -57.53 -42.04 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.501 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 488' ' ' GLY . . . . . 0.408 ' HA2' ' CD2' ' A' ' 408' ' ' LEU . . . -58.42 -47.15 91.42 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.97 -44.34 82.54 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.7 -53.52 47.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.006 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.411 HG21 HG11 ' A' ' 404' ' ' VAL . 48.9 mt -56.62 -40.0 66.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.465 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.53 -50.42 59.3 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -49.05 76.38 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.419 ' O ' HG23 ' A' ' 498' ' ' VAL . 4.8 tt -58.12 -48.91 78.77 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.475 ' CG2' ' HA2' ' A' ' 401' ' ' GLY . 88.7 m -52.17 -49.22 64.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.734 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.16 89.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.868 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -66.95 -28.64 73.88 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.685 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 494' ' ' LEU . 39.9 t -92.98 -44.36 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.576 0.227 . . . . 0.0 111.526 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.68 63.83 0.62 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 N--CA 1.468 0.45 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.714 -179.955 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 120.982 0.42 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.15 168.28 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.979 0.419 . . . . 0.0 111.907 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.83 ' HB2' HG21 ' A' ' 404' ' ' VAL . 9.6 pt20 -59.72 101.95 0.13 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.201 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.793 ' HA2' HD13 ' A' ' 494' ' ' LEU . . . -162.8 -77.46 0.03 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.439 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.4 t -60.54 -56.01 26.45 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.706 0.289 . . . . 0.0 111.244 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' A' ' 443' ' ' TYR . 1.6 t -61.24 -46.76 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.922 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.83 HG21 ' HB2' ' A' ' 400' ' ' GLN . 60.8 t -58.9 -47.91 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.326 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.89 83.61 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.091 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -57.03 -51.78 67.9 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.41 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -56.08 -51.27 68.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.185 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.537 HD12 ' CG1' ' A' ' 487' ' ' VAL . 4.1 tt -55.62 -44.02 76.67 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.312 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.57 -54.03 46.71 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.474 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.7 78.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.752 0.31 . . . . 0.0 110.454 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 407' ' ' ALA . 88.7 t -60.4 -55.2 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.292 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.562 ' HA ' HG22 ' A' ' 415' ' ' ILE . 0.6 OUTLIER -59.59 -41.99 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.195 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 2.9 m -61.53 -54.8 38.4 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.677 0.275 . . . . 0.0 110.467 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.651 HD13 ' HD1' ' A' ' 432' ' ' TYR . 0.3 OUTLIER -60.71 -50.05 75.02 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.062 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.865 HD11 HG23 ' A' ' 480' ' ' THR . 4.4 tt -59.81 -41.46 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.761 -0.199 . . . . 0.0 111.029 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.95 78.26 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 34.4 mtt -59.6 -47.26 86.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.852 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -56.08 -55.1 37.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.758 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -56.23 -46.47 79.54 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.121 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.04 -48.74 80.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.401 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' MET . . . . . 0.53 ' SD ' ' HB2' ' A' ' 423' ' ' PHE . 1.4 ttm -65.97 -34.93 79.23 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.021 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 76.8 62.36 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.126 0.489 . . . . 0.0 111.329 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' PHE . . . . . 0.53 ' HB2' ' SD ' ' A' ' 421' ' ' MET . 4.9 t80 -136.55 148.17 47.42 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.666 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.254 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.471 HD12 HD21 ' A' ' 414' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.775 0.321 . . . . 0.0 110.885 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.667 HG22 HD12 ' A' ' 433' ' ' LEU . 8.5 p -48.91 -39.85 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.397 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -62.68 -54.05 45.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.659 0.266 . . . . 0.0 110.358 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 16.5 tp -59.63 -43.14 93.95 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.651 ' HD1' HD13 ' A' ' 414' ' ' LEU . 25.6 t80 -58.48 -51.93 67.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.409 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.743 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.1 OUTLIER -55.44 -49.53 72.21 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.839 178.314 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.58 -55.05 18.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.484 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.52 -51.27 58.82 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.726 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 52.4 t -53.46 -42.67 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 120.675 0.274 . . . . 0.0 110.68 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 433' ' ' LEU . 98.7 t -61.49 -46.23 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.45 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.19 -55.57 19.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 120.912 0.387 . . . . 0.0 110.135 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.61 -46.23 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.172 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.538 ' HB1' ' OD1' ' A' ' 455' ' ' ASN . . . -55.57 -47.79 75.85 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.44 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.09 -45.41 75.41 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.574 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -74.72 -27.74 60.5 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.909 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.45 ' HB2' HG11 ' A' ' 403' ' ' VAL . 9.8 t80 -86.48 -41.06 14.7 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -67.31 57.81 0.27 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 114.151 0.42 . . . . 0.0 114.151 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -46.41 6.75 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.51 66.92 75.33 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.835 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 56.0 Cg_endo -69.37 86.09 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.617 2.211 . . . . 0.0 112.869 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.56 62.78 0.39 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.681 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 453' ' ' VAL . 54.8 t 68.8 -59.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.071 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.652 HG12 HD11 ' A' ' 454' ' ' ILE . 89.3 t -52.06 -62.92 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.595 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 451' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' A' ' 454' ' ' ILE . . . -52.01 -40.2 60.64 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.689 0.281 . . . . 0.0 111.382 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.1 OUTLIER -62.66 -54.63 36.58 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.194 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 449' ' ' VAL . 66.7 t -55.07 -45.62 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.417 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.652 HD11 HG12 ' A' ' 450' ' ' VAL . 27.3 mt -56.77 -50.54 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.525 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 455' ' ' ASN . . . . . 0.538 ' OD1' ' HB1' ' A' ' 440' ' ' ALA . 17.0 m-80 -61.22 -48.14 82.84 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.085 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 456' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 452' ' ' THR . 88.6 t -61.06 -58.5 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.244 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 4.0 t -50.36 -49.33 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.285 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -48.08 79.85 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.073 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -58.2 -54.35 48.02 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.651 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -58.01 -51.5 69.42 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.298 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 479' ' ' LEU . 6.9 mp -61.14 -58.12 9.67 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.838 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 462' ' ' PHE . . . . . 0.552 ' O ' HD21 ' A' ' 433' ' ' LEU . 2.0 m-85 -80.82 68.16 6.97 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.613 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.5 t80 . . . . . 0 N--CA 1.465 0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.283 -179.774 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.96 0.41 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.81 -59.81 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.223 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -40.73 74.11 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.656 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -49.85 74.69 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -47.77 83.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.103 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 479' ' ' LEU . . . . . 0.566 ' HA ' HD23 ' A' ' 461' ' ' LEU . 6.2 mp -58.79 -52.99 63.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.138 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 480' ' ' THR . . . . . 0.865 HG23 HD11 ' A' ' 415' ' ' ILE . 18.1 m -54.48 -47.48 72.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.252 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -59.72 -48.93 79.71 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.726 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.92 83.64 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.481 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 487' ' ' VAL . 34.3 m -65.66 -41.84 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 50.8 mtp -58.81 -52.52 65.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -45.87 81.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 486' ' ' THR . . . . . 0.643 ' O ' HG23 ' A' ' 490' ' ' VAL . 85.4 m -55.27 -48.99 73.22 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.443 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 483' ' ' VAL . 99.5 t -57.63 -47.6 85.11 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.617 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 488' ' ' GLY . . . . . 0.89 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -53.02 -45.7 61.92 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 1.3 tt -58.68 -46.88 86.24 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 486' ' ' THR . 41.4 t -58.02 -41.65 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.889 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.89 HD12 ' HA2' ' A' ' 488' ' ' GLY . 55.0 mt -58.14 -53.28 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.97 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -56.79 -49.4 70.86 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.888 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -45.32 92.27 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.687 0.279 . . . . 0.0 110.761 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.793 HD13 ' HA2' ' A' ' 401' ' ' GLY . 0.2 OUTLIER -62.74 -46.47 87.93 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.077 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.498 ' N ' ' HG ' ' A' ' 494' ' ' LEU . 3.5 m -53.84 -46.44 71.2 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.49 -45.75 91.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.681 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.14 -47.85 88.95 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.24 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 494' ' ' LEU . 7.4 p -73.68 59.86 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.588 0.709 . . . . 0.0 110.672 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 499' ' ' ARG . . . . . 0.57 ' NH1' HG13 ' A' ' 498' ' ' VAL . 82.7 mmt-85 -152.32 -62.48 0.16 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.442 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--N 1.332 -0.181 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.767 179.548 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.787 HD12 ' CD1' ' A' ' 443' ' ' TYR . 34.0 pt 44.66 -152.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.042 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.77 ' HA ' HG21 ' A' ' 404' ' ' VAL . 52.6 tp60 45.83 47.82 12.05 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.191 0.52 . . . . 0.0 111.616 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.453 ' HA2' HG23 ' A' ' 495' ' ' THR . . . -141.7 -137.49 3.39 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.192 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.8 -41.92 57.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.735 0.268 . . . . 0.0 111.272 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 8.6 m -59.36 -47.56 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.894 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.77 HG21 ' HA ' ' A' ' 400' ' ' GLN . 39.0 t -64.53 -41.54 92.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.83 88.57 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.076 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.99 -50.06 74.93 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.119 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.437 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -54.44 -51.71 64.11 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.285 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.411 HD21 HD12 ' A' ' 491' ' ' ILE . 2.7 mp -58.68 -45.68 88.89 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.171 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.3 t -54.58 -50.72 67.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.04 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.46 -52.3 58.71 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.033 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 439' ' ' VAL . 46.6 t -52.92 -53.08 23.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.333 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 415' ' ' ILE . 35.9 mt -61.92 -49.91 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.207 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 39.5 m -55.28 -45.63 76.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.675 0.274 . . . . 0.0 110.502 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 3.1 mp -65.47 -54.59 26.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.265 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.471 ' HB ' ' CE1' ' A' ' 432' ' ' TYR . 0.1 OUTLIER -56.81 -44.18 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.452 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -61.23 -51.42 69.05 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.648 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 33.8 mtp -59.2 -49.4 78.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.579 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.517 ' HG2' ' HB3' ' A' ' 428' ' ' LEU . 2.8 mt-30 -60.09 -61.14 2.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.308 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 35.7 t90 -47.54 -44.9 26.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.699 0.285 . . . . 0.0 110.573 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 4.7 tt -63.45 -46.5 85.96 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.551 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 1.8 ttt -68.14 -39.97 82.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.959 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -139.09 96.95 3.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -71.2 59.24 0.26 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 C--O 1.236 0.354 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.872 -179.375 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.517 ' HB3' ' HG2' ' A' ' 418' ' ' GLN . 1.5 mm? . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.16 -26.02 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.15 -51.11 63.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.587 0.232 . . . . 0.0 111.05 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.2 -40.9 97.61 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.154 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.656 ' O ' HG23 ' A' ' 436' ' ' VAL . 54.9 t80 -62.11 -50.98 69.73 Favored 'General case' 0 CA--C 1.526 0.034 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.612 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 6.1 tt -52.7 -52.38 56.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.37 -50.64 67.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.266 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -57.31 -49.09 75.4 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.679 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 432' ' ' TYR . 64.8 t -55.77 -47.79 78.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 47.4 t -56.09 -47.13 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.063 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.0 -52.99 54.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.398 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 411' ' ' VAL . 66.5 t -54.49 -51.96 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.573 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 444' ' ' GLY . . . -59.92 -42.33 93.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.321 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 6.8 tt -64.15 -50.53 67.83 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.67 0.271 . . . . 0.0 111.651 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' PHE . . . . . 0.505 ' O ' ' HD2' ' A' ' 445' ' ' ARG . 0.6 OUTLIER -70.92 -35.62 72.33 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.787 ' CD1' HD12 ' A' ' 399' ' ' ILE . 37.0 t80 -87.78 -26.64 22.77 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 440' ' ' ALA . . . -61.98 -6.23 9.24 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 115.076 0.79 . . . . 0.0 115.076 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.614 ' HD3' HG21 ' A' ' 399' ' ' ILE . 2.7 ptm180 -63.08 -23.79 67.61 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.112 0.956 . . . . 0.0 111.475 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' TRP . . . . . 0.596 ' HB3' HD11 ' A' ' 399' ' ' ILE . 0.0 OUTLIER -131.6 93.0 29.63 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 120.71 0.29 . . . . 0.0 110.751 179.35 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.7 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 11.7 Cg_endo -56.03 -67.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.772 2.315 . . . . 0.0 112.843 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 10.8 t 58.03 -89.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.355 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 453' ' ' VAL . 21.7 t -148.97 -59.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.664 0.269 . . . . 0.0 110.857 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.571 ' HB ' ' OH ' ' A' ' 443' ' ' TYR . 40.7 t -52.74 -47.35 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 451' ' ' ALA . . . . . 0.7 ' HB3' ' HA ' ' A' ' 447' ' ' PRO . . . -59.71 -40.97 89.73 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 456' ' ' VAL . 93.3 m -59.41 -47.41 85.57 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 457' ' ' VAL . 58.1 t -60.15 -48.59 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.485 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 16.4 mm -54.06 -43.56 59.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.998 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -58.11 -50.27 74.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.845 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 452' ' ' THR . 42.4 t -57.77 -52.41 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.663 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 453' ' ' VAL . 77.5 t -54.08 -50.34 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.239 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 13.1 t -58.3 -44.57 88.62 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.954 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -55.37 -59.21 5.12 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.888 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.49 -50.08 75.32 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.678 0.275 . . . . 0.0 110.452 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 9.1 tt -50.74 -43.51 58.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.716 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -55.51 -26.37 42.53 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.375 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 72.4 t80 . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 120.648 0.261 . . . . 0.0 110.963 179.11 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 42.8 t -40.75 -44.34 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 122.421 0.289 . . . . 0.0 111.545 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -62.54 -40.41 96.7 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.599 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -51.91 55.85 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.7 tt -55.33 -54.28 45.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.802 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 479' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 483' ' ' VAL . 0.6 OUTLIER -54.99 -48.43 73.31 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.975 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 69.0 m -55.0 -44.0 74.12 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.802 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.22 -50.46 71.19 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.337 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.46 88.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.635 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 479' ' ' LEU . 91.9 t -63.14 -50.05 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.953 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 21.8 mtt -56.45 -52.67 63.8 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.141 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 2.5 tp -54.87 -46.29 74.7 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 486' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 490' ' ' VAL . 42.9 m -57.36 -48.74 78.22 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.914 178.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 483' ' ' VAL . 73.1 t -56.55 -46.33 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.47 -44.54 90.3 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 42.0 tp -56.52 -46.69 80.43 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.941 0.401 . . . . 0.0 109.983 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 486' ' ' THR . 34.3 t -63.22 -46.28 96.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.855 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.621 HG23 HE22 ' A' ' 400' ' ' GLN . 15.9 mt -55.67 -44.68 77.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.218 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.54 -45.75 92.18 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.694 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -54.43 -53.32 55.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.595 0.236 . . . . 0.0 110.971 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 491' ' ' ILE . 2.2 pp -68.57 -41.03 80.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.552 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 400' ' ' GLN . 79.6 m -60.16 -45.0 94.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.802 0.335 . . . . 0.0 110.415 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.15 79.37 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.449 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.35 -47.12 92.6 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.242 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 495' ' ' THR . 8.0 p -64.84 -30.96 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.644 0.259 . . . . 0.0 111.235 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.59 66.71 0.73 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.897 0.379 . . . . 0.0 110.769 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.469 0.48 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.92 -179.735 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 120.766 0.317 . . . . 0.0 111.676 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 446' ' ' TRP . 3.8 tt -173.62 -49.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.922 0.391 . . . . 0.0 111.324 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.577 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 0.0 OUTLIER -149.37 163.57 37.36 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.928 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.741 ' HA2' HG23 ' A' ' 495' ' ' THR . . . 131.08 -137.03 9.17 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.825 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.2 t -54.32 -49.69 69.11 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.54 -52.57 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.053 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.577 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 21.2 t -59.94 -48.68 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.587 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.81 69.87 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.654 0.264 . . . . 0.0 110.372 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -55.84 -49.96 71.87 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.167 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.858 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -56.65 -47.05 80.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.004 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 1.6 mp -56.76 -47.34 80.32 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 413' ' ' THR . 38.5 t -51.85 -52.48 49.18 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.042 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -55.06 -55.06 35.29 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.326 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 407' ' ' ALA . 42.2 t -52.72 -43.94 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.751 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.19 -55.07 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.476 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 409' ' ' SER . 44.3 p -55.93 -42.31 75.91 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.69 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -56.37 17.46 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.57 -43.82 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.733 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -60.44 -52.14 66.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.572 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 8.2 mtt -50.67 -49.73 56.53 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.72 -42.67 85.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.929 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -56.45 -44.24 80.29 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.352 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.43 45.7 1.3 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.114 0.483 . . . . 0.0 110.548 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 11.3 ttm -163.97 144.82 8.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.466 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -75.74 75.62 2.71 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.895 0.378 . . . . 0.0 111.604 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 428' ' ' LEU . 0.8 OUTLIER -138.13 128.27 25.83 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.052 0.453 . . . . 0.0 111.635 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 C--O 1.236 0.365 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.646 -179.935 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' A' ' 423' ' ' PHE . 1.1 tt . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.683 0.278 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 4.4 p -52.15 -28.07 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.78 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 30.2 mtt -51.37 -44.56 62.14 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.722 0.296 . . . . 0.0 110.455 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -47.69 84.62 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.175 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -62.2 -47.29 85.12 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 437' ' ' VAL . 7.8 tt -53.48 -51.54 62.42 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.78 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 438' ' ' VAL . 5.0 mp -60.33 -46.4 90.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.86 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.654 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -53.18 -55.42 24.33 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.314 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 20.0 m -61.2 -39.61 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.659 0.229 . . . . 0.0 110.462 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 433' ' ' LEU . 34.3 t -57.89 -48.49 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 434' ' ' LEU . 65.1 t -61.14 -48.02 90.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.858 HG22 ' HB1' ' A' ' 407' ' ' ALA . 94.4 t -51.84 -51.37 28.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.063 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.696 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -62.49 -42.21 99.33 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.787 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 3.1 tp -49.11 -46.21 44.57 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -79.76 -36.89 36.55 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.38 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 439' ' ' VAL . 1.2 t80 -60.29 -23.67 64.35 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.131 0.573 . . . . 0.0 112.485 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 446' ' ' TRP . . . -69.0 -123.13 0.03 OUTLIER Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.653 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.71 -67.96 0.13 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.629 0.252 . . . . 0.0 110.871 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' TRP . . . . . 0.465 ' HB2' HD12 ' A' ' 399' ' ' ILE . 7.9 m-90 -126.99 71.02 75.21 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-O 121.111 0.481 . . . . 0.0 109.764 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.71 70.43 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.69 2.26 . . . . 0.0 113.249 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -57.41 12.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.824 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 27.2 t -153.53 -61.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.031 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 454' ' ' ILE . 0.2 OUTLIER -44.88 -43.54 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.159 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -54.04 -52.21 61.58 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.933 0.397 . . . . 0.0 110.718 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.3 OUTLIER -60.04 -43.53 95.28 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.894 178.598 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 457' ' ' VAL . 88.4 t -56.46 -52.22 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.561 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 450' ' ' VAL . 38.3 mm -61.07 -45.03 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.709 0.29 . . . . 0.0 110.305 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -55.93 -46.11 78.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.825 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 452' ' ' THR . 90.5 t -65.97 -47.48 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.506 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 453' ' ' VAL . 57.7 t -54.66 -47.41 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.709 0.29 . . . . 0.0 110.657 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 70.0 m -60.88 -54.02 50.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -52.58 -47.73 66.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.474 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -60.05 4.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.755 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.9 tp -44.12 -41.45 5.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.656 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -39.97 -36.63 0.49 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.9 t80 . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 474' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 477' ' ' TYR . 7.5 t0 . . . . . 0 C--O 1.237 0.429 0 CA-C-O 121.151 0.5 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.25 -43.67 77.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.93 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -51.17 70.4 Favored 'General case' 0 C--O 1.228 -0.056 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 477' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 474' ' ' ASP . 34.6 t80 -53.14 -47.91 68.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.352 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.5 tt -53.24 -46.97 69.4 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 479' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 483' ' ' VAL . 0.1 OUTLIER -59.99 -44.72 94.34 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.512 177.703 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 19.6 m -53.29 -47.87 68.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.294 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -61.49 -47.29 86.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.257 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -57.52 -45.75 84.63 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.584 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 487' ' ' VAL . 67.7 t -64.76 -52.9 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.324 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.3 ttt -52.85 -52.35 57.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.802 0.334 . . . . 0.0 110.487 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 485' ' ' LEU . 0.2 OUTLIER -56.8 -49.75 74.42 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.086 178.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 486' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 490' ' ' VAL . 41.8 m -54.78 -45.94 74.35 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.012 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 483' ' ' VAL . 65.3 t -54.95 -51.91 48.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.905 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.52 80.05 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.418 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.41 -46.77 76.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.857 0.36 . . . . 0.0 110.134 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 486' ' ' THR . 88.7 t -62.91 -49.67 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.221 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.488 HD13 HG12 ' A' ' 487' ' ' VAL . 0.9 OUTLIER -56.52 -38.33 56.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.99 -52.19 39.27 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -55.31 -48.5 74.03 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.944 0.402 . . . . 0.0 109.992 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -45.78 90.62 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.216 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.741 HG23 ' HA2' ' A' ' 401' ' ' GLY . 55.9 m -52.98 -43.72 66.63 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.339 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.45 85.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.307 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -69.11 -52.25 24.17 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.08 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.76 -25.23 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 14.9 tpp85 -51.4 -25.88 6.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 179.379 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 398' ' ' GLN . . . . . 0.455 ' O ' ' HD3' ' A' ' 445' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.53 0.205 . . . . 0.0 111.217 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.7 tp -42.1 -42.26 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.858 ' HB3' HG21 ' A' ' 404' ' ' VAL . 0.8 OUTLIER -166.71 67.58 0.1 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.85 0.357 . . . . 0.0 110.8 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -99.55 -113.1 3.42 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.771 -0.728 . . . . 0.0 114.345 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 14.3 m -34.5 -55.28 0.54 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 442' ' ' PHE . 23.7 m -53.37 -44.11 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.858 HG21 ' HB3' ' A' ' 400' ' ' GLN . 75.3 t -71.21 -44.08 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.905 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.21 76.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.25 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.66 -48.81 70.87 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.607 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.81 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -55.94 -60.09 3.97 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.998 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.892 HD11 HG22 ' A' ' 487' ' ' VAL . 0.1 OUTLIER -53.04 -53.99 41.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.022 179.604 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 23.9 t -53.95 -52.18 61.46 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.427 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -53.48 -48.51 68.86 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.013 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 407' ' ' ALA . 31.8 t -57.17 -49.41 79.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.258 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.662 HD11 HD12 ' A' ' 408' ' ' LEU . 53.4 mt -57.32 -50.92 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.49 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 25.6 m -57.37 -48.07 80.0 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.824 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -59.93 -52.27 66.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.645 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.432 ' CD1' HG12 ' A' ' 411' ' ' VAL . 94.7 mt -56.95 -49.23 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.894 0.378 . . . . 0.0 110.559 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.92 -55.2 37.6 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.292 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 24.1 ttm -54.2 -46.22 72.4 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.27 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 1.007 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 14.7 mt-30 -50.57 -50.45 53.67 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.819 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -70.87 -37.77 73.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.161 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.11 -56.99 12.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.414 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.55 77.0 0.33 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.974 0.416 . . . . 0.0 111.524 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 1.007 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -163.31 -170.58 2.31 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.19 168.87 9.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 111.633 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.396 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.239 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.532 0.28 0 CA-C-O 121.179 0.514 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.609 HG13 ' H ' ' A' ' 430' ' ' MET . 0.9 OUTLIER -155.37 -67.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.807 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 430' ' ' MET . . . . . 0.609 ' H ' HG13 ' A' ' 429' ' ' VAL . 0.0 OUTLIER -60.94 -53.54 56.03 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -38.16 84.36 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.836 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 436' ' ' VAL . 63.6 t80 -63.88 -54.77 29.61 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -54.58 45.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.727 0.299 . . . . 0.0 110.717 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.63 -53.62 55.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.946 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.11 -50.97 60.29 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.732 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 432' ' ' TYR . 43.0 t -57.42 -44.56 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.857 0.328 . . . . 0.0 110.725 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 20.3 t -57.04 -60.7 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.24 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 35.5 m -60.77 -43.62 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.543 0.211 . . . . 0.0 111.273 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.2 t -56.39 -51.0 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -61.85 -48.42 80.62 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.271 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.85 -44.67 70.54 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.829 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' PHE . . . . . 0.57 ' HA ' ' CG2' ' A' ' 403' ' ' VAL . 0.0 OUTLIER -71.62 -52.46 17.88 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.165 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.472 ' O ' ' N ' ' A' ' 445' ' ' ARG . 4.1 t80 -55.01 -29.21 56.86 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.996 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -65.7 58.77 0.13 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.74 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.1 OUTLIER -164.9 42.18 0.08 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.968 0.507 . . . . 0.0 110.601 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 446' ' ' TRP . . . . . 0.466 ' HB2' ' O ' ' A' ' 445' ' ' ARG . 27.4 m0 76.4 142.34 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.065 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.569 ' O ' ' HB3' ' A' ' 451' ' ' ALA . 37.4 Cg_endo -65.54 -39.87 20.08 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.469 2.112 . . . . 0.0 112.08 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.47 ' O ' HG22 ' A' ' 450' ' ' VAL . 0.4 OUTLIER 51.14 20.11 0.82 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.3 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 39.5 t 65.62 -63.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 448' ' ' SER . 1.8 m -52.18 -48.14 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 451' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 447' ' ' PRO . . . -61.19 -47.68 85.02 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.739 0.304 . . . . 0.0 110.719 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 30.5 m -59.25 -55.09 39.35 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.401 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.65 -43.04 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.266 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.948 HG23 HG23 ' A' ' 486' ' ' THR . 10.1 mt -63.63 -59.29 4.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.6 0.238 . . . . 0.0 111.069 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -54.3 -48.58 71.13 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 38.7 t -60.95 -65.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.261 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 54.9 t -47.26 -47.26 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.601 0.238 . . . . 0.0 111.072 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 11.3 t -55.83 -58.13 9.13 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.02 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.19 -51.64 68.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.164 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.25 -43.29 78.54 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.536 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 1.4 mp -68.66 -46.08 70.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.284 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -55.88 107.5 0.35 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.926 0.394 . . . . 0.0 110.893 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 CA--C 1.53 0.188 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.448 -179.815 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.466 0.345 0 CA-C-O 120.807 0.337 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.672 HG12 HD12 ' A' ' 479' ' ' LEU . 76.4 t -59.47 -52.19 63.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.01 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -63.55 -37.0 85.64 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.854 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -64.5 -55.77 18.46 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.6 -47.16 82.9 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.88 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 479' ' ' LEU . . . . . 0.672 HD12 HG12 ' A' ' 475' ' ' VAL . 5.7 mt -56.48 -52.88 63.04 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 480' ' ' THR . . . . . 0.515 HG22 ' SD ' ' A' ' 484' ' ' MET . 37.8 m -54.72 -45.86 74.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.13 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -59.96 -46.93 87.84 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.032 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.77 72.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.412 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 487' ' ' VAL . 28.5 m -64.34 -45.54 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 121.142 -0.223 . . . . 0.0 110.7 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 484' ' ' MET . . . . . 0.515 ' SD ' HG22 ' A' ' 480' ' ' THR . 16.1 mtt -56.82 -55.03 39.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.23 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.27 -46.18 79.79 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.004 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 486' ' ' THR . . . . . 0.948 HG23 HG23 ' A' ' 454' ' ' ILE . 88.9 m -54.13 -51.91 62.75 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.959 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.892 HG22 HD11 ' A' ' 408' ' ' LEU . 94.5 t -55.94 -51.82 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.652 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.6 -48.11 79.37 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.407 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.89 -46.81 88.14 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.736 0.303 . . . . 0.0 110.78 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 486' ' ' THR . 63.6 t -65.38 -60.11 3.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.367 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.422 ' HA ' ' CD2' ' A' ' 494' ' ' LEU . 0.6 OUTLIER -52.8 -43.56 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.36 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.56 -53.31 42.52 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.065 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -58.3 -51.72 68.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.559 0.219 . . . . 0.0 111.499 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.567 ' CD2' HG11 ' A' ' 404' ' ' VAL . 1.2 pp -61.97 -47.21 85.87 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 56.8 m -57.43 -48.14 79.92 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.652 0.263 . . . . 0.0 110.909 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.51 56.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.732 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -54.73 -49.44 61.61 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.159 -0.544 . . . . 0.0 112.994 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 494' ' ' LEU . 8.6 p -65.83 -41.5 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 16.8 mtm105 -68.51 -44.19 75.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.842 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 121.254 0.55 . . . . 0.0 111.719 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.516 ' O ' ' HG2' ' A' ' 400' ' ' GLN . 1.1 tp -56.07 113.87 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.805 0.336 . . . . 0.0 110.451 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.823 ' HA ' HG21 ' A' ' 404' ' ' VAL . 0.0 OUTLIER 59.58 69.46 0.71 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.824 0.821 . . . . 0.0 111.086 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.535 ' HA2' ' CG2' ' A' ' 498' ' ' VAL . . . -128.58 -150.27 7.17 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.817 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.86 -51.33 61.42 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.291 0.236 . . . . 0.0 111.525 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 20.1 m -55.22 -40.19 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.477 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 400' ' ' GLN . 2.7 t -62.42 -49.57 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.217 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.58 81.1 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.877 0.37 . . . . 0.0 110.192 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.9 81.24 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.223 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.726 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -59.04 -47.93 83.45 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.113 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 408' ' ' LEU . 7.8 tt -55.82 -51.15 68.47 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.925 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -45.23 86.62 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.341 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.11 82.13 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.196 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.484 HG21 HG21 ' A' ' 439' ' ' VAL . 53.5 t -55.7 -56.96 9.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.579 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 415' ' ' ILE . 51.0 mt -53.17 -42.52 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.892 0.377 . . . . 0.0 110.114 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 29.2 m -60.68 -46.38 90.59 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.817 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.77 -44.32 93.93 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.874 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 412' ' ' ILE . 61.4 mt -54.87 -48.46 74.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.29 83.6 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.562 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 10.5 mtt -59.87 -52.1 66.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.817 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.61 ' HB3' HD22 ' A' ' 428' ' ' LEU . 14.4 mm100 -56.76 -50.77 71.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.479 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' TRP . . . . . 0.403 ' HA ' ' O ' ' A' ' 422' ' ' ALA . 0.0 OUTLIER -58.78 -42.12 88.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.621 179.229 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -30.08 71.07 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.322 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 7.3 ttt -91.66 -43.51 9.56 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.558 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.812 ' HB3' HD21 ' A' ' 428' ' ' LEU . . . -135.33 156.32 49.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.819 0.343 . . . . 0.0 111.431 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -116.41 25.4 10.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.622 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 111.617 -179.977 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 422' ' ' ALA . 45.0 mt . . . . . 0 C--O 1.236 0.394 0 CA-C-O 120.611 0.243 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 3.4 t -60.92 -45.04 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.921 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 20.7 mtt -48.64 -57.06 6.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 110.237 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.79 -47.76 83.67 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.103 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.487 ' HE1' HD11 ' A' ' 415' ' ' ILE . 20.2 t80 -52.97 -52.39 58.35 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.148 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.587 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.2 OUTLIER -60.49 -42.88 97.21 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.514 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.39 -48.52 65.6 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.553 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.11 -44.23 98.42 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.744 HG11 ' CB ' ' A' ' 458' ' ' SER . 69.6 t -56.9 -40.82 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 433' ' ' LEU . 65.7 t -61.19 -47.91 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.37 -48.33 85.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.726 HG22 ' HB1' ' A' ' 407' ' ' ALA . 76.9 t -57.42 -50.17 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.969 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.11 82.9 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.451 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 441' ' ' LEU . 0.6 OUTLIER -53.17 -50.48 64.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.897 178.355 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -70.76 -21.43 62.52 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.177 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.537 ' OH ' HG13 ' A' ' 490' ' ' VAL . 0.2 OUTLIER -77.24 -2.47 34.84 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -71.1 -161.38 4.2 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.807 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.472 ' O ' HD13 ' A' ' 399' ' ' ILE . 0.0 OUTLIER 78.33 106.08 0.07 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.932 0.493 . . . . 0.0 111.159 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 446' ' ' TRP . . . . . 0.418 ' HB2' ' O ' ' A' ' 445' ' ' ARG . 46.2 m0 67.51 89.29 0.1 OUTLIER Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.67 128.77 25.52 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 112.821 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 91.7 p -113.07 -87.18 0.56 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.302 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 453' ' ' VAL . 7.2 p -178.17 -46.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.548 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 454' ' ' ILE . 53.5 t -54.39 -48.58 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.103 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 451' ' ' ALA . . . . . 0.498 ' O ' HG13 ' A' ' 454' ' ' ILE . . . -54.86 -42.35 71.92 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.172 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.2 OUTLIER -63.89 -49.08 74.11 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.973 178.638 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 449' ' ' VAL . 61.5 t -57.69 -56.18 17.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.799 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 451' ' ' ALA . 1.9 pp -59.17 -41.73 84.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.717 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 455' ' ' ASN . . . . . 0.435 ' N ' HD12 ' A' ' 454' ' ' ILE . 1.2 m120 -55.82 -52.21 64.79 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 456' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 452' ' ' THR . 93.0 t -55.18 -47.86 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.871 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 40.3 t -48.79 -54.08 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.282 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' SER . . . . . 0.744 ' CB ' HG11 ' A' ' 436' ' ' VAL . 0.1 OUTLIER -59.61 -43.23 93.81 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.463 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -54.98 -58.46 7.52 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.368 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' ASP . . . . . 0.451 ' OD2' HG12 ' A' ' 456' ' ' VAL . 29.4 m-20 -62.13 -37.38 84.94 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.269 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.538 HD11 HD12 ' A' ' 479' ' ' LEU . 1.6 tp -64.78 -22.96 67.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.531 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' PHE . . . . . 0.55 ' CD1' ' HG ' ' A' ' 433' ' ' LEU . 15.5 t80 -58.9 70.17 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.347 0.594 . . . . 0.0 111.463 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 461' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.088 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.775 0.322 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.43 ' CG1' HD23 ' A' ' 479' ' ' LEU . 83.0 t -53.19 -45.74 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.331 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -35.05 71.9 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.387 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -71.01 -50.95 28.54 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 42.6 mt -58.9 -49.17 78.8 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.596 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 479' ' ' LEU . . . . . 0.538 HD12 HD11 ' A' ' 461' ' ' LEU . 2.9 mm? -57.51 -52.14 66.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.261 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 480' ' ' THR . . . . . 0.447 ' HA ' HG22 ' A' ' 483' ' ' VAL . 39.0 m -57.19 -42.7 81.73 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.976 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -58.03 -49.04 78.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.309 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.02 -49.44 76.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.368 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 480' ' ' THR . 17.4 m -65.64 -37.36 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.751 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 8.7 mtt -62.66 -53.76 49.59 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 4.7 tp -56.02 -43.34 77.66 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.428 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 486' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 490' ' ' VAL . 32.9 m -59.15 -48.18 82.56 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.784 178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 15.6 t -58.03 -47.68 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.096 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 488' ' ' GLY . . . . . 0.511 ' O ' HG13 ' A' ' 491' ' ' ILE . . . -53.41 -44.72 66.53 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -45.77 83.2 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.796 0.331 . . . . 0.0 110.169 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 486' ' ' THR . 69.8 t -58.88 -54.37 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.553 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.52 ' O ' ' HG ' ' A' ' 494' ' ' LEU . 2.3 pp -57.29 -42.45 80.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 492' ' ' GLY . . . . . 0.414 ' N ' HD12 ' A' ' 491' ' ' ILE . . . -63.71 -45.04 95.43 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.294 -0.955 . . . . 0.0 110.982 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.59 -55.7 28.96 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.304 0.241 . . . . 0.0 110.797 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.658 ' HA ' ' HG3' ' A' ' 400' ' ' GLN . 3.2 pp -61.76 -39.56 92.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.804 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 96.4 m -52.87 -48.77 66.86 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -72.72 -48.8 35.67 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.706 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -51.43 -36.26 37.73 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 116.33 -0.395 . . . . 0.0 113.611 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.535 ' CG2' ' HA2' ' A' ' 401' ' ' GLY . 76.0 t -74.36 -10.11 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.945 0.373 . . . . 0.0 111.883 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -122.27 179.04 4.69 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.014 0.435 . . . . 0.0 111.299 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.996 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 120.769 0.318 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 2.9 mt -74.32 -53.34 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.408 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.735 ' HG3' HD13 ' A' ' 494' ' ' LEU . 0.0 OUTLIER -146.05 44.64 1.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' ' 404' ' ' VAL . . . -111.12 -101.48 2.62 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.278 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 9.1 t -47.23 -40.84 17.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.844 0.322 . . . . 0.0 111.142 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 404' ' ' VAL . 22.4 m -63.04 -48.74 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.755 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 401' ' ' GLY . 2.5 p -69.01 -42.19 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 121.159 -0.217 . . . . 0.0 111.309 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.04 -57.35 13.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 111.048 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.53 -49.4 77.94 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.72 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -54.43 -58.68 6.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.43 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.841 HD11 HG13 ' A' ' 487' ' ' VAL . 0.1 OUTLIER -61.47 -49.93 74.8 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.283 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 409' ' ' SER . . . . . 0.436 ' O ' HG23 ' A' ' 413' ' ' THR . 13.7 t -51.43 -52.65 44.41 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.68 68.63 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.109 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.529 HG12 HD12 ' A' ' 415' ' ' ILE . 15.1 t -52.06 -41.81 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 18.7 mm -62.58 -52.3 61.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.923 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 409' ' ' SER . 24.3 p -60.1 -48.13 82.99 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.763 -0.199 . . . . 0.0 110.644 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' A' ' 431' ' ' LEU . 96.3 mt -59.33 -51.06 71.54 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.745 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.529 HD12 HG12 ' A' ' 411' ' ' VAL . 40.2 mt -59.61 -48.29 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.6 -56.36 22.95 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.755 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 9.2 mtt -53.03 -46.74 68.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.656 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.711 ' HG2' HD23 ' A' ' 428' ' ' LEU . 18.1 tm0? -60.77 -58.29 9.1 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.63 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' TRP . . . . . 0.521 ' HE3' HD12 ' A' ' 420' ' ' LEU . 71.6 t90 -51.93 -42.8 63.1 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.007 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.521 HD12 ' HE3' ' A' ' 419' ' ' TRP . 0.2 OUTLIER -61.32 -25.55 67.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.448 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.55 137.08 34.11 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.953 0.406 . . . . 0.0 110.905 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -72.76 75.16 1.13 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 111.439 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.07 173.81 13.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.125 0.488 . . . . 0.0 111.698 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 C--O 1.237 0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.541 -179.915 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.711 HD23 ' HG2' ' A' ' 418' ' ' GLN . 2.3 mm? . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 430' ' ' MET . 11.0 p -48.0 -43.53 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 430' ' ' MET . . . . . 0.47 ' O ' ' HB2' ' A' ' 434' ' ' LEU . 21.4 ttm -57.6 -57.58 12.08 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.026 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.618 ' HB3' HD22 ' A' ' 414' ' ' LEU . 1.1 mt -57.84 -42.58 84.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.028 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.55 ' HB3' HD21 ' A' ' 461' ' ' LEU . 5.7 m-85 -62.42 -60.03 4.13 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.055 0.455 . . . . 0.0 110.597 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.74 -57.06 14.08 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.483 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 430' ' ' MET . 8.1 mp -52.11 -46.84 65.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.984 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.18 -65.14 3.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.897 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.775 HG11 HD13 ' A' ' 461' ' ' LEU . 34.4 m -59.11 -38.23 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 441' ' ' LEU . 19.5 t -63.48 -52.35 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.923 -0.126 . . . . 0.0 110.796 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 14.9 t -55.76 -52.73 45.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 110.377 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 96.5 t -58.41 -54.62 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.256 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.59 ' HA ' HD13 ' A' ' 454' ' ' ILE . . . -56.95 -52.09 66.58 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 437' ' ' VAL . 1.3 tp -56.73 -47.92 78.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.609 0.242 . . . . 0.0 110.963 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -67.24 -28.98 68.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.964 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -67.84 176.62 2.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.245 0.545 . . . . 0.0 111.629 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 122.15 42.72 0.42 Allowed Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 113.104 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -134.97 116.38 14.62 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.317 0.247 . . . . 0.0 110.391 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 25.6 m95 64.77 97.85 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.598 0 CA-C-O 120.872 0.368 . . . . 0.0 111.899 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.61 76.91 1.84 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.504 2.136 . . . . 0.0 112.279 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 449' ' ' VAL . 97.6 p -104.37 -85.07 0.47 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.683 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.42 ' N ' ' OG ' ' A' ' 448' ' ' SER . 2.7 p -137.68 -51.26 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 4.5 m -46.24 -46.14 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' ALA . . . . . 0.477 ' O ' HG13 ' A' ' 454' ' ' ILE . . . -58.78 -49.07 79.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.886 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 8.2 m -57.51 -41.65 81.2 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.731 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 449' ' ' VAL . 59.4 t -61.08 -59.0 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 440' ' ' ALA . 1.8 pp -60.5 -42.24 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.478 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 455' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 451' ' ' ALA . 1.4 t30 -58.88 -54.68 44.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.545 0.212 . . . . 0.0 110.705 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.93 -55.48 23.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.522 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 3.1 t -48.45 -45.34 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.212 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 2.6 t -59.8 -57.13 14.23 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.156 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -46.35 -51.21 15.26 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.726 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -64.84 -44.64 89.11 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.595 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.775 HD13 HG11 ' A' ' 436' ' ' VAL . 2.0 tt -48.83 -38.81 23.29 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.52 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -51.12 -26.39 6.53 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.263 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 CA--C 1.539 0.551 0 CA-C-O 120.818 0.342 . . . . 0.0 111.178 179.327 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.237 0.419 0 CA-C-O 120.626 0.251 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 17.8 m -50.22 -41.45 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.301 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -53.23 -58.32 7.48 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.706 0.289 . . . . 0.0 111.024 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -56.94 -50.09 73.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -56.18 23.39 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.003 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.89 -50.71 71.69 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.815 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 18.1 m -55.27 -51.5 66.46 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.687 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -59.32 -55.77 30.5 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.02 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -54.14 -47.63 71.7 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.653 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.92 -53.84 36.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.163 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 52.2 mtp -53.9 -52.52 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.282 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -56.12 25.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.997 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 486' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 490' ' ' VAL . 9.7 m -56.01 -57.68 11.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.988 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.841 HG13 HD11 ' A' ' 408' ' ' LEU . 39.2 t -53.2 -53.03 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.239 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -55.48 -52.92 44.63 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.2 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.1 -45.95 79.26 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.655 0.264 . . . . 0.0 110.377 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 486' ' ' THR . 68.4 t -60.34 -50.01 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.034 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.642 HD11 ' CD2' ' A' ' 408' ' ' LEU . 97.2 mt -51.64 -48.22 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 120.788 0.328 . . . . 0.0 110.368 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -67.65 -45.04 79.46 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.954 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -49.41 73.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.288 0.235 . . . . 0.0 111.477 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.735 HD13 ' HG3' ' A' ' 400' ' ' GLN . 3.1 pp -69.22 -43.96 73.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.373 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.526 ' N ' HD12 ' A' ' 494' ' ' LEU . 26.6 m -63.73 -41.31 98.08 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.561 0.22 . . . . 0.0 111.304 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -68.47 -50.03 55.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.313 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -67.97 -56.98 9.29 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.151 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.591 HG21 ' OE1' ' A' ' 400' ' ' GLN . 32.2 t -75.52 64.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.319 0.581 . . . . 0.0 110.987 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 499' ' ' ARG . . . . . 0.416 ' NH1' ' HB3' ' A' ' 499' ' ' ARG . 7.6 ttp-105 -148.73 41.73 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.946 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.386 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.475 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.448 0.166 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.08 -76.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.211 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.995 ' HG2' HG11 ' A' ' 404' ' ' VAL . 5.6 mt-30 -117.07 124.82 50.18 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.874 -0.148 . . . . 0.0 110.94 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 1.007 ' HA2' HD23 ' A' ' 494' ' ' LEU . . . -158.22 -132.66 1.44 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.364 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -41.09 61.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.93 0.365 . . . . 0.0 110.988 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.458 HG23 ' N ' ' A' ' 404' ' ' VAL . 18.0 m -55.86 -52.49 48.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.599 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.995 HG11 ' HG2' ' A' ' 400' ' ' GLN . 16.3 m -72.79 -31.79 37.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 121.194 -0.203 . . . . 0.0 110.94 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.07 -45.05 90.47 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.889 0.375 . . . . 0.0 110.101 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.48 -50.91 61.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.874 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 440' ' ' ALA . . . -56.01 -48.11 76.52 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.099 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.758 HD21 HG13 ' A' ' 487' ' ' VAL . 2.9 tp -58.99 -45.01 91.69 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.812 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 58.1 m -53.28 -44.32 68.16 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.24 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' ALA . . . . . 0.415 ' HB3' HG13 ' A' ' 436' ' ' VAL . . . -62.92 -48.16 80.14 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.266 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.429 HG12 HD11 ' A' ' 415' ' ' ILE . 75.3 t -57.7 -54.66 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.355 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 415' ' ' ILE . 93.4 mt -52.68 -48.23 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.885 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 35.7 m -57.38 -45.23 84.68 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.661 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' A' ' 432' ' ' TYR . 1.4 mm? -56.7 -55.95 27.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.208 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 412' ' ' ILE . 9.7 mt -54.86 -47.12 75.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.442 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.14 79.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.08 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -44.84 82.49 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.549 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 1.04 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 14.4 tt0 -57.7 -58.13 9.7 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.607 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -57.3 -35.77 70.24 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.62 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 421' ' ' MET . 1.0 OUTLIER -70.62 -53.49 15.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.476 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 421' ' ' MET . . . . . 0.434 ' HB2' HD23 ' A' ' 420' ' ' LEU . 1.7 mtt -171.83 71.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 1.04 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -156.71 115.04 3.29 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.918 0.389 . . . . 0.0 111.061 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -72.98 94.22 1.84 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.036 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 CA--C 1.536 0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.865 179.138 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 120.485 0.183 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.439 HG21 ' HB1' ' A' ' 422' ' ' ALA . 89.2 t -53.28 -46.37 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.888 0.375 . . . . 0.0 110.302 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -49.47 76.02 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.125 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 4.0 mp -58.42 -48.44 80.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.362 -0.381 . . . . 0.0 109.979 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.632 ' HB3' HD11 ' A' ' 414' ' ' LEU . 0.2 OUTLIER -55.53 -54.97 37.32 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.172 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.4 OUTLIER -56.62 -43.11 79.88 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.183 178.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 438' ' ' VAL . 0.1 OUTLIER -56.46 -52.21 65.53 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.594 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -55.22 -47.7 72.95 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 432' ' ' TYR . 92.3 t -56.43 -47.3 81.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 433' ' ' LEU . 68.1 t -58.43 -44.61 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.848 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 434' ' ' LEU . 64.2 t -58.44 -45.55 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.432 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 72.6 t -56.81 -53.11 46.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.977 0.418 . . . . 0.0 110.328 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.451 ' HB2' ' HB1' ' A' ' 407' ' ' ALA . . . -59.71 -47.09 87.02 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.405 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -40.97 80.22 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.595 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.66 -37.4 86.41 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.699 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.23 -43.64 15.87 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.578 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.48 172.94 37.75 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.469 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.699 ' O ' ' HB1' ' A' ' 451' ' ' ALA . 3.7 mtt180 -130.63 -170.82 2.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 111.961 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' TRP . . . . . 0.56 ' H ' ' HD2' ' A' ' 447' ' ' PRO . 22.8 m-90 -110.93 -59.64 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.56 ' HD2' ' H ' ' A' ' 446' ' ' TRP . 53.7 Cg_endo -69.03 61.38 1.33 Allowed 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.205 1.937 . . . . 0.0 113.311 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.12 29.21 1.09 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.332 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 92.9 t 56.63 -83.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.68 0.392 . . . . 0.0 111.814 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 15.6 m -54.6 -44.83 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.563 0.221 . . . . 0.0 110.893 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' ALA . . . . . 0.699 ' HB1' ' O ' ' A' ' 445' ' ' ARG . . . -57.76 -43.43 85.43 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.756 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -50.5 73.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.066 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 49.1 t -59.38 -48.59 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.57 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.12 -47.48 86.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.154 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.2 -49.97 75.81 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.12 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 31.8 t -54.69 -53.79 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.5 ' CG1' HD13 ' A' ' 461' ' ' LEU . 24.3 t -48.94 -53.49 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.147 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -39.81 72.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.59 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -56.21 -55.81 28.64 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.414 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.93 -42.26 99.74 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.858 0.361 . . . . 0.0 110.656 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.5 HD13 ' CG1' ' A' ' 457' ' ' VAL . 0.1 OUTLIER -63.78 -23.8 67.5 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.511 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -67.72 73.48 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.197 0.523 . . . . 0.0 110.918 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.252 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.994 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.681 0.277 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.623 HG12 HD12 ' A' ' 479' ' ' LEU . 99.1 t -59.47 -58.32 7.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.321 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -33.61 67.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.136 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -70.55 -53.45 16.05 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.17 -48.32 73.94 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.033 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 479' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 483' ' ' VAL . 1.1 mt -57.24 -48.52 78.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.652 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 61.3 m -57.87 -42.75 85.19 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.437 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -56.18 -50.9 69.89 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.887 0.375 . . . . 0.0 110.14 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.75 88.23 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.142 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 479' ' ' LEU . 54.4 t -61.62 -45.34 98.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.803 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 95.4 mtp -55.11 -54.64 40.6 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.756 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.446 ' O ' HD13 ' A' ' 485' ' ' LEU . 0.5 OUTLIER -57.47 -44.06 84.56 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 62.6 m -53.92 -49.77 67.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.071 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.758 HG13 HD21 ' A' ' 408' ' ' LEU . 88.5 t -62.44 -50.51 79.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.113 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -52.55 -42.76 58.28 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.9 -46.51 87.46 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.99 -53.34 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.232 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 7.2 tp -59.64 -39.85 80.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 120.571 0.224 . . . . 0.0 110.967 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -66.49 -47.58 68.8 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -56.14 -40.68 74.19 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.628 -0.286 . . . . 0.0 110.241 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 1.007 HD23 ' HA2' ' A' ' 401' ' ' GLY . 0.0 OUTLIER -69.59 -47.15 64.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.555 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.778 ' N ' HD13 ' A' ' 494' ' ' LEU . 91.3 m -49.97 -48.45 52.19 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.638 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -83.13 -45.28 14.14 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.681 0.277 . . . . 0.0 111.474 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -47.84 -61.73 4.6 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.812 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 498' ' ' VAL . 50.8 t -74.34 60.08 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.551 0.691 . . . . 0.0 110.122 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -169.81 -52.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.654 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 120.88 0.372 . . . . 0.0 111.884 179.567 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.447 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 400' ' ' GLN . 0.2 OUTLIER -61.59 129.59 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.863 0.363 . . . . 0.0 110.924 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.647 ' N ' HD13 ' A' ' 399' ' ' ILE . 1.4 mm-40 57.78 64.23 1.6 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.195 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -128.64 -169.24 12.57 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.75 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 24.9 t -41.0 -56.42 2.28 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.626 0.25 . . . . 0.0 111.608 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.438 HG11 ' CE1' ' A' ' 442' ' ' PHE . 98.2 t -53.04 -43.17 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.84 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.5 -46.72 94.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.233 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' ALA . . . . . 0.829 ' HB2' HD13 ' A' ' 494' ' ' LEU . . . -55.67 -49.42 72.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.84 0.352 . . . . 0.0 110.068 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.66 -53.27 59.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.679 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -52.19 -49.28 64.16 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.783 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.548 ' HA ' HG22 ' A' ' 411' ' ' VAL . 1.1 tp -60.27 -44.17 95.56 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -45.7 89.89 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.881 0.372 . . . . 0.0 110.262 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.27 -53.88 42.0 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.216 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 408' ' ' LEU . 35.4 m -58.86 -48.23 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.136 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.418 ' N ' HG23 ' A' ' 411' ' ' VAL . 56.9 mt -55.04 -46.84 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 82.5 m -57.12 -45.47 83.44 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.762 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.565 HD23 HD23 ' A' ' 431' ' ' LEU . 1.3 mp -59.9 -50.76 72.49 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.215 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.52 HG22 ' CE3' ' A' ' 419' ' ' TRP . 12.2 mm -55.76 -47.9 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.023 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.06 92.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.053 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 1.5 tpt -57.25 -46.98 82.52 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.055 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.472 ' HB2' HD21 ' A' ' 428' ' ' LEU . 3.3 mt-30 -65.53 -37.67 87.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.181 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' TRP . . . . . 0.52 ' CE3' HG22 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -60.61 -37.35 81.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.614 179.055 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.17 57.2 0.1 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.202 0.525 . . . . 0.0 110.886 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' MET . . . . . 0.588 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 4.3 mtp -136.49 -37.26 0.69 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.829 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 90.54 84.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.136 0.574 . . . . 0.0 111.161 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.3 -174.01 0.38 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.737 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 14.5 p30 . . . . . 0 CA--C 1.536 0.439 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.927 179.573 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 418' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 14.7 p -45.28 -34.17 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 29.1 mtt -56.74 -58.97 5.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.834 0.35 . . . . 0.0 110.275 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.565 HD23 HD23 ' A' ' 414' ' ' LEU . 6.1 mp -67.85 -40.3 83.71 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.41 ' O ' HG23 ' A' ' 436' ' ' VAL . 1.5 t80 -54.49 -56.45 18.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.913 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.53 -45.67 84.78 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.22 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 438' ' ' VAL . 0.5 OUTLIER -52.93 -51.26 61.97 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 178.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -63.42 -44.05 97.34 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.846 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.525 HG11 ' CZ ' ' A' ' 459' ' ' PHE . 39.9 t -56.34 -53.73 36.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.48 0.181 . . . . 0.0 111.025 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.73 -43.38 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.602 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 434' ' ' LEU . 44.0 t -58.71 -52.45 59.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 435' ' ' GLY . 70.2 t -56.11 -53.64 36.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.405 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -53.75 -47.13 70.96 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.463 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 4.0 tt -52.02 -47.26 65.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.776 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' PHE . . . . . 0.438 ' CE1' HG11 ' A' ' 403' ' ' VAL . 20.2 m-85 -68.4 -33.3 74.0 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.717 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 445' ' ' ARG . 3.8 m-85 -70.38 -21.86 62.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.607 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -63.53 67.55 0.04 OUTLIER Glycine 0 C--N 1.341 0.826 0 C-N-CA 121.571 -0.347 . . . . 0.0 113.271 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.0 OUTLIER -140.71 -61.83 0.49 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.121 0.486 . . . . 0.0 110.076 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -154.05 88.38 3.51 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.999 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.24 176.17 2.18 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.941 2.427 . . . . 0.0 113.663 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.8 m -171.21 153.19 3.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.409 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 453' ' ' VAL . 58.0 t -39.9 -60.92 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.567 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.623 HG11 ' OD1' ' A' ' 493' ' ' ASN . 46.7 t -51.06 -56.29 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 451' ' ' ALA . . . . . 0.644 ' HA ' HD12 ' A' ' 454' ' ' ILE . . . -53.55 -48.41 69.13 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.782 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 456' ' ' VAL . 88.7 m -57.97 -46.12 85.66 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.248 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 449' ' ' VAL . 88.9 t -60.97 -44.12 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.121 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 451' ' ' ALA . 30.6 mt -56.57 -50.96 71.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 120.889 0.376 . . . . 0.0 110.218 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.62 -50.29 73.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.71 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 452' ' ' THR . 90.3 t -56.43 -52.34 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.145 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 453' ' ' VAL . 55.2 t -53.68 -49.79 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.722 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -44.75 96.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.375 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 459' ' ' PHE . . . . . 0.525 ' CZ ' HG11 ' A' ' 436' ' ' VAL . 2.3 m-85 -58.58 -48.65 80.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.774 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.93 -44.91 96.56 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.943 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.445 HD11 HD22 ' A' ' 479' ' ' LEU . 30.0 tp -58.9 -48.23 82.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.989 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -87.14 92.94 9.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.019 0.438 . . . . 0.0 111.475 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 28.8 t80 . . . . . 0 CA--C 1.539 0.553 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.044 -179.747 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 479' ' ' LEU . 6.7 p -53.52 -42.86 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.25 -47.67 85.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.579 0.228 . . . . 0.0 111.269 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.29 -51.0 61.74 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.609 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.7 -53.44 56.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.861 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 479' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 475' ' ' VAL . 0.1 OUTLIER -57.9 -48.08 80.9 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.173 179.139 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 99.4 m -53.9 -52.54 60.2 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.397 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -59.3 -48.61 80.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.709 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.85 75.17 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.995 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 487' ' ' VAL . 93.6 t -65.52 -52.84 46.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.497 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 3.3 ttt -52.23 -51.73 56.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.866 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -49.43 77.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.333 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 486' ' ' THR . . . . . 0.478 HG23 HG23 ' A' ' 454' ' ' ILE . 88.6 m -54.57 -58.27 8.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.159 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 483' ' ' VAL . 36.0 m -59.81 -43.92 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.814 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 488' ' ' GLY . . . . . 0.493 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -55.24 -51.45 54.13 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 489' ' ' LEU . . . . . 0.586 HD22 HG13 ' A' ' 450' ' ' VAL . 5.6 mt -55.36 -46.57 76.46 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.522 HG21 ' CD2' ' A' ' 408' ' ' LEU . 59.0 t -57.07 -45.17 84.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.577 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.493 HD12 ' HA2' ' A' ' 488' ' ' GLY . 50.3 mt -58.46 -46.31 89.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.792 0.33 . . . . 0.0 110.615 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.76 -53.57 33.84 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.93 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 493' ' ' ASN . . . . . 0.623 ' OD1' HG11 ' A' ' 450' ' ' VAL . 2.1 m120 -56.76 -46.52 81.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.642 0.258 . . . . 0.0 110.78 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.829 HD13 ' HB2' ' A' ' 405' ' ' ALA . 0.6 OUTLIER -60.38 -46.3 90.47 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.165 178.768 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 89.9 m -54.86 -51.13 66.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.948 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.7 84.57 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.009 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -57.86 -44.0 94.52 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.439 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.56 -48.49 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 120.581 0.229 . . . . 0.0 110.498 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -79.4 54.1 1.65 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.136 0.493 . . . . 0.0 110.325 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 C--O 1.233 0.206 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.701 -179.343 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 398' ' ' GLN . . . . . 0.758 ' HA ' HG21 ' A' ' 498' ' ' VAL . 1.0 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.556 0.217 . . . . 0.0 110.524 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.644 ' HB ' HD21 ' A' ' 494' ' ' LEU . 1.2 mp -90.51 -58.1 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.733 0.302 . . . . 0.0 110.455 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.511 ' HB2' HD23 ' A' ' 494' ' ' LEU . 0.7 OUTLIER -159.62 91.43 0.99 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.625 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -141.82 -98.13 0.31 Allowed Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.172 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 5.5 t -55.25 -55.03 36.04 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.667 0.27 . . . . 0.0 111.254 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 443' ' ' TYR . 17.6 m -50.46 -45.0 25.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.055 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.443 HG12 ' CD1' ' A' ' 491' ' ' ILE . 3.2 t -70.44 -37.42 70.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.379 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.31 96.67 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.31 -49.99 67.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.784 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.563 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -55.61 -50.79 69.21 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.327 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 408' ' ' LEU . 0.2 OUTLIER -58.96 -45.88 89.43 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.229 178.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 53.4 m -52.94 -42.22 65.25 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.145 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.41 -48.52 75.09 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.393 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 407' ' ' ALA . 17.4 t -57.89 -46.93 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.393 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 23.0 mm -59.71 -45.33 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 49.0 m -58.78 -48.19 82.11 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.028 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 432' ' ' TYR . 1.6 mp -56.18 -48.47 76.29 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.149 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.442 HG22 ' HD1' ' A' ' 419' ' ' TRP . 32.5 mm -61.53 -45.78 97.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.389 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -52.44 -51.58 58.47 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.033 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -47.36 85.94 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.624 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -50.63 -42.49 56.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.54 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' TRP . . . . . 0.442 ' HD1' HG22 ' A' ' 415' ' ' ILE . 44.7 m95 -67.78 -45.02 76.03 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.503 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.51 -40.47 93.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.424 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' MET . . . . . 0.427 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 29.2 mtt -146.17 134.19 21.47 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.137 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 72.04 74.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.205 0.526 . . . . 0.0 111.398 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -55.02 159.47 2.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.877 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 . . . . . 0 CA--C 1.536 0.414 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.452 -179.888 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.55 HG13 HD23 ' A' ' 414' ' ' LEU . 54.8 t -41.52 -37.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -41.17 -54.3 2.93 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 7.1 tp -57.64 -52.55 64.97 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.005 0.431 . . . . 0.0 110.494 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.64 ' HB3' HD21 ' A' ' 414' ' ' LEU . 46.5 m-85 -58.36 -48.94 78.95 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.085 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.408 ' N ' HD21 ' A' ' 414' ' ' LEU . 0.2 OUTLIER -53.47 -47.76 69.46 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.915 178.748 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 437' ' ' VAL . 2.8 tp -53.66 -49.68 67.42 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.888 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.49 -44.47 97.96 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.79 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 432' ' ' TYR . 63.8 t -58.16 -52.56 57.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 122.058 0.143 . . . . 0.0 111.011 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 434' ' ' LEU . 33.3 m -56.57 -40.92 71.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.7 -46.78 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 435' ' ' GLY . 99.1 t -55.33 -49.62 71.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.12 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.01 75.42 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.542 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -37.9 73.2 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.734 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -70.63 -45.19 65.65 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.508 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.466 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 2.9 m-85 -68.63 -49.1 61.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.508 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' A' ' 445' ' ' ARG . . . -67.43 161.33 48.45 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.787 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 444' ' ' GLY . 0.0 OUTLIER -155.86 -61.01 0.11 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 122.631 -0.335 . . . . 0.0 111.501 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -81.02 108.23 9.71 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.689 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.844 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 29.7 Cg_endo -64.02 -50.21 3.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.352 2.034 . . . . 0.0 112.528 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 58.2 m 43.31 43.67 4.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.859 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 26.9 t 68.42 -57.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.463 HG12 ' CD1' ' A' ' 454' ' ' ILE . 13.1 t -47.5 -55.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 451' ' ' ALA . . . . . 0.844 ' HB3' ' HA ' ' A' ' 447' ' ' PRO . . . -57.57 -48.24 79.9 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.635 0.255 . . . . 0.0 110.976 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 456' ' ' VAL . 12.6 m -56.21 -53.59 55.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.665 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 457' ' ' VAL . 42.8 t -56.24 -54.51 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.664 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.463 ' CD1' HG12 ' A' ' 450' ' ' VAL . 52.3 mt -52.63 -52.2 28.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.578 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -55.72 -53.41 56.98 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.396 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 452' ' ' THR . 44.8 t -51.88 -52.34 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.516 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 453' ' ' VAL . 86.2 t -49.73 -52.75 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.672 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 1.2 p -60.75 -41.25 95.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.762 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -61.12 -41.23 96.32 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.807 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -73.03 -42.16 63.46 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.478 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.599 HD11 HD22 ' A' ' 479' ' ' LEU . 3.6 tt -59.18 -46.56 88.09 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.769 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -101.17 -167.23 1.4 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.114 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.348 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 35.7 t70 . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 33.3 t -56.0 -59.77 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -40.79 95.9 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.16 -51.35 54.85 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.531 0.205 . . . . 0.0 110.849 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -51.86 67.28 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.829 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 479' ' ' LEU . . . . . 0.599 HD22 HD11 ' A' ' 461' ' ' LEU . 0.8 OUTLIER -56.18 -53.67 54.32 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.642 0.258 . . . . 0.0 110.378 179.222 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 480' ' ' THR . . . . . 0.458 HG22 ' SD ' ' A' ' 484' ' ' MET . 42.8 m -54.29 -48.65 71.03 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.776 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 481' ' ' PHE . . . . . 0.593 ' CE1' HD13 ' A' ' 485' ' ' LEU . 9.5 t80 -61.3 -47.38 86.21 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 110.979 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.57 73.55 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.267 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.637 ' O ' HG23 ' A' ' 487' ' ' VAL . 31.3 m -64.13 -42.25 94.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 484' ' ' MET . . . . . 0.458 ' SD ' HG22 ' A' ' 480' ' ' THR . 22.3 mtt -57.74 -52.82 63.89 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.336 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.593 HD13 ' CE1' ' A' ' 481' ' ' PHE . 0.4 OUTLIER -58.33 -47.02 85.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.21 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 28.0 m -56.09 -50.21 71.67 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.197 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.831 HG12 HD11 ' A' ' 491' ' ' ILE . 84.7 t -59.64 -52.77 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.005 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 488' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -52.91 -44.47 61.6 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.692 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 7.1 tt -55.43 -56.49 19.55 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 487' ' ' VAL . 30.0 m -61.07 -37.39 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.561 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.831 HD11 HG12 ' A' ' 487' ' ' VAL . 62.8 mt -59.61 -44.96 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.25 -51.4 50.01 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.34 -46.34 72.9 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 110.1 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.644 HD21 ' HB ' ' A' ' 399' ' ' ILE . 16.2 tp -64.81 -44.9 88.39 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.901 178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 98.0 m -52.1 -51.29 58.69 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -58.68 -48.2 81.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.236 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -60.5 -50.84 63.23 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.056 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.758 HG21 ' HA ' ' A' ' 398' ' ' GLN . 7.0 p -73.1 -40.43 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 49.63 1.77 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.083 0.468 . . . . 0.0 111.205 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.62 179.63 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 120.971 0.415 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.4 tp -167.09 144.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.202 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.723 ' NE2' HG11 ' A' ' 450' ' ' VAL . 3.5 mm-40 52.2 50.67 17.93 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.942 0.401 . . . . 0.0 111.331 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -159.28 -98.96 0.15 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.031 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.8 m -45.72 -54.17 8.28 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 404' ' ' VAL . 14.8 p -57.02 -44.62 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.992 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.582 HG11 ' CD2' ' A' ' 494' ' ' LEU . 71.8 t -59.4 -51.8 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.478 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.21 -55.84 29.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.896 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -55.14 -47.67 74.75 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.896 0.379 . . . . 0.0 110.534 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.459 ' HB2' ' CG2' ' A' ' 439' ' ' VAL . . . -56.41 -60.24 3.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.377 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -51.65 67.04 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.292 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 3.2 m -55.59 -53.4 56.89 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.567 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.97 -49.13 77.32 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.598 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.583 HG13 HD13 ' A' ' 415' ' ' ILE . 35.2 t -60.6 -57.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.605 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.2 tp -55.0 -42.55 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 46.4 m -61.47 -56.59 18.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.047 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.41 -50.04 75.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.812 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.583 HD13 HG13 ' A' ' 411' ' ' VAL . 1.1 mp -55.69 -53.04 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 420' ' ' LEU . . . -57.66 -53.99 51.95 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.109 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 26.5 mtp -56.88 -54.95 40.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -51.92 61.13 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' TRP . . . . . 0.542 ' CD2' HG23 ' A' ' 415' ' ' ILE . 43.7 m0 -57.65 -33.0 67.84 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.148 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 3.7 tp -57.26 -29.51 63.88 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 110.904 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 2.8 ttp -97.39 -45.66 6.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.054 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 419' ' ' TRP . . . -131.18 116.74 18.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.643 0.259 . . . . 0.0 111.267 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -86.24 44.87 1.17 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.286 179.752 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.623 0.249 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 430' ' ' MET . 5.3 p -131.32 -52.9 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 430' ' ' MET . . . . . 0.446 ' N ' HG13 ' A' ' 429' ' ' VAL . 1.4 mmt -51.2 -47.19 62.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.611 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 1.5 mt -58.5 -58.75 7.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.339 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.56 ' HE1' HD11 ' A' ' 415' ' ' ILE . 33.7 m-85 -51.72 -51.51 55.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.796 0.331 . . . . 0.0 110.456 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.05 -58.17 9.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.624 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 1.7 mp -49.11 -51.39 32.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.371 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.47 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -63.43 -59.7 8.48 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.894 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 38.3 t -52.35 -50.71 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.25 -56.87 14.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 24.2 t -53.58 -50.91 47.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.566 0.222 . . . . 0.0 110.903 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 435' ' ' GLY . 75.0 t -56.38 -55.01 21.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.883 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -53.93 -50.1 67.19 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.086 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -54.26 48.66 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.221 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -32.1 67.51 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.776 0.322 . . . . 0.0 111.06 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.51 ' CE1' ' HG2' ' A' ' 400' ' ' GLN . 14.1 t80 -84.43 -1.38 55.53 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.447 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.18 -169.17 7.53 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.322 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 63.81 44.68 4.79 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.836 0.351 . . . . 0.0 111.35 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -164.7 133.9 2.82 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.629 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -87.04 122.41 1.85 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.844 2.363 . . . . 0.0 112.62 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 28.5 t -176.2 171.4 2.5 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.137 0.494 . . . . 0.0 111.873 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 26.3 t -89.14 -21.28 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.563 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.723 HG11 ' NE2' ' A' ' 400' ' ' GLN . 93.3 t -62.94 -58.02 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.838 -0.165 . . . . 0.0 111.376 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -53.05 -44.04 67.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.629 0.252 . . . . 0.0 111.192 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -61.23 2.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.744 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 41.9 t -53.73 -45.54 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.71 0.29 . . . . 0.0 110.788 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 16.2 mm -58.91 -55.2 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.23 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.35 -49.29 74.83 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 77.1 t -58.95 -57.29 11.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 120.609 0.242 . . . . 0.0 110.843 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 17.5 t -55.4 -49.77 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.02 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 59.5 p -58.33 -47.9 82.25 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.589 0.233 . . . . 0.0 110.949 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -60.8 -58.82 6.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.41 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.17 -45.01 92.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.619 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -63.57 -33.64 76.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.279 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 462' ' ' PHE . . . . . 0.413 ' CZ ' HG23 ' A' ' 429' ' ' VAL . 2.4 t80 -70.46 59.96 0.2 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.032 0.444 . . . . 0.0 111.098 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.503 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 476' ' ' GLN . 7.3 p -47.87 -50.98 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.459 ' N ' HG13 ' A' ' 475' ' ' VAL . 0.8 OUTLIER -69.0 -37.36 78.66 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.834 -0.166 . . . . 0.0 111.357 179.675 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.47 -47.85 84.34 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.96 -47.33 71.95 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.116 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 479' ' ' LEU . . . . . 0.408 HD13 HG22 ' A' ' 475' ' ' VAL . 0.1 OUTLIER -54.8 -47.15 74.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.622 178.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 12.1 m -64.18 -51.75 62.26 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -56.74 -44.16 81.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.582 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.76 -53.22 60.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.369 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 487' ' ' VAL . 35.0 m -63.19 -43.0 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.061 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 6.8 mtt -60.7 -56.1 25.26 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.676 0.274 . . . . 0.0 110.766 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 9.7 tp -55.43 -44.67 76.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.397 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 486' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 490' ' ' VAL . 35.7 m -60.01 -52.81 63.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.4 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 483' ' ' VAL . 69.8 t -56.27 -48.76 79.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.716 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -60.7 -51.67 57.21 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.381 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.95 80.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.742 0.306 . . . . 0.0 110.859 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 486' ' ' THR . 96.1 t -64.4 -54.75 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.573 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.546 HD12 HD21 ' A' ' 494' ' ' LEU . 4.7 tp -55.68 -41.38 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 120.474 0.178 . . . . 0.0 111.208 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.69 -54.78 29.0 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.476 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -63.2 -43.42 98.23 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 400' ' ' GLN . 0.5 OUTLIER -61.81 -46.03 91.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 121.413 -0.115 . . . . 0.0 111.298 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 1.2 m -65.58 -40.79 93.15 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.521 0.201 . . . . 0.0 110.719 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -70.22 -37.33 74.99 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.697 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -79.43 -42.86 11.06 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.589 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.25 -31.84 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 117.033 0.417 . . . . 0.0 111.829 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -104.16 123.97 48.26 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.874 0.368 . . . . 0.0 110.559 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.492 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.872 0.368 . . . . 0.0 111.553 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.514 ' CG1' ' HB2' ' A' ' 446' ' ' TRP . 2.9 mp -53.88 100.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.878 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.747 ' HA ' HG21 ' A' ' 404' ' ' VAL . 2.8 mm100 70.53 87.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.404 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -151.94 -150.16 5.28 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.824 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 29.0 t -53.01 -49.63 65.83 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.482 0.182 . . . . 0.0 111.304 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 39.7 t -54.74 -49.45 68.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 110.19 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' A' ' 400' ' ' GLN . 54.2 t -58.85 -46.73 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.281 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.65 77.7 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.884 0.374 . . . . 0.0 110.173 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.96 67.8 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.505 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.632 ' HB1' HG13 ' A' ' 439' ' ' VAL . . . -55.75 -48.73 74.75 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.254 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.568 HD23 HD11 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -56.22 -47.84 77.63 Favored 'General case' 0 C--O 1.23 0.056 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.722 178.556 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.6 t -52.78 -43.0 65.54 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.155 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.4 71.8 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.836 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.669 ' CG2' HG21 ' A' ' 439' ' ' VAL . 97.3 t -58.75 -50.59 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.914 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.568 HD11 HD23 ' A' ' 408' ' ' LEU . 27.2 mt -57.03 -45.61 83.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.231 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 41.3 m -60.38 -49.11 78.87 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.127 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.8 mt -58.14 -53.09 62.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.295 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -45.97 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.893 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -54.73 -54.07 46.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.665 0.269 . . . . 0.0 110.387 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 2.2 ttm -61.89 -42.91 99.64 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.524 ' HG2' ' HG ' ' A' ' 428' ' ' LEU . 0.5 OUTLIER -60.1 -28.47 67.86 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.544 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -40.41 12.25 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.566 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 421' ' ' MET . 1.6 tt -73.78 87.09 1.72 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.96 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' MET . . . . . 0.416 ' CB ' ' O ' ' A' ' 420' ' ' LEU . 1.5 ttt 83.11 158.97 0.12 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.701 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 54.04 59.86 3.98 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 110.587 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' PHE . . . . . 0.402 ' O ' ' HB3' ' A' ' 424' ' ' ASP . 0.8 OUTLIER -63.31 173.23 1.6 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.501 -178.792 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 423' ' ' PHE . 49.9 t0 . . . . . 0 N--CA 1.467 0.383 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.523 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.524 ' HG ' ' HG2' ' A' ' 418' ' ' GLN . 4.5 mm? . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.507 HG22 HD23 ' A' ' 433' ' ' LEU . 9.1 p -47.33 -35.67 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.64 -52.32 40.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.137 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.78 -45.82 77.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.834 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.609 ' O ' HG23 ' A' ' 436' ' ' VAL . 0.6 OUTLIER -55.2 -50.17 70.05 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.193 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.77 HD21 ' HB2' ' A' ' 462' ' ' PHE . 0.6 OUTLIER -60.95 -49.71 76.34 Favored 'General case' 0 N--CA 1.46 0.032 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.008 178.771 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 1.7 tt -51.99 -46.23 64.8 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.77 68.71 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.728 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.842 HG11 ' HB3' ' A' ' 458' ' ' SER . 91.3 t -56.67 -39.81 65.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.776 0.322 . . . . 0.0 110.5 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 433' ' ' LEU . 53.6 t -61.05 -57.02 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.675 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 30.2 m -59.23 -39.4 78.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 120.748 0.309 . . . . 0.0 110.397 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.669 HG21 ' CG2' ' A' ' 411' ' ' VAL . 4.0 t -59.43 -58.75 5.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.138 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.37 -42.78 78.39 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.612 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.7 tp -51.35 -52.68 43.48 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.556 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -71.61 -36.74 70.9 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.964 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.515 ' CE2' HG22 ' A' ' 404' ' ' VAL . 1.6 t80 -63.09 -38.13 89.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 445' ' ' ARG . . . -47.92 104.77 0.09 OUTLIER Glycine 0 C--N 1.339 0.728 0 CA-C-N 116.366 -0.379 . . . . 0.0 113.477 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 444' ' ' GLY . 0.1 OUTLIER -144.72 -66.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.621 0.248 . . . . 0.0 110.908 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 446' ' ' TRP . . . . . 0.514 ' HB2' ' CG1' ' A' ' 399' ' ' ILE . 0.6 OUTLIER -127.26 125.12 23.95 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.633 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.27 87.78 1.03 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.488 2.125 . . . . 0.0 112.554 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 449' ' ' VAL . 91.0 p -108.24 -93.47 0.41 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.356 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.408 ' N ' ' OG ' ' A' ' 448' ' ' SER . 3.4 p -146.16 -49.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 451' ' ' ALA . 1.5 m -46.18 -54.16 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.599 0.238 . . . . 0.0 111.337 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 451' ' ' ALA . . . . . 0.419 ' H ' HG23 ' A' ' 450' ' ' VAL . . . -57.28 -41.44 79.73 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.887 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.06 -52.97 61.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.393 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 69.8 t -54.29 -50.1 58.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.68 -47.23 86.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.082 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -55.87 -49.7 72.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.433 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.97 -56.73 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.332 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.31 -41.7 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.891 0.377 . . . . 0.0 110.763 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' SER . . . . . 0.842 ' HB3' HG11 ' A' ' 436' ' ' VAL . 19.3 m -65.58 -48.91 70.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.651 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.66 -48.67 80.28 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.132 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.41 -54.97 39.22 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.015 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.8 -45.58 70.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.542 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' PHE . . . . . 0.77 ' HB2' HD21 ' A' ' 433' ' ' LEU . 0.1 OUTLIER -38.84 -40.54 0.64 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.44 0.296 . . . . 0.0 111.307 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 65.0 t80 . . . . . 0 CA--C 1.533 0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.2 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 17.9 t70 . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.4 0.143 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 15.3 m -47.99 -45.16 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -32.87 73.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.537 0.208 . . . . 0.0 110.716 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -47.51 55.78 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 4.6 tt -59.15 -48.97 79.64 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.977 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 479' ' ' LEU . . . . . 0.461 HD13 HG23 ' A' ' 483' ' ' VAL . 0.6 OUTLIER -59.03 -49.39 78.06 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.844 178.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 87.7 m -55.98 -44.0 78.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.914 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -56.42 -49.12 75.45 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.75 -43.56 94.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.475 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.461 HG23 HD13 ' A' ' 479' ' ' LEU . 69.5 t -60.48 -50.1 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.376 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 34.9 mtp -59.3 -52.37 65.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.359 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -47.42 73.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.936 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 34.7 m -58.83 -50.8 72.62 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.049 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.06 -52.65 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.784 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.83 87.56 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.054 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.26 -51.24 70.8 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.375 0.131 . . . . 0.0 110.92 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.461 HG21 HD11 ' A' ' 408' ' ' LEU . 25.8 m -63.21 -39.37 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.011 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 494' ' ' LEU . 26.1 mt -56.5 -50.77 71.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 120.966 0.412 . . . . 0.0 110.194 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -66.98 -45.45 82.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.363 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.3 -52.31 61.89 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.155 0.182 . . . . 0.0 111.082 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.645 ' HA ' ' HB3' ' A' ' 400' ' ' GLN . 4.5 pp -64.15 -39.79 94.77 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.526 ' N ' HD12 ' A' ' 494' ' ' LEU . 91.6 m -57.81 -43.99 86.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.164 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -73.74 -56.66 4.72 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.037 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -50.48 -42.65 43.73 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.338 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 4.9 p -69.38 -10.49 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.38 104.18 14.65 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.563 0.221 . . . . 0.0 110.777 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 N--CA 1.47 0.57 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.45 -179.783 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.723 0.296 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.5 tp -150.73 139.57 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.16 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.539 ' HA ' HG21 ' A' ' 404' ' ' VAL . 43.5 tt0 -59.82 136.45 58.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.066 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.409 ' H ' ' HB ' ' A' ' 404' ' ' VAL . . . 132.44 -101.88 0.47 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.878 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 12.7 t -58.74 -72.19 0.1 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' VAL . . . . . 0.51 ' HB ' ' CD2' ' A' ' 441' ' ' LEU . 34.1 m -48.03 -43.75 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 120.554 0.216 . . . . 0.0 111.525 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.539 HG21 ' HA ' ' A' ' 400' ' ' GLN . 76.9 t -60.76 -54.57 33.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.812 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.14 83.68 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.21 65.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.509 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.937 ' HB1' HG22 ' A' ' 438' ' ' VAL . . . -55.76 -55.69 29.36 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.604 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 487' ' ' VAL . 2.0 tt -57.62 -44.23 85.38 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.458 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 412' ' ' ILE . 35.8 t -52.61 -44.61 66.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.641 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.33 -46.77 82.05 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.276 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.837 ' CG2' HG21 ' A' ' 438' ' ' VAL . 75.5 t -59.13 -52.25 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.523 ' HA ' HG22 ' A' ' 415' ' ' ILE . 0.4 OUTLIER -59.25 -41.73 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.384 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 59.8 m -63.28 -45.48 91.25 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.523 HD22 HD22 ' A' ' 434' ' ' LEU . 0.9 OUTLIER -59.5 -57.04 14.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.235 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 412' ' ' ILE . 18.4 tt -56.99 -39.82 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.263 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.31 75.08 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 32.3 mtt -60.09 -45.28 93.46 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.763 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' GLN . . . . . 0.421 ' OE1' ' HA ' ' A' ' 415' ' ' ILE . 98.9 mt-30 -54.74 -57.18 12.54 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' TRP . . . . . 0.456 ' HB2' ' CD2' ' A' ' 423' ' ' PHE . 0.1 OUTLIER -48.29 -45.45 34.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.226 178.635 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.28 -32.19 47.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' MET . . . . . 0.584 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 0.8 OUTLIER -120.7 42.72 2.94 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.929 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 99.64 110.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.657 0.783 . . . . 0.0 111.706 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 423' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' A' ' 419' ' ' TRP . 5.5 t80 -70.64 98.41 1.49 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.417 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 21.1 t0 . . . . . 0 CA--C 1.534 0.334 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.208 179.72 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 428' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.463 0.21 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.36 -51.35 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.694 0.283 . . . . 0.0 110.35 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 7.1 ttt -65.4 -49.14 70.35 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.41 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -46.68 85.7 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.594 ' CE2' HG11 ' A' ' 436' ' ' VAL . 2.1 t80 -60.66 -51.13 70.68 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 9.2 tt -54.74 -51.13 66.62 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.307 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' LEU . . . . . 0.523 HD22 HD22 ' A' ' 414' ' ' LEU . 2.1 tp -58.36 -47.5 83.59 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.637 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.5 -58.65 12.23 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.859 -0.61 . . . . 0.0 113.072 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' VAL . . . . . 0.594 HG11 ' CE2' ' A' ' 432' ' ' TYR . 35.4 m -53.92 -42.93 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.811 0.305 . . . . 0.0 111.684 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.576 ' O ' HD12 ' A' ' 441' ' ' LEU . 28.9 t -61.44 -57.54 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.536 0.207 . . . . 0.0 110.676 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 438' ' ' VAL . . . . . 0.937 HG22 ' HB1' ' A' ' 407' ' ' ALA . 99.4 t -56.62 -49.64 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.999 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.744 HG11 ' HB2' ' A' ' 458' ' ' SER . 73.1 t -57.25 -48.34 82.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.107 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -55.08 -48.21 73.85 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.576 HD12 ' O ' ' A' ' 437' ' ' VAL . 0.2 OUTLIER -58.04 -42.83 86.2 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.176 177.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 442' ' ' PHE . . . . . 0.67 ' CD1' HD13 ' A' ' 454' ' ' ILE . 0.2 OUTLIER -63.84 -41.5 97.81 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.211 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 445' ' ' ARG . 22.4 t80 -77.35 -37.9 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.191 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -63.92 67.87 0.05 OUTLIER Glycine 0 C--N 1.338 0.666 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.34 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 400' ' ' GLN . 0.0 OUTLIER -140.43 -55.22 0.52 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.594 0.235 . . . . 0.0 110.962 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 446' ' ' TRP . . . . . 0.501 ' CD2' ' HD2' ' A' ' 447' ' ' PRO . 0.0 OUTLIER 175.34 139.14 0.19 Allowed Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.156 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.501 ' HD2' ' CD2' ' A' ' 446' ' ' TRP . 36.5 Cg_endo -64.12 67.88 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.592 2.195 . . . . 0.0 112.343 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.491 ' OG ' ' NH2' ' A' ' 445' ' ' ARG . 0.8 OUTLIER -104.39 42.28 1.22 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.518 -179.311 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 453' ' ' VAL . 50.6 t 67.27 -64.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.928 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.7 m -50.81 -47.9 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 454' ' ' ILE . . . -54.22 -53.3 55.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 110.393 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 452' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.6 OUTLIER -56.03 -48.74 75.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.611 178.488 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 449' ' ' VAL . 84.6 t -53.71 -46.42 62.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.464 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.67 HD13 ' CD1' ' A' ' 442' ' ' PHE . 34.5 mt -55.75 -45.27 79.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -61.72 -45.66 93.01 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 452' ' ' THR . 58.0 t -53.36 -50.93 45.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.02 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 74.6 t -53.08 -50.31 46.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' SER . . . . . 0.744 ' HB2' HG11 ' A' ' 439' ' ' VAL . 1.4 t -55.06 -43.11 73.54 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.737 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.49 -45.91 92.23 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.23 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.67 -37.72 68.68 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.285 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -22.45 33.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.366 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -66.58 70.71 0.07 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 111.838 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 CA--C 1.534 0.362 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.955 179.694 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 474' ' ' ASP . . . . . 0.451 ' O ' HD12 ' A' ' 478' ' ' LEU . 3.9 m-20 . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 476' ' ' GLN . 11.6 p -51.89 -44.05 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.087 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.403 ' N ' HG13 ' A' ' 475' ' ' VAL . 0.6 OUTLIER -66.5 -44.35 82.84 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.559 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -56.17 -58.14 9.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.086 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 474' ' ' ASP . 1.5 mp -59.66 -51.45 69.74 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 479' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 483' ' ' VAL . 7.4 tt -55.47 -58.22 8.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.732 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 480' ' ' THR . . . . . 0.402 ' N ' HD23 ' A' ' 479' ' ' LEU . 3.1 m -54.45 -41.83 69.89 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.574 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -56.45 -47.87 78.23 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.86 94.24 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.275 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 479' ' ' LEU . 39.2 t -63.14 -47.04 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.021 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -59.81 -51.54 69.31 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 tt -54.77 -45.06 74.17 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 486' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 490' ' ' VAL . 70.6 m -58.99 -49.25 78.6 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.993 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 487' ' ' VAL . . . . . 0.477 HG21 HD11 ' A' ' 408' ' ' LEU . 18.2 t -52.21 -51.5 30.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.119 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 488' ' ' GLY . . . . . 0.481 ' O ' HG13 ' A' ' 491' ' ' ILE . . . -55.75 -45.59 85.12 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.858 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.03 -46.07 92.2 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 110.353 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 486' ' ' THR . 94.9 t -61.55 -56.52 17.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.007 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 488' ' ' GLY . 2.5 pp -58.83 -37.02 64.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.692 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.43 -59.22 8.03 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -53.8 -46.41 71.06 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.68 ' C ' HD13 ' A' ' 494' ' ' LEU . 1.3 tm? -55.33 -46.66 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.703 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 99.2 m -54.33 -50.01 68.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.228 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.42 77.65 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.358 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -54.52 -50.6 56.43 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.218 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.542 HG23 HD22 ' A' ' 494' ' ' LEU . 66.9 t -64.89 -35.34 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.76 0.314 . . . . 0.0 110.664 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 499' ' ' ARG . . . . . 0.489 ' HD2' ' HB2' ' A' ' 500' ' ' TYR . 7.0 tmm_? -62.06 -51.39 68.18 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.132 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 500' ' ' TYR . . . . . 0.489 ' HB2' ' HD2' ' A' ' 499' ' ' ARG . 11.3 t80 . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 120.721 0.296 . . . . 0.0 111.678 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 120.625 0.25 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.468 HG22 HG22 ' A' ' 498' ' ' VAL . 1.0 OUTLIER -76.61 -167.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 400' ' ' GLN . . . . . 0.966 ' HG2' HG21 ' A' ' 404' ' ' VAL . 3.6 tt0 -60.29 93.89 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.958 -0.464 . . . . 0.0 111.228 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.861 ' HA3' HG21 ' A' ' 498' ' ' VAL . . . -156.82 -120.84 0.66 Allowed Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.269 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 67.0 m -50.74 -46.2 59.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.764 0.282 . . . . 0.0 111.256 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 15.9 m -55.88 -41.42 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.945 0.402 . . . . 0.0 110.963 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' VAL . . . . . 0.966 HG21 ' HG2' ' A' ' 400' ' ' GLN . 58.9 t -73.44 -43.62 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.796 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.14 -47.53 80.92 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.78 -48.33 81.12 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.163 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' ALA . . . . . 0.768 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -54.83 -50.71 67.93 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.465 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -49.84 76.07 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.23 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 409' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 412' ' ' ILE . 0.3 OUTLIER -56.73 -40.09 75.09 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.147 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -66.71 -54.77 19.47 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.612 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 407' ' ' ALA . 55.9 t -55.69 -48.38 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.057 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 412' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 409' ' ' SER . 0.3 OUTLIER -60.46 -42.32 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.422 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 91.2 m -61.48 -45.52 93.9 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.751 ' HB3' HD11 ' A' ' 431' ' ' LEU . 20.6 mt -60.21 -57.2 13.81 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.546 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.643 HG13 HD21 ' A' ' 428' ' ' LEU . 16.2 tt -57.76 -39.93 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.953 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -62.81 -51.56 66.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.812 0.339 . . . . 0.0 110.305 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 20.9 mtp -58.46 -47.34 84.34 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.545 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -46.1 89.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.834 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' TRP . . . . . 0.478 ' HA ' ' O ' ' A' ' 422' ' ' ALA . 1.2 m0 -57.35 -38.89 74.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.52 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.42 -28.1 58.44 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.983 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -44.63 6.44 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.776 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 419' ' ' TRP . . . -125.97 138.14 53.73 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.845 0.355 . . . . 0.0 111.601 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.81 162.24 24.12 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--O 1.236 0.388 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.473 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.643 HD21 HG13 ' A' ' 415' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.492 0.187 . . . . 0.0 111.281 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 430' ' ' MET . 4.0 p -44.91 -51.12 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.697 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 430' ' ' MET . . . . . 0.426 ' N ' HG13 ' A' ' 429' ' ' VAL . 4.7 mtm -66.73 -47.22 72.97 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.779 0.323 . . . . 0.0 110.365 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' LEU . . . . . 0.751 HD11 ' HB3' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -55.65 -51.45 67.18 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.388 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 432' ' ' TYR . . . . . 0.499 ' OH ' ' HB2' ' A' ' 458' ' ' SER . 44.0 t80 -59.15 -44.59 92.11 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.163 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.5 OUTLIER -55.83 -54.21 47.3 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.546 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 6.1 mt -57.48 -42.38 82.53 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.187 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.15 -58.43 13.57 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.479 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 32.8 m -53.99 -34.67 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.784 0.292 . . . . 0.0 110.607 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 437' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 433' ' ' LEU . 54.3 t -63.26 -51.25 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.14 -46.4 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.373 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' VAL . . . . . 0.768 HG22 ' HB1' ' A' ' 407' ' ' ALA . 15.1 t -60.46 -46.11 95.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.135 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.76 76.39 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.127 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.34 -46.57 69.54 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -63.67 -38.52 91.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.45 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' TYR . . . . . 0.742 ' CE1' HG22 ' A' ' 404' ' ' VAL . 5.6 m-85 -74.13 -17.82 60.88 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.79 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -56.76 80.32 0.01 OUTLIER Glycine 0 C--N 1.342 0.876 0 C-N-CA 121.711 -0.281 . . . . 0.0 112.96 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 443' ' ' TYR . 12.3 ttt85 -174.11 -55.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.32 0.248 . . . . 0.0 110.841 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -163.88 81.15 1.44 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.456 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -89.91 158.98 4.99 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.959 2.439 . . . . 0.0 113.075 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.0 t -129.63 178.73 6.27 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.982 0.42 . . . . 0.0 111.678 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 91.5 t -55.34 -39.29 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.964 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 9.2 m -48.14 -46.36 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.645 0.259 . . . . 0.0 111.443 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' ALA . . . . . 0.401 ' HB2' ' HE2' ' A' ' 443' ' ' TYR . . . -64.28 -45.21 89.01 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -48.54 81.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.526 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.28 -54.75 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.326 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.698 HG22 HG23 ' A' ' 486' ' ' THR . 33.2 pt -57.11 -40.54 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.378 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -68.01 -50.34 56.08 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.36 -52.74 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.567 HG12 HD22 ' A' ' 461' ' ' LEU . 37.6 t -55.88 -41.41 66.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.285 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 458' ' ' SER . . . . . 0.499 ' HB2' ' OH ' ' A' ' 432' ' ' TYR . 64.9 m -62.95 -50.45 70.77 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.19 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -55.26 -52.36 63.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.559 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.4 -53.42 58.39 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.806 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.567 HD22 HG12 ' A' ' 457' ' ' VAL . 3.9 mp -56.2 -38.71 71.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.887 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -75.09 -28.65 60.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.978 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.9 t80 . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.977 0.418 . . . . 0.0 111.524 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 C--O 1.237 0.403 0 CA-C-O 120.771 0.319 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.34 -37.01 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.771 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -57.99 -39.91 79.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.488 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -46.7 64.15 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.01 -53.38 57.66 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.873 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.83 -43.97 90.78 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.013 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 54.7 m -54.15 -47.47 71.89 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -64.63 -46.6 81.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.449 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.47 78.26 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.528 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.69 -43.53 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.901 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 26.7 mtt -57.45 -51.09 70.85 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.183 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.0 tp -59.57 -45.53 91.59 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.827 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 486' ' ' THR . . . . . 0.698 HG23 HG22 ' A' ' 454' ' ' ILE . 88.1 m -56.11 -48.97 75.15 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.269 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.02 -51.24 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.494 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 491' ' ' ILE . . . -54.69 -47.03 72.97 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.983 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -47.34 84.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.668 0.27 . . . . 0.0 110.491 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.559 ' CG2' HG21 ' A' ' 454' ' ' ILE . 39.2 t -60.18 -52.95 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.58 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.519 ' HA ' HD21 ' A' ' 494' ' ' LEU . 9.2 tp -57.47 -42.32 80.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.84 -0.164 . . . . 0.0 110.662 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.8 -42.73 94.97 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -57.37 -56.25 24.25 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.642 0.377 . . . . 0.0 110.79 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 494' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' A' ' 491' ' ' ILE . 3.9 pp -61.88 -40.46 95.46 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.344 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 495' ' ' THR . . . . . 0.454 ' N ' HD12 ' A' ' 494' ' ' LEU . 45.5 m -62.88 -33.76 75.97 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.374 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -83.08 -42.2 17.7 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.192 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -63.54 -57.73 13.76 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.408 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 498' ' ' VAL . . . . . 0.861 HG21 ' HA3' ' A' ' 401' ' ' GLY . 2.7 t -62.83 94.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.868 0.366 . . . . 0.0 111.229 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 499' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 498' ' ' VAL . 3.8 ptm180 154.67 -37.22 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.942 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 120.894 0.378 . . . . 0.0 111.269 -179.575 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 3.0 mmm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.481 0.181 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.34 123.5 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.74 0.305 . . . . 0.0 111.541 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.07 154.59 24.03 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.401 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 399' ' ' ILE . 13.2 tt -73.56 101.1 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.95 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.444 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 4.7 mm-40 66.66 80.11 0.22 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.325 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -133.04 -134.52 3.51 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.071 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 13.4 m -47.09 -38.91 12.16 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 35.5 t -59.79 -47.35 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.452 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.589 HG13 ' CE2' ' A' ' 442' ' ' PHE . 12.7 t -60.51 -48.32 88.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.406 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.68 69.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.738 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.68 -50.45 73.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.064 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 1.084 ' HB1' HG13 ' A' ' 438' ' ' VAL . . . -57.85 -55.95 28.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.67 ' HG ' HG11 ' A' ' 490' ' ' VAL . 0.4 OUTLIER -59.14 -40.57 85.91 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.652 179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 37.8 t -57.12 -57.59 11.9 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.301 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -53.18 -42.32 66.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.705 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.795 HG23 HG21 ' A' ' 438' ' ' VAL . 25.0 t -61.61 -59.06 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.27 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.0 tp -55.5 -43.48 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 121.358 -0.137 . . . . 0.0 110.948 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 52.9 m -59.58 -51.52 69.49 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 434' ' ' LEU . 8.5 tp -57.94 -46.44 85.04 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.368 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.799 HG12 HD11 ' A' ' 431' ' ' LEU . 75.0 mt -57.71 -52.44 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.601 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.29 -48.42 80.53 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.058 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 22.3 mtt -59.66 -52.81 63.92 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.024 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -60.57 -47.31 86.74 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.353 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' TRP . . . . . 0.519 ' HA ' ' O ' ' A' ' 424' ' ' ASP . 0.0 OUTLIER -59.56 -44.07 93.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.945 0.402 . . . . 0.0 110.185 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 4.9 tt -64.12 -42.57 96.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 6.1 tpt -67.84 126.9 30.9 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.871 0.367 . . . . 0.0 111.727 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 70.82 -98.98 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.918 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.23 41.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.661 0.267 . . . . 0.0 111.519 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 419' ' ' TRP . 4.5 p30 -148.44 157.25 43.35 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.805 0.336 . . . . 0.0 111.198 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 426' ' ' ALA . . . -70.15 -30.74 67.97 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.211 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 425' ' ' ALA . . . 167.06 163.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.523 0.515 . . . . 0.0 110.758 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -90.05 38.07 0.91 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.754 0.311 . . . . 0.0 111.247 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 7.9 mt 47.46 30.63 1.67 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 71.4 t -143.61 -69.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.915 -0.13 . . . . 0.0 111.311 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -52.49 34.19 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.671 0.272 . . . . 0.0 111.111 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.799 HD11 HG12 ' A' ' 415' ' ' ILE . 17.5 tp -62.97 -40.52 97.97 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.04 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 462' ' ' PHE . 54.0 t80 -67.18 -48.57 67.53 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.928 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.8 OUTLIER -56.28 -59.38 5.03 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.7 0.286 . . . . 0.0 110.568 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 414' ' ' LEU . 0.1 OUTLIER -59.72 -45.19 92.93 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.293 178.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.734 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -53.85 -55.06 27.51 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.859 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 39.3 t -55.17 -47.74 77.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 433' ' ' LEU . 59.6 t -54.03 -50.2 55.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 1.084 HG13 ' HB1' ' A' ' 407' ' ' ALA . 41.2 t -61.27 -43.04 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.158 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 435' ' ' GLY . 98.0 t -54.9 -45.83 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -58.32 -47.09 84.83 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.672 HD23 ' HB2' ' A' ' 407' ' ' ALA . 2.1 tp -56.14 -44.71 79.49 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.171 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' PHE . . . . . 0.589 ' CE2' HG13 ' A' ' 404' ' ' VAL . 3.2 t80 -64.38 -45.2 88.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.552 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -52.87 -43.39 66.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.355 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -74.72 48.39 1.94 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.874 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 399' ' ' ILE . 0.6 OUTLIER -136.68 29.45 2.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.41 0.284 . . . . 0.0 110.8 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 446' ' ' TRP . . . . . 0.401 ' CB ' ' O ' ' A' ' 445' ' ' ARG . 0.0 OUTLIER 83.74 125.88 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.561 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.21 97.16 1.12 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.669 2.246 . . . . 0.0 112.728 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.0 m -121.3 38.95 3.95 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.861 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 97.7 t 67.76 -55.13 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.794 HG21 ' OD1' ' A' ' 493' ' ' ASN . 7.0 m -41.83 -46.76 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -59.63 -47.5 85.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.851 0.358 . . . . 0.0 110.205 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 20.8 m -56.46 -49.16 75.41 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.929 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.3 -52.97 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.343 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.577 HG23 HG23 ' A' ' 486' ' ' THR . 19.8 mt -53.3 -50.81 45.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.752 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -59.82 -51.91 67.72 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.666 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.9 t -54.05 -52.21 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 54.6 t -52.01 -54.55 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.509 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -44.2 92.03 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.827 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -57.41 -57.51 12.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.834 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -41.95 91.52 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.847 0.356 . . . . 0.0 110.695 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.556 ' HG ' ' CB ' ' A' ' 482' ' ' ALA . 1.3 mm? -68.59 -21.01 64.54 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.461 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 432' ' ' TYR . 60.5 t80 -61.68 76.25 0.02 OUTLIER 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.568 0.699 . . . . 0.0 111.135 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 461' ' ' LEU . 0.9 OUTLIER 179.37 -55.36 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.331 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.854 HD13 HD13 ' A' ' 478' ' ' LEU . 17.8 tt -91.45 50.44 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.254 0.55 . . . . 0.0 111.24 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.878 ' HB3' ' HD3' ' A' ' 466' ' ' PRO . . . -98.78 -59.47 0.13 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.625 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.878 ' HD3' ' HB3' ' A' ' 465' ' ' ALA . 37.9 Cg_exo -57.91 149.81 67.68 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.533 2.155 . . . . 0.0 112.762 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.15 61.03 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.088 0.47 . . . . 0.0 111.593 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 466' ' ' PRO . . . 160.32 -72.21 0.22 Allowed Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.433 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 469' ' ' THR . . . . . 0.821 HG21 ' HA ' ' A' ' 464' ' ' ILE . 15.3 t 31.02 46.01 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 43.52 35.29 0.93 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -91.42 167.02 12.57 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.991 0.424 . . . . 0.0 111.825 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.12 -40.25 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.65 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 22.7 t -84.67 -176.78 6.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.879 0.371 . . . . 0.0 111.378 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 477' ' ' TYR . 10.4 t0 -74.54 98.52 3.38 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.103 0.478 . . . . 0.0 110.948 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.806 HG22 HG13 ' A' ' 464' ' ' ILE . 95.9 t -56.49 -48.3 80.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.205 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -47.61 76.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.874 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 477' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 474' ' ' ASP . 1.3 m-85 -66.38 -52.83 42.78 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.026 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.854 HD13 HD13 ' A' ' 464' ' ' ILE . 0.1 OUTLIER -52.15 -51.55 57.29 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.617 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 479' ' ' LEU . . . . . 0.667 ' O ' HG23 ' A' ' 483' ' ' VAL . 17.1 tp -61.18 -46.98 88.25 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.046 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 82.8 m -52.32 -49.4 64.32 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.626 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.33 -52.87 63.8 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.39 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ALA . . . . . 0.556 ' CB ' ' HG ' ' A' ' 461' ' ' LEU . . . -54.74 -42.27 71.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.842 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 479' ' ' LEU . 88.1 t -64.48 -49.08 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.003 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 9.2 ttm -56.99 -52.36 65.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.585 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 28.7 tp -56.02 -50.35 71.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.933 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' THR . . . . . 0.691 ' HA ' HD12 ' A' ' 489' ' ' LEU . 35.8 m -56.02 -47.13 78.39 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.285 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 483' ' ' VAL . 42.1 t -57.57 -48.39 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.909 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -54.08 -43.92 73.28 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.509 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 486' ' ' THR . 4.7 mt -64.19 -49.52 71.7 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.78 0.324 . . . . 0.0 110.25 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.67 HG11 ' HG ' ' A' ' 408' ' ' LEU . 65.2 t -58.66 -55.27 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.352 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 20.9 tt -57.21 -42.29 79.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.857 -0.156 . . . . 0.0 110.795 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -60.67 -50.3 69.07 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.504 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' ASN . . . . . 0.794 ' OD1' HG21 ' A' ' 450' ' ' VAL . 15.9 m-80 -61.03 -54.7 41.57 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.574 0.226 . . . . 0.0 110.526 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.11 -43.53 66.94 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.662 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 58.3 m -61.85 -50.61 71.55 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.206 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.11 82.86 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.174 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -57.63 -51.33 58.58 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.455 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 92.5 t -71.19 -47.73 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 120.988 0.423 . . . . 0.0 110.72 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 499' ' ' ARG . . . . . 0.88 ' HD3' ' HB2' ' A' ' 502' ' ' ALA . 1.1 tmm_? -105.35 87.33 2.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.114 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -57.85 -52.31 65.99 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.614 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.51 160.43 38.07 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 111.422 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.88 ' HB2' ' HD3' ' A' ' 499' ' ' ARG . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.059 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' MET . . . . . 0.939 ' N ' ' HG ' ' A' ' 402' ' ' SER . 1.7 mpt? . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 120.883 0.373 . . . . 0.0 111.487 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 8.1 p -166.9 131.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.249 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' GLN . . . . . 0.543 ' HB3' ' HB1' ' A' ' 502' ' ' ALA . 0.0 OUTLIER 63.62 -171.73 0.17 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.636 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.413 HD12 ' OE1' ' A' ' 400' ' ' GLN . 2.7 pt -73.71 149.02 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.714 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.413 ' OE1' HD12 ' A' ' 399' ' ' ILE . 2.4 mp0 61.48 -167.46 0.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.883 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 84.29 -110.66 3.37 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.542 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' SER . . . . . 0.939 ' HG ' ' N ' ' A' ' 396' ' ' MET . 33.7 m -52.99 -48.14 67.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.578 0.227 . . . . 0.0 111.472 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.782 HG21 ' HG2' ' A' ' 445' ' ' ARG . 10.5 t -55.13 -52.97 39.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.931 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.496 HG11 HD23 ' A' ' 494' ' ' LEU . 22.8 t -60.41 -46.44 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.24 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.26 76.97 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.566 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.56 -55.06 35.01 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.652 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -56.37 -48.49 76.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.434 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.98 HD11 HG13 ' A' ' 487' ' ' VAL . 2.1 tp -57.95 -49.48 76.64 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.388 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.667 ' HA ' HD12 ' A' ' 412' ' ' ILE . 41.0 t -53.64 -48.13 69.66 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.63 82.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.262 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 407' ' ' ALA . 41.7 t -63.23 -42.54 96.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.151 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 409' ' ' SER . 23.8 mt -61.84 -53.31 49.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.585 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 409' ' ' SER . 42.7 p -58.54 -44.92 89.78 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.449 HD21 ' HG ' ' A' ' 431' ' ' LEU . 18.2 tp -57.46 -49.42 76.33 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.137 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 14.9 mm -59.75 -54.14 38.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.924 0.393 . . . . 0.0 110.19 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -52.1 -49.84 62.81 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.894 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 10.5 mtt -63.7 -43.15 97.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.838 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 0.0 OUTLIER -57.56 -45.67 84.86 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.183 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -35.21 36.39 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -51.83 -57.39 9.47 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 4.6 mtp -145.71 59.86 1.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.957 0.408 . . . . 0.0 111.603 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 418' ' ' GLN . . . -171.83 -177.06 1.87 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.394 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 426' ' ' ALA . 53.6 m-85 -91.89 150.69 20.91 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.74 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.575 ' HB3' ' N ' ' A' ' 469' ' ' THR . 0.8 OUTLIER -48.56 116.58 1.65 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.473 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 468' ' ' GLY . . . 59.0 24.05 12.23 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.622 ' HB2' ' HB2' ' A' ' 423' ' ' PHE . . . -66.17 163.25 18.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.727 0.299 . . . . 0.0 111.245 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' ASN . . . . . 0.437 ' CG ' ' HB2' ' A' ' 430' ' ' MET . 7.3 t-20 77.72 63.48 0.03 OUTLIER 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.997 0.427 . . . . 0.0 111.11 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' A' ' 464' ' ' ILE . 1.1 mm? -48.54 -50.35 32.45 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.65 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.3 t -54.67 -61.95 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.437 ' HB2' ' CG ' ' A' ' 427' ' ' ASN . 8.2 mmt -55.77 -47.89 76.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.855 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.449 ' HG ' HD21 ' A' ' 414' ' ' LEU . 0.5 OUTLIER -57.58 -50.05 74.4 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.903 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.06 -49.95 70.31 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.039 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.8 OUTLIER -56.18 -55.84 28.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.859 0.361 . . . . 0.0 110.57 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.439 ' O ' HG22 ' A' ' 438' ' ' VAL . 5.2 mp -57.58 -47.32 82.41 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.981 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.605 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -52.98 -57.87 13.38 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.687 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 433' ' ' LEU . 27.5 m -54.99 -39.96 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 117.044 0.422 . . . . 0.0 110.93 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 433' ' ' LEU . 53.1 t -60.63 -57.75 10.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.074 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 434' ' ' LEU . 15.8 m -60.93 -39.29 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.661 0.267 . . . . 0.0 110.666 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 435' ' ' GLY . 55.8 t -59.1 -50.65 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.047 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.28 -47.78 77.94 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.974 0.416 . . . . 0.0 110.141 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.41 -47.87 80.6 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.58 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' PHE . . . . . 0.562 ' HA ' ' CG1' ' A' ' 403' ' ' VAL . 39.8 t80 -62.09 -46.13 90.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.763 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -60.44 -44.49 95.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.451 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.415 ' O ' ' HD3' ' A' ' 445' ' ' ARG . . . -67.59 53.93 0.33 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.549 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.782 ' HG2' HG21 ' A' ' 403' ' ' VAL . 0.7 OUTLIER -152.23 45.61 0.74 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 79.96 126.39 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.614 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.78 124.23 7.99 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.58 2.187 . . . . 0.0 112.407 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.7 t -143.18 152.0 41.28 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.28 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 453' ' ' VAL . 11.9 p -50.79 -45.85 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.629 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.571 HG12 HD11 ' A' ' 454' ' ' ILE . 13.8 t -57.48 -53.0 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.606 0.241 . . . . 0.0 110.668 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -56.08 -50.79 70.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.292 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 456' ' ' VAL . 28.7 m -55.81 -45.59 78.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 449' ' ' VAL . 96.3 t -58.75 -51.66 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.491 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.571 HD11 HG12 ' A' ' 450' ' ' VAL . 8.3 mt -57.86 -52.06 62.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 120.863 0.363 . . . . 0.0 110.589 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.62 -51.66 66.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.597 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 452' ' ' THR . 55.9 t -57.67 -55.69 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.742 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 453' ' ' VAL . 54.0 t -45.75 -52.11 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.685 0.278 . . . . 0.0 110.615 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -43.85 98.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.817 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.47 -58.27 9.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.987 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.41 -41.94 69.89 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.976 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.79 -27.92 63.27 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.994 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' PHE . . . . . 0.563 ' CD2' ' HG3' ' A' ' 466' ' ' PRO . 6.1 t80 -63.56 102.65 0.45 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.892 0.377 . . . . 0.0 111.584 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -144.49 81.97 1.68 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.257 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.512 ' HA ' HD11 ' A' ' 428' ' ' LEU . 20.2 mt 58.12 87.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.455 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 464' ' ' ILE . . . 74.98 72.12 0.22 Allowed Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.715 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.563 ' HG3' ' CD2' ' A' ' 462' ' ' PHE . 54.8 Cg_endo -68.1 156.0 67.44 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.679 2.253 . . . . 0.0 113.129 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 467' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 466' ' ' PRO . 0.0 OUTLIER 84.67 -70.6 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.865 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.536 ' C ' ' HB3' ' A' ' 424' ' ' ASP . . . -123.01 165.14 15.69 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.985 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 469' ' ' THR . . . . . 0.575 ' N ' ' HB3' ' A' ' 424' ' ' ASP . 2.7 t -175.13 160.38 2.71 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.724 0.297 . . . . 0.0 111.279 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.38 66.35 3.94 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.075 0.464 . . . . 0.0 110.815 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -124.17 -63.79 1.18 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.133 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' VAL . . . . . 0.837 HG23 HG12 ' A' ' 475' ' ' VAL . 0.3 OUTLIER -142.54 151.87 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.976 0.417 . . . . 0.0 112.115 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.5 t -92.76 30.07 1.64 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.203 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.24 -69.39 0.81 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.947 0.403 . . . . 0.0 110.623 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.837 HG12 HG23 ' A' ' 472' ' ' VAL . 10.7 p -55.55 -38.81 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.095 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -45.59 74.3 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.951 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.88 -49.99 46.84 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.675 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -52.63 61.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 479' ' ' LEU . . . . . 0.455 HD13 HG22 ' A' ' 475' ' ' VAL . 7.1 mp -60.53 -50.73 72.38 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.545 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 95.2 m -53.89 -46.44 71.38 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.443 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.86 -47.68 84.76 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.286 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -57.9 -44.42 86.77 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.126 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.74 -45.6 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.039 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 65.9 mtp -58.19 -52.76 64.2 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.14 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.73 -43.22 76.38 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 46.5 m -58.94 -48.3 81.98 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.623 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.98 HG13 HD11 ' A' ' 408' ' ' LEU . 24.2 t -56.32 -50.5 71.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.684 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 488' ' ' GLY . . . . . 0.464 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -54.69 -46.63 74.39 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.06 -49.56 76.49 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.476 HG12 HD23 ' A' ' 494' ' ' LEU . 79.6 t -55.93 -47.89 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.375 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.601 ' HA ' HD21 ' A' ' 494' ' ' LEU . 52.6 mt -54.89 -42.35 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.531 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -69.28 -45.9 59.31 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.55 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -56.21 -52.08 65.71 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.586 0.232 . . . . 0.0 110.916 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.601 HD21 ' HA ' ' A' ' 491' ' ' ILE . 4.0 pp -62.6 -44.83 95.33 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.422 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.57 ' N ' HD12 ' A' ' 494' ' ' LEU . 90.7 m -57.23 -43.87 83.28 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 496' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 500' ' ' TYR . . . -66.53 -54.32 25.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.584 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -53.7 -52.98 38.59 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.704 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 4.8 t -47.89 -33.58 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 120.609 0.243 . . . . 0.0 111.355 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.05 22.6 15.71 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.419 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 500' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 496' ' ' ALA . 1.6 t80 -137.03 61.46 1.62 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.791 0.329 . . . . 0.0 111.011 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 79.82 130.88 0.05 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.193 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 398' ' ' GLN . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.65 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 120.43 0.157 . . . . 0.0 111.414 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 6.8 m -93.15 129.59 43.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.832 0.349 . . . . 0.0 111.09 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' GLN . . . . . 0.445 HE22 HG23 ' A' ' 495' ' ' THR . 32.8 tt0 -54.79 -56.11 22.93 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.274 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.454 ' CD1' ' HB3' ' A' ' 446' ' ' TRP . 19.5 mm 70.83 131.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 123.39 0.431 . . . . 0.0 111.165 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.59 ' HA ' HG21 ' A' ' 404' ' ' VAL . 42.1 mt-30 54.86 51.67 13.28 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.593 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.647 ' HA2' ' OG1' ' A' ' 495' ' ' THR . . . -147.09 -123.79 1.47 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.293 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 55.0 m -56.95 -49.69 74.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.65 0.262 . . . . 0.0 111.537 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 443' ' ' TYR . 30.1 m -55.76 -48.3 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.614 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.641 HG12 HD13 ' A' ' 491' ' ' ILE . 40.8 t -69.13 -40.91 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.75 97.54 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -62.27 -51.44 67.68 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.794 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' A' ' 440' ' ' ALA . . . -55.01 -49.24 72.03 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.677 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 484' ' ' MET . 0.5 OUTLIER -58.04 -42.88 86.31 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.761 178.229 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -50.48 62.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.056 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.16 -48.5 78.56 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.929 0.395 . . . . 0.0 109.996 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.3 t -55.55 -57.92 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.017 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.579 HD12 ' CD1' ' A' ' 485' ' ' LEU . 19.2 tt -56.75 -41.14 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.489 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 1.3 m -56.97 -50.07 73.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.694 HD12 HG23 ' A' ' 429' ' ' VAL . 3.1 mm? -60.75 -47.31 86.88 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.934 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 412' ' ' ILE . 93.7 mt -52.37 -49.98 40.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.994 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.63 77.87 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.08 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 2.0 mtt -56.5 -44.92 81.18 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.258 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 1.02 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 2.9 tm0? -60.18 -50.16 74.76 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.116 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -57.67 -35.82 71.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.205 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -50.93 42.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.826 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 1.1 ttp 179.46 65.43 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 1.02 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -151.25 -174.9 4.96 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 122.379 -0.201 . . . . 0.0 111.463 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' PHE . . . . . 0.582 ' O ' HG11 ' A' ' 429' ' ' VAL . 0.2 OUTLIER -119.05 178.03 4.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.933 0.397 . . . . 0.0 111.988 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.41 98.19 10.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.418 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 430' ' ' MET . . . 45.86 43.39 10.04 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -81.43 -73.16 0.39 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.201 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -125.81 -84.71 0.63 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.069 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.29 -56.97 15.34 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.677 0.275 . . . . 0.0 110.907 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.694 HG23 HD12 ' A' ' 414' ' ' LEU . 7.3 p -55.41 -33.56 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.805 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.59 ' CE ' HD13 ' A' ' 434' ' ' LEU . 0.0 OUTLIER -57.0 -52.25 66.02 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.254 178.76 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.15 -44.3 95.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.072 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.695 ' O ' HG23 ' A' ' 436' ' ' VAL . 8.1 m-85 -56.97 -56.72 18.1 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.733 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.679 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.4 OUTLIER -56.28 -44.29 79.66 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.068 178.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.59 HD13 ' CE ' ' A' ' 430' ' ' MET . 6.2 tp -54.56 -51.16 66.12 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.94 -45.95 93.08 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 432' ' ' TYR . 42.9 t -57.08 -44.28 82.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 433' ' ' LEU . 98.4 t -55.87 -47.04 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.874 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.71 -47.07 86.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.419 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.62 -51.78 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.594 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.423 ' HB2' ' HB1' ' A' ' 407' ' ' ALA . . . -57.65 -50.08 74.36 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.543 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -47.91 79.3 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.406 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.09 -40.89 95.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.377 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.516 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 6.7 m-30 -65.88 -44.99 83.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.006 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.82 58.62 1.74 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.488 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 445' ' ' ARG . 21.2 tpt180 -89.86 60.13 4.86 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.184 0.516 . . . . 0.0 110.922 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' TRP . . . . . 0.454 ' HB3' ' CD1' ' A' ' 399' ' ' ILE . 15.4 t-105 -178.56 125.7 0.26 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.466 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 446' ' ' TRP . 68.9 Cg_endo -95.01 128.23 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.289 2.659 . . . . 0.0 112.939 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.451 ' OG ' ' NE1' ' A' ' 446' ' ' TRP . 14.6 m -164.69 65.82 0.14 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.791 0.329 . . . . 0.0 111.725 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 453' ' ' VAL . 60.5 t 64.92 -69.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.969 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.9 t -53.26 -46.2 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.564 0.221 . . . . 0.0 110.812 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.57 90.97 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 1.4 m -61.14 -52.29 65.5 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 449' ' ' VAL . 47.4 t -55.28 -47.73 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.771 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.36 -50.04 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.757 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.31 -48.76 70.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.949 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 63.1 t -56.02 -56.14 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.215 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.72 -46.1 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.819 0.342 . . . . 0.0 110.097 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 18.0 t -54.63 -47.42 73.5 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.92 -50.66 72.88 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.414 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.37 -41.82 76.81 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.794 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.596 ' HG ' ' HB2' ' A' ' 465' ' ' ALA . 4.7 tt -70.97 -38.18 72.78 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.811 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.48 150.1 2.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.513 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 6.4 t80 69.65 -61.08 0.45 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.663 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 64.2 mt -55.35 -56.29 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.13 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 466' ' ' PRO . . . -44.81 -61.52 2.16 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 465' ' ' ALA . 72.2 Cg_endo -74.7 -18.71 19.3 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.66 2.24 . . . . 0.0 113.521 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.67 63.91 1.56 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.179 0.514 . . . . 0.0 111.253 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 146.74 57.15 0.02 OUTLIER Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.104 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 3.2 m -147.83 144.12 27.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.699 0.285 . . . . 0.0 110.824 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' LEU . . . . . 0.481 HD22 ' HB ' ' A' ' 472' ' ' VAL . 0.7 OUTLIER -102.71 97.6 7.75 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.012 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.85 56.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' VAL . . . . . 0.481 ' HB ' HD22 ' A' ' 470' ' ' LEU . 69.2 t -151.96 -54.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 29.6 t -154.37 42.33 0.5 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 477' ' ' TYR . 7.9 t70 -66.48 112.61 4.17 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.925 0.393 . . . . 0.0 111.762 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.85 -40.86 74.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.996 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -66.01 -42.49 89.63 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' TYR . . . . . 0.461 ' HB2' ' HB3' ' A' ' 474' ' ' ASP . 0.8 OUTLIER -59.7 -54.96 40.3 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.381 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.7 tt -55.67 -48.75 74.52 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.207 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.19 -45.23 79.88 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.955 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 480' ' ' THR . . . . . 0.417 HG22 ' SD ' ' A' ' 484' ' ' MET . 24.8 m -57.56 -44.66 85.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.819 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 481' ' ' PHE . . . . . 0.413 ' CE1' HD13 ' A' ' 485' ' ' LEU . 26.1 t80 -61.48 -48.95 78.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.76 80.38 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.482 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 487' ' ' VAL . 78.0 t -63.68 -48.39 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.85 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' MET . . . . . 0.494 ' O ' HD11 ' A' ' 408' ' ' LEU . 21.6 mtt -54.47 -55.07 32.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.546 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.579 ' CD1' HD12 ' A' ' 412' ' ' ILE . 2.0 tp -52.8 -48.37 66.96 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.999 0.428 . . . . 0.0 109.969 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 24.2 m -56.41 -48.93 75.94 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.935 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 483' ' ' VAL . 91.7 t -56.98 -42.4 78.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.092 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.395 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 488' ' ' GLY . . . . . 0.757 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -56.65 -45.84 89.86 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.47 -49.85 71.42 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.47 -44.25 88.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.867 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.757 HD12 ' HA2' ' A' ' 488' ' ' GLY . 15.7 mt -55.89 -42.29 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.967 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 495' ' ' THR . . . -62.17 -49.31 76.02 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.479 -0.867 . . . . 0.0 110.995 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -54.06 -48.93 70.06 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.747 0.308 . . . . 0.0 110.348 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.526 HD23 ' CB ' ' A' ' 400' ' ' GLN . 11.1 tp -67.79 -35.93 79.54 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.665 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.647 ' OG1' ' HA2' ' A' ' 401' ' ' GLY . 98.0 m -51.51 -49.86 61.09 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -64.71 -47.05 79.74 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.509 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -54.46 -43.29 77.1 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.876 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 68.0 t -76.12 -43.13 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.752 0.311 . . . . 0.0 110.524 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -62.11 -47.14 85.92 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.294 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -97.38 60.83 1.65 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.992 0.425 . . . . 0.0 110.984 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -129.85 147.71 51.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.238 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.098 179.879 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 396' ' ' MET . . . . . 0.405 ' O ' ' HB ' ' A' ' 397' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.153 0.025 . . . . 0.0 110.976 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 396' ' ' MET . 36.6 t 77.07 136.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 123.473 0.483 . . . . 0.0 111.192 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.84 -61.08 1.13 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.338 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 399' ' ' ILE . 19.5 tt -144.34 114.62 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.704 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.558 ' NE2' HG11 ' A' ' 450' ' ' VAL . 0.0 OUTLIER 66.46 -175.04 0.19 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.475 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.541 ' HA2' ' OG1' ' A' ' 495' ' ' THR . . . 115.71 -131.43 9.65 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.975 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -37.22 72.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.43 0.157 . . . . 0.0 111.373 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.52 HG23 ' H ' ' A' ' 404' ' ' VAL . 15.2 m -55.8 -57.8 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.525 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.52 ' H ' HG23 ' A' ' 403' ' ' VAL . 24.6 m -63.55 -38.02 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.457 ' HB2' HG21 ' A' ' 491' ' ' ILE . . . -56.67 -48.85 76.7 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.119 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 409' ' ' SER . . . -61.68 -46.09 91.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.631 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -56.46 -56.59 19.27 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.362 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.513 HD21 ' HG2' ' A' ' 484' ' ' MET . 0.6 OUTLIER -59.18 -39.95 84.14 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.127 178.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 406' ' ' ALA . 33.6 t -51.08 -51.6 51.71 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.326 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.46 -47.43 81.85 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.308 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.579 HG22 HG21 ' A' ' 436' ' ' VAL . 69.7 t -53.57 -58.19 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.66 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.598 HD13 ' HG3' ' A' ' 484' ' ' MET . 4.2 tp -58.5 -39.91 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.602 0.239 . . . . 0.0 110.74 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 85.9 m -61.33 -44.36 97.33 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 109.809 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -50.06 72.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.857 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.42 HD13 ' OE1' ' A' ' 418' ' ' GLN . 8.7 mm -56.49 -46.11 82.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.044 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -54.38 -49.42 69.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.779 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 1.7 ttm -57.82 -42.77 84.98 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.074 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 1.052 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 0.8 OUTLIER -55.43 -50.86 68.7 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.083 178.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -58.25 -41.99 85.42 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.63 -54.44 42.75 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.725 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -179.19 78.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 1.052 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -155.21 168.99 25.22 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 111.933 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -67.65 178.58 1.62 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.644 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.574 ' HB2' HG23 ' A' ' 469' ' ' THR . 0.6 OUTLIER -87.17 -177.76 6.07 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.768 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 465' ' ' ALA . . . -66.81 57.64 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.118 0.485 . . . . 0.0 111.664 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 424' ' ' ASP . . . -152.5 -61.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.554 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -89.65 117.46 28.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.24 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 72.52 -58.57 0.59 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.264 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.424 HG22 ' NE2' ' A' ' 418' ' ' GLN . 40.3 t -51.42 -51.28 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.483 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 3.2 ttm -55.68 -43.78 76.72 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 110.195 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.51 -48.75 78.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.799 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.413 ' O ' HG22 ' A' ' 436' ' ' VAL . 7.5 m-85 -57.45 -48.01 80.3 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.678 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 437' ' ' VAL . 3.2 tp -57.52 -47.1 82.89 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.009 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 438' ' ' VAL . 0.1 OUTLIER -54.68 -48.78 71.98 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.834 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -56.53 -57.72 18.01 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.508 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.579 HG21 HG22 ' A' ' 411' ' ' VAL . 10.1 m -56.08 -44.34 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.723 0.262 . . . . 0.0 110.653 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 433' ' ' LEU . 56.3 t -57.77 -46.54 86.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 434' ' ' LEU . 37.9 t -58.14 -45.58 88.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 51.8 t -55.88 -47.41 79.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.65 -47.26 86.32 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.167 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -41.41 81.84 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.316 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -66.79 -44.88 80.13 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.627 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.433 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 9.9 m-85 -70.77 -47.68 58.36 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.344 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -61.89 134.68 46.55 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.807 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -138.58 -56.12 0.63 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.568 0.223 . . . . 0.0 111.386 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.84 121.08 75.91 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 120.772 0.32 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -88.87 161.28 6.1 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.159 2.573 . . . . 0.0 114.237 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.551 ' H ' ' HB3' ' A' ' 451' ' ' ALA . 1.2 p 176.9 -174.14 0.11 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.453 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.7 t -45.91 -48.17 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.573 0.225 . . . . 0.0 111.434 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.558 HG11 ' NE2' ' A' ' 400' ' ' GLN . 47.3 t -58.35 -50.39 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.633 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.551 ' HB3' ' H ' ' A' ' 448' ' ' SER . . . -57.22 -45.63 83.66 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.255 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 93.0 m -54.99 -52.15 64.02 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.59 -46.52 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.227 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 451' ' ' ALA . 53.8 mt -55.59 -50.25 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.598 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -53.4 56.66 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.817 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 64.5 t -53.52 -55.73 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 111.159 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 57.9 t -54.65 -47.6 72.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 4.4 t -59.56 -44.31 93.32 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.288 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -53.1 -49.59 66.16 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.467 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.75 -46.97 73.72 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.358 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 466' ' ' PRO . 0.4 OUTLIER -52.22 -36.89 53.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.016 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.89 59.14 0.16 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.18 0.514 . . . . 0.0 111.022 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -158.18 61.72 0.45 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.775 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 464' ' ' ILE . 4.3 mt 63.1 31.85 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.231 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.818 ' HB3' ' HB ' ' A' ' 469' ' ' THR . . . 51.71 73.08 1.03 Allowed Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.981 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 461' ' ' LEU . 77.7 Cg_exo -50.31 95.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.178 2.585 . . . . 0.0 112.501 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 467' ' ' ARG . . . . . 0.439 ' NH1' ' OG1' ' A' ' 480' ' ' THR . 1.5 ttm180 173.52 -50.06 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.42 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 149.53 53.59 0.02 OUTLIER Glycine 0 C--N 1.33 0.25 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.598 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' THR . . . . . 0.818 ' HB ' ' HB3' ' A' ' 465' ' ' ALA . 6.0 t -65.46 -34.62 78.72 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 470' ' ' LEU . . . . . 0.572 HD22 ' CG2' ' A' ' 469' ' ' THR . 2.2 mm? -75.19 -54.0 7.86 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.613 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -119.31 76.66 1.14 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.134 0.492 . . . . 0.0 111.409 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' VAL . . . . . 0.719 HG23 ' HB2' ' A' ' 476' ' ' GLN . 14.5 p -78.25 130.3 36.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.612 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 46.9 m -121.98 -77.16 0.59 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -135.12 -65.48 0.61 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.433 0.158 . . . . 0.0 111.27 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 59.7 t -42.24 -42.78 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.016 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.719 ' HB2' HG23 ' A' ' 472' ' ' VAL . 20.8 mp0 -54.48 -55.23 31.14 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.819 0.342 . . . . 0.0 111.107 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -69.82 -49.98 47.37 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.147 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.49 -54.93 25.99 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.968 0.413 . . . . 0.0 110.803 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 483' ' ' VAL . 3.2 tt -59.38 -48.8 80.25 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.617 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 480' ' ' THR . . . . . 0.439 ' OG1' ' NH1' ' A' ' 467' ' ' ARG . 73.8 m -57.59 -39.19 76.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.928 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -49.46 74.75 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.04 -44.08 91.74 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.036 0.446 . . . . 0.0 110.353 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 479' ' ' LEU . 85.8 t -62.06 -52.27 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.269 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 484' ' ' MET . . . . . 0.598 ' HG3' HD13 ' A' ' 412' ' ' ILE . 0.0 OUTLIER -56.69 -49.5 74.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.488 179.106 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 4.5 tt -56.21 -47.15 78.96 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 35.0 m -58.44 -50.98 71.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.224 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.475 ' CG1' HD13 ' A' ' 408' ' ' LEU . 60.6 t -57.5 -47.42 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.413 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -57.3 -48.67 78.55 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 5.7 tt -55.42 -50.23 70.34 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 55.2 t -56.53 -48.39 80.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.859 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' A' ' 405' ' ' ALA . 90.4 mt -58.55 -41.24 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.454 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.56 -58.31 12.82 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.666 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -55.58 -47.4 76.5 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.065 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.462 HD12 ' HB3' ' A' ' 400' ' ' GLN . 2.7 tm? -58.74 -44.99 90.64 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.455 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.541 ' OG1' ' HA2' ' A' ' 401' ' ' GLY . 72.0 m -59.7 -42.93 94.11 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.94 -57.93 9.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.959 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.78 -48.17 85.69 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.615 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.9 p -60.92 -29.64 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 3.7 ttm105 -91.66 -43.04 9.84 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.672 0.272 . . . . 0.0 110.91 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.64 95.95 5.39 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.031 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.44 -36.04 34.14 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.365 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.071 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 1.2 mmm . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 6.2 m -63.65 125.61 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.937 0.399 . . . . 0.0 111.602 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -91.74 74.21 5.79 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 110.721 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 37.2 mm -56.99 -38.97 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.022 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.97 140.05 47.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.823 0.344 . . . . 0.0 111.356 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 165.08 -110.27 0.41 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.252 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.6 t -53.92 -44.76 70.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 110.168 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.711 HG11 ' CB ' ' A' ' 443' ' ' TYR . 19.9 t -59.71 -54.28 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.788 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 21.3 m -61.06 -42.48 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.536 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.81 53.7 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.8 87.73 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.934 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -55.86 -51.83 66.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.836 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.465 HD23 HD12 ' A' ' 491' ' ' ILE . 2.4 tm? -55.19 -43.93 74.84 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.2 t -57.81 -44.56 86.44 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.129 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.35 96.57 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.239 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 407' ' ' ALA . 79.2 t -60.06 -51.39 73.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.107 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.422 HD11 HD11 ' A' ' 408' ' ' LEU . 51.6 mt -56.16 -46.28 81.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' THR . . . . . 0.447 HG22 ' SD ' ' A' ' 417' ' ' MET . 36.5 m -57.69 -48.01 80.74 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.142 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 432' ' ' TYR . 9.3 tp -59.11 -57.42 13.15 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.358 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 5.2 tt -58.23 -43.97 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.583 0.23 . . . . 0.0 111.053 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.37 -54.69 43.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.465 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' MET . . . . . 0.447 ' SD ' HG22 ' A' ' 413' ' ' THR . 7.1 mtp -55.86 -49.99 71.83 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.86 -53.51 39.68 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.735 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -57.79 -43.04 85.35 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.526 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 421' ' ' MET . 6.1 tt -67.0 -50.44 62.22 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.518 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' MET . . . . . 0.683 ' HB2' HD23 ' A' ' 420' ' ' LEU . 0.0 OUTLIER -145.17 126.04 14.41 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.617 0.246 . . . . 0.0 111.518 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 68.92 88.14 0.11 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.684 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 424' ' ' ASP . 4.2 t80 -76.21 149.31 37.25 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.354 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.501 ' CG ' ' HB ' ' A' ' 469' ' ' THR . 54.8 m-20 69.75 174.18 0.3 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.923 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.444 ' HA ' ' CG1' ' A' ' 429' ' ' VAL . . . -96.06 98.2 10.17 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.83 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -140.83 -100.62 0.15 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.08 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -82.31 136.24 35.06 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.1 mp 69.08 -56.01 0.55 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.351 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.444 ' CG1' ' HA ' ' A' ' 425' ' ' ALA . 85.4 t -51.19 -37.71 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.61 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.5 -44.95 12.92 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.572 0.225 . . . . 0.0 110.978 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.91 -51.17 69.24 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 109.961 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.489 ' HB3' ' CD1' ' A' ' 414' ' ' LEU . 56.2 m-85 -57.83 -46.63 84.46 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.137 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 437' ' ' VAL . 2.5 tm? -57.51 -51.99 67.2 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.69 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 438' ' ' VAL . 1.8 mp -56.0 -46.71 78.66 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.015 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -51.45 -50.98 39.42 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 87.5 t -56.94 -45.81 83.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.867 0.365 . . . . 0.0 110.047 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 433' ' ' LEU . 85.4 t -57.89 -43.82 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.345 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 434' ' ' LEU . 88.4 t -57.33 -53.22 46.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.517 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.02 -48.69 87.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.744 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.452 ' HA ' ' CE2' ' A' ' 443' ' ' TYR . . . -55.5 -49.67 71.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.138 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.63 -48.98 70.36 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.91 -44.02 73.79 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.711 ' CB ' HG11 ' A' ' 403' ' ' VAL . 0.1 OUTLIER -86.02 -34.26 20.82 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -67.44 71.55 0.23 Allowed Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.136 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 446' ' ' TRP . 4.9 mtm180 -122.53 151.78 41.02 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.444 0.164 . . . . 0.0 110.928 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' TRP . . . . . 0.435 ' CB ' ' O ' ' A' ' 445' ' ' ARG . 1.6 t-105 83.07 131.66 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.031 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.13 111.01 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.652 2.234 . . . . 0.0 112.13 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.3 t -145.03 136.19 24.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.493 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.499 ' O ' HG22 ' A' ' 453' ' ' VAL . 39.1 t -45.66 -59.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.698 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.604 HG11 ' HB3' ' A' ' 494' ' ' LEU . 14.1 m -54.38 -46.34 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.408 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -64.18 -47.72 78.71 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.826 0.346 . . . . 0.0 110.65 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 28.5 m -57.45 -56.73 18.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.253 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 449' ' ' VAL . 34.4 m -59.73 -44.44 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.124 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.402 ' N ' HG23 ' A' ' 453' ' ' VAL . 36.7 mt -59.27 -50.08 81.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.13 -49.47 66.49 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.321 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 52.0 t -54.88 -53.64 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.956 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.4 t -51.57 -52.56 20.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 2.0 p -57.71 -38.76 75.81 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.012 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -60.89 -48.87 79.84 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -60.43 -46.65 89.26 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.8 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.95 -19.62 62.55 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.821 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' PHE . . . . . 0.422 ' CD2' ' HG3' ' A' ' 466' ' ' PRO . 0.1 OUTLIER -66.72 -167.77 0.05 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 111.217 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 467' ' ' ARG . 6.9 t80 69.59 -59.17 0.5 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.207 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 17.5 tt -73.61 -42.25 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.618 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.705 ' HB3' ' HD3' ' A' ' 466' ' ' PRO . . . -66.56 -61.55 5.01 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.794 -0.185 . . . . 0.0 111.076 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.705 ' HD3' ' HB3' ' A' ' 465' ' ' ALA . 71.7 Cg_endo -73.45 56.87 3.41 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.374 2.049 . . . . 0.0 111.964 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 467' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 463' ' ' PHE . 0.0 OUTLIER -157.28 -50.25 0.07 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.625 -179.48 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 136.75 89.36 0.25 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.443 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' THR . . . . . 0.501 ' HB ' ' CG ' ' A' ' 424' ' ' ASP . 0.2 OUTLIER -90.19 139.28 30.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 111.417 -179.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.47 38.27 0.77 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.368 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -157.57 82.02 0.89 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.086 0.47 . . . . 0.0 111.049 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' VAL . . . . . 0.527 ' HA ' ' HB2' ' A' ' 476' ' ' GLN . 38.7 t -109.13 -60.08 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.553 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.58 -66.15 0.19 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.614 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -158.96 -66.19 0.08 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.173 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 476' ' ' GLN . 7.3 p -39.29 -48.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 472' ' ' VAL . 0.3 OUTLIER -59.65 -40.49 87.86 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.507 0.194 . . . . 0.0 111.245 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -72.66 -49.13 33.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.622 0.249 . . . . 0.0 110.413 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.13 -51.44 67.92 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.234 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.24 -50.02 75.05 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.691 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 97.8 m -54.19 -42.04 69.26 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.999 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -58.5 -48.92 79.21 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.459 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.85 96.72 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.731 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.69 -49.18 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.235 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -49.04 79.37 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.103 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 6.1 tt -56.61 -46.49 80.87 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 490' ' ' VAL . 45.8 m -56.67 -48.47 77.54 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.435 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.0 -47.72 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.002 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.64 -46.58 88.66 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 16.8 tp -58.11 -48.7 79.38 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 486' ' ' THR . 89.6 t -60.31 -48.55 87.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.64 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.544 ' HA ' HD21 ' A' ' 494' ' ' LEU . 83.7 mt -57.06 -46.17 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.152 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.44 -44.14 97.18 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.13 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -57.54 -56.51 20.89 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.325 0.25 . . . . 0.0 111.125 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.604 ' HB3' HG11 ' A' ' 450' ' ' VAL . 3.0 pp -58.71 -43.32 90.06 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.485 ' N ' HD12 ' A' ' 494' ' ' LEU . 15.3 m -61.13 -49.24 78.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.687 0.28 . . . . 0.0 110.589 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.84 97.89 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.036 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.65 67.64 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.446 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 499' ' ' ARG . 8.1 p -66.06 -44.25 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 499' ' ' ARG . . . . . 0.421 ' N ' HG13 ' A' ' 498' ' ' VAL . 0.0 OUTLIER -80.46 63.71 5.01 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.043 0.449 . . . . 0.0 110.812 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.86 119.15 3.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.667 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -123.71 39.3 3.99 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.992 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.27 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.135 -179.937 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.368 0.128 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 6.4 m -134.9 48.13 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.972 0.415 . . . . 0.0 111.562 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -62.13 115.92 4.52 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.769 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.93 -164.96 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.728 ' HA ' HG21 ' A' ' 404' ' ' VAL . 11.8 mt-30 -68.79 69.05 0.16 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.771 0.319 . . . . 0.0 111.839 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 494' ' ' LEU . . . -124.89 -124.8 2.87 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.653 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.61 -55.66 12.82 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 51.0 t -52.17 -48.15 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 110.828 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' A' ' 400' ' ' GLN . 2.9 t -59.78 -48.11 88.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.442 ' HB2' HD22 ' A' ' 494' ' ' LEU . . . -58.61 -48.48 80.85 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.772 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.7 -55.92 28.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.927 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.644 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -54.82 -49.45 70.99 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.795 0.331 . . . . 0.0 110.564 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 1.048 HD13 HG21 ' A' ' 490' ' ' VAL . 0.7 OUTLIER -56.06 -49.68 73.09 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.205 178.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 30.0 t -49.66 -53.01 26.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.292 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -55.48 -47.29 76.38 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.498 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.441 ' CG2' HG21 ' A' ' 439' ' ' VAL . 37.7 t -57.07 -46.49 84.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.337 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 408' ' ' LEU . 38.1 mm -55.69 -46.81 79.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.154 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -39.71 95.36 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.197 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.585 HD23 ' HD1' ' A' ' 432' ' ' TYR . 0.7 OUTLIER -62.63 -52.13 64.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.724 179.337 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.41 ' HB ' ' CE1' ' A' ' 432' ' ' TYR . 3.0 tp -59.07 -42.03 85.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.59 -49.17 78.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 4.0 ttt -58.95 -42.88 90.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.128 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.604 ' HG2' ' HG ' ' A' ' 428' ' ' LEU . 0.0 OUTLIER -56.5 -54.6 43.85 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.031 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -54.88 -41.72 71.22 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 3.7 tp -75.08 50.06 0.46 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.14 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 2.0 mtt 177.26 -59.08 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -153.29 129.04 10.13 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.462 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -92.26 33.16 1.1 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.882 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -100.26 168.8 9.55 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.081 0.467 . . . . 0.0 111.353 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 464' ' ' ILE . . . -126.87 32.89 5.04 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.01 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -105.93 -55.15 2.37 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.432 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.92 -63.31 1.3 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.384 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.604 ' HG ' ' HG2' ' A' ' 418' ' ' GLN . 4.6 mm? -54.56 -38.35 66.54 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.652 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.885 HG22 ' HG ' ' A' ' 433' ' ' LEU . 1.5 p -46.05 -42.24 4.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.033 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 85.1 mmm -51.23 -54.44 25.65 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 110.929 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 431' ' ' LEU . 2.7 mp -64.31 -47.89 77.72 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.491 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.585 ' HD1' HD23 ' A' ' 414' ' ' LEU . 28.4 t80 -59.95 -50.49 73.53 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.517 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.885 ' HG ' HG22 ' A' ' 429' ' ' VAL . 19.8 mt -54.97 -43.86 73.89 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.407 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 438' ' ' VAL . 4.1 tt -57.6 -54.09 50.8 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.579 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -58.46 -50.42 66.97 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.239 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 432' ' ' TYR . 76.9 t -58.39 -44.52 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.12 -48.22 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 434' ' ' LEU . 97.8 t -55.87 -46.0 79.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.644 HG22 ' HB1' ' A' ' 407' ' ' ALA . 23.9 t -60.07 -50.21 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.492 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -57.24 -48.85 77.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.8 tt -53.74 -45.4 70.52 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -65.33 -38.76 91.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.005 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.662 ' CE1' HG22 ' A' ' 404' ' ' VAL . 0.2 OUTLIER -65.42 -45.41 84.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.445 179.369 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 445' ' ' ARG . . . -64.17 76.79 0.05 OUTLIER Glycine 0 C--N 1.337 0.584 0 N-CA-C 114.61 0.604 . . . . 0.0 114.61 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' A' ' 444' ' ' GLY . 0.0 OUTLIER -148.61 -65.78 0.24 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.775 0.322 . . . . 0.0 110.422 178.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -128.84 66.28 75.13 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 121.186 0.517 . . . . 0.0 109.823 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.649 ' CB ' ' HB3' ' A' ' 451' ' ' ALA . 83.3 Cg_endo -80.13 155.69 22.74 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.018 2.479 . . . . 0.0 113.819 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.8 73.87 1.44 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.488 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 453' ' ' VAL . 79.2 t 72.12 -65.74 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.499 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.476 ' CG1' HD22 ' A' ' 489' ' ' LEU . 2.9 m -50.98 -53.21 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 120.553 0.216 . . . . 0.0 110.96 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.649 ' HB3' ' CB ' ' A' ' 447' ' ' PRO . . . -58.46 -39.8 80.89 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.923 0.392 . . . . 0.0 110.384 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.89 -50.46 73.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.326 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 449' ' ' VAL . 45.0 t -55.85 -52.39 49.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.853 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' A' ' 451' ' ' ALA . 17.3 tt -60.93 -39.38 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.446 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -56.22 -46.85 79.36 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 78.3 t -58.83 -54.99 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.907 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 42.1 t -52.72 -41.81 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.286 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 1.4 t -56.96 -44.09 82.23 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.0 -50.02 74.84 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.911 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -58.99 -42.06 89.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.926 0.393 . . . . 0.0 110.51 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -43.43 84.2 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.65 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 462' ' ' PHE . . . . . 0.463 ' HA ' HD13 ' A' ' 433' ' ' LEU . 6.3 t80 -68.9 58.56 0.09 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.215 0.531 . . . . 0.0 111.122 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -176.78 49.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.173 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 425' ' ' ALA . 10.1 mt 58.83 37.44 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.439 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 464' ' ' ILE . . . 71.79 136.66 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.168 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -38.24 -38.61 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.624 2.883 . . . . 0.0 113.484 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.05 25.14 5.26 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 464' ' ' ILE . . . 87.8 -63.66 3.79 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.691 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 8.6 t -160.12 155.01 24.43 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.723 0.296 . . . . 0.0 110.781 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 478' ' ' LEU . 12.9 tp -75.41 67.63 1.99 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.99 0.424 . . . . 0.0 111.636 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -109.39 67.55 0.65 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.126 0.488 . . . . 0.0 111.453 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 1.1 t -141.08 35.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.525 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 6.3 t 71.22 160.29 0.22 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.555 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.14 33.03 1.59 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.743 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.486 HG23 HD23 ' A' ' 470' ' ' LEU . 11.2 p -51.13 -44.52 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.92 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.407 ' N ' HG13 ' A' ' 475' ' ' VAL . 1.3 tt0 -61.52 -58.13 9.37 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.588 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -55.15 -44.59 75.26 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.048 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.512 ' HB3' HD21 ' A' ' 470' ' ' LEU . 2.8 tt -56.94 -52.25 65.96 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.776 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.58 -46.23 90.78 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 55.3 m -54.49 -47.47 72.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.198 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -61.8 -53.94 49.03 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.667 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -53.91 -44.77 70.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.948 0.404 . . . . 0.0 110.738 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 487' ' ' VAL . 40.2 t -65.0 -50.18 76.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.332 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 34.2 mtt -53.93 -53.58 50.73 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.722 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 21.3 tp -55.78 -50.79 69.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.397 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' THR . . . . . 0.59 HG22 HD11 ' A' ' 408' ' ' LEU . 25.7 m -55.72 -47.25 77.22 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.543 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 483' ' ' VAL . 78.9 t -60.34 -49.24 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.46 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -58.11 -45.5 93.85 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.752 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' LEU . . . . . 0.476 HD22 ' CG1' ' A' ' 450' ' ' VAL . 20.5 mt -62.45 -48.09 81.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.84 0.352 . . . . 0.0 110.09 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 1.048 HG21 HD13 ' A' ' 408' ' ' LEU . 5.0 t -58.76 -59.33 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.043 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.504 ' HA ' HD23 ' A' ' 494' ' ' LEU . 2.6 pp -55.84 -35.39 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.087 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -60.36 -56.41 24.64 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.368 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -41.74 99.54 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.642 ' HA ' ' HA2' ' A' ' 401' ' ' GLY . 0.2 OUTLIER -57.86 -50.23 74.0 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.166 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 1.1 m -64.23 -44.36 92.12 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.6 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.82 80.29 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.988 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -67.2 -46.32 72.87 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.455 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 90.4 t -74.37 -42.66 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.737 0.303 . . . . 0.0 111.342 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -96.83 101.14 12.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.851 0.358 . . . . 0.0 110.922 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -53.17 115.97 2.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.776 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.45 144.47 28.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.119 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.437 -0.792 . . . . 0.0 111.315 179.878 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 2.1 tmt? . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.481 0.182 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 8.0 p -160.69 140.51 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.01 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -54.51 -65.87 0.5 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.591 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.523 HG23 ' H ' ' A' ' 400' ' ' GLN . 1.5 tp -165.57 -61.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.437 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.536 ' HG3' ' CE1' ' A' ' 443' ' ' TYR . 21.9 tt0 -150.24 114.83 5.23 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.615 0.245 . . . . 0.0 111.08 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.475 ' HA2' ' CG2' ' A' ' 495' ' ' THR . . . -175.7 -113.01 0.32 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.697 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.98 -52.19 2.47 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.773 0.656 . . . . 0.0 112.773 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.595 HG12 HG13 ' A' ' 439' ' ' VAL . 29.5 t -50.53 -56.2 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.746 0.308 . . . . 0.0 111.414 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 491' ' ' ILE . 12.1 t -64.98 -40.79 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.873 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.7 82.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.81 83.96 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.661 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.97 ' HB2' HG11 ' A' ' 439' ' ' VAL . . . -53.54 -56.7 14.86 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.15 178.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.408 ' CD2' ' HA2' ' A' ' 488' ' ' GLY . 2.9 mp -55.89 -43.05 76.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.315 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.1 m -55.91 -53.25 59.1 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.78 -48.96 78.18 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.137 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.789 HG22 ' HE1' ' A' ' 432' ' ' TYR . 55.8 t -55.05 -41.9 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.335 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 415' ' ' ILE . 11.9 mm -58.46 -50.87 77.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.2 -38.8 77.45 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.257 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 411' ' ' VAL . 9.3 mt -65.65 -58.11 6.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 412' ' ' ILE . 2.3 tp -55.3 -39.7 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.601 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.98 83.87 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 32.5 ttm -54.79 -50.92 67.32 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.836 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -60.73 -40.19 91.43 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.202 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' TRP . . . . . 0.468 ' CE2' ' HB3' ' A' ' 477' ' ' TYR . 1.0 OUTLIER -56.44 -39.72 73.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.049 179.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.66 -36.8 16.03 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.842 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' MET . . . . . 0.415 ' HB3' ' CE2' ' A' ' 423' ' ' PHE . 0.0 OUTLIER -88.98 -164.82 1.2 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.926 0.393 . . . . 0.0 111.405 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -159.46 124.74 4.15 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.213 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' PHE . . . . . 0.479 ' CE1' HD13 ' A' ' 428' ' ' LEU . 3.6 p90 -177.07 172.07 2.01 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.853 0.358 . . . . 0.0 111.246 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.46 178.38 5.31 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.531 ' HB2' HG21 ' A' ' 469' ' ' THR . . . -87.19 -19.41 28.44 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -55.58 155.38 5.62 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 49.5 t30 68.52 -63.55 0.34 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.583 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.479 HD13 ' CE1' ' A' ' 423' ' ' PHE . 0.3 OUTLIER -59.92 -49.25 78.44 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.292 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 433' ' ' LEU . 7.4 p -50.2 -39.91 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 121.175 -0.21 . . . . 0.0 110.763 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -51.58 35.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.395 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.46 -48.61 78.71 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.789 ' HE1' HG22 ' A' ' 411' ' ' VAL . 22.2 t80 -57.96 -51.83 68.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.724 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.621 HD22 ' HD1' ' A' ' 462' ' ' PHE . 0.0 OUTLIER -55.13 -42.63 73.26 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.121 178.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.493 ' O ' HG23 ' A' ' 438' ' ' VAL . 3.6 tp -55.16 -51.89 65.04 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -59.28 -48.32 86.51 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.786 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 432' ' ' TYR . 57.9 t -57.44 -41.33 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.682 0.277 . . . . 0.0 110.375 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 433' ' ' LEU . 53.6 t -62.75 -43.02 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.928 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 434' ' ' LEU . 71.8 t -59.15 -50.31 80.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.97 HG11 ' HB2' ' A' ' 407' ' ' ALA . 69.7 t -60.8 -43.45 95.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.844 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 444' ' ' GLY . . . -57.71 -50.51 72.95 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.415 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.58 -40.16 78.37 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.847 0.356 . . . . 0.0 110.197 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' PHE . . . . . 0.446 ' HB3' ' CG1' ' A' ' 403' ' ' VAL . 1.3 t80 -69.11 -35.97 77.01 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.275 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.536 ' CE1' ' HG3' ' A' ' 400' ' ' GLN . 8.0 t80 -88.26 -19.26 27.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 440' ' ' ALA . . . -60.35 64.1 0.01 OUTLIER Glycine 0 C--N 1.337 0.612 0 N-CA-C 114.753 0.661 . . . . 0.0 114.753 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.0 OUTLIER -97.49 -34.78 10.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 109.99 178.54 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 446' ' ' TRP . . . . . 0.433 ' CZ3' ' HD3' ' A' ' 445' ' ' ARG . 6.1 m-90 -152.15 130.5 6.23 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.1 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.452 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 10.1 Cg_endo -51.22 -62.8 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.564 2.176 . . . . 0.0 112.413 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 45.2 t 47.64 33.47 3.05 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 453' ' ' VAL . 49.0 t 66.29 -60.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 451' ' ' ALA . 9.9 m -48.26 -52.2 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 447' ' ' PRO . . . -57.07 -46.3 82.62 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.663 0.268 . . . . 0.0 111.078 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.565 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.8 OUTLIER -60.57 -52.51 64.87 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.033 178.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 449' ' ' VAL . 67.6 t -54.08 -48.14 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.544 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 454' ' ' ILE . 17.2 mm -53.89 -57.63 5.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 110.473 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -49.62 66.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.595 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 452' ' ' THR . 92.8 t -55.37 -54.06 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.527 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 45.7 t -48.29 -50.45 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -40.02 87.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.634 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.27 -56.87 15.62 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.207 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.99 -41.55 97.48 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.342 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 1.0 OUTLIER -65.07 -31.18 72.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 462' ' ' PHE . . . . . 0.621 ' HD1' HD22 ' A' ' 433' ' ' LEU . 70.2 t80 -38.56 135.43 0.8 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.901 0.381 . . . . 0.0 111.8 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 77.01 -50.29 0.55 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.297 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.468 ' O ' ' HB3' ' A' ' 465' ' ' ALA . 6.0 mt -74.89 -47.77 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 1.04 ' HB1' ' HD2' ' A' ' 466' ' ' PRO . . . 72.1 178.9 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 120.63 0.253 . . . . 0.0 111.382 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 1.04 ' HD2' ' HB1' ' A' ' 465' ' ' ALA . 36.7 Cg_endo -65.58 161.46 38.45 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.366 2.044 . . . . 0.0 112.483 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 17.9 mtt85 -65.25 165.02 12.26 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.024 0.44 . . . . 0.0 111.707 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 86.85 29.16 24.22 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.537 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' THR . . . . . 0.531 HG21 ' HB2' ' A' ' 425' ' ' ALA . 3.1 m -101.63 -58.24 1.92 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.957 0.378 . . . . 0.0 111.507 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.42 -46.36 11.77 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.674 0.273 . . . . 0.0 111.587 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -95.78 133.61 39.71 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.244 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.15 130.75 35.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.978 0.418 . . . . 0.0 111.142 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.3 m -173.63 99.77 0.11 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.2 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -53.29 -42.62 66.78 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.57 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 13.8 m -50.23 -43.9 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.664 -0.243 . . . . 0.0 111.616 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.98 -40.75 94.6 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.886 0.374 . . . . 0.0 110.654 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' TYR . . . . . 0.468 ' HB3' ' CE2' ' A' ' 419' ' ' TRP . 16.7 m-85 -68.79 -51.89 36.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.7 -49.33 73.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.64 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 2.1 tt -57.62 -53.29 59.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.289 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 48.0 m -53.83 -45.95 71.02 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.33 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -47.7 85.21 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.101 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -55.98 -45.41 78.97 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.329 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 487' ' ' VAL . 78.8 t -62.64 -50.47 79.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.131 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 26.3 ttm -54.64 -48.23 72.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.723 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.73 -46.11 86.87 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.195 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 52.0 m -55.49 -57.89 10.03 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.729 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 483' ' ' VAL . 27.2 m -57.53 -42.04 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.501 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 488' ' ' GLY . . . . . 0.408 ' HA2' ' CD2' ' A' ' 408' ' ' LEU . . . -58.42 -47.15 91.42 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.97 -44.34 82.54 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.7 -53.52 47.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.006 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.411 HG21 HG11 ' A' ' 404' ' ' VAL . 48.9 mt -56.62 -40.0 66.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.465 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.53 -50.42 59.3 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -49.05 76.38 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.419 ' O ' HG23 ' A' ' 498' ' ' VAL . 4.8 tt -58.12 -48.91 78.77 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.475 ' CG2' ' HA2' ' A' ' 401' ' ' GLY . 88.7 m -52.17 -49.22 64.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.734 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.16 89.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.868 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -66.95 -28.64 73.88 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.685 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 494' ' ' LEU . 39.9 t -92.98 -44.36 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.576 0.227 . . . . 0.0 111.526 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.68 63.83 0.62 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -90.09 -76.42 0.43 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.714 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.92 -50.86 6.39 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.911 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.262 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.372 179.361 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 396' ' ' MET . . . . . 0.909 ' HB2' HG23 ' A' ' 498' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.395 0.141 . . . . 0.0 111.109 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 12.1 m -148.36 125.53 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.399 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 46.2 46.41 13.2 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.982 0.42 . . . . 0.0 111.51 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.446 HG22 ' CG ' ' A' ' 396' ' ' MET . 0.5 OUTLIER -138.15 168.28 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.979 0.419 . . . . 0.0 111.907 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.83 ' HB2' HG21 ' A' ' 404' ' ' VAL . 9.6 pt20 -59.72 101.95 0.13 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.201 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.793 ' HA2' HD13 ' A' ' 494' ' ' LEU . . . -162.8 -77.46 0.03 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.439 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.4 t -60.54 -56.01 26.45 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.706 0.289 . . . . 0.0 111.244 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' A' ' 443' ' ' TYR . 1.6 t -61.24 -46.76 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.922 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.83 HG21 ' HB2' ' A' ' 400' ' ' GLN . 60.8 t -58.9 -47.91 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.326 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.89 83.61 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.091 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -57.03 -51.78 67.9 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.41 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -56.08 -51.27 68.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.185 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.537 HD12 ' CG1' ' A' ' 487' ' ' VAL . 4.1 tt -55.62 -44.02 76.67 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.312 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.57 -54.03 46.71 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.474 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.7 78.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.752 0.31 . . . . 0.0 110.454 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 407' ' ' ALA . 88.7 t -60.4 -55.2 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.292 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.562 ' HA ' HG22 ' A' ' 415' ' ' ILE . 0.6 OUTLIER -59.59 -41.99 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.195 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 2.9 m -61.53 -54.8 38.4 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.677 0.275 . . . . 0.0 110.467 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.651 HD13 ' HD1' ' A' ' 432' ' ' TYR . 0.3 OUTLIER -60.71 -50.05 75.02 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.062 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.865 HD11 HG23 ' A' ' 480' ' ' THR . 4.4 tt -59.81 -41.46 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.761 -0.199 . . . . 0.0 111.029 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.95 78.26 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 34.4 mtt -59.6 -47.26 86.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.852 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -56.08 -55.1 37.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.758 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -56.23 -46.47 79.54 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.121 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.04 -48.74 80.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.401 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' MET . . . . . 0.53 ' SD ' ' HB2' ' A' ' 423' ' ' PHE . 1.4 ttm -65.97 -34.93 79.23 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.021 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 76.8 62.36 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.126 0.489 . . . . 0.0 111.329 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' PHE . . . . . 0.762 ' HE2' ' HB3' ' A' ' 426' ' ' ALA . 4.9 t80 -136.55 148.17 47.42 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.666 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.69 -164.72 0.69 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.254 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -81.7 90.15 6.31 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.813 0.339 . . . . 0.0 111.515 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.762 ' HB3' ' HE2' ' A' ' 423' ' ' PHE . . . -153.29 134.32 14.01 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 427' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 466' ' ' PRO . 1.6 m-80 63.9 -77.55 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.097 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.471 HD12 HD21 ' A' ' 414' ' ' LEU . 0.2 OUTLIER -48.45 -41.89 30.79 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.775 0.321 . . . . 0.0 110.885 179.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.667 HG22 HD12 ' A' ' 433' ' ' LEU . 8.5 p -48.91 -39.85 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.397 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -62.68 -54.05 45.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.659 0.266 . . . . 0.0 110.358 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 16.5 tp -59.63 -43.14 93.95 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.651 ' HD1' HD13 ' A' ' 414' ' ' LEU . 25.6 t80 -58.48 -51.93 67.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.409 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.743 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.1 OUTLIER -55.44 -49.53 72.21 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.839 178.314 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.58 -55.05 18.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.484 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.52 -51.27 58.82 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.726 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 52.4 t -53.46 -42.67 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 120.675 0.274 . . . . 0.0 110.68 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 433' ' ' LEU . 98.7 t -61.49 -46.23 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.45 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.19 -55.57 19.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 120.912 0.387 . . . . 0.0 110.135 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.61 -46.23 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.172 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.538 ' HB1' ' OD1' ' A' ' 455' ' ' ASN . . . -55.57 -47.79 75.85 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.44 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.09 -45.41 75.41 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.574 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -74.72 -27.74 60.5 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.909 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.45 ' HB2' HG11 ' A' ' 403' ' ' VAL . 9.8 t80 -86.48 -41.06 14.7 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -67.31 57.81 0.27 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 114.151 0.42 . . . . 0.0 114.151 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -46.41 6.75 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.51 66.92 75.33 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.835 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 56.0 Cg_endo -69.37 86.09 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.617 2.211 . . . . 0.0 112.869 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.56 62.78 0.39 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.681 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 453' ' ' VAL . 54.8 t 68.8 -59.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.071 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.652 HG12 HD11 ' A' ' 454' ' ' ILE . 89.3 t -52.06 -62.92 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.595 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' A' ' 454' ' ' ILE . . . -52.01 -40.2 60.64 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.689 0.281 . . . . 0.0 111.382 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.1 OUTLIER -62.66 -54.63 36.58 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.194 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 449' ' ' VAL . 66.7 t -55.07 -45.62 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.417 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.652 HD11 HG12 ' A' ' 450' ' ' VAL . 27.3 mt -56.77 -50.54 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.525 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 455' ' ' ASN . . . . . 0.538 ' OD1' ' HB1' ' A' ' 440' ' ' ALA . 17.0 m-80 -61.22 -48.14 82.84 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.085 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 452' ' ' THR . 88.6 t -61.06 -58.5 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.244 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 4.0 t -50.36 -49.33 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.285 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -48.08 79.85 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.073 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -58.2 -54.35 48.02 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.651 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -58.01 -51.5 69.42 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.298 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 479' ' ' LEU . 6.9 mp -61.14 -58.12 9.67 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.838 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 462' ' ' PHE . . . . . 0.552 ' O ' HD21 ' A' ' 433' ' ' LEU . 2.0 m-85 -80.82 68.16 6.97 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.613 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -56.52 135.19 54.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.283 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.709 ' HA ' HD13 ' A' ' 433' ' ' LEU . 4.8 tt -65.96 77.0 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.366 0.603 . . . . 0.0 111.498 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.417 ' HA ' ' HD2' ' A' ' 466' ' ' PRO . . . -100.45 96.33 5.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.151 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 465' ' ' ALA . 6.8 Cg_endo -48.55 -52.28 8.78 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.755 2.304 . . . . 0.0 112.283 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.4 -36.51 22.37 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.766 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 131.64 -160.53 23.52 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.166 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 23.6 m -158.73 156.57 30.1 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.682 -0.305 . . . . 0.0 110.778 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 4.6 mt -85.29 156.08 21.09 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.742 0.306 . . . . 0.0 111.12 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -126.77 137.0 53.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.732 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.68 -26.69 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.978 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.5 m -177.13 -53.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.139 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.73 49.82 1.29 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.96 0.41 . . . . 0.0 111.797 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.81 -59.81 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.223 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -40.73 74.11 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.656 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -49.85 74.69 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -47.77 83.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.103 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 479' ' ' LEU . . . . . 0.566 ' HA ' HD23 ' A' ' 461' ' ' LEU . 6.2 mp -58.79 -52.99 63.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.138 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 480' ' ' THR . . . . . 0.865 HG23 HD11 ' A' ' 415' ' ' ILE . 18.1 m -54.48 -47.48 72.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.252 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -59.72 -48.93 79.71 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.726 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.92 83.64 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.481 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 487' ' ' VAL . 34.3 m -65.66 -41.84 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 50.8 mtp -58.81 -52.52 65.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -45.87 81.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 486' ' ' THR . . . . . 0.643 ' O ' HG23 ' A' ' 490' ' ' VAL . 85.4 m -55.27 -48.99 73.22 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.443 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 483' ' ' VAL . 99.5 t -57.63 -47.6 85.11 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.617 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 488' ' ' GLY . . . . . 0.89 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -53.02 -45.7 61.92 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 1.3 tt -58.68 -46.88 86.24 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 486' ' ' THR . 41.4 t -58.02 -41.65 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.889 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.89 HD12 ' HA2' ' A' ' 488' ' ' GLY . 55.0 mt -58.14 -53.28 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.97 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -56.79 -49.4 70.86 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.888 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -45.32 92.27 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.687 0.279 . . . . 0.0 110.761 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.793 HD13 ' HA2' ' A' ' 401' ' ' GLY . 0.2 OUTLIER -62.74 -46.47 87.93 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.077 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.498 ' N ' ' HG ' ' A' ' 494' ' ' LEU . 3.5 m -53.84 -46.44 71.2 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.49 -45.75 91.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.681 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.14 -47.85 88.95 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.24 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.909 HG23 ' HB2' ' A' ' 396' ' ' MET . 7.4 p -73.68 59.86 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.588 0.709 . . . . 0.0 110.672 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 499' ' ' ARG . . . . . 0.57 ' NH1' HG13 ' A' ' 498' ' ' VAL . 82.7 mmt-85 -152.32 -62.48 0.16 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.442 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -153.62 128.02 9.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.767 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.77 135.35 33.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.898 0.38 . . . . 0.0 111.302 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.168 179.922 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 120.392 0.139 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.2 143.94 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.112 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -101.01 65.22 1.08 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.152 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.787 HD12 ' CD1' ' A' ' 443' ' ' TYR . 34.0 pt 44.66 -152.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.042 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.77 ' HA ' HG21 ' A' ' 404' ' ' VAL . 52.6 tp60 45.83 47.82 12.05 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.191 0.52 . . . . 0.0 111.616 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.453 ' HA2' HG23 ' A' ' 495' ' ' THR . . . -141.7 -137.49 3.39 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.192 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.8 -41.92 57.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.735 0.268 . . . . 0.0 111.272 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 8.6 m -59.36 -47.56 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.894 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.77 HG21 ' HA ' ' A' ' 400' ' ' GLN . 39.0 t -64.53 -41.54 92.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.83 88.57 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.076 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.99 -50.06 74.93 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.119 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.437 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -54.44 -51.71 64.11 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.285 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.411 HD21 HD12 ' A' ' 491' ' ' ILE . 2.7 mp -58.68 -45.68 88.89 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.171 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.3 t -54.58 -50.72 67.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.04 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.46 -52.3 58.71 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.033 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 439' ' ' VAL . 46.6 t -52.92 -53.08 23.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.333 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 415' ' ' ILE . 35.9 mt -61.92 -49.91 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.207 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 39.5 m -55.28 -45.63 76.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.675 0.274 . . . . 0.0 110.502 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 3.1 mp -65.47 -54.59 26.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.265 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.471 ' HB ' ' CE1' ' A' ' 432' ' ' TYR . 0.1 OUTLIER -56.81 -44.18 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.452 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -61.23 -51.42 69.05 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.648 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 33.8 mtp -59.2 -49.4 78.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.579 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.517 ' HG2' ' HB3' ' A' ' 428' ' ' LEU . 2.8 mt-30 -60.09 -61.14 2.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.308 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 35.7 t90 -47.54 -44.9 26.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.699 0.285 . . . . 0.0 110.573 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 4.7 tt -63.45 -46.5 85.96 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.551 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 1.8 ttt -68.14 -39.97 82.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.959 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -139.09 96.95 3.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -71.2 59.24 0.26 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -169.39 118.78 0.66 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.872 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.788 ' CB ' ' HB1' ' A' ' 465' ' ' ALA . . . -76.31 67.57 2.57 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.045 0.45 . . . . 0.0 111.254 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -109.26 -74.02 0.67 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.728 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -95.59 -59.27 1.91 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.517 ' HB3' ' HG2' ' A' ' 418' ' ' GLN . 1.5 mm? -48.26 -35.01 11.24 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.16 -26.02 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.15 -51.11 63.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.587 0.232 . . . . 0.0 111.05 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.2 -40.9 97.61 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.154 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.656 ' O ' HG23 ' A' ' 436' ' ' VAL . 54.9 t80 -62.11 -50.98 69.73 Favored 'General case' 0 CA--C 1.526 0.034 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.612 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 6.1 tt -52.7 -52.38 56.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.37 -50.64 67.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.266 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -57.31 -49.09 75.4 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.679 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 432' ' ' TYR . 64.8 t -55.77 -47.79 78.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 47.4 t -56.09 -47.13 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.063 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.0 -52.99 54.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.398 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 411' ' ' VAL . 66.5 t -54.49 -51.96 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.573 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 444' ' ' GLY . . . -59.92 -42.33 93.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.321 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 6.8 tt -64.15 -50.53 67.83 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.67 0.271 . . . . 0.0 111.651 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' PHE . . . . . 0.505 ' O ' ' HD2' ' A' ' 445' ' ' ARG . 0.6 OUTLIER -70.92 -35.62 72.33 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.787 ' CD1' HD12 ' A' ' 399' ' ' ILE . 37.0 t80 -87.78 -26.64 22.77 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 440' ' ' ALA . . . -61.98 -6.23 9.24 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 115.076 0.79 . . . . 0.0 115.076 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.614 ' HD3' HG21 ' A' ' 399' ' ' ILE . 2.7 ptm180 -63.08 -23.79 67.61 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.112 0.956 . . . . 0.0 111.475 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' TRP . . . . . 0.596 ' HB3' HD11 ' A' ' 399' ' ' ILE . 0.0 OUTLIER -131.6 93.0 29.63 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 120.71 0.29 . . . . 0.0 110.751 179.35 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.7 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 11.7 Cg_endo -56.03 -67.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.772 2.315 . . . . 0.0 112.843 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 10.8 t 58.03 -89.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.355 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 453' ' ' VAL . 21.7 t -148.97 -59.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.664 0.269 . . . . 0.0 110.857 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.571 ' HB ' ' OH ' ' A' ' 443' ' ' TYR . 40.7 t -52.74 -47.35 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.7 ' HB3' ' HA ' ' A' ' 447' ' ' PRO . . . -59.71 -40.97 89.73 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 456' ' ' VAL . 93.3 m -59.41 -47.41 85.57 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 457' ' ' VAL . 58.1 t -60.15 -48.59 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.485 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 16.4 mm -54.06 -43.56 59.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.998 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -58.11 -50.27 74.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.845 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 452' ' ' THR . 42.4 t -57.77 -52.41 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.663 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 453' ' ' VAL . 77.5 t -54.08 -50.34 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.239 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 13.1 t -58.3 -44.57 88.62 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.954 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -55.37 -59.21 5.12 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.888 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' ASP . . . . . 0.458 ' OD2' HD11 ' A' ' 464' ' ' ILE . 6.0 t70 -59.49 -50.08 75.32 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.678 0.275 . . . . 0.0 110.452 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 9.1 tt -50.74 -43.51 58.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.716 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' PHE . . . . . 0.511 ' O ' ' HB3' ' A' ' 466' ' ' PRO . 7.5 t80 -55.51 -26.37 42.53 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.375 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -86.06 -27.33 24.8 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.648 0.261 . . . . 0.0 110.963 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.458 HD11 ' OD2' ' A' ' 460' ' ' ASP . 10.1 mt -87.31 -48.74 15.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.788 ' HB1' ' CB ' ' A' ' 425' ' ' ALA . . . -133.67 58.2 31.15 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.511 ' HB3' ' O ' ' A' ' 462' ' ' PHE . 56.7 Cg_endo -73.69 -45.9 0.37 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.151 1.901 . . . . 0.0 112.493 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 467' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 466' ' ' PRO . 2.1 ttt85 176.82 -47.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.233 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . -93.0 57.89 2.47 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.151 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' THR . . . . . 0.658 ' CG2' ' HB3' ' A' ' 425' ' ' ALA . 7.6 t -122.99 138.24 54.74 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.87 132.47 55.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.061 0.458 . . . . 0.0 111.681 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' A' ' 472' ' ' VAL . . . -80.4 161.96 24.71 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.79 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 472' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 471' ' ' ALA . 8.4 p 176.71 -38.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.841 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 15.0 p -89.42 -45.3 9.55 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.568 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 33.5 t70 71.85 -45.28 0.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.809 0.444 . . . . 0.0 111.93 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 42.8 t -40.75 -44.34 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 122.421 0.289 . . . . 0.0 111.545 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -62.54 -40.41 96.7 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.599 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' TYR . . . . . 0.674 ' OH ' ' HB2' ' A' ' 425' ' ' ALA . 0.2 OUTLIER -65.65 -51.91 55.85 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.7 tt -55.33 -54.28 45.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.802 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 483' ' ' VAL . 0.6 OUTLIER -54.99 -48.43 73.31 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.975 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 69.0 m -55.0 -44.0 74.12 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.802 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.22 -50.46 71.19 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.337 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.46 88.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.635 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 479' ' ' LEU . 91.9 t -63.14 -50.05 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.953 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 21.8 mtt -56.45 -52.67 63.8 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.141 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 2.5 tp -54.87 -46.29 74.7 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 490' ' ' VAL . 42.9 m -57.36 -48.74 78.22 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.914 178.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 483' ' ' VAL . 73.1 t -56.55 -46.33 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.47 -44.54 90.3 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 42.0 tp -56.52 -46.69 80.43 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.941 0.401 . . . . 0.0 109.983 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 486' ' ' THR . 34.3 t -63.22 -46.28 96.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.855 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.621 HG23 HE22 ' A' ' 400' ' ' GLN . 15.9 mt -55.67 -44.68 77.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.218 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.54 -45.75 92.18 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.694 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -54.43 -53.32 55.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.595 0.236 . . . . 0.0 110.971 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 491' ' ' ILE . 2.2 pp -68.57 -41.03 80.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.552 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 400' ' ' GLN . 79.6 m -60.16 -45.0 94.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.802 0.335 . . . . 0.0 110.415 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.15 79.37 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.449 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.35 -47.12 92.6 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.242 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 495' ' ' THR . 8.0 p -64.84 -30.96 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.644 0.259 . . . . 0.0 111.235 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.59 66.71 0.73 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.897 0.379 . . . . 0.0 110.769 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 5.0 t80 76.91 80.85 0.09 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.92 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -84.33 145.41 28.26 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.672 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.03 179.588 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.061 -0.019 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 96.8 t 65.7 92.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.973 0.416 . . . . 0.0 111.524 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -128.9 35.95 4.27 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.676 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 446' ' ' TRP . 3.8 tt -173.62 -49.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.922 0.391 . . . . 0.0 111.324 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.577 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 0.0 OUTLIER -149.37 163.57 37.36 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.928 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.741 ' HA2' HG23 ' A' ' 495' ' ' THR . . . 131.08 -137.03 9.17 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.825 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.2 t -54.32 -49.69 69.11 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.54 -52.57 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.053 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.577 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 21.2 t -59.94 -48.68 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.587 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.81 69.87 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.654 0.264 . . . . 0.0 110.372 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -55.84 -49.96 71.87 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.167 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.858 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -56.65 -47.05 80.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.004 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 1.6 mp -56.76 -47.34 80.32 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 413' ' ' THR . 38.5 t -51.85 -52.48 49.18 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.042 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -55.06 -55.06 35.29 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.326 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 407' ' ' ALA . 42.2 t -52.72 -43.94 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.751 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.19 -55.07 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.476 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 409' ' ' SER . 44.3 p -55.93 -42.31 75.91 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.69 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -56.37 17.46 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.57 -43.82 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.733 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -60.44 -52.14 66.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.572 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 8.2 mtt -50.67 -49.73 56.53 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.72 -42.67 85.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.929 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' TRP . . . . . 0.404 ' O ' ' HG ' ' A' ' 470' ' ' LEU . 4.7 t90 -56.45 -44.24 80.29 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.352 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.43 45.7 1.3 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.114 0.483 . . . . 0.0 110.548 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 11.3 ttm -163.97 144.82 8.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.466 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -75.74 75.62 2.71 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.895 0.378 . . . . 0.0 111.604 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 428' ' ' LEU . 0.8 OUTLIER -138.13 128.27 25.83 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.052 0.453 . . . . 0.0 111.635 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.486 ' HA ' ' HA2' ' A' ' 468' ' ' GLY . 3.1 m-20 -80.26 159.98 25.7 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.646 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -71.56 59.5 0.31 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.185 0.517 . . . . 0.0 111.48 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -146.51 141.52 27.12 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 66.4 -66.6 0.17 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.1 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' A' ' 423' ' ' PHE . 1.1 tt -63.73 -39.12 93.51 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.683 0.278 . . . . 0.0 110.787 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 4.4 p -52.15 -28.07 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.78 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 30.2 mtt -51.37 -44.56 62.14 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.722 0.296 . . . . 0.0 110.455 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -47.69 84.62 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.175 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -62.2 -47.29 85.12 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 437' ' ' VAL . 7.8 tt -53.48 -51.54 62.42 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.78 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 438' ' ' VAL . 5.0 mp -60.33 -46.4 90.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.86 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.654 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -53.18 -55.42 24.33 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.314 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 20.0 m -61.2 -39.61 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.659 0.229 . . . . 0.0 110.462 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 433' ' ' LEU . 34.3 t -57.89 -48.49 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 434' ' ' LEU . 65.1 t -61.14 -48.02 90.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.858 HG22 ' HB1' ' A' ' 407' ' ' ALA . 94.4 t -51.84 -51.37 28.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.063 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.696 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -62.49 -42.21 99.33 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.787 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 3.1 tp -49.11 -46.21 44.57 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -79.76 -36.89 36.55 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.38 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 439' ' ' VAL . 1.2 t80 -60.29 -23.67 64.35 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.131 0.573 . . . . 0.0 112.485 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 446' ' ' TRP . . . -69.0 -123.13 0.03 OUTLIER Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.653 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.71 -67.96 0.13 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.629 0.252 . . . . 0.0 110.871 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' TRP . . . . . 0.465 ' HB2' HD12 ' A' ' 399' ' ' ILE . 7.9 m-90 -126.99 71.02 75.21 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-O 121.111 0.481 . . . . 0.0 109.764 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.71 70.43 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.69 2.26 . . . . 0.0 113.249 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -57.41 12.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.824 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 27.2 t -153.53 -61.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.031 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 454' ' ' ILE . 0.2 OUTLIER -44.88 -43.54 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.159 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -54.04 -52.21 61.58 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.933 0.397 . . . . 0.0 110.718 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.3 OUTLIER -60.04 -43.53 95.28 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.894 178.598 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 457' ' ' VAL . 88.4 t -56.46 -52.22 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.561 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 450' ' ' VAL . 38.3 mm -61.07 -45.03 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.709 0.29 . . . . 0.0 110.305 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -55.93 -46.11 78.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.825 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 452' ' ' THR . 90.5 t -65.97 -47.48 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.506 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 453' ' ' VAL . 57.7 t -54.66 -47.41 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.709 0.29 . . . . 0.0 110.657 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 70.0 m -60.88 -54.02 50.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -52.58 -47.73 66.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.474 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -60.05 4.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.755 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.9 tp -44.12 -41.45 5.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.656 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -39.97 -36.63 0.49 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -118.73 31.36 6.69 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 18.0 mt -107.86 -47.74 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.698 0.285 . . . . 0.0 111.444 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.0 113.39 4.56 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.774 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.67 59.28 1.13 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.885 2.39 . . . . 0.0 112.697 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.0 -70.89 0.12 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.888 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 424' ' ' ASP . . . -82.27 113.53 3.67 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.33 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.29 58.56 0.18 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 470' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 419' ' ' TRP . 4.0 tt -165.69 -60.15 0.03 OUTLIER 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.085 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . 59.27 -161.47 0.26 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.27 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.38 -49.57 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.607 0.242 . . . . 0.0 111.452 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 6.2 t -151.04 76.54 1.24 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.048 0.451 . . . . 0.0 110.81 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 477' ' ' TYR . 7.5 t0 -90.22 100.08 12.98 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.151 0.5 . . . . 0.0 111.482 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.25 -43.67 77.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.93 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -51.17 70.4 Favored 'General case' 0 C--O 1.228 -0.056 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 474' ' ' ASP . 34.6 t80 -53.14 -47.91 68.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.352 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.5 tt -53.24 -46.97 69.4 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 483' ' ' VAL . 0.1 OUTLIER -59.99 -44.72 94.34 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.512 177.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 19.6 m -53.29 -47.87 68.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.294 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -61.49 -47.29 86.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.257 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -57.52 -45.75 84.63 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.584 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 487' ' ' VAL . 67.7 t -64.76 -52.9 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.324 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.3 ttt -52.85 -52.35 57.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.802 0.334 . . . . 0.0 110.487 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 485' ' ' LEU . 0.2 OUTLIER -56.8 -49.75 74.42 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.086 178.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 486' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 490' ' ' VAL . 41.8 m -54.78 -45.94 74.35 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.012 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 483' ' ' VAL . 65.3 t -54.95 -51.91 48.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.905 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.52 80.05 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.418 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.41 -46.77 76.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.857 0.36 . . . . 0.0 110.134 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 486' ' ' THR . 88.7 t -62.91 -49.67 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.221 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.488 HD13 HG12 ' A' ' 487' ' ' VAL . 0.9 OUTLIER -56.52 -38.33 56.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.99 -52.19 39.27 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -55.31 -48.5 74.03 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.944 0.402 . . . . 0.0 109.992 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -45.78 90.62 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.216 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.741 HG23 ' HA2' ' A' ' 401' ' ' GLY . 55.9 m -52.98 -43.72 66.63 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.339 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.45 85.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.307 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -69.11 -52.25 24.17 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.08 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.76 -25.23 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 14.9 tpp85 -51.4 -25.88 6.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -75.82 -1.21 24.09 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -125.03 132.46 53.21 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.611 0.243 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.138 -0.935 . . . . 0.0 111.396 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 396' ' ' MET . . . . . 0.823 ' N ' HE22 ' A' ' 398' ' ' GLN . 6.4 mmm . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.414 0.15 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 40.5 t 70.64 96.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.121 0.486 . . . . 0.0 110.755 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' GLN . . . . . 0.823 HE22 ' N ' ' A' ' 396' ' ' MET . 0.1 OUTLIER -158.63 170.31 22.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.217 -179.414 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.7 tp -42.1 -42.26 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.858 ' HB3' HG21 ' A' ' 404' ' ' VAL . 0.8 OUTLIER -166.71 67.58 0.1 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.85 0.357 . . . . 0.0 110.8 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -99.55 -113.1 3.42 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.771 -0.728 . . . . 0.0 114.345 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 14.3 m -34.5 -55.28 0.54 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 442' ' ' PHE . 23.7 m -53.37 -44.11 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.858 HG21 ' HB3' ' A' ' 400' ' ' GLN . 75.3 t -71.21 -44.08 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.905 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.21 76.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.25 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.66 -48.81 70.87 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.607 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.81 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -55.94 -60.09 3.97 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.998 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.892 HD11 HG22 ' A' ' 487' ' ' VAL . 0.1 OUTLIER -53.04 -53.99 41.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.022 179.604 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 23.9 t -53.95 -52.18 61.46 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.427 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -53.48 -48.51 68.86 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.013 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 407' ' ' ALA . 31.8 t -57.17 -49.41 79.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.258 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.662 HD11 HD12 ' A' ' 408' ' ' LEU . 53.4 mt -57.32 -50.92 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.49 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 25.6 m -57.37 -48.07 80.0 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.824 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.403 HD12 HE21 ' A' ' 418' ' ' GLN . 1.4 mm? -59.93 -52.27 66.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.645 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.554 HG12 ' CG ' ' A' ' 466' ' ' PRO . 94.7 mt -56.95 -49.23 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.894 0.378 . . . . 0.0 110.559 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.92 -55.2 37.6 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.292 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 24.1 ttm -54.2 -46.22 72.4 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.27 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 1.007 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 39.1 mt-30 -50.57 -50.45 53.67 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.819 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -70.87 -37.77 73.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.161 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.11 -56.99 12.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.414 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.55 77.0 0.33 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.974 0.416 . . . . 0.0 111.524 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 1.007 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -163.31 -170.58 2.31 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.19 168.87 9.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 111.633 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -36.9 111.44 0.15 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.239 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.513 ' HB1' HD22 ' A' ' 431' ' ' LEU . . . 54.67 23.59 4.87 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . 61.77 39.94 13.48 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.913 0.387 . . . . 0.0 111.803 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 71.78 161.07 0.23 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.868 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 2.6 mp -93.3 57.71 2.71 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.143 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.609 HG13 ' H ' ' A' ' 430' ' ' MET . 0.9 OUTLIER -155.37 -67.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.807 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.609 ' H ' HG13 ' A' ' 429' ' ' VAL . 0.0 OUTLIER -60.94 -53.54 56.03 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.513 HD22 ' HB1' ' A' ' 425' ' ' ALA . 0.3 OUTLIER -60.79 -38.16 84.36 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.836 178.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 436' ' ' VAL . 63.6 t80 -63.88 -54.77 29.61 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -54.58 45.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.727 0.299 . . . . 0.0 110.717 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.63 -53.62 55.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.946 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.11 -50.97 60.29 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.732 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 432' ' ' TYR . 43.0 t -57.42 -44.56 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.857 0.328 . . . . 0.0 110.725 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 20.3 t -57.04 -60.7 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.24 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 35.5 m -60.77 -43.62 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.543 0.211 . . . . 0.0 111.273 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.2 t -56.39 -51.0 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -61.85 -48.42 80.62 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.271 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.85 -44.67 70.54 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.829 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' PHE . . . . . 0.57 ' HA ' ' CG2' ' A' ' 403' ' ' VAL . 0.0 OUTLIER -71.62 -52.46 17.88 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.165 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.472 ' O ' ' N ' ' A' ' 445' ' ' ARG . 4.1 t80 -55.01 -29.21 56.86 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.996 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -65.7 58.77 0.13 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.74 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.1 OUTLIER -164.9 42.18 0.08 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.968 0.507 . . . . 0.0 110.601 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 446' ' ' TRP . . . . . 0.466 ' HB2' ' O ' ' A' ' 445' ' ' ARG . 27.4 m0 76.4 142.34 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.065 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.569 ' O ' ' HB3' ' A' ' 451' ' ' ALA . 37.4 Cg_endo -65.54 -39.87 20.08 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.469 2.112 . . . . 0.0 112.08 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.47 ' O ' HG22 ' A' ' 450' ' ' VAL . 0.4 OUTLIER 51.14 20.11 0.82 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.3 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 39.5 t 65.62 -63.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 448' ' ' SER . 1.8 m -52.18 -48.14 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 447' ' ' PRO . . . -61.19 -47.68 85.02 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.739 0.304 . . . . 0.0 110.719 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 30.5 m -59.25 -55.09 39.35 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.401 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.65 -43.04 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.266 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.948 HG23 HG23 ' A' ' 486' ' ' THR . 10.1 mt -63.63 -59.29 4.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.6 0.238 . . . . 0.0 111.069 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -54.3 -48.58 71.13 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 38.7 t -60.95 -65.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.261 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 54.9 t -47.26 -47.26 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.601 0.238 . . . . 0.0 111.072 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 11.3 t -55.83 -58.13 9.13 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.02 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.19 -51.64 68.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.164 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.25 -43.29 78.54 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.536 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 1.4 mp -68.66 -46.08 70.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.284 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -55.88 107.5 0.35 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.926 0.394 . . . . 0.0 110.893 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -98.42 -61.42 1.38 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.448 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -116.2 -54.32 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.541 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.536 ' CB ' ' HB ' ' A' ' 469' ' ' THR . . . -137.15 144.49 46.21 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 111.575 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.554 ' CG ' HG12 ' A' ' 415' ' ' ILE . 37.6 Cg_endo -65.29 -19.29 62.05 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.823 2.349 . . . . 0.0 113.173 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 467' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 466' ' ' PRO . 0.0 OUTLIER 177.54 64.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.051 0.453 . . . . 0.0 110.322 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 148.86 81.88 0.04 OUTLIER Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.586 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' THR . . . . . 0.605 HG23 ' H ' ' A' ' 470' ' ' LEU . 0.1 OUTLIER -136.01 -70.8 0.47 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.501 0.191 . . . . 0.0 111.161 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 470' ' ' LEU . . . . . 0.605 ' H ' HG23 ' A' ' 469' ' ' THR . 0.2 OUTLIER -102.41 159.6 15.28 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.742 0.306 . . . . 0.0 110.785 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -70.96 62.31 0.29 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.144 0.497 . . . . 0.0 111.006 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' VAL . . . . . 0.489 HG23 HD23 ' A' ' 470' ' ' LEU . 58.8 t -138.82 121.34 17.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.095 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 473' ' ' SER . . . . . 0.624 ' HA ' ' HG2' ' A' ' 476' ' ' GLN . 0.3 OUTLIER -70.84 -46.54 62.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.833 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.69 -49.37 10.48 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.599 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.672 HG12 HD12 ' A' ' 479' ' ' LEU . 76.4 t -59.47 -52.19 63.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.01 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.624 ' HG2' ' HA ' ' A' ' 473' ' ' SER . 20.7 pt20 -63.55 -37.0 85.64 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.854 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -64.5 -55.77 18.46 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.6 -47.16 82.9 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.88 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' LEU . . . . . 0.672 HD12 HG12 ' A' ' 475' ' ' VAL . 5.7 mt -56.48 -52.88 63.04 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 480' ' ' THR . . . . . 0.515 HG22 ' SD ' ' A' ' 484' ' ' MET . 37.8 m -54.72 -45.86 74.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.13 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -59.96 -46.93 87.84 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.032 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.77 72.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.412 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 487' ' ' VAL . 28.5 m -64.34 -45.54 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 121.142 -0.223 . . . . 0.0 110.7 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 484' ' ' MET . . . . . 0.515 ' SD ' HG22 ' A' ' 480' ' ' THR . 16.1 mtt -56.82 -55.03 39.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.23 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.27 -46.18 79.79 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.004 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' THR . . . . . 0.948 HG23 HG23 ' A' ' 454' ' ' ILE . 88.9 m -54.13 -51.91 62.75 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.959 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.892 HG22 HD11 ' A' ' 408' ' ' LEU . 94.5 t -55.94 -51.82 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.652 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.6 -48.11 79.37 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.407 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.89 -46.81 88.14 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.736 0.303 . . . . 0.0 110.78 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 486' ' ' THR . 63.6 t -65.38 -60.11 3.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.367 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.422 ' HA ' ' CD2' ' A' ' 494' ' ' LEU . 0.6 OUTLIER -52.8 -43.56 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.36 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.56 -53.31 42.52 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.065 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -58.3 -51.72 68.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.559 0.219 . . . . 0.0 111.499 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.567 ' CD2' HG11 ' A' ' 404' ' ' VAL . 1.2 pp -61.97 -47.21 85.87 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 56.8 m -57.43 -48.14 79.92 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.652 0.263 . . . . 0.0 110.909 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.51 56.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.732 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -54.73 -49.44 61.61 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.159 -0.544 . . . . 0.0 112.994 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 494' ' ' LEU . 8.6 p -65.83 -41.5 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 16.8 mtm105 -68.51 -44.19 75.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.842 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 76.82 136.33 0.06 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.254 0.55 . . . . 0.0 111.719 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -142.73 47.35 1.56 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.756 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.116 -179.911 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 396' ' ' MET . . . . . 0.995 ' N ' ' HG ' ' A' ' 402' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.701 0.286 . . . . 0.0 111.629 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 5.3 m -108.25 111.89 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.307 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -169.96 169.63 8.06 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.496 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.516 ' O ' ' HG2' ' A' ' 400' ' ' GLN . 1.1 tp -56.07 113.87 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.805 0.336 . . . . 0.0 110.451 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.823 ' HA ' HG21 ' A' ' 404' ' ' VAL . 0.0 OUTLIER 59.58 69.46 0.71 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.824 0.821 . . . . 0.0 111.086 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.535 ' HA2' ' CG2' ' A' ' 498' ' ' VAL . . . -128.58 -150.27 7.17 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.817 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' SER . . . . . 0.995 ' HG ' ' N ' ' A' ' 396' ' ' MET . 0.7 OUTLIER -52.86 -51.33 61.42 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.291 0.236 . . . . 0.0 111.525 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 20.1 m -55.22 -40.19 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.477 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 400' ' ' GLN . 2.7 t -62.42 -49.57 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.217 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.58 81.1 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.877 0.37 . . . . 0.0 110.192 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.9 81.24 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.223 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.726 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -59.04 -47.93 83.45 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.113 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 408' ' ' LEU . 7.8 tt -55.82 -51.15 68.47 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.925 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -45.23 86.62 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.341 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.11 82.13 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.196 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.484 HG21 HG21 ' A' ' 439' ' ' VAL . 53.5 t -55.7 -56.96 9.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.579 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 415' ' ' ILE . 51.0 mt -53.17 -42.52 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.892 0.377 . . . . 0.0 110.114 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 29.2 m -60.68 -46.38 90.59 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.817 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.77 -44.32 93.93 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.874 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 412' ' ' ILE . 61.4 mt -54.87 -48.46 74.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.29 83.6 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.562 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 10.5 mtt -59.87 -52.1 66.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.817 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.61 ' HB3' HD22 ' A' ' 428' ' ' LEU . 14.4 mm100 -56.76 -50.77 71.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.479 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' TRP . . . . . 0.535 ' HB2' ' HA2' ' A' ' 468' ' ' GLY . 0.0 OUTLIER -58.78 -42.12 88.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.621 179.229 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -30.08 71.07 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.322 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 7.3 ttt -91.66 -43.51 9.56 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.558 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.812 ' HB3' HD21 ' A' ' 428' ' ' LEU . . . -135.33 156.32 49.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.819 0.343 . . . . 0.0 111.431 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -116.41 25.4 10.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.622 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -102.64 163.35 12.27 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 111.617 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -115.8 33.13 5.67 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -118.44 -71.34 0.74 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.061 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -65.15 -41.26 94.9 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.993 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 422' ' ' ALA . 45.0 mt -69.81 -45.17 68.49 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.876 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 3.4 t -60.92 -45.04 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.921 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 20.7 mtt -48.64 -57.06 6.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 110.237 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.79 -47.76 83.67 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.103 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.487 ' HE1' HD11 ' A' ' 415' ' ' ILE . 20.2 t80 -52.97 -52.39 58.35 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.148 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.587 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.2 OUTLIER -60.49 -42.88 97.21 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.514 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.39 -48.52 65.6 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.553 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.11 -44.23 98.42 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.744 HG11 ' CB ' ' A' ' 458' ' ' SER . 69.6 t -56.9 -40.82 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 433' ' ' LEU . 65.7 t -61.19 -47.91 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.37 -48.33 85.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.726 HG22 ' HB1' ' A' ' 407' ' ' ALA . 76.9 t -57.42 -50.17 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.969 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.11 82.9 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.451 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 441' ' ' LEU . 0.6 OUTLIER -53.17 -50.48 64.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.897 178.355 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -70.76 -21.43 62.52 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.177 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.537 ' OH ' HG13 ' A' ' 490' ' ' VAL . 0.2 OUTLIER -77.24 -2.47 34.84 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -71.1 -161.38 4.2 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.807 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.472 ' O ' HD13 ' A' ' 399' ' ' ILE . 0.0 OUTLIER 78.33 106.08 0.07 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.932 0.493 . . . . 0.0 111.159 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 446' ' ' TRP . . . . . 0.418 ' HB2' ' O ' ' A' ' 445' ' ' ARG . 46.2 m0 67.51 89.29 0.1 OUTLIER Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.67 128.77 25.52 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 112.821 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 91.7 p -113.07 -87.18 0.56 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.302 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 453' ' ' VAL . 7.2 p -178.17 -46.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.548 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 454' ' ' ILE . 53.5 t -54.39 -48.58 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.103 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.498 ' O ' HG13 ' A' ' 454' ' ' ILE . . . -54.86 -42.35 71.92 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.172 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.2 OUTLIER -63.89 -49.08 74.11 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.973 178.638 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 449' ' ' VAL . 61.5 t -57.69 -56.18 17.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.799 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 451' ' ' ALA . 1.9 pp -59.17 -41.73 84.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.717 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 455' ' ' ASN . . . . . 0.435 ' N ' HD12 ' A' ' 454' ' ' ILE . 1.2 m120 -55.82 -52.21 64.79 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 452' ' ' THR . 93.0 t -55.18 -47.86 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.871 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 40.3 t -48.79 -54.08 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.282 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' SER . . . . . 0.744 ' CB ' HG11 ' A' ' 436' ' ' VAL . 0.1 OUTLIER -59.61 -43.23 93.81 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.463 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -54.98 -58.46 7.52 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.368 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' ASP . . . . . 0.451 ' OD2' HG12 ' A' ' 456' ' ' VAL . 29.4 m-20 -62.13 -37.38 84.94 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.269 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.538 HD11 HD12 ' A' ' 479' ' ' LEU . 1.6 tp -64.78 -22.96 67.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.531 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' PHE . . . . . 0.55 ' CD1' ' HG ' ' A' ' 433' ' ' LEU . 15.5 t80 -58.9 70.17 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.347 0.594 . . . . 0.0 111.463 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 461' ' ' LEU . 0.4 OUTLIER 175.33 -45.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.088 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 36.4 mm -131.46 97.57 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.006 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.474 ' O ' HG22 ' A' ' 469' ' ' THR . . . -94.91 148.16 34.28 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.724 ' HG3' HG11 ' A' ' 483' ' ' VAL . 88.8 Cg_endo -76.43 170.84 19.17 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.01 2.473 . . . . 0.0 112.825 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.19 76.73 0.09 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.364 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.535 ' HA2' ' HB2' ' A' ' 419' ' ' TRP . . . 161.1 -66.68 0.26 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.317 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 469' ' ' THR . . . . . 0.476 ' O ' ' HG3' ' A' ' 476' ' ' GLN . 5.5 t -81.43 115.0 20.56 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.813 0.339 . . . . 0.0 111.86 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 470' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 473' ' ' SER . 3.7 mm? 55.17 66.29 1.27 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.301 0.572 . . . . 0.0 111.306 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -49.76 140.06 12.09 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.186 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 472' ' ' VAL . 8.4 p 43.09 32.04 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.913 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 473' ' ' SER . . . . . 0.564 ' HB2' ' HB3' ' A' ' 470' ' ' LEU . 49.0 m -104.02 57.41 0.72 Allowed 'General case' 0 C--O 1.234 0.246 0 O-C-N 122.218 -0.301 . . . . 0.0 111.216 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 9.9 t70 63.78 -74.51 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.209 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.43 ' CG1' HD23 ' A' ' 479' ' ' LEU . 83.0 t -53.19 -45.74 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.331 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 469' ' ' THR . 0.0 OUTLIER -58.64 -35.05 71.9 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.387 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -71.01 -50.95 28.54 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 42.6 mt -58.9 -49.17 78.8 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.596 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 466' ' ' PRO . 2.9 mm? -57.51 -52.14 66.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.261 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 480' ' ' THR . . . . . 0.447 ' HA ' HG22 ' A' ' 483' ' ' VAL . 39.0 m -57.19 -42.7 81.73 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.976 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -58.03 -49.04 78.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.309 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.02 -49.44 76.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.368 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.724 HG11 ' HG3' ' A' ' 466' ' ' PRO . 17.4 m -65.64 -37.36 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.751 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 8.7 mtt -62.66 -53.76 49.59 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 4.7 tp -56.02 -43.34 77.66 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.428 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 486' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 490' ' ' VAL . 32.9 m -59.15 -48.18 82.56 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.784 178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 15.6 t -58.03 -47.68 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.096 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' GLY . . . . . 0.511 ' O ' HG13 ' A' ' 491' ' ' ILE . . . -53.41 -44.72 66.53 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -45.77 83.2 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.796 0.331 . . . . 0.0 110.169 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 486' ' ' THR . 69.8 t -58.88 -54.37 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.553 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.52 ' O ' ' HG ' ' A' ' 494' ' ' LEU . 2.3 pp -57.29 -42.45 80.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.414 ' N ' HD12 ' A' ' 491' ' ' ILE . . . -63.71 -45.04 95.43 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.294 -0.955 . . . . 0.0 110.982 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.59 -55.7 28.96 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.304 0.241 . . . . 0.0 110.797 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.658 ' HA ' ' HG3' ' A' ' 400' ' ' GLN . 3.2 pp -61.76 -39.56 92.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.804 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 96.4 m -52.87 -48.77 66.86 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -72.72 -48.8 35.67 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.706 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -51.43 -36.26 37.73 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 116.33 -0.395 . . . . 0.0 113.611 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.535 ' CG2' ' HA2' ' A' ' 401' ' ' GLY . 76.0 t -74.36 -10.11 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.945 0.373 . . . . 0.0 111.883 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -122.27 179.04 4.69 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.014 0.435 . . . . 0.0 111.299 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -116.78 125.37 51.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.996 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -147.0 145.21 29.65 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.132 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.24 179.425 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.605 0.24 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 4.0 m -120.52 136.15 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.01 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -165.45 162.8 19.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.569 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 2.9 mt -74.32 -53.34 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.408 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.735 ' HG3' HD13 ' A' ' 494' ' ' LEU . 0.0 OUTLIER -146.05 44.64 1.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' ' 404' ' ' VAL . . . -111.12 -101.48 2.62 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.278 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 9.1 t -47.23 -40.84 17.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.844 0.322 . . . . 0.0 111.142 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 404' ' ' VAL . 22.4 m -63.04 -48.74 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.755 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 401' ' ' GLY . 2.5 p -69.01 -42.19 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 121.159 -0.217 . . . . 0.0 111.309 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.04 -57.35 13.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 111.048 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.53 -49.4 77.94 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.72 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -54.43 -58.68 6.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.43 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.841 HD11 HG13 ' A' ' 487' ' ' VAL . 0.1 OUTLIER -61.47 -49.93 74.8 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.283 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.436 ' O ' HG23 ' A' ' 413' ' ' THR . 13.7 t -51.43 -52.65 44.41 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.68 68.63 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.109 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.529 HG12 HD12 ' A' ' 415' ' ' ILE . 15.1 t -52.06 -41.81 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 18.7 mm -62.58 -52.3 61.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.923 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 409' ' ' SER . 24.3 p -60.1 -48.13 82.99 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.763 -0.199 . . . . 0.0 110.644 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' A' ' 431' ' ' LEU . 96.3 mt -59.33 -51.06 71.54 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.745 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.529 HD12 HG12 ' A' ' 411' ' ' VAL . 40.2 mt -59.61 -48.29 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.6 -56.36 22.95 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.755 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 9.2 mtt -53.03 -46.74 68.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.656 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.711 ' HG2' HD23 ' A' ' 428' ' ' LEU . 18.1 tm0? -60.77 -58.29 9.1 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.63 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' TRP . . . . . 0.521 ' HE3' HD12 ' A' ' 420' ' ' LEU . 71.6 t90 -51.93 -42.8 63.1 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.007 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.521 HD12 ' HE3' ' A' ' 419' ' ' TRP . 0.2 OUTLIER -61.32 -25.55 67.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.448 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.55 137.08 34.11 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.953 0.406 . . . . 0.0 110.905 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -72.76 75.16 1.13 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 111.439 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 427' ' ' ASN . 0.2 OUTLIER -162.07 173.81 13.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.125 0.488 . . . . 0.0 111.698 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -99.37 -177.08 3.48 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.541 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.487 ' CB ' ' HB2' ' A' ' 465' ' ' ALA . . . -68.38 -32.64 72.87 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.945 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -49.08 -45.25 42.91 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' ASN . . . . . 0.503 ' HB2' ' CD1' ' A' ' 423' ' ' PHE . 21.0 t-20 -60.86 -47.6 85.65 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.678 0.275 . . . . 0.0 111.367 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.711 HD23 ' HG2' ' A' ' 418' ' ' GLN . 2.3 mm? -91.52 28.45 1.72 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 430' ' ' MET . 11.0 p -48.0 -43.53 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.47 ' O ' ' HB2' ' A' ' 434' ' ' LEU . 21.4 ttm -57.6 -57.58 12.08 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.026 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.618 ' HB3' HD22 ' A' ' 414' ' ' LEU . 1.1 mt -57.84 -42.58 84.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.028 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.55 ' HB3' HD21 ' A' ' 461' ' ' LEU . 5.7 m-85 -62.42 -60.03 4.13 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.055 0.455 . . . . 0.0 110.597 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.74 -57.06 14.08 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.483 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 430' ' ' MET . 8.1 mp -52.11 -46.84 65.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.984 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.18 -65.14 3.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.897 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.775 HG11 HD13 ' A' ' 461' ' ' LEU . 34.4 m -59.11 -38.23 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 441' ' ' LEU . 19.5 t -63.48 -52.35 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.923 -0.126 . . . . 0.0 110.796 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 14.9 t -55.76 -52.73 45.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 110.377 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 96.5 t -58.41 -54.62 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.256 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.59 ' HA ' HD13 ' A' ' 454' ' ' ILE . . . -56.95 -52.09 66.58 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 437' ' ' VAL . 1.3 tp -56.73 -47.92 78.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.609 0.242 . . . . 0.0 110.963 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -67.24 -28.98 68.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.964 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -67.84 176.62 2.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.245 0.545 . . . . 0.0 111.629 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 122.15 42.72 0.42 Allowed Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 113.104 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -134.97 116.38 14.62 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.317 0.247 . . . . 0.0 110.391 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 25.6 m95 64.77 97.85 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.598 0 CA-C-O 120.872 0.368 . . . . 0.0 111.899 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.61 76.91 1.84 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.504 2.136 . . . . 0.0 112.279 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 449' ' ' VAL . 97.6 p -104.37 -85.07 0.47 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.683 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.42 ' N ' ' OG ' ' A' ' 448' ' ' SER . 2.7 p -137.68 -51.26 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 4.5 m -46.24 -46.14 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.477 ' O ' HG13 ' A' ' 454' ' ' ILE . . . -58.78 -49.07 79.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.886 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 8.2 m -57.51 -41.65 81.2 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.731 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 449' ' ' VAL . 59.4 t -61.08 -59.0 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 440' ' ' ALA . 1.8 pp -60.5 -42.24 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.478 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 455' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 451' ' ' ALA . 1.4 t30 -58.88 -54.68 44.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.545 0.212 . . . . 0.0 110.705 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.93 -55.48 23.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.522 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.762 HG13 ' HG3' ' A' ' 466' ' ' PRO . 3.1 t -48.45 -45.34 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.212 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 2.6 t -59.8 -57.13 14.23 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.156 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -46.35 -51.21 15.26 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.726 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' ASP . . . . . 0.525 ' HB3' ' HA ' ' A' ' 466' ' ' PRO . 11.8 m-20 -64.84 -44.64 89.11 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.595 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.775 HD13 HG11 ' A' ' 436' ' ' VAL . 2.0 tt -48.83 -38.81 23.29 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.52 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -51.12 -26.39 6.53 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.263 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -100.99 48.68 0.89 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.818 0.342 . . . . 0.0 111.178 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' A' ' 465' ' ' ALA . 2.3 mt 70.95 66.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.176 0.512 . . . . 0.0 111.371 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.61 ' C ' ' HA ' ' A' ' 461' ' ' LEU . . . 72.89 150.02 0.13 Allowed Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.646 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.762 ' HG3' HG13 ' A' ' 457' ' ' VAL . 43.3 Cg_endo -66.22 55.75 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.592 2.195 . . . . 0.0 112.207 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 467' ' ' ARG . . . . . 0.552 ' HG2' HD13 ' A' ' 479' ' ' LEU . 3.2 mpp_? -164.97 -55.76 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.809 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 142.67 -59.46 0.54 Allowed Glycine 0 C--N 1.337 0.616 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.447 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 62.2 p -151.18 179.38 8.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.634 0.254 . . . . 0.0 110.763 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.02 -172.8 2.16 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 111.736 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . 57.79 -120.71 1.29 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.666 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' VAL . . . . . 0.553 ' O ' ' HB3' ' A' ' 473' ' ' SER . 95.9 t 66.96 -59.01 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 473' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 472' ' ' VAL . 48.1 t 104.42 158.95 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.926 0.89 . . . . 0.0 111.171 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 64.49 -62.69 0.18 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.607 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 17.8 m -50.22 -41.45 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.301 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -53.23 -58.32 7.48 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.706 0.289 . . . . 0.0 111.024 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -56.94 -50.09 73.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -56.18 23.39 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.003 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 479' ' ' LEU . . . . . 0.552 HD13 ' HG2' ' A' ' 467' ' ' ARG . 12.6 mt -56.89 -50.71 71.69 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.815 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 18.1 m -55.27 -51.5 66.46 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.687 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -59.32 -55.77 30.5 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.02 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -54.14 -47.63 71.7 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.653 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.92 -53.84 36.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.163 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 52.2 mtp -53.9 -52.52 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.282 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -56.12 25.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.997 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 486' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 490' ' ' VAL . 9.7 m -56.01 -57.68 11.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.988 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.841 HG13 HD11 ' A' ' 408' ' ' LEU . 39.2 t -53.2 -53.03 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.239 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -55.48 -52.92 44.63 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.2 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.1 -45.95 79.26 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.655 0.264 . . . . 0.0 110.377 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 486' ' ' THR . 68.4 t -60.34 -50.01 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.034 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.642 HD11 ' CD2' ' A' ' 408' ' ' LEU . 97.2 mt -51.64 -48.22 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 120.788 0.328 . . . . 0.0 110.368 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -67.65 -45.04 79.46 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.954 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -49.41 73.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.288 0.235 . . . . 0.0 111.477 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.735 HD13 ' HG3' ' A' ' 400' ' ' GLN . 3.1 pp -69.22 -43.96 73.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.373 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.526 ' N ' HD12 ' A' ' 494' ' ' LEU . 26.6 m -63.73 -41.31 98.08 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.561 0.22 . . . . 0.0 111.304 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -68.47 -50.03 55.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.313 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -67.97 -56.98 9.29 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.151 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.591 HG21 ' OE1' ' A' ' 400' ' ' GLN . 32.2 t -75.52 64.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.319 0.581 . . . . 0.0 110.987 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 499' ' ' ARG . . . . . 0.416 ' NH1' ' HB3' ' A' ' 499' ' ' ARG . 7.6 ttp-105 -148.73 41.73 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.946 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 59.87 46.24 11.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.475 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.47 -35.2 12.41 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.32 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.379 -0.82 . . . . 0.0 110.975 179.894 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 59.6 ttp . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.436 0.16 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 3.9 m -150.46 131.83 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.964 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -89.76 -38.39 13.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.08 -76.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.211 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.995 ' HG2' HG11 ' A' ' 404' ' ' VAL . 5.6 mt-30 -117.07 124.82 50.18 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.874 -0.148 . . . . 0.0 110.94 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 1.007 ' HA2' HD23 ' A' ' 494' ' ' LEU . . . -158.22 -132.66 1.44 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.364 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -41.09 61.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.93 0.365 . . . . 0.0 110.988 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.458 HG23 ' N ' ' A' ' 404' ' ' VAL . 18.0 m -55.86 -52.49 48.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.599 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.995 HG11 ' HG2' ' A' ' 400' ' ' GLN . 16.3 m -72.79 -31.79 37.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 121.194 -0.203 . . . . 0.0 110.94 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.07 -45.05 90.47 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.889 0.375 . . . . 0.0 110.101 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.48 -50.91 61.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.874 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 440' ' ' ALA . . . -56.01 -48.11 76.52 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.099 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.758 HD21 HG13 ' A' ' 487' ' ' VAL . 2.9 tp -58.99 -45.01 91.69 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.812 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 58.1 m -53.28 -44.32 68.16 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.24 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' ALA . . . . . 0.415 ' HB3' HG13 ' A' ' 436' ' ' VAL . . . -62.92 -48.16 80.14 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.266 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.429 HG12 HD11 ' A' ' 415' ' ' ILE . 75.3 t -57.7 -54.66 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.355 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 415' ' ' ILE . 93.4 mt -52.68 -48.23 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.885 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 35.7 m -57.38 -45.23 84.68 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.661 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' A' ' 432' ' ' TYR . 1.4 mm? -56.7 -55.95 27.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.208 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 412' ' ' ILE . 9.7 mt -54.86 -47.12 75.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.442 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.14 79.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.08 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -44.84 82.49 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.549 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 1.04 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 14.4 tt0 -57.7 -58.13 9.7 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.607 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -57.3 -35.77 70.24 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.62 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 421' ' ' MET . 1.0 OUTLIER -70.62 -53.49 15.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.476 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 421' ' ' MET . . . . . 0.434 ' HB2' HD23 ' A' ' 420' ' ' LEU . 1.7 mtt -171.83 71.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 1.04 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -156.71 115.04 3.29 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.918 0.389 . . . . 0.0 111.061 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -72.98 94.22 1.84 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.036 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 57.93 -177.22 0.07 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.865 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 465' ' ' ALA . . . -91.86 50.44 1.68 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 111.391 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' A' ' 430' ' ' MET . . . -131.42 146.68 52.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.785 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 63.16 103.43 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.921 0.391 . . . . 0.0 111.02 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.9 -60.06 0.52 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.832 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.454 ' CG1' ' HA ' ' A' ' 425' ' ' ALA . 89.2 t -53.28 -46.37 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.888 0.375 . . . . 0.0 110.302 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.403 ' HB2' ' HA ' ' A' ' 426' ' ' ALA . 0.0 OUTLIER -57.32 -49.47 76.02 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.125 178.815 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 4.0 mp -58.42 -48.44 80.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.362 -0.381 . . . . 0.0 109.979 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.632 ' HB3' HD11 ' A' ' 414' ' ' LEU . 0.2 OUTLIER -55.53 -54.97 37.32 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.172 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.507 HD21 ' HD3' ' A' ' 467' ' ' ARG . 0.4 OUTLIER -56.62 -43.11 79.88 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.183 178.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 438' ' ' VAL . 0.1 OUTLIER -56.46 -52.21 65.53 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.594 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -55.22 -47.7 72.95 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 432' ' ' TYR . 92.3 t -56.43 -47.3 81.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 433' ' ' LEU . 68.1 t -58.43 -44.61 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.848 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 434' ' ' LEU . 64.2 t -58.44 -45.55 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.432 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 72.6 t -56.81 -53.11 46.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.977 0.418 . . . . 0.0 110.328 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.451 ' HB2' ' HB1' ' A' ' 407' ' ' ALA . . . -59.71 -47.09 87.02 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.405 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -40.97 80.22 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.595 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.66 -37.4 86.41 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.699 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.23 -43.64 15.87 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.578 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.48 172.94 37.75 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.469 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.699 ' O ' ' HB1' ' A' ' 451' ' ' ALA . 3.7 mtt180 -130.63 -170.82 2.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 111.961 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' TRP . . . . . 0.56 ' H ' ' HD2' ' A' ' 447' ' ' PRO . 22.8 m-90 -110.93 -59.64 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.56 ' HD2' ' H ' ' A' ' 446' ' ' TRP . 53.7 Cg_endo -69.03 61.38 1.33 Allowed 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.205 1.937 . . . . 0.0 113.311 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.12 29.21 1.09 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.332 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 92.9 t 56.63 -83.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.68 0.392 . . . . 0.0 111.814 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 15.6 m -54.6 -44.83 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.563 0.221 . . . . 0.0 110.893 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.699 ' HB1' ' O ' ' A' ' 445' ' ' ARG . . . -57.76 -43.43 85.43 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.756 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -50.5 73.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.066 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 49.1 t -59.38 -48.59 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.57 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.12 -47.48 86.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.154 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.2 -49.97 75.81 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.12 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 31.8 t -54.69 -53.79 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.5 ' CG1' HD13 ' A' ' 461' ' ' LEU . 24.3 t -48.94 -53.49 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.147 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -39.81 72.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.59 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -56.21 -55.81 28.64 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.414 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.93 -42.26 99.74 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.858 0.361 . . . . 0.0 110.656 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.5 HD13 ' CG1' ' A' ' 457' ' ' VAL . 0.1 OUTLIER -63.78 -23.8 67.5 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.511 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -67.72 73.48 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.197 0.523 . . . . 0.0 110.918 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.54 -66.62 0.21 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.994 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.82 31.47 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.124 0.488 . . . . 0.0 111.423 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 425' ' ' ALA . . . 48.79 65.31 7.26 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.814 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.489 ' HG2' ' HG ' ' A' ' 461' ' ' LEU . 31.2 Cg_exo -60.63 76.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.93 2.42 . . . . 0.0 113.051 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 467' ' ' ARG . . . . . 0.507 ' HD3' HD21 ' A' ' 433' ' ' LEU . 0.0 OUTLIER -132.66 84.13 2.12 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.515 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 476' ' ' GLN . . . 57.2 40.29 91.41 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.786 -0.643 . . . . 0.0 113.32 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 469' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 469' ' ' THR . 8.8 t -85.81 81.34 8.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.273 0.559 . . . . 0.0 111.238 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 470' ' ' LEU . . . . . 0.674 HD12 HG12 ' A' ' 472' ' ' VAL . 0.1 OUTLIER 175.9 108.07 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.685 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -69.45 67.95 0.22 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.119 0.485 . . . . 0.0 112.107 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' VAL . . . . . 0.674 HG12 HD12 ' A' ' 470' ' ' LEU . 8.6 p -159.85 141.63 4.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.883 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 42.3 t -72.48 58.13 0.4 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.866 0.365 . . . . 0.0 111.005 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.58 -74.91 0.16 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.623 HG12 HD12 ' A' ' 479' ' ' LEU . 99.1 t -59.47 -58.32 7.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.321 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.584 ' HA ' ' HA2' ' A' ' 468' ' ' GLY . 0.0 OUTLIER -57.01 -33.61 67.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.136 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -70.55 -53.45 16.05 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.17 -48.32 73.94 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.033 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 479' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 483' ' ' VAL . 1.1 mt -57.24 -48.52 78.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.652 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 61.3 m -57.87 -42.75 85.19 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.437 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -56.18 -50.9 69.89 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.887 0.375 . . . . 0.0 110.14 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.75 88.23 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.142 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 479' ' ' LEU . 54.4 t -61.62 -45.34 98.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.803 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 95.4 mtp -55.11 -54.64 40.6 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.756 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.446 ' O ' HD13 ' A' ' 485' ' ' LEU . 0.5 OUTLIER -57.47 -44.06 84.56 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 62.6 m -53.92 -49.77 67.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.071 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.758 HG13 HD21 ' A' ' 408' ' ' LEU . 88.5 t -62.44 -50.51 79.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.113 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -52.55 -42.76 58.28 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.9 -46.51 87.46 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.99 -53.34 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.232 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 7.2 tp -59.64 -39.85 80.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 120.571 0.224 . . . . 0.0 110.967 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -66.49 -47.58 68.8 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -56.14 -40.68 74.19 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.628 -0.286 . . . . 0.0 110.241 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 1.007 HD23 ' HA2' ' A' ' 401' ' ' GLY . 0.0 OUTLIER -69.59 -47.15 64.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.555 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.778 ' N ' HD13 ' A' ' 494' ' ' LEU . 91.3 m -49.97 -48.45 52.19 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.638 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -83.13 -45.28 14.14 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.681 0.277 . . . . 0.0 111.474 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 501' ' ' GLN . . . -47.84 -61.73 4.6 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.812 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 498' ' ' VAL . 50.8 t -74.34 60.08 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.551 0.691 . . . . 0.0 110.122 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -169.81 -52.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.654 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -170.89 67.16 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.88 0.372 . . . . 0.0 111.884 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.623 ' HB3' ' HA2' ' A' ' 497' ' ' GLY . 0.7 OUTLIER -144.58 124.14 13.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.198 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.966 179.854 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 396' ' ' MET . . . . . 0.712 ' O ' HG22 ' A' ' 397' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 111.17 0.063 . . . . 0.0 111.17 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 396' ' ' MET . 2.5 m 56.03 179.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 123.572 0.545 . . . . 0.0 112.237 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.8 -158.34 0.09 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.489 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 400' ' ' GLN . 0.2 OUTLIER -61.59 129.59 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.863 0.363 . . . . 0.0 110.924 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.647 ' N ' HD13 ' A' ' 399' ' ' ILE . 1.4 mm-40 57.78 64.23 1.6 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.195 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -128.64 -169.24 12.57 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.75 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 24.9 t -41.0 -56.42 2.28 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.626 0.25 . . . . 0.0 111.608 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.438 HG11 ' CE1' ' A' ' 442' ' ' PHE . 98.2 t -53.04 -43.17 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.84 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.5 -46.72 94.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.233 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ALA . . . . . 0.829 ' HB2' HD13 ' A' ' 494' ' ' LEU . . . -55.67 -49.42 72.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.84 0.352 . . . . 0.0 110.068 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.66 -53.27 59.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.679 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -52.19 -49.28 64.16 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.783 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.548 ' HA ' HG22 ' A' ' 411' ' ' VAL . 1.1 tp -60.27 -44.17 95.56 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -45.7 89.89 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.881 0.372 . . . . 0.0 110.262 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.27 -53.88 42.0 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.216 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 408' ' ' LEU . 35.4 m -58.86 -48.23 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.136 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.418 ' N ' HG23 ' A' ' 411' ' ' VAL . 56.9 mt -55.04 -46.84 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 82.5 m -57.12 -45.47 83.44 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.762 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.565 HD23 HD23 ' A' ' 431' ' ' LEU . 1.3 mp -59.9 -50.76 72.49 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.215 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.52 HG22 ' CE3' ' A' ' 419' ' ' TRP . 12.2 mm -55.76 -47.9 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.023 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.06 92.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.053 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 1.5 tpt -57.25 -46.98 82.52 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.055 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.472 ' HB2' HD21 ' A' ' 428' ' ' LEU . 3.3 mt-30 -65.53 -37.67 87.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.181 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' TRP . . . . . 0.52 ' CE3' HG22 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -60.61 -37.35 81.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.614 179.055 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.17 57.2 0.1 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.202 0.525 . . . . 0.0 110.886 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' MET . . . . . 0.588 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 4.3 mtp -136.49 -37.26 0.69 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.829 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 90.54 84.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.136 0.574 . . . . 0.0 111.161 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.3 -174.01 0.38 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.737 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.423 ' HB3' ' C ' ' A' ' 468' ' ' GLY . 14.5 p30 -75.77 -169.13 1.0 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.927 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.434 ' HB3' ' HD2' ' A' ' 466' ' ' PRO . . . -85.95 5.52 32.78 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 1.028 ' HA ' ' HB1' ' A' ' 465' ' ' ALA . . . -66.29 165.44 13.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.796 0.331 . . . . 0.0 111.203 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 70.31 -58.25 0.55 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.129 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 418' ' ' GLN . 0.4 OUTLIER -40.8 -36.36 0.62 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.914 ' HB ' ' HB2' ' A' ' 465' ' ' ALA . 14.7 p -45.28 -34.17 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 29.1 mtt -56.74 -58.97 5.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.834 0.35 . . . . 0.0 110.275 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.565 HD23 HD23 ' A' ' 414' ' ' LEU . 6.1 mp -67.85 -40.3 83.71 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.41 ' O ' HG23 ' A' ' 436' ' ' VAL . 1.5 t80 -54.49 -56.45 18.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.913 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.53 -45.67 84.78 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.22 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 438' ' ' VAL . 0.5 OUTLIER -52.93 -51.26 61.97 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 178.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -63.42 -44.05 97.34 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.846 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.525 HG11 ' CZ ' ' A' ' 459' ' ' PHE . 39.9 t -56.34 -53.73 36.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.48 0.181 . . . . 0.0 111.025 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.73 -43.38 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.602 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 434' ' ' LEU . 44.0 t -58.71 -52.45 59.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 435' ' ' GLY . 70.2 t -56.11 -53.64 36.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.405 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -53.75 -47.13 70.96 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.463 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 4.0 tt -52.02 -47.26 65.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.776 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' PHE . . . . . 0.438 ' CE1' HG11 ' A' ' 403' ' ' VAL . 20.2 m-85 -68.4 -33.3 74.0 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.717 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 445' ' ' ARG . 3.8 m-85 -70.38 -21.86 62.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.607 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -63.53 67.55 0.04 OUTLIER Glycine 0 C--N 1.341 0.826 0 C-N-CA 121.571 -0.347 . . . . 0.0 113.271 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.0 OUTLIER -140.71 -61.83 0.49 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.121 0.486 . . . . 0.0 110.076 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -154.05 88.38 3.51 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.999 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.24 176.17 2.18 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.941 2.427 . . . . 0.0 113.663 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.8 m -171.21 153.19 3.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.409 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 453' ' ' VAL . 58.0 t -39.9 -60.92 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.567 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.623 HG11 ' OD1' ' A' ' 493' ' ' ASN . 46.7 t -51.06 -56.29 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.644 ' HA ' HD12 ' A' ' 454' ' ' ILE . . . -53.55 -48.41 69.13 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.782 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 456' ' ' VAL . 88.7 m -57.97 -46.12 85.66 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.248 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 449' ' ' VAL . 88.9 t -60.97 -44.12 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.121 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 451' ' ' ALA . 30.6 mt -56.57 -50.96 71.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 120.889 0.376 . . . . 0.0 110.218 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.62 -50.29 73.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.71 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 452' ' ' THR . 90.3 t -56.43 -52.34 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.145 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 453' ' ' VAL . 55.2 t -53.68 -49.79 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.722 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -44.75 96.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.375 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 459' ' ' PHE . . . . . 0.525 ' CZ ' HG11 ' A' ' 436' ' ' VAL . 2.3 m-85 -58.58 -48.65 80.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.774 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.93 -44.91 96.56 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.943 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.445 HD11 HD22 ' A' ' 479' ' ' LEU . 30.0 tp -58.9 -48.23 82.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.989 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -87.14 92.94 9.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.019 0.438 . . . . 0.0 111.475 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 466' ' ' PRO . 28.8 t80 -68.12 61.8 0.08 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.044 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 11.1 mt 38.99 50.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.894 0.378 . . . . 0.0 111.999 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 1.028 ' HB1' ' HA ' ' A' ' 426' ' ' ALA . . . 66.52 65.68 0.76 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.111 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 425' ' ' ALA . 38.5 Cg_endo -65.75 147.23 85.44 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.48 2.12 . . . . 0.0 112.156 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 467' ' ' ARG . . . . . 0.471 ' HA ' ' HD3' ' A' ' 467' ' ' ARG . 6.9 mmt180 -79.15 147.93 32.5 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.066 0.46 . . . . 0.0 111.175 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 468' ' ' GLY . . . . . 0.423 ' C ' ' HB3' ' A' ' 424' ' ' ASP . . . 78.17 -65.61 3.29 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.589 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.2 m 47.71 24.49 0.56 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.97 -53.69 2.66 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.553 0.216 . . . . 0.0 111.125 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -72.8 64.35 0.66 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.109 0.48 . . . . 0.0 111.177 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' A' ' 475' ' ' VAL . 78.0 t -126.69 121.89 59.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.85 115.06 1.13 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.948 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.34 42.03 17.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.374 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' A' ' 472' ' ' VAL . 6.7 p -53.52 -42.86 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.25 -47.67 85.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.579 0.228 . . . . 0.0 111.269 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.29 -51.0 61.74 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.609 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.7 -53.44 56.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.861 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 479' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 475' ' ' VAL . 0.1 OUTLIER -57.9 -48.08 80.9 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.173 179.139 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 99.4 m -53.9 -52.54 60.2 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.397 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -59.3 -48.61 80.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.709 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.85 75.17 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.995 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 487' ' ' VAL . 93.6 t -65.52 -52.84 46.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.497 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 3.3 ttt -52.23 -51.73 56.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.866 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -49.43 77.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.333 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 486' ' ' THR . . . . . 0.478 HG23 HG23 ' A' ' 454' ' ' ILE . 88.6 m -54.57 -58.27 8.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.159 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 483' ' ' VAL . 36.0 m -59.81 -43.92 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.814 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 488' ' ' GLY . . . . . 0.493 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -55.24 -51.45 54.13 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 489' ' ' LEU . . . . . 0.586 HD22 HG13 ' A' ' 450' ' ' VAL . 5.6 mt -55.36 -46.57 76.46 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.522 HG21 ' CD2' ' A' ' 408' ' ' LEU . 59.0 t -57.07 -45.17 84.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.577 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.493 HD12 ' HA2' ' A' ' 488' ' ' GLY . 50.3 mt -58.46 -46.31 89.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.792 0.33 . . . . 0.0 110.615 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.76 -53.57 33.84 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.93 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 493' ' ' ASN . . . . . 0.623 ' OD1' HG11 ' A' ' 450' ' ' VAL . 2.1 m120 -56.76 -46.52 81.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.642 0.258 . . . . 0.0 110.78 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.829 HD13 ' HB2' ' A' ' 405' ' ' ALA . 0.6 OUTLIER -60.38 -46.3 90.47 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.165 178.768 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 89.9 m -54.86 -51.13 66.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.948 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.7 84.57 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.009 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -57.86 -44.0 94.52 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.439 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.56 -48.49 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 120.581 0.229 . . . . 0.0 110.498 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -79.4 54.1 1.65 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.136 0.493 . . . . 0.0 110.325 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -67.45 126.34 28.98 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.701 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -151.43 -64.74 0.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.057 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.379 179.898 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.394 0.14 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.32 138.78 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.089 0.471 . . . . 0.0 112.094 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' GLN . . . . . 0.758 ' HA ' HG21 ' A' ' 498' ' ' VAL . 1.0 OUTLIER -161.59 150.81 16.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.524 179.607 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.644 ' HB ' HD21 ' A' ' 494' ' ' LEU . 1.2 mp -90.51 -58.1 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.733 0.302 . . . . 0.0 110.455 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.511 ' HB2' HD23 ' A' ' 494' ' ' LEU . 0.7 OUTLIER -159.62 91.43 0.99 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.625 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -141.82 -98.13 0.31 Allowed Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.172 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 5.5 t -55.25 -55.03 36.04 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.667 0.27 . . . . 0.0 111.254 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 443' ' ' TYR . 17.6 m -50.46 -45.0 25.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.055 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.443 HG12 ' CD1' ' A' ' 491' ' ' ILE . 3.2 t -70.44 -37.42 70.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.379 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.31 96.67 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.31 -49.99 67.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.784 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.563 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -55.61 -50.79 69.21 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.327 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 408' ' ' LEU . 0.2 OUTLIER -58.96 -45.88 89.43 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.229 178.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 53.4 m -52.94 -42.22 65.25 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.145 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.41 -48.52 75.09 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.393 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 407' ' ' ALA . 17.4 t -57.89 -46.93 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.393 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 23.0 mm -59.71 -45.33 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 49.0 m -58.78 -48.19 82.11 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.028 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 432' ' ' TYR . 1.6 mp -56.18 -48.47 76.29 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.149 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.442 HG22 ' HD1' ' A' ' 419' ' ' TRP . 32.5 mm -61.53 -45.78 97.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.389 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -52.44 -51.58 58.47 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.033 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -47.36 85.94 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.624 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -50.63 -42.49 56.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.54 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' TRP . . . . . 0.442 ' HD1' HG22 ' A' ' 415' ' ' ILE . 44.7 m95 -67.78 -45.02 76.03 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.503 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.51 -40.47 93.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.424 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' MET . . . . . 0.427 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 29.2 mtt -146.17 134.19 21.47 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.137 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 72.04 74.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.205 0.526 . . . . 0.0 111.398 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -55.02 159.47 2.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.877 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.574 ' HA ' HG23 ' A' ' 472' ' ' VAL . 94.8 m-20 65.16 173.45 0.21 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.452 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -101.2 39.2 1.44 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.74 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -141.7 84.64 1.91 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.917 0.389 . . . . 0.0 111.568 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -174.73 -67.23 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.265 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.87 -38.98 1.1 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.55 HG13 HD23 ' A' ' 414' ' ' LEU . 54.8 t -41.52 -37.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -41.17 -54.3 2.93 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 7.1 tp -57.64 -52.55 64.97 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.005 0.431 . . . . 0.0 110.494 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.64 ' HB3' HD21 ' A' ' 414' ' ' LEU . 46.5 m-85 -58.36 -48.94 78.95 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.085 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.408 ' N ' HD21 ' A' ' 414' ' ' LEU . 0.2 OUTLIER -53.47 -47.76 69.46 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.915 178.748 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 437' ' ' VAL . 2.8 tp -53.66 -49.68 67.42 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.888 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.49 -44.47 97.96 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.79 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 432' ' ' TYR . 63.8 t -58.16 -52.56 57.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 122.058 0.143 . . . . 0.0 111.011 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 434' ' ' LEU . 33.3 m -56.57 -40.92 71.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.7 -46.78 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 435' ' ' GLY . 99.1 t -55.33 -49.62 71.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.12 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.01 75.42 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.542 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -37.9 73.2 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.734 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -70.63 -45.19 65.65 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.508 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.466 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 2.9 m-85 -68.63 -49.1 61.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.508 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' A' ' 445' ' ' ARG . . . -67.43 161.33 48.45 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.787 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 444' ' ' GLY . 0.0 OUTLIER -155.86 -61.01 0.11 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 122.631 -0.335 . . . . 0.0 111.501 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -81.02 108.23 9.71 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.689 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.844 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 29.7 Cg_endo -64.02 -50.21 3.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.352 2.034 . . . . 0.0 112.528 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 58.2 m 43.31 43.67 4.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.859 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 26.9 t 68.42 -57.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.463 HG12 ' CD1' ' A' ' 454' ' ' ILE . 13.1 t -47.5 -55.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.844 ' HB3' ' HA ' ' A' ' 447' ' ' PRO . . . -57.57 -48.24 79.9 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.635 0.255 . . . . 0.0 110.976 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 456' ' ' VAL . 12.6 m -56.21 -53.59 55.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.665 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 457' ' ' VAL . 42.8 t -56.24 -54.51 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.664 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.463 ' CD1' HG12 ' A' ' 450' ' ' VAL . 52.3 mt -52.63 -52.2 28.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.578 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -55.72 -53.41 56.98 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.396 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 452' ' ' THR . 44.8 t -51.88 -52.34 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.516 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 453' ' ' VAL . 86.2 t -49.73 -52.75 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.672 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 1.2 p -60.75 -41.25 95.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.762 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -61.12 -41.23 96.32 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.807 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -73.03 -42.16 63.46 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.478 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.599 HD11 HD22 ' A' ' 479' ' ' LEU . 3.6 tt -59.18 -46.56 88.09 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.769 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -101.17 -167.23 1.4 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.114 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -169.25 41.12 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 3.8 mt 48.75 70.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.571 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -44.1 100.87 0.24 Allowed Pre-proline 0 N--CA 1.47 0.528 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.7 -55.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.097 2.531 . . . . 0.0 112.687 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -132.76 -58.65 0.92 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.732 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . -132.41 124.26 3.83 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 18.3 m -98.81 -75.9 0.55 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.801 0.3 . . . . 0.0 111.362 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.48 159.65 0.43 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.647 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -70.86 121.61 18.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.174 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 424' ' ' ASP . 14.9 t -53.21 -57.8 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 33.5 t 54.53 -150.39 0.4 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.057 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -83.38 -42.83 16.59 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 33.3 t -56.0 -59.77 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -40.79 95.9 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.16 -51.35 54.85 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.531 0.205 . . . . 0.0 110.849 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -51.86 67.28 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.829 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 479' ' ' LEU . . . . . 0.599 HD22 HD11 ' A' ' 461' ' ' LEU . 0.8 OUTLIER -56.18 -53.67 54.32 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.642 0.258 . . . . 0.0 110.378 179.222 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 480' ' ' THR . . . . . 0.458 HG22 ' SD ' ' A' ' 484' ' ' MET . 42.8 m -54.29 -48.65 71.03 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.776 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 481' ' ' PHE . . . . . 0.593 ' CE1' HD13 ' A' ' 485' ' ' LEU . 9.5 t80 -61.3 -47.38 86.21 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 110.979 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.57 73.55 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.267 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.637 ' O ' HG23 ' A' ' 487' ' ' VAL . 31.3 m -64.13 -42.25 94.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 484' ' ' MET . . . . . 0.458 ' SD ' HG22 ' A' ' 480' ' ' THR . 22.3 mtt -57.74 -52.82 63.89 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.336 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.593 HD13 ' CE1' ' A' ' 481' ' ' PHE . 0.4 OUTLIER -58.33 -47.02 85.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.21 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 28.0 m -56.09 -50.21 71.67 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.197 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.831 HG12 HD11 ' A' ' 491' ' ' ILE . 84.7 t -59.64 -52.77 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.005 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 488' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -52.91 -44.47 61.6 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.692 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 7.1 tt -55.43 -56.49 19.55 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 487' ' ' VAL . 30.0 m -61.07 -37.39 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.561 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.831 HD11 HG12 ' A' ' 487' ' ' VAL . 62.8 mt -59.61 -44.96 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.25 -51.4 50.01 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.34 -46.34 72.9 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 110.1 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.644 HD21 ' HB ' ' A' ' 399' ' ' ILE . 16.2 tp -64.81 -44.9 88.39 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.901 178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 98.0 m -52.1 -51.29 58.69 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -58.68 -48.2 81.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.236 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -60.5 -50.84 63.23 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.056 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.758 HG21 ' HA ' ' A' ' 398' ' ' GLN . 7.0 p -73.1 -40.43 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 49.63 1.77 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.083 0.468 . . . . 0.0 111.205 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -131.79 -49.78 0.96 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.62 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -105.42 -171.75 1.97 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.53 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.423 179.95 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 120.398 0.142 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.642 HG11 HG23 ' A' ' 498' ' ' VAL . 90.2 t -150.44 109.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.732 0.301 . . . . 0.0 111.13 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -99.22 52.03 0.95 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.971 0.415 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.4 tp -167.09 144.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.202 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.723 ' NE2' HG11 ' A' ' 450' ' ' VAL . 3.5 mm-40 52.2 50.67 17.93 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.942 0.401 . . . . 0.0 111.331 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -159.28 -98.96 0.15 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.031 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.8 m -45.72 -54.17 8.28 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 404' ' ' VAL . 14.8 p -57.02 -44.62 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.992 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.582 HG11 ' CD2' ' A' ' 494' ' ' LEU . 71.8 t -59.4 -51.8 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.478 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.21 -55.84 29.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.896 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -55.14 -47.67 74.75 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.896 0.379 . . . . 0.0 110.534 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.459 ' HB2' ' CG2' ' A' ' 439' ' ' VAL . . . -56.41 -60.24 3.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.377 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -51.65 67.04 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.292 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 3.2 m -55.59 -53.4 56.89 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.567 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.97 -49.13 77.32 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.598 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.583 HG13 HD13 ' A' ' 415' ' ' ILE . 35.2 t -60.6 -57.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.605 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.2 tp -55.0 -42.55 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 46.4 m -61.47 -56.59 18.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.047 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.41 -50.04 75.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.812 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.583 HD13 HG13 ' A' ' 411' ' ' VAL . 1.1 mp -55.69 -53.04 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 420' ' ' LEU . . . -57.66 -53.99 51.95 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.109 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 26.5 mtp -56.88 -54.95 40.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -51.92 61.13 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' TRP . . . . . 0.542 ' CD2' HG23 ' A' ' 415' ' ' ILE . 43.7 m0 -57.65 -33.0 67.84 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.148 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 3.7 tp -57.26 -29.51 63.88 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 110.904 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 2.8 ttp -97.39 -45.66 6.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.054 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 419' ' ' TRP . . . -131.18 116.74 18.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.643 0.259 . . . . 0.0 111.267 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -86.24 44.87 1.17 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -126.34 152.75 45.81 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.286 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.563 ' HB3' ' H ' ' A' ' 465' ' ' ALA . . . -131.44 28.11 4.68 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.805 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' ALA . . . . . 0.653 ' HA ' HG23 ' A' ' 464' ' ' ILE . . . -86.6 -52.32 5.62 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.797 0.332 . . . . 0.0 110.641 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -74.27 -35.34 63.75 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.665 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.11 101.93 3.43 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.533 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 430' ' ' MET . 5.3 p -131.32 -52.9 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.446 ' N ' HG13 ' A' ' 429' ' ' VAL . 1.4 mmt -51.2 -47.19 62.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.611 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 1.5 mt -58.5 -58.75 7.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.339 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.56 ' HE1' HD11 ' A' ' 415' ' ' ILE . 33.7 m-85 -51.72 -51.51 55.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.796 0.331 . . . . 0.0 110.456 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.05 -58.17 9.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.624 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 1.7 mp -49.11 -51.39 32.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.371 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.47 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -63.43 -59.7 8.48 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.894 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 38.3 t -52.35 -50.71 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.25 -56.87 14.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 24.2 t -53.58 -50.91 47.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.566 0.222 . . . . 0.0 110.903 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 435' ' ' GLY . 75.0 t -56.38 -55.01 21.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.883 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -53.93 -50.1 67.19 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.086 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -54.26 48.66 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.221 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -32.1 67.51 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.776 0.322 . . . . 0.0 111.06 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.51 ' CE1' ' HG2' ' A' ' 400' ' ' GLN . 14.1 t80 -84.43 -1.38 55.53 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.447 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.18 -169.17 7.53 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.322 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 63.81 44.68 4.79 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.836 0.351 . . . . 0.0 111.35 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -164.7 133.9 2.82 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.629 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -87.04 122.41 1.85 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.844 2.363 . . . . 0.0 112.62 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 28.5 t -176.2 171.4 2.5 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.137 0.494 . . . . 0.0 111.873 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 26.3 t -89.14 -21.28 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.563 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.723 HG11 ' NE2' ' A' ' 400' ' ' GLN . 93.3 t -62.94 -58.02 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.838 -0.165 . . . . 0.0 111.376 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -53.05 -44.04 67.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.629 0.252 . . . . 0.0 111.192 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -61.23 2.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.744 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 41.9 t -53.73 -45.54 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.71 0.29 . . . . 0.0 110.788 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 16.2 mm -58.91 -55.2 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.23 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.35 -49.29 74.83 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 77.1 t -58.95 -57.29 11.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 120.609 0.242 . . . . 0.0 110.843 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 17.5 t -55.4 -49.77 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.02 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 59.5 p -58.33 -47.9 82.25 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.589 0.233 . . . . 0.0 110.949 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -60.8 -58.82 6.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.41 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.17 -45.01 92.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.619 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -63.57 -33.64 76.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.279 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 462' ' ' PHE . . . . . 0.413 ' CZ ' HG23 ' A' ' 429' ' ' VAL . 2.4 t80 -70.46 59.96 0.2 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.032 0.444 . . . . 0.0 111.098 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.5 32.4 4.84 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.503 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.653 HG23 ' HA ' ' A' ' 426' ' ' ALA . 55.4 mt 69.28 104.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.987 0.422 . . . . 0.0 111.929 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.563 ' H ' ' HB3' ' A' ' 425' ' ' ALA . . . -64.61 144.43 98.72 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.9 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.81 171.45 10.99 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.594 2.196 . . . . 0.0 113.128 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -64.71 78.47 0.04 OUTLIER 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.893 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 142.89 62.26 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.709 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 5.0 t -107.52 40.76 1.63 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.987 0.422 . . . . 0.0 111.438 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 16.9 tp -153.31 80.49 1.18 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.58 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . 51.01 44.8 28.44 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.054 0.454 . . . . 0.0 111.872 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' VAL . . . . . 0.512 HG12 ' HB2' ' A' ' 476' ' ' GLN . 8.0 p -78.07 -35.23 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.167 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 37.4 t -177.71 -163.22 0.07 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.5 0.191 . . . . 0.0 111.063 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -43.1 -57.2 3.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.875 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 476' ' ' GLN . 7.3 p -47.87 -50.98 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.512 ' HB2' HG12 ' A' ' 472' ' ' VAL . 0.8 OUTLIER -69.0 -37.36 78.66 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.834 -0.166 . . . . 0.0 111.357 179.675 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.47 -47.85 84.34 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.96 -47.33 71.95 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.116 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' LEU . . . . . 0.408 HD13 HG22 ' A' ' 475' ' ' VAL . 0.1 OUTLIER -54.8 -47.15 74.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.622 178.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 12.1 m -64.18 -51.75 62.26 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -56.74 -44.16 81.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.582 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.76 -53.22 60.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.369 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 487' ' ' VAL . 35.0 m -63.19 -43.0 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.061 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 6.8 mtt -60.7 -56.1 25.26 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.676 0.274 . . . . 0.0 110.766 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 9.7 tp -55.43 -44.67 76.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.397 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 490' ' ' VAL . 35.7 m -60.01 -52.81 63.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.4 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 483' ' ' VAL . 69.8 t -56.27 -48.76 79.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.716 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -60.7 -51.67 57.21 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.381 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.95 80.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.742 0.306 . . . . 0.0 110.859 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 486' ' ' THR . 96.1 t -64.4 -54.75 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.573 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.546 HD12 HD21 ' A' ' 494' ' ' LEU . 4.7 tp -55.68 -41.38 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 120.474 0.178 . . . . 0.0 111.208 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.69 -54.78 29.0 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.476 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -63.2 -43.42 98.23 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 400' ' ' GLN . 0.5 OUTLIER -61.81 -46.03 91.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 121.413 -0.115 . . . . 0.0 111.298 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 1.2 m -65.58 -40.79 93.15 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.521 0.201 . . . . 0.0 110.719 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -70.22 -37.33 74.99 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.697 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -79.43 -42.86 11.06 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.589 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.642 HG23 HG11 ' A' ' 397' ' ' VAL . 9.9 p -53.25 -31.84 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 117.033 0.417 . . . . 0.0 111.829 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 499' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 502' ' ' ALA . 15.4 ttm105 -104.16 123.97 48.26 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.874 0.368 . . . . 0.0 110.559 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 500' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 501' ' ' GLN . 0.2 OUTLIER -52.47 104.77 0.1 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.492 -179.363 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.532 ' O ' ' HB3' ' A' ' 502' ' ' ALA . 2.8 mp0 68.74 38.13 2.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.335 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 501' ' ' GLN . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 117.833 -1.079 . . . . 0.0 112.15 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 111.367 0.136 . . . . 0.0 111.367 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' VAL . . . . . 0.527 HG12 HG21 ' A' ' 403' ' ' VAL . 6.1 m -79.22 65.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.198 0.523 . . . . 0.0 110.959 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.47 166.91 14.02 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.553 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.514 ' CG1' ' HB2' ' A' ' 446' ' ' TRP . 2.9 mp -53.88 100.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.878 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.747 ' HA ' HG21 ' A' ' 404' ' ' VAL . 2.8 mm100 70.53 87.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.404 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -151.94 -150.16 5.28 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.824 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 29.0 t -53.01 -49.63 65.83 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.482 0.182 . . . . 0.0 111.304 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.527 HG21 HG12 ' A' ' 397' ' ' VAL . 39.7 t -54.74 -49.45 68.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 110.19 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' A' ' 400' ' ' GLN . 54.2 t -58.85 -46.73 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.281 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.65 77.7 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.884 0.374 . . . . 0.0 110.173 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.96 67.8 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.505 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.632 ' HB1' HG13 ' A' ' 439' ' ' VAL . . . -55.75 -48.73 74.75 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.254 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.568 HD23 HD11 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -56.22 -47.84 77.63 Favored 'General case' 0 C--O 1.23 0.056 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.722 178.556 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.6 t -52.78 -43.0 65.54 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.155 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.4 71.8 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.836 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.669 ' CG2' HG21 ' A' ' 439' ' ' VAL . 97.3 t -58.75 -50.59 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.914 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.568 HD11 HD23 ' A' ' 408' ' ' LEU . 27.2 mt -57.03 -45.61 83.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.231 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 41.3 m -60.38 -49.11 78.87 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.127 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.8 mt -58.14 -53.09 62.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.295 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -45.97 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.893 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -54.73 -54.07 46.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.665 0.269 . . . . 0.0 110.387 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 2.2 ttm -61.89 -42.91 99.64 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.524 ' HG2' ' HG ' ' A' ' 428' ' ' LEU . 0.5 OUTLIER -60.1 -28.47 67.86 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.544 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -40.41 12.25 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.566 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 421' ' ' MET . 1.6 tt -73.78 87.09 1.72 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.96 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' MET . . . . . 0.416 ' CB ' ' O ' ' A' ' 420' ' ' LEU . 1.5 ttt 83.11 158.97 0.12 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.701 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 54.04 59.86 3.98 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 110.587 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' PHE . . . . . 0.402 ' O ' ' HB3' ' A' ' 424' ' ' ASP . 0.8 OUTLIER -63.31 173.23 1.6 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.501 -178.792 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.849 ' HA ' HG21 ' A' ' 469' ' ' THR . 49.9 t0 85.27 126.48 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.523 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.638 ' HB3' ' CA ' ' A' ' 466' ' ' PRO . . . -88.51 -14.55 37.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.584 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -38.58 -56.13 1.34 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.71 0.29 . . . . 0.0 111.647 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -92.75 -39.38 11.28 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.802 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.524 ' HG ' ' HG2' ' A' ' 418' ' ' GLN . 4.5 mm? -60.12 -36.36 77.29 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.507 HG22 HD23 ' A' ' 433' ' ' LEU . 9.1 p -47.33 -35.67 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.64 -52.32 40.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.137 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.78 -45.82 77.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.834 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.609 ' O ' HG23 ' A' ' 436' ' ' VAL . 0.6 OUTLIER -55.2 -50.17 70.05 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.193 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.77 HD21 ' HB2' ' A' ' 462' ' ' PHE . 0.6 OUTLIER -60.95 -49.71 76.34 Favored 'General case' 0 N--CA 1.46 0.032 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.008 178.771 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 1.7 tt -51.99 -46.23 64.8 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.77 68.71 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.728 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.842 HG11 ' HB3' ' A' ' 458' ' ' SER . 91.3 t -56.67 -39.81 65.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.776 0.322 . . . . 0.0 110.5 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 433' ' ' LEU . 53.6 t -61.05 -57.02 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.675 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 30.2 m -59.23 -39.4 78.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 120.748 0.309 . . . . 0.0 110.397 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.669 HG21 ' CG2' ' A' ' 411' ' ' VAL . 4.0 t -59.43 -58.75 5.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.138 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.37 -42.78 78.39 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.612 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.7 tp -51.35 -52.68 43.48 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.556 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -71.61 -36.74 70.9 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.964 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.515 ' CE2' HG22 ' A' ' 404' ' ' VAL . 1.6 t80 -63.09 -38.13 89.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 445' ' ' ARG . . . -47.92 104.77 0.09 OUTLIER Glycine 0 C--N 1.339 0.728 0 CA-C-N 116.366 -0.379 . . . . 0.0 113.477 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 444' ' ' GLY . 0.1 OUTLIER -144.72 -66.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.621 0.248 . . . . 0.0 110.908 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 446' ' ' TRP . . . . . 0.514 ' HB2' ' CG1' ' A' ' 399' ' ' ILE . 0.6 OUTLIER -127.26 125.12 23.95 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.633 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.27 87.78 1.03 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.488 2.125 . . . . 0.0 112.554 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 449' ' ' VAL . 91.0 p -108.24 -93.47 0.41 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.356 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.408 ' N ' ' OG ' ' A' ' 448' ' ' SER . 3.4 p -146.16 -49.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 451' ' ' ALA . 1.5 m -46.18 -54.16 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.599 0.238 . . . . 0.0 111.337 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.419 ' H ' HG23 ' A' ' 450' ' ' VAL . . . -57.28 -41.44 79.73 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.887 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.06 -52.97 61.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.393 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 69.8 t -54.29 -50.1 58.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.68 -47.23 86.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.082 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -55.87 -49.7 72.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.433 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.97 -56.73 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.332 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.31 -41.7 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.891 0.377 . . . . 0.0 110.763 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' SER . . . . . 0.842 ' HB3' HG11 ' A' ' 436' ' ' VAL . 19.3 m -65.58 -48.91 70.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.651 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.66 -48.67 80.28 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.132 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' ASP . . . . . 0.839 ' HB3' HD12 ' A' ' 464' ' ' ILE . 2.6 m-20 -60.41 -54.97 39.22 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.015 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.681 ' HG ' ' HB2' ' A' ' 465' ' ' ALA . 0.5 OUTLIER -53.8 -45.58 70.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.542 179.438 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 462' ' ' PHE . . . . . 0.77 ' HB2' HD21 ' A' ' 433' ' ' LEU . 0.1 OUTLIER -38.84 -40.54 0.64 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.44 0.296 . . . . 0.0 111.307 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -105.03 -44.17 4.86 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.839 HD12 ' HB3' ' A' ' 460' ' ' ASP . 81.4 mt -59.25 -32.52 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.681 ' HB2' ' HG ' ' A' ' 461' ' ' LEU . . . -67.98 -62.15 3.53 Favored Pre-proline 0 CA--C 1.535 0.372 0 O-C-N 122.272 -0.268 . . . . 0.0 111.195 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.638 ' CA ' ' HB3' ' A' ' 425' ' ' ALA . 37.5 Cg_endo -64.88 -39.8 23.87 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.468 2.112 . . . . 0.0 112.307 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -85.95 62.61 7.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.104 0.478 . . . . 0.0 111.201 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 138.26 42.95 0.09 OUTLIER Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.336 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' THR . . . . . 0.849 HG21 ' HA ' ' A' ' 424' ' ' ASP . 2.0 t -79.94 -31.17 40.02 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.32 72.6 0.67 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 110.819 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 476' ' ' GLN . . . -84.57 126.67 33.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.948 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 472' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 472' ' ' VAL . 13.2 p -75.38 56.12 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.438 0.637 . . . . 0.0 111.731 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 30.9 m 53.16 35.75 20.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -138.05 -79.46 0.36 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.881 -0.145 . . . . 0.0 111.235 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.435 HG23 ' CB ' ' A' ' 471' ' ' ALA . 15.3 m -47.99 -45.16 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 471' ' ' ALA . 0.0 OUTLIER -62.63 -32.87 73.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.537 0.208 . . . . 0.0 110.716 179.257 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -47.51 55.78 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 4.6 tt -59.15 -48.97 79.64 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.977 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' LEU . . . . . 0.461 HD13 HG23 ' A' ' 483' ' ' VAL . 0.6 OUTLIER -59.03 -49.39 78.06 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.844 178.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 87.7 m -55.98 -44.0 78.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.914 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -56.42 -49.12 75.45 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.75 -43.56 94.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.475 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.461 HG23 HD13 ' A' ' 479' ' ' LEU . 69.5 t -60.48 -50.1 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.376 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 34.9 mtp -59.3 -52.37 65.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.359 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -47.42 73.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.936 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 34.7 m -58.83 -50.8 72.62 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.049 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.06 -52.65 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.784 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.83 87.56 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.054 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.26 -51.24 70.8 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.375 0.131 . . . . 0.0 110.92 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.461 HG21 HD11 ' A' ' 408' ' ' LEU . 25.8 m -63.21 -39.37 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.011 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 494' ' ' LEU . 26.1 mt -56.5 -50.77 71.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 120.966 0.412 . . . . 0.0 110.194 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -66.98 -45.45 82.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.363 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.3 -52.31 61.89 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.155 0.182 . . . . 0.0 111.082 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.645 ' HA ' ' HB3' ' A' ' 400' ' ' GLN . 4.5 pp -64.15 -39.79 94.77 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.526 ' N ' HD12 ' A' ' 494' ' ' LEU . 91.6 m -57.81 -43.99 86.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.164 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -73.74 -56.66 4.72 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.037 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -50.48 -42.65 43.73 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.338 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 4.9 p -69.38 -10.49 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.38 104.18 14.65 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.563 0.221 . . . . 0.0 110.777 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.1 t80 79.63 166.59 0.19 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.45 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.39 -52.11 4.29 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.008 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.14 -0.933 . . . . 0.0 111.08 179.992 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 2.4 tpt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.511 0.195 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.41 142.68 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -140.16 142.54 35.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.367 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.5 tp -150.73 139.57 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.16 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.539 ' HA ' HG21 ' A' ' 404' ' ' VAL . 43.5 tt0 -59.82 136.45 58.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.066 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.409 ' H ' ' HB ' ' A' ' 404' ' ' VAL . . . 132.44 -101.88 0.47 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.878 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 12.7 t -58.74 -72.19 0.1 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' VAL . . . . . 0.51 ' HB ' ' CD2' ' A' ' 441' ' ' LEU . 34.1 m -48.03 -43.75 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 120.554 0.216 . . . . 0.0 111.525 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.539 HG21 ' HA ' ' A' ' 400' ' ' GLN . 76.9 t -60.76 -54.57 33.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.812 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.14 83.68 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.21 65.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.509 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.937 ' HB1' HG22 ' A' ' 438' ' ' VAL . . . -55.76 -55.69 29.36 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.604 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 487' ' ' VAL . 2.0 tt -57.62 -44.23 85.38 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.458 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 412' ' ' ILE . 35.8 t -52.61 -44.61 66.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.641 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.33 -46.77 82.05 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.276 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.837 ' CG2' HG21 ' A' ' 438' ' ' VAL . 75.5 t -59.13 -52.25 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.523 ' HA ' HG22 ' A' ' 415' ' ' ILE . 0.4 OUTLIER -59.25 -41.73 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.384 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 59.8 m -63.28 -45.48 91.25 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.523 HD22 HD22 ' A' ' 434' ' ' LEU . 0.9 OUTLIER -59.5 -57.04 14.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.235 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 412' ' ' ILE . 18.4 tt -56.99 -39.82 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.263 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.31 75.08 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 32.3 mtt -60.09 -45.28 93.46 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.763 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.421 ' OE1' ' HA ' ' A' ' 415' ' ' ILE . 98.9 mt-30 -54.74 -57.18 12.54 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' TRP . . . . . 0.456 ' HB2' ' CD2' ' A' ' 423' ' ' PHE . 0.1 OUTLIER -48.29 -45.45 34.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.226 178.635 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.28 -32.19 47.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' MET . . . . . 0.584 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 0.8 OUTLIER -120.7 42.72 2.94 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.929 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 99.64 110.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.657 0.783 . . . . 0.0 111.706 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' A' ' 419' ' ' TRP . 5.5 t80 -70.64 98.41 1.49 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.417 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -159.96 158.08 30.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.208 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.605 ' HA ' HD13 ' A' ' 431' ' ' LEU . . . -72.86 65.29 0.72 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.081 0.467 . . . . 0.0 111.174 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -54.1 127.99 28.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.592 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 57.36 75.3 0.38 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.515 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.791 ' HG ' HG23 ' A' ' 464' ' ' ILE . 0.9 OUTLIER -45.57 -49.12 14.26 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.438 -179.547 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.36 -51.35 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.694 0.283 . . . . 0.0 110.35 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 7.1 ttt -65.4 -49.14 70.35 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.41 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.605 HD13 ' HA ' ' A' ' 425' ' ' ALA . 0.6 OUTLIER -58.31 -46.68 85.7 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.594 ' CE2' HG11 ' A' ' 436' ' ' VAL . 2.1 t80 -60.66 -51.13 70.68 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 9.2 tt -54.74 -51.13 66.62 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.307 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' LEU . . . . . 0.523 HD22 HD22 ' A' ' 414' ' ' LEU . 2.1 tp -58.36 -47.5 83.59 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.637 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.5 -58.65 12.23 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.859 -0.61 . . . . 0.0 113.072 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' VAL . . . . . 0.594 HG11 ' CE2' ' A' ' 432' ' ' TYR . 35.4 m -53.92 -42.93 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.811 0.305 . . . . 0.0 111.684 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.576 ' O ' HD12 ' A' ' 441' ' ' LEU . 28.9 t -61.44 -57.54 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.536 0.207 . . . . 0.0 110.676 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' VAL . . . . . 0.937 HG22 ' HB1' ' A' ' 407' ' ' ALA . 99.4 t -56.62 -49.64 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.999 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.744 HG11 ' HB2' ' A' ' 458' ' ' SER . 73.1 t -57.25 -48.34 82.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.107 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -55.08 -48.21 73.85 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.576 HD12 ' O ' ' A' ' 437' ' ' VAL . 0.2 OUTLIER -58.04 -42.83 86.2 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.176 177.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 442' ' ' PHE . . . . . 0.67 ' CD1' HD13 ' A' ' 454' ' ' ILE . 0.2 OUTLIER -63.84 -41.5 97.81 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.211 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 445' ' ' ARG . 22.4 t80 -77.35 -37.9 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.191 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -63.92 67.87 0.05 OUTLIER Glycine 0 C--N 1.338 0.666 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.34 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 400' ' ' GLN . 0.0 OUTLIER -140.43 -55.22 0.52 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.594 0.235 . . . . 0.0 110.962 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 446' ' ' TRP . . . . . 0.501 ' CD2' ' HD2' ' A' ' 447' ' ' PRO . 0.0 OUTLIER 175.34 139.14 0.19 Allowed Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.156 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.501 ' HD2' ' CD2' ' A' ' 446' ' ' TRP . 36.5 Cg_endo -64.12 67.88 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.592 2.195 . . . . 0.0 112.343 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.491 ' OG ' ' NH2' ' A' ' 445' ' ' ARG . 0.8 OUTLIER -104.39 42.28 1.22 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.518 -179.311 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 453' ' ' VAL . 50.6 t 67.27 -64.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.928 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.7 m -50.81 -47.9 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 454' ' ' ILE . . . -54.22 -53.3 55.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 110.393 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 452' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.6 OUTLIER -56.03 -48.74 75.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.611 178.488 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 449' ' ' VAL . 84.6 t -53.71 -46.42 62.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.464 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.67 HD13 ' CD1' ' A' ' 442' ' ' PHE . 34.5 mt -55.75 -45.27 79.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -61.72 -45.66 93.01 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 452' ' ' THR . 58.0 t -53.36 -50.93 45.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.02 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 74.6 t -53.08 -50.31 46.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' SER . . . . . 0.744 ' HB2' HG11 ' A' ' 439' ' ' VAL . 1.4 t -55.06 -43.11 73.54 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.737 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.49 -45.91 92.23 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.23 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.67 -37.72 68.68 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.285 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.418 HD13 ' HD2' ' A' ' 466' ' ' PRO . 0.1 OUTLIER -83.25 -22.45 33.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.366 179.281 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -66.58 70.71 0.07 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 111.838 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -162.5 42.98 0.13 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.955 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.791 HG23 ' HG ' ' A' ' 428' ' ' LEU . 34.0 mt 45.23 64.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.429 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . 54.41 63.67 7.09 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 120.995 0.426 . . . . 0.0 110.706 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' PRO . . . . . 0.418 ' HD2' HD13 ' A' ' 461' ' ' LEU . 10.8 Cg_endo -53.6 -52.84 7.63 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.893 2.395 . . . . 0.0 113.381 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 467' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 467' ' ' ARG . 0.0 OUTLIER -167.79 72.13 0.11 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.94 0.4 . . . . 0.0 111.599 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . -178.38 44.34 0.09 OUTLIER Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.04 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.3 p -143.88 99.24 3.37 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 117.105 0.453 . . . . 0.0 110.948 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.05 147.17 17.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.079 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ALA . . . . . 0.444 ' HA ' ' HB3' ' A' ' 423' ' ' PHE . . . -64.17 -46.51 83.72 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.449 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 3.0 m -115.49 94.7 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 111.15 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 46.5 t -149.93 99.19 2.81 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.691 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' ASP . . . . . 0.451 ' O ' HD12 ' A' ' 478' ' ' LEU . 3.9 m-20 -55.05 -47.67 74.49 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.571 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 476' ' ' GLN . 11.6 p -51.89 -44.05 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.087 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.403 ' N ' HG13 ' A' ' 475' ' ' VAL . 0.6 OUTLIER -66.5 -44.35 82.84 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.559 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -56.17 -58.14 9.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.086 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 474' ' ' ASP . 1.5 mp -59.66 -51.45 69.74 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 479' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 483' ' ' VAL . 7.4 tt -55.47 -58.22 8.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.732 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 480' ' ' THR . . . . . 0.402 ' N ' HD23 ' A' ' 479' ' ' LEU . 3.1 m -54.45 -41.83 69.89 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.574 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -56.45 -47.87 78.23 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.86 94.24 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.275 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 479' ' ' LEU . 39.2 t -63.14 -47.04 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.021 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -59.81 -51.54 69.31 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 tt -54.77 -45.06 74.17 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 490' ' ' VAL . 70.6 m -58.99 -49.25 78.6 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.993 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 487' ' ' VAL . . . . . 0.477 HG21 HD11 ' A' ' 408' ' ' LEU . 18.2 t -52.21 -51.5 30.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.119 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 488' ' ' GLY . . . . . 0.481 ' O ' HG13 ' A' ' 491' ' ' ILE . . . -55.75 -45.59 85.12 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.858 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.03 -46.07 92.2 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 110.353 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 486' ' ' THR . 94.9 t -61.55 -56.52 17.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.007 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 488' ' ' GLY . 2.5 pp -58.83 -37.02 64.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.692 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.43 -59.22 8.03 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -53.8 -46.41 71.06 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.68 ' C ' HD13 ' A' ' 494' ' ' LEU . 1.3 tm? -55.33 -46.66 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.703 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 99.2 m -54.33 -50.01 68.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.228 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.42 77.65 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.358 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 501' ' ' GLN . . . -54.52 -50.6 56.43 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.218 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.542 HG23 HD22 ' A' ' 494' ' ' LEU . 66.9 t -64.89 -35.34 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.76 0.314 . . . . 0.0 110.664 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 499' ' ' ARG . . . . . 0.489 ' HD2' ' HB2' ' A' ' 500' ' ' TYR . 7.0 tmm_? -62.06 -51.39 68.18 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.132 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 500' ' ' TYR . . . . . 0.489 ' HB2' ' HD2' ' A' ' 499' ' ' ARG . 11.3 t80 -174.98 70.15 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.721 0.296 . . . . 0.0 111.678 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.458 ' O ' ' HA2' ' A' ' 497' ' ' GLY . 58.4 mt-30 68.54 -56.36 0.51 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.829 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.681 -0.675 . . . . 0.0 111.341 179.93 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.572 0.225 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.91 131.78 67.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.833 0.349 . . . . 0.0 111.374 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -171.89 1.92 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.468 HG22 HG22 ' A' ' 498' ' ' VAL . 1.0 OUTLIER -76.61 -167.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 400' ' ' GLN . . . . . 0.966 ' HG2' HG21 ' A' ' 404' ' ' VAL . 3.6 tt0 -60.29 93.89 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.958 -0.464 . . . . 0.0 111.228 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.861 ' HA3' HG21 ' A' ' 498' ' ' VAL . . . -156.82 -120.84 0.66 Allowed Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.269 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 67.0 m -50.74 -46.2 59.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.764 0.282 . . . . 0.0 111.256 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 15.9 m -55.88 -41.42 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.945 0.402 . . . . 0.0 110.963 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' VAL . . . . . 0.966 HG21 ' HG2' ' A' ' 400' ' ' GLN . 58.9 t -73.44 -43.62 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.796 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.14 -47.53 80.92 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.78 -48.33 81.12 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.163 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' ALA . . . . . 0.768 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -54.83 -50.71 67.93 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.465 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -49.84 76.07 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.23 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 412' ' ' ILE . 0.3 OUTLIER -56.73 -40.09 75.09 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.147 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -66.71 -54.77 19.47 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.612 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 407' ' ' ALA . 55.9 t -55.69 -48.38 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.057 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 409' ' ' SER . 0.3 OUTLIER -60.46 -42.32 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.422 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 91.2 m -61.48 -45.52 93.9 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.751 ' HB3' HD11 ' A' ' 431' ' ' LEU . 20.6 mt -60.21 -57.2 13.81 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.546 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.643 HG13 HD21 ' A' ' 428' ' ' LEU . 16.2 tt -57.76 -39.93 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.953 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -62.81 -51.56 66.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.812 0.339 . . . . 0.0 110.305 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 20.9 mtp -58.46 -47.34 84.34 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.545 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -46.1 89.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.834 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' TRP . . . . . 0.478 ' HA ' ' O ' ' A' ' 422' ' ' ALA . 1.2 m0 -57.35 -38.89 74.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.52 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.42 -28.1 58.44 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.983 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -44.63 6.44 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.776 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 419' ' ' TRP . . . -125.97 138.14 53.73 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.845 0.355 . . . . 0.0 111.601 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.81 162.24 24.12 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 60.66 -91.48 0.03 OUTLIER 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.473 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.578 ' HB1' ' HB2' ' A' ' 428' ' ' LEU . . . -151.03 -74.64 0.15 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . 67.08 -68.12 0.15 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.636 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -115.39 13.98 16.65 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.643 HD21 HG13 ' A' ' 415' ' ' ILE . 0.1 OUTLIER -64.45 -32.72 74.47 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.492 0.187 . . . . 0.0 111.281 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 430' ' ' MET . 4.0 p -44.91 -51.12 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.697 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.426 ' N ' HG13 ' A' ' 429' ' ' VAL . 4.7 mtm -66.73 -47.22 72.97 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.779 0.323 . . . . 0.0 110.365 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.751 HD11 ' HB3' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -55.65 -51.45 67.18 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.388 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 432' ' ' TYR . . . . . 0.499 ' OH ' ' HB2' ' A' ' 458' ' ' SER . 44.0 t80 -59.15 -44.59 92.11 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.163 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.5 OUTLIER -55.83 -54.21 47.3 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.546 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 6.1 mt -57.48 -42.38 82.53 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.187 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.15 -58.43 13.57 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.479 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 32.8 m -53.99 -34.67 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.784 0.292 . . . . 0.0 110.607 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 433' ' ' LEU . 54.3 t -63.26 -51.25 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.14 -46.4 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.373 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.768 HG22 ' HB1' ' A' ' 407' ' ' ALA . 15.1 t -60.46 -46.11 95.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.135 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.76 76.39 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.127 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.34 -46.57 69.54 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -63.67 -38.52 91.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.45 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' TYR . . . . . 0.742 ' CE1' HG22 ' A' ' 404' ' ' VAL . 5.6 m-85 -74.13 -17.82 60.88 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.79 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -56.76 80.32 0.01 OUTLIER Glycine 0 C--N 1.342 0.876 0 C-N-CA 121.711 -0.281 . . . . 0.0 112.96 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 443' ' ' TYR . 12.3 ttt85 -174.11 -55.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.32 0.248 . . . . 0.0 110.841 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -163.88 81.15 1.44 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.456 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -89.91 158.98 4.99 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.959 2.439 . . . . 0.0 113.075 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.0 t -129.63 178.73 6.27 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.982 0.42 . . . . 0.0 111.678 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 91.5 t -55.34 -39.29 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.964 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 9.2 m -48.14 -46.36 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.645 0.259 . . . . 0.0 111.443 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' ALA . . . . . 0.401 ' HB2' ' HE2' ' A' ' 443' ' ' TYR . . . -64.28 -45.21 89.01 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -48.54 81.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.526 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.28 -54.75 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.326 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.698 HG22 HG23 ' A' ' 486' ' ' THR . 33.2 pt -57.11 -40.54 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.378 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -68.01 -50.34 56.08 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.36 -52.74 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.567 HG12 HD22 ' A' ' 461' ' ' LEU . 37.6 t -55.88 -41.41 66.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.285 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 458' ' ' SER . . . . . 0.499 ' HB2' ' OH ' ' A' ' 432' ' ' TYR . 64.9 m -62.95 -50.45 70.77 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.19 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -55.26 -52.36 63.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.559 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.4 -53.42 58.39 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.806 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.567 HD22 HG12 ' A' ' 457' ' ' VAL . 3.9 mp -56.2 -38.71 71.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.887 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -75.09 -28.65 60.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.978 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.9 t80 53.56 45.78 27.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.977 0.418 . . . . 0.0 111.524 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 464' ' ' ILE . 6.1 mm 64.54 12.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.34 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' ALA . . . . . 0.527 ' HB1' ' HB1' ' A' ' 425' ' ' ALA . . . 36.6 73.7 0.66 Allowed Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.1 161.18 27.23 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.922 2.414 . . . . 0.0 113.046 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 8.7 mtm-85 -53.97 -35.11 61.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.552 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . -133.79 116.9 1.76 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.313 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 4.9 m -95.63 155.45 16.74 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.874 0.369 . . . . 0.0 110.938 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' LEU . . . . . 0.691 ' HB3' HG23 ' A' ' 472' ' ' VAL . 1.2 mp -55.16 -34.26 63.66 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . 61.46 49.35 5.27 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.192 0.52 . . . . 0.0 111.218 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' VAL . . . . . 0.691 HG23 ' HB3' ' A' ' 470' ' ' LEU . 37.4 t -107.11 150.86 9.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.487 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 473' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 475' ' ' VAL . 6.5 t -75.6 -168.22 0.81 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.041 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 65.55 -66.63 0.15 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.744 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 473' ' ' SER . 10.5 p -57.34 -37.01 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.771 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -57.99 -39.91 79.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.488 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -46.7 64.15 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.01 -53.38 57.66 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.873 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.83 -43.97 90.78 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.013 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 54.7 m -54.15 -47.47 71.89 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -64.63 -46.6 81.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.449 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.47 78.26 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.528 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.69 -43.53 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.901 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 26.7 mtt -57.45 -51.09 70.85 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.183 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.0 tp -59.57 -45.53 91.59 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.827 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' THR . . . . . 0.698 HG23 HG22 ' A' ' 454' ' ' ILE . 88.1 m -56.11 -48.97 75.15 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.269 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.02 -51.24 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.494 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 491' ' ' ILE . . . -54.69 -47.03 72.97 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.983 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -47.34 84.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.668 0.27 . . . . 0.0 110.491 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.559 ' CG2' HG21 ' A' ' 454' ' ' ILE . 39.2 t -60.18 -52.95 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.58 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.519 ' HA ' HD21 ' A' ' 494' ' ' LEU . 9.2 tp -57.47 -42.32 80.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.84 -0.164 . . . . 0.0 110.662 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.8 -42.73 94.97 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -57.37 -56.25 24.25 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.642 0.377 . . . . 0.0 110.79 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' A' ' 491' ' ' ILE . 3.9 pp -61.88 -40.46 95.46 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.344 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 495' ' ' THR . . . . . 0.454 ' N ' HD12 ' A' ' 494' ' ' LEU . 45.5 m -62.88 -33.76 75.97 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.374 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -83.08 -42.2 17.7 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.192 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -63.54 -57.73 13.76 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.408 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 498' ' ' VAL . . . . . 0.861 HG21 ' HA3' ' A' ' 401' ' ' GLY . 2.7 t -62.83 94.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.868 0.366 . . . . 0.0 111.229 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 499' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 498' ' ' VAL . 3.8 ptm180 154.67 -37.22 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.942 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -70.38 63.79 0.26 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.894 0.378 . . . . 0.0 111.269 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.565 ' O ' ' HB3' ' A' ' 502' ' ' ALA . 2.4 mm-40 69.6 85.39 0.14 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.68 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 501' ' ' GLN . . . . . . . . 0 C--O 1.254 1.327 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.728 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.239 0.542 0 CA-C-O 120.896 0.379 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 399' ' ' ILE . 13.2 tt -73.56 101.1 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.95 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.444 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 4.7 mm-40 66.66 80.11 0.22 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.325 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -133.04 -134.52 3.51 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.071 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 13.4 m -47.09 -38.91 12.16 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 35.5 t -59.79 -47.35 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.452 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.589 HG13 ' CE2' ' A' ' 442' ' ' PHE . 12.7 t -60.51 -48.32 88.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.406 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.68 69.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.738 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.68 -50.45 73.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.064 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 1.084 ' HB1' HG13 ' A' ' 438' ' ' VAL . . . -57.85 -55.95 28.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.67 ' HG ' HG11 ' A' ' 490' ' ' VAL . 0.4 OUTLIER -59.14 -40.57 85.91 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.652 179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 37.8 t -57.12 -57.59 11.9 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.301 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -53.18 -42.32 66.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.705 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.795 HG23 HG21 ' A' ' 438' ' ' VAL . 25.0 t -61.61 -59.06 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.27 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.0 tp -55.5 -43.48 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 121.358 -0.137 . . . . 0.0 110.948 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 52.9 m -59.58 -51.52 69.49 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 434' ' ' LEU . 8.5 tp -57.94 -46.44 85.04 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.368 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.799 HG12 HD11 ' A' ' 431' ' ' LEU . 75.0 mt -57.71 -52.44 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.601 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.29 -48.42 80.53 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.058 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 22.3 mtt -59.66 -52.81 63.92 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.024 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -60.57 -47.31 86.74 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.353 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . 0.519 ' HA ' ' O ' ' A' ' 424' ' ' ASP . 0.0 OUTLIER -59.56 -44.07 93.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.945 0.402 . . . . 0.0 110.185 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 4.9 tt -64.12 -42.57 96.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 6.1 tpt -67.84 126.9 30.9 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.871 0.367 . . . . 0.0 111.727 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 70.82 -98.98 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.918 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.23 41.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.661 0.267 . . . . 0.0 111.519 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 419' ' ' TRP . 4.5 p30 . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.805 0.336 . . . . 0.0 111.198 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 71.4 t -143.61 -69.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.915 -0.13 . . . . 0.0 111.311 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -52.49 34.19 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.671 0.272 . . . . 0.0 111.111 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.799 HD11 HG12 ' A' ' 415' ' ' ILE . 17.5 tp -62.97 -40.52 97.97 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.04 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 462' ' ' PHE . 54.0 t80 -67.18 -48.57 67.53 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.928 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.8 OUTLIER -56.28 -59.38 5.03 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.7 0.286 . . . . 0.0 110.568 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 414' ' ' LEU . 0.1 OUTLIER -59.72 -45.19 92.93 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.293 178.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.734 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -53.85 -55.06 27.51 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.859 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 39.3 t -55.17 -47.74 77.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 433' ' ' LEU . 59.6 t -54.03 -50.2 55.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 1.084 HG13 ' HB1' ' A' ' 407' ' ' ALA . 41.2 t -61.27 -43.04 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.158 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 435' ' ' GLY . 98.0 t -54.9 -45.83 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -58.32 -47.09 84.83 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.672 HD23 ' HB2' ' A' ' 407' ' ' ALA . 2.1 tp -56.14 -44.71 79.49 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.171 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . 0.589 ' CE2' HG13 ' A' ' 404' ' ' VAL . 3.2 t80 -64.38 -45.2 88.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.552 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -52.87 -43.39 66.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.355 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -74.72 48.39 1.94 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.874 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 399' ' ' ILE . 0.6 OUTLIER -136.68 29.45 2.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.41 0.284 . . . . 0.0 110.8 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . 0.401 ' CB ' ' O ' ' A' ' 445' ' ' ARG . 0.0 OUTLIER 83.74 125.88 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.561 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.21 97.16 1.12 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.669 2.246 . . . . 0.0 112.728 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.0 m -121.3 38.95 3.95 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.861 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 97.7 t 67.76 -55.13 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.794 HG21 ' OD1' ' A' ' 493' ' ' ASN . 7.0 m -41.83 -46.76 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -59.63 -47.5 85.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.851 0.358 . . . . 0.0 110.205 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 20.8 m -56.46 -49.16 75.41 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.929 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.3 -52.97 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.343 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.577 HG23 HG23 ' A' ' 486' ' ' THR . 19.8 mt -53.3 -50.81 45.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.752 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.502 ' ND2' HG11 ' A' ' 439' ' ' VAL . 12.6 t-20 -59.82 -51.91 67.72 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.666 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.9 t -54.05 -52.21 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 54.6 t -52.01 -54.55 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.509 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -44.2 92.03 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.827 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -57.41 -57.51 12.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.834 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -41.95 91.52 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.847 0.356 . . . . 0.0 110.695 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.556 ' HG ' ' CB ' ' A' ' 482' ' ' ALA . 1.3 mm? -68.59 -21.01 64.54 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.461 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 432' ' ' TYR . 60.5 t80 -61.68 76.25 0.02 OUTLIER 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.568 0.699 . . . . 0.0 111.135 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 461' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.331 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 477' ' ' TYR . 10.4 t0 . . . . . 0 C--O 1.235 0.334 0 CA-C-O 121.103 0.478 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 95.9 t -56.49 -48.3 80.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.205 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -47.61 76.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.874 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 474' ' ' ASP . 1.3 m-85 -66.38 -52.83 42.78 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.026 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.15 -51.55 57.29 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.617 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . 0.667 ' O ' HG23 ' A' ' 483' ' ' VAL . 17.1 tp -61.18 -46.98 88.25 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.046 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 82.8 m -52.32 -49.4 64.32 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.626 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.33 -52.87 63.8 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.39 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . 0.556 ' CB ' ' HG ' ' A' ' 461' ' ' LEU . . . -54.74 -42.27 71.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.842 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 479' ' ' LEU . 88.1 t -64.48 -49.08 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.003 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 9.2 ttm -56.99 -52.36 65.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.585 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 28.7 tp -56.02 -50.35 71.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.933 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . 0.691 ' HA ' HD12 ' A' ' 489' ' ' LEU . 35.8 m -56.02 -47.13 78.39 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.285 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 483' ' ' VAL . 42.1 t -57.57 -48.39 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.909 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -54.08 -43.92 73.28 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.509 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 486' ' ' THR . 4.7 mt -64.19 -49.52 71.7 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.78 0.324 . . . . 0.0 110.25 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.67 HG11 ' HG ' ' A' ' 408' ' ' LEU . 65.2 t -58.66 -55.27 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.352 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 20.9 tt -57.21 -42.29 79.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.857 -0.156 . . . . 0.0 110.795 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -60.67 -50.3 69.07 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.504 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . 0.794 ' OD1' HG21 ' A' ' 450' ' ' VAL . 15.9 m-80 -61.03 -54.7 41.57 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.574 0.226 . . . . 0.0 110.526 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.11 -43.53 66.94 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.662 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 58.3 m -61.85 -50.61 71.55 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.206 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.11 82.86 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.174 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -57.63 -51.33 58.58 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.455 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 92.5 t -71.19 -47.73 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 120.988 0.423 . . . . 0.0 110.72 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . 0.506 ' O ' ' HD2' ' A' ' 499' ' ' ARG . 1.1 tmm_? -105.35 87.33 2.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.114 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 29.3 t80 . . . . . 0 CA--C 1.532 0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.614 -179.361 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.583 0 CA-C-O 120.9 0.381 . . . . 0.0 111.636 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.413 HD12 ' OE1' ' A' ' 400' ' ' GLN . 2.7 pt -73.71 149.02 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.714 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.413 ' OE1' HD12 ' A' ' 399' ' ' ILE . 2.4 mp0 61.48 -167.46 0.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.883 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 84.29 -110.66 3.37 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.542 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 33.7 m -52.99 -48.14 67.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.578 0.227 . . . . 0.0 111.472 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.782 HG21 ' HG2' ' A' ' 445' ' ' ARG . 10.5 t -55.13 -52.97 39.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.931 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.496 HG11 HD23 ' A' ' 494' ' ' LEU . 22.8 t -60.41 -46.44 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.24 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.26 76.97 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.566 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.56 -55.06 35.01 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.652 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -56.37 -48.49 76.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.434 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.98 HD11 HG13 ' A' ' 487' ' ' VAL . 2.1 tp -57.95 -49.48 76.64 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.388 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . 0.667 ' HA ' HD12 ' A' ' 412' ' ' ILE . 41.0 t -53.64 -48.13 69.66 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.63 82.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.262 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 407' ' ' ALA . 41.7 t -63.23 -42.54 96.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.151 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 409' ' ' SER . 23.8 mt -61.84 -53.31 49.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.585 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 409' ' ' SER . 42.7 p -58.54 -44.92 89.78 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.449 HD21 ' HG ' ' A' ' 431' ' ' LEU . 18.2 tp -57.46 -49.42 76.33 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.137 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 14.9 mm -59.75 -54.14 38.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.924 0.393 . . . . 0.0 110.19 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -52.1 -49.84 62.81 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.894 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 10.5 mtt -63.7 -43.15 97.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.838 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 0.0 OUTLIER -57.56 -45.67 84.86 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.183 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -35.21 36.39 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -51.83 -57.39 9.47 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 4.6 mtp -145.71 59.86 1.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.957 0.408 . . . . 0.0 111.603 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 418' ' ' GLN . . . -171.83 -177.06 1.87 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.394 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -91.89 150.69 20.91 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.74 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.409 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.473 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 N--CA 1.467 0.415 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.3 t -54.67 -61.95 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 8.2 mmt -55.77 -47.89 76.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.855 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.449 ' HG ' HD21 ' A' ' 414' ' ' LEU . 0.5 OUTLIER -57.58 -50.05 74.4 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.903 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.06 -49.95 70.31 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.039 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.8 OUTLIER -56.18 -55.84 28.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.859 0.361 . . . . 0.0 110.57 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.439 ' O ' HG22 ' A' ' 438' ' ' VAL . 5.2 mp -57.58 -47.32 82.41 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.981 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.605 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -52.98 -57.87 13.38 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.687 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 433' ' ' LEU . 27.5 m -54.99 -39.96 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 117.044 0.422 . . . . 0.0 110.93 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 433' ' ' LEU . 53.1 t -60.63 -57.75 10.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.074 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 434' ' ' LEU . 15.8 m -60.93 -39.29 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.661 0.267 . . . . 0.0 110.666 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 435' ' ' GLY . 55.8 t -59.1 -50.65 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.047 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.28 -47.78 77.94 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.974 0.416 . . . . 0.0 110.141 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.41 -47.87 80.6 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.58 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . 0.562 ' HA ' ' CG1' ' A' ' 403' ' ' VAL . 39.8 t80 -62.09 -46.13 90.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.763 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -60.44 -44.49 95.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.451 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.415 ' O ' ' HD3' ' A' ' 445' ' ' ARG . . . -67.59 53.93 0.33 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.549 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.782 ' HG2' HG21 ' A' ' 403' ' ' VAL . 0.7 OUTLIER -152.23 45.61 0.74 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 79.96 126.39 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.614 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.78 124.23 7.99 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.58 2.187 . . . . 0.0 112.407 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.7 t -143.18 152.0 41.28 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.28 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 453' ' ' VAL . 11.9 p -50.79 -45.85 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.629 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.571 HG12 HD11 ' A' ' 454' ' ' ILE . 13.8 t -57.48 -53.0 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.606 0.241 . . . . 0.0 110.668 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -56.08 -50.79 70.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.292 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 456' ' ' VAL . 28.7 m -55.81 -45.59 78.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 449' ' ' VAL . 96.3 t -58.75 -51.66 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.491 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.571 HD11 HG12 ' A' ' 450' ' ' VAL . 8.3 mt -57.86 -52.06 62.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 120.863 0.363 . . . . 0.0 110.589 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.62 -51.66 66.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.597 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 452' ' ' THR . 55.9 t -57.67 -55.69 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.742 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 453' ' ' VAL . 54.0 t -45.75 -52.11 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.685 0.278 . . . . 0.0 110.615 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -43.85 98.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.817 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.47 -58.27 9.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.987 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.41 -41.94 69.89 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.976 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.79 -27.92 63.27 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.994 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -63.56 102.65 0.45 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.892 0.377 . . . . 0.0 111.584 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 25.5 t80 . . . . . 0 N--CA 1.464 0.259 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.257 179.795 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.236 0.392 0 CA-C-O 120.947 0.403 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.455 HG22 HD13 ' A' ' 479' ' ' LEU . 10.7 p -55.55 -38.81 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.095 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -45.59 74.3 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.951 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.88 -49.99 46.84 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.675 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -52.63 61.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . 0.455 HD13 HG22 ' A' ' 475' ' ' VAL . 7.1 mp -60.53 -50.73 72.38 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.545 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 95.2 m -53.89 -46.44 71.38 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.443 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.86 -47.68 84.76 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.286 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -57.9 -44.42 86.77 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.126 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.74 -45.6 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.039 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 65.9 mtp -58.19 -52.76 64.2 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.14 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.73 -43.22 76.38 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 46.5 m -58.94 -48.3 81.98 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.623 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.98 HG13 HD11 ' A' ' 408' ' ' LEU . 24.2 t -56.32 -50.5 71.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.684 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . 0.464 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -54.69 -46.63 74.39 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.06 -49.56 76.49 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.476 HG12 HD23 ' A' ' 494' ' ' LEU . 79.6 t -55.93 -47.89 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.375 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.601 ' HA ' HD21 ' A' ' 494' ' ' LEU . 52.6 mt -54.89 -42.35 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.531 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -69.28 -45.9 59.31 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.55 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -56.21 -52.08 65.71 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.586 0.232 . . . . 0.0 110.916 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.601 HD21 ' HA ' ' A' ' 491' ' ' ILE . 4.0 pp -62.6 -44.83 95.33 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.422 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.57 ' N ' HD12 ' A' ' 494' ' ' LEU . 90.7 m -57.23 -43.87 83.28 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 500' ' ' TYR . . . -66.53 -54.32 25.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.584 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -53.7 -52.98 38.59 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.704 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 4.8 t -47.89 -33.58 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 120.609 0.243 . . . . 0.0 111.355 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.05 22.6 15.71 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.419 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 496' ' ' ALA . 1.6 t80 . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 120.791 0.329 . . . . 0.0 111.011 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . 0.445 HE22 HG23 ' A' ' 495' ' ' THR . 32.8 tt0 . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.356 0.122 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.454 ' CD1' ' HB3' ' A' ' 446' ' ' TRP . 19.5 mm 70.83 131.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 123.39 0.431 . . . . 0.0 111.165 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.59 ' HA ' HG21 ' A' ' 404' ' ' VAL . 42.1 mt-30 54.86 51.67 13.28 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.593 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.647 ' HA2' ' OG1' ' A' ' 495' ' ' THR . . . -147.09 -123.79 1.47 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.293 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 55.0 m -56.95 -49.69 74.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.65 0.262 . . . . 0.0 111.537 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 443' ' ' TYR . 30.1 m -55.76 -48.3 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.614 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.641 HG12 HD13 ' A' ' 491' ' ' ILE . 40.8 t -69.13 -40.91 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.75 97.54 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -62.27 -51.44 67.68 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.794 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' A' ' 440' ' ' ALA . . . -55.01 -49.24 72.03 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.677 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 484' ' ' MET . 0.5 OUTLIER -58.04 -42.88 86.31 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.761 178.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -50.48 62.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.056 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.16 -48.5 78.56 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.929 0.395 . . . . 0.0 109.996 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.3 t -55.55 -57.92 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.017 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.579 HD12 ' CD1' ' A' ' 485' ' ' LEU . 19.2 tt -56.75 -41.14 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.489 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 1.3 m -56.97 -50.07 73.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.694 HD12 HG23 ' A' ' 429' ' ' VAL . 3.1 mm? -60.75 -47.31 86.88 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.934 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 412' ' ' ILE . 93.7 mt -52.37 -49.98 40.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.994 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.63 77.87 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.08 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 2.0 mtt -56.5 -44.92 81.18 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.258 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 1.02 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 2.9 tm0? -60.18 -50.16 74.76 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.116 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -57.67 -35.82 71.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.205 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -50.93 42.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.826 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 1.1 ttp 179.46 65.43 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 1.02 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -151.25 -174.9 4.96 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 122.379 -0.201 . . . . 0.0 111.463 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . 0.582 ' O ' HG11 ' A' ' 429' ' ' VAL . 0.2 OUTLIER -119.05 178.03 4.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.933 0.397 . . . . 0.0 111.988 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.418 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.677 0.275 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.694 HG23 HD12 ' A' ' 414' ' ' LEU . 7.3 p -55.41 -33.56 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.805 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . 0.59 ' CE ' HD13 ' A' ' 434' ' ' LEU . 0.0 OUTLIER -57.0 -52.25 66.02 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.254 178.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.15 -44.3 95.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.072 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.695 ' O ' HG23 ' A' ' 436' ' ' VAL . 8.1 m-85 -56.97 -56.72 18.1 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.733 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.679 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.4 OUTLIER -56.28 -44.29 79.66 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.068 178.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.59 HD13 ' CE ' ' A' ' 430' ' ' MET . 6.2 tp -54.56 -51.16 66.12 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.94 -45.95 93.08 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 432' ' ' TYR . 42.9 t -57.08 -44.28 82.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 433' ' ' LEU . 98.4 t -55.87 -47.04 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.874 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.71 -47.07 86.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.419 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.62 -51.78 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.594 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.423 ' HB2' ' HB1' ' A' ' 407' ' ' ALA . . . -57.65 -50.08 74.36 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.543 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -47.91 79.3 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.406 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.09 -40.89 95.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.377 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.516 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 6.7 m-30 -65.88 -44.99 83.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.006 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.82 58.62 1.74 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.488 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 445' ' ' ARG . 21.2 tpt180 -89.86 60.13 4.86 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.184 0.516 . . . . 0.0 110.922 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . 0.454 ' HB3' ' CD1' ' A' ' 399' ' ' ILE . 15.4 t-105 -178.56 125.7 0.26 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.466 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 446' ' ' TRP . 68.9 Cg_endo -95.01 128.23 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.289 2.659 . . . . 0.0 112.939 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.451 ' OG ' ' NE1' ' A' ' 446' ' ' TRP . 14.6 m -164.69 65.82 0.14 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.791 0.329 . . . . 0.0 111.725 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 453' ' ' VAL . 60.5 t 64.92 -69.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.969 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.9 t -53.26 -46.2 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.564 0.221 . . . . 0.0 110.812 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.57 90.97 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 1.4 m -61.14 -52.29 65.5 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 449' ' ' VAL . 47.4 t -55.28 -47.73 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.771 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.36 -50.04 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.757 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.31 -48.76 70.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.949 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 63.1 t -56.02 -56.14 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.215 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.72 -46.1 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.819 0.342 . . . . 0.0 110.097 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 18.0 t -54.63 -47.42 73.5 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.92 -50.66 72.88 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.414 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.37 -41.82 76.81 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.794 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.7 tt -70.97 -38.18 72.78 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.811 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.48 150.1 2.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.513 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.663 -179.242 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 477' ' ' TYR . 7.9 t70 . . . . . 0 C--O 1.235 0.338 0 CA-C-O 120.925 0.393 . . . . 0.0 111.762 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.85 -40.86 74.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.996 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -66.01 -42.49 89.63 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . 0.461 ' HB2' ' HB3' ' A' ' 474' ' ' ASP . 0.8 OUTLIER -59.7 -54.96 40.3 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.381 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.7 tt -55.67 -48.75 74.52 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.207 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.19 -45.23 79.88 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.955 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . 0.417 HG22 ' SD ' ' A' ' 484' ' ' MET . 24.8 m -57.56 -44.66 85.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.819 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . 0.413 ' CE1' HD13 ' A' ' 485' ' ' LEU . 26.1 t80 -61.48 -48.95 78.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.76 80.38 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.482 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 487' ' ' VAL . 78.0 t -63.68 -48.39 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.85 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . 0.494 ' O ' HD11 ' A' ' 408' ' ' LEU . 21.6 mtt -54.47 -55.07 32.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.546 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.579 ' CD1' HD12 ' A' ' 412' ' ' ILE . 2.0 tp -52.8 -48.37 66.96 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.999 0.428 . . . . 0.0 109.969 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 24.2 m -56.41 -48.93 75.94 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.935 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 483' ' ' VAL . 91.7 t -56.98 -42.4 78.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.092 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.395 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . 0.757 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -56.65 -45.84 89.86 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.47 -49.85 71.42 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.47 -44.25 88.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.867 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.757 HD12 ' HA2' ' A' ' 488' ' ' GLY . 15.7 mt -55.89 -42.29 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.967 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 495' ' ' THR . . . -62.17 -49.31 76.02 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.479 -0.867 . . . . 0.0 110.995 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -54.06 -48.93 70.06 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.747 0.308 . . . . 0.0 110.348 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.526 HD23 ' CB ' ' A' ' 400' ' ' GLN . 11.1 tp -67.79 -35.93 79.54 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.665 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.647 ' OG1' ' HA2' ' A' ' 401' ' ' GLY . 98.0 m -51.51 -49.86 61.09 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -64.71 -47.05 79.74 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.509 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -54.46 -43.29 77.1 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.876 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 68.0 t -76.12 -43.13 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.752 0.311 . . . . 0.0 110.524 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -62.11 -47.14 85.92 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.294 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 120.992 0.425 . . . . 0.0 110.984 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 120.58 0.229 . . . . 0.0 111.338 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 399' ' ' ILE . 19.5 tt -144.34 114.62 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.704 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.558 ' NE2' HG11 ' A' ' 450' ' ' VAL . 0.0 OUTLIER 66.46 -175.04 0.19 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.475 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.541 ' HA2' ' OG1' ' A' ' 495' ' ' THR . . . 115.71 -131.43 9.65 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.975 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -37.22 72.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.43 0.157 . . . . 0.0 111.373 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.52 HG23 ' H ' ' A' ' 404' ' ' VAL . 15.2 m -55.8 -57.8 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.525 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.52 ' H ' HG23 ' A' ' 403' ' ' VAL . 24.6 m -63.55 -38.02 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.457 ' HB2' HG21 ' A' ' 491' ' ' ILE . . . -56.67 -48.85 76.7 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.119 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 409' ' ' SER . . . -61.68 -46.09 91.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.631 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -56.46 -56.59 19.27 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.362 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.513 HD21 ' HG2' ' A' ' 484' ' ' MET . 0.6 OUTLIER -59.18 -39.95 84.14 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.127 178.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 406' ' ' ALA . 33.6 t -51.08 -51.6 51.71 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.326 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.46 -47.43 81.85 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.308 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.579 HG22 HG21 ' A' ' 436' ' ' VAL . 69.7 t -53.57 -58.19 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.66 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.598 HD13 ' HG3' ' A' ' 484' ' ' MET . 4.2 tp -58.5 -39.91 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.602 0.239 . . . . 0.0 110.74 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 85.9 m -61.33 -44.36 97.33 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 109.809 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -50.06 72.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.857 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.42 HD13 ' OE1' ' A' ' 418' ' ' GLN . 8.7 mm -56.49 -46.11 82.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.044 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -54.38 -49.42 69.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.779 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 1.7 ttm -57.82 -42.77 84.98 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.074 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 1.052 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 0.8 OUTLIER -55.43 -50.86 68.7 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.083 178.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -58.25 -41.99 85.42 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.63 -54.44 42.75 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.725 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -179.19 78.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 1.052 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -155.21 168.99 25.22 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 111.933 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -67.65 178.58 1.62 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.644 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.534 0.364 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.768 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 120.505 0.193 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.424 HG22 ' NE2' ' A' ' 418' ' ' GLN . 40.3 t -51.42 -51.28 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.483 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 3.2 ttm -55.68 -43.78 76.72 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 110.195 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.51 -48.75 78.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.799 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.413 ' O ' HG22 ' A' ' 436' ' ' VAL . 7.5 m-85 -57.45 -48.01 80.3 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.678 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 437' ' ' VAL . 3.2 tp -57.52 -47.1 82.89 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.009 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 438' ' ' VAL . 0.1 OUTLIER -54.68 -48.78 71.98 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.834 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -56.53 -57.72 18.01 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.508 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.579 HG21 HG22 ' A' ' 411' ' ' VAL . 10.1 m -56.08 -44.34 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.723 0.262 . . . . 0.0 110.653 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 433' ' ' LEU . 56.3 t -57.77 -46.54 86.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 434' ' ' LEU . 37.9 t -58.14 -45.58 88.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 51.8 t -55.88 -47.41 79.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.65 -47.26 86.32 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.167 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -41.41 81.84 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.316 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -66.79 -44.88 80.13 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.627 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.433 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 9.9 m-85 -70.77 -47.68 58.36 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.344 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -61.89 134.68 46.55 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.807 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -138.58 -56.12 0.63 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.568 0.223 . . . . 0.0 111.386 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.84 121.08 75.91 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 120.772 0.32 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -88.87 161.28 6.1 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.159 2.573 . . . . 0.0 114.237 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.551 ' H ' ' HB3' ' A' ' 451' ' ' ALA . 1.2 p 176.9 -174.14 0.11 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.453 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.7 t -45.91 -48.17 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.573 0.225 . . . . 0.0 111.434 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.558 HG11 ' NE2' ' A' ' 400' ' ' GLN . 47.3 t -58.35 -50.39 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.633 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . 0.551 ' HB3' ' H ' ' A' ' 448' ' ' SER . . . -57.22 -45.63 83.66 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.255 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 93.0 m -54.99 -52.15 64.02 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.59 -46.52 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.227 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 451' ' ' ALA . 53.8 mt -55.59 -50.25 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.598 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -53.4 56.66 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.817 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 64.5 t -53.52 -55.73 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 111.159 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 57.9 t -54.65 -47.6 72.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 4.4 t -59.56 -44.31 93.32 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.288 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -53.1 -49.59 66.16 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.467 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.75 -46.97 73.72 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.358 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.22 -36.89 53.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.016 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.89 59.14 0.16 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.18 0.514 . . . . 0.0 111.022 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 10.1 t80 . . . . . 0 CA--C 1.533 0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.775 -179.683 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 8.6 t70 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.433 0.158 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 59.7 t -42.24 -42.78 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.016 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -54.48 -55.23 31.14 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.819 0.342 . . . . 0.0 111.107 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -69.82 -49.98 47.37 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.147 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.49 -54.93 25.99 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.968 0.413 . . . . 0.0 110.803 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 483' ' ' VAL . 3.2 tt -59.38 -48.8 80.25 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.617 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 73.8 m -57.59 -39.19 76.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.928 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -49.46 74.75 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.04 -44.08 91.74 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.036 0.446 . . . . 0.0 110.353 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 479' ' ' LEU . 85.8 t -62.06 -52.27 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.269 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . 0.598 ' HG3' HD13 ' A' ' 412' ' ' ILE . 0.0 OUTLIER -56.69 -49.5 74.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.488 179.106 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 4.5 tt -56.21 -47.15 78.96 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 35.0 m -58.44 -50.98 71.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.224 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.475 ' CG1' HD13 ' A' ' 408' ' ' LEU . 60.6 t -57.5 -47.42 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.413 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -57.3 -48.67 78.55 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 5.7 tt -55.42 -50.23 70.34 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 55.2 t -56.53 -48.39 80.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.859 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' A' ' 405' ' ' ALA . 90.4 mt -58.55 -41.24 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.454 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.56 -58.31 12.82 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.666 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -55.58 -47.4 76.5 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.065 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.462 HD12 ' HB3' ' A' ' 400' ' ' GLN . 2.7 tm? -58.74 -44.99 90.64 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.455 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.541 ' OG1' ' HA2' ' A' ' 401' ' ' GLY . 72.0 m -59.7 -42.93 94.11 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.94 -57.93 9.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.959 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.78 -48.17 85.69 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.615 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.9 p -60.92 -29.64 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 3.7 ttm105 -91.66 -43.04 9.84 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.672 0.272 . . . . 0.0 110.91 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.031 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 37.2 mm -56.99 -38.97 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.022 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.97 140.05 47.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.823 0.344 . . . . 0.0 111.356 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 165.08 -110.27 0.41 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.252 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.6 t -53.92 -44.76 70.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 110.168 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.711 HG11 ' CB ' ' A' ' 443' ' ' TYR . 19.9 t -59.71 -54.28 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.788 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 21.3 m -61.06 -42.48 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.536 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.81 53.7 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.8 87.73 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.934 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -55.86 -51.83 66.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.836 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.465 HD23 HD12 ' A' ' 491' ' ' ILE . 2.4 tm? -55.19 -43.93 74.84 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.2 t -57.81 -44.56 86.44 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.129 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.35 96.57 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.239 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 407' ' ' ALA . 79.2 t -60.06 -51.39 73.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.107 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.422 HD11 HD11 ' A' ' 408' ' ' LEU . 51.6 mt -56.16 -46.28 81.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . 0.447 HG22 ' SD ' ' A' ' 417' ' ' MET . 36.5 m -57.69 -48.01 80.74 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.142 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 432' ' ' TYR . 9.3 tp -59.11 -57.42 13.15 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.358 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 5.2 tt -58.23 -43.97 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.583 0.23 . . . . 0.0 111.053 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.37 -54.69 43.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.465 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . 0.447 ' SD ' HG22 ' A' ' 413' ' ' THR . 7.1 mtp -55.86 -49.99 71.83 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.86 -53.51 39.68 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.735 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -57.79 -43.04 85.35 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.526 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 421' ' ' MET . 6.1 tt -67.0 -50.44 62.22 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.518 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . 0.683 ' HB2' HD23 ' A' ' 420' ' ' LEU . 0.0 OUTLIER -145.17 126.04 14.41 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.617 0.246 . . . . 0.0 111.518 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 68.92 88.14 0.11 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.684 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 424' ' ' ASP . 4.2 t80 -76.21 149.31 37.25 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.354 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 423' ' ' PHE . 54.8 m-20 . . . . . 0 N--CA 1.468 0.43 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.923 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 120.641 0.258 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 85.4 t -51.19 -37.71 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.61 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.5 -44.95 12.92 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.572 0.225 . . . . 0.0 110.978 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.91 -51.17 69.24 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 109.961 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.489 ' HB3' ' CD1' ' A' ' 414' ' ' LEU . 56.2 m-85 -57.83 -46.63 84.46 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.137 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 437' ' ' VAL . 2.5 tm? -57.51 -51.99 67.2 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.69 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 438' ' ' VAL . 1.8 mp -56.0 -46.71 78.66 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.015 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -51.45 -50.98 39.42 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 87.5 t -56.94 -45.81 83.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.867 0.365 . . . . 0.0 110.047 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 433' ' ' LEU . 85.4 t -57.89 -43.82 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.345 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 434' ' ' LEU . 88.4 t -57.33 -53.22 46.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.517 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.02 -48.69 87.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.744 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.452 ' HA ' ' CE2' ' A' ' 443' ' ' TYR . . . -55.5 -49.67 71.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.138 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.63 -48.98 70.36 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.91 -44.02 73.79 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.711 ' CB ' HG11 ' A' ' 403' ' ' VAL . 0.1 OUTLIER -86.02 -34.26 20.82 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -67.44 71.55 0.23 Allowed Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.136 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 446' ' ' TRP . 4.9 mtm180 -122.53 151.78 41.02 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.444 0.164 . . . . 0.0 110.928 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . 0.435 ' CB ' ' O ' ' A' ' 445' ' ' ARG . 1.6 t-105 83.07 131.66 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.031 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.13 111.01 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.652 2.234 . . . . 0.0 112.13 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.3 t -145.03 136.19 24.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.493 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.499 ' O ' HG22 ' A' ' 453' ' ' VAL . 39.1 t -45.66 -59.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.698 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.604 HG11 ' HB3' ' A' ' 494' ' ' LEU . 14.1 m -54.38 -46.34 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.408 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -64.18 -47.72 78.71 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.826 0.346 . . . . 0.0 110.65 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 28.5 m -57.45 -56.73 18.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.253 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 449' ' ' VAL . 34.4 m -59.73 -44.44 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.124 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.402 ' N ' HG23 ' A' ' 453' ' ' VAL . 36.7 mt -59.27 -50.08 81.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.13 -49.47 66.49 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.321 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 52.0 t -54.88 -53.64 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.956 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.4 t -51.57 -52.56 20.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 2.0 p -57.71 -38.76 75.81 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.012 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -60.89 -48.87 79.84 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -60.43 -46.65 89.26 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.8 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.95 -19.62 62.55 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.821 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -167.77 0.05 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 111.217 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 6.9 t80 . . . . . 0 N--CA 1.465 0.289 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.207 -179.65 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.369 0.128 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 476' ' ' GLN . 7.3 p -39.29 -48.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.412 ' N ' HG13 ' A' ' 475' ' ' VAL . 0.3 OUTLIER -59.65 -40.49 87.86 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.507 0.194 . . . . 0.0 111.245 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -72.66 -49.13 33.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.622 0.249 . . . . 0.0 110.413 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.13 -51.44 67.92 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.234 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.24 -50.02 75.05 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.691 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 97.8 m -54.19 -42.04 69.26 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.999 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -58.5 -48.92 79.21 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.459 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.85 96.72 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.731 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.69 -49.18 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.235 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -49.04 79.37 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.103 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 6.1 tt -56.61 -46.49 80.87 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 490' ' ' VAL . 45.8 m -56.67 -48.47 77.54 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.435 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.0 -47.72 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.002 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.64 -46.58 88.66 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 16.8 tp -58.11 -48.7 79.38 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 486' ' ' THR . 89.6 t -60.31 -48.55 87.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.64 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.544 ' HA ' HD21 ' A' ' 494' ' ' LEU . 83.7 mt -57.06 -46.17 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.152 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.44 -44.14 97.18 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.13 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -57.54 -56.51 20.89 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.325 0.25 . . . . 0.0 111.125 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.604 ' HB3' HG11 ' A' ' 450' ' ' VAL . 3.0 pp -58.71 -43.32 90.06 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.485 ' N ' HD12 ' A' ' 494' ' ' LEU . 15.3 m -61.13 -49.24 78.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.687 0.28 . . . . 0.0 110.589 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.84 97.89 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.036 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.65 67.64 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.446 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 499' ' ' ARG . 8.1 p -66.06 -44.25 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . 0.421 ' N ' HG13 ' A' ' 498' ' ' VAL . 0.0 OUTLIER -80.46 63.71 5.01 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.043 0.449 . . . . 0.0 110.812 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.292 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.667 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 . . . . . 0 C--O 1.235 0.315 0 CA-C-O 120.705 0.288 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.93 -164.96 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.728 ' HA ' HG21 ' A' ' 404' ' ' VAL . 11.8 mt-30 -68.79 69.05 0.16 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.771 0.319 . . . . 0.0 111.839 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 494' ' ' LEU . . . -124.89 -124.8 2.87 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.653 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.61 -55.66 12.82 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 51.0 t -52.17 -48.15 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 110.828 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' A' ' 400' ' ' GLN . 2.9 t -59.78 -48.11 88.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.442 ' HB2' HD22 ' A' ' 494' ' ' LEU . . . -58.61 -48.48 80.85 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.772 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.7 -55.92 28.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.927 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.644 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -54.82 -49.45 70.99 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.795 0.331 . . . . 0.0 110.564 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 1.048 HD13 HG21 ' A' ' 490' ' ' VAL . 0.7 OUTLIER -56.06 -49.68 73.09 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.205 178.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 30.0 t -49.66 -53.01 26.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.292 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -55.48 -47.29 76.38 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.498 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.441 ' CG2' HG21 ' A' ' 439' ' ' VAL . 37.7 t -57.07 -46.49 84.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.337 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 408' ' ' LEU . 38.1 mm -55.69 -46.81 79.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.154 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -39.71 95.36 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.197 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.585 HD23 ' HD1' ' A' ' 432' ' ' TYR . 0.7 OUTLIER -62.63 -52.13 64.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.724 179.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.41 ' HB ' ' CE1' ' A' ' 432' ' ' TYR . 3.0 tp -59.07 -42.03 85.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.59 -49.17 78.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 4.0 ttt -58.95 -42.88 90.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.128 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.604 ' HG2' ' HG ' ' A' ' 428' ' ' LEU . 0.0 OUTLIER -56.5 -54.6 43.85 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.031 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -54.88 -41.72 71.22 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 3.7 tp -75.08 50.06 0.46 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.14 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 2.0 mtt 177.26 -59.08 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -153.29 129.04 10.13 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.462 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -92.26 33.16 1.1 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.882 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 121.081 0.467 . . . . 0.0 111.353 179.757 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.604 ' HG ' ' HG2' ' A' ' 418' ' ' GLN . 4.6 mm? . . . . . 0 C--O 1.238 0.462 0 CA-C-O 120.662 0.268 . . . . 0.0 111.652 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.885 HG22 ' HG ' ' A' ' 433' ' ' LEU . 1.5 p -46.05 -42.24 4.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.033 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 85.1 mmm -51.23 -54.44 25.65 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 110.929 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.456 HD12 ' H ' ' A' ' 431' ' ' LEU . 2.7 mp -64.31 -47.89 77.72 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.491 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.585 ' HD1' HD23 ' A' ' 414' ' ' LEU . 28.4 t80 -59.95 -50.49 73.53 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.517 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.885 ' HG ' HG22 ' A' ' 429' ' ' VAL . 19.8 mt -54.97 -43.86 73.89 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.407 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 438' ' ' VAL . 4.1 tt -57.6 -54.09 50.8 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.579 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -58.46 -50.42 66.97 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.239 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 432' ' ' TYR . 76.9 t -58.39 -44.52 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.12 -48.22 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 434' ' ' LEU . 97.8 t -55.87 -46.0 79.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.644 HG22 ' HB1' ' A' ' 407' ' ' ALA . 23.9 t -60.07 -50.21 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.492 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -57.24 -48.85 77.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.8 tt -53.74 -45.4 70.52 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -65.33 -38.76 91.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.005 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.662 ' CE1' HG22 ' A' ' 404' ' ' VAL . 0.2 OUTLIER -65.42 -45.41 84.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.445 179.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 445' ' ' ARG . . . -64.17 76.79 0.05 OUTLIER Glycine 0 C--N 1.337 0.584 0 N-CA-C 114.61 0.604 . . . . 0.0 114.61 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' A' ' 444' ' ' GLY . 0.0 OUTLIER -148.61 -65.78 0.24 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.775 0.322 . . . . 0.0 110.422 178.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -128.84 66.28 75.13 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 121.186 0.517 . . . . 0.0 109.823 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.649 ' CB ' ' HB3' ' A' ' 451' ' ' ALA . 83.3 Cg_endo -80.13 155.69 22.74 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.018 2.479 . . . . 0.0 113.819 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.8 73.87 1.44 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.488 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 453' ' ' VAL . 79.2 t 72.12 -65.74 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.499 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.476 ' CG1' HD22 ' A' ' 489' ' ' LEU . 2.9 m -50.98 -53.21 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 120.553 0.216 . . . . 0.0 110.96 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . 0.649 ' HB3' ' CB ' ' A' ' 447' ' ' PRO . . . -58.46 -39.8 80.89 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.923 0.392 . . . . 0.0 110.384 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.89 -50.46 73.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.326 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 449' ' ' VAL . 45.0 t -55.85 -52.39 49.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.853 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' A' ' 451' ' ' ALA . 17.3 tt -60.93 -39.38 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.446 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -56.22 -46.85 79.36 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 78.3 t -58.83 -54.99 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.907 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 42.1 t -52.72 -41.81 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.286 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 1.4 t -56.96 -44.09 82.23 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.0 -50.02 74.84 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.911 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -58.99 -42.06 89.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.926 0.393 . . . . 0.0 110.51 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -43.43 84.2 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.65 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . 0.463 ' HA ' HD13 ' A' ' 433' ' ' LEU . 6.3 t80 -68.9 58.56 0.09 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.215 0.531 . . . . 0.0 111.122 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 CA--C 1.532 0.273 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.173 -179.684 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.614 0 CA-C-O 120.843 0.354 . . . . 0.0 111.743 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 476' ' ' GLN . 11.2 p -51.13 -44.52 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.92 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.407 ' N ' HG13 ' A' ' 475' ' ' VAL . 1.3 tt0 -61.52 -58.13 9.37 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.588 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -55.15 -44.59 75.26 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.048 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.8 tt -56.94 -52.25 65.96 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.776 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.58 -46.23 90.78 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 55.3 m -54.49 -47.47 72.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.198 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -61.8 -53.94 49.03 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.667 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -53.91 -44.77 70.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.948 0.404 . . . . 0.0 110.738 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 487' ' ' VAL . 40.2 t -65.0 -50.18 76.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.332 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 34.2 mtt -53.93 -53.58 50.73 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.722 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 21.3 tp -55.78 -50.79 69.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.397 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . 0.59 HG22 HD11 ' A' ' 408' ' ' LEU . 25.7 m -55.72 -47.25 77.22 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.543 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 483' ' ' VAL . 78.9 t -60.34 -49.24 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.46 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -58.11 -45.5 93.85 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.752 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . 0.476 HD22 ' CG1' ' A' ' 450' ' ' VAL . 20.5 mt -62.45 -48.09 81.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.84 0.352 . . . . 0.0 110.09 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 1.048 HG21 HD13 ' A' ' 408' ' ' LEU . 5.0 t -58.76 -59.33 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.043 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.504 ' HA ' HD23 ' A' ' 494' ' ' LEU . 2.6 pp -55.84 -35.39 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.087 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -60.36 -56.41 24.64 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.368 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -41.74 99.54 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.642 ' HA ' ' HA2' ' A' ' 401' ' ' GLY . 0.2 OUTLIER -57.86 -50.23 74.0 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.166 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 1.1 m -64.23 -44.36 92.12 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.6 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.82 80.29 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.988 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -67.2 -46.32 72.87 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.455 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 90.4 t -74.37 -42.66 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.737 0.303 . . . . 0.0 111.342 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -96.83 101.14 12.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.851 0.358 . . . . 0.0 110.922 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.466 0.372 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.776 -179.753 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.523 HG23 ' H ' ' A' ' 400' ' ' GLN . 1.5 tp -165.57 -61.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.437 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.536 ' HG3' ' CE1' ' A' ' 443' ' ' TYR . 21.9 tt0 -150.24 114.83 5.23 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.615 0.245 . . . . 0.0 111.08 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.475 ' HA2' ' CG2' ' A' ' 495' ' ' THR . . . -175.7 -113.01 0.32 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.697 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.98 -52.19 2.47 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.773 0.656 . . . . 0.0 112.773 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.595 HG12 HG13 ' A' ' 439' ' ' VAL . 29.5 t -50.53 -56.2 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.746 0.308 . . . . 0.0 111.414 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 491' ' ' ILE . 12.1 t -64.98 -40.79 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.873 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.7 82.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.81 83.96 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.661 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.97 ' HB2' HG11 ' A' ' 439' ' ' VAL . . . -53.54 -56.7 14.86 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.15 178.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.408 ' CD2' ' HA2' ' A' ' 488' ' ' GLY . 2.9 mp -55.89 -43.05 76.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.315 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.1 m -55.91 -53.25 59.1 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.78 -48.96 78.18 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.137 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.789 HG22 ' HE1' ' A' ' 432' ' ' TYR . 55.8 t -55.05 -41.9 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.335 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 415' ' ' ILE . 11.9 mm -58.46 -50.87 77.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.2 -38.8 77.45 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.257 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 411' ' ' VAL . 9.3 mt -65.65 -58.11 6.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 412' ' ' ILE . 2.3 tp -55.3 -39.7 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.601 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.98 83.87 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 32.5 ttm -54.79 -50.92 67.32 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.836 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -60.73 -40.19 91.43 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.202 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . 0.468 ' CE2' ' HB3' ' A' ' 477' ' ' TYR . 1.0 OUTLIER -56.44 -39.72 73.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.049 179.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.66 -36.8 16.03 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.842 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . 0.415 ' HB3' ' CE2' ' A' ' 423' ' ' PHE . 0.0 OUTLIER -88.98 -164.82 1.2 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.926 0.393 . . . . 0.0 111.405 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -159.46 124.74 4.15 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.213 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . 0.479 ' CE1' HD13 ' A' ' 428' ' ' LEU . 3.6 p90 -177.07 172.07 2.01 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.853 0.358 . . . . 0.0 111.246 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 CA--C 1.534 0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.479 HD13 ' CE1' ' A' ' 423' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.182 0 N-CA-C 111.292 0.108 . . . . 0.0 111.292 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 433' ' ' LEU . 7.4 p -50.2 -39.91 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 121.175 -0.21 . . . . 0.0 110.763 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -51.58 35.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.395 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.46 -48.61 78.71 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.789 ' HE1' HG22 ' A' ' 411' ' ' VAL . 22.2 t80 -57.96 -51.83 68.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.724 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.621 HD22 ' HD1' ' A' ' 462' ' ' PHE . 0.0 OUTLIER -55.13 -42.63 73.26 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.121 178.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.493 ' O ' HG23 ' A' ' 438' ' ' VAL . 3.6 tp -55.16 -51.89 65.04 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -59.28 -48.32 86.51 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.786 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 432' ' ' TYR . 57.9 t -57.44 -41.33 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.682 0.277 . . . . 0.0 110.375 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 433' ' ' LEU . 53.6 t -62.75 -43.02 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.928 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 434' ' ' LEU . 71.8 t -59.15 -50.31 80.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.97 HG11 ' HB2' ' A' ' 407' ' ' ALA . 69.7 t -60.8 -43.45 95.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.844 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 444' ' ' GLY . . . -57.71 -50.51 72.95 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.415 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.58 -40.16 78.37 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.847 0.356 . . . . 0.0 110.197 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . 0.446 ' HB3' ' CG1' ' A' ' 403' ' ' VAL . 1.3 t80 -69.11 -35.97 77.01 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.275 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.536 ' CE1' ' HG3' ' A' ' 400' ' ' GLN . 8.0 t80 -88.26 -19.26 27.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 440' ' ' ALA . . . -60.35 64.1 0.01 OUTLIER Glycine 0 C--N 1.337 0.612 0 N-CA-C 114.753 0.661 . . . . 0.0 114.753 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.0 OUTLIER -97.49 -34.78 10.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 109.99 178.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . 0.433 ' CZ3' ' HD3' ' A' ' 445' ' ' ARG . 6.1 m-90 -152.15 130.5 6.23 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.1 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.452 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 10.1 Cg_endo -51.22 -62.8 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.564 2.176 . . . . 0.0 112.413 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 45.2 t 47.64 33.47 3.05 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 453' ' ' VAL . 49.0 t 66.29 -60.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 451' ' ' ALA . 9.9 m -48.26 -52.2 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 447' ' ' PRO . . . -57.07 -46.3 82.62 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.663 0.268 . . . . 0.0 111.078 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.565 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.8 OUTLIER -60.57 -52.51 64.87 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.033 178.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 449' ' ' VAL . 67.6 t -54.08 -48.14 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.544 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 454' ' ' ILE . 17.2 mm -53.89 -57.63 5.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 110.473 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -49.62 66.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.595 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 452' ' ' THR . 92.8 t -55.37 -54.06 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.527 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 45.7 t -48.29 -50.45 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -40.02 87.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.634 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.27 -56.87 15.62 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.207 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.99 -41.55 97.48 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.342 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 1.0 OUTLIER -65.07 -31.18 72.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . 0.621 ' HD1' HD22 ' A' ' 433' ' ' LEU . 70.2 t80 -38.56 135.43 0.8 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.901 0.381 . . . . 0.0 111.8 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.469 0.48 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.297 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.466 0.331 0 N-CA-C 111.57 0.211 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 13.8 m -50.23 -43.9 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.664 -0.243 . . . . 0.0 111.616 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.98 -40.75 94.6 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.886 0.374 . . . . 0.0 110.654 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . 0.468 ' HB3' ' CE2' ' A' ' 419' ' ' TRP . 16.7 m-85 -68.79 -51.89 36.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.7 -49.33 73.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.64 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 2.1 tt -57.62 -53.29 59.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.289 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 48.0 m -53.83 -45.95 71.02 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.33 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -47.7 85.21 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.101 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -55.98 -45.41 78.97 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.329 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 487' ' ' VAL . 78.8 t -62.64 -50.47 79.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.131 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 26.3 ttm -54.64 -48.23 72.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.723 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.73 -46.11 86.87 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.195 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 52.0 m -55.49 -57.89 10.03 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.729 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 483' ' ' VAL . 27.2 m -57.53 -42.04 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.501 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . 0.408 ' HA2' ' CD2' ' A' ' 408' ' ' LEU . . . -58.42 -47.15 91.42 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.97 -44.34 82.54 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.7 -53.52 47.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.006 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.411 HG21 HG11 ' A' ' 404' ' ' VAL . 48.9 mt -56.62 -40.0 66.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.465 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.53 -50.42 59.3 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -49.05 76.38 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.419 ' O ' HG23 ' A' ' 498' ' ' VAL . 4.8 tt -58.12 -48.91 78.77 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.475 ' CG2' ' HA2' ' A' ' 401' ' ' GLY . 88.7 m -52.17 -49.22 64.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.734 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.16 89.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.868 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -66.95 -28.64 73.88 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.685 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 494' ' ' LEU . 39.9 t -92.98 -44.36 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.576 0.227 . . . . 0.0 111.526 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.68 63.83 0.62 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 N--CA 1.468 0.45 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.714 -179.955 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 120.982 0.42 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -138.15 168.28 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.979 0.419 . . . . 0.0 111.907 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.83 ' HB2' HG21 ' A' ' 404' ' ' VAL . 9.6 pt20 -59.72 101.95 0.13 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.201 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.793 ' HA2' HD13 ' A' ' 494' ' ' LEU . . . -162.8 -77.46 0.03 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.439 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.4 t -60.54 -56.01 26.45 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.706 0.289 . . . . 0.0 111.244 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' A' ' 443' ' ' TYR . 1.6 t -61.24 -46.76 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.922 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.83 HG21 ' HB2' ' A' ' 400' ' ' GLN . 60.8 t -58.9 -47.91 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.326 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.89 83.61 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.091 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -57.03 -51.78 67.9 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.41 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -56.08 -51.27 68.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.185 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.537 HD12 ' CG1' ' A' ' 487' ' ' VAL . 4.1 tt -55.62 -44.02 76.67 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.312 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.57 -54.03 46.71 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.474 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.7 78.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.752 0.31 . . . . 0.0 110.454 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 407' ' ' ALA . 88.7 t -60.4 -55.2 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.292 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.562 ' HA ' HG22 ' A' ' 415' ' ' ILE . 0.6 OUTLIER -59.59 -41.99 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.195 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 2.9 m -61.53 -54.8 38.4 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.677 0.275 . . . . 0.0 110.467 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.651 HD13 ' HD1' ' A' ' 432' ' ' TYR . 0.3 OUTLIER -60.71 -50.05 75.02 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.062 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.865 HD11 HG23 ' A' ' 480' ' ' THR . 4.4 tt -59.81 -41.46 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.761 -0.199 . . . . 0.0 111.029 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.95 78.26 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 34.4 mtt -59.6 -47.26 86.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.852 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -56.08 -55.1 37.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.758 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -56.23 -46.47 79.54 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.121 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.04 -48.74 80.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.401 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . 0.53 ' SD ' ' HB2' ' A' ' 423' ' ' PHE . 1.4 ttm -65.97 -34.93 79.23 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.021 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 76.8 62.36 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.126 0.489 . . . . 0.0 111.329 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . 0.53 ' HB2' ' SD ' ' A' ' 421' ' ' MET . 4.9 t80 -136.55 148.17 47.42 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.666 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.482 ' HA ' ' NE2' ' A' ' 476' ' ' GLN . 0.3 OUTLIER . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.254 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.471 HD12 HD21 ' A' ' 414' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.775 0.321 . . . . 0.0 110.885 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.667 HG22 HD12 ' A' ' 433' ' ' LEU . 8.5 p -48.91 -39.85 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.397 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -62.68 -54.05 45.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.659 0.266 . . . . 0.0 110.358 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 16.5 tp -59.63 -43.14 93.95 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.651 ' HD1' HD13 ' A' ' 414' ' ' LEU . 25.6 t80 -58.48 -51.93 67.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.409 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.743 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.1 OUTLIER -55.44 -49.53 72.21 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.839 178.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.58 -55.05 18.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.484 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.52 -51.27 58.82 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.726 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 52.4 t -53.46 -42.67 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 120.675 0.274 . . . . 0.0 110.68 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 433' ' ' LEU . 98.7 t -61.49 -46.23 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.45 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.19 -55.57 19.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 120.912 0.387 . . . . 0.0 110.135 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.61 -46.23 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.172 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.538 ' HB1' ' OD1' ' A' ' 455' ' ' ASN . . . -55.57 -47.79 75.85 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.44 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.09 -45.41 75.41 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.574 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -74.72 -27.74 60.5 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.909 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.45 ' HB2' HG11 ' A' ' 403' ' ' VAL . 9.8 t80 -86.48 -41.06 14.7 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -67.31 57.81 0.27 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 114.151 0.42 . . . . 0.0 114.151 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -46.41 6.75 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.51 66.92 75.33 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.835 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 56.0 Cg_endo -69.37 86.09 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.617 2.211 . . . . 0.0 112.869 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.56 62.78 0.39 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.681 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 453' ' ' VAL . 54.8 t 68.8 -59.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.071 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.652 HG12 HD11 ' A' ' 454' ' ' ILE . 89.3 t -52.06 -62.92 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.595 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' A' ' 454' ' ' ILE . . . -52.01 -40.2 60.64 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.689 0.281 . . . . 0.0 111.382 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.1 OUTLIER -62.66 -54.63 36.58 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.194 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 449' ' ' VAL . 66.7 t -55.07 -45.62 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.417 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.652 HD11 HG12 ' A' ' 450' ' ' VAL . 27.3 mt -56.77 -50.54 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.525 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.538 ' OD1' ' HB1' ' A' ' 440' ' ' ALA . 17.0 m-80 -61.22 -48.14 82.84 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.085 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 452' ' ' THR . 88.6 t -61.06 -58.5 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.244 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 4.0 t -50.36 -49.33 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.285 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -48.08 79.85 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.073 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -58.2 -54.35 48.02 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.651 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -58.01 -51.5 69.42 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.298 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 479' ' ' LEU . 6.9 mp -61.14 -58.12 9.67 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.838 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . 0.552 ' O ' HD21 ' A' ' 433' ' ' LEU . 2.0 m-85 -80.82 68.16 6.97 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.613 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.5 t80 . . . . . 0 N--CA 1.465 0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.283 -179.774 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.96 0.41 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.81 -59.81 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.223 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 424' ' ' ASP . 4.0 tt0 -56.1 -40.73 74.11 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.656 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -49.85 74.69 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -47.77 83.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.103 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . 0.566 ' HA ' HD23 ' A' ' 461' ' ' LEU . 6.2 mp -58.79 -52.99 63.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.138 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . 0.865 HG23 HD11 ' A' ' 415' ' ' ILE . 18.1 m -54.48 -47.48 72.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.252 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -59.72 -48.93 79.71 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.726 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.92 83.64 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.481 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 487' ' ' VAL . 34.3 m -65.66 -41.84 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 50.8 mtp -58.81 -52.52 65.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -45.87 81.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . 0.643 ' O ' HG23 ' A' ' 490' ' ' VAL . 85.4 m -55.27 -48.99 73.22 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.443 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 483' ' ' VAL . 99.5 t -57.63 -47.6 85.11 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.617 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . 0.89 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -53.02 -45.7 61.92 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 1.3 tt -58.68 -46.88 86.24 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 486' ' ' THR . 41.4 t -58.02 -41.65 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.889 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.89 HD12 ' HA2' ' A' ' 488' ' ' GLY . 55.0 mt -58.14 -53.28 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.97 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -56.79 -49.4 70.86 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.888 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -45.32 92.27 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.687 0.279 . . . . 0.0 110.761 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.793 HD13 ' HA2' ' A' ' 401' ' ' GLY . 0.2 OUTLIER -62.74 -46.47 87.93 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.077 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.498 ' N ' ' HG ' ' A' ' 494' ' ' LEU . 3.5 m -53.84 -46.44 71.2 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.49 -45.75 91.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.681 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.14 -47.85 88.95 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.24 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 494' ' ' LEU . 7.4 p -73.68 59.86 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.588 0.709 . . . . 0.0 110.672 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . 0.57 ' NH1' HG13 ' A' ' 498' ' ' VAL . 82.7 mmt-85 -152.32 -62.48 0.16 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.442 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--N 1.332 -0.181 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.767 179.548 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.787 HD12 ' CD1' ' A' ' 443' ' ' TYR . 34.0 pt 44.66 -152.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.042 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.77 ' HA ' HG21 ' A' ' 404' ' ' VAL . 52.6 tp60 45.83 47.82 12.05 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.191 0.52 . . . . 0.0 111.616 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.453 ' HA2' HG23 ' A' ' 495' ' ' THR . . . -141.7 -137.49 3.39 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.192 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.8 -41.92 57.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.735 0.268 . . . . 0.0 111.272 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 8.6 m -59.36 -47.56 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.894 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.77 HG21 ' HA ' ' A' ' 400' ' ' GLN . 39.0 t -64.53 -41.54 92.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.83 88.57 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.076 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.99 -50.06 74.93 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.119 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.437 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -54.44 -51.71 64.11 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.285 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.411 HD21 HD12 ' A' ' 491' ' ' ILE . 2.7 mp -58.68 -45.68 88.89 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.171 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.3 t -54.58 -50.72 67.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.04 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.46 -52.3 58.71 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.033 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 439' ' ' VAL . 46.6 t -52.92 -53.08 23.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.333 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 415' ' ' ILE . 35.9 mt -61.92 -49.91 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.207 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 39.5 m -55.28 -45.63 76.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.675 0.274 . . . . 0.0 110.502 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 3.1 mp -65.47 -54.59 26.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.265 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.471 ' HB ' ' CE1' ' A' ' 432' ' ' TYR . 0.1 OUTLIER -56.81 -44.18 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.452 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -61.23 -51.42 69.05 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.648 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 33.8 mtp -59.2 -49.4 78.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.579 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.517 ' HG2' ' HB3' ' A' ' 428' ' ' LEU . 2.8 mt-30 -60.09 -61.14 2.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.308 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 35.7 t90 -47.54 -44.9 26.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.699 0.285 . . . . 0.0 110.573 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 4.7 tt -63.45 -46.5 85.96 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.551 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 1.8 ttt -68.14 -39.97 82.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.959 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -139.09 96.95 3.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -71.2 59.24 0.26 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 C--O 1.236 0.354 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.872 -179.375 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.517 ' HB3' ' HG2' ' A' ' 418' ' ' GLN . 1.5 mm? . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.16 -26.02 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.15 -51.11 63.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.587 0.232 . . . . 0.0 111.05 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.2 -40.9 97.61 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.154 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.656 ' O ' HG23 ' A' ' 436' ' ' VAL . 54.9 t80 -62.11 -50.98 69.73 Favored 'General case' 0 CA--C 1.526 0.034 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.612 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 6.1 tt -52.7 -52.38 56.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.37 -50.64 67.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.266 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -57.31 -49.09 75.4 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.679 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 432' ' ' TYR . 64.8 t -55.77 -47.79 78.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 47.4 t -56.09 -47.13 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.063 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.0 -52.99 54.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.398 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 411' ' ' VAL . 66.5 t -54.49 -51.96 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.573 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 444' ' ' GLY . . . -59.92 -42.33 93.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.321 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 6.8 tt -64.15 -50.53 67.83 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.67 0.271 . . . . 0.0 111.651 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . 0.505 ' O ' ' HD2' ' A' ' 445' ' ' ARG . 0.6 OUTLIER -70.92 -35.62 72.33 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.787 ' CD1' HD12 ' A' ' 399' ' ' ILE . 37.0 t80 -87.78 -26.64 22.77 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 440' ' ' ALA . . . -61.98 -6.23 9.24 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 115.076 0.79 . . . . 0.0 115.076 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.614 ' HD3' HG21 ' A' ' 399' ' ' ILE . 2.7 ptm180 -63.08 -23.79 67.61 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.112 0.956 . . . . 0.0 111.475 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . 0.596 ' HB3' HD11 ' A' ' 399' ' ' ILE . 0.0 OUTLIER -131.6 93.0 29.63 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 120.71 0.29 . . . . 0.0 110.751 179.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.7 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 11.7 Cg_endo -56.03 -67.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.772 2.315 . . . . 0.0 112.843 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 10.8 t 58.03 -89.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.355 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 453' ' ' VAL . 21.7 t -148.97 -59.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.664 0.269 . . . . 0.0 110.857 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.571 ' HB ' ' OH ' ' A' ' 443' ' ' TYR . 40.7 t -52.74 -47.35 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . 0.7 ' HB3' ' HA ' ' A' ' 447' ' ' PRO . . . -59.71 -40.97 89.73 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 456' ' ' VAL . 93.3 m -59.41 -47.41 85.57 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 457' ' ' VAL . 58.1 t -60.15 -48.59 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.485 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 16.4 mm -54.06 -43.56 59.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.998 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -58.11 -50.27 74.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.845 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 452' ' ' THR . 42.4 t -57.77 -52.41 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.663 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 453' ' ' VAL . 77.5 t -54.08 -50.34 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.239 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 13.1 t -58.3 -44.57 88.62 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.954 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -55.37 -59.21 5.12 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.888 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.49 -50.08 75.32 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.678 0.275 . . . . 0.0 110.452 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 9.1 tt -50.74 -43.51 58.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.716 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -55.51 -26.37 42.53 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.375 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 72.4 t80 . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 120.648 0.261 . . . . 0.0 110.963 179.11 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 42.8 t -40.75 -44.34 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 122.421 0.289 . . . . 0.0 111.545 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -62.54 -40.41 96.7 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.599 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -51.91 55.85 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.7 tt -55.33 -54.28 45.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.802 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 483' ' ' VAL . 0.6 OUTLIER -54.99 -48.43 73.31 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.975 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 69.0 m -55.0 -44.0 74.12 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.802 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.22 -50.46 71.19 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.337 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.46 88.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.635 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 479' ' ' LEU . 91.9 t -63.14 -50.05 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.953 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 21.8 mtt -56.45 -52.67 63.8 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.141 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 2.5 tp -54.87 -46.29 74.7 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 490' ' ' VAL . 42.9 m -57.36 -48.74 78.22 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.914 178.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 483' ' ' VAL . 73.1 t -56.55 -46.33 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.47 -44.54 90.3 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 42.0 tp -56.52 -46.69 80.43 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.941 0.401 . . . . 0.0 109.983 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 486' ' ' THR . 34.3 t -63.22 -46.28 96.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.855 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.621 HG23 HE22 ' A' ' 400' ' ' GLN . 15.9 mt -55.67 -44.68 77.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.218 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.54 -45.75 92.18 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.694 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -54.43 -53.32 55.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.595 0.236 . . . . 0.0 110.971 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 491' ' ' ILE . 2.2 pp -68.57 -41.03 80.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.552 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 400' ' ' GLN . 79.6 m -60.16 -45.0 94.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.802 0.335 . . . . 0.0 110.415 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.15 79.37 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.449 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.35 -47.12 92.6 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.242 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 495' ' ' THR . 8.0 p -64.84 -30.96 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.644 0.259 . . . . 0.0 111.235 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.59 66.71 0.73 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.897 0.379 . . . . 0.0 110.769 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.469 0.48 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.92 -179.735 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 120.766 0.317 . . . . 0.0 111.676 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 446' ' ' TRP . 3.8 tt -173.62 -49.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.922 0.391 . . . . 0.0 111.324 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.577 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 0.0 OUTLIER -149.37 163.57 37.36 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.928 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.741 ' HA2' HG23 ' A' ' 495' ' ' THR . . . 131.08 -137.03 9.17 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.825 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.2 t -54.32 -49.69 69.11 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.54 -52.57 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.053 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.577 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 21.2 t -59.94 -48.68 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.587 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.81 69.87 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.654 0.264 . . . . 0.0 110.372 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -55.84 -49.96 71.87 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.167 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.858 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -56.65 -47.05 80.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.004 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 1.6 mp -56.76 -47.34 80.32 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 413' ' ' THR . 38.5 t -51.85 -52.48 49.18 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.042 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -55.06 -55.06 35.29 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.326 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 407' ' ' ALA . 42.2 t -52.72 -43.94 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.751 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.19 -55.07 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.476 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 409' ' ' SER . 44.3 p -55.93 -42.31 75.91 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.69 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -56.37 17.46 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.57 -43.82 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.733 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -60.44 -52.14 66.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.572 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 8.2 mtt -50.67 -49.73 56.53 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.72 -42.67 85.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.929 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -56.45 -44.24 80.29 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.352 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.43 45.7 1.3 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.114 0.483 . . . . 0.0 110.548 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 11.3 ttm -163.97 144.82 8.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.466 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -75.74 75.62 2.71 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.895 0.378 . . . . 0.0 111.604 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 428' ' ' LEU . 0.8 OUTLIER -138.13 128.27 25.83 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.052 0.453 . . . . 0.0 111.635 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 C--O 1.236 0.365 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.646 -179.935 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' A' ' 423' ' ' PHE . 1.1 tt . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.683 0.278 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 4.4 p -52.15 -28.07 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.78 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 30.2 mtt -51.37 -44.56 62.14 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.722 0.296 . . . . 0.0 110.455 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -47.69 84.62 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.175 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -62.2 -47.29 85.12 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 437' ' ' VAL . 7.8 tt -53.48 -51.54 62.42 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.78 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 438' ' ' VAL . 5.0 mp -60.33 -46.4 90.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.86 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.654 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -53.18 -55.42 24.33 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.314 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 20.0 m -61.2 -39.61 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.659 0.229 . . . . 0.0 110.462 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 433' ' ' LEU . 34.3 t -57.89 -48.49 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 434' ' ' LEU . 65.1 t -61.14 -48.02 90.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.858 HG22 ' HB1' ' A' ' 407' ' ' ALA . 94.4 t -51.84 -51.37 28.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.063 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.696 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -62.49 -42.21 99.33 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.787 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 3.1 tp -49.11 -46.21 44.57 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -79.76 -36.89 36.55 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.38 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 439' ' ' VAL . 1.2 t80 -60.29 -23.67 64.35 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.131 0.573 . . . . 0.0 112.485 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 446' ' ' TRP . . . -69.0 -123.13 0.03 OUTLIER Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.653 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.71 -67.96 0.13 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.629 0.252 . . . . 0.0 110.871 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . 0.465 ' HB2' HD12 ' A' ' 399' ' ' ILE . 7.9 m-90 -126.99 71.02 75.21 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-O 121.111 0.481 . . . . 0.0 109.764 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.71 70.43 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.69 2.26 . . . . 0.0 113.249 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -57.41 12.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.824 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 27.2 t -153.53 -61.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.031 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 454' ' ' ILE . 0.2 OUTLIER -44.88 -43.54 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.159 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -54.04 -52.21 61.58 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.933 0.397 . . . . 0.0 110.718 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.3 OUTLIER -60.04 -43.53 95.28 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.894 178.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 457' ' ' VAL . 88.4 t -56.46 -52.22 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.561 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 450' ' ' VAL . 38.3 mm -61.07 -45.03 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.709 0.29 . . . . 0.0 110.305 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -55.93 -46.11 78.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.825 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 452' ' ' THR . 90.5 t -65.97 -47.48 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.506 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 453' ' ' VAL . 57.7 t -54.66 -47.41 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.709 0.29 . . . . 0.0 110.657 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 70.0 m -60.88 -54.02 50.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -52.58 -47.73 66.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.474 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -60.05 4.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.755 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.9 tp -44.12 -41.45 5.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.656 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -39.97 -36.63 0.49 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.9 t80 . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 477' ' ' TYR . 7.5 t0 . . . . . 0 C--O 1.237 0.429 0 CA-C-O 121.151 0.5 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.25 -43.67 77.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.93 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -51.17 70.4 Favored 'General case' 0 C--O 1.228 -0.056 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 474' ' ' ASP . 34.6 t80 -53.14 -47.91 68.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.352 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.5 tt -53.24 -46.97 69.4 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 483' ' ' VAL . 0.1 OUTLIER -59.99 -44.72 94.34 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.512 177.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 19.6 m -53.29 -47.87 68.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.294 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -61.49 -47.29 86.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.257 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -57.52 -45.75 84.63 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.584 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 487' ' ' VAL . 67.7 t -64.76 -52.9 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.324 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.3 ttt -52.85 -52.35 57.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.802 0.334 . . . . 0.0 110.487 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 485' ' ' LEU . 0.2 OUTLIER -56.8 -49.75 74.42 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.086 178.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 490' ' ' VAL . 41.8 m -54.78 -45.94 74.35 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.012 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 483' ' ' VAL . 65.3 t -54.95 -51.91 48.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.905 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.52 80.05 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.418 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.41 -46.77 76.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.857 0.36 . . . . 0.0 110.134 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 486' ' ' THR . 88.7 t -62.91 -49.67 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.221 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.488 HD13 HG12 ' A' ' 487' ' ' VAL . 0.9 OUTLIER -56.52 -38.33 56.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.99 -52.19 39.27 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -55.31 -48.5 74.03 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.944 0.402 . . . . 0.0 109.992 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -45.78 90.62 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.216 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.741 HG23 ' HA2' ' A' ' 401' ' ' GLY . 55.9 m -52.98 -43.72 66.63 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.339 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.45 85.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.307 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -69.11 -52.25 24.17 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.08 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.76 -25.23 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 14.9 tpp85 -51.4 -25.88 6.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 179.379 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . 0.528 HE21 HG21 ' A' ' 498' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.53 0.205 . . . . 0.0 111.217 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.7 tp -42.1 -42.26 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.858 ' HB3' HG21 ' A' ' 404' ' ' VAL . 0.8 OUTLIER -166.71 67.58 0.1 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.85 0.357 . . . . 0.0 110.8 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -99.55 -113.1 3.42 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.771 -0.728 . . . . 0.0 114.345 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 14.3 m -34.5 -55.28 0.54 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 442' ' ' PHE . 23.7 m -53.37 -44.11 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.858 HG21 ' HB3' ' A' ' 400' ' ' GLN . 75.3 t -71.21 -44.08 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.905 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.21 76.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.25 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.66 -48.81 70.87 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.607 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.81 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -55.94 -60.09 3.97 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.998 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.892 HD11 HG22 ' A' ' 487' ' ' VAL . 0.1 OUTLIER -53.04 -53.99 41.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.022 179.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 23.9 t -53.95 -52.18 61.46 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.427 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -53.48 -48.51 68.86 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.013 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 407' ' ' ALA . 31.8 t -57.17 -49.41 79.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.258 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.662 HD11 HD12 ' A' ' 408' ' ' LEU . 53.4 mt -57.32 -50.92 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.49 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 25.6 m -57.37 -48.07 80.0 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.824 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.403 HD12 HE21 ' A' ' 418' ' ' GLN . 1.4 mm? -59.93 -52.27 66.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.645 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.432 ' CD1' HG12 ' A' ' 411' ' ' VAL . 94.7 mt -56.95 -49.23 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.894 0.378 . . . . 0.0 110.559 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.92 -55.2 37.6 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.292 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 24.1 ttm -54.2 -46.22 72.4 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.27 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 1.007 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 39.1 mt-30 -50.57 -50.45 53.67 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.819 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -70.87 -37.77 73.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.161 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.11 -56.99 12.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.414 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.55 77.0 0.33 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.974 0.416 . . . . 0.0 111.524 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 1.007 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -163.31 -170.58 2.31 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.19 168.87 9.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 111.633 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.396 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.239 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 CA--C 1.532 0.28 0 CA-C-O 121.179 0.514 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.609 HG13 ' H ' ' A' ' 430' ' ' MET . 0.9 OUTLIER -155.37 -67.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.807 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . 0.609 ' H ' HG13 ' A' ' 429' ' ' VAL . 0.0 OUTLIER -60.94 -53.54 56.03 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.79 -38.16 84.36 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.836 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 436' ' ' VAL . 63.6 t80 -63.88 -54.77 29.61 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -54.58 45.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.727 0.299 . . . . 0.0 110.717 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.63 -53.62 55.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.946 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.11 -50.97 60.29 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.732 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 432' ' ' TYR . 43.0 t -57.42 -44.56 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.857 0.328 . . . . 0.0 110.725 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 20.3 t -57.04 -60.7 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.24 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 35.5 m -60.77 -43.62 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.543 0.211 . . . . 0.0 111.273 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.2 t -56.39 -51.0 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -61.85 -48.42 80.62 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.271 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.85 -44.67 70.54 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.829 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . 0.57 ' HA ' ' CG2' ' A' ' 403' ' ' VAL . 0.0 OUTLIER -71.62 -52.46 17.88 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.165 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.472 ' O ' ' N ' ' A' ' 445' ' ' ARG . 4.1 t80 -55.01 -29.21 56.86 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.996 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -65.7 58.77 0.13 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.74 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.1 OUTLIER -164.9 42.18 0.08 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.968 0.507 . . . . 0.0 110.601 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . 0.466 ' HB2' ' O ' ' A' ' 445' ' ' ARG . 27.4 m0 76.4 142.34 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.065 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.569 ' O ' ' HB3' ' A' ' 451' ' ' ALA . 37.4 Cg_endo -65.54 -39.87 20.08 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.469 2.112 . . . . 0.0 112.08 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.47 ' O ' HG22 ' A' ' 450' ' ' VAL . 0.4 OUTLIER 51.14 20.11 0.82 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 39.5 t 65.62 -63.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 448' ' ' SER . 1.8 m -52.18 -48.14 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 447' ' ' PRO . . . -61.19 -47.68 85.02 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.739 0.304 . . . . 0.0 110.719 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 30.5 m -59.25 -55.09 39.35 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.401 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.65 -43.04 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.266 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.948 HG23 HG23 ' A' ' 486' ' ' THR . 10.1 mt -63.63 -59.29 4.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.6 0.238 . . . . 0.0 111.069 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -54.3 -48.58 71.13 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 38.7 t -60.95 -65.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.261 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 54.9 t -47.26 -47.26 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.601 0.238 . . . . 0.0 111.072 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 11.3 t -55.83 -58.13 9.13 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.02 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.19 -51.64 68.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.164 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.25 -43.29 78.54 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.536 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 1.4 mp -68.66 -46.08 70.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.284 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -55.88 107.5 0.35 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.926 0.394 . . . . 0.0 110.893 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 CA--C 1.53 0.188 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.448 -179.815 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.466 0.345 0 CA-C-O 120.807 0.337 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.672 HG12 HD12 ' A' ' 479' ' ' LEU . 76.4 t -59.47 -52.19 63.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.01 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -63.55 -37.0 85.64 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.854 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -64.5 -55.77 18.46 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.6 -47.16 82.9 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.88 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . 0.672 HD12 HG12 ' A' ' 475' ' ' VAL . 5.7 mt -56.48 -52.88 63.04 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . 0.515 HG22 ' SD ' ' A' ' 484' ' ' MET . 37.8 m -54.72 -45.86 74.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.13 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -59.96 -46.93 87.84 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.032 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.77 72.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.412 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 487' ' ' VAL . 28.5 m -64.34 -45.54 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 121.142 -0.223 . . . . 0.0 110.7 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . 0.515 ' SD ' HG22 ' A' ' 480' ' ' THR . 16.1 mtt -56.82 -55.03 39.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.23 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.27 -46.18 79.79 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.004 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . 0.948 HG23 HG23 ' A' ' 454' ' ' ILE . 88.9 m -54.13 -51.91 62.75 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.959 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.892 HG22 HD11 ' A' ' 408' ' ' LEU . 94.5 t -55.94 -51.82 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.652 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.6 -48.11 79.37 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.407 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.89 -46.81 88.14 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.736 0.303 . . . . 0.0 110.78 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 486' ' ' THR . 63.6 t -65.38 -60.11 3.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.367 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.422 ' HA ' ' CD2' ' A' ' 494' ' ' LEU . 0.6 OUTLIER -52.8 -43.56 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.36 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.56 -53.31 42.52 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.065 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -58.3 -51.72 68.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.559 0.219 . . . . 0.0 111.499 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.567 ' CD2' HG11 ' A' ' 404' ' ' VAL . 1.2 pp -61.97 -47.21 85.87 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 56.8 m -57.43 -48.14 79.92 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.652 0.263 . . . . 0.0 110.909 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.51 56.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.732 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -54.73 -49.44 61.61 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.159 -0.544 . . . . 0.0 112.994 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.528 HG21 HE21 ' A' ' 398' ' ' GLN . 8.6 p -65.83 -41.5 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 16.8 mtm105 -68.51 -44.19 75.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.842 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 121.254 0.55 . . . . 0.0 111.719 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.516 ' O ' ' HG2' ' A' ' 400' ' ' GLN . 1.1 tp -56.07 113.87 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.805 0.336 . . . . 0.0 110.451 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.823 ' HA ' HG21 ' A' ' 404' ' ' VAL . 0.0 OUTLIER 59.58 69.46 0.71 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.824 0.821 . . . . 0.0 111.086 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.535 ' HA2' ' CG2' ' A' ' 498' ' ' VAL . . . -128.58 -150.27 7.17 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.817 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.86 -51.33 61.42 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.291 0.236 . . . . 0.0 111.525 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 20.1 m -55.22 -40.19 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.477 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 400' ' ' GLN . 2.7 t -62.42 -49.57 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.217 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.58 81.1 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.877 0.37 . . . . 0.0 110.192 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.9 81.24 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.223 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.726 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -59.04 -47.93 83.45 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.113 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 408' ' ' LEU . 7.8 tt -55.82 -51.15 68.47 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.925 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -45.23 86.62 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.341 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.11 82.13 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.196 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.484 HG21 HG21 ' A' ' 439' ' ' VAL . 53.5 t -55.7 -56.96 9.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.579 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 415' ' ' ILE . 51.0 mt -53.17 -42.52 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.892 0.377 . . . . 0.0 110.114 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 29.2 m -60.68 -46.38 90.59 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.817 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.77 -44.32 93.93 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.874 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 412' ' ' ILE . 61.4 mt -54.87 -48.46 74.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.29 83.6 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.562 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 10.5 mtt -59.87 -52.1 66.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.817 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.61 ' HB3' HD22 ' A' ' 428' ' ' LEU . 14.4 mm100 -56.76 -50.77 71.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.479 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . 0.403 ' HA ' ' O ' ' A' ' 422' ' ' ALA . 0.0 OUTLIER -58.78 -42.12 88.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.621 179.229 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -30.08 71.07 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.322 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 7.3 ttt -91.66 -43.51 9.56 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.558 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.812 ' HB3' HD21 ' A' ' 428' ' ' LEU . . . -135.33 156.32 49.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.819 0.343 . . . . 0.0 111.431 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -116.41 25.4 10.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.622 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 111.617 -179.977 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 422' ' ' ALA . 45.0 mt . . . . . 0 C--O 1.236 0.394 0 CA-C-O 120.611 0.243 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 3.4 t -60.92 -45.04 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.921 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 20.7 mtt -48.64 -57.06 6.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 110.237 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.79 -47.76 83.67 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.103 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.487 ' HE1' HD11 ' A' ' 415' ' ' ILE . 20.2 t80 -52.97 -52.39 58.35 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.148 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.587 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.2 OUTLIER -60.49 -42.88 97.21 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.39 -48.52 65.6 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.553 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.11 -44.23 98.42 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.744 HG11 ' CB ' ' A' ' 458' ' ' SER . 69.6 t -56.9 -40.82 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 433' ' ' LEU . 65.7 t -61.19 -47.91 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.37 -48.33 85.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.726 HG22 ' HB1' ' A' ' 407' ' ' ALA . 76.9 t -57.42 -50.17 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.969 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.11 82.9 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.451 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 441' ' ' LEU . 0.6 OUTLIER -53.17 -50.48 64.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.897 178.355 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -70.76 -21.43 62.52 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.177 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.537 ' OH ' HG13 ' A' ' 490' ' ' VAL . 0.2 OUTLIER -77.24 -2.47 34.84 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -71.1 -161.38 4.2 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.807 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.472 ' O ' HD13 ' A' ' 399' ' ' ILE . 0.0 OUTLIER 78.33 106.08 0.07 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.932 0.493 . . . . 0.0 111.159 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . 0.418 ' HB2' ' O ' ' A' ' 445' ' ' ARG . 46.2 m0 67.51 89.29 0.1 OUTLIER Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.67 128.77 25.52 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 112.821 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 91.7 p -113.07 -87.18 0.56 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.302 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 453' ' ' VAL . 7.2 p -178.17 -46.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.548 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 454' ' ' ILE . 53.5 t -54.39 -48.58 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.103 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . 0.498 ' O ' HG13 ' A' ' 454' ' ' ILE . . . -54.86 -42.35 71.92 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.172 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.2 OUTLIER -63.89 -49.08 74.11 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.973 178.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 449' ' ' VAL . 61.5 t -57.69 -56.18 17.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.799 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 451' ' ' ALA . 1.9 pp -59.17 -41.73 84.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.717 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.435 ' N ' HD12 ' A' ' 454' ' ' ILE . 1.2 m120 -55.82 -52.21 64.79 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 452' ' ' THR . 93.0 t -55.18 -47.86 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.871 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 40.3 t -48.79 -54.08 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.282 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . 0.744 ' CB ' HG11 ' A' ' 436' ' ' VAL . 0.1 OUTLIER -59.61 -43.23 93.81 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.463 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -54.98 -58.46 7.52 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.368 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . 0.451 ' OD2' HG12 ' A' ' 456' ' ' VAL . 29.4 m-20 -62.13 -37.38 84.94 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.269 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.538 HD11 HD12 ' A' ' 479' ' ' LEU . 1.6 tp -64.78 -22.96 67.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.531 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . 0.55 ' CD1' ' HG ' ' A' ' 433' ' ' LEU . 15.5 t80 -58.9 70.17 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.347 0.594 . . . . 0.0 111.463 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 461' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.088 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.775 0.322 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.43 ' CG1' HD23 ' A' ' 479' ' ' LEU . 83.0 t -53.19 -45.74 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.331 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -35.05 71.9 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.387 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -71.01 -50.95 28.54 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 42.6 mt -58.9 -49.17 78.8 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.596 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . 0.538 HD12 HD11 ' A' ' 461' ' ' LEU . 2.9 mm? -57.51 -52.14 66.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.261 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . 0.447 ' HA ' HG22 ' A' ' 483' ' ' VAL . 39.0 m -57.19 -42.7 81.73 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.976 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -58.03 -49.04 78.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.309 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.02 -49.44 76.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.368 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 480' ' ' THR . 17.4 m -65.64 -37.36 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.751 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 8.7 mtt -62.66 -53.76 49.59 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 4.7 tp -56.02 -43.34 77.66 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.428 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 490' ' ' VAL . 32.9 m -59.15 -48.18 82.56 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.784 178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 15.6 t -58.03 -47.68 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.096 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . 0.511 ' O ' HG13 ' A' ' 491' ' ' ILE . . . -53.41 -44.72 66.53 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -45.77 83.2 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.796 0.331 . . . . 0.0 110.169 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 486' ' ' THR . 69.8 t -58.88 -54.37 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.553 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.52 ' O ' ' HG ' ' A' ' 494' ' ' LEU . 2.3 pp -57.29 -42.45 80.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . 0.414 ' N ' HD12 ' A' ' 491' ' ' ILE . . . -63.71 -45.04 95.43 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.294 -0.955 . . . . 0.0 110.982 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.59 -55.7 28.96 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.304 0.241 . . . . 0.0 110.797 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.658 ' HA ' ' HG3' ' A' ' 400' ' ' GLN . 3.2 pp -61.76 -39.56 92.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.804 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 96.4 m -52.87 -48.77 66.86 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -72.72 -48.8 35.67 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.706 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -51.43 -36.26 37.73 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 116.33 -0.395 . . . . 0.0 113.611 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.535 ' CG2' ' HA2' ' A' ' 401' ' ' GLY . 76.0 t -74.36 -10.11 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.945 0.373 . . . . 0.0 111.883 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -122.27 179.04 4.69 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.014 0.435 . . . . 0.0 111.299 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.996 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 120.769 0.318 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 2.9 mt -74.32 -53.34 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.408 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.756 ' NE2' HG21 ' A' ' 498' ' ' VAL . 0.2 OUTLIER -146.05 44.64 1.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' ' 404' ' ' VAL . . . -111.12 -101.48 2.62 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.278 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 9.1 t -47.23 -40.84 17.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.844 0.322 . . . . 0.0 111.142 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 404' ' ' VAL . 22.4 m -63.04 -48.74 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.755 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 401' ' ' GLY . 2.5 p -69.01 -42.19 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 121.159 -0.217 . . . . 0.0 111.309 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.04 -57.35 13.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 111.048 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.53 -49.4 77.94 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.72 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -54.43 -58.68 6.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.43 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.841 HD11 HG13 ' A' ' 487' ' ' VAL . 0.1 OUTLIER -61.47 -49.93 74.8 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.283 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . 0.436 ' O ' HG23 ' A' ' 413' ' ' THR . 13.7 t -51.43 -52.65 44.41 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.68 68.63 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.109 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.529 HG12 HD12 ' A' ' 415' ' ' ILE . 15.1 t -52.06 -41.81 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 18.7 mm -62.58 -52.3 61.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.923 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 409' ' ' SER . 24.3 p -60.1 -48.13 82.99 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.763 -0.199 . . . . 0.0 110.644 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' A' ' 431' ' ' LEU . 96.3 mt -59.33 -51.06 71.54 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.745 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.529 HD12 HG12 ' A' ' 411' ' ' VAL . 40.2 mt -59.61 -48.29 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.6 -56.36 22.95 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.755 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 9.2 mtt -53.03 -46.74 68.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.656 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.711 ' HG2' HD23 ' A' ' 428' ' ' LEU . 18.1 tm0? -60.77 -58.29 9.1 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.63 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . 0.521 ' HE3' HD12 ' A' ' 420' ' ' LEU . 71.6 t90 -51.93 -42.8 63.1 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.007 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.521 HD12 ' HE3' ' A' ' 419' ' ' TRP . 0.2 OUTLIER -61.32 -25.55 67.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.448 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.55 137.08 34.11 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.953 0.406 . . . . 0.0 110.905 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -72.76 75.16 1.13 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 111.439 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.07 173.81 13.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.125 0.488 . . . . 0.0 111.698 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 C--O 1.237 0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.541 -179.915 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.711 HD23 ' HG2' ' A' ' 418' ' ' GLN . 2.3 mm? . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 430' ' ' MET . 11.0 p -48.0 -43.53 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . 0.47 ' O ' ' HB2' ' A' ' 434' ' ' LEU . 21.4 ttm -57.6 -57.58 12.08 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.026 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.618 ' HB3' HD22 ' A' ' 414' ' ' LEU . 1.1 mt -57.84 -42.58 84.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.028 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.55 ' HB3' HD21 ' A' ' 461' ' ' LEU . 5.7 m-85 -62.42 -60.03 4.13 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.055 0.455 . . . . 0.0 110.597 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.74 -57.06 14.08 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.483 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 430' ' ' MET . 8.1 mp -52.11 -46.84 65.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.984 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.18 -65.14 3.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.897 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.775 HG11 HD13 ' A' ' 461' ' ' LEU . 34.4 m -59.11 -38.23 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 441' ' ' LEU . 19.5 t -63.48 -52.35 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.923 -0.126 . . . . 0.0 110.796 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 14.9 t -55.76 -52.73 45.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 110.377 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 96.5 t -58.41 -54.62 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.256 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.59 ' HA ' HD13 ' A' ' 454' ' ' ILE . . . -56.95 -52.09 66.58 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 437' ' ' VAL . 1.3 tp -56.73 -47.92 78.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.609 0.242 . . . . 0.0 110.963 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -67.24 -28.98 68.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.964 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -67.84 176.62 2.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.245 0.545 . . . . 0.0 111.629 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 122.15 42.72 0.42 Allowed Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 113.104 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -134.97 116.38 14.62 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.317 0.247 . . . . 0.0 110.391 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 25.6 m95 64.77 97.85 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.598 0 CA-C-O 120.872 0.368 . . . . 0.0 111.899 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.61 76.91 1.84 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.504 2.136 . . . . 0.0 112.279 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 449' ' ' VAL . 97.6 p -104.37 -85.07 0.47 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.683 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.42 ' N ' ' OG ' ' A' ' 448' ' ' SER . 2.7 p -137.68 -51.26 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 4.5 m -46.24 -46.14 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . 0.477 ' O ' HG13 ' A' ' 454' ' ' ILE . . . -58.78 -49.07 79.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.886 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 8.2 m -57.51 -41.65 81.2 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.731 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 449' ' ' VAL . 59.4 t -61.08 -59.0 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 440' ' ' ALA . 1.8 pp -60.5 -42.24 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.478 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 451' ' ' ALA . 1.4 t30 -58.88 -54.68 44.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.545 0.212 . . . . 0.0 110.705 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.93 -55.48 23.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.522 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 3.1 t -48.45 -45.34 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.212 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 2.6 t -59.8 -57.13 14.23 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.156 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -46.35 -51.21 15.26 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.726 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -64.84 -44.64 89.11 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.595 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.775 HD13 HG11 ' A' ' 436' ' ' VAL . 2.0 tt -48.83 -38.81 23.29 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.52 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -51.12 -26.39 6.53 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.263 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 CA--C 1.539 0.551 0 CA-C-O 120.818 0.342 . . . . 0.0 111.178 179.327 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.237 0.419 0 CA-C-O 120.626 0.251 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 17.8 m -50.22 -41.45 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.301 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -53.23 -58.32 7.48 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.706 0.289 . . . . 0.0 111.024 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -56.94 -50.09 73.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -56.18 23.39 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.003 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.89 -50.71 71.69 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.815 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 18.1 m -55.27 -51.5 66.46 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.687 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -59.32 -55.77 30.5 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.02 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -54.14 -47.63 71.7 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.653 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.92 -53.84 36.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.163 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 52.2 mtp -53.9 -52.52 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.282 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -56.12 25.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.997 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 490' ' ' VAL . 9.7 m -56.01 -57.68 11.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.988 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.841 HG13 HD11 ' A' ' 408' ' ' LEU . 39.2 t -53.2 -53.03 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.239 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -55.48 -52.92 44.63 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.2 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.1 -45.95 79.26 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.655 0.264 . . . . 0.0 110.377 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 486' ' ' THR . 68.4 t -60.34 -50.01 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.034 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.642 HD11 ' CD2' ' A' ' 408' ' ' LEU . 97.2 mt -51.64 -48.22 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 120.788 0.328 . . . . 0.0 110.368 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -67.65 -45.04 79.46 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.954 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -49.41 73.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.288 0.235 . . . . 0.0 111.477 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.735 HD13 ' HG3' ' A' ' 400' ' ' GLN . 3.1 pp -69.22 -43.96 73.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.373 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.526 ' N ' HD12 ' A' ' 494' ' ' LEU . 26.6 m -63.73 -41.31 98.08 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.561 0.22 . . . . 0.0 111.304 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -68.47 -50.03 55.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.313 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -67.97 -56.98 9.29 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.151 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.756 HG21 ' NE2' ' A' ' 400' ' ' GLN . 32.2 t -75.52 64.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.319 0.581 . . . . 0.0 110.987 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . 0.416 ' HB3' ' NH1' ' A' ' 499' ' ' ARG . 7.6 ttp-105 -148.73 41.73 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.946 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.386 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.475 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.448 0.166 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.08 -76.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.211 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.995 ' HG2' HG11 ' A' ' 404' ' ' VAL . 5.6 mt-30 -117.07 124.82 50.18 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.874 -0.148 . . . . 0.0 110.94 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 1.007 ' HA2' HD23 ' A' ' 494' ' ' LEU . . . -158.22 -132.66 1.44 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.364 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -41.09 61.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.93 0.365 . . . . 0.0 110.988 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.458 HG23 ' N ' ' A' ' 404' ' ' VAL . 18.0 m -55.86 -52.49 48.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.599 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.995 HG11 ' HG2' ' A' ' 400' ' ' GLN . 16.3 m -72.79 -31.79 37.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 121.194 -0.203 . . . . 0.0 110.94 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.07 -45.05 90.47 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.889 0.375 . . . . 0.0 110.101 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.48 -50.91 61.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.874 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 440' ' ' ALA . . . -56.01 -48.11 76.52 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.099 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.758 HD21 HG13 ' A' ' 487' ' ' VAL . 2.9 tp -58.99 -45.01 91.69 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.812 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 58.1 m -53.28 -44.32 68.16 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.24 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . 0.415 ' HB3' HG13 ' A' ' 436' ' ' VAL . . . -62.92 -48.16 80.14 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.266 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.429 HG12 HD11 ' A' ' 415' ' ' ILE . 75.3 t -57.7 -54.66 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.355 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 415' ' ' ILE . 93.4 mt -52.68 -48.23 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.885 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 35.7 m -57.38 -45.23 84.68 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.661 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' A' ' 432' ' ' TYR . 1.4 mm? -56.7 -55.95 27.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.208 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 412' ' ' ILE . 9.7 mt -54.86 -47.12 75.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.442 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.14 79.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.08 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -44.84 82.49 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.549 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 1.04 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 14.4 tt0 -57.7 -58.13 9.7 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.607 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -57.3 -35.77 70.24 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.62 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 421' ' ' MET . 1.0 OUTLIER -70.62 -53.49 15.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.476 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . 0.434 ' HB2' HD23 ' A' ' 420' ' ' LEU . 1.7 mtt -171.83 71.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 1.04 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -156.71 115.04 3.29 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.918 0.389 . . . . 0.0 111.061 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -72.98 94.22 1.84 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.036 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 CA--C 1.536 0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.865 179.138 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 120.485 0.183 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.439 HG21 ' HB1' ' A' ' 422' ' ' ALA . 89.2 t -53.28 -46.37 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.888 0.375 . . . . 0.0 110.302 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -49.47 76.02 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.125 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 4.0 mp -58.42 -48.44 80.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.362 -0.381 . . . . 0.0 109.979 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.632 ' HB3' HD11 ' A' ' 414' ' ' LEU . 0.2 OUTLIER -55.53 -54.97 37.32 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.172 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.4 OUTLIER -56.62 -43.11 79.88 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.183 178.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 438' ' ' VAL . 0.1 OUTLIER -56.46 -52.21 65.53 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -55.22 -47.7 72.95 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 432' ' ' TYR . 92.3 t -56.43 -47.3 81.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 433' ' ' LEU . 68.1 t -58.43 -44.61 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.848 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 434' ' ' LEU . 64.2 t -58.44 -45.55 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.432 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 72.6 t -56.81 -53.11 46.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.977 0.418 . . . . 0.0 110.328 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.451 ' HB2' ' HB1' ' A' ' 407' ' ' ALA . . . -59.71 -47.09 87.02 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.405 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -40.97 80.22 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.595 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.66 -37.4 86.41 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.699 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.23 -43.64 15.87 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.578 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.48 172.94 37.75 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.469 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.699 ' O ' ' HB1' ' A' ' 451' ' ' ALA . 3.7 mtt180 -130.63 -170.82 2.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 111.961 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . 0.56 ' H ' ' HD2' ' A' ' 447' ' ' PRO . 22.8 m-90 -110.93 -59.64 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.56 ' HD2' ' H ' ' A' ' 446' ' ' TRP . 53.7 Cg_endo -69.03 61.38 1.33 Allowed 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.205 1.937 . . . . 0.0 113.311 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.12 29.21 1.09 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.332 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 92.9 t 56.63 -83.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.68 0.392 . . . . 0.0 111.814 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 15.6 m -54.6 -44.83 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.563 0.221 . . . . 0.0 110.893 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . 0.699 ' HB1' ' O ' ' A' ' 445' ' ' ARG . . . -57.76 -43.43 85.43 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.756 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -50.5 73.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.066 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 49.1 t -59.38 -48.59 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.57 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.12 -47.48 86.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.154 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.2 -49.97 75.81 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.12 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 31.8 t -54.69 -53.79 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.5 ' CG1' HD13 ' A' ' 461' ' ' LEU . 24.3 t -48.94 -53.49 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.147 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -39.81 72.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.59 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -56.21 -55.81 28.64 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.414 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.93 -42.26 99.74 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.858 0.361 . . . . 0.0 110.656 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.5 HD13 ' CG1' ' A' ' 457' ' ' VAL . 0.1 OUTLIER -63.78 -23.8 67.5 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.511 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -67.72 73.48 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.197 0.523 . . . . 0.0 110.918 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.252 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.994 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.681 0.277 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.623 HG12 HD12 ' A' ' 479' ' ' LEU . 99.1 t -59.47 -58.32 7.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.321 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -33.61 67.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.136 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -70.55 -53.45 16.05 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.17 -48.32 73.94 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.033 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 483' ' ' VAL . 1.1 mt -57.24 -48.52 78.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.652 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 61.3 m -57.87 -42.75 85.19 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.437 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -56.18 -50.9 69.89 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.887 0.375 . . . . 0.0 110.14 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.75 88.23 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.142 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 479' ' ' LEU . 54.4 t -61.62 -45.34 98.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.803 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 95.4 mtp -55.11 -54.64 40.6 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.756 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 485' ' ' LEU . 0.5 OUTLIER -57.47 -44.06 84.56 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 62.6 m -53.92 -49.77 67.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.071 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.758 HG13 HD21 ' A' ' 408' ' ' LEU . 88.5 t -62.44 -50.51 79.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.113 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -52.55 -42.76 58.28 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.9 -46.51 87.46 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.99 -53.34 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.232 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 7.2 tp -59.64 -39.85 80.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 120.571 0.224 . . . . 0.0 110.967 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -66.49 -47.58 68.8 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -56.14 -40.68 74.19 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.628 -0.286 . . . . 0.0 110.241 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 1.007 HD23 ' HA2' ' A' ' 401' ' ' GLY . 0.0 OUTLIER -69.59 -47.15 64.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.778 ' N ' HD13 ' A' ' 494' ' ' LEU . 91.3 m -49.97 -48.45 52.19 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.638 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -83.13 -45.28 14.14 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.681 0.277 . . . . 0.0 111.474 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -47.84 -61.73 4.6 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.812 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 498' ' ' VAL . 50.8 t -74.34 60.08 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.551 0.691 . . . . 0.0 110.122 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -169.81 -52.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.654 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 120.88 0.372 . . . . 0.0 111.884 179.567 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.447 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 400' ' ' GLN . 0.2 OUTLIER -61.59 129.59 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.863 0.363 . . . . 0.0 110.924 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.647 ' N ' HD13 ' A' ' 399' ' ' ILE . 1.4 mm-40 57.78 64.23 1.6 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.195 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -128.64 -169.24 12.57 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.75 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 24.9 t -41.0 -56.42 2.28 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.626 0.25 . . . . 0.0 111.608 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.438 HG11 ' CE1' ' A' ' 442' ' ' PHE . 98.2 t -53.04 -43.17 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.84 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.5 -46.72 94.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.233 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . 0.829 ' HB2' HD13 ' A' ' 494' ' ' LEU . . . -55.67 -49.42 72.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.84 0.352 . . . . 0.0 110.068 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.66 -53.27 59.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.679 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -52.19 -49.28 64.16 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.783 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.548 ' HA ' HG22 ' A' ' 411' ' ' VAL . 1.1 tp -60.27 -44.17 95.56 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -45.7 89.89 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.881 0.372 . . . . 0.0 110.262 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.27 -53.88 42.0 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.216 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 408' ' ' LEU . 35.4 m -58.86 -48.23 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.136 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.418 ' N ' HG23 ' A' ' 411' ' ' VAL . 56.9 mt -55.04 -46.84 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 82.5 m -57.12 -45.47 83.44 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.762 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.565 HD23 HD23 ' A' ' 431' ' ' LEU . 1.3 mp -59.9 -50.76 72.49 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.215 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.52 HG22 ' CE3' ' A' ' 419' ' ' TRP . 12.2 mm -55.76 -47.9 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.023 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.06 92.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.053 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 1.5 tpt -57.25 -46.98 82.52 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.055 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.472 ' HB2' HD21 ' A' ' 428' ' ' LEU . 3.3 mt-30 -65.53 -37.67 87.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.181 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . 0.52 ' CE3' HG22 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -60.61 -37.35 81.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.614 179.055 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.17 57.2 0.1 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.202 0.525 . . . . 0.0 110.886 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . 0.588 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 4.3 mtp -136.49 -37.26 0.69 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.829 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 90.54 84.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.136 0.574 . . . . 0.0 111.161 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.3 -174.01 0.38 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.737 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 14.5 p30 . . . . . 0 CA--C 1.536 0.439 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.927 179.573 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 418' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 14.7 p -45.28 -34.17 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 29.1 mtt -56.74 -58.97 5.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.834 0.35 . . . . 0.0 110.275 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.565 HD23 HD23 ' A' ' 414' ' ' LEU . 6.1 mp -67.85 -40.3 83.71 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.41 ' O ' HG23 ' A' ' 436' ' ' VAL . 1.5 t80 -54.49 -56.45 18.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.913 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.53 -45.67 84.78 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.22 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 438' ' ' VAL . 0.5 OUTLIER -52.93 -51.26 61.97 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 178.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -63.42 -44.05 97.34 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.846 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.525 HG11 ' CZ ' ' A' ' 459' ' ' PHE . 39.9 t -56.34 -53.73 36.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.48 0.181 . . . . 0.0 111.025 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.73 -43.38 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.602 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 434' ' ' LEU . 44.0 t -58.71 -52.45 59.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 435' ' ' GLY . 70.2 t -56.11 -53.64 36.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.405 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -53.75 -47.13 70.96 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.463 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 4.0 tt -52.02 -47.26 65.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.776 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . 0.438 ' CE1' HG11 ' A' ' 403' ' ' VAL . 20.2 m-85 -68.4 -33.3 74.0 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.717 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 445' ' ' ARG . 3.8 m-85 -70.38 -21.86 62.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.607 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -63.53 67.55 0.04 OUTLIER Glycine 0 C--N 1.341 0.826 0 C-N-CA 121.571 -0.347 . . . . 0.0 113.271 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.0 OUTLIER -140.71 -61.83 0.49 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.121 0.486 . . . . 0.0 110.076 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -154.05 88.38 3.51 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.999 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.24 176.17 2.18 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.941 2.427 . . . . 0.0 113.663 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.8 m -171.21 153.19 3.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.409 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 453' ' ' VAL . 58.0 t -39.9 -60.92 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.567 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.623 HG11 ' OD1' ' A' ' 493' ' ' ASN . 46.7 t -51.06 -56.29 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . 0.644 ' HA ' HD12 ' A' ' 454' ' ' ILE . . . -53.55 -48.41 69.13 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.782 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 456' ' ' VAL . 88.7 m -57.97 -46.12 85.66 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.248 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 449' ' ' VAL . 88.9 t -60.97 -44.12 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.121 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 451' ' ' ALA . 30.6 mt -56.57 -50.96 71.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 120.889 0.376 . . . . 0.0 110.218 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.62 -50.29 73.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.71 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 452' ' ' THR . 90.3 t -56.43 -52.34 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.145 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 453' ' ' VAL . 55.2 t -53.68 -49.79 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.722 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -44.75 96.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.375 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . 0.525 ' CZ ' HG11 ' A' ' 436' ' ' VAL . 2.3 m-85 -58.58 -48.65 80.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.774 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.93 -44.91 96.56 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.943 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.445 HD11 HD22 ' A' ' 479' ' ' LEU . 30.0 tp -58.9 -48.23 82.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.989 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -87.14 92.94 9.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.019 0.438 . . . . 0.0 111.475 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 28.8 t80 . . . . . 0 CA--C 1.539 0.553 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.044 -179.747 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 479' ' ' LEU . 6.7 p -53.52 -42.86 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.25 -47.67 85.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.579 0.228 . . . . 0.0 111.269 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.29 -51.0 61.74 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.609 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.7 -53.44 56.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.861 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 475' ' ' VAL . 0.1 OUTLIER -57.9 -48.08 80.9 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.173 179.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 99.4 m -53.9 -52.54 60.2 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.397 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -59.3 -48.61 80.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.709 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.85 75.17 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.995 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 487' ' ' VAL . 93.6 t -65.52 -52.84 46.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.497 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 3.3 ttt -52.23 -51.73 56.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.866 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -49.43 77.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.333 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . 0.478 HG23 HG23 ' A' ' 454' ' ' ILE . 88.6 m -54.57 -58.27 8.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.159 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 483' ' ' VAL . 36.0 m -59.81 -43.92 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.814 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . 0.493 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -55.24 -51.45 54.13 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . 0.586 HD22 HG13 ' A' ' 450' ' ' VAL . 5.6 mt -55.36 -46.57 76.46 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.522 HG21 ' CD2' ' A' ' 408' ' ' LEU . 59.0 t -57.07 -45.17 84.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.577 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.493 HD12 ' HA2' ' A' ' 488' ' ' GLY . 50.3 mt -58.46 -46.31 89.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.792 0.33 . . . . 0.0 110.615 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.76 -53.57 33.84 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.93 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . 0.623 ' OD1' HG11 ' A' ' 450' ' ' VAL . 2.1 m120 -56.76 -46.52 81.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.642 0.258 . . . . 0.0 110.78 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.829 HD13 ' HB2' ' A' ' 405' ' ' ALA . 0.6 OUTLIER -60.38 -46.3 90.47 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.165 178.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 89.9 m -54.86 -51.13 66.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.948 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.7 84.57 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.009 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -57.86 -44.0 94.52 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.439 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.56 -48.49 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 120.581 0.229 . . . . 0.0 110.498 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -79.4 54.1 1.65 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.136 0.493 . . . . 0.0 110.325 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 C--O 1.233 0.206 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.701 -179.343 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . 0.758 ' HA ' HG21 ' A' ' 498' ' ' VAL . 1.0 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.556 0.217 . . . . 0.0 110.524 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.644 ' HB ' HD21 ' A' ' 494' ' ' LEU . 1.2 mp -90.51 -58.1 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.733 0.302 . . . . 0.0 110.455 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.511 ' HB2' HD23 ' A' ' 494' ' ' LEU . 0.7 OUTLIER -159.62 91.43 0.99 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.625 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -141.82 -98.13 0.31 Allowed Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.172 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 5.5 t -55.25 -55.03 36.04 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.667 0.27 . . . . 0.0 111.254 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 443' ' ' TYR . 17.6 m -50.46 -45.0 25.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.055 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.443 HG12 ' CD1' ' A' ' 491' ' ' ILE . 3.2 t -70.44 -37.42 70.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.379 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.31 96.67 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.31 -49.99 67.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.784 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.563 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -55.61 -50.79 69.21 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.327 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 408' ' ' LEU . 0.2 OUTLIER -58.96 -45.88 89.43 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.229 178.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 53.4 m -52.94 -42.22 65.25 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.145 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.41 -48.52 75.09 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.393 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 407' ' ' ALA . 17.4 t -57.89 -46.93 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.393 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 23.0 mm -59.71 -45.33 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 49.0 m -58.78 -48.19 82.11 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.028 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 432' ' ' TYR . 1.6 mp -56.18 -48.47 76.29 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.149 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.442 HG22 ' HD1' ' A' ' 419' ' ' TRP . 32.5 mm -61.53 -45.78 97.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.389 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -52.44 -51.58 58.47 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.033 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -47.36 85.94 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.624 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -50.63 -42.49 56.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.54 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . 0.442 ' HD1' HG22 ' A' ' 415' ' ' ILE . 44.7 m95 -67.78 -45.02 76.03 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.503 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.51 -40.47 93.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.424 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . 0.427 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 29.2 mtt -146.17 134.19 21.47 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.137 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 72.04 74.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.205 0.526 . . . . 0.0 111.398 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -55.02 159.47 2.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.877 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 . . . . . 0 CA--C 1.536 0.414 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.452 -179.888 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.55 HG13 HD23 ' A' ' 414' ' ' LEU . 54.8 t -41.52 -37.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -41.17 -54.3 2.93 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 7.1 tp -57.64 -52.55 64.97 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.005 0.431 . . . . 0.0 110.494 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.64 ' HB3' HD21 ' A' ' 414' ' ' LEU . 46.5 m-85 -58.36 -48.94 78.95 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.085 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.408 ' N ' HD21 ' A' ' 414' ' ' LEU . 0.2 OUTLIER -53.47 -47.76 69.46 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.915 178.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 437' ' ' VAL . 2.8 tp -53.66 -49.68 67.42 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.888 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.49 -44.47 97.96 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.79 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 432' ' ' TYR . 63.8 t -58.16 -52.56 57.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 122.058 0.143 . . . . 0.0 111.011 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 434' ' ' LEU . 33.3 m -56.57 -40.92 71.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.7 -46.78 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 435' ' ' GLY . 99.1 t -55.33 -49.62 71.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.12 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.01 75.42 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.542 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -37.9 73.2 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.734 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -70.63 -45.19 65.65 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.508 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.466 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 2.9 m-85 -68.63 -49.1 61.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.508 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' A' ' 445' ' ' ARG . . . -67.43 161.33 48.45 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.787 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 444' ' ' GLY . 0.0 OUTLIER -155.86 -61.01 0.11 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 122.631 -0.335 . . . . 0.0 111.501 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -81.02 108.23 9.71 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.689 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.844 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 29.7 Cg_endo -64.02 -50.21 3.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.352 2.034 . . . . 0.0 112.528 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 58.2 m 43.31 43.67 4.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.859 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 26.9 t 68.42 -57.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.463 HG12 ' CD1' ' A' ' 454' ' ' ILE . 13.1 t -47.5 -55.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . 0.844 ' HB3' ' HA ' ' A' ' 447' ' ' PRO . . . -57.57 -48.24 79.9 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.635 0.255 . . . . 0.0 110.976 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 456' ' ' VAL . 12.6 m -56.21 -53.59 55.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.665 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 457' ' ' VAL . 42.8 t -56.24 -54.51 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.664 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.463 ' CD1' HG12 ' A' ' 450' ' ' VAL . 52.3 mt -52.63 -52.2 28.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.578 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -55.72 -53.41 56.98 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.396 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 452' ' ' THR . 44.8 t -51.88 -52.34 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.516 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 453' ' ' VAL . 86.2 t -49.73 -52.75 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.672 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 1.2 p -60.75 -41.25 95.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.762 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -61.12 -41.23 96.32 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.807 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -73.03 -42.16 63.46 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.478 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.599 HD11 HD22 ' A' ' 479' ' ' LEU . 3.6 tt -59.18 -46.56 88.09 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.769 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -101.17 -167.23 1.4 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.114 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.348 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 35.7 t70 . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 33.3 t -56.0 -59.77 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -40.79 95.9 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.16 -51.35 54.85 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.531 0.205 . . . . 0.0 110.849 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -51.86 67.28 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.829 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . 0.599 HD22 HD11 ' A' ' 461' ' ' LEU . 0.8 OUTLIER -56.18 -53.67 54.32 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.642 0.258 . . . . 0.0 110.378 179.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . 0.458 HG22 ' SD ' ' A' ' 484' ' ' MET . 42.8 m -54.29 -48.65 71.03 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.776 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . 0.593 ' CE1' HD13 ' A' ' 485' ' ' LEU . 9.5 t80 -61.3 -47.38 86.21 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 110.979 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.57 73.55 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.267 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.637 ' O ' HG23 ' A' ' 487' ' ' VAL . 31.3 m -64.13 -42.25 94.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . 0.458 ' SD ' HG22 ' A' ' 480' ' ' THR . 22.3 mtt -57.74 -52.82 63.89 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.336 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.593 HD13 ' CE1' ' A' ' 481' ' ' PHE . 0.4 OUTLIER -58.33 -47.02 85.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.21 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 28.0 m -56.09 -50.21 71.67 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.197 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.831 HG12 HD11 ' A' ' 491' ' ' ILE . 84.7 t -59.64 -52.77 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.005 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -52.91 -44.47 61.6 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.692 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 7.1 tt -55.43 -56.49 19.55 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 487' ' ' VAL . 30.0 m -61.07 -37.39 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.561 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.831 HD11 HG12 ' A' ' 487' ' ' VAL . 62.8 mt -59.61 -44.96 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.25 -51.4 50.01 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.34 -46.34 72.9 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 110.1 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.644 HD21 ' HB ' ' A' ' 399' ' ' ILE . 16.2 tp -64.81 -44.9 88.39 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.901 178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 98.0 m -52.1 -51.29 58.69 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -58.68 -48.2 81.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.236 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -60.5 -50.84 63.23 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.056 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.758 HG21 ' HA ' ' A' ' 398' ' ' GLN . 7.0 p -73.1 -40.43 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 49.63 1.77 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.083 0.468 . . . . 0.0 111.205 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.62 179.63 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 120.971 0.415 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.4 tp -167.09 144.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.202 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.723 ' NE2' HG11 ' A' ' 450' ' ' VAL . 3.5 mm-40 52.2 50.67 17.93 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.942 0.401 . . . . 0.0 111.331 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -159.28 -98.96 0.15 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.031 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.8 m -45.72 -54.17 8.28 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 404' ' ' VAL . 14.8 p -57.02 -44.62 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.992 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.582 HG11 ' CD2' ' A' ' 494' ' ' LEU . 71.8 t -59.4 -51.8 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.478 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.21 -55.84 29.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.896 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -55.14 -47.67 74.75 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.896 0.379 . . . . 0.0 110.534 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.459 ' CB ' HG21 ' A' ' 439' ' ' VAL . . . -56.41 -60.24 3.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.377 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -51.65 67.04 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.292 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 3.2 m -55.59 -53.4 56.89 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.567 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.97 -49.13 77.32 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.598 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.583 HG13 HD13 ' A' ' 415' ' ' ILE . 35.2 t -60.6 -57.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.605 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.2 tp -55.0 -42.55 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 46.4 m -61.47 -56.59 18.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.047 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.41 -50.04 75.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.812 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.583 HD13 HG13 ' A' ' 411' ' ' VAL . 1.1 mp -55.69 -53.04 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 420' ' ' LEU . . . -57.66 -53.99 51.95 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.109 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 26.5 mtp -56.88 -54.95 40.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -51.92 61.13 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . 0.542 ' CD2' HG23 ' A' ' 415' ' ' ILE . 43.7 m0 -57.65 -33.0 67.84 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.148 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 3.7 tp -57.26 -29.51 63.88 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 110.904 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 2.8 ttp -97.39 -45.66 6.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.054 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 419' ' ' TRP . . . -131.18 116.74 18.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.643 0.259 . . . . 0.0 111.267 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -86.24 44.87 1.17 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.286 179.752 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.623 0.249 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 430' ' ' MET . 5.3 p -131.32 -52.9 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . 0.446 ' N ' HG13 ' A' ' 429' ' ' VAL . 1.4 mmt -51.2 -47.19 62.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.611 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 1.5 mt -58.5 -58.75 7.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.339 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.56 ' HE1' HD11 ' A' ' 415' ' ' ILE . 33.7 m-85 -51.72 -51.51 55.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.796 0.331 . . . . 0.0 110.456 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.05 -58.17 9.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.624 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 1.7 mp -49.11 -51.39 32.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.371 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.47 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -63.43 -59.7 8.48 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.894 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 38.3 t -52.35 -50.71 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.25 -56.87 14.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 24.2 t -53.58 -50.91 47.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.566 0.222 . . . . 0.0 110.903 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 435' ' ' GLY . 75.0 t -56.38 -55.01 21.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.883 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.493 ' HB1' HD21 ' A' ' 455' ' ' ASN . . . -53.93 -50.1 67.19 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.086 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -54.26 48.66 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.221 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -32.1 67.51 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.776 0.322 . . . . 0.0 111.06 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.51 ' CE1' ' HG2' ' A' ' 400' ' ' GLN . 14.1 t80 -84.43 -1.38 55.53 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.447 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.18 -169.17 7.53 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.322 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 63.81 44.68 4.79 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.836 0.351 . . . . 0.0 111.35 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -164.7 133.9 2.82 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.629 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -87.04 122.41 1.85 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.844 2.363 . . . . 0.0 112.62 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 28.5 t -176.2 171.4 2.5 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.137 0.494 . . . . 0.0 111.873 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 26.3 t -89.14 -21.28 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.563 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.723 HG11 ' NE2' ' A' ' 400' ' ' GLN . 93.3 t -62.94 -58.02 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.838 -0.165 . . . . 0.0 111.376 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -53.05 -44.04 67.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.629 0.252 . . . . 0.0 111.192 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -61.23 2.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.744 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 41.9 t -53.73 -45.54 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.71 0.29 . . . . 0.0 110.788 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 16.2 mm -58.91 -55.2 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.23 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . 0.493 HD21 ' HB1' ' A' ' 440' ' ' ALA . 2.5 m-80 -56.35 -49.29 74.83 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 77.1 t -58.95 -57.29 11.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 120.609 0.242 . . . . 0.0 110.843 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 17.5 t -55.4 -49.77 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.02 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 59.5 p -58.33 -47.9 82.25 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.589 0.233 . . . . 0.0 110.949 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -60.8 -58.82 6.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.41 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.17 -45.01 92.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.619 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -63.57 -33.64 76.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.279 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . 0.413 ' CZ ' HG23 ' A' ' 429' ' ' VAL . 2.4 t80 -70.46 59.96 0.2 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.032 0.444 . . . . 0.0 111.098 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.503 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 476' ' ' GLN . 7.3 p -47.87 -50.98 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.459 ' N ' HG13 ' A' ' 475' ' ' VAL . 0.8 OUTLIER -69.0 -37.36 78.66 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.834 -0.166 . . . . 0.0 111.357 179.675 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.47 -47.85 84.34 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.96 -47.33 71.95 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.116 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . 0.408 HD13 HG22 ' A' ' 475' ' ' VAL . 0.1 OUTLIER -54.8 -47.15 74.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.622 178.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 12.1 m -64.18 -51.75 62.26 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -56.74 -44.16 81.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.582 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.76 -53.22 60.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.369 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 487' ' ' VAL . 35.0 m -63.19 -43.0 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.061 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 6.8 mtt -60.7 -56.1 25.26 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.676 0.274 . . . . 0.0 110.766 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 9.7 tp -55.43 -44.67 76.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.397 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 490' ' ' VAL . 35.7 m -60.01 -52.81 63.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.4 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 483' ' ' VAL . 69.8 t -56.27 -48.76 79.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.716 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -60.7 -51.67 57.21 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.381 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.95 80.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.742 0.306 . . . . 0.0 110.859 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 486' ' ' THR . 96.1 t -64.4 -54.75 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.573 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.546 HD12 HD21 ' A' ' 494' ' ' LEU . 4.7 tp -55.68 -41.38 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 120.474 0.178 . . . . 0.0 111.208 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.69 -54.78 29.0 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.476 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -63.2 -43.42 98.23 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 400' ' ' GLN . 0.5 OUTLIER -61.81 -46.03 91.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 121.413 -0.115 . . . . 0.0 111.298 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 1.2 m -65.58 -40.79 93.15 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.521 0.201 . . . . 0.0 110.719 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -70.22 -37.33 74.99 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.697 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -79.43 -42.86 11.06 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.589 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.25 -31.84 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 117.033 0.417 . . . . 0.0 111.829 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 -104.16 123.97 48.26 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.874 0.368 . . . . 0.0 110.559 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.492 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.872 0.368 . . . . 0.0 111.553 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.514 ' CG1' ' HB2' ' A' ' 446' ' ' TRP . 2.9 mp -53.88 100.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.878 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.747 ' HA ' HG21 ' A' ' 404' ' ' VAL . 2.8 mm100 70.53 87.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.404 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -151.94 -150.16 5.28 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.824 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 29.0 t -53.01 -49.63 65.83 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.482 0.182 . . . . 0.0 111.304 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 39.7 t -54.74 -49.45 68.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 110.19 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' A' ' 400' ' ' GLN . 54.2 t -58.85 -46.73 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.281 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.65 77.7 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.884 0.374 . . . . 0.0 110.173 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.96 67.8 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.505 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.632 ' HB1' HG13 ' A' ' 439' ' ' VAL . . . -55.75 -48.73 74.75 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.254 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.568 HD23 HD11 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -56.22 -47.84 77.63 Favored 'General case' 0 C--O 1.23 0.056 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.722 178.556 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.6 t -52.78 -43.0 65.54 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.155 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.4 71.8 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.836 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.669 ' CG2' HG21 ' A' ' 439' ' ' VAL . 97.3 t -58.75 -50.59 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.914 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.568 HD11 HD23 ' A' ' 408' ' ' LEU . 27.2 mt -57.03 -45.61 83.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.231 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 41.3 m -60.38 -49.11 78.87 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.127 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.8 mt -58.14 -53.09 62.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.295 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -45.97 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.893 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -54.73 -54.07 46.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.665 0.269 . . . . 0.0 110.387 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 2.2 ttm -61.89 -42.91 99.64 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.524 ' HG2' ' HG ' ' A' ' 428' ' ' LEU . 0.5 OUTLIER -60.1 -28.47 67.86 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.544 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -40.41 12.25 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.566 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 421' ' ' MET . 1.6 tt -73.78 87.09 1.72 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.96 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . 0.416 ' CB ' ' O ' ' A' ' 420' ' ' LEU . 1.5 ttt 83.11 158.97 0.12 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.701 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 54.04 59.86 3.98 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 110.587 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . 0.402 ' O ' ' HB3' ' A' ' 424' ' ' ASP . 0.8 OUTLIER -63.31 173.23 1.6 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.501 -178.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 423' ' ' PHE . 49.9 t0 . . . . . 0 N--CA 1.467 0.383 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.523 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.524 ' HG ' ' HG2' ' A' ' 418' ' ' GLN . 4.5 mm? . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.507 HG22 HD23 ' A' ' 433' ' ' LEU . 9.1 p -47.33 -35.67 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.64 -52.32 40.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.137 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.78 -45.82 77.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.834 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.609 ' O ' HG23 ' A' ' 436' ' ' VAL . 0.6 OUTLIER -55.2 -50.17 70.05 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.193 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.77 HD21 ' HB2' ' A' ' 462' ' ' PHE . 0.6 OUTLIER -60.95 -49.71 76.34 Favored 'General case' 0 N--CA 1.46 0.032 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.008 178.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 1.7 tt -51.99 -46.23 64.8 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.77 68.71 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.728 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.842 HG11 ' HB3' ' A' ' 458' ' ' SER . 91.3 t -56.67 -39.81 65.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.776 0.322 . . . . 0.0 110.5 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 433' ' ' LEU . 53.6 t -61.05 -57.02 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.675 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 30.2 m -59.23 -39.4 78.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 120.748 0.309 . . . . 0.0 110.397 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.669 HG21 ' CG2' ' A' ' 411' ' ' VAL . 4.0 t -59.43 -58.75 5.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.138 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.37 -42.78 78.39 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.612 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.7 tp -51.35 -52.68 43.48 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.556 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -71.61 -36.74 70.9 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.964 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.515 ' CE2' HG22 ' A' ' 404' ' ' VAL . 1.6 t80 -63.09 -38.13 89.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 445' ' ' ARG . . . -47.92 104.77 0.09 OUTLIER Glycine 0 C--N 1.339 0.728 0 CA-C-N 116.366 -0.379 . . . . 0.0 113.477 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 444' ' ' GLY . 0.1 OUTLIER -144.72 -66.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.621 0.248 . . . . 0.0 110.908 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . 0.514 ' HB2' ' CG1' ' A' ' 399' ' ' ILE . 0.6 OUTLIER -127.26 125.12 23.95 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.633 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.27 87.78 1.03 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.488 2.125 . . . . 0.0 112.554 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 449' ' ' VAL . 91.0 p -108.24 -93.47 0.41 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.356 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.408 ' N ' ' OG ' ' A' ' 448' ' ' SER . 3.4 p -146.16 -49.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 451' ' ' ALA . 1.5 m -46.18 -54.16 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.599 0.238 . . . . 0.0 111.337 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . 0.419 ' H ' HG23 ' A' ' 450' ' ' VAL . . . -57.28 -41.44 79.73 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.887 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.06 -52.97 61.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.393 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 69.8 t -54.29 -50.1 58.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.68 -47.23 86.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.082 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -55.87 -49.7 72.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.433 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.97 -56.73 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.332 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.31 -41.7 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.891 0.377 . . . . 0.0 110.763 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . 0.842 ' HB3' HG11 ' A' ' 436' ' ' VAL . 19.3 m -65.58 -48.91 70.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.651 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.66 -48.67 80.28 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.132 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.41 -54.97 39.22 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.015 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.8 -45.58 70.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.542 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . 0.77 ' HB2' HD21 ' A' ' 433' ' ' LEU . 0.1 OUTLIER -38.84 -40.54 0.64 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.44 0.296 . . . . 0.0 111.307 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 65.0 t80 . . . . . 0 CA--C 1.533 0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.2 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 17.9 t70 . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.4 0.143 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 15.3 m -47.99 -45.16 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -32.87 73.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.537 0.208 . . . . 0.0 110.716 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -47.51 55.78 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 4.6 tt -59.15 -48.97 79.64 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.977 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . 0.461 HD13 HG23 ' A' ' 483' ' ' VAL . 0.6 OUTLIER -59.03 -49.39 78.06 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.844 178.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 87.7 m -55.98 -44.0 78.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.914 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -56.42 -49.12 75.45 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.75 -43.56 94.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.475 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.461 HG23 HD13 ' A' ' 479' ' ' LEU . 69.5 t -60.48 -50.1 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.376 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 34.9 mtp -59.3 -52.37 65.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.359 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -47.42 73.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.936 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 34.7 m -58.83 -50.8 72.62 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.049 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.06 -52.65 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.784 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.83 87.56 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.054 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.26 -51.24 70.8 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.375 0.131 . . . . 0.0 110.92 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.461 HG21 HD11 ' A' ' 408' ' ' LEU . 25.8 m -63.21 -39.37 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.011 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 494' ' ' LEU . 26.1 mt -56.5 -50.77 71.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 120.966 0.412 . . . . 0.0 110.194 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -66.98 -45.45 82.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.363 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.3 -52.31 61.89 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.155 0.182 . . . . 0.0 111.082 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.645 ' HA ' ' HB3' ' A' ' 400' ' ' GLN . 4.5 pp -64.15 -39.79 94.77 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.526 ' N ' HD12 ' A' ' 494' ' ' LEU . 91.6 m -57.81 -43.99 86.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.164 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -73.74 -56.66 4.72 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.037 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -50.48 -42.65 43.73 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.338 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 4.9 p -69.38 -10.49 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.38 104.18 14.65 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.563 0.221 . . . . 0.0 110.777 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 N--CA 1.47 0.57 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.45 -179.783 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.723 0.296 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.5 tp -150.73 139.57 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.16 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.539 ' HA ' HG21 ' A' ' 404' ' ' VAL . 43.5 tt0 -59.82 136.45 58.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.066 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.409 ' H ' ' HB ' ' A' ' 404' ' ' VAL . . . 132.44 -101.88 0.47 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.878 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 12.7 t -58.74 -72.19 0.1 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . 0.51 ' HB ' ' CD2' ' A' ' 441' ' ' LEU . 34.1 m -48.03 -43.75 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 120.554 0.216 . . . . 0.0 111.525 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.539 HG21 ' HA ' ' A' ' 400' ' ' GLN . 76.9 t -60.76 -54.57 33.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.812 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.14 83.68 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.21 65.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.509 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.937 ' HB1' HG22 ' A' ' 438' ' ' VAL . . . -55.76 -55.69 29.36 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.604 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 487' ' ' VAL . 2.0 tt -57.62 -44.23 85.38 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.458 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 412' ' ' ILE . 35.8 t -52.61 -44.61 66.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.641 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.33 -46.77 82.05 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.276 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.837 ' CG2' HG21 ' A' ' 438' ' ' VAL . 75.5 t -59.13 -52.25 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.523 ' HA ' HG22 ' A' ' 415' ' ' ILE . 0.4 OUTLIER -59.25 -41.73 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.384 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 59.8 m -63.28 -45.48 91.25 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.523 HD22 HD22 ' A' ' 434' ' ' LEU . 0.9 OUTLIER -59.5 -57.04 14.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.235 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 412' ' ' ILE . 18.4 tt -56.99 -39.82 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.263 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.31 75.08 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 32.3 mtt -60.09 -45.28 93.46 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.763 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . 0.421 ' OE1' ' HA ' ' A' ' 415' ' ' ILE . 98.9 mt-30 -54.74 -57.18 12.54 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . 0.456 ' HB2' ' CD2' ' A' ' 423' ' ' PHE . 0.1 OUTLIER -48.29 -45.45 34.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.226 178.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.28 -32.19 47.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . 0.584 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 0.8 OUTLIER -120.7 42.72 2.94 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.929 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 99.64 110.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.657 0.783 . . . . 0.0 111.706 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' A' ' 419' ' ' TRP . 5.5 t80 -70.64 98.41 1.49 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.417 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 21.1 t0 . . . . . 0 CA--C 1.534 0.334 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.208 179.72 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 428' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.463 0.21 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.36 -51.35 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.694 0.283 . . . . 0.0 110.35 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 7.1 ttt -65.4 -49.14 70.35 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.41 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -46.68 85.7 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.594 ' CE2' HG11 ' A' ' 436' ' ' VAL . 2.1 t80 -60.66 -51.13 70.68 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 9.2 tt -54.74 -51.13 66.62 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.307 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . 0.523 HD22 HD22 ' A' ' 414' ' ' LEU . 2.1 tp -58.36 -47.5 83.59 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.637 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.5 -58.65 12.23 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.859 -0.61 . . . . 0.0 113.072 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . 0.594 HG11 ' CE2' ' A' ' 432' ' ' TYR . 35.4 m -53.92 -42.93 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.811 0.305 . . . . 0.0 111.684 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.576 ' O ' HD12 ' A' ' 441' ' ' LEU . 28.9 t -61.44 -57.54 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.536 0.207 . . . . 0.0 110.676 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . 0.937 HG22 ' HB1' ' A' ' 407' ' ' ALA . 99.4 t -56.62 -49.64 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.999 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.744 HG11 ' HB2' ' A' ' 458' ' ' SER . 73.1 t -57.25 -48.34 82.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.107 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -55.08 -48.21 73.85 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.576 HD12 ' O ' ' A' ' 437' ' ' VAL . 0.2 OUTLIER -58.04 -42.83 86.2 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.176 177.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . 0.67 ' CD1' HD13 ' A' ' 454' ' ' ILE . 0.2 OUTLIER -63.84 -41.5 97.81 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.211 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 445' ' ' ARG . 22.4 t80 -77.35 -37.9 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.191 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -63.92 67.87 0.05 OUTLIER Glycine 0 C--N 1.338 0.666 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.34 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 400' ' ' GLN . 0.0 OUTLIER -140.43 -55.22 0.52 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.594 0.235 . . . . 0.0 110.962 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . 0.501 ' CD2' ' HD2' ' A' ' 447' ' ' PRO . 0.0 OUTLIER 175.34 139.14 0.19 Allowed Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.156 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.501 ' HD2' ' CD2' ' A' ' 446' ' ' TRP . 36.5 Cg_endo -64.12 67.88 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.592 2.195 . . . . 0.0 112.343 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.491 ' OG ' ' NH2' ' A' ' 445' ' ' ARG . 0.8 OUTLIER -104.39 42.28 1.22 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.518 -179.311 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 453' ' ' VAL . 50.6 t 67.27 -64.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.928 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.7 m -50.81 -47.9 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 454' ' ' ILE . . . -54.22 -53.3 55.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 110.393 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.6 OUTLIER -56.03 -48.74 75.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.611 178.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 449' ' ' VAL . 84.6 t -53.71 -46.42 62.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.464 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.67 HD13 ' CD1' ' A' ' 442' ' ' PHE . 34.5 mt -55.75 -45.27 79.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -61.72 -45.66 93.01 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 452' ' ' THR . 58.0 t -53.36 -50.93 45.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.02 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 74.6 t -53.08 -50.31 46.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . 0.744 ' HB2' HG11 ' A' ' 439' ' ' VAL . 1.4 t -55.06 -43.11 73.54 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.737 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.49 -45.91 92.23 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.23 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.67 -37.72 68.68 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.285 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -22.45 33.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.366 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -66.58 70.71 0.07 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 111.838 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 CA--C 1.534 0.362 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.955 179.694 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . 0.451 ' O ' HD12 ' A' ' 478' ' ' LEU . 3.9 m-20 . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 476' ' ' GLN . 11.6 p -51.89 -44.05 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.087 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.403 ' N ' HG13 ' A' ' 475' ' ' VAL . 0.6 OUTLIER -66.5 -44.35 82.84 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -56.17 -58.14 9.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.086 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 474' ' ' ASP . 1.5 mp -59.66 -51.45 69.74 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 483' ' ' VAL . 7.4 tt -55.47 -58.22 8.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.732 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . 0.402 ' N ' HD23 ' A' ' 479' ' ' LEU . 3.1 m -54.45 -41.83 69.89 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.574 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -56.45 -47.87 78.23 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.86 94.24 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.275 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 479' ' ' LEU . 39.2 t -63.14 -47.04 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.021 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -59.81 -51.54 69.31 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 tt -54.77 -45.06 74.17 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 490' ' ' VAL . 70.6 m -58.99 -49.25 78.6 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.993 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . 0.477 HG21 HD11 ' A' ' 408' ' ' LEU . 18.2 t -52.21 -51.5 30.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.119 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . 0.481 ' O ' HG13 ' A' ' 491' ' ' ILE . . . -55.75 -45.59 85.12 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.858 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.03 -46.07 92.2 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 110.353 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 486' ' ' THR . 94.9 t -61.55 -56.52 17.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.007 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 488' ' ' GLY . 2.5 pp -58.83 -37.02 64.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.692 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.43 -59.22 8.03 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -53.8 -46.41 71.06 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.68 HD13 ' C ' ' A' ' 494' ' ' LEU . 1.3 tm? -55.33 -46.66 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.703 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 99.2 m -54.33 -50.01 68.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.228 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.42 77.65 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.358 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -54.52 -50.6 56.43 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.218 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.542 HG23 HD22 ' A' ' 494' ' ' LEU . 66.9 t -64.89 -35.34 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.76 0.314 . . . . 0.0 110.664 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . 0.489 ' HD2' ' HB2' ' A' ' 500' ' ' TYR . 7.0 tmm_? -62.06 -51.39 68.18 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.132 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . 0.489 ' HB2' ' HD2' ' A' ' 499' ' ' ARG . 11.3 t80 . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 120.721 0.296 . . . . 0.0 111.678 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 120.625 0.25 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.468 HG22 HG22 ' A' ' 498' ' ' VAL . 1.0 OUTLIER -76.61 -167.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . 0.966 ' HG2' HG21 ' A' ' 404' ' ' VAL . 3.6 tt0 -60.29 93.89 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.958 -0.464 . . . . 0.0 111.228 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.861 ' HA3' HG21 ' A' ' 498' ' ' VAL . . . -156.82 -120.84 0.66 Allowed Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.269 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 67.0 m -50.74 -46.2 59.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.764 0.282 . . . . 0.0 111.256 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 15.9 m -55.88 -41.42 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.945 0.402 . . . . 0.0 110.963 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' VAL . . . . . 0.966 HG21 ' HG2' ' A' ' 400' ' ' GLN . 58.9 t -73.44 -43.62 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.796 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.14 -47.53 80.92 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.78 -48.33 81.12 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.163 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' ALA . . . . . 0.768 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -54.83 -50.71 67.93 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.465 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -49.84 76.07 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.23 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 412' ' ' ILE . 0.3 OUTLIER -56.73 -40.09 75.09 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.147 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -66.71 -54.77 19.47 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.612 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 407' ' ' ALA . 55.9 t -55.69 -48.38 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.057 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 409' ' ' SER . 0.3 OUTLIER -60.46 -42.32 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.422 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 91.2 m -61.48 -45.52 93.9 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.751 ' HB3' HD11 ' A' ' 431' ' ' LEU . 20.6 mt -60.21 -57.2 13.81 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.546 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.643 HG13 HD21 ' A' ' 428' ' ' LEU . 16.2 tt -57.76 -39.93 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.953 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -62.81 -51.56 66.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.812 0.339 . . . . 0.0 110.305 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 20.9 mtp -58.46 -47.34 84.34 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.545 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -46.1 89.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.834 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' TRP . . . . . 0.478 ' HA ' ' O ' ' A' ' 422' ' ' ALA . 1.2 m0 -57.35 -38.89 74.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.52 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.42 -28.1 58.44 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.983 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -44.63 6.44 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.776 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 419' ' ' TRP . . . -125.97 138.14 53.73 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.845 0.355 . . . . 0.0 111.601 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.81 162.24 24.12 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--O 1.236 0.388 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.473 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.643 HD21 HG13 ' A' ' 415' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.492 0.187 . . . . 0.0 111.281 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 430' ' ' MET . 4.0 p -44.91 -51.12 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.697 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . 0.426 ' N ' HG13 ' A' ' 429' ' ' VAL . 4.7 mtm -66.73 -47.22 72.97 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.779 0.323 . . . . 0.0 110.365 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' LEU . . . . . 0.751 HD11 ' HB3' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -55.65 -51.45 67.18 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.388 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' TYR . . . . . 0.499 ' OH ' ' HB2' ' A' ' 458' ' ' SER . 44.0 t80 -59.15 -44.59 92.11 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.163 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.5 OUTLIER -55.83 -54.21 47.3 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 6.1 mt -57.48 -42.38 82.53 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.187 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.15 -58.43 13.57 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.479 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 32.8 m -53.99 -34.67 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.784 0.292 . . . . 0.0 110.607 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 433' ' ' LEU . 54.3 t -63.26 -51.25 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.14 -46.4 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.373 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . 0.768 HG22 ' HB1' ' A' ' 407' ' ' ALA . 15.1 t -60.46 -46.11 95.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.135 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.76 76.39 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.127 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.34 -46.57 69.54 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -63.67 -38.52 91.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.45 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' TYR . . . . . 0.742 ' CE1' HG22 ' A' ' 404' ' ' VAL . 5.6 m-85 -74.13 -17.82 60.88 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.79 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -56.76 80.32 0.01 OUTLIER Glycine 0 C--N 1.342 0.876 0 C-N-CA 121.711 -0.281 . . . . 0.0 112.96 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 443' ' ' TYR . 12.3 ttt85 -174.11 -55.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.32 0.248 . . . . 0.0 110.841 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -163.88 81.15 1.44 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.456 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -89.91 158.98 4.99 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.959 2.439 . . . . 0.0 113.075 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.0 t -129.63 178.73 6.27 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.982 0.42 . . . . 0.0 111.678 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 91.5 t -55.34 -39.29 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.964 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 9.2 m -48.14 -46.36 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.645 0.259 . . . . 0.0 111.443 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' ALA . . . . . 0.401 ' HB2' ' HE2' ' A' ' 443' ' ' TYR . . . -64.28 -45.21 89.01 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -48.54 81.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.526 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.28 -54.75 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.326 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.698 HG22 HG23 ' A' ' 486' ' ' THR . 33.2 pt -57.11 -40.54 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.378 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -68.01 -50.34 56.08 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.36 -52.74 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.567 HG12 HD22 ' A' ' 461' ' ' LEU . 37.6 t -55.88 -41.41 66.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.285 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' SER . . . . . 0.499 ' HB2' ' OH ' ' A' ' 432' ' ' TYR . 64.9 m -62.95 -50.45 70.77 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.19 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -55.26 -52.36 63.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.559 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.4 -53.42 58.39 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.806 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.567 HD22 HG12 ' A' ' 457' ' ' VAL . 3.9 mp -56.2 -38.71 71.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.887 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -75.09 -28.65 60.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.978 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.9 t80 . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.977 0.418 . . . . 0.0 111.524 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 C--O 1.237 0.403 0 CA-C-O 120.771 0.319 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.34 -37.01 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.771 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -57.99 -39.91 79.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.488 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -46.7 64.15 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.01 -53.38 57.66 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.873 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.83 -43.97 90.78 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.013 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 54.7 m -54.15 -47.47 71.89 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -64.63 -46.6 81.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.449 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.47 78.26 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.528 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.69 -43.53 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.901 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 26.7 mtt -57.45 -51.09 70.85 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.183 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.0 tp -59.57 -45.53 91.59 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.827 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' THR . . . . . 0.698 HG23 HG22 ' A' ' 454' ' ' ILE . 88.1 m -56.11 -48.97 75.15 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.269 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.02 -51.24 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.494 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 491' ' ' ILE . . . -54.69 -47.03 72.97 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.983 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -47.34 84.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.668 0.27 . . . . 0.0 110.491 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.559 ' CG2' HG21 ' A' ' 454' ' ' ILE . 39.2 t -60.18 -52.95 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.58 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.519 ' HA ' HD21 ' A' ' 494' ' ' LEU . 9.2 tp -57.47 -42.32 80.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.84 -0.164 . . . . 0.0 110.662 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.8 -42.73 94.97 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -57.37 -56.25 24.25 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.642 0.377 . . . . 0.0 110.79 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' A' ' 491' ' ' ILE . 3.9 pp -61.88 -40.46 95.46 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.344 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' THR . . . . . 0.454 ' N ' HD12 ' A' ' 494' ' ' LEU . 45.5 m -62.88 -33.76 75.97 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.374 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -83.08 -42.2 17.7 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.192 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -63.54 -57.73 13.76 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.408 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . 0.861 HG21 ' HA3' ' A' ' 401' ' ' GLY . 2.7 t -62.83 94.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.868 0.366 . . . . 0.0 111.229 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 498' ' ' VAL . 3.8 ptm180 154.67 -37.22 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.942 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 120.894 0.378 . . . . 0.0 111.269 -179.575 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 3.0 mmm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.481 0.181 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.34 123.5 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 120.74 0.305 . . . . 0.0 111.541 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -111.07 154.59 24.03 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.401 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 399' ' ' ILE . 13.2 tt -73.56 101.1 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.95 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.444 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 4.7 mm-40 66.66 80.11 0.22 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.325 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -133.04 -134.52 3.51 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.071 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 13.4 m -47.09 -38.91 12.16 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 35.5 t -59.79 -47.35 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.452 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.589 HG13 ' CE2' ' A' ' 442' ' ' PHE . 12.7 t -60.51 -48.32 88.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.406 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.68 69.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.738 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.68 -50.45 73.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.064 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 1.084 ' HB1' HG13 ' A' ' 438' ' ' VAL . . . -57.85 -55.95 28.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.07 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.67 ' HG ' HG11 ' A' ' 490' ' ' VAL . 0.4 OUTLIER -59.14 -40.57 85.91 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.652 179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 37.8 t -57.12 -57.59 11.9 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.301 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -53.18 -42.32 66.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.705 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.795 HG23 HG21 ' A' ' 438' ' ' VAL . 25.0 t -61.61 -59.06 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.27 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 8.0 tp -55.5 -43.48 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 121.358 -0.137 . . . . 0.0 110.948 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 52.9 m -59.58 -51.52 69.49 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 434' ' ' LEU . 8.5 tp -57.94 -46.44 85.04 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.368 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.799 HG12 HD11 ' A' ' 431' ' ' LEU . 75.0 mt -57.71 -52.44 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.601 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.29 -48.42 80.53 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.058 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 22.3 mtt -59.66 -52.81 63.92 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.024 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -60.57 -47.31 86.74 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.353 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . 0.519 ' HA ' ' O ' ' A' ' 424' ' ' ASP . 0.0 OUTLIER -59.56 -44.07 93.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.945 0.402 . . . . 0.0 110.185 179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 4.9 tt -64.12 -42.57 96.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.129 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 6.1 tpt -67.84 126.9 30.9 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.871 0.367 . . . . 0.0 111.727 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 70.82 -98.98 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.918 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.23 41.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.661 0.267 . . . . 0.0 111.519 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 419' ' ' TRP . 4.5 p30 -148.44 157.25 43.35 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.805 0.336 . . . . 0.0 111.198 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 426' ' ' ALA . . . -70.15 -30.74 67.97 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.211 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 425' ' ' ALA . . . 167.06 163.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.523 0.515 . . . . 0.0 110.758 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -90.05 38.07 0.91 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.754 0.311 . . . . 0.0 111.247 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 7.9 mt 47.46 30.63 1.67 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 71.4 t -143.61 -69.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.915 -0.13 . . . . 0.0 111.311 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -52.49 34.19 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.671 0.272 . . . . 0.0 111.111 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.799 HD11 HG12 ' A' ' 415' ' ' ILE . 17.5 tp -62.97 -40.52 97.97 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.04 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 462' ' ' PHE . 54.0 t80 -67.18 -48.57 67.53 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.928 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.411 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.8 OUTLIER -56.28 -59.38 5.03 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.7 0.286 . . . . 0.0 110.568 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.523 HD13 HD13 ' A' ' 414' ' ' LEU . 0.1 OUTLIER -59.72 -45.19 92.93 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.293 178.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.734 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -53.85 -55.06 27.51 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.859 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 39.3 t -55.17 -47.74 77.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 433' ' ' LEU . 59.6 t -54.03 -50.2 55.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 1.084 HG13 ' HB1' ' A' ' 407' ' ' ALA . 41.2 t -61.27 -43.04 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.158 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 435' ' ' GLY . 98.0 t -54.9 -45.83 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -58.32 -47.09 84.83 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.672 HD23 ' HB2' ' A' ' 407' ' ' ALA . 2.1 tp -56.14 -44.71 79.49 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.171 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . 0.589 ' CE2' HG13 ' A' ' 404' ' ' VAL . 3.2 t80 -64.38 -45.2 88.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.552 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -52.87 -43.39 66.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.355 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -74.72 48.39 1.94 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.874 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.453 ' O ' HG13 ' A' ' 399' ' ' ILE . 0.6 OUTLIER -136.68 29.45 2.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.41 0.284 . . . . 0.0 110.8 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . 0.401 ' CB ' ' O ' ' A' ' 445' ' ' ARG . 0.0 OUTLIER 83.74 125.88 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.561 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.21 97.16 1.12 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.669 2.246 . . . . 0.0 112.728 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.0 m -121.3 38.95 3.95 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.861 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 97.7 t 67.76 -55.13 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.794 HG21 ' OD1' ' A' ' 493' ' ' ASN . 7.0 m -41.83 -46.76 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -59.63 -47.5 85.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.851 0.358 . . . . 0.0 110.205 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 20.8 m -56.46 -49.16 75.41 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.929 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.3 -52.97 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.343 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.577 HG23 HG23 ' A' ' 486' ' ' THR . 19.8 mt -53.3 -50.81 45.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.752 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.502 ' ND2' HG11 ' A' ' 439' ' ' VAL . 12.6 t-20 -59.82 -51.91 67.72 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.666 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.9 t -54.05 -52.21 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 54.6 t -52.01 -54.55 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.509 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -44.2 92.03 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.827 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -57.41 -57.51 12.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.834 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -41.95 91.52 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.847 0.356 . . . . 0.0 110.695 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.556 ' HG ' ' CB ' ' A' ' 482' ' ' ALA . 1.3 mm? -68.59 -21.01 64.54 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.461 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 432' ' ' TYR . 60.5 t80 -61.68 76.25 0.02 OUTLIER 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.568 0.699 . . . . 0.0 111.135 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' A' ' 461' ' ' LEU . 0.9 OUTLIER 179.37 -55.36 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.331 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.854 HD13 HD13 ' A' ' 478' ' ' LEU . 17.8 tt -91.45 50.44 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.254 0.55 . . . . 0.0 111.24 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.878 ' HB3' ' HD3' ' A' ' 466' ' ' PRO . . . -98.78 -59.47 0.13 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.625 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.878 ' HD3' ' HB3' ' A' ' 465' ' ' ALA . 37.9 Cg_exo -57.91 149.81 67.68 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.533 2.155 . . . . 0.0 112.762 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.15 61.03 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.088 0.47 . . . . 0.0 111.593 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 466' ' ' PRO . . . 160.32 -72.21 0.22 Allowed Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.433 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . 0.821 HG21 ' HA ' ' A' ' 464' ' ' ILE . 15.3 t 31.02 46.01 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 43.52 35.29 0.93 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -91.42 167.02 12.57 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.991 0.424 . . . . 0.0 111.825 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.12 -40.25 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.65 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 22.7 t -84.67 -176.78 6.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.879 0.371 . . . . 0.0 111.378 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 477' ' ' TYR . 10.4 t0 -74.54 98.52 3.38 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.103 0.478 . . . . 0.0 110.948 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.806 HG22 HG13 ' A' ' 464' ' ' ILE . 95.9 t -56.49 -48.3 80.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.205 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.6 -47.61 76.21 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.874 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 474' ' ' ASP . 1.3 m-85 -66.38 -52.83 42.78 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.026 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.854 HD13 HD13 ' A' ' 464' ' ' ILE . 0.1 OUTLIER -52.15 -51.55 57.29 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.617 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . 0.667 ' O ' HG23 ' A' ' 483' ' ' VAL . 17.1 tp -61.18 -46.98 88.25 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.046 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 82.8 m -52.32 -49.4 64.32 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.626 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -58.33 -52.87 63.8 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.39 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . 0.556 ' CB ' ' HG ' ' A' ' 461' ' ' LEU . . . -54.74 -42.27 71.4 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.842 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 479' ' ' LEU . 88.1 t -64.48 -49.08 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.003 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 9.2 ttm -56.99 -52.36 65.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.585 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 28.7 tp -56.02 -50.35 71.15 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.933 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . 0.691 ' HA ' HD12 ' A' ' 489' ' ' LEU . 35.8 m -56.02 -47.13 78.39 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.285 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 483' ' ' VAL . 42.1 t -57.57 -48.39 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.909 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -54.08 -43.92 73.28 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.509 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . 0.691 HD12 ' HA ' ' A' ' 486' ' ' THR . 4.7 mt -64.19 -49.52 71.7 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.78 0.324 . . . . 0.0 110.25 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.67 HG11 ' HG ' ' A' ' 408' ' ' LEU . 65.2 t -58.66 -55.27 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.352 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 20.9 tt -57.21 -42.29 79.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.857 -0.156 . . . . 0.0 110.795 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -60.67 -50.3 69.07 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.504 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . 0.794 ' OD1' HG21 ' A' ' 450' ' ' VAL . 15.9 m-80 -61.03 -54.7 41.57 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.574 0.226 . . . . 0.0 110.526 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.11 -43.53 66.94 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.662 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 58.3 m -61.85 -50.61 71.55 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.206 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -59.25 -48.11 82.86 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.174 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -57.63 -51.33 58.58 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.455 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 92.5 t -71.19 -47.73 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 120.988 0.423 . . . . 0.0 110.72 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . 0.88 ' HD3' ' HB2' ' A' ' 502' ' ' ALA . 1.1 tmm_? -105.35 87.33 2.59 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.114 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -57.85 -52.31 65.99 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.614 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.51 160.43 38.07 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 111.422 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.88 ' HB2' ' HD3' ' A' ' 499' ' ' ARG . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.059 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . 0.939 ' N ' ' HG ' ' A' ' 402' ' ' SER . 1.7 mpt? . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 120.883 0.373 . . . . 0.0 111.487 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 8.1 p -166.9 131.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.249 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . 0.543 ' HB3' ' HB1' ' A' ' 502' ' ' ALA . 0.0 OUTLIER 63.62 -171.73 0.17 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.636 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.413 HD12 ' OE1' ' A' ' 400' ' ' GLN . 2.7 pt -73.71 149.02 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.714 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.413 ' OE1' HD12 ' A' ' 399' ' ' ILE . 2.4 mp0 61.48 -167.46 0.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.883 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 84.29 -110.66 3.37 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.542 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . 0.939 ' HG ' ' N ' ' A' ' 396' ' ' MET . 33.7 m -52.99 -48.14 67.7 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.578 0.227 . . . . 0.0 111.472 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.782 HG21 ' HG2' ' A' ' 445' ' ' ARG . 10.5 t -55.13 -52.97 39.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.931 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.496 HG11 HD23 ' A' ' 494' ' ' LEU . 22.8 t -60.41 -46.44 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.24 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.26 76.97 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.566 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.56 -55.06 35.01 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.652 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -56.37 -48.49 76.73 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.434 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.98 HD11 HG13 ' A' ' 487' ' ' VAL . 2.1 tp -57.95 -49.48 76.64 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.388 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.667 ' HA ' HD12 ' A' ' 412' ' ' ILE . 41.0 t -53.64 -48.13 69.66 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.63 82.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.262 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 407' ' ' ALA . 41.7 t -63.23 -42.54 96.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.151 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' A' ' 409' ' ' SER . 23.8 mt -61.84 -53.31 49.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.585 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 409' ' ' SER . 42.7 p -58.54 -44.92 89.78 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.449 HD21 ' HG ' ' A' ' 431' ' ' LEU . 18.2 tp -57.46 -49.42 76.33 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.137 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 14.9 mm -59.75 -54.14 38.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.924 0.393 . . . . 0.0 110.19 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -52.1 -49.84 62.81 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.894 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 10.5 mtt -63.7 -43.15 97.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.838 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 0.0 OUTLIER -57.56 -45.67 84.86 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.183 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -35.21 36.39 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -51.83 -57.39 9.47 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 4.6 mtp -145.71 59.86 1.26 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.957 0.408 . . . . 0.0 111.603 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 418' ' ' GLN . . . -171.83 -177.06 1.87 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.394 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . 0.622 ' HB2' ' HB2' ' A' ' 426' ' ' ALA . 53.6 m-85 -91.89 150.69 20.91 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.74 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.575 ' HB3' ' N ' ' A' ' 469' ' ' THR . 0.8 OUTLIER -48.56 116.58 1.65 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.473 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 468' ' ' GLY . . . 59.0 24.05 12.23 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.622 ' HB2' ' HB2' ' A' ' 423' ' ' PHE . . . -66.17 163.25 18.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.727 0.299 . . . . 0.0 111.245 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . 0.437 ' CG ' ' HB2' ' A' ' 430' ' ' MET . 7.3 t-20 77.72 63.48 0.03 OUTLIER 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.997 0.427 . . . . 0.0 111.11 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' A' ' 464' ' ' ILE . 1.1 mm? -48.54 -50.35 32.45 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.65 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.3 t -54.67 -61.95 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.437 ' HB2' ' CG ' ' A' ' 427' ' ' ASN . 8.2 mmt -55.77 -47.89 76.24 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.855 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.449 ' HG ' HD21 ' A' ' 414' ' ' LEU . 0.5 OUTLIER -57.58 -50.05 74.4 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.903 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -64.06 -49.95 70.31 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.039 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.8 OUTLIER -56.18 -55.84 28.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.859 0.361 . . . . 0.0 110.57 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.439 ' O ' HG22 ' A' ' 438' ' ' VAL . 5.2 mp -57.58 -47.32 82.41 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.367 -0.379 . . . . 0.0 109.981 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.605 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -52.98 -57.87 13.38 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.687 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 433' ' ' LEU . 27.5 m -54.99 -39.96 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 117.044 0.422 . . . . 0.0 110.93 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 433' ' ' LEU . 53.1 t -60.63 -57.75 10.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.074 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 434' ' ' LEU . 15.8 m -60.93 -39.29 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.661 0.267 . . . . 0.0 110.666 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 435' ' ' GLY . 55.8 t -59.1 -50.65 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.047 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.28 -47.78 77.94 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.974 0.416 . . . . 0.0 110.141 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.41 -47.87 80.6 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.58 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . 0.562 ' HA ' ' CG1' ' A' ' 403' ' ' VAL . 39.8 t80 -62.09 -46.13 90.42 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.763 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -60.44 -44.49 95.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.451 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.415 ' O ' ' HD3' ' A' ' 445' ' ' ARG . . . -67.59 53.93 0.33 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.549 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.782 ' HG2' HG21 ' A' ' 403' ' ' VAL . 0.7 OUTLIER -152.23 45.61 0.74 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 79.96 126.39 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.614 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.78 124.23 7.99 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.58 2.187 . . . . 0.0 112.407 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.7 t -143.18 152.0 41.28 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.28 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.766 ' O ' HG23 ' A' ' 453' ' ' VAL . 11.9 p -50.79 -45.85 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.629 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.571 HG12 HD11 ' A' ' 454' ' ' ILE . 13.8 t -57.48 -53.0 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.606 0.241 . . . . 0.0 110.668 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -56.08 -50.79 70.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.292 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 456' ' ' VAL . 28.7 m -55.81 -45.59 78.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.494 178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 449' ' ' VAL . 96.3 t -58.75 -51.66 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.491 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.571 HD11 HG12 ' A' ' 450' ' ' VAL . 8.3 mt -57.86 -52.06 62.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 120.863 0.363 . . . . 0.0 110.589 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.62 -51.66 66.44 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.597 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 452' ' ' THR . 55.9 t -57.67 -55.69 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.742 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 453' ' ' VAL . 54.0 t -45.75 -52.11 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 120.685 0.278 . . . . 0.0 110.615 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -43.85 98.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.817 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.47 -58.27 9.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.987 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.41 -41.94 69.89 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.976 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.79 -27.92 63.27 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.994 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . 0.563 ' CD2' ' HG3' ' A' ' 466' ' ' PRO . 6.1 t80 -63.56 102.65 0.45 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.892 0.377 . . . . 0.0 111.584 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -144.49 81.97 1.68 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.257 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.512 ' HA ' HD11 ' A' ' 428' ' ' LEU . 20.2 mt 58.12 87.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.455 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 464' ' ' ILE . . . 74.98 72.12 0.22 Allowed Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.715 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.563 ' HG3' ' CD2' ' A' ' 462' ' ' PHE . 54.8 Cg_endo -68.1 156.0 67.44 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.679 2.253 . . . . 0.0 113.129 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 466' ' ' PRO . 0.0 OUTLIER 84.67 -70.6 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.865 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.536 ' C ' ' HB3' ' A' ' 424' ' ' ASP . . . -123.01 165.14 15.69 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.985 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . 0.575 ' N ' ' HB3' ' A' ' 424' ' ' ASP . 2.7 t -175.13 160.38 2.71 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.724 0.297 . . . . 0.0 111.279 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.38 66.35 3.94 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.075 0.464 . . . . 0.0 110.815 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -124.17 -63.79 1.18 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.133 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . 0.837 HG23 HG12 ' A' ' 475' ' ' VAL . 0.3 OUTLIER -142.54 151.87 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.976 0.417 . . . . 0.0 112.115 -179.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.5 t -92.76 30.07 1.64 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.203 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.24 -69.39 0.81 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.947 0.403 . . . . 0.0 110.623 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.837 HG12 HG23 ' A' ' 472' ' ' VAL . 10.7 p -55.55 -38.81 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.095 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -45.59 74.3 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.951 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.88 -49.99 46.84 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.675 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -52.63 61.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . 0.455 HD13 HG22 ' A' ' 475' ' ' VAL . 7.1 mp -60.53 -50.73 72.38 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.545 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 95.2 m -53.89 -46.44 71.38 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.443 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.86 -47.68 84.76 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.286 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -57.9 -44.42 86.77 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.126 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.74 -45.6 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.039 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 65.9 mtp -58.19 -52.76 64.2 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.14 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 13.7 tp -55.73 -43.22 76.38 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 46.5 m -58.94 -48.3 81.98 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.623 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.98 HG13 HD11 ' A' ' 408' ' ' LEU . 24.2 t -56.32 -50.5 71.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.684 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . 0.464 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -54.69 -46.63 74.39 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.06 -49.56 76.49 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.476 HG12 HD23 ' A' ' 494' ' ' LEU . 79.6 t -55.93 -47.89 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.375 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.601 ' HA ' HD21 ' A' ' 494' ' ' LEU . 52.6 mt -54.89 -42.35 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.531 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -69.28 -45.9 59.31 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.55 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -56.21 -52.08 65.71 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.586 0.232 . . . . 0.0 110.916 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.601 HD21 ' HA ' ' A' ' 491' ' ' ILE . 4.0 pp -62.6 -44.83 95.33 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.422 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.57 ' N ' HD12 ' A' ' 494' ' ' LEU . 90.7 m -57.23 -43.87 83.28 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 500' ' ' TYR . . . -66.53 -54.32 25.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.584 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -53.7 -52.98 38.59 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.704 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 4.8 t -47.89 -33.58 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 120.609 0.243 . . . . 0.0 111.355 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.05 22.6 15.71 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.419 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 496' ' ' ALA . 1.6 t80 -137.03 61.46 1.62 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.791 0.329 . . . . 0.0 111.011 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 79.82 130.88 0.05 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.193 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 398' ' ' GLN . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.65 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 120.43 0.157 . . . . 0.0 111.414 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 6.8 m -93.15 129.59 43.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.832 0.349 . . . . 0.0 111.09 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . 0.445 HE22 HG23 ' A' ' 495' ' ' THR . 32.8 tt0 -54.79 -56.11 22.93 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.274 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.454 ' CD1' ' HB3' ' A' ' 446' ' ' TRP . 19.5 mm 70.83 131.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 123.39 0.431 . . . . 0.0 111.165 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.59 ' HA ' HG21 ' A' ' 404' ' ' VAL . 42.1 mt-30 54.86 51.67 13.28 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.593 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.647 ' HA2' ' OG1' ' A' ' 495' ' ' THR . . . -147.09 -123.79 1.47 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.634 -0.793 . . . . 0.0 113.293 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 55.0 m -56.95 -49.69 74.9 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.65 0.262 . . . . 0.0 111.537 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 443' ' ' TYR . 30.1 m -55.76 -48.3 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.614 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.641 HG12 HD13 ' A' ' 491' ' ' ILE . 40.8 t -69.13 -40.91 81.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.75 97.54 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -62.27 -51.44 67.68 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.794 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' A' ' 440' ' ' ALA . . . -55.01 -49.24 72.03 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.677 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 484' ' ' MET . 0.5 OUTLIER -58.04 -42.88 86.31 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.761 178.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -50.48 62.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.056 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.16 -48.5 78.56 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.929 0.395 . . . . 0.0 109.996 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 92.3 t -55.55 -57.92 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.017 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.579 HD12 ' CD1' ' A' ' 485' ' ' LEU . 19.2 tt -56.75 -41.14 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.489 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 1.3 m -56.97 -50.07 73.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.694 HD12 HG23 ' A' ' 429' ' ' VAL . 3.1 mm? -60.75 -47.31 86.88 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.934 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 412' ' ' ILE . 93.7 mt -52.37 -49.98 40.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.994 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.63 77.87 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.08 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 2.0 mtt -56.5 -44.92 81.18 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.258 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 1.02 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 2.9 tm0? -60.18 -50.16 74.76 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.116 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -57.67 -35.82 71.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.205 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.25 -50.93 42.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.826 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 1.1 ttp 179.46 65.43 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 1.02 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -151.25 -174.9 4.96 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 122.379 -0.201 . . . . 0.0 111.463 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . 0.582 ' O ' HG11 ' A' ' 429' ' ' VAL . 0.2 OUTLIER -119.05 178.03 4.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.933 0.397 . . . . 0.0 111.988 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.41 98.19 10.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.418 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 430' ' ' MET . . . 45.86 43.39 10.04 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -81.43 -73.16 0.39 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.201 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -125.81 -84.71 0.63 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.069 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.29 -56.97 15.34 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.677 0.275 . . . . 0.0 110.907 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.694 HG23 HD12 ' A' ' 414' ' ' LEU . 7.3 p -55.41 -33.56 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.805 178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.59 ' CE ' HD13 ' A' ' 434' ' ' LEU . 0.0 OUTLIER -57.0 -52.25 66.02 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.254 178.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.15 -44.3 95.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.072 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.695 ' O ' HG23 ' A' ' 436' ' ' VAL . 8.1 m-85 -56.97 -56.72 18.1 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.733 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.679 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.4 OUTLIER -56.28 -44.29 79.66 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.068 178.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.59 HD13 ' CE ' ' A' ' 430' ' ' MET . 6.2 tp -54.56 -51.16 66.12 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.94 -45.95 93.08 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 432' ' ' TYR . 42.9 t -57.08 -44.28 82.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 433' ' ' LEU . 98.4 t -55.87 -47.04 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.874 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.71 -47.07 86.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.419 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.62 -51.78 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.594 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.423 ' HB2' ' HB1' ' A' ' 407' ' ' ALA . . . -57.65 -50.08 74.36 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.543 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -47.91 79.3 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.406 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -61.09 -40.89 95.43 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.377 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.516 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 6.7 m-30 -65.88 -44.99 83.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.006 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -72.82 58.62 1.74 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.488 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 445' ' ' ARG . 21.2 tpt180 -89.86 60.13 4.86 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.184 0.516 . . . . 0.0 110.922 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . 0.454 ' HB3' ' CD1' ' A' ' 399' ' ' ILE . 15.4 t-105 -178.56 125.7 0.26 Allowed Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.466 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 446' ' ' TRP . 68.9 Cg_endo -95.01 128.23 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.289 2.659 . . . . 0.0 112.939 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.451 ' OG ' ' NE1' ' A' ' 446' ' ' TRP . 14.6 m -164.69 65.82 0.14 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.791 0.329 . . . . 0.0 111.725 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 453' ' ' VAL . 60.5 t 64.92 -69.24 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.969 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.9 t -53.26 -46.2 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.564 0.221 . . . . 0.0 110.812 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.57 90.97 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 1.4 m -61.14 -52.29 65.5 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 449' ' ' VAL . 47.4 t -55.28 -47.73 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.771 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.36 -50.04 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.757 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.31 -48.76 70.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.949 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 63.1 t -56.02 -56.14 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.215 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 89.2 t -52.72 -46.1 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.819 0.342 . . . . 0.0 110.097 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 18.0 t -54.63 -47.42 73.5 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.92 -50.66 72.88 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.414 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.37 -41.82 76.81 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.794 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.596 ' HG ' ' HB2' ' A' ' 465' ' ' ALA . 4.7 tt -70.97 -38.18 72.78 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.811 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -50.48 150.1 2.82 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.513 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 6.4 t80 69.65 -61.08 0.45 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.663 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 64.2 mt -55.35 -56.29 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.13 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 466' ' ' PRO . . . -44.81 -61.52 2.16 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 465' ' ' ALA . 72.2 Cg_endo -74.7 -18.71 19.3 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.66 2.24 . . . . 0.0 113.521 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.67 63.91 1.56 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.179 0.514 . . . . 0.0 111.253 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 146.74 57.15 0.02 OUTLIER Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.104 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 3.2 m -147.83 144.12 27.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.699 0.285 . . . . 0.0 110.824 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . 0.481 HD22 ' HB ' ' A' ' 472' ' ' VAL . 0.7 OUTLIER -102.71 97.6 7.75 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.012 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -67.85 56.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . 0.481 ' HB ' HD22 ' A' ' 470' ' ' LEU . 69.2 t -151.96 -54.28 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 29.6 t -154.37 42.33 0.5 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 477' ' ' TYR . 7.9 t70 -66.48 112.61 4.17 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.925 0.393 . . . . 0.0 111.762 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.85 -40.86 74.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.996 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -66.01 -42.49 89.63 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . 0.461 ' HB2' ' HB3' ' A' ' 474' ' ' ASP . 0.8 OUTLIER -59.7 -54.96 40.3 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.381 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.7 tt -55.67 -48.75 74.52 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.207 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.19 -45.23 79.88 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.955 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . 0.417 HG22 ' SD ' ' A' ' 484' ' ' MET . 24.8 m -57.56 -44.66 85.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.819 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . 0.413 ' CE1' HD13 ' A' ' 485' ' ' LEU . 26.1 t80 -61.48 -48.95 78.76 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.76 80.38 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.482 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 487' ' ' VAL . 78.0 t -63.68 -48.39 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.85 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . 0.494 ' O ' HD11 ' A' ' 408' ' ' LEU . 21.6 mtt -54.47 -55.07 32.69 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.546 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.579 ' CD1' HD12 ' A' ' 412' ' ' ILE . 2.0 tp -52.8 -48.37 66.96 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.999 0.428 . . . . 0.0 109.969 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 24.2 m -56.41 -48.93 75.94 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.935 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 483' ' ' VAL . 91.7 t -56.98 -42.4 78.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.092 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.395 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . 0.757 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -56.65 -45.84 89.86 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.47 -49.85 71.42 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.47 -44.25 88.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.867 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.757 HD12 ' HA2' ' A' ' 488' ' ' GLY . 15.7 mt -55.89 -42.29 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.967 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 495' ' ' THR . . . -62.17 -49.31 76.02 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.479 -0.867 . . . . 0.0 110.995 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -54.06 -48.93 70.06 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.747 0.308 . . . . 0.0 110.348 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.526 HD23 ' CB ' ' A' ' 400' ' ' GLN . 11.1 tp -67.79 -35.93 79.54 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.665 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.647 ' OG1' ' HA2' ' A' ' 401' ' ' GLY . 98.0 m -51.51 -49.86 61.09 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -64.71 -47.05 79.74 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.509 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -54.46 -43.29 77.1 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.876 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 68.0 t -76.12 -43.13 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.752 0.311 . . . . 0.0 110.524 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -62.11 -47.14 85.92 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.294 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -97.38 60.83 1.65 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.992 0.425 . . . . 0.0 110.984 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -129.85 147.71 51.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.238 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.098 179.879 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . 0.405 ' O ' ' HB ' ' A' ' 397' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.153 0.025 . . . . 0.0 110.976 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 396' ' ' MET . 36.6 t 77.07 136.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 123.473 0.483 . . . . 0.0 111.192 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.84 -61.08 1.13 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.338 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 399' ' ' ILE . 19.5 tt -144.34 114.62 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.704 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.558 ' NE2' HG11 ' A' ' 450' ' ' VAL . 0.0 OUTLIER 66.46 -175.04 0.19 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.475 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.541 ' HA2' ' OG1' ' A' ' 495' ' ' THR . . . 115.71 -131.43 9.65 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.975 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -37.22 72.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.43 0.157 . . . . 0.0 111.373 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.52 HG23 ' H ' ' A' ' 404' ' ' VAL . 15.2 m -55.8 -57.8 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.525 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.52 ' H ' HG23 ' A' ' 403' ' ' VAL . 24.6 m -63.55 -38.02 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.457 ' HB2' HG21 ' A' ' 491' ' ' ILE . . . -56.67 -48.85 76.7 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.119 178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 409' ' ' SER . . . -61.68 -46.09 91.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.631 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -56.46 -56.59 19.27 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.362 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.513 HD21 ' HG2' ' A' ' 484' ' ' MET . 0.6 OUTLIER -59.18 -39.95 84.14 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.127 178.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 406' ' ' ALA . 33.6 t -51.08 -51.6 51.71 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.326 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -63.46 -47.43 81.85 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.308 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.579 HG22 HG21 ' A' ' 436' ' ' VAL . 69.7 t -53.57 -58.19 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.66 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.598 HD13 ' HG3' ' A' ' 484' ' ' MET . 4.2 tp -58.5 -39.91 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.602 0.239 . . . . 0.0 110.74 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 85.9 m -61.33 -44.36 97.33 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 109.809 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -50.06 72.07 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.857 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.42 HD13 ' OE1' ' A' ' 418' ' ' GLN . 8.7 mm -56.49 -46.11 82.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.044 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -54.38 -49.42 69.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.779 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 1.7 ttm -57.82 -42.77 84.98 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.074 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 1.052 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 0.8 OUTLIER -55.43 -50.86 68.7 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.083 178.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -58.25 -41.99 85.42 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.63 -54.44 42.75 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.725 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -179.19 78.65 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 1.052 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -155.21 168.99 25.22 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.973 0.416 . . . . 0.0 111.933 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -67.65 178.58 1.62 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.644 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.574 ' HB2' HG23 ' A' ' 469' ' ' THR . 0.6 OUTLIER -87.17 -177.76 6.07 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.768 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 465' ' ' ALA . . . -66.81 57.64 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.118 0.485 . . . . 0.0 111.664 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 424' ' ' ASP . . . -152.5 -61.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.554 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -89.65 117.46 28.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.24 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 72.52 -58.57 0.59 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.264 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.424 HG22 ' NE2' ' A' ' 418' ' ' GLN . 40.3 t -51.42 -51.28 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.483 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 3.2 ttm -55.68 -43.78 76.72 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 110.195 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.51 -48.75 78.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.799 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.413 ' O ' HG22 ' A' ' 436' ' ' VAL . 7.5 m-85 -57.45 -48.01 80.3 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.678 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 437' ' ' VAL . 3.2 tp -57.52 -47.1 82.89 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.009 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 438' ' ' VAL . 0.1 OUTLIER -54.68 -48.78 71.98 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.834 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -56.53 -57.72 18.01 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.508 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.579 HG21 HG22 ' A' ' 411' ' ' VAL . 10.1 m -56.08 -44.34 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.723 0.262 . . . . 0.0 110.653 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 433' ' ' LEU . 56.3 t -57.77 -46.54 86.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 434' ' ' LEU . 37.9 t -58.14 -45.58 88.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 51.8 t -55.88 -47.41 79.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.65 -47.26 86.32 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.167 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -41.41 81.84 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.316 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -66.79 -44.88 80.13 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.627 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.433 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 9.9 m-85 -70.77 -47.68 58.36 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.344 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -61.89 134.68 46.55 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.807 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -138.58 -56.12 0.63 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.568 0.223 . . . . 0.0 111.386 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.84 121.08 75.91 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 120.772 0.32 . . . . 0.0 110.895 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -88.87 161.28 6.1 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.159 2.573 . . . . 0.0 114.237 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.551 ' H ' ' HB3' ' A' ' 451' ' ' ALA . 1.2 p 176.9 -174.14 0.11 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.453 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.7 t -45.91 -48.17 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.573 0.225 . . . . 0.0 111.434 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.558 HG11 ' NE2' ' A' ' 400' ' ' GLN . 47.3 t -58.35 -50.39 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.633 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.551 ' HB3' ' H ' ' A' ' 448' ' ' SER . . . -57.22 -45.63 83.66 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.255 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 93.0 m -54.99 -52.15 64.02 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.59 -46.52 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.227 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 451' ' ' ALA . 53.8 mt -55.59 -50.25 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.598 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -53.4 56.66 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.817 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 64.5 t -53.52 -55.73 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 111.159 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 57.9 t -54.65 -47.6 72.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.658 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 4.4 t -59.56 -44.31 93.32 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.288 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -53.1 -49.59 66.16 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.467 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.75 -46.97 73.72 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.358 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 466' ' ' PRO . 0.4 OUTLIER -52.22 -36.89 53.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.016 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -69.89 59.14 0.16 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.18 0.514 . . . . 0.0 111.022 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -158.18 61.72 0.45 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.775 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.554 ' O ' HG22 ' A' ' 464' ' ' ILE . 4.3 mt 63.1 31.85 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.231 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.818 ' HB3' ' HB ' ' A' ' 469' ' ' THR . . . 51.71 73.08 1.03 Allowed Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.981 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 461' ' ' LEU . 77.7 Cg_exo -50.31 95.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.178 2.585 . . . . 0.0 112.501 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . 0.439 ' NH1' ' OG1' ' A' ' 480' ' ' THR . 1.5 ttm180 173.52 -50.06 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.42 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 149.53 53.59 0.02 OUTLIER Glycine 0 C--N 1.33 0.25 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.598 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . 0.818 ' HB ' ' HB3' ' A' ' 465' ' ' ALA . 6.0 t -65.46 -34.62 78.72 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . 0.572 HD22 ' CG2' ' A' ' 469' ' ' THR . 2.2 mm? -75.19 -54.0 7.86 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.613 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -119.31 76.66 1.14 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.134 0.492 . . . . 0.0 111.409 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . 0.719 HG23 ' HB2' ' A' ' 476' ' ' GLN . 14.5 p -78.25 130.3 36.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.612 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 46.9 m -121.98 -77.16 0.59 Allowed 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -135.12 -65.48 0.61 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.433 0.158 . . . . 0.0 111.27 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 59.7 t -42.24 -42.78 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.016 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.719 ' HB2' HG23 ' A' ' 472' ' ' VAL . 20.8 mp0 -54.48 -55.23 31.14 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.819 0.342 . . . . 0.0 111.107 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -69.82 -49.98 47.37 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.147 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.49 -54.93 25.99 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.968 0.413 . . . . 0.0 110.803 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 483' ' ' VAL . 3.2 tt -59.38 -48.8 80.25 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.617 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . 0.439 ' OG1' ' NH1' ' A' ' 467' ' ' ARG . 73.8 m -57.59 -39.19 76.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.928 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -49.46 74.75 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.04 -44.08 91.74 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.036 0.446 . . . . 0.0 110.353 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 479' ' ' LEU . 85.8 t -62.06 -52.27 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.269 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . 0.598 ' HG3' HD13 ' A' ' 412' ' ' ILE . 0.0 OUTLIER -56.69 -49.5 74.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.488 179.106 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 4.5 tt -56.21 -47.15 78.96 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 35.0 m -58.44 -50.98 71.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.224 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.475 ' CG1' HD13 ' A' ' 408' ' ' LEU . 60.6 t -57.5 -47.42 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.413 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -57.3 -48.67 78.55 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 5.7 tt -55.42 -50.23 70.34 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 55.2 t -56.53 -48.39 80.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.859 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' A' ' 405' ' ' ALA . 90.4 mt -58.55 -41.24 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.454 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.56 -58.31 12.82 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.666 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -55.58 -47.4 76.5 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.065 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.462 HD12 ' HB3' ' A' ' 400' ' ' GLN . 2.7 tm? -58.74 -44.99 90.64 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.455 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.541 ' OG1' ' HA2' ' A' ' 401' ' ' GLY . 72.0 m -59.7 -42.93 94.11 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.94 -57.93 9.08 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.959 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.78 -48.17 85.69 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.615 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 2.9 p -60.92 -29.64 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 3.7 ttm105 -91.66 -43.04 9.84 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.672 0.272 . . . . 0.0 110.91 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.64 95.95 5.39 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.031 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.44 -36.04 34.14 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.365 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.071 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 1.2 mmm . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 6.2 m -63.65 125.61 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.937 0.399 . . . . 0.0 111.602 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -91.74 74.21 5.79 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.119 0.485 . . . . 0.0 110.721 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 37.2 mm -56.99 -38.97 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.022 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.97 140.05 47.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.823 0.344 . . . . 0.0 111.356 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . 165.08 -110.27 0.41 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.252 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 1.6 t -53.92 -44.76 70.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 110.168 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.711 HG11 ' CB ' ' A' ' 443' ' ' TYR . 19.9 t -59.71 -54.28 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.788 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 21.3 m -61.06 -42.48 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.536 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.91 -53.81 53.7 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.8 87.73 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.934 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -55.86 -51.83 66.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.836 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.465 HD23 HD12 ' A' ' 491' ' ' ILE . 2.4 tm? -55.19 -43.93 74.84 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 177.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.2 t -57.81 -44.56 86.44 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.129 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.35 96.57 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.239 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 407' ' ' ALA . 79.2 t -60.06 -51.39 73.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.107 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.422 HD11 HD11 ' A' ' 408' ' ' LEU . 51.6 mt -56.16 -46.28 81.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.208 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . 0.447 HG22 ' SD ' ' A' ' 417' ' ' MET . 36.5 m -57.69 -48.01 80.74 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.142 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 432' ' ' TYR . 9.3 tp -59.11 -57.42 13.15 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.358 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 5.2 tt -58.23 -43.97 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.583 0.23 . . . . 0.0 111.053 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.37 -54.69 43.8 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.465 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . 0.447 ' SD ' HG22 ' A' ' 413' ' ' THR . 7.1 mtp -55.86 -49.99 71.83 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.86 -53.51 39.68 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.735 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -57.79 -43.04 85.35 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.526 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 421' ' ' MET . 6.1 tt -67.0 -50.44 62.22 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.518 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . 0.683 ' HB2' HD23 ' A' ' 420' ' ' LEU . 0.0 OUTLIER -145.17 126.04 14.41 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.617 0.246 . . . . 0.0 111.518 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 68.92 88.14 0.11 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.684 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 424' ' ' ASP . 4.2 t80 -76.21 149.31 37.25 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.354 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.501 ' CG ' ' HB ' ' A' ' 469' ' ' THR . 54.8 m-20 69.75 174.18 0.3 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.923 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.444 ' HA ' ' CG1' ' A' ' 429' ' ' VAL . . . -96.06 98.2 10.17 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.83 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -140.83 -100.62 0.15 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.08 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -82.31 136.24 35.06 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.1 mp 69.08 -56.01 0.55 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.351 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.444 ' CG1' ' HA ' ' A' ' 425' ' ' ALA . 85.4 t -51.19 -37.71 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.61 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -45.5 -44.95 12.92 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.572 0.225 . . . . 0.0 110.978 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 1.1 mp -61.91 -51.17 69.24 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.927 0.394 . . . . 0.0 109.961 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.489 ' HB3' ' CD1' ' A' ' 414' ' ' LEU . 56.2 m-85 -57.83 -46.63 84.46 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.137 178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 437' ' ' VAL . 2.5 tm? -57.51 -51.99 67.2 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.69 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 438' ' ' VAL . 1.8 mp -56.0 -46.71 78.66 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.015 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -51.45 -50.98 39.42 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 87.5 t -56.94 -45.81 83.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.867 0.365 . . . . 0.0 110.047 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 433' ' ' LEU . 85.4 t -57.89 -43.82 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.345 178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 434' ' ' LEU . 88.4 t -57.33 -53.22 46.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.517 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.02 -48.69 87.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.744 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.452 ' HA ' ' CE2' ' A' ' 443' ' ' TYR . . . -55.5 -49.67 71.96 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.138 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.63 -48.98 70.36 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.91 -44.02 73.79 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.711 ' CB ' HG11 ' A' ' 403' ' ' VAL . 0.1 OUTLIER -86.02 -34.26 20.82 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -67.44 71.55 0.23 Allowed Glycine 0 C--N 1.337 0.594 0 C-N-CA 121.192 -0.527 . . . . 0.0 113.136 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 446' ' ' TRP . 4.9 mtm180 -122.53 151.78 41.02 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.444 0.164 . . . . 0.0 110.928 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . 0.435 ' CB ' ' O ' ' A' ' 445' ' ' ARG . 1.6 t-105 83.07 131.66 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.031 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.13 111.01 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.652 2.234 . . . . 0.0 112.13 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.3 t -145.03 136.19 24.94 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.493 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.499 ' O ' HG22 ' A' ' 453' ' ' VAL . 39.1 t -45.66 -59.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.698 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.604 HG11 ' HB3' ' A' ' 494' ' ' LEU . 14.1 m -54.38 -46.34 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.408 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -64.18 -47.72 78.71 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.826 0.346 . . . . 0.0 110.65 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 28.5 m -57.45 -56.73 18.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.253 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 449' ' ' VAL . 34.4 m -59.73 -44.44 93.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.124 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.402 ' N ' HG23 ' A' ' 453' ' ' VAL . 36.7 mt -59.27 -50.08 81.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -53.13 -49.47 66.49 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.321 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 52.0 t -54.88 -53.64 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.956 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 54.4 t -51.57 -52.56 20.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 2.0 p -57.71 -38.76 75.81 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.012 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -60.89 -48.87 79.84 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -60.43 -46.65 89.26 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.8 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.6 tp -70.95 -19.62 62.55 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.821 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . 0.422 ' CD2' ' HG3' ' A' ' 466' ' ' PRO . 0.1 OUTLIER -66.72 -167.77 0.05 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 111.217 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 467' ' ' ARG . 6.9 t80 69.59 -59.17 0.5 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.207 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 17.5 tt -73.61 -42.25 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.618 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.705 ' HB3' ' HD3' ' A' ' 466' ' ' PRO . . . -66.56 -61.55 5.01 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.794 -0.185 . . . . 0.0 111.076 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.705 ' HD3' ' HB3' ' A' ' 465' ' ' ALA . 71.7 Cg_endo -73.45 56.87 3.41 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.374 2.049 . . . . 0.0 111.964 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 463' ' ' PHE . 0.0 OUTLIER -157.28 -50.25 0.07 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.625 -179.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 136.75 89.36 0.25 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.443 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . 0.501 ' HB ' ' CG ' ' A' ' 424' ' ' ASP . 0.2 OUTLIER -90.19 139.28 30.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 111.417 -179.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.47 38.27 0.77 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.368 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -157.57 82.02 0.89 Allowed 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.086 0.47 . . . . 0.0 111.049 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . 0.527 ' HA ' ' HB2' ' A' ' 476' ' ' GLN . 38.7 t -109.13 -60.08 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.553 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.58 -66.15 0.19 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.614 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -158.96 -66.19 0.08 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.173 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 476' ' ' GLN . 7.3 p -39.29 -48.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 472' ' ' VAL . 0.3 OUTLIER -59.65 -40.49 87.86 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.507 0.194 . . . . 0.0 111.245 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -72.66 -49.13 33.69 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.622 0.249 . . . . 0.0 110.413 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.13 -51.44 67.92 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.234 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.24 -50.02 75.05 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.691 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 97.8 m -54.19 -42.04 69.26 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.999 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -58.5 -48.92 79.21 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.459 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.96 -44.85 96.72 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.731 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.69 -49.18 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.235 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -49.04 79.37 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.103 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 6.1 tt -56.61 -46.49 80.87 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 490' ' ' VAL . 45.8 m -56.67 -48.47 77.54 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.435 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 42.9 t -57.0 -47.72 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.002 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.64 -46.58 88.66 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 16.8 tp -58.11 -48.7 79.38 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 486' ' ' THR . 89.6 t -60.31 -48.55 87.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.64 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.544 ' HA ' HD21 ' A' ' 494' ' ' LEU . 83.7 mt -57.06 -46.17 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.152 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.44 -44.14 97.18 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.13 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -57.54 -56.51 20.89 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.325 0.25 . . . . 0.0 111.125 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.604 ' HB3' HG11 ' A' ' 450' ' ' VAL . 3.0 pp -58.71 -43.32 90.06 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.874 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.485 ' N ' HD12 ' A' ' 494' ' ' LEU . 15.3 m -61.13 -49.24 78.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.687 0.28 . . . . 0.0 110.589 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.84 97.89 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.036 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -65.21 -48.65 67.64 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.446 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 499' ' ' ARG . 8.1 p -66.06 -44.25 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . 0.421 ' N ' HG13 ' A' ' 498' ' ' VAL . 0.0 OUTLIER -80.46 63.71 5.01 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.043 0.449 . . . . 0.0 110.812 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.86 119.15 3.64 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.667 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -123.71 39.3 3.99 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.992 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.27 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.135 -179.937 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.368 0.128 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 6.4 m -134.9 48.13 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.972 0.415 . . . . 0.0 111.562 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -62.13 115.92 4.52 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.769 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.93 -164.96 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.728 ' HA ' HG21 ' A' ' 404' ' ' VAL . 11.8 mt-30 -68.79 69.05 0.16 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.771 0.319 . . . . 0.0 111.839 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 494' ' ' LEU . . . -124.89 -124.8 2.87 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.653 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.61 -55.66 12.82 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 51.0 t -52.17 -48.15 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.744 0.307 . . . . 0.0 110.828 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' A' ' 400' ' ' GLN . 2.9 t -59.78 -48.11 88.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.629 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.442 ' HB2' HD22 ' A' ' 494' ' ' LEU . . . -58.61 -48.48 80.85 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.772 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.7 -55.92 28.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.927 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.644 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -54.82 -49.45 70.99 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.795 0.331 . . . . 0.0 110.564 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 1.048 HD13 HG21 ' A' ' 490' ' ' VAL . 0.7 OUTLIER -56.06 -49.68 73.09 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.205 178.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 30.0 t -49.66 -53.01 26.81 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.292 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -55.48 -47.29 76.38 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.498 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.441 ' CG2' HG21 ' A' ' 439' ' ' VAL . 37.7 t -57.07 -46.49 84.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.337 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 408' ' ' LEU . 38.1 mm -55.69 -46.81 79.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.154 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.26 -39.71 95.36 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.197 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.585 HD23 ' HD1' ' A' ' 432' ' ' TYR . 0.7 OUTLIER -62.63 -52.13 64.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.724 179.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.41 ' HB ' ' CE1' ' A' ' 432' ' ' TYR . 3.0 tp -59.07 -42.03 85.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.59 -49.17 78.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 4.0 ttt -58.95 -42.88 90.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.128 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.604 ' HG2' ' HG ' ' A' ' 428' ' ' LEU . 0.0 OUTLIER -56.5 -54.6 43.85 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.031 178.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -54.88 -41.72 71.22 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.385 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 3.7 tp -75.08 50.06 0.46 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.14 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 2.0 mtt 177.26 -59.08 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.935 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -153.29 129.04 10.13 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.462 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -92.26 33.16 1.1 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.882 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -100.26 168.8 9.55 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.081 0.467 . . . . 0.0 111.353 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 464' ' ' ILE . . . -126.87 32.89 5.04 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.01 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -105.93 -55.15 2.37 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.432 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.92 -63.31 1.3 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.384 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.604 ' HG ' ' HG2' ' A' ' 418' ' ' GLN . 4.6 mm? -54.56 -38.35 66.54 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.652 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.885 HG22 ' HG ' ' A' ' 433' ' ' LEU . 1.5 p -46.05 -42.24 4.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.033 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 85.1 mmm -51.23 -54.44 25.65 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 110.929 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.456 HD12 ' H ' ' A' ' 431' ' ' LEU . 2.7 mp -64.31 -47.89 77.72 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.491 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.585 ' HD1' HD23 ' A' ' 414' ' ' LEU . 28.4 t80 -59.95 -50.49 73.53 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.517 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.885 ' HG ' HG22 ' A' ' 429' ' ' VAL . 19.8 mt -54.97 -43.86 73.89 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.407 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 438' ' ' VAL . 4.1 tt -57.6 -54.09 50.8 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.579 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -58.46 -50.42 66.97 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.239 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 432' ' ' TYR . 76.9 t -58.39 -44.52 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.12 -48.22 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 434' ' ' LEU . 97.8 t -55.87 -46.0 79.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.644 HG22 ' HB1' ' A' ' 407' ' ' ALA . 23.9 t -60.07 -50.21 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.492 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -57.24 -48.85 77.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.827 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.8 tt -53.74 -45.4 70.52 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -65.33 -38.76 91.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.005 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.662 ' CE1' HG22 ' A' ' 404' ' ' VAL . 0.2 OUTLIER -65.42 -45.41 84.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.445 179.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.432 ' O ' ' HD3' ' A' ' 445' ' ' ARG . . . -64.17 76.79 0.05 OUTLIER Glycine 0 C--N 1.337 0.584 0 N-CA-C 114.61 0.604 . . . . 0.0 114.61 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' A' ' 444' ' ' GLY . 0.0 OUTLIER -148.61 -65.78 0.24 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.775 0.322 . . . . 0.0 110.422 178.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -128.84 66.28 75.13 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 121.186 0.517 . . . . 0.0 109.823 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.649 ' CB ' ' HB3' ' A' ' 451' ' ' ALA . 83.3 Cg_endo -80.13 155.69 22.74 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.018 2.479 . . . . 0.0 113.819 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.8 73.87 1.44 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.488 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 453' ' ' VAL . 79.2 t 72.12 -65.74 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.499 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.476 ' CG1' HD22 ' A' ' 489' ' ' LEU . 2.9 m -50.98 -53.21 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 120.553 0.216 . . . . 0.0 110.96 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.649 ' HB3' ' CB ' ' A' ' 447' ' ' PRO . . . -58.46 -39.8 80.89 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.923 0.392 . . . . 0.0 110.384 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.89 -50.46 73.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.326 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 449' ' ' VAL . 45.0 t -55.85 -52.39 49.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.853 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' A' ' 451' ' ' ALA . 17.3 tt -60.93 -39.38 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.966 -0.293 . . . . 0.0 110.446 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -56.22 -46.85 79.36 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 78.3 t -58.83 -54.99 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.907 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 42.1 t -52.72 -41.81 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.286 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 1.4 t -56.96 -44.09 82.23 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.0 -50.02 74.84 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.911 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -58.99 -42.06 89.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.926 0.393 . . . . 0.0 110.51 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -43.43 84.2 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.65 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . 0.463 ' HA ' HD13 ' A' ' 433' ' ' LEU . 6.3 t80 -68.9 58.56 0.09 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.215 0.531 . . . . 0.0 111.122 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -176.78 49.45 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.173 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 425' ' ' ALA . 10.1 mt 58.83 37.44 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.439 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 464' ' ' ILE . . . 71.79 136.66 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.168 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -38.24 -38.61 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.624 2.883 . . . . 0.0 113.484 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.05 25.14 5.26 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 464' ' ' ILE . . . 87.8 -63.66 3.79 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.691 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 8.6 t -160.12 155.01 24.43 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.723 0.296 . . . . 0.0 110.781 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 478' ' ' LEU . 12.9 tp -75.41 67.63 1.99 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.99 0.424 . . . . 0.0 111.636 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -109.39 67.55 0.65 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.126 0.488 . . . . 0.0 111.453 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 1.1 t -141.08 35.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.525 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 6.3 t 71.22 160.29 0.22 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.555 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.14 33.03 1.59 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.743 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.486 HG23 HD23 ' A' ' 470' ' ' LEU . 11.2 p -51.13 -44.52 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.92 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.407 ' N ' HG13 ' A' ' 475' ' ' VAL . 1.3 tt0 -61.52 -58.13 9.37 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.588 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -55.15 -44.59 75.26 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.048 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.512 ' HB3' HD21 ' A' ' 470' ' ' LEU . 2.8 tt -56.94 -52.25 65.96 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.776 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.58 -46.23 90.78 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 55.3 m -54.49 -47.47 72.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.198 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -61.8 -53.94 49.03 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.667 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -53.91 -44.77 70.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.948 0.404 . . . . 0.0 110.738 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 487' ' ' VAL . 40.2 t -65.0 -50.18 76.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.332 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 34.2 mtt -53.93 -53.58 50.73 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.722 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 21.3 tp -55.78 -50.79 69.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.397 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . 0.59 HG22 HD11 ' A' ' 408' ' ' LEU . 25.7 m -55.72 -47.25 77.22 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.543 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 483' ' ' VAL . 78.9 t -60.34 -49.24 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.46 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -58.11 -45.5 93.85 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.752 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . 0.476 HD22 ' CG1' ' A' ' 450' ' ' VAL . 20.5 mt -62.45 -48.09 81.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.84 0.352 . . . . 0.0 110.09 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 1.048 HG21 HD13 ' A' ' 408' ' ' LEU . 5.0 t -58.76 -59.33 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.043 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.504 ' HA ' HD23 ' A' ' 494' ' ' LEU . 2.6 pp -55.84 -35.39 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.087 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -60.36 -56.41 24.64 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.368 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -41.74 99.54 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.642 ' HA ' ' HA2' ' A' ' 401' ' ' GLY . 0.2 OUTLIER -57.86 -50.23 74.0 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.166 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 1.1 m -64.23 -44.36 92.12 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.6 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.82 80.29 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.988 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -67.2 -46.32 72.87 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.455 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 90.4 t -74.37 -42.66 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.737 0.303 . . . . 0.0 111.342 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 -96.83 101.14 12.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.851 0.358 . . . . 0.0 110.922 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -53.17 115.97 2.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.776 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.45 144.47 28.51 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.119 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.437 -0.792 . . . . 0.0 111.315 179.878 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 2.1 tmt? . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.481 0.182 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 8.0 p -160.69 140.51 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.01 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -54.51 -65.87 0.5 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.591 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.523 HG23 ' H ' ' A' ' 400' ' ' GLN . 1.5 tp -165.57 -61.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.437 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.536 ' HG3' ' CE1' ' A' ' 443' ' ' TYR . 21.9 tt0 -150.24 114.83 5.23 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.615 0.245 . . . . 0.0 111.08 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.475 ' HA2' ' CG2' ' A' ' 495' ' ' THR . . . -175.7 -113.01 0.32 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.428 -0.891 . . . . 0.0 113.697 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.98 -52.19 2.47 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.773 0.656 . . . . 0.0 112.773 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.595 HG12 HG13 ' A' ' 439' ' ' VAL . 29.5 t -50.53 -56.2 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.746 0.308 . . . . 0.0 111.414 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.411 HG11 HG21 ' A' ' 491' ' ' ILE . 12.1 t -64.98 -40.79 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.873 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.7 82.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.64 -46.81 83.96 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.661 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.97 ' HB2' HG11 ' A' ' 439' ' ' VAL . . . -53.54 -56.7 14.86 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.15 178.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.408 ' CD2' ' HA2' ' A' ' 488' ' ' GLY . 2.9 mp -55.89 -43.05 76.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.315 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 46.1 m -55.91 -53.25 59.1 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.78 -48.96 78.18 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.137 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.789 HG22 ' HE1' ' A' ' 432' ' ' TYR . 55.8 t -55.05 -41.9 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.335 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.446 ' O ' HG22 ' A' ' 415' ' ' ILE . 11.9 mm -58.46 -50.87 77.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.2 -38.8 77.45 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.257 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 411' ' ' VAL . 9.3 mt -65.65 -58.11 6.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 412' ' ' ILE . 2.3 tp -55.3 -39.7 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.601 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.98 83.87 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 32.5 ttm -54.79 -50.92 67.32 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.836 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -60.73 -40.19 91.43 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.202 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . 0.468 ' CE2' ' HB3' ' A' ' 477' ' ' TYR . 1.0 OUTLIER -56.44 -39.72 73.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.049 179.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.66 -36.8 16.03 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.842 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . 0.415 ' HB3' ' CE2' ' A' ' 423' ' ' PHE . 0.0 OUTLIER -88.98 -164.82 1.2 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.926 0.393 . . . . 0.0 111.405 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -159.46 124.74 4.15 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.213 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . 0.479 ' CE1' HD13 ' A' ' 428' ' ' LEU . 3.6 p90 -177.07 172.07 2.01 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.853 0.358 . . . . 0.0 111.246 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.46 178.38 5.31 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.531 ' HB2' HG21 ' A' ' 469' ' ' THR . . . -87.19 -19.41 28.44 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -55.58 155.38 5.62 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 49.5 t30 68.52 -63.55 0.34 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.583 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.479 HD13 ' CE1' ' A' ' 423' ' ' PHE . 0.3 OUTLIER -59.92 -49.25 78.44 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.292 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 433' ' ' LEU . 7.4 p -50.2 -39.91 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 121.175 -0.21 . . . . 0.0 110.763 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -51.58 35.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.395 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.46 -48.61 78.71 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.789 ' HE1' HG22 ' A' ' 411' ' ' VAL . 22.2 t80 -57.96 -51.83 68.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.724 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.621 HD22 ' HD1' ' A' ' 462' ' ' PHE . 0.0 OUTLIER -55.13 -42.63 73.26 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.121 178.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.493 ' O ' HG23 ' A' ' 438' ' ' VAL . 3.6 tp -55.16 -51.89 65.04 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -59.28 -48.32 86.51 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.786 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 432' ' ' TYR . 57.9 t -57.44 -41.33 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.682 0.277 . . . . 0.0 110.375 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 433' ' ' LEU . 53.6 t -62.75 -43.02 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.928 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 434' ' ' LEU . 71.8 t -59.15 -50.31 80.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.97 HG11 ' HB2' ' A' ' 407' ' ' ALA . 69.7 t -60.8 -43.45 95.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.844 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 444' ' ' GLY . . . -57.71 -50.51 72.95 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.415 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.58 -40.16 78.37 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.847 0.356 . . . . 0.0 110.197 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . 0.446 ' HB3' ' CG1' ' A' ' 403' ' ' VAL . 1.3 t80 -69.11 -35.97 77.01 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.275 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.536 ' CE1' ' HG3' ' A' ' 400' ' ' GLN . 8.0 t80 -88.26 -19.26 27.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 440' ' ' ALA . . . -60.35 64.1 0.01 OUTLIER Glycine 0 C--N 1.337 0.612 0 N-CA-C 114.753 0.661 . . . . 0.0 114.753 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.0 OUTLIER -97.49 -34.78 10.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 109.99 178.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . 0.433 ' CZ3' ' HD3' ' A' ' 445' ' ' ARG . 6.1 m-90 -152.15 130.5 6.23 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.1 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.452 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 10.1 Cg_endo -51.22 -62.8 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.564 2.176 . . . . 0.0 112.413 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 45.2 t 47.64 33.47 3.05 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 453' ' ' VAL . 49.0 t 66.29 -60.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 451' ' ' ALA . 9.9 m -48.26 -52.2 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 447' ' ' PRO . . . -57.07 -46.3 82.62 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.663 0.268 . . . . 0.0 111.078 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.565 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.8 OUTLIER -60.57 -52.51 64.87 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.033 178.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 449' ' ' VAL . 67.6 t -54.08 -48.14 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.544 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 454' ' ' ILE . 17.2 mm -53.89 -57.63 5.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 110.473 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -49.62 66.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.595 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 452' ' ' THR . 92.8 t -55.37 -54.06 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.527 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 45.7 t -48.29 -50.45 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -40.02 87.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.634 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.27 -56.87 15.62 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.207 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -63.99 -41.55 97.48 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.342 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 1.0 OUTLIER -65.07 -31.18 72.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . 0.621 ' HD1' HD22 ' A' ' 433' ' ' LEU . 70.2 t80 -38.56 135.43 0.8 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.901 0.381 . . . . 0.0 111.8 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 77.01 -50.29 0.55 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.297 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.468 ' O ' ' HB3' ' A' ' 465' ' ' ALA . 6.0 mt -74.89 -47.77 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 1.04 ' HB1' ' HD2' ' A' ' 466' ' ' PRO . . . 72.1 178.9 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 120.63 0.253 . . . . 0.0 111.382 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 1.04 ' HD2' ' HB1' ' A' ' 465' ' ' ALA . 36.7 Cg_endo -65.58 161.46 38.45 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.366 2.044 . . . . 0.0 112.483 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 17.9 mtt85 -65.25 165.02 12.26 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.024 0.44 . . . . 0.0 111.707 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 86.85 29.16 24.22 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.537 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . 0.531 HG21 ' HB2' ' A' ' 425' ' ' ALA . 3.1 m -101.63 -58.24 1.92 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.957 0.378 . . . . 0.0 111.507 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.42 -46.36 11.77 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.674 0.273 . . . . 0.0 111.587 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -95.78 133.61 39.71 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.244 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 20.8 t -81.15 130.75 35.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.978 0.418 . . . . 0.0 111.142 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.3 m -173.63 99.77 0.11 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.2 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -53.29 -42.62 66.78 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.57 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 13.8 m -50.23 -43.9 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.664 -0.243 . . . . 0.0 111.616 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -60.98 -40.75 94.6 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.886 0.374 . . . . 0.0 110.654 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . 0.468 ' HB3' ' CE2' ' A' ' 419' ' ' TRP . 16.7 m-85 -68.79 -51.89 36.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.367 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.7 -49.33 73.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.64 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 2.1 tt -57.62 -53.29 59.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.289 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 48.0 m -53.83 -45.95 71.02 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.33 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -47.7 85.21 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.101 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -55.98 -45.41 78.97 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.329 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 487' ' ' VAL . 78.8 t -62.64 -50.47 79.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.131 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 26.3 ttm -54.64 -48.23 72.54 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.723 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.73 -46.11 86.87 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.195 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 52.0 m -55.49 -57.89 10.03 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.729 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 483' ' ' VAL . 27.2 m -57.53 -42.04 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.501 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . 0.408 ' HA2' ' CD2' ' A' ' 408' ' ' LEU . . . -58.42 -47.15 91.42 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.97 -44.34 82.54 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 76.3 t -60.7 -53.52 47.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.006 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.411 HG21 HG11 ' A' ' 404' ' ' VAL . 48.9 mt -56.62 -40.0 66.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.465 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.53 -50.42 59.3 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.74 -49.05 76.38 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.419 ' O ' HG23 ' A' ' 498' ' ' VAL . 4.8 tt -58.12 -48.91 78.77 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.475 ' CG2' ' HA2' ' A' ' 401' ' ' GLY . 88.7 m -52.17 -49.22 64.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.734 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.16 89.17 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.868 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -66.95 -28.64 73.88 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.685 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 494' ' ' LEU . 39.9 t -92.98 -44.36 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 120.576 0.227 . . . . 0.0 111.526 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.68 63.83 0.62 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -90.09 -76.42 0.43 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.714 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.92 -50.86 6.39 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.911 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.262 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.372 179.361 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . 0.909 ' HB2' HG23 ' A' ' 498' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.395 0.141 . . . . 0.0 111.109 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 12.1 m -148.36 125.53 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.399 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 46.2 46.41 13.2 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.982 0.42 . . . . 0.0 111.51 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.446 HG22 ' CG ' ' A' ' 396' ' ' MET . 0.5 OUTLIER -138.15 168.28 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.979 0.419 . . . . 0.0 111.907 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.83 ' HB2' HG21 ' A' ' 404' ' ' VAL . 9.6 pt20 -59.72 101.95 0.13 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.201 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.793 ' HA2' HD13 ' A' ' 494' ' ' LEU . . . -162.8 -77.46 0.03 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.165 -0.541 . . . . 0.0 112.439 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.4 t -60.54 -56.01 26.45 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.706 0.289 . . . . 0.0 111.244 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' A' ' 443' ' ' TYR . 1.6 t -61.24 -46.76 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.922 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.83 HG21 ' HB2' ' A' ' 400' ' ' GLN . 60.8 t -58.9 -47.91 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.326 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.06 -47.89 83.61 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.091 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -57.03 -51.78 67.9 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.41 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -56.08 -51.27 68.47 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.185 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.537 HD12 ' CG1' ' A' ' 487' ' ' VAL . 4.1 tt -55.62 -44.02 76.67 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.312 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.57 -54.03 46.71 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.474 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.7 78.61 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.752 0.31 . . . . 0.0 110.454 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 407' ' ' ALA . 88.7 t -60.4 -55.2 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.292 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.562 ' HA ' HG22 ' A' ' 415' ' ' ILE . 0.6 OUTLIER -59.59 -41.99 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.745 -0.207 . . . . 0.0 111.195 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 2.9 m -61.53 -54.8 38.4 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.677 0.275 . . . . 0.0 110.467 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.651 HD13 ' HD1' ' A' ' 432' ' ' TYR . 0.3 OUTLIER -60.71 -50.05 75.02 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.062 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.865 HD11 HG23 ' A' ' 480' ' ' THR . 4.4 tt -59.81 -41.46 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.761 -0.199 . . . . 0.0 111.029 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.95 78.26 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 34.4 mtt -59.6 -47.26 86.28 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.852 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -56.08 -55.1 37.05 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.758 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -56.23 -46.47 79.54 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.121 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.04 -48.74 80.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.401 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . 0.53 ' SD ' ' HB2' ' A' ' 423' ' ' PHE . 1.4 ttm -65.97 -34.93 79.23 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.021 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 76.8 62.36 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.126 0.489 . . . . 0.0 111.329 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . 0.762 ' HE2' ' HB3' ' A' ' 426' ' ' ALA . 4.9 t80 -136.55 148.17 47.42 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.666 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.482 ' HA ' ' NE2' ' A' ' 476' ' ' GLN . 0.3 OUTLIER -79.69 -164.72 0.69 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.254 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -81.7 90.15 6.31 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.813 0.339 . . . . 0.0 111.515 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.762 ' HB3' ' HE2' ' A' ' 423' ' ' PHE . . . -153.29 134.32 14.01 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 466' ' ' PRO . 1.6 m-80 63.9 -77.55 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.097 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.471 HD12 HD21 ' A' ' 414' ' ' LEU . 0.2 OUTLIER -48.45 -41.89 30.79 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.775 0.321 . . . . 0.0 110.885 179.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.667 HG22 HD12 ' A' ' 433' ' ' LEU . 8.5 p -48.91 -39.85 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.397 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -62.68 -54.05 45.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.659 0.266 . . . . 0.0 110.358 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 16.5 tp -59.63 -43.14 93.95 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.651 ' HD1' HD13 ' A' ' 414' ' ' LEU . 25.6 t80 -58.48 -51.93 67.79 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.409 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.743 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.1 OUTLIER -55.44 -49.53 72.21 Favored 'General case' 0 C--O 1.227 -0.105 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.839 178.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.58 -55.05 18.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.484 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.52 -51.27 58.82 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.726 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 52.4 t -53.46 -42.67 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 120.675 0.274 . . . . 0.0 110.68 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 433' ' ' LEU . 98.7 t -61.49 -46.23 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.45 179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.19 -55.57 19.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 120.912 0.387 . . . . 0.0 110.135 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.61 -46.23 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.172 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.538 ' HB1' ' OD1' ' A' ' 455' ' ' ASN . . . -55.57 -47.79 75.85 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.44 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.09 -45.41 75.41 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.574 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -74.72 -27.74 60.5 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.909 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.45 ' HB2' HG11 ' A' ' 403' ' ' VAL . 9.8 t80 -86.48 -41.06 14.7 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -67.31 57.81 0.27 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 114.151 0.42 . . . . 0.0 114.151 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.26 -46.41 6.75 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.51 66.92 75.33 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.835 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 56.0 Cg_endo -69.37 86.09 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.617 2.211 . . . . 0.0 112.869 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.56 62.78 0.39 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.681 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 453' ' ' VAL . 54.8 t 68.8 -59.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.071 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.652 HG12 HD11 ' A' ' 454' ' ' ILE . 89.3 t -52.06 -62.92 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.595 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' A' ' 454' ' ' ILE . . . -52.01 -40.2 60.64 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.689 0.281 . . . . 0.0 111.382 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.1 OUTLIER -62.66 -54.63 36.58 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.194 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 449' ' ' VAL . 66.7 t -55.07 -45.62 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.417 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.652 HD11 HG12 ' A' ' 450' ' ' VAL . 27.3 mt -56.77 -50.54 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.525 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.538 ' OD1' ' HB1' ' A' ' 440' ' ' ALA . 17.0 m-80 -61.22 -48.14 82.84 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.085 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 452' ' ' THR . 88.6 t -61.06 -58.5 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.244 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 4.0 t -50.36 -49.33 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.285 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -48.08 79.85 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.073 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -58.2 -54.35 48.02 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.651 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -58.01 -51.5 69.42 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.298 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 479' ' ' LEU . 6.9 mp -61.14 -58.12 9.67 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.838 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . 0.552 ' O ' HD21 ' A' ' 433' ' ' LEU . 2.0 m-85 -80.82 68.16 6.97 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.613 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -56.52 135.19 54.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.283 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.709 ' HA ' HD13 ' A' ' 433' ' ' LEU . 4.8 tt -65.96 77.0 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.366 0.603 . . . . 0.0 111.498 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.417 ' HA ' ' HD2' ' A' ' 466' ' ' PRO . . . -100.45 96.33 5.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.151 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 465' ' ' ALA . 6.8 Cg_endo -48.55 -52.28 8.78 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.755 2.304 . . . . 0.0 112.283 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.4 -36.51 22.37 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.766 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 131.64 -160.53 23.52 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.166 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 23.6 m -158.73 156.57 30.1 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.682 -0.305 . . . . 0.0 110.778 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 4.6 mt -85.29 156.08 21.09 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.742 0.306 . . . . 0.0 111.12 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -126.77 137.0 53.16 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.732 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 9.7 p -61.68 -26.69 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.978 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.5 m -177.13 -53.47 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.139 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.73 49.82 1.29 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.96 0.41 . . . . 0.0 111.797 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 86.0 t -64.81 -59.81 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.223 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 424' ' ' ASP . 4.0 tt0 -56.1 -40.73 74.11 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.656 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -49.85 74.69 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -47.77 83.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.103 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . 0.566 ' HA ' HD23 ' A' ' 461' ' ' LEU . 6.2 mp -58.79 -52.99 63.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.138 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . 0.865 HG23 HD11 ' A' ' 415' ' ' ILE . 18.1 m -54.48 -47.48 72.94 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.252 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -59.72 -48.93 79.71 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.726 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.48 -47.92 83.64 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.481 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 487' ' ' VAL . 34.3 m -65.66 -41.84 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 50.8 mtp -58.81 -52.52 65.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -45.87 81.44 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . 0.643 ' O ' HG23 ' A' ' 490' ' ' VAL . 85.4 m -55.27 -48.99 73.22 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.443 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 483' ' ' VAL . 99.5 t -57.63 -47.6 85.11 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.057 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.617 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . 0.89 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -53.02 -45.7 61.92 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 1.3 tt -58.68 -46.88 86.24 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 486' ' ' THR . 41.4 t -58.02 -41.65 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.889 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.89 HD12 ' HA2' ' A' ' 488' ' ' GLY . 55.0 mt -58.14 -53.28 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.97 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -56.79 -49.4 70.86 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.888 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -45.32 92.27 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.687 0.279 . . . . 0.0 110.761 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.793 HD13 ' HA2' ' A' ' 401' ' ' GLY . 0.2 OUTLIER -62.74 -46.47 87.93 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.077 179.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.498 ' N ' ' HG ' ' A' ' 494' ' ' LEU . 3.5 m -53.84 -46.44 71.2 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -62.49 -45.75 91.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.681 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.14 -47.85 88.95 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.24 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.909 HG23 ' HB2' ' A' ' 396' ' ' MET . 7.4 p -73.68 59.86 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.588 0.709 . . . . 0.0 110.672 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . 0.57 ' NH1' HG13 ' A' ' 498' ' ' VAL . 82.7 mmt-85 -152.32 -62.48 0.16 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.442 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -153.62 128.02 9.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.767 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.77 135.35 33.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.898 0.38 . . . . 0.0 111.302 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.168 179.922 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 120.392 0.139 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.2 143.94 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.112 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -101.01 65.22 1.08 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.152 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.787 HD12 ' CD1' ' A' ' 443' ' ' TYR . 34.0 pt 44.66 -152.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.042 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.77 ' HA ' HG21 ' A' ' 404' ' ' VAL . 52.6 tp60 45.83 47.82 12.05 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.191 0.52 . . . . 0.0 111.616 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.453 ' HA2' HG23 ' A' ' 495' ' ' THR . . . -141.7 -137.49 3.39 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.192 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.8 -41.92 57.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.735 0.268 . . . . 0.0 111.272 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 8.6 m -59.36 -47.56 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.894 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.77 HG21 ' HA ' ' A' ' 400' ' ' GLN . 39.0 t -64.53 -41.54 92.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.83 88.57 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.076 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.99 -50.06 74.93 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.119 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.437 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -54.44 -51.71 64.11 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.285 178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.411 HD21 HD12 ' A' ' 491' ' ' ILE . 2.7 mp -58.68 -45.68 88.89 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.171 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.3 t -54.58 -50.72 67.33 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.04 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.46 -52.3 58.71 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.033 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 439' ' ' VAL . 46.6 t -52.92 -53.08 23.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.333 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 415' ' ' ILE . 35.9 mt -61.92 -49.91 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.207 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 39.5 m -55.28 -45.63 76.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.675 0.274 . . . . 0.0 110.502 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 3.1 mp -65.47 -54.59 26.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.265 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.471 ' HB ' ' CE1' ' A' ' 432' ' ' TYR . 0.1 OUTLIER -56.81 -44.18 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.452 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -61.23 -51.42 69.05 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.648 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 33.8 mtp -59.2 -49.4 78.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.579 179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.517 ' HG2' ' HB3' ' A' ' 428' ' ' LEU . 2.8 mt-30 -60.09 -61.14 2.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.308 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 35.7 t90 -47.54 -44.9 26.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.699 0.285 . . . . 0.0 110.573 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 4.7 tt -63.45 -46.5 85.96 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.551 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 1.8 ttt -68.14 -39.97 82.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.959 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -139.09 96.95 3.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -71.2 59.24 0.26 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -169.39 118.78 0.66 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.872 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.788 ' CB ' ' HB1' ' A' ' 465' ' ' ALA . . . -76.31 67.57 2.57 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.045 0.45 . . . . 0.0 111.254 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -109.26 -74.02 0.67 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.728 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -95.59 -59.27 1.91 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.517 ' HB3' ' HG2' ' A' ' 418' ' ' GLN . 1.5 mm? -48.26 -35.01 11.24 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.16 -26.02 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.15 -51.11 63.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.587 0.232 . . . . 0.0 111.05 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.2 -40.9 97.61 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.154 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.656 ' O ' HG23 ' A' ' 436' ' ' VAL . 54.9 t80 -62.11 -50.98 69.73 Favored 'General case' 0 CA--C 1.526 0.034 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.612 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 6.1 tt -52.7 -52.38 56.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.37 -50.64 67.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.266 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -57.31 -49.09 75.4 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.679 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 432' ' ' TYR . 64.8 t -55.77 -47.79 78.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 47.4 t -56.09 -47.13 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.063 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.0 -52.99 54.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.398 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 411' ' ' VAL . 66.5 t -54.49 -51.96 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.573 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 444' ' ' GLY . . . -59.92 -42.33 93.7 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.321 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 6.8 tt -64.15 -50.53 67.83 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.67 0.271 . . . . 0.0 111.651 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . 0.505 ' O ' ' HD2' ' A' ' 445' ' ' ARG . 0.6 OUTLIER -70.92 -35.62 72.33 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.787 ' CD1' HD12 ' A' ' 399' ' ' ILE . 37.0 t80 -87.78 -26.64 22.77 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 440' ' ' ALA . . . -61.98 -6.23 9.24 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 115.076 0.79 . . . . 0.0 115.076 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.614 ' HD3' HG21 ' A' ' 399' ' ' ILE . 2.7 ptm180 -63.08 -23.79 67.61 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.112 0.956 . . . . 0.0 111.475 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . 0.596 ' HB3' HD11 ' A' ' 399' ' ' ILE . 0.0 OUTLIER -131.6 93.0 29.63 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 120.71 0.29 . . . . 0.0 110.751 179.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.7 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 11.7 Cg_endo -56.03 -67.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.772 2.315 . . . . 0.0 112.843 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 10.8 t 58.03 -89.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.355 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 453' ' ' VAL . 21.7 t -148.97 -59.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.664 0.269 . . . . 0.0 110.857 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.571 ' HB ' ' OH ' ' A' ' 443' ' ' TYR . 40.7 t -52.74 -47.35 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.7 ' HB3' ' HA ' ' A' ' 447' ' ' PRO . . . -59.71 -40.97 89.73 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 456' ' ' VAL . 93.3 m -59.41 -47.41 85.57 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 457' ' ' VAL . 58.1 t -60.15 -48.59 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.485 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 16.4 mm -54.06 -43.56 59.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.998 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -58.11 -50.27 74.07 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.845 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 452' ' ' THR . 42.4 t -57.77 -52.41 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.663 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 453' ' ' VAL . 77.5 t -54.08 -50.34 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.239 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 13.1 t -58.3 -44.57 88.62 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.954 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -55.37 -59.21 5.12 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.888 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . 0.458 ' OD2' HD11 ' A' ' 464' ' ' ILE . 6.0 t70 -59.49 -50.08 75.32 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.678 0.275 . . . . 0.0 110.452 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 9.1 tt -50.74 -43.51 58.13 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.716 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . 0.511 ' O ' ' HB3' ' A' ' 466' ' ' PRO . 7.5 t80 -55.51 -26.37 42.53 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.375 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -86.06 -27.33 24.8 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.648 0.261 . . . . 0.0 110.963 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.458 HD11 ' OD2' ' A' ' 460' ' ' ASP . 10.1 mt -87.31 -48.74 15.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.788 ' HB1' ' CB ' ' A' ' 425' ' ' ALA . . . -133.67 58.2 31.15 Favored Pre-proline 0 CA--C 1.538 0.509 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.511 ' HB3' ' O ' ' A' ' 462' ' ' PHE . 56.7 Cg_endo -73.69 -45.9 0.37 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.151 1.901 . . . . 0.0 112.493 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 466' ' ' PRO . 2.1 ttt85 176.82 -47.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.233 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . -93.0 57.89 2.47 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.151 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . 0.658 ' CG2' ' HB3' ' A' ' 425' ' ' ALA . 7.6 t -122.99 138.24 54.74 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.87 132.47 55.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.061 0.458 . . . . 0.0 111.681 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' A' ' 472' ' ' VAL . . . -80.4 161.96 24.71 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.79 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 471' ' ' ALA . 8.4 p 176.71 -38.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.841 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 15.0 p -89.42 -45.3 9.55 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.568 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 33.5 t70 71.85 -45.28 0.61 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.809 0.444 . . . . 0.0 111.93 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 42.8 t -40.75 -44.34 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 122.421 0.289 . . . . 0.0 111.545 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -62.54 -40.41 96.7 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.599 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . 0.674 ' OH ' ' HB2' ' A' ' 425' ' ' ALA . 0.2 OUTLIER -65.65 -51.91 55.85 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 2.7 tt -55.33 -54.28 45.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.802 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 483' ' ' VAL . 0.6 OUTLIER -54.99 -48.43 73.31 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.975 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 69.0 m -55.0 -44.0 74.12 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.802 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.22 -50.46 71.19 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.337 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.46 88.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.635 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 479' ' ' LEU . 91.9 t -63.14 -50.05 80.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.953 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 21.8 mtt -56.45 -52.67 63.8 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.141 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 2.5 tp -54.87 -46.29 74.7 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 490' ' ' VAL . 42.9 m -57.36 -48.74 78.22 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.914 178.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 483' ' ' VAL . 73.1 t -56.55 -46.33 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.47 -44.54 90.3 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 42.0 tp -56.52 -46.69 80.43 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.941 0.401 . . . . 0.0 109.983 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 486' ' ' THR . 34.3 t -63.22 -46.28 96.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.855 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.621 HG23 HE22 ' A' ' 400' ' ' GLN . 15.9 mt -55.67 -44.68 77.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.218 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.54 -45.75 92.18 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.694 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -54.43 -53.32 55.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.595 0.236 . . . . 0.0 110.971 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 491' ' ' ILE . 2.2 pp -68.57 -41.03 80.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.552 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 400' ' ' GLN . 79.6 m -60.16 -45.0 94.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.802 0.335 . . . . 0.0 110.415 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -68.04 -43.15 79.37 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.449 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -61.35 -47.12 92.6 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.242 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 495' ' ' THR . 8.0 p -64.84 -30.96 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.644 0.259 . . . . 0.0 111.235 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.59 66.71 0.73 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.897 0.379 . . . . 0.0 110.769 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 5.0 t80 76.91 80.85 0.09 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.92 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -84.33 145.41 28.26 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.672 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.03 179.588 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.061 -0.019 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 96.8 t 65.7 92.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.973 0.416 . . . . 0.0 111.524 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -128.9 35.95 4.27 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.676 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.465 HD12 ' HB2' ' A' ' 446' ' ' TRP . 3.8 tt -173.62 -49.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.922 0.391 . . . . 0.0 111.324 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.577 ' HA ' ' CG2' ' A' ' 404' ' ' VAL . 0.0 OUTLIER -149.37 163.57 37.36 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.928 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.741 ' HA2' HG23 ' A' ' 495' ' ' THR . . . 131.08 -137.03 9.17 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.825 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 2.2 t -54.32 -49.69 69.11 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 46.6 t -56.54 -52.57 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.053 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.577 ' CG2' ' HA ' ' A' ' 400' ' ' GLN . 21.2 t -59.94 -48.68 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.587 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.81 69.87 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.654 0.264 . . . . 0.0 110.372 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -55.84 -49.96 71.87 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.167 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.858 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -56.65 -47.05 80.6 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.004 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 1.6 mp -56.76 -47.34 80.32 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 413' ' ' THR . 38.5 t -51.85 -52.48 49.18 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.042 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -55.06 -55.06 35.29 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.326 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 407' ' ' ALA . 42.2 t -52.72 -43.94 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.751 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.19 -55.07 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.476 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 409' ' ' SER . 44.3 p -55.93 -42.31 75.91 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.69 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -56.37 17.46 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.57 -43.82 83.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.733 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -60.44 -52.14 66.47 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.572 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 8.2 mtt -50.67 -49.73 56.53 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.72 -42.67 85.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.929 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . 0.404 ' O ' ' HG ' ' A' ' 470' ' ' LEU . 4.7 t90 -56.45 -44.24 80.29 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.352 179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.43 45.7 1.3 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.114 0.483 . . . . 0.0 110.548 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 11.3 ttm -163.97 144.82 8.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.466 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -75.74 75.62 2.71 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.895 0.378 . . . . 0.0 111.604 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 428' ' ' LEU . 0.8 OUTLIER -138.13 128.27 25.83 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.052 0.453 . . . . 0.0 111.635 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.486 ' HA ' ' HA2' ' A' ' 468' ' ' GLY . 3.1 m-20 -80.26 159.98 25.7 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.646 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -71.56 59.5 0.31 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.185 0.517 . . . . 0.0 111.48 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -146.51 141.52 27.12 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 66.4 -66.6 0.17 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.1 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.566 ' HB2' ' CE1' ' A' ' 423' ' ' PHE . 1.1 tt -63.73 -39.12 93.51 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.683 0.278 . . . . 0.0 110.787 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 4.4 p -52.15 -28.07 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.78 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 30.2 mtt -51.37 -44.56 62.14 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.722 0.296 . . . . 0.0 110.455 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -47.69 84.62 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.175 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -62.2 -47.29 85.12 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 437' ' ' VAL . 7.8 tt -53.48 -51.54 62.42 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.78 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 438' ' ' VAL . 5.0 mp -60.33 -46.4 90.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.86 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.654 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -53.18 -55.42 24.33 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.314 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 20.0 m -61.2 -39.61 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.659 0.229 . . . . 0.0 110.462 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 433' ' ' LEU . 34.3 t -57.89 -48.49 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 434' ' ' LEU . 65.1 t -61.14 -48.02 90.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.858 HG22 ' HB1' ' A' ' 407' ' ' ALA . 94.4 t -51.84 -51.37 28.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.063 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.696 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -62.49 -42.21 99.33 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.787 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 3.1 tp -49.11 -46.21 44.57 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -79.76 -36.89 36.55 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.38 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 439' ' ' VAL . 1.2 t80 -60.29 -23.67 64.35 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.131 0.573 . . . . 0.0 112.485 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 446' ' ' TRP . . . -69.0 -123.13 0.03 OUTLIER Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.202 -0.523 . . . . 0.0 113.653 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.71 -67.96 0.13 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.629 0.252 . . . . 0.0 110.871 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . 0.465 ' HB2' HD12 ' A' ' 399' ' ' ILE . 7.9 m-90 -126.99 71.02 75.21 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-O 121.111 0.481 . . . . 0.0 109.764 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.71 70.43 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.69 2.26 . . . . 0.0 113.249 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -57.41 12.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.824 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 27.2 t -153.53 -61.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.031 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 454' ' ' ILE . 0.2 OUTLIER -44.88 -43.54 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.159 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -54.04 -52.21 61.58 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.933 0.397 . . . . 0.0 110.718 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.539 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.3 OUTLIER -60.04 -43.53 95.28 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.894 178.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 457' ' ' VAL . 88.4 t -56.46 -52.22 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.561 178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 450' ' ' VAL . 38.3 mm -61.07 -45.03 99.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.709 0.29 . . . . 0.0 110.305 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -55.93 -46.11 78.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.825 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 452' ' ' THR . 90.5 t -65.97 -47.48 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.506 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 453' ' ' VAL . 57.7 t -54.66 -47.41 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.709 0.29 . . . . 0.0 110.657 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 70.0 m -60.88 -54.02 50.22 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.182 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -52.58 -47.73 66.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.474 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -60.05 4.43 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.755 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.9 tp -44.12 -41.45 5.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.656 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -39.97 -36.63 0.49 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -118.73 31.36 6.69 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 18.0 mt -107.86 -47.74 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.698 0.285 . . . . 0.0 111.444 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.0 113.39 4.56 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.774 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.67 59.28 1.13 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.885 2.39 . . . . 0.0 112.697 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.0 -70.89 0.12 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.888 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 424' ' ' ASP . . . -82.27 113.53 3.67 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.33 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.29 58.56 0.18 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 419' ' ' TRP . 4.0 tt -165.69 -60.15 0.03 OUTLIER 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.085 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . 59.27 -161.47 0.26 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.27 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 44.7 t -115.38 -49.57 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 120.607 0.242 . . . . 0.0 111.452 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 6.2 t -151.04 76.54 1.24 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.048 0.451 . . . . 0.0 110.81 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 477' ' ' TYR . 7.5 t0 -90.22 100.08 12.98 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.151 0.5 . . . . 0.0 111.482 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.25 -43.67 77.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.93 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -51.17 70.4 Favored 'General case' 0 C--O 1.228 -0.056 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 474' ' ' ASP . 34.6 t80 -53.14 -47.91 68.33 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.352 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.5 tt -53.24 -46.97 69.4 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 483' ' ' VAL . 0.1 OUTLIER -59.99 -44.72 94.34 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.512 177.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 19.6 m -53.29 -47.87 68.83 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.294 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -61.49 -47.29 86.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.257 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -57.52 -45.75 84.63 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.584 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 487' ' ' VAL . 67.7 t -64.76 -52.9 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.324 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.3 ttt -52.85 -52.35 57.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.802 0.334 . . . . 0.0 110.487 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 485' ' ' LEU . 0.2 OUTLIER -56.8 -49.75 74.42 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.086 178.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 490' ' ' VAL . 41.8 m -54.78 -45.94 74.35 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.012 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 483' ' ' VAL . 65.3 t -54.95 -51.91 48.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.905 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -55.4 -46.52 80.05 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.418 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.41 -46.77 76.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.857 0.36 . . . . 0.0 110.134 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 486' ' ' THR . 88.7 t -62.91 -49.67 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.221 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.488 HD13 HG12 ' A' ' 487' ' ' VAL . 0.9 OUTLIER -56.52 -38.33 56.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.312 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.99 -52.19 39.27 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -55.31 -48.5 74.03 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.944 0.402 . . . . 0.0 109.992 178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -45.78 90.62 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.216 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.741 HG23 ' HA2' ' A' ' 401' ' ' GLY . 55.9 m -52.98 -43.72 66.63 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.339 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.45 85.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.307 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -69.11 -52.25 24.17 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.08 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.76 -25.23 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 14.9 tpp85 -51.4 -25.88 6.94 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -75.82 -1.21 24.09 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -125.03 132.46 53.21 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.611 0.243 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.138 -0.935 . . . . 0.0 111.396 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . 0.415 ' N ' ' OE1' ' A' ' 398' ' ' GLN . 6.4 mmm . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.414 0.15 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 40.5 t 70.64 96.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.121 0.486 . . . . 0.0 110.755 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . 0.528 HE21 HG21 ' A' ' 498' ' ' VAL . 0.5 OUTLIER -158.63 170.31 22.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.217 -179.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 6.7 tp -42.1 -42.26 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.858 ' HB3' HG21 ' A' ' 404' ' ' VAL . 0.8 OUTLIER -166.71 67.58 0.1 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.85 0.357 . . . . 0.0 110.8 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -99.55 -113.1 3.42 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.771 -0.728 . . . . 0.0 114.345 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 14.3 m -34.5 -55.28 0.54 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 442' ' ' PHE . 23.7 m -53.37 -44.11 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.858 HG21 ' HB3' ' A' ' 400' ' ' GLN . 75.3 t -71.21 -44.08 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.905 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.21 76.95 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.843 0.354 . . . . 0.0 110.25 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.66 -48.81 70.87 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.607 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.81 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -55.94 -60.09 3.97 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.998 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.892 HD11 HG22 ' A' ' 487' ' ' VAL . 0.1 OUTLIER -53.04 -53.99 41.98 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.022 179.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 23.9 t -53.95 -52.18 61.46 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.427 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -53.48 -48.51 68.86 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.013 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 407' ' ' ALA . 31.8 t -57.17 -49.41 79.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.258 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.662 HD11 HD12 ' A' ' 408' ' ' LEU . 53.4 mt -57.32 -50.92 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.49 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 25.6 m -57.37 -48.07 80.0 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.824 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.403 HD12 HE21 ' A' ' 418' ' ' GLN . 1.4 mm? -59.93 -52.27 66.12 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.645 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.554 HG12 ' CG ' ' A' ' 466' ' ' PRO . 94.7 mt -56.95 -49.23 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.894 0.378 . . . . 0.0 110.559 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.92 -55.2 37.6 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.292 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 24.1 ttm -54.2 -46.22 72.4 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.27 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 1.007 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 39.1 mt-30 -50.57 -50.45 53.67 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.819 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -70.87 -37.77 73.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.161 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.11 -56.99 12.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.414 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.55 77.0 0.33 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.974 0.416 . . . . 0.0 111.524 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 1.007 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -163.31 -170.58 2.31 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.19 168.87 9.18 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.855 0.359 . . . . 0.0 111.633 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -36.9 111.44 0.15 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.239 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.513 ' HB1' HD22 ' A' ' 431' ' ' LEU . . . 54.67 23.59 4.87 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . 61.77 39.94 13.48 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.913 0.387 . . . . 0.0 111.803 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 71.78 161.07 0.23 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.868 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 2.6 mp -93.3 57.71 2.71 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.143 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.609 HG13 ' H ' ' A' ' 430' ' ' MET . 0.9 OUTLIER -155.37 -67.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.807 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.609 ' H ' HG13 ' A' ' 429' ' ' VAL . 0.0 OUTLIER -60.94 -53.54 56.03 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.513 HD22 ' HB1' ' A' ' 425' ' ' ALA . 0.3 OUTLIER -60.79 -38.16 84.36 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.836 178.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.414 ' O ' HG23 ' A' ' 436' ' ' VAL . 63.6 t80 -63.88 -54.77 29.61 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -54.58 45.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.727 0.299 . . . . 0.0 110.717 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.63 -53.62 55.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.946 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.11 -50.97 60.29 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.732 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 432' ' ' TYR . 43.0 t -57.42 -44.56 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.857 0.328 . . . . 0.0 110.725 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 20.3 t -57.04 -60.7 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.24 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 35.5 m -60.77 -43.62 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.543 0.211 . . . . 0.0 111.273 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.2 t -56.39 -51.0 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -61.85 -48.42 80.62 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.271 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.85 -44.67 70.54 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.829 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . 0.57 ' HA ' ' CG2' ' A' ' 403' ' ' VAL . 0.0 OUTLIER -71.62 -52.46 17.88 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.165 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.472 ' O ' ' N ' ' A' ' 445' ' ' ARG . 4.1 t80 -55.01 -29.21 56.86 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.996 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -65.7 58.77 0.13 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.74 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.472 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.1 OUTLIER -164.9 42.18 0.08 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.968 0.507 . . . . 0.0 110.601 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . 0.466 ' HB2' ' O ' ' A' ' 445' ' ' ARG . 27.4 m0 76.4 142.34 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.065 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.569 ' O ' ' HB3' ' A' ' 451' ' ' ALA . 37.4 Cg_endo -65.54 -39.87 20.08 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.469 2.112 . . . . 0.0 112.08 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.47 ' O ' HG22 ' A' ' 450' ' ' VAL . 0.4 OUTLIER 51.14 20.11 0.82 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 39.5 t 65.62 -63.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 448' ' ' SER . 1.8 m -52.18 -48.14 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 447' ' ' PRO . . . -61.19 -47.68 85.02 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.739 0.304 . . . . 0.0 110.719 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 30.5 m -59.25 -55.09 39.35 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.401 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.65 -43.04 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.266 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.948 HG23 HG23 ' A' ' 486' ' ' THR . 10.1 mt -63.63 -59.29 4.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.6 0.238 . . . . 0.0 111.069 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -54.3 -48.58 71.13 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.444 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 38.7 t -60.95 -65.12 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.261 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 54.9 t -47.26 -47.26 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 120.601 0.238 . . . . 0.0 111.072 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 11.3 t -55.83 -58.13 9.13 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.02 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.19 -51.64 68.9 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.164 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.25 -43.29 78.54 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.536 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 1.4 mp -68.66 -46.08 70.06 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.284 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -55.88 107.5 0.35 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.926 0.394 . . . . 0.0 110.893 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -98.42 -61.42 1.38 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.448 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -116.2 -54.32 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.541 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.536 ' CB ' ' HB ' ' A' ' 469' ' ' THR . . . -137.15 144.49 46.21 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 111.575 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.554 ' CG ' HG12 ' A' ' 415' ' ' ILE . 37.6 Cg_endo -65.29 -19.29 62.05 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.823 2.349 . . . . 0.0 113.173 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 466' ' ' PRO . 0.0 OUTLIER 177.54 64.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.051 0.453 . . . . 0.0 110.322 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 148.86 81.88 0.04 OUTLIER Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.586 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . 0.605 HG23 ' H ' ' A' ' 470' ' ' LEU . 0.1 OUTLIER -136.01 -70.8 0.47 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.501 0.191 . . . . 0.0 111.161 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . 0.605 ' H ' HG23 ' A' ' 469' ' ' THR . 0.2 OUTLIER -102.41 159.6 15.28 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.742 0.306 . . . . 0.0 110.785 179.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -70.96 62.31 0.29 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.144 0.497 . . . . 0.0 111.006 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . 0.489 HG23 HD23 ' A' ' 470' ' ' LEU . 58.8 t -138.82 121.34 17.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.095 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . 0.624 ' HA ' ' HG2' ' A' ' 476' ' ' GLN . 0.3 OUTLIER -70.84 -46.54 62.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.833 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -44.69 -49.37 10.48 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.599 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.672 HG12 HD12 ' A' ' 479' ' ' LEU . 76.4 t -59.47 -52.19 63.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.01 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.624 ' HG2' ' HA ' ' A' ' 473' ' ' SER . 20.7 pt20 -63.55 -37.0 85.64 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.854 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -64.5 -55.77 18.46 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 1.3 mp -57.6 -47.16 82.9 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.88 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . 0.672 HD12 HG12 ' A' ' 475' ' ' VAL . 5.7 mt -56.48 -52.88 63.04 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . 0.515 HG22 ' SD ' ' A' ' 484' ' ' MET . 37.8 m -54.72 -45.86 74.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.13 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -59.96 -46.93 87.84 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.032 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.77 72.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.412 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.638 ' O ' HG23 ' A' ' 487' ' ' VAL . 28.5 m -64.34 -45.54 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 121.142 -0.223 . . . . 0.0 110.7 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . 0.515 ' SD ' HG22 ' A' ' 480' ' ' THR . 16.1 mtt -56.82 -55.03 39.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.23 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.27 -46.18 79.79 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.004 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . 0.948 HG23 HG23 ' A' ' 454' ' ' ILE . 88.9 m -54.13 -51.91 62.75 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.959 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.892 HG22 HD11 ' A' ' 408' ' ' LEU . 94.5 t -55.94 -51.82 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.652 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -56.6 -48.11 79.37 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.407 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.89 -46.81 88.14 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.736 0.303 . . . . 0.0 110.78 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 486' ' ' THR . 63.6 t -65.38 -60.11 3.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.367 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.422 ' HA ' ' CD2' ' A' ' 494' ' ' LEU . 0.6 OUTLIER -52.8 -43.56 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.36 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.56 -53.31 42.52 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.065 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -58.3 -51.72 68.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.559 0.219 . . . . 0.0 111.499 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.567 ' CD2' HG11 ' A' ' 404' ' ' VAL . 1.2 pp -61.97 -47.21 85.87 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.511 0.189 . . . . 0.0 111.511 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 56.8 m -57.43 -48.14 79.92 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.652 0.263 . . . . 0.0 110.909 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.51 56.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.732 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -54.73 -49.44 61.61 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.159 -0.544 . . . . 0.0 112.994 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.528 HG21 HE21 ' A' ' 398' ' ' GLN . 8.6 p -65.83 -41.5 90.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 16.8 mtm105 -68.51 -44.19 75.22 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.842 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 76.82 136.33 0.06 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.254 0.55 . . . . 0.0 111.719 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -142.73 47.35 1.56 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.756 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.116 -179.911 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . 0.995 ' N ' ' HG ' ' A' ' 402' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.701 0.286 . . . . 0.0 111.629 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 5.3 m -108.25 111.89 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.307 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -169.96 169.63 8.06 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.496 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.516 ' O ' ' HG2' ' A' ' 400' ' ' GLN . 1.1 tp -56.07 113.87 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.805 0.336 . . . . 0.0 110.451 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.823 ' HA ' HG21 ' A' ' 404' ' ' VAL . 0.0 OUTLIER 59.58 69.46 0.71 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.824 0.821 . . . . 0.0 111.086 -178.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.535 ' HA2' ' CG2' ' A' ' 498' ' ' VAL . . . -128.58 -150.27 7.17 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.817 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . 0.995 ' HG ' ' N ' ' A' ' 396' ' ' MET . 0.7 OUTLIER -52.86 -51.33 61.42 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.291 0.236 . . . . 0.0 111.525 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 20.1 m -55.22 -40.19 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.477 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 400' ' ' GLN . 2.7 t -62.42 -49.57 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.217 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.58 81.1 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.877 0.37 . . . . 0.0 110.192 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.9 81.24 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.223 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.726 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -59.04 -47.93 83.45 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.113 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 408' ' ' LEU . 7.8 tt -55.82 -51.15 68.47 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.925 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -45.23 86.62 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.341 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -58.64 -48.11 82.13 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.196 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.484 HG21 HG21 ' A' ' 439' ' ' VAL . 53.5 t -55.7 -56.96 9.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.579 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 415' ' ' ILE . 51.0 mt -53.17 -42.52 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.892 0.377 . . . . 0.0 110.114 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 29.2 m -60.68 -46.38 90.59 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.817 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.77 -44.32 93.93 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.874 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 412' ' ' ILE . 61.4 mt -54.87 -48.46 74.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.29 83.6 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.562 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 10.5 mtt -59.87 -52.1 66.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.817 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.61 ' HB3' HD22 ' A' ' 428' ' ' LEU . 14.4 mm100 -56.76 -50.77 71.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.479 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . 0.535 ' HB2' ' HA2' ' A' ' 468' ' ' GLY . 0.0 OUTLIER -58.78 -42.12 88.25 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.621 179.229 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -30.08 71.07 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.322 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 7.3 ttt -91.66 -43.51 9.56 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.558 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.812 ' HB3' HD21 ' A' ' 428' ' ' LEU . . . -135.33 156.32 49.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.819 0.343 . . . . 0.0 111.431 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -116.41 25.4 10.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.622 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -102.64 163.35 12.27 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.021 0.439 . . . . 0.0 111.617 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -115.8 33.13 5.67 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -118.44 -71.34 0.74 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.061 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -65.15 -41.26 94.9 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.993 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 422' ' ' ALA . 45.0 mt -69.81 -45.17 68.49 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.876 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 3.4 t -60.92 -45.04 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.921 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 20.7 mtt -48.64 -57.06 6.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 110.237 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.79 -47.76 83.67 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.103 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.487 ' HE1' HD11 ' A' ' 415' ' ' ILE . 20.2 t80 -52.97 -52.39 58.35 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.148 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.587 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.2 OUTLIER -60.49 -42.88 97.21 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.39 -48.52 65.6 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.553 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.11 -44.23 98.42 Favored Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.744 HG11 ' CB ' ' A' ' 458' ' ' SER . 69.6 t -56.9 -40.82 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 433' ' ' LEU . 65.7 t -61.19 -47.91 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.37 -48.33 85.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.726 HG22 ' HB1' ' A' ' 407' ' ' ALA . 76.9 t -57.42 -50.17 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.969 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.11 82.9 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.451 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 441' ' ' LEU . 0.6 OUTLIER -53.17 -50.48 64.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.897 178.355 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -70.76 -21.43 62.52 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.177 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.537 ' OH ' HG13 ' A' ' 490' ' ' VAL . 0.2 OUTLIER -77.24 -2.47 34.84 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -71.1 -161.38 4.2 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.807 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.472 ' O ' HD13 ' A' ' 399' ' ' ILE . 0.0 OUTLIER 78.33 106.08 0.07 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.932 0.493 . . . . 0.0 111.159 -179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . 0.418 ' HB2' ' O ' ' A' ' 445' ' ' ARG . 46.2 m0 67.51 89.29 0.1 OUTLIER Pre-proline 0 N--CA 1.468 0.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.67 128.77 25.52 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 112.821 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 91.7 p -113.07 -87.18 0.56 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.302 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 453' ' ' VAL . 7.2 p -178.17 -46.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.548 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 454' ' ' ILE . 53.5 t -54.39 -48.58 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.103 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.498 ' O ' HG13 ' A' ' 454' ' ' ILE . . . -54.86 -42.35 71.92 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.172 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.2 OUTLIER -63.89 -49.08 74.11 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.973 178.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 449' ' ' VAL . 61.5 t -57.69 -56.18 17.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.799 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 451' ' ' ALA . 1.9 pp -59.17 -41.73 84.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.717 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.435 ' N ' HD12 ' A' ' 454' ' ' ILE . 1.2 m120 -55.82 -52.21 64.79 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 452' ' ' THR . 93.0 t -55.18 -47.86 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.871 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 40.3 t -48.79 -54.08 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.282 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . 0.744 ' CB ' HG11 ' A' ' 436' ' ' VAL . 0.1 OUTLIER -59.61 -43.23 93.81 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.463 178.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -54.98 -58.46 7.52 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.368 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . 0.451 ' OD2' HG12 ' A' ' 456' ' ' VAL . 29.4 m-20 -62.13 -37.38 84.94 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.269 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.538 HD11 HD12 ' A' ' 479' ' ' LEU . 1.6 tp -64.78 -22.96 67.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.531 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . 0.55 ' CD1' ' HG ' ' A' ' 433' ' ' LEU . 15.5 t80 -58.9 70.17 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.347 0.594 . . . . 0.0 111.463 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 461' ' ' LEU . 0.4 OUTLIER 175.33 -45.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.088 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 36.4 mm -131.46 97.57 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.006 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.474 ' O ' HG22 ' A' ' 469' ' ' THR . . . -94.91 148.16 34.28 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.724 ' HG3' HG11 ' A' ' 483' ' ' VAL . 88.8 Cg_endo -76.43 170.84 19.17 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.01 2.473 . . . . 0.0 112.825 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.19 76.73 0.09 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.364 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.535 ' HA2' ' HB2' ' A' ' 419' ' ' TRP . . . 161.1 -66.68 0.26 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.317 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . 0.476 ' O ' ' HG3' ' A' ' 476' ' ' GLN . 5.5 t -81.43 115.0 20.56 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.813 0.339 . . . . 0.0 111.86 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 473' ' ' SER . 3.7 mm? 55.17 66.29 1.27 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.301 0.572 . . . . 0.0 111.306 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -49.76 140.06 12.09 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.186 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . 0.41 ' O ' HG22 ' A' ' 472' ' ' VAL . 8.4 p 43.09 32.04 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.913 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . 0.564 ' HB2' ' HB3' ' A' ' 470' ' ' LEU . 49.0 m -104.02 57.41 0.72 Allowed 'General case' 0 C--O 1.234 0.246 0 O-C-N 122.218 -0.301 . . . . 0.0 111.216 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 9.9 t70 63.78 -74.51 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.209 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.43 ' CG1' HD23 ' A' ' 479' ' ' LEU . 83.0 t -53.19 -45.74 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.331 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 469' ' ' THR . 0.0 OUTLIER -58.64 -35.05 71.9 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.387 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -71.01 -50.95 28.54 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 42.6 mt -58.9 -49.17 78.8 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.596 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 466' ' ' PRO . 2.9 mm? -57.51 -52.14 66.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.261 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . 0.447 ' HA ' HG22 ' A' ' 483' ' ' VAL . 39.0 m -57.19 -42.7 81.73 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.976 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -58.03 -49.04 78.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.309 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.02 -49.44 76.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.368 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.724 HG11 ' HG3' ' A' ' 466' ' ' PRO . 17.4 m -65.64 -37.36 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.751 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 8.7 mtt -62.66 -53.76 49.59 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 4.7 tp -56.02 -43.34 77.66 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.428 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 490' ' ' VAL . 32.9 m -59.15 -48.18 82.56 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.784 178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 15.6 t -58.03 -47.68 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.096 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . 0.511 ' O ' HG13 ' A' ' 491' ' ' ILE . . . -53.41 -44.72 66.53 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -45.77 83.2 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.796 0.331 . . . . 0.0 110.169 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 486' ' ' THR . 69.8 t -58.88 -54.37 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.553 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.52 ' O ' ' HG ' ' A' ' 494' ' ' LEU . 2.3 pp -57.29 -42.45 80.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.414 ' N ' HD12 ' A' ' 491' ' ' ILE . . . -63.71 -45.04 95.43 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.294 -0.955 . . . . 0.0 110.982 178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.59 -55.7 28.96 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.304 0.241 . . . . 0.0 110.797 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.658 ' HA ' ' HG3' ' A' ' 400' ' ' GLN . 3.2 pp -61.76 -39.56 92.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.804 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 96.4 m -52.87 -48.77 66.86 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -72.72 -48.8 35.67 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.706 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -51.43 -36.26 37.73 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 116.33 -0.395 . . . . 0.0 113.611 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.535 ' CG2' ' HA2' ' A' ' 401' ' ' GLY . 76.0 t -74.36 -10.11 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 116.945 0.373 . . . . 0.0 111.883 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -122.27 179.04 4.69 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.014 0.435 . . . . 0.0 111.299 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -116.78 125.37 51.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.996 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -147.0 145.21 29.65 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.132 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.24 179.425 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.605 0.24 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 4.0 m -120.52 136.15 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.01 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -165.45 162.8 19.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.569 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 2.9 mt -74.32 -53.34 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.408 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.756 ' NE2' HG21 ' A' ' 498' ' ' VAL . 0.2 OUTLIER -146.05 44.64 1.25 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.613 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' ' 404' ' ' VAL . . . -111.12 -101.48 2.62 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.278 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 9.1 t -47.23 -40.84 17.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.844 0.322 . . . . 0.0 111.142 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 404' ' ' VAL . 22.4 m -63.04 -48.74 86.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.755 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 401' ' ' GLY . 2.5 p -69.01 -42.19 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 121.159 -0.217 . . . . 0.0 111.309 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.04 -57.35 13.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 111.048 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -59.53 -49.4 77.94 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.72 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -54.43 -58.68 6.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.43 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.841 HD11 HG13 ' A' ' 487' ' ' VAL . 0.1 OUTLIER -61.47 -49.93 74.8 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.283 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.436 ' O ' HG23 ' A' ' 413' ' ' THR . 13.7 t -51.43 -52.65 44.41 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.68 68.63 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.109 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.529 HG12 HD12 ' A' ' 415' ' ' ILE . 15.1 t -52.06 -41.81 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 18.7 mm -62.58 -52.3 61.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.923 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 409' ' ' SER . 24.3 p -60.1 -48.13 82.99 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.763 -0.199 . . . . 0.0 110.644 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.618 HD22 ' HB3' ' A' ' 431' ' ' LEU . 96.3 mt -59.33 -51.06 71.54 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.745 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.529 HD12 HG12 ' A' ' 411' ' ' VAL . 40.2 mt -59.61 -48.29 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.6 -56.36 22.95 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.755 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 9.2 mtt -53.03 -46.74 68.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.656 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.711 ' HG2' HD23 ' A' ' 428' ' ' LEU . 18.1 tm0? -60.77 -58.29 9.1 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.63 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . 0.521 ' HE3' HD12 ' A' ' 420' ' ' LEU . 71.6 t90 -51.93 -42.8 63.1 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.007 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.521 HD12 ' HE3' ' A' ' 419' ' ' TRP . 0.2 OUTLIER -61.32 -25.55 67.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.448 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.55 137.08 34.11 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.953 0.406 . . . . 0.0 110.905 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . -72.76 75.16 1.13 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 111.439 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 427' ' ' ASN . 0.2 OUTLIER -162.07 173.81 13.86 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.125 0.488 . . . . 0.0 111.698 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -99.37 -177.08 3.48 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.541 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.487 ' CB ' ' HB2' ' A' ' 465' ' ' ALA . . . -68.38 -32.64 72.87 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.945 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -49.08 -45.25 42.91 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . 0.503 ' HB2' ' CD1' ' A' ' 423' ' ' PHE . 21.0 t-20 -60.86 -47.6 85.65 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.678 0.275 . . . . 0.0 111.367 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.711 HD23 ' HG2' ' A' ' 418' ' ' GLN . 2.3 mm? -91.52 28.45 1.72 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 430' ' ' MET . 11.0 p -48.0 -43.53 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.47 ' O ' ' HB2' ' A' ' 434' ' ' LEU . 21.4 ttm -57.6 -57.58 12.08 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.026 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.618 ' HB3' HD22 ' A' ' 414' ' ' LEU . 1.1 mt -57.84 -42.58 84.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.028 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.55 ' HB3' HD21 ' A' ' 461' ' ' LEU . 5.7 m-85 -62.42 -60.03 4.13 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.055 0.455 . . . . 0.0 110.597 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.74 -57.06 14.08 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.483 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 430' ' ' MET . 8.1 mp -52.11 -46.84 65.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.984 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -57.18 -65.14 3.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.897 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.775 HG11 HD13 ' A' ' 461' ' ' LEU . 34.4 m -59.11 -38.23 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 441' ' ' LEU . 19.5 t -63.48 -52.35 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.923 -0.126 . . . . 0.0 110.796 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 14.9 t -55.76 -52.73 45.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 110.377 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 96.5 t -58.41 -54.62 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.256 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.59 ' HA ' HD13 ' A' ' 454' ' ' ILE . . . -56.95 -52.09 66.58 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 437' ' ' VAL . 1.3 tp -56.73 -47.92 78.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.609 0.242 . . . . 0.0 110.963 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -67.24 -28.98 68.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.964 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -67.84 176.62 2.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.245 0.545 . . . . 0.0 111.629 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 122.15 42.72 0.42 Allowed Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 113.104 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -134.97 116.38 14.62 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.317 0.247 . . . . 0.0 110.391 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 25.6 m95 64.77 97.85 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.598 0 CA-C-O 120.872 0.368 . . . . 0.0 111.899 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.61 76.91 1.84 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.504 2.136 . . . . 0.0 112.279 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 449' ' ' VAL . 97.6 p -104.37 -85.07 0.47 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.683 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.42 ' N ' ' OG ' ' A' ' 448' ' ' SER . 2.7 p -137.68 -51.26 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 4.5 m -46.24 -46.14 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.477 ' O ' HG13 ' A' ' 454' ' ' ILE . . . -58.78 -49.07 79.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.886 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 8.2 m -57.51 -41.65 81.2 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.731 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 449' ' ' VAL . 59.4 t -61.08 -59.0 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 440' ' ' ALA . 1.8 pp -60.5 -42.24 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.478 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 451' ' ' ALA . 1.4 t30 -58.88 -54.68 44.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.545 0.212 . . . . 0.0 110.705 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 39.2 t -62.93 -55.48 23.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.522 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.762 HG13 ' HG3' ' A' ' 466' ' ' PRO . 3.1 t -48.45 -45.34 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.212 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 2.6 t -59.8 -57.13 14.23 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.156 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -46.35 -51.21 15.26 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.726 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . 0.525 ' HB3' ' HA ' ' A' ' 466' ' ' PRO . 11.8 m-20 -64.84 -44.64 89.11 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.595 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.775 HD13 HG11 ' A' ' 436' ' ' VAL . 2.0 tt -48.83 -38.81 23.29 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.52 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -51.12 -26.39 6.53 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.263 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -100.99 48.68 0.89 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.818 0.342 . . . . 0.0 111.178 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' A' ' 465' ' ' ALA . 2.3 mt 70.95 66.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.176 0.512 . . . . 0.0 111.371 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.61 ' C ' ' HA ' ' A' ' 461' ' ' LEU . . . 72.89 150.02 0.13 Allowed Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.646 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.762 ' HG3' HG13 ' A' ' 457' ' ' VAL . 43.3 Cg_endo -66.22 55.75 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.592 2.195 . . . . 0.0 112.207 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . 0.552 ' HG2' HD13 ' A' ' 479' ' ' LEU . 3.2 mpp_? -164.97 -55.76 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.809 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 142.67 -59.46 0.54 Allowed Glycine 0 C--N 1.337 0.616 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.447 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 62.2 p -151.18 179.38 8.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.634 0.254 . . . . 0.0 110.763 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.02 -172.8 2.16 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.936 0.398 . . . . 0.0 111.736 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . 57.79 -120.71 1.29 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.666 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . 0.553 ' O ' ' HB3' ' A' ' 473' ' ' SER . 95.9 t 66.96 -59.01 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 472' ' ' VAL . 48.1 t 104.42 158.95 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.926 0.89 . . . . 0.0 111.171 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 64.49 -62.69 0.18 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.607 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 17.8 m -50.22 -41.45 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.301 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -53.23 -58.32 7.48 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.706 0.289 . . . . 0.0 111.024 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -56.94 -50.09 73.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -56.18 23.39 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.003 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . 0.552 HD13 ' HG2' ' A' ' 467' ' ' ARG . 12.6 mt -56.89 -50.71 71.69 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.815 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 18.1 m -55.27 -51.5 66.46 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.687 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -59.32 -55.77 30.5 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.02 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -54.14 -47.63 71.7 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.653 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.92 -53.84 36.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.163 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 52.2 mtp -53.9 -52.52 60.25 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.282 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.21 -56.12 25.94 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.997 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 490' ' ' VAL . 9.7 m -56.01 -57.68 11.09 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.988 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.841 HG13 HD11 ' A' ' 408' ' ' LEU . 39.2 t -53.2 -53.03 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.239 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -55.48 -52.92 44.63 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.2 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.1 -45.95 79.26 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.655 0.264 . . . . 0.0 110.377 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 486' ' ' THR . 68.4 t -60.34 -50.01 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.034 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.642 HD11 ' CD2' ' A' ' 408' ' ' LEU . 97.2 mt -51.64 -48.22 37.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 120.788 0.328 . . . . 0.0 110.368 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -67.65 -45.04 79.46 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.954 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -49.41 73.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.288 0.235 . . . . 0.0 111.477 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.735 HD13 ' HG3' ' A' ' 400' ' ' GLN . 3.1 pp -69.22 -43.96 73.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.373 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.526 ' N ' HD12 ' A' ' 494' ' ' LEU . 26.6 m -63.73 -41.31 98.08 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.561 0.22 . . . . 0.0 111.304 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -68.47 -50.03 55.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.313 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -67.97 -56.98 9.29 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.151 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.756 HG21 ' NE2' ' A' ' 400' ' ' GLN . 32.2 t -75.52 64.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 121.319 0.581 . . . . 0.0 110.987 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . 0.416 ' HB3' ' NH1' ' A' ' 499' ' ' ARG . 7.6 ttp-105 -148.73 41.73 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.946 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 59.87 46.24 11.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.475 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.47 -35.2 12.41 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.32 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.379 -0.82 . . . . 0.0 110.975 179.894 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 59.6 ttp . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.436 0.16 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 3.9 m -150.46 131.83 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.964 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -89.76 -38.39 13.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.08 -76.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.211 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.995 ' HG2' HG11 ' A' ' 404' ' ' VAL . 5.6 mt-30 -117.07 124.82 50.18 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.874 -0.148 . . . . 0.0 110.94 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 1.007 ' HA2' HD23 ' A' ' 494' ' ' LEU . . . -158.22 -132.66 1.44 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.364 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -41.09 61.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.93 0.365 . . . . 0.0 110.988 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.458 HG23 ' N ' ' A' ' 404' ' ' VAL . 18.0 m -55.86 -52.49 48.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.599 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.995 HG11 ' HG2' ' A' ' 400' ' ' GLN . 16.3 m -72.79 -31.79 37.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 121.194 -0.203 . . . . 0.0 110.94 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.07 -45.05 90.47 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.889 0.375 . . . . 0.0 110.101 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.48 -50.91 61.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.874 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 440' ' ' ALA . . . -56.01 -48.11 76.52 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.099 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.758 HD21 HG13 ' A' ' 487' ' ' VAL . 2.9 tp -58.99 -45.01 91.69 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.812 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 58.1 m -53.28 -44.32 68.16 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.24 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . 0.415 ' HB3' HG13 ' A' ' 436' ' ' VAL . . . -62.92 -48.16 80.14 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.266 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.429 HG12 HD11 ' A' ' 415' ' ' ILE . 75.3 t -57.7 -54.66 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.355 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 415' ' ' ILE . 93.4 mt -52.68 -48.23 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.885 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 35.7 m -57.38 -45.23 84.68 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.661 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' A' ' 432' ' ' TYR . 1.4 mm? -56.7 -55.95 27.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.208 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 412' ' ' ILE . 9.7 mt -54.86 -47.12 75.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.442 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.12 -46.14 79.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.08 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -44.84 82.49 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.549 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 1.04 ' HA ' ' HB3' ' A' ' 422' ' ' ALA . 14.4 tt0 -57.7 -58.13 9.7 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.607 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -57.3 -35.77 70.24 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.62 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 421' ' ' MET . 1.0 OUTLIER -70.62 -53.49 15.69 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.476 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . 0.434 ' HB2' HD23 ' A' ' 420' ' ' LEU . 1.7 mtt -171.83 71.82 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 1.04 ' HB3' ' HA ' ' A' ' 418' ' ' GLN . . . -156.71 115.04 3.29 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.918 0.389 . . . . 0.0 111.061 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -72.98 94.22 1.84 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.036 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 57.93 -177.22 0.07 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.865 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 465' ' ' ALA . . . -91.86 50.44 1.68 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 111.391 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' A' ' 430' ' ' MET . . . -131.42 146.68 52.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.785 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 63.16 103.43 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.921 0.391 . . . . 0.0 111.02 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.9 -60.06 0.52 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.832 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.454 ' CG1' ' HA ' ' A' ' 425' ' ' ALA . 89.2 t -53.28 -46.37 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.888 0.375 . . . . 0.0 110.302 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.403 ' HB2' ' HA ' ' A' ' 426' ' ' ALA . 0.0 OUTLIER -57.32 -49.47 76.02 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.125 178.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 4.0 mp -58.42 -48.44 80.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.362 -0.381 . . . . 0.0 109.979 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.632 ' HB3' HD11 ' A' ' 414' ' ' LEU . 0.2 OUTLIER -55.53 -54.97 37.32 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.172 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.507 HD21 ' HD3' ' A' ' 467' ' ' ARG . 0.4 OUTLIER -56.62 -43.11 79.88 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.183 178.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 438' ' ' VAL . 0.1 OUTLIER -56.46 -52.21 65.53 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -55.22 -47.7 72.95 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 432' ' ' TYR . 92.3 t -56.43 -47.3 81.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 433' ' ' LEU . 68.1 t -58.43 -44.61 89.14 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.069 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.848 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 434' ' ' LEU . 64.2 t -58.44 -45.55 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.432 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 72.6 t -56.81 -53.11 46.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 120.977 0.418 . . . . 0.0 110.328 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.451 ' HB2' ' HB1' ' A' ' 407' ' ' ALA . . . -59.71 -47.09 87.02 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.405 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -40.97 80.22 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.595 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.66 -37.4 86.41 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.699 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.23 -43.64 15.87 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.578 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -69.48 172.94 37.75 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.274 -0.489 . . . . 0.0 113.469 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.699 ' O ' ' HB1' ' A' ' 451' ' ' ALA . 3.7 mtt180 -130.63 -170.82 2.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 111.961 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . 0.56 ' H ' ' HD2' ' A' ' 447' ' ' PRO . 22.8 m-90 -110.93 -59.64 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.56 ' HD2' ' H ' ' A' ' 446' ' ' TRP . 53.7 Cg_endo -69.03 61.38 1.33 Allowed 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.205 1.937 . . . . 0.0 113.311 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.12 29.21 1.09 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.332 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 92.9 t 56.63 -83.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.68 0.392 . . . . 0.0 111.814 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 15.6 m -54.6 -44.83 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.563 0.221 . . . . 0.0 110.893 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.699 ' HB1' ' O ' ' A' ' 445' ' ' ARG . . . -57.76 -43.43 85.43 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.756 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.72 -50.5 73.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.066 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 49.1 t -59.38 -48.59 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.57 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.12 -47.48 86.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.154 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.2 -49.97 75.81 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.12 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 31.8 t -54.69 -53.79 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.5 ' CG1' HD13 ' A' ' 461' ' ' LEU . 24.3 t -48.94 -53.49 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.147 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -39.81 72.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.59 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -56.21 -55.81 28.64 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.414 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -62.93 -42.26 99.74 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.858 0.361 . . . . 0.0 110.656 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.5 HD13 ' CG1' ' A' ' 457' ' ' VAL . 0.1 OUTLIER -63.78 -23.8 67.5 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.511 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -67.72 73.48 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.197 0.523 . . . . 0.0 110.918 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.54 -66.62 0.21 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.994 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.82 31.47 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.124 0.488 . . . . 0.0 111.423 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 425' ' ' ALA . . . 48.79 65.31 7.26 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.814 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.489 ' HG2' ' HG ' ' A' ' 461' ' ' LEU . 31.2 Cg_exo -60.63 76.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.93 2.42 . . . . 0.0 113.051 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . 0.507 ' HD3' HD21 ' A' ' 433' ' ' LEU . 0.0 OUTLIER -132.66 84.13 2.12 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.667 179.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 476' ' ' GLN . . . 57.2 40.29 91.41 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.786 -0.643 . . . . 0.0 113.32 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 469' ' ' THR . 8.8 t -85.81 81.34 8.61 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.273 0.559 . . . . 0.0 111.238 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . 0.674 HD12 HG12 ' A' ' 472' ' ' VAL . 0.1 OUTLIER 175.9 108.07 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.685 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -69.45 67.95 0.22 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.119 0.485 . . . . 0.0 112.107 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . 0.674 HG12 HD12 ' A' ' 470' ' ' LEU . 8.6 p -159.85 141.63 4.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.883 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 42.3 t -72.48 58.13 0.4 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.866 0.365 . . . . 0.0 111.005 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.58 -74.91 0.16 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.892 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.623 HG12 HD12 ' A' ' 479' ' ' LEU . 99.1 t -59.47 -58.32 7.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.321 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.584 ' HA ' ' HA2' ' A' ' 468' ' ' GLY . 0.0 OUTLIER -57.01 -33.61 67.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.136 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -70.55 -53.45 16.05 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.17 -48.32 73.94 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.033 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 483' ' ' VAL . 1.1 mt -57.24 -48.52 78.62 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.652 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 61.3 m -57.87 -42.75 85.19 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.437 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -56.18 -50.9 69.89 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.887 0.375 . . . . 0.0 110.14 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.75 88.23 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.142 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 479' ' ' LEU . 54.4 t -61.62 -45.34 98.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.803 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 95.4 mtp -55.11 -54.64 40.6 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.756 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 485' ' ' LEU . 0.5 OUTLIER -57.47 -44.06 84.56 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 62.6 m -53.92 -49.77 67.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.071 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.758 HG13 HD21 ' A' ' 408' ' ' LEU . 88.5 t -62.44 -50.51 79.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.113 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -52.55 -42.76 58.28 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 9.7 tp -62.9 -46.51 87.46 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 178.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 72.9 t -59.99 -53.34 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.232 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 7.2 tp -59.64 -39.85 80.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 120.571 0.224 . . . . 0.0 110.967 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -66.49 -47.58 68.8 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -56.14 -40.68 74.19 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.628 -0.286 . . . . 0.0 110.241 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 1.007 HD23 ' HA2' ' A' ' 401' ' ' GLY . 0.0 OUTLIER -69.59 -47.15 64.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.778 ' N ' HD13 ' A' ' 494' ' ' LEU . 91.3 m -49.97 -48.45 52.19 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.638 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -83.13 -45.28 14.14 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.681 0.277 . . . . 0.0 111.474 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 501' ' ' GLN . . . -47.84 -61.73 4.6 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.812 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 498' ' ' VAL . 50.8 t -74.34 60.08 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.551 0.691 . . . . 0.0 110.122 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -169.81 -52.0 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.654 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -170.89 67.16 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.88 0.372 . . . . 0.0 111.884 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.623 ' HB3' ' HA2' ' A' ' 497' ' ' GLY . 0.7 OUTLIER -144.58 124.14 13.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.198 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.966 179.854 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . 0.712 ' O ' HG22 ' A' ' 397' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 111.17 0.063 . . . . 0.0 111.17 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 396' ' ' MET . 2.5 m 56.03 179.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 123.572 0.545 . . . . 0.0 112.237 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.8 -158.34 0.09 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.489 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 400' ' ' GLN . 0.2 OUTLIER -61.59 129.59 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.863 0.363 . . . . 0.0 110.924 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.647 ' N ' HD13 ' A' ' 399' ' ' ILE . 1.4 mm-40 57.78 64.23 1.6 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.195 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -128.64 -169.24 12.57 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.75 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 24.9 t -41.0 -56.42 2.28 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.626 0.25 . . . . 0.0 111.608 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.438 HG11 ' CE1' ' A' ' 442' ' ' PHE . 98.2 t -53.04 -43.17 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.84 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.5 -46.72 94.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.233 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . 0.829 ' HB2' HD13 ' A' ' 494' ' ' LEU . . . -55.67 -49.42 72.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.84 0.352 . . . . 0.0 110.068 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.66 -53.27 59.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.679 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 411' ' ' VAL . . . -52.19 -49.28 64.16 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.783 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.548 ' HA ' HG22 ' A' ' 411' ' ' VAL . 1.1 tp -60.27 -44.17 95.56 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.97 -45.7 89.89 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.881 0.372 . . . . 0.0 110.262 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.27 -53.88 42.0 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.216 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 408' ' ' LEU . 35.4 m -58.86 -48.23 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.136 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.418 ' N ' HG23 ' A' ' 411' ' ' VAL . 56.9 mt -55.04 -46.84 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 82.5 m -57.12 -45.47 83.44 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.762 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.565 HD23 HD23 ' A' ' 431' ' ' LEU . 1.3 mp -59.9 -50.76 72.49 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.215 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.52 HG22 ' CE3' ' A' ' 419' ' ' TRP . 12.2 mm -55.76 -47.9 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.023 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -59.43 -45.06 92.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.053 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 1.5 tpt -57.25 -46.98 82.52 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.055 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.472 ' HB2' HD21 ' A' ' 428' ' ' LEU . 3.3 mt-30 -65.53 -37.67 87.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.181 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . 0.52 ' CE3' HG22 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -60.61 -37.35 81.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.614 179.055 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.17 57.2 0.1 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.202 0.525 . . . . 0.0 110.886 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . 0.588 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 4.3 mtp -136.49 -37.26 0.69 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.829 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 90.54 84.29 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.136 0.574 . . . . 0.0 111.161 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -178.3 -174.01 0.38 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.737 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.423 ' HB3' ' C ' ' A' ' 468' ' ' GLY . 14.5 p30 -75.77 -169.13 1.0 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.927 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.434 ' HB3' ' HD2' ' A' ' 466' ' ' PRO . . . -85.95 5.52 32.78 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 1.028 ' HA ' ' HB1' ' A' ' 465' ' ' ALA . . . -66.29 165.44 13.97 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.796 0.331 . . . . 0.0 111.203 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 70.31 -58.25 0.55 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.129 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 418' ' ' GLN . 0.4 OUTLIER -40.8 -36.36 0.62 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.914 ' HB ' ' HB2' ' A' ' 465' ' ' ALA . 14.7 p -45.28 -34.17 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 29.1 mtt -56.74 -58.97 5.79 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.834 0.35 . . . . 0.0 110.275 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.565 HD23 HD23 ' A' ' 414' ' ' LEU . 6.1 mp -67.85 -40.3 83.71 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.41 ' O ' HG23 ' A' ' 436' ' ' VAL . 1.5 t80 -54.49 -56.45 18.62 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.913 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.53 -45.67 84.78 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.22 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 438' ' ' VAL . 0.5 OUTLIER -52.93 -51.26 61.97 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.273 178.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -63.42 -44.05 97.34 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.846 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.525 HG11 ' CZ ' ' A' ' 459' ' ' PHE . 39.9 t -56.34 -53.73 36.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.48 0.181 . . . . 0.0 111.025 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.73 -43.38 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.602 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 434' ' ' LEU . 44.0 t -58.71 -52.45 59.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 435' ' ' GLY . 70.2 t -56.11 -53.64 36.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.405 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -53.75 -47.13 70.96 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.463 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 4.0 tt -52.02 -47.26 65.09 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.776 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . 0.438 ' CE1' HG11 ' A' ' 403' ' ' VAL . 20.2 m-85 -68.4 -33.3 74.0 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.717 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 445' ' ' ARG . 3.8 m-85 -70.38 -21.86 62.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.607 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -63.53 67.55 0.04 OUTLIER Glycine 0 C--N 1.341 0.826 0 C-N-CA 121.571 -0.347 . . . . 0.0 113.271 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 443' ' ' TYR . 0.0 OUTLIER -140.71 -61.83 0.49 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.121 0.486 . . . . 0.0 110.076 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -154.05 88.38 3.51 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.999 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.24 176.17 2.18 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.941 2.427 . . . . 0.0 113.663 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.8 m -171.21 153.19 3.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.409 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 453' ' ' VAL . 58.0 t -39.9 -60.92 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.567 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.623 HG11 ' OD1' ' A' ' 493' ' ' ASN . 46.7 t -51.06 -56.29 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.644 ' HA ' HD12 ' A' ' 454' ' ' ILE . . . -53.55 -48.41 69.13 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.782 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.594 ' O ' HG23 ' A' ' 456' ' ' VAL . 88.7 m -57.97 -46.12 85.66 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.248 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 449' ' ' VAL . 88.9 t -60.97 -44.12 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.121 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 451' ' ' ALA . 30.6 mt -56.57 -50.96 71.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 120.889 0.376 . . . . 0.0 110.218 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.62 -50.29 73.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.71 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 452' ' ' THR . 90.3 t -56.43 -52.34 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.145 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 453' ' ' VAL . 55.2 t -53.68 -49.79 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.722 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -44.75 96.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.375 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . 0.525 ' CZ ' HG11 ' A' ' 436' ' ' VAL . 2.3 m-85 -58.58 -48.65 80.23 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.774 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.93 -44.91 96.56 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.943 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.445 HD11 HD22 ' A' ' 479' ' ' LEU . 30.0 tp -58.9 -48.23 82.17 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.989 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -87.14 92.94 9.23 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.019 0.438 . . . . 0.0 111.475 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 466' ' ' PRO . 28.8 t80 -68.12 61.8 0.08 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.044 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 11.1 mt 38.99 50.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.894 0.378 . . . . 0.0 111.999 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 1.028 ' HB1' ' HA ' ' A' ' 426' ' ' ALA . . . 66.52 65.68 0.76 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.111 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 425' ' ' ALA . 38.5 Cg_endo -65.75 147.23 85.44 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.48 2.12 . . . . 0.0 112.156 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . 0.471 ' HD3' ' HA ' ' A' ' 467' ' ' ARG . 6.9 mmt180 -79.15 147.93 32.5 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.066 0.46 . . . . 0.0 111.175 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . 0.423 ' C ' ' HB3' ' A' ' 424' ' ' ASP . . . 78.17 -65.61 3.29 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.589 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.2 m 47.71 24.49 0.56 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.97 -53.69 2.66 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.553 0.216 . . . . 0.0 111.125 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -72.8 64.35 0.66 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.109 0.48 . . . . 0.0 111.177 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' A' ' 475' ' ' VAL . 78.0 t -126.69 121.89 59.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.85 115.06 1.13 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.948 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.34 42.03 17.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.374 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' A' ' 472' ' ' VAL . 6.7 p -53.52 -42.86 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.25 -47.67 85.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.579 0.228 . . . . 0.0 111.269 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.29 -51.0 61.74 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.609 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.7 -53.44 56.53 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.861 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 475' ' ' VAL . 0.1 OUTLIER -57.9 -48.08 80.9 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.173 179.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 99.4 m -53.9 -52.54 60.2 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.397 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -59.3 -48.61 80.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.709 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.85 75.17 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.995 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.484 ' O ' HG22 ' A' ' 487' ' ' VAL . 93.6 t -65.52 -52.84 46.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.497 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 3.3 ttt -52.23 -51.73 56.55 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.866 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.64 -49.43 77.78 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.333 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . 0.478 HG23 HG23 ' A' ' 454' ' ' ILE . 88.6 m -54.57 -58.27 8.13 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.159 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 483' ' ' VAL . 36.0 m -59.81 -43.92 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.814 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . 0.493 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -55.24 -51.45 54.13 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . 0.586 HD22 HG13 ' A' ' 450' ' ' VAL . 5.6 mt -55.36 -46.57 76.46 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.522 HG21 ' CD2' ' A' ' 408' ' ' LEU . 59.0 t -57.07 -45.17 84.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.577 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.493 HD12 ' HA2' ' A' ' 488' ' ' GLY . 50.3 mt -58.46 -46.31 89.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.792 0.33 . . . . 0.0 110.615 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -64.76 -53.57 33.84 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.93 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . 0.623 ' OD1' HG11 ' A' ' 450' ' ' VAL . 2.1 m120 -56.76 -46.52 81.38 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.642 0.258 . . . . 0.0 110.78 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.829 HD13 ' HB2' ' A' ' 405' ' ' ALA . 0.6 OUTLIER -60.38 -46.3 90.47 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.165 178.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 89.9 m -54.86 -51.13 66.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.948 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.7 84.57 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.009 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -57.86 -44.0 94.52 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.439 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.56 -48.49 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 120.581 0.229 . . . . 0.0 110.498 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -79.4 54.1 1.65 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.136 0.493 . . . . 0.0 110.325 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -67.45 126.34 28.98 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.701 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -151.43 -64.74 0.18 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.057 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.379 179.898 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.394 0.14 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.32 138.78 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.089 0.471 . . . . 0.0 112.094 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . 0.758 ' HA ' HG21 ' A' ' 498' ' ' VAL . 1.0 OUTLIER -161.59 150.81 16.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.524 179.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.644 ' HB ' HD21 ' A' ' 494' ' ' LEU . 1.2 mp -90.51 -58.1 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.733 0.302 . . . . 0.0 110.455 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.511 ' HB2' HD23 ' A' ' 494' ' ' LEU . 0.7 OUTLIER -159.62 91.43 0.99 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.625 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -141.82 -98.13 0.31 Allowed Glycine 0 C--N 1.339 0.696 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.172 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 5.5 t -55.25 -55.03 36.04 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.667 0.27 . . . . 0.0 111.254 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 443' ' ' TYR . 17.6 m -50.46 -45.0 25.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.055 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.443 HG12 ' CD1' ' A' ' 491' ' ' ILE . 3.2 t -70.44 -37.42 70.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.379 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.31 96.67 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.31 -49.99 67.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.784 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.563 ' O ' HG23 ' A' ' 411' ' ' VAL . . . -55.61 -50.79 69.21 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.327 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 408' ' ' LEU . 0.2 OUTLIER -58.96 -45.88 89.43 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.229 178.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 53.4 m -52.94 -42.22 65.25 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.145 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.41 -48.52 75.09 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.393 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 407' ' ' ALA . 17.4 t -57.89 -46.93 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.393 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 23.0 mm -59.71 -45.33 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 49.0 m -58.78 -48.19 82.11 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.028 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' A' ' 432' ' ' TYR . 1.6 mp -56.18 -48.47 76.29 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.149 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.442 HG22 ' HD1' ' A' ' 419' ' ' TRP . 32.5 mm -61.53 -45.78 97.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.389 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -52.44 -51.58 58.47 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.033 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -47.36 85.94 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.624 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -50.63 -42.49 56.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.54 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . 0.442 ' HD1' HG22 ' A' ' 415' ' ' ILE . 44.7 m95 -67.78 -45.02 76.03 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.503 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.51 -40.47 93.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.424 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . 0.427 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 29.2 mtt -146.17 134.19 21.47 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.137 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 72.04 74.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.205 0.526 . . . . 0.0 111.398 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -55.02 159.47 2.4 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.877 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.574 ' HA ' HG23 ' A' ' 472' ' ' VAL . 94.8 m-20 65.16 173.45 0.21 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.452 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -101.2 39.2 1.44 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.74 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -141.7 84.64 1.91 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.917 0.389 . . . . 0.0 111.568 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -174.73 -67.23 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.265 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.87 -38.98 1.1 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.55 HG13 HD23 ' A' ' 414' ' ' LEU . 54.8 t -41.52 -37.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -41.17 -54.3 2.93 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 7.1 tp -57.64 -52.55 64.97 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.005 0.431 . . . . 0.0 110.494 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.64 ' HB3' HD21 ' A' ' 414' ' ' LEU . 46.5 m-85 -58.36 -48.94 78.95 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.085 178.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.408 ' N ' HD21 ' A' ' 414' ' ' LEU . 0.2 OUTLIER -53.47 -47.76 69.46 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.915 178.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 437' ' ' VAL . 2.8 tp -53.66 -49.68 67.42 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.888 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.49 -44.47 97.96 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.79 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 432' ' ' TYR . 63.8 t -58.16 -52.56 57.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 122.058 0.143 . . . . 0.0 111.011 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 434' ' ' LEU . 33.3 m -56.57 -40.92 71.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.7 -46.78 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 435' ' ' GLY . 99.1 t -55.33 -49.62 71.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.12 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.01 75.42 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.542 178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -37.9 73.2 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.734 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -70.63 -45.19 65.65 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.508 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.466 ' HB3' ' HB ' ' A' ' 403' ' ' VAL . 2.9 m-85 -68.63 -49.1 61.83 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.508 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' A' ' 445' ' ' ARG . . . -67.43 161.33 48.45 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.787 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 444' ' ' GLY . 0.0 OUTLIER -155.86 -61.01 0.11 Allowed 'General case' 0 N--CA 1.466 0.347 0 O-C-N 122.631 -0.335 . . . . 0.0 111.501 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -81.02 108.23 9.71 Favored Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.689 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.844 ' HA ' ' HB3' ' A' ' 451' ' ' ALA . 29.7 Cg_endo -64.02 -50.21 3.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.352 2.034 . . . . 0.0 112.528 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 58.2 m 43.31 43.67 4.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.859 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 26.9 t 68.42 -57.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.463 HG12 ' CD1' ' A' ' 454' ' ' ILE . 13.1 t -47.5 -55.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.844 ' HB3' ' HA ' ' A' ' 447' ' ' PRO . . . -57.57 -48.24 79.9 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.635 0.255 . . . . 0.0 110.976 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 456' ' ' VAL . 12.6 m -56.21 -53.59 55.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.665 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 457' ' ' VAL . 42.8 t -56.24 -54.51 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.664 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.463 ' CD1' HG12 ' A' ' 450' ' ' VAL . 52.3 mt -52.63 -52.2 28.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.578 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -55.72 -53.41 56.98 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.396 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 452' ' ' THR . 44.8 t -51.88 -52.34 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.516 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 453' ' ' VAL . 86.2 t -49.73 -52.75 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.672 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 1.2 p -60.75 -41.25 95.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.762 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -61.12 -41.23 96.32 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.807 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -73.03 -42.16 63.46 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.478 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.599 HD11 HD22 ' A' ' 479' ' ' LEU . 3.6 tt -59.18 -46.56 88.09 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.769 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -101.17 -167.23 1.4 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.114 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -169.25 41.12 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 3.8 mt 48.75 70.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.571 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -44.1 100.87 0.24 Allowed Pre-proline 0 N--CA 1.47 0.528 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.7 -55.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.097 2.531 . . . . 0.0 112.687 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -132.76 -58.65 0.92 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.732 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . -132.41 124.26 3.83 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 18.3 m -98.81 -75.9 0.55 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.801 0.3 . . . . 0.0 111.362 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.48 159.65 0.43 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.647 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . -70.86 121.61 18.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.174 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 424' ' ' ASP . 14.9 t -53.21 -57.8 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 33.5 t 54.53 -150.39 0.4 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.057 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -83.38 -42.83 16.59 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 33.3 t -56.0 -59.77 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -40.79 95.9 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.16 -51.35 54.85 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.531 0.205 . . . . 0.0 110.849 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.79 -51.86 67.28 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.829 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . 0.599 HD22 HD11 ' A' ' 461' ' ' LEU . 0.8 OUTLIER -56.18 -53.67 54.32 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.642 0.258 . . . . 0.0 110.378 179.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . 0.458 HG22 ' SD ' ' A' ' 484' ' ' MET . 42.8 m -54.29 -48.65 71.03 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.776 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . 0.593 ' CE1' HD13 ' A' ' 485' ' ' LEU . 9.5 t80 -61.3 -47.38 86.21 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 110.979 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.57 73.55 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.267 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.637 ' O ' HG23 ' A' ' 487' ' ' VAL . 31.3 m -64.13 -42.25 94.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . 0.458 ' SD ' HG22 ' A' ' 480' ' ' THR . 22.3 mtt -57.74 -52.82 63.89 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.336 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.593 HD13 ' CE1' ' A' ' 481' ' ' PHE . 0.4 OUTLIER -58.33 -47.02 85.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.21 178.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 28.0 m -56.09 -50.21 71.67 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.197 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.831 HG12 HD11 ' A' ' 491' ' ' ILE . 84.7 t -59.64 -52.77 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.005 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' A' ' 491' ' ' ILE . . . -52.91 -44.47 61.6 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.692 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 7.1 tt -55.43 -56.49 19.55 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 487' ' ' VAL . 30.0 m -61.07 -37.39 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.561 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.831 HD11 HG12 ' A' ' 487' ' ' VAL . 62.8 mt -59.61 -44.96 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.25 -51.4 50.01 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.34 -46.34 72.9 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 110.1 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.644 HD21 ' HB ' ' A' ' 399' ' ' ILE . 16.2 tp -64.81 -44.9 88.39 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.901 178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 98.0 m -52.1 -51.29 58.69 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -58.68 -48.2 81.9 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.236 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -60.5 -50.84 63.23 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.056 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.758 HG21 ' HA ' ' A' ' 398' ' ' GLN . 7.0 p -73.1 -40.43 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.89 49.63 1.77 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.083 0.468 . . . . 0.0 111.205 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -131.79 -49.78 0.96 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.62 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -105.42 -171.75 1.97 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.53 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.088 -0.958 . . . . 0.0 111.423 179.95 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 120.398 0.142 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.642 HG11 HG23 ' A' ' 498' ' ' VAL . 90.2 t -150.44 109.98 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 120.732 0.301 . . . . 0.0 111.13 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -99.22 52.03 0.95 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.971 0.415 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 3.4 tp -167.09 144.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.202 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.723 ' NE2' HG11 ' A' ' 450' ' ' VAL . 3.5 mm-40 52.2 50.67 17.93 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.942 0.401 . . . . 0.0 111.331 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -159.28 -98.96 0.15 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.031 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 4.8 m -45.72 -54.17 8.28 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.412 HG13 ' N ' ' A' ' 404' ' ' VAL . 14.8 p -57.02 -44.62 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.992 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.582 HG11 ' CD2' ' A' ' 494' ' ' LEU . 71.8 t -59.4 -51.8 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.478 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.21 -55.84 29.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.896 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -55.14 -47.67 74.75 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.896 0.379 . . . . 0.0 110.534 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.459 ' CB ' HG21 ' A' ' 439' ' ' VAL . . . -56.41 -60.24 3.81 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.377 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -51.65 67.04 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.292 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 3.2 m -55.59 -53.4 56.89 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.567 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -61.97 -49.13 77.32 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.598 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.583 HG13 HD13 ' A' ' 415' ' ' ILE . 35.2 t -60.6 -57.52 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.605 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . . . . . . . . . 10.2 tp -55.0 -42.55 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 46.4 m -61.47 -56.59 18.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.047 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.41 -50.04 75.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.812 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.583 HD13 HG13 ' A' ' 411' ' ' VAL . 1.1 mp -55.69 -53.04 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.531 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 420' ' ' LEU . . . -57.66 -53.99 51.95 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.702 -0.227 . . . . 0.0 111.109 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 26.5 mtp -56.88 -54.95 40.7 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -51.92 61.13 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . 0.542 ' CD2' HG23 ' A' ' 415' ' ' ILE . 43.7 m0 -57.65 -33.0 67.84 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.148 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 416' ' ' ALA . 3.7 tp -57.26 -29.51 63.88 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.568 0.223 . . . . 0.0 110.904 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 2.8 ttp -97.39 -45.66 6.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.054 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 419' ' ' TRP . . . -131.18 116.74 18.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.643 0.259 . . . . 0.0 111.267 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -86.24 44.87 1.17 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -126.34 152.75 45.81 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.932 0.396 . . . . 0.0 111.286 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.563 ' HB3' ' H ' ' A' ' 465' ' ' ALA . . . -131.44 28.11 4.68 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.805 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . 0.653 ' HA ' HG23 ' A' ' 464' ' ' ILE . . . -86.6 -52.32 5.62 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.797 0.332 . . . . 0.0 110.641 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -74.27 -35.34 63.75 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.665 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.11 101.93 3.43 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.533 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 430' ' ' MET . 5.3 p -131.32 -52.9 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.578 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.446 ' N ' HG13 ' A' ' 429' ' ' VAL . 1.4 mmt -51.2 -47.19 62.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.611 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 1.5 mt -58.5 -58.75 7.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.339 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.56 ' HE1' HD11 ' A' ' 415' ' ' ILE . 33.7 m-85 -51.72 -51.51 55.55 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.796 0.331 . . . . 0.0 110.456 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.05 -58.17 9.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.624 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 1.7 mp -49.11 -51.39 32.21 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.371 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.47 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -63.43 -59.7 8.48 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.894 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 38.3 t -52.35 -50.71 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.25 -56.87 14.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 24.2 t -53.58 -50.91 47.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.566 0.222 . . . . 0.0 110.903 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 435' ' ' GLY . 75.0 t -56.38 -55.01 21.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.883 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.493 ' HB1' HD21 ' A' ' 455' ' ' ASN . . . -53.93 -50.1 67.19 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.086 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -54.26 48.66 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.221 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -32.1 67.51 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.776 0.322 . . . . 0.0 111.06 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.51 ' CE1' ' HG2' ' A' ' 400' ' ' GLN . 14.1 t80 -84.43 -1.38 55.53 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.447 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -70.18 -169.17 7.53 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.322 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 63.81 44.68 4.79 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.836 0.351 . . . . 0.0 111.35 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 22.0 t-105 -164.7 133.9 2.82 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.629 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -87.04 122.41 1.85 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.844 2.363 . . . . 0.0 112.62 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 28.5 t -176.2 171.4 2.5 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.137 0.494 . . . . 0.0 111.873 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 26.3 t -89.14 -21.28 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.563 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.723 HG11 ' NE2' ' A' ' 400' ' ' GLN . 93.3 t -62.94 -58.02 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.838 -0.165 . . . . 0.0 111.376 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . . . . . . . . . . . -53.05 -44.04 67.12 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.629 0.252 . . . . 0.0 111.192 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -61.23 2.7 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.744 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 41.9 t -53.73 -45.54 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.71 0.29 . . . . 0.0 110.788 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 16.2 mm -58.91 -55.2 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.23 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . 0.493 HD21 ' HB1' ' A' ' 440' ' ' ALA . 2.5 m-80 -56.35 -49.29 74.83 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 77.1 t -58.95 -57.29 11.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 120.609 0.242 . . . . 0.0 110.843 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 461' ' ' LEU . 17.5 t -55.4 -49.77 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.02 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . . . . . . . . . 59.5 p -58.33 -47.9 82.25 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.589 0.233 . . . . 0.0 110.949 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -60.8 -58.82 6.82 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.41 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.17 -45.01 92.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.619 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -63.57 -33.64 76.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.279 179.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . 0.413 ' CZ ' HG23 ' A' ' 429' ' ' VAL . 2.4 t80 -70.46 59.96 0.2 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.032 0.444 . . . . 0.0 111.098 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.5 32.4 4.84 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.503 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.653 HG23 ' HA ' ' A' ' 426' ' ' ALA . 55.4 mt 69.28 104.06 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.987 0.422 . . . . 0.0 111.929 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.563 ' H ' ' HB3' ' A' ' 425' ' ' ALA . . . -64.61 144.43 98.72 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.9 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.81 171.45 10.99 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.594 2.196 . . . . 0.0 113.128 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -64.71 78.47 0.04 OUTLIER 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.893 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 142.89 62.26 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.709 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 5.0 t -107.52 40.76 1.63 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.987 0.422 . . . . 0.0 111.438 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 16.9 tp -153.31 80.49 1.18 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.58 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . 51.01 44.8 28.44 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.054 0.454 . . . . 0.0 111.872 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . 0.512 HG12 ' HB2' ' A' ' 476' ' ' GLN . 8.0 p -78.07 -35.23 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.167 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 37.4 t -177.71 -163.22 0.07 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.5 0.191 . . . . 0.0 111.063 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -43.1 -57.2 3.02 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.875 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 476' ' ' GLN . 7.3 p -47.87 -50.98 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.512 ' HB2' HG12 ' A' ' 472' ' ' VAL . 0.8 OUTLIER -69.0 -37.36 78.66 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.834 -0.166 . . . . 0.0 111.357 179.675 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -60.47 -47.85 84.34 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 5.4 mp -66.96 -47.33 71.95 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.116 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . 0.408 HD13 HG22 ' A' ' 475' ' ' VAL . 0.1 OUTLIER -54.8 -47.15 74.36 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.622 178.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 12.1 m -64.18 -51.75 62.26 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -56.74 -44.16 81.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.582 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.76 -53.22 60.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.369 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 487' ' ' VAL . 35.0 m -63.19 -43.0 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.061 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 6.8 mtt -60.7 -56.1 25.26 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.676 0.274 . . . . 0.0 110.766 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 9.7 tp -55.43 -44.67 76.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.397 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 490' ' ' VAL . 35.7 m -60.01 -52.81 63.78 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.4 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 483' ' ' VAL . 69.8 t -56.27 -48.76 79.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.716 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -60.7 -51.67 57.21 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.381 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -46.95 80.7 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.742 0.306 . . . . 0.0 110.859 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 486' ' ' THR . 96.1 t -64.4 -54.75 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.573 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.546 HD12 HD21 ' A' ' 494' ' ' LEU . 4.7 tp -55.68 -41.38 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 120.474 0.178 . . . . 0.0 111.208 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.69 -54.78 29.0 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.476 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -63.2 -43.42 98.23 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 400' ' ' GLN . 0.5 OUTLIER -61.81 -46.03 91.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 121.413 -0.115 . . . . 0.0 111.298 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 1.2 m -65.58 -40.79 93.15 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.521 0.201 . . . . 0.0 110.719 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -70.22 -37.33 74.99 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.697 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -79.43 -42.86 11.06 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.589 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.642 HG23 HG11 ' A' ' 397' ' ' VAL . 9.9 p -53.25 -31.84 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 117.033 0.417 . . . . 0.0 111.829 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 502' ' ' ALA . 15.4 ttm105 -104.16 123.97 48.26 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.874 0.368 . . . . 0.0 110.559 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 501' ' ' GLN . 0.2 OUTLIER -52.47 104.77 0.1 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.492 -179.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.532 ' O ' ' HB3' ' A' ' 502' ' ' ALA . 2.8 mp0 68.74 38.13 2.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.335 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 501' ' ' GLN . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 117.833 -1.079 . . . . 0.0 112.15 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 111.367 0.136 . . . . 0.0 111.367 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . 0.527 HG12 HG21 ' A' ' 403' ' ' VAL . 6.1 m -79.22 65.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.198 0.523 . . . . 0.0 110.959 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.47 166.91 14.02 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.553 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.514 ' CG1' ' HB2' ' A' ' 446' ' ' TRP . 2.9 mp -53.88 100.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.878 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.747 ' HA ' HG21 ' A' ' 404' ' ' VAL . 2.8 mm100 70.53 87.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.404 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -151.94 -150.16 5.28 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.824 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 29.0 t -53.01 -49.63 65.83 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.482 0.182 . . . . 0.0 111.304 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.527 HG21 HG12 ' A' ' 397' ' ' VAL . 39.7 t -54.74 -49.45 68.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 110.19 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.747 HG21 ' HA ' ' A' ' 400' ' ' GLN . 54.2 t -58.85 -46.73 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.079 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.281 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.65 77.7 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.884 0.374 . . . . 0.0 110.173 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.96 67.8 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.505 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.632 ' HB1' HG13 ' A' ' 439' ' ' VAL . . . -55.75 -48.73 74.75 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.254 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.568 HD23 HD11 ' A' ' 412' ' ' ILE . 0.1 OUTLIER -56.22 -47.84 77.63 Favored 'General case' 0 C--O 1.23 0.056 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.722 178.556 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 4.6 t -52.78 -43.0 65.54 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.155 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.4 71.8 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.836 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.669 ' CG2' HG21 ' A' ' 439' ' ' VAL . 97.3 t -58.75 -50.59 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.914 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.568 HD11 HD23 ' A' ' 408' ' ' LEU . 27.2 mt -57.03 -45.61 83.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.231 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 41.3 m -60.38 -49.11 78.87 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.127 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 1.8 mt -58.14 -53.09 62.23 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.295 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.16 -45.97 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.893 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -54.73 -54.07 46.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.665 0.269 . . . . 0.0 110.387 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 2.2 ttm -61.89 -42.91 99.64 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.524 ' HG2' ' HG ' ' A' ' 428' ' ' LEU . 0.5 OUTLIER -60.1 -28.47 67.86 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.544 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -40.41 12.25 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.566 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 421' ' ' MET . 1.6 tt -73.78 87.09 1.72 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.96 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . 0.416 ' CB ' ' O ' ' A' ' 420' ' ' LEU . 1.5 ttt 83.11 158.97 0.12 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.701 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . . . . . . . . . . . 54.04 59.86 3.98 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.17 0.51 . . . . 0.0 110.587 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . 0.402 ' O ' ' HB3' ' A' ' 424' ' ' ASP . 0.8 OUTLIER -63.31 173.23 1.6 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.501 -178.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.849 ' HA ' HG21 ' A' ' 469' ' ' THR . 49.9 t0 85.27 126.48 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.523 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.638 ' HB3' ' CA ' ' A' ' 466' ' ' PRO . . . -88.51 -14.55 37.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.584 179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -38.58 -56.13 1.34 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.71 0.29 . . . . 0.0 111.647 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -92.75 -39.38 11.28 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.802 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.524 ' HG ' ' HG2' ' A' ' 418' ' ' GLN . 4.5 mm? -60.12 -36.36 77.29 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.507 HG22 HD23 ' A' ' 433' ' ' LEU . 9.1 p -47.33 -35.67 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.64 -52.32 40.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.137 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.78 -45.82 77.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.834 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.609 ' O ' HG23 ' A' ' 436' ' ' VAL . 0.6 OUTLIER -55.2 -50.17 70.05 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.193 178.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.77 HD21 ' HB2' ' A' ' 462' ' ' PHE . 0.6 OUTLIER -60.95 -49.71 76.34 Favored 'General case' 0 N--CA 1.46 0.032 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.008 178.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 1.7 tt -51.99 -46.23 64.8 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.77 68.71 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.728 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.842 HG11 ' HB3' ' A' ' 458' ' ' SER . 91.3 t -56.67 -39.81 65.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.776 0.322 . . . . 0.0 110.5 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 433' ' ' LEU . 53.6 t -61.05 -57.02 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.675 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 30.2 m -59.23 -39.4 78.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 120.748 0.309 . . . . 0.0 110.397 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.669 HG21 ' CG2' ' A' ' 411' ' ' VAL . 4.0 t -59.43 -58.75 5.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.138 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -56.37 -42.78 78.39 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.612 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 2.7 tp -51.35 -52.68 43.48 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.556 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -71.61 -36.74 70.9 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.964 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.515 ' CE2' HG22 ' A' ' 404' ' ' VAL . 1.6 t80 -63.09 -38.13 89.96 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 445' ' ' ARG . . . -47.92 104.77 0.09 OUTLIER Glycine 0 C--N 1.339 0.728 0 CA-C-N 116.366 -0.379 . . . . 0.0 113.477 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 444' ' ' GLY . 0.1 OUTLIER -144.72 -66.24 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.621 0.248 . . . . 0.0 110.908 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . 0.514 ' HB2' ' CG1' ' A' ' 399' ' ' ILE . 0.6 OUTLIER -127.26 125.12 23.95 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.633 179.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.27 87.78 1.03 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.488 2.125 . . . . 0.0 112.554 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 449' ' ' VAL . 91.0 p -108.24 -93.47 0.41 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.356 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.408 ' N ' ' OG ' ' A' ' 448' ' ' SER . 3.4 p -146.16 -49.07 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 451' ' ' ALA . 1.5 m -46.18 -54.16 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.599 0.238 . . . . 0.0 111.337 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.419 ' H ' HG23 ' A' ' 450' ' ' VAL . . . -57.28 -41.44 79.73 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.887 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.06 -52.97 61.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.393 179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 69.8 t -54.29 -50.1 58.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.68 -47.23 86.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.082 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -55.87 -49.7 72.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.433 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.97 -56.73 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.332 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.31 -41.7 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.891 0.377 . . . . 0.0 110.763 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . 0.842 ' HB3' HG11 ' A' ' 436' ' ' VAL . 19.3 m -65.58 -48.91 70.74 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.651 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.66 -48.67 80.28 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.132 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . 0.839 ' HB3' HD12 ' A' ' 464' ' ' ILE . 2.6 m-20 -60.41 -54.97 39.22 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.015 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.681 ' HG ' ' HB2' ' A' ' 465' ' ' ALA . 0.5 OUTLIER -53.8 -45.58 70.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.542 179.438 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . 0.77 ' HB2' HD21 ' A' ' 433' ' ' LEU . 0.1 OUTLIER -38.84 -40.54 0.64 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.44 0.296 . . . . 0.0 111.307 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -105.03 -44.17 4.86 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.839 HD12 ' HB3' ' A' ' 460' ' ' ASP . 81.4 mt -59.25 -32.52 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.681 ' HB2' ' HG ' ' A' ' 461' ' ' LEU . . . -67.98 -62.15 3.53 Favored Pre-proline 0 CA--C 1.535 0.372 0 O-C-N 122.272 -0.268 . . . . 0.0 111.195 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.638 ' CA ' ' HB3' ' A' ' 425' ' ' ALA . 37.5 Cg_endo -64.88 -39.8 23.87 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.468 2.112 . . . . 0.0 112.307 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -85.95 62.61 7.55 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.104 0.478 . . . . 0.0 111.201 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 138.26 42.95 0.09 OUTLIER Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.336 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . 0.849 HG21 ' HA ' ' A' ' 424' ' ' ASP . 2.0 t -79.94 -31.17 40.02 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.32 72.6 0.67 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.278 0.561 . . . . 0.0 110.819 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 476' ' ' GLN . . . -84.57 126.67 33.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.948 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 472' ' ' VAL . 13.2 p -75.38 56.12 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.438 0.637 . . . . 0.0 111.731 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 30.9 m 53.16 35.75 20.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -138.05 -79.46 0.36 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.881 -0.145 . . . . 0.0 111.235 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.435 HG23 ' CB ' ' A' ' 471' ' ' ALA . 15.3 m -47.99 -45.16 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 471' ' ' ALA . 0.0 OUTLIER -62.63 -32.87 73.98 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.537 0.208 . . . . 0.0 110.716 179.257 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -47.51 55.78 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 4.6 tt -59.15 -48.97 79.64 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.977 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . 0.461 HD13 HG23 ' A' ' 483' ' ' VAL . 0.6 OUTLIER -59.03 -49.39 78.06 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.844 178.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 87.7 m -55.98 -44.0 78.11 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.914 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -56.42 -49.12 75.45 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -59.75 -43.56 94.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.475 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.461 HG23 HD13 ' A' ' 479' ' ' LEU . 69.5 t -60.48 -50.1 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.376 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 34.9 mtp -59.3 -52.37 65.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.359 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -47.42 73.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.936 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . . . . . . . . . 34.7 m -58.83 -50.8 72.62 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.049 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 24.4 t -55.06 -52.65 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.784 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . . . . . . . . . . . -58.44 -47.83 87.56 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.054 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.26 -51.24 70.8 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.375 0.131 . . . . 0.0 110.92 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.461 HG21 HD11 ' A' ' 408' ' ' LEU . 25.8 m -63.21 -39.37 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 121.164 -0.215 . . . . 0.0 111.011 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 494' ' ' LEU . 26.1 mt -56.5 -50.77 71.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 120.966 0.412 . . . . 0.0 110.194 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -66.98 -45.45 82.96 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.363 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -54.3 -52.31 61.89 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.155 0.182 . . . . 0.0 111.082 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.645 ' HA ' ' HB3' ' A' ' 400' ' ' GLN . 4.5 pp -64.15 -39.79 94.77 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.526 ' N ' HD12 ' A' ' 494' ' ' LEU . 91.6 m -57.81 -43.99 86.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.164 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -73.74 -56.66 4.72 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.037 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -50.48 -42.65 43.73 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.342 -0.456 . . . . 0.0 113.338 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 4.9 p -69.38 -10.49 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.38 104.18 14.65 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.563 0.221 . . . . 0.0 110.777 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.1 t80 79.63 166.59 0.19 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.45 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.39 -52.11 4.29 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.008 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.14 -0.933 . . . . 0.0 111.08 179.992 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 2.4 tpt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.511 0.195 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.41 142.68 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -140.16 142.54 35.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.367 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 7.5 tp -150.73 139.57 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.16 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.539 ' HA ' HG21 ' A' ' 404' ' ' VAL . 43.5 tt0 -59.82 136.45 58.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.066 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.409 ' H ' ' HB ' ' A' ' 404' ' ' VAL . . . 132.44 -101.88 0.47 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.878 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 12.7 t -58.74 -72.19 0.1 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . 0.51 ' HB ' ' CD2' ' A' ' 441' ' ' LEU . 34.1 m -48.03 -43.75 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 120.554 0.216 . . . . 0.0 111.525 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.539 HG21 ' HA ' ' A' ' 400' ' ' GLN . 76.9 t -60.76 -54.57 33.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.812 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.11 -45.14 83.68 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.21 65.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.509 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.937 ' HB1' HG22 ' A' ' 438' ' ' VAL . . . -55.76 -55.69 29.36 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.604 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.477 HD11 HG21 ' A' ' 487' ' ' VAL . 2.0 tt -57.62 -44.23 85.38 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.458 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.425 ' O ' HG22 ' A' ' 412' ' ' ILE . 35.8 t -52.61 -44.61 66.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.641 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -64.33 -46.77 82.05 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.276 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.837 ' CG2' HG21 ' A' ' 438' ' ' VAL . 75.5 t -59.13 -52.25 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.523 ' HA ' HG22 ' A' ' 415' ' ' ILE . 0.4 OUTLIER -59.25 -41.73 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.384 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 59.8 m -63.28 -45.48 91.25 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.523 HD22 HD22 ' A' ' 434' ' ' LEU . 0.9 OUTLIER -59.5 -57.04 14.7 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.235 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 412' ' ' ILE . 18.4 tt -56.99 -39.82 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.263 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.31 75.08 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 32.3 mtt -60.09 -45.28 93.46 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.763 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.421 ' OE1' ' HA ' ' A' ' 415' ' ' ILE . 98.9 mt-30 -54.74 -57.18 12.54 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . 0.456 ' HB2' ' CD2' ' A' ' 423' ' ' PHE . 0.1 OUTLIER -48.29 -45.45 34.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.226 178.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.5 tp -53.28 -32.19 47.44 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.87 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . 0.584 ' O ' ' HB3' ' A' ' 422' ' ' ALA . 0.8 OUTLIER -120.7 42.72 2.94 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.929 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 421' ' ' MET . . . 99.64 110.29 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.657 0.783 . . . . 0.0 111.706 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' A' ' 419' ' ' TRP . 5.5 t80 -70.64 98.41 1.49 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.417 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -159.96 158.08 30.03 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.208 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.605 ' HA ' HD13 ' A' ' 431' ' ' LEU . . . -72.86 65.29 0.72 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.081 0.467 . . . . 0.0 111.174 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . -54.1 127.99 28.92 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.592 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 57.36 75.3 0.38 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.515 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.791 ' HG ' HG23 ' A' ' 464' ' ' ILE . 0.9 OUTLIER -45.57 -49.12 14.26 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.438 -179.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 96.3 t -53.36 -51.35 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.694 0.283 . . . . 0.0 110.35 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . . . . . . . . . 7.1 ttt -65.4 -49.14 70.35 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.41 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.605 HD13 ' HA ' ' A' ' 425' ' ' ALA . 0.6 OUTLIER -58.31 -46.68 85.7 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.594 ' CE2' HG11 ' A' ' 436' ' ' VAL . 2.1 t80 -60.66 -51.13 70.68 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 9.2 tt -54.74 -51.13 66.62 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.307 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . 0.523 HD22 HD22 ' A' ' 414' ' ' LEU . 2.1 tp -58.36 -47.5 83.59 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.637 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.5 -58.65 12.23 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.859 -0.61 . . . . 0.0 113.072 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . 0.594 HG11 ' CE2' ' A' ' 432' ' ' TYR . 35.4 m -53.92 -42.93 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.811 0.305 . . . . 0.0 111.684 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.576 ' O ' HD12 ' A' ' 441' ' ' LEU . 28.9 t -61.44 -57.54 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 120.536 0.207 . . . . 0.0 110.676 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . 0.937 HG22 ' HB1' ' A' ' 407' ' ' ALA . 99.4 t -56.62 -49.64 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.999 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.744 HG11 ' HB2' ' A' ' 458' ' ' SER . 73.1 t -57.25 -48.34 82.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.107 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -55.08 -48.21 73.85 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.576 HD12 ' O ' ' A' ' 437' ' ' VAL . 0.2 OUTLIER -58.04 -42.83 86.2 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.176 177.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . 0.67 ' CD1' HD13 ' A' ' 454' ' ' ILE . 0.2 OUTLIER -63.84 -41.5 97.81 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.211 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 445' ' ' ARG . 22.4 t80 -77.35 -37.9 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.191 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -63.92 67.87 0.05 OUTLIER Glycine 0 C--N 1.338 0.666 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.34 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 400' ' ' GLN . 0.0 OUTLIER -140.43 -55.22 0.52 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.594 0.235 . . . . 0.0 110.962 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . 0.501 ' CD2' ' HD2' ' A' ' 447' ' ' PRO . 0.0 OUTLIER 175.34 139.14 0.19 Allowed Pre-proline 0 C--O 1.237 0.423 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.156 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.501 ' HD2' ' CD2' ' A' ' 446' ' ' TRP . 36.5 Cg_endo -64.12 67.88 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.592 2.195 . . . . 0.0 112.343 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.491 ' OG ' ' NH2' ' A' ' 445' ' ' ARG . 0.8 OUTLIER -104.39 42.28 1.22 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.518 -179.311 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 453' ' ' VAL . 50.6 t 67.27 -64.3 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.928 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.7 m -50.81 -47.9 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 454' ' ' ILE . . . -54.22 -53.3 55.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.928 0.394 . . . . 0.0 110.393 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 456' ' ' VAL . 0.6 OUTLIER -56.03 -48.74 75.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.611 178.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 449' ' ' VAL . 84.6 t -53.71 -46.42 62.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.464 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.67 HD13 ' CD1' ' A' ' 442' ' ' PHE . 34.5 mt -55.75 -45.27 79.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -61.72 -45.66 93.01 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 452' ' ' THR . 58.0 t -53.36 -50.93 45.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.02 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . . . . . . . . . 74.6 t -53.08 -50.31 46.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . 0.744 ' HB2' HG11 ' A' ' 439' ' ' VAL . 1.4 t -55.06 -43.11 73.54 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.737 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.49 -45.91 92.23 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.23 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.67 -37.72 68.68 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.285 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.418 HD13 ' HD2' ' A' ' 466' ' ' PRO . 0.1 OUTLIER -83.25 -22.45 33.05 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.366 179.281 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -66.58 70.71 0.07 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 111.838 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -162.5 42.98 0.13 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.955 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.791 HG23 ' HG ' ' A' ' 428' ' ' LEU . 34.0 mt 45.23 64.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.429 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . 54.41 63.67 7.09 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-O 120.995 0.426 . . . . 0.0 110.706 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . 0.418 ' HD2' HD13 ' A' ' 461' ' ' LEU . 10.8 Cg_endo -53.6 -52.84 7.63 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.893 2.395 . . . . 0.0 113.381 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . 0.49 ' O ' ' HD2' ' A' ' 467' ' ' ARG . 0.0 OUTLIER -167.79 72.13 0.11 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.94 0.4 . . . . 0.0 111.599 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . -178.38 44.34 0.09 OUTLIER Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.294 -0.955 . . . . 0.0 114.04 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.3 p -143.88 99.24 3.37 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 117.105 0.453 . . . . 0.0 110.948 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.05 147.17 17.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.079 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . 0.444 ' HA ' ' HB3' ' A' ' 423' ' ' PHE . . . -64.17 -46.51 83.72 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.449 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . . . . . . . . . 3.0 m -115.49 94.7 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 120.898 0.38 . . . . 0.0 111.15 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 46.5 t -149.93 99.19 2.81 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.691 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . 0.451 ' O ' HD12 ' A' ' 478' ' ' LEU . 3.9 m-20 -55.05 -47.67 74.49 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.571 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 476' ' ' GLN . 11.6 p -51.89 -44.05 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.087 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.403 ' N ' HG13 ' A' ' 475' ' ' VAL . 0.6 OUTLIER -66.5 -44.35 82.84 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -56.17 -58.14 9.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.086 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 474' ' ' ASP . 1.5 mp -59.66 -51.45 69.74 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.047 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 483' ' ' VAL . 7.4 tt -55.47 -58.22 8.65 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.732 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . 0.402 ' N ' HD23 ' A' ' 479' ' ' LEU . 3.1 m -54.45 -41.83 69.89 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.574 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -56.45 -47.87 78.23 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.86 94.24 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.275 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 479' ' ' LEU . 39.2 t -63.14 -47.04 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.021 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -59.81 -51.54 69.31 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 tt -54.77 -45.06 74.17 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 490' ' ' VAL . 70.6 m -58.99 -49.25 78.6 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.993 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . 0.477 HG21 HD11 ' A' ' 408' ' ' LEU . 18.2 t -52.21 -51.5 30.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.119 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . 0.481 ' O ' HG13 ' A' ' 491' ' ' ILE . . . -55.75 -45.59 85.12 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.858 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.03 -46.07 92.2 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 110.353 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 486' ' ' THR . 94.9 t -61.55 -56.52 17.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.007 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 488' ' ' GLY . 2.5 pp -58.83 -37.02 64.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.692 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.43 -59.22 8.03 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -53.8 -46.41 71.06 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.68 HD13 ' C ' ' A' ' 494' ' ' LEU . 1.3 tm? -55.33 -46.66 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.703 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . . . . . . . . . 99.2 m -54.33 -50.01 68.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.228 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.42 77.65 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.358 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 501' ' ' GLN . . . -54.52 -50.6 56.43 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.218 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.542 HG23 HD22 ' A' ' 494' ' ' LEU . 66.9 t -64.89 -35.34 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.76 0.314 . . . . 0.0 110.664 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . 0.489 ' HD2' ' HB2' ' A' ' 500' ' ' TYR . 7.0 tmm_? -62.06 -51.39 68.18 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.132 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . 0.489 ' HB2' ' HD2' ' A' ' 499' ' ' ARG . 11.3 t80 -174.98 70.15 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.721 0.296 . . . . 0.0 111.678 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.458 ' O ' ' HA2' ' A' ' 497' ' ' GLY . 58.4 mt-30 68.54 -56.36 0.51 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.829 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.681 -0.675 . . . . 0.0 111.341 179.93 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.572 0.225 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.91 131.78 67.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.833 0.349 . . . . 0.0 111.374 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -171.89 1.92 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.468 HG22 HG22 ' A' ' 498' ' ' VAL . 1.0 OUTLIER -76.61 -167.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . 0.966 ' HG2' HG21 ' A' ' 404' ' ' VAL . 3.6 tt0 -60.29 93.89 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.958 -0.464 . . . . 0.0 111.228 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.861 ' HA3' HG21 ' A' ' 498' ' ' VAL . . . -156.82 -120.84 0.66 Allowed Glycine 0 C--N 1.333 0.393 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.269 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 67.0 m -50.74 -46.2 59.12 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.764 0.282 . . . . 0.0 111.256 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' VAL . . . . . . . . . . . . . 15.9 m -55.88 -41.42 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.945 0.402 . . . . 0.0 110.963 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' VAL . . . . . 0.966 HG21 ' HG2' ' A' ' 400' ' ' GLN . 58.9 t -73.44 -43.62 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.796 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.14 -47.53 80.92 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.78 -48.33 81.12 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.163 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . 0.768 ' HB1' HG22 ' A' ' 439' ' ' VAL . . . -54.83 -50.71 67.93 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.465 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -49.84 76.07 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.23 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 412' ' ' ILE . 0.3 OUTLIER -56.73 -40.09 75.09 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.147 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' ALA . . . . . . . . . . . . . . . -66.71 -54.77 19.47 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.612 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 407' ' ' ALA . 55.9 t -55.69 -48.38 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.057 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 409' ' ' SER . 0.3 OUTLIER -60.46 -42.32 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.422 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' THR . . . . . . . . . . . . . 91.2 m -61.48 -45.52 93.9 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.751 ' HB3' HD11 ' A' ' 431' ' ' LEU . 20.6 mt -60.21 -57.2 13.81 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.546 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.643 HG13 HD21 ' A' ' 428' ' ' LEU . 16.2 tt -57.76 -39.93 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.953 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -62.81 -51.56 66.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.812 0.339 . . . . 0.0 110.305 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' MET . . . . . . . . . . . . . 20.9 mtp -58.46 -47.34 84.34 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.545 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.63 -46.1 89.79 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.834 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' TRP . . . . . 0.478 ' HA ' ' O ' ' A' ' 422' ' ' ALA . 1.2 m0 -57.35 -38.89 74.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.52 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.42 -28.1 58.44 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.983 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -44.63 6.44 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.776 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 419' ' ' TRP . . . -125.97 138.14 53.73 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.845 0.355 . . . . 0.0 111.601 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.81 162.24 24.12 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 60.66 -91.48 0.03 OUTLIER 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.473 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.578 ' HB1' ' HB2' ' A' ' 428' ' ' LEU . . . -151.03 -74.64 0.15 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' ALA . . . . . . . . . . . . . . . 67.08 -68.12 0.15 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.636 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -115.39 13.98 16.65 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.643 HD21 HG13 ' A' ' 415' ' ' ILE . 0.1 OUTLIER -64.45 -32.72 74.47 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.492 0.187 . . . . 0.0 111.281 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 430' ' ' MET . 4.0 p -44.91 -51.12 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.697 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.426 ' N ' HG13 ' A' ' 429' ' ' VAL . 4.7 mtm -66.73 -47.22 72.97 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.779 0.323 . . . . 0.0 110.365 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.751 HD11 ' HB3' ' A' ' 414' ' ' LEU . 0.5 OUTLIER -55.65 -51.45 67.18 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.388 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' TYR . . . . . 0.499 ' OH ' ' HB2' ' A' ' 458' ' ' SER . 44.0 t80 -59.15 -44.59 92.11 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.163 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 437' ' ' VAL . 0.5 OUTLIER -55.83 -54.21 47.3 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' LEU . . . . . . . . . . . . . 6.1 mt -57.48 -42.38 82.53 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.187 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 439' ' ' VAL . . . -61.15 -58.43 13.57 Favored Glycine 0 C--N 1.338 0.685 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.479 179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' VAL . . . . . . . . . . . . . 32.8 m -53.99 -34.67 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.784 0.292 . . . . 0.0 110.607 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 433' ' ' LEU . 54.3 t -63.26 -51.25 73.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.14 -46.4 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.373 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.768 HG22 ' HB1' ' A' ' 407' ' ' ALA . 15.1 t -60.46 -46.11 95.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.135 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.76 76.39 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.127 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.34 -46.57 69.54 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -63.67 -38.52 91.42 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.45 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' TYR . . . . . 0.742 ' CE1' HG22 ' A' ' 404' ' ' VAL . 5.6 m-85 -74.13 -17.82 60.88 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.79 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -56.76 80.32 0.01 OUTLIER Glycine 0 C--N 1.342 0.876 0 C-N-CA 121.711 -0.281 . . . . 0.0 112.96 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 443' ' ' TYR . 12.3 ttt85 -174.11 -55.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.32 0.248 . . . . 0.0 110.841 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -163.88 81.15 1.44 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.456 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -89.91 158.98 4.99 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.959 2.439 . . . . 0.0 113.075 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.0 t -129.63 178.73 6.27 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.982 0.42 . . . . 0.0 111.678 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 91.5 t -55.34 -39.29 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.964 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 9.2 m -48.14 -46.36 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.645 0.259 . . . . 0.0 111.443 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' ALA . . . . . 0.401 ' HB2' ' HE2' ' A' ' 443' ' ' TYR . . . -64.28 -45.21 89.01 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -48.54 81.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.526 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.28 -54.75 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.326 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.698 HG22 HG23 ' A' ' 486' ' ' THR . 33.2 pt -57.11 -40.54 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.787 -0.188 . . . . 0.0 111.378 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -68.01 -50.34 56.08 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.36 -52.74 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.567 HG12 HD22 ' A' ' 461' ' ' LEU . 37.6 t -55.88 -41.41 66.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.285 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' SER . . . . . 0.499 ' HB2' ' OH ' ' A' ' 432' ' ' TYR . 64.9 m -62.95 -50.45 70.77 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.19 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -55.26 -52.36 63.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.559 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.4 -53.42 58.39 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.806 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.567 HD22 HG12 ' A' ' 457' ' ' VAL . 3.9 mp -56.2 -38.71 71.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.887 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -75.09 -28.65 60.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.978 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' PHE . . . . . . . . . . . . . 1.9 t80 53.56 45.78 27.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.977 0.418 . . . . 0.0 111.524 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 464' ' ' ILE . 6.1 mm 64.54 12.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.34 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . 0.527 ' HB1' ' HB1' ' A' ' 425' ' ' ALA . . . 36.6 73.7 0.66 Allowed Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.1 161.18 27.23 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.922 2.414 . . . . 0.0 113.046 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' ARG . . . . . . . . . . . . . 8.7 mtm-85 -53.97 -35.11 61.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.552 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . -133.79 116.9 1.76 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.171 -0.537 . . . . 0.0 112.313 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 4.9 m -95.63 155.45 16.74 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.874 0.369 . . . . 0.0 110.938 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' LEU . . . . . 0.691 ' HB3' HG23 ' A' ' 472' ' ' VAL . 1.2 mp -55.16 -34.26 63.66 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ALA . . . . . . . . . . . . . . . 61.46 49.35 5.27 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.192 0.52 . . . . 0.0 111.218 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' VAL . . . . . 0.691 HG23 ' HB3' ' A' ' 470' ' ' LEU . 37.4 t -107.11 150.86 9.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.487 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 475' ' ' VAL . 6.5 t -75.6 -168.22 0.81 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.041 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 65.55 -66.63 0.15 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.744 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 473' ' ' SER . 10.5 p -57.34 -37.01 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.771 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -57.99 -39.91 79.42 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.488 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -46.7 64.15 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.01 -53.38 57.66 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.873 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.83 -43.97 90.78 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.013 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' THR . . . . . . . . . . . . . 54.7 m -54.15 -47.47 71.89 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -64.63 -46.6 81.86 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.449 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.47 78.26 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.528 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.69 -43.53 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.901 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 26.7 mtt -57.45 -51.09 70.85 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.183 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.0 tp -59.57 -45.53 91.59 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.827 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' THR . . . . . 0.698 HG23 HG22 ' A' ' 454' ' ' ILE . 88.1 m -56.11 -48.97 75.15 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.269 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.02 -51.24 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.494 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 491' ' ' ILE . . . -54.69 -47.03 72.97 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.983 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -47.34 84.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.668 0.27 . . . . 0.0 110.491 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.559 ' CG2' HG21 ' A' ' 454' ' ' ILE . 39.2 t -60.18 -52.95 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.58 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.519 ' HA ' HD21 ' A' ' 494' ' ' LEU . 9.2 tp -57.47 -42.32 80.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.84 -0.164 . . . . 0.0 110.662 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -65.8 -42.73 94.97 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -57.37 -56.25 24.25 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 122.642 0.377 . . . . 0.0 110.79 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' A' ' 491' ' ' ILE . 3.9 pp -61.88 -40.46 95.46 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.344 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' THR . . . . . 0.454 ' N ' HD12 ' A' ' 494' ' ' LEU . 45.5 m -62.88 -33.76 75.97 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.374 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' ALA . . . . . . . . . . . . . . . -83.08 -42.2 17.7 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.192 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . -63.54 -57.73 13.76 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.408 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . 0.861 HG21 ' HA3' ' A' ' 401' ' ' GLY . 2.7 t -62.83 94.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 120.868 0.366 . . . . 0.0 111.229 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 498' ' ' VAL . 3.8 ptm180 154.67 -37.22 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.942 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -70.38 63.79 0.26 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.894 0.378 . . . . 0.0 111.269 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.565 ' O ' ' HB3' ' A' ' 502' ' ' ALA . 2.4 mm-40 69.6 85.39 0.14 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.68 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 501' ' ' GLN . . . . . . . . 0 C--O 1.254 1.327 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.728 -179.477 . . . . . . . . 1 1 . 1 stop_ save_